Citrus Sinensis ID: 017395
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 372 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FHD7 | 487 | Probable serine/threonine | yes | no | 1.0 | 0.763 | 0.787 | 1e-179 | |
| Q944A7 | 512 | Probable serine/threonine | no | no | 0.897 | 0.652 | 0.664 | 1e-134 | |
| Q7XJT7 | 465 | Probable inactive recepto | no | no | 0.919 | 0.735 | 0.456 | 5e-87 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.830 | 0.753 | 0.319 | 8e-39 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.736 | 0.704 | 0.323 | 3e-37 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.744 | 0.672 | 0.324 | 1e-36 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.747 | 0.671 | 0.347 | 2e-36 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.787 | 0.741 | 0.314 | 3e-35 | |
| P43298 | 942 | Probable receptor protein | no | no | 0.741 | 0.292 | 0.319 | 9e-35 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.720 | 0.653 | 0.333 | 1e-34 |
| >sp|Q9FHD7|Y5126_ARATH Probable serine/threonine-protein kinase At5g41260 OS=Arabidopsis thaliana GN=At5g41260 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 627 bits (1617), Expect = e-179, Method: Compositional matrix adjust.
Identities = 293/372 (78%), Positives = 331/372 (88%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLV+A++ LQKD E+ SH L+G+P+ A LSPLG+ACLR DLTAIHEI+EKLGY
Sbjct: 301 PNPKSLVSAMIPLQKDLEIASHQLLGVPNSATTTALSPLGEACLRSDLTAIHEIIEKLGY 360
Query: 361 KDDEGAATEVCF 372
KDDEGA TE+ F
Sbjct: 361 KDDEGATTELSF 372
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q944A7|Y4523_ARATH Probable serine/threonine-protein kinase At4g35230 OS=Arabidopsis thaliana GN=At4g35230 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1227), Expect = e-134, Method: Compositional matrix adjust.
Identities = 226/340 (66%), Positives = 276/340 (81%), Gaps = 6/340 (1%)
Query: 38 VPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA 97
+P F E+S L+ AT+ F+ +NIVSE GEKAPN+VYKG+L+N+ IAVK+F + AWP+
Sbjct: 55 IPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMAWPEP 114
Query: 98 RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
+QF EEA VG+LR+ RLANL+G CC+GDERLLVAE+MPNDTLAKHLFHWE Q ++WAMR
Sbjct: 115 KQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIEWAMR 174
Query: 158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217
LRV +IAEAL+YC+++ R LYHDLNAYR++FD+D +PRLSCFGLMKNSRDG+SYSTNLA
Sbjct: 175 LRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYSTNLA 234
Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +NI L DS LEG+F
Sbjct: 235 YTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHLEGKF 294
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAA---- 333
S++E T +V LAS+CLQYEPRERPN + LV L LQ ++VPS+V++GI A
Sbjct: 295 STEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDVPSYVMLGIKKQEEAPSTP 354
Query: 334 -LPLSPLGDACLRMDLTAIHEILEKLGYKDDEGAATEVCF 372
PLSPLG+AC RMDLTAIH+IL Y+DDEG E+ F
Sbjct: 355 QRPLSPLGEACSRMDLTAIHQILVMTHYRDDEG-TNELSF 393
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XJT7|SSP_ARATH Probable inactive receptor-like kinase SSP OS=Arabidopsis thaliana GN=SSP PE=1 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 168/368 (45%), Positives = 239/368 (64%), Gaps = 26/368 (7%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGC C LS S D +E + G P ++S L+TAT+ F+ EN
Sbjct: 1 MGC-CYSLS-----STVDPVQDHTTDASSEPRNGGGEDPPLTKFSFSALKTATNHFSPEN 54
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVS+ + +VV+KG+L+N +A+KRFN AW D + FLEEA+ VG+LR++RL NL+G
Sbjct: 55 IVSD---QTSDVVFKGRLQNGGFVAIKRFNNMAWSDPKLFLEEAQRVGKLRHKRLVNLIG 111
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC+GD+R LVA++M NDTLAK LF + Q M W++RLRVA +AEAL+YC + A Y+
Sbjct: 112 YCCDGDKRFLVADFMANDTLAKRLFQRKYQTMDWSIRLRVAYFVAEALDYCNTAGFASYN 171
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
+L+AY+++FD+D + LSCFGLMK + + + TG V PE+V+Y FGT
Sbjct: 172 NLSAYKVLFDEDGDACLSCFGLMKEINNDQ-------------ITTGSVNPENVIYRFGT 218
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+L++LLSGK IPPSHA ++I +N+ L D L+G+FS DE + +LAS+CL+YE +E
Sbjct: 219 VLVNLLSGKQIPPSHAPEMIHRKNVFKLMDPYLKGKFSIDEANVVYKLASQCLKYEGQES 278
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPH----GAAALPLSPLGDACLRMDLTAIHEILE 356
PN + +V L TLQ TE PS+ ++ + + +++ LSPLG+ACLRMDL +IH IL
Sbjct: 279 PNTKEIVATLETLQTRTEAPSYEVVEMTNQEKDASSSSNLSPLGEACLRMDLASIHSILV 338
Query: 357 KLGYKDDE 364
GY DD+
Sbjct: 339 LAGYDDDK 346
|
Probable inactive protein kinase that activates the YODA MAP kinase cascade, regulating the asymmetric first division, and thus embryo polarity. Acts as an adapter at the plasma membrane, possibly recruiting an activator. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 111/347 (31%), Positives = 168/347 (48%), Gaps = 38/347 (10%)
Query: 3 CECSKLSACCSGSEYGEAAPEAQDVENEEKPGVD----NVPVFCEYSIETLRTATSGFAM 58
E S S + G +A V P + P +S L++AT F
Sbjct: 11 AESSGASTKYDAKDIGSLGSKASSVSVRPSPRTEGEILQSPNLKSFSFAELKSATRNFRP 70
Query: 59 ENIVSEHGEKAPNVVYKGKLENQ----------FRIAVKRFNRSAWPDARQFLEEARAVG 108
++++ GE V+KG ++ + IAVK+ N+ W +++L E +G
Sbjct: 71 DSVL---GEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLG 127
Query: 109 QLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAE 166
Q +R L L+G C E + RLLV E+MP +L HLF QP+ W +RL+VAL A+
Sbjct: 128 QFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAK 187
Query: 167 ALEYCTSKE-RALYHDLNAYRIVFDDDVNPRLSCFGLMKNS--RDGRSYSTNL----AFT 219
L + S E R +Y D I+ D + N +LS FGL K+ D ST + +
Sbjct: 188 GLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYA 247
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHALD--------LIRDRNIQT 267
PEYL TG +T +S +YSFG +LL+LLSG+ PS + L+ R I
Sbjct: 248 APEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFR 307
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314
+ D+ L+ Q+S +E ++ L+ RCL E + RPN +V+ L +Q
Sbjct: 308 VIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQ 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 102/315 (32%), Positives = 160/315 (50%), Gaps = 41/315 (13%)
Query: 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLE----------NQFRIAVKRFNRSA 93
+S L+ AT F +++V GE V++G L+ + IAVKR N
Sbjct: 49 FSFNELKLATRNFRSDSVV---GEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDG 105
Query: 94 WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF---HWETQ 150
+ R++L E +GQL + L L+G C E ++RLLV E+M +L HLF + + +
Sbjct: 106 FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFK 165
Query: 151 PMKWAMRLRVALHIAEALEYCTSKE-RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209
P+ W +R++VAL A+ L + S + +Y D+ A I+ D D N +LS FGL +RDG
Sbjct: 166 PLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGL---ARDG 222
Query: 210 ----RSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHA 256
+SY + + PEY+ TG + S +YSFG +LL+LL G+ H P+
Sbjct: 223 PMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKE 282
Query: 257 LDLI--------RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308
+L+ R + + D+ L Q+ + L +A +CL +EP+ RP +V
Sbjct: 283 QNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVR 342
Query: 309 ALVTLQKDTEVPSHV 323
ALV LQ P++V
Sbjct: 343 ALVQLQDSVVKPANV 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 101/311 (32%), Positives = 160/311 (51%), Gaps = 34/311 (10%)
Query: 39 PVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQ----------FRIAVKR 88
P ++ L+ AT F ++++ E G + V+KG ++ Q IAVK+
Sbjct: 52 PNLKSFTFAELKAATRNFRPDSVLGEGGFGS---VFKGWIDEQTLTASKPGTGVVIAVKK 108
Query: 89 FNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE 148
N+ W +++L E +GQ + L L+G C E + RLLV E+MP +L HLF
Sbjct: 109 LNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 168
Query: 149 T--QPMKWAMRLRVALHIAEALEYCTSKERA-LYHDLNAYRIVFDDDVNPRLSCFGLMKN 205
+ QP+ W +RL+VAL A+ L + + E + +Y D I+ D + N +LS FGL K+
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKD 228
Query: 206 --SRDGRSYSTNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPS 254
+ D ST + + PEYL TG +T +S +YS+G +LL++LSG K+ PP
Sbjct: 229 GPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPG 288
Query: 255 HAL-------DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
L R + + D+ L+ Q+S +E ++ LA RCL +E + RPN +V
Sbjct: 289 EQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVV 348
Query: 308 TALVTLQKDTE 318
+ L +Q E
Sbjct: 349 SHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (386), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 109/314 (34%), Positives = 156/314 (49%), Gaps = 36/314 (11%)
Query: 25 QDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRI 84
Q+ N+E V N +S L TAT F E ++ GE VYKGKLE I
Sbjct: 48 QNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLI---GEGGFGRVYKGKLEKTGMI 104
Query: 85 -AVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
AVK+ +R+ ++F+ E + L ++ L NL+G C +GD+RLLV EYM +L H
Sbjct: 105 VAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDH 164
Query: 144 LFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSC 199
L + P+ W R+R+AL A LEY K +Y DL A I+ D + N +LS
Sbjct: 165 LLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSD 224
Query: 200 FGLMKNS--RDGRSYSTNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
FGL K D + S+ + + PEY RTG++T +S +YSFG +LL+L++G+ +
Sbjct: 225 FGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRV-- 282
Query: 254 SHALDLIRDRNIQTLT-----------------DSCLEGQFSSDEGTELVRLASRCLQYE 296
+D R ++ Q L D LEG F + V +A+ CLQ E
Sbjct: 283 ---IDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEE 339
Query: 297 PRERPNPRSLVTAL 310
RP +VTAL
Sbjct: 340 ATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (376), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 104/331 (31%), Positives = 163/331 (49%), Gaps = 38/331 (11%)
Query: 24 AQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQ-- 81
AQ E E + + PV ++ L+ AT F ++++ GE V+KG L+
Sbjct: 39 AQKTEGEI---LSSTPV-KSFTFNELKLATRNFRPDSVI---GEGGFGCVFKGWLDESTL 91
Query: 82 --------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133
IAVK+ N+ + R++L E +GQL + L L+G C E + RLLV E
Sbjct: 92 TPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYE 151
Query: 134 YMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSKE-RALYHDLNAYRIVFD 190
+M +L HLF +P+ W +R+ VAL A+ L + S + +Y D+ A I+ D
Sbjct: 152 FMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 211
Query: 191 DDVNPRLSCFGLMKNSRDGR-SYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
D N +LS FGL ++ G SY + + PEY+ +G + S +YSFG LLL+
Sbjct: 212 ADYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLE 271
Query: 245 LLSGK----HIPPSHALDLI--------RDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
+LSGK H P+ +L+ R + + D+ L+ Q+ +E + +A +C
Sbjct: 272 ILSGKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQC 331
Query: 293 LQYEPRERPNPRSLVTALVTLQKDTEVPSHV 323
L +EP+ RP +V AL LQ + PS
Sbjct: 332 LSFEPKSRPTMDQVVRALQQLQDNLGKPSQT 362
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (372), Expect = 9e-35, Method: Compositional matrix adjust.
Identities = 101/316 (31%), Positives = 169/316 (53%), Gaps = 40/316 (12%)
Query: 45 SIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRS--AWPDARQFLE 102
SI+ LR+ T+ F+ +NI+ G VVYKG+L + +IAVKR A +F
Sbjct: 577 SIQVLRSVTNNFSSDNIL---GSGGFGVVYKGELHDGTKIAVKRMENGVIAGKGFAEFKS 633
Query: 103 EARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLR 159
E + ++R+R L LLG C +G+E+LLV EYMP TL++HLF W +P+ W RL
Sbjct: 634 EIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKPLLWKQRLT 693
Query: 160 VALHIAEALEYC--TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTNL 216
+AL +A +EY + + ++ DL I+ DD+ +++ FGL++ + +G+ S T +
Sbjct: 694 LALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 753
Query: 217 AFT----PPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLI-------- 260
A T PEY TGRVT + +YSFG +L++L++G+ P ++ L+
Sbjct: 754 AGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEESIHLVSWFKRMYI 813
Query: 261 -RDRNIQTLTDSCLEGQFSSDEGT-----ELVRLASRCLQYEPRERPN---PRSLVTALV 311
++ + + D+ ++ DE T + LA C EP +RP+ +++++LV
Sbjct: 814 NKEASFKKAIDTTID----LDEETLASVHTVAELAGHCCAREPYQRPDMGHAVNILSSLV 869
Query: 312 TLQKDTEVPSHVLMGI 327
L K ++ + GI
Sbjct: 870 ELWKPSDQNPEDIYGI 885
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (372), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 99/297 (33%), Positives = 144/297 (48%), Gaps = 29/297 (9%)
Query: 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRI-------AVKRFNRSAWPD 96
+++ L T T F + I+ E G VYKG +++ R+ AVK N+
Sbjct: 57 FTLFELETITKSFRPDYILGEGGF---GTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQG 113
Query: 97 ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAM 156
R++L E +GQLR+ L L+G CCE D RLLV E+M +L HLF T P+ W+
Sbjct: 114 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSR 173
Query: 157 RLRVALHIAEALEYCTSKER-ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213
R+ +AL A+ L + + ER +Y D I+ D D +LS FGL K G S
Sbjct: 174 RMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 214 TNL----AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLI----- 260
T + + PEY+ TG +T S +YSFG +LL++L+G+ PS +L+
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 261 ---RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314
R + + D LE Q+S + LA CL P+ RP +V L LQ
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 372 | ||||||
| 224071868 | 487 | predicted protein [Populus trichocarpa] | 1.0 | 0.763 | 0.852 | 0.0 | |
| 224058519 | 488 | predicted protein [Populus trichocarpa] | 1.0 | 0.762 | 0.838 | 0.0 | |
| 225426412 | 488 | PREDICTED: probable serine/threonine-pro | 1.0 | 0.762 | 0.844 | 0.0 | |
| 225454188 | 491 | PREDICTED: probable serine/threonine-pro | 1.0 | 0.757 | 0.822 | 0.0 | |
| 357520451 | 495 | Protein kinase-like protein [Medicago tr | 1.0 | 0.751 | 0.820 | 0.0 | |
| 449452322 | 486 | PREDICTED: probable serine/threonine-pro | 0.994 | 0.761 | 0.827 | 1e-180 | |
| 356513393 | 489 | PREDICTED: probable serine/threonine-pro | 0.997 | 0.758 | 0.8 | 1e-178 | |
| 297805526 | 487 | kinase family protein [Arabidopsis lyrat | 1.0 | 0.763 | 0.793 | 1e-178 | |
| 15237604 | 487 | putative serine/threonine-protein kinase | 1.0 | 0.763 | 0.787 | 1e-177 | |
| 297840147 | 487 | kinase family protein [Arabidopsis lyrat | 1.0 | 0.763 | 0.803 | 1e-177 |
| >gi|224071868|ref|XP_002303586.1| predicted protein [Populus trichocarpa] gi|222841018|gb|EEE78565.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/372 (85%), Positives = 342/372 (91%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCECSKLS CC S+Y + PE ++ NEEK +D++P F EY+IETLR ATSGF++EN
Sbjct: 1 MGCECSKLSKCCWSSDYNGSVPEDRNEVNEEKSELDDLPAFREYNIETLRMATSGFSVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ R+AVKRFNRSAWPDARQFLEEARAVGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRVAVKRFNRSAWPDARQFLEEARAVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EGDERLLVAE+MPNDTLAKHLFHWET+PMKWAMRLRVALH+A+ALEYCTSK RALYH
Sbjct: 121 CCGEGDERLLVAEFMPNDTLAKHLFHWETKPMKWAMRLRVALHLAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRIVFDD+ NPRLSCFGLMKN RDG+SYSTNLAFTPPEYLRTGRV PESV+YSFGT
Sbjct: 181 DLNAYRIVFDDEGNPRLSCFGLMKNRRDGKSYSTNLAFTPPEYLRTGRVIPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFTNDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PN +SLV AL+ LQKDTEVPSH LMGI GAAALPLSPLG+ACLRMDLTAIHEILEKLGY
Sbjct: 301 PNSKSLVAALIPLQKDTEVPSHELMGIQDGAAALPLSPLGEACLRMDLTAIHEILEKLGY 360
Query: 361 KDDEGAATEVCF 372
KDDEG ATE+ F
Sbjct: 361 KDDEGTATELSF 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058519|ref|XP_002299534.1| predicted protein [Populus trichocarpa] gi|222846792|gb|EEE84339.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/372 (83%), Positives = 341/372 (91%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCECSKL+ CC S+Y + PE + + EE+ +D++P F EY+IETLR ATSGF++EN
Sbjct: 1 MGCECSKLTKCCWSSDYNGSVPEDHNEDKEERSELDDLPAFREYNIETLRMATSGFSVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RI VKRFNRS+WPDARQFLEEAR VGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRIVVKRFNRSSWPDARQFLEEARTVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCEGDERLLV+E+MPNDTLAKHLFHWETQPMKWAMRLRVALH+A+ALEYC SK RALYH
Sbjct: 121 CCCEGDERLLVSEFMPNDTLAKHLFHWETQPMKWAMRLRVALHLAQALEYCASKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR+VFDD+ NPRLSCFGLMKNS DG+SYSTNLAFTPPEYLRTGRVT ESV+YSFGT
Sbjct: 181 DLNAYRVVFDDEGNPRLSCFGLMKNSIDGKSYSTNLAFTPPEYLRTGRVTAESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L+DSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLSDSCLEGQFANDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLV AL+ LQKDTEVPSH LMGI GAAALPLSPLG+ACLRMDLTAIHEILEKLGY
Sbjct: 301 PNPKSLVAALIPLQKDTEVPSHELMGIQDGAAALPLSPLGEACLRMDLTAIHEILEKLGY 360
Query: 361 KDDEGAATEVCF 372
KDDEGAATE+ F
Sbjct: 361 KDDEGAATELSF 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426412|ref|XP_002270065.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297742525|emb|CBI34674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/372 (84%), Positives = 335/372 (90%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGC+CSK CC SE E VENEE D++P F EY+I+ LR ATSGFA EN
Sbjct: 1 MGCQCSKFWVCCWDSEQKGLVVEPPSVENEENSEADDLPAFHEYTIDQLRMATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RIAVKRFN+SAWPDARQFLEEAR+VGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNKSAWPDARQFLEEARSVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EGDERLLVAE+MPNDTLAKHLFHWETQPMKWAMRLRVAL++A+ALEYCTSK RALYH
Sbjct: 121 CCSEGDERLLVAEFMPNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRIVFDDD +PRLSCFG+MKNSRDG+SYSTNLAFTPPEYLRTGRVTPESVMYSFGT
Sbjct: 181 DLNAYRIVFDDDGDPRLSCFGMMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQFSSD+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSSDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLV AL+ LQK+TEVPSHVLMG+P A LPLSPLG+ACLRMDLTAIHEILEKLGY
Sbjct: 301 PNPKSLVAALIPLQKETEVPSHVLMGMPQSGATLPLSPLGEACLRMDLTAIHEILEKLGY 360
Query: 361 KDDEGAATEVCF 372
KDDEGA TE+ F
Sbjct: 361 KDDEGATTELSF 372
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225454188|ref|XP_002272416.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297745267|emb|CBI40347.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/372 (82%), Positives = 335/372 (90%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGC+CSKL+ CC S++ + EA DV+N EK VD +PVFCEY+ E L+ ATSGFA+EN
Sbjct: 1 MGCQCSKLAPCCWDSQFKGSVLEAPDVDNGEKSEVDYLPVFCEYTFEQLKNATSGFAVEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ RIAVKRFNR AWPDARQF EEARAVGQLRN RLANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRVAWPDARQFSEEARAVGQLRNHRLANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCE +ERLLVAEYMPN+TLAKHLFHWETQPMKWAMRLRV LH+A+ALEYCT + RALYH
Sbjct: 121 CCCEDNERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTGRGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRI+FD+D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRILFDEDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRN+Q LTDSCLEGQF++D+GTELVRLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTNDDGTELVRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLV AL LQK+TEVPSHVLMGIPH A+ PLSPLG+AC RMDLTAIHEILE +GY
Sbjct: 301 PNPKSLVAALTPLQKETEVPSHVLMGIPHSASFSPLSPLGEACSRMDLTAIHEILESVGY 360
Query: 361 KDDEGAATEVCF 372
KDDEG E+ F
Sbjct: 361 KDDEGMTNELSF 372
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520451|ref|XP_003630514.1| Protein kinase-like protein [Medicago truncatula] gi|355524536|gb|AET04990.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/374 (82%), Positives = 336/374 (89%), Gaps = 2/374 (0%)
Query: 1 MGCECSKLSACCSGSEYGEA-APEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAM 58
MGC SK S CC +E G PEA ENE+ N + F EY+I+ LR ATSGFA+
Sbjct: 7 MGCNFSKYSTCCCSTEQGGVQVPEANIEENEDNNVEGNGLASFREYTIDQLRKATSGFAI 66
Query: 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL 118
ENIVSEHGEKAPNVVYKGKLENQ RIAVKRFN+S WPDA QFLEEARAVGQLR++RLANL
Sbjct: 67 ENIVSEHGEKAPNVVYKGKLENQVRIAVKRFNKSNWPDAHQFLEEARAVGQLRSQRLANL 126
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
LGCCCEGDERLLV+EYM NDTLAKHLFHWETQPMKWAMRLRVAL++A+ALEYCTSK RAL
Sbjct: 127 LGCCCEGDERLLVSEYMSNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRAL 186
Query: 179 YHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSF 238
YHDLNAYR++FDDD NP+LSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV YSF
Sbjct: 187 YHDLNAYRVLFDDDFNPKLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVTYSF 246
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
GTLLLDLLSGKHIPPSHALDLIRDRN+Q+LTDSCLEGQFS DEGTELVRLASRCLQ EPR
Sbjct: 247 GTLLLDLLSGKHIPPSHALDLIRDRNLQSLTDSCLEGQFSDDEGTELVRLASRCLQSEPR 306
Query: 299 ERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKL 358
ERPNP+SLVTAL+ LQKD+EVPSHVLMGIP G+AA PL+PLG+ACLRMDLT+IHE+LEK+
Sbjct: 307 ERPNPKSLVTALIPLQKDSEVPSHVLMGIPDGSAAFPLTPLGEACLRMDLTSIHEVLEKI 366
Query: 359 GYKDDEGAATEVCF 372
GYKDDEGAATE+ F
Sbjct: 367 GYKDDEGAATELSF 380
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452322|ref|XP_004143908.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Cucumis sativus] gi|449495800|ref|XP_004159948.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1639), Expect = e-180, Method: Compositional matrix adjust.
Identities = 308/372 (82%), Positives = 334/372 (89%), Gaps = 2/372 (0%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCECSK S C GSE + D E+ K D +P F E++I+ LRTATSGFA+EN
Sbjct: 1 MGCECSKFSDCF-GSEETKPVARVPDNESIGKSEFD-LPAFREFTIDQLRTATSGFAVEN 58
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKL+NQ RIAVKRFNRSAWPDARQFL+EARAVGQLRN+RLANLLG
Sbjct: 59 IVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRSAWPDARQFLDEARAVGQLRNQRLANLLG 118
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EG+ERLLVAE+MPN+TLAKHLFHWE QPMKW+MRLRVALH+A+ALEYCTSK RALYH
Sbjct: 119 CCFEGEERLLVAEFMPNETLAKHLFHWENQPMKWSMRLRVALHLAQALEYCTSKGRALYH 178
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRIVFDD+ NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG +TPESV+YSFGT
Sbjct: 179 DLNAYRIVFDDEGNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGGITPESVIYSFGT 238
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ LTDSCLEGQFS+DEGTELVRLASRCLQYEPRER
Sbjct: 239 LLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSNDEGTELVRLASRCLQYEPRER 298
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PN +SLVTAL+ LQKD EVPSHVLMGIP AAAL LSPLG+A LRMDLTAIHE+LE +GY
Sbjct: 299 PNTKSLVTALIPLQKDLEVPSHVLMGIPQDAAALNLSPLGEASLRMDLTAIHEVLEMIGY 358
Query: 361 KDDEGAATEVCF 372
KDDEGAATE+ F
Sbjct: 359 KDDEGAATELSF 370
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513393|ref|XP_003525398.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 300/375 (80%), Positives = 338/375 (90%), Gaps = 4/375 (1%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQ-DVENEEK--PGVDNVPVFCEYSIETLRTATSGFA 57
MGC SK +ACC+GSE A EAQ D NE+ GVD +P F E++I+ LR ATSGFA
Sbjct: 1 MGCGFSKYTACCTGSEQDGLAAEAQVDGGNEDNVVEGVD-LPWFHEFTIDQLRKATSGFA 59
Query: 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLAN 117
+ENIVSEHGEKAPNVVYKG+L+NQ RIAVKRFNR+AWP+A+ FLEEARAVGQLRN+RL N
Sbjct: 60 IENIVSEHGEKAPNVVYKGRLDNQMRIAVKRFNRNAWPEAQPFLEEARAVGQLRNQRLIN 119
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
LLGCCCEG+ERLLVAEYMPNDTL KHLFHWETQPM+WAMR+RVAL +A+ALEYCTSK RA
Sbjct: 120 LLGCCCEGEERLLVAEYMPNDTLTKHLFHWETQPMRWAMRMRVALCLAQALEYCTSKGRA 179
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYS 237
LYHDLNAYR+++DDD NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESV YS
Sbjct: 180 LYHDLNAYRVLYDDDYNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVTYS 239
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
FGTLLLDLLSGKHIPPSHALDLIRD+N+Q L+DSCLEG+ ++D+GTELVRLASRCLQ EP
Sbjct: 240 FGTLLLDLLSGKHIPPSHALDLIRDKNLQMLSDSCLEGELTNDDGTELVRLASRCLQSEP 299
Query: 298 RERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEK 357
RERPNP+SLV AL+ LQKD+EVPSHVLMGIP G AA PLSPLG+ACLRMDLTA+HE++EK
Sbjct: 300 RERPNPKSLVAALIPLQKDSEVPSHVLMGIPDGTAAFPLSPLGEACLRMDLTALHEVMEK 359
Query: 358 LGYKDDEGAATEVCF 372
+GYKDDEGAATE+ F
Sbjct: 360 IGYKDDEGAATELSF 374
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297805526|ref|XP_002870647.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297316483|gb|EFH46906.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 295/372 (79%), Positives = 332/372 (89%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EG+ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEGEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLV+A++ LQKD E+ SH L+GIP+ A LSPLG+ACLR DLTAIHEI+EKLGY
Sbjct: 301 PNPKSLVSAMIPLQKDLEIASHQLLGIPNSATTTALSPLGEACLRPDLTAIHEIIEKLGY 360
Query: 361 KDDEGAATEVCF 372
KDDEGA TE+ F
Sbjct: 361 KDDEGATTELSF 372
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15237604|ref|NP_198942.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|75333858|sp|Q9FHD7.1|Y5126_ARATH RecName: Full=Probable serine/threonine-protein kinase At5g41260 gi|10177770|dbj|BAB11102.1| protein kinase-like [Arabidopsis thaliana] gi|115311489|gb|ABI93925.1| At5g41260 [Arabidopsis thaliana] gi|332007275|gb|AED94658.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1617), Expect = e-177, Method: Compositional matrix adjust.
Identities = 293/372 (78%), Positives = 331/372 (88%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLV+A++ LQKD E+ SH L+G+P+ A LSPLG+ACLR DLTAIHEI+EKLGY
Sbjct: 301 PNPKSLVSAMIPLQKDLEIASHQLLGVPNSATTTALSPLGEACLRSDLTAIHEIIEKLGY 360
Query: 361 KDDEGAATEVCF 372
KDDEGA TE+ F
Sbjct: 361 KDDEGATTELSF 372
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297840147|ref|XP_002887955.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297333796|gb|EFH64214.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1616), Expect = e-177, Method: Compositional matrix adjust.
Identities = 299/372 (80%), Positives = 329/372 (88%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKL A C SE + ++ + + +++P F E+SIETLR ATSGFA EN
Sbjct: 1 MGCEVSKLCAFCCVSEPEGSNHGVTGLDEDRRGEGNDLPQFREFSIETLRNATSGFATEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKL+NQ RIAVKRFNR AWPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRKAWPDSRQFLEEAKAVGQLRNYRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC EG+ERLLVAE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCT K RALYH
Sbjct: 121 CCYEGEERLLVAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTGKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESVMYS+GT
Sbjct: 181 DLNAYRVLFDDDSNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYSYGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DSCLEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLIDSCLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLVTA++ LQKD E PSH LMGIP A+ PLSPLG+ACLR DLTAIHEILEKL Y
Sbjct: 301 PNPKSLVTAMIPLQKDLETPSHQLMGIPSSASTTPLSPLGEACLRTDLTAIHEILEKLSY 360
Query: 361 KDDEGAATEVCF 372
KDDEGAATE+ F
Sbjct: 361 KDDEGAATELSF 372
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 372 | ||||||
| TAIR|locus:2031279 | 487 | BSK7 "brassinosteroid-signalin | 0.997 | 0.761 | 0.809 | 4.5e-162 | |
| TAIR|locus:2155115 | 487 | BSK8 "brassinosteroid-signalin | 1.0 | 0.763 | 0.787 | 2.5e-161 | |
| TAIR|locus:2127118 | 489 | BSK3 "brassinosteroid-signalin | 0.997 | 0.758 | 0.768 | 2.4e-156 | |
| TAIR|locus:2154538 | 489 | BSK5 "brassinosteroid-signalin | 0.989 | 0.752 | 0.731 | 2.4e-147 | |
| TAIR|locus:2198160 | 483 | BSK4 "brassinosteroid-signalin | 0.970 | 0.747 | 0.728 | 1.4e-142 | |
| TAIR|locus:2084475 | 490 | BSK6 "brassinosteroid-signalin | 0.989 | 0.751 | 0.695 | 5.6e-139 | |
| TAIR|locus:2122058 | 512 | BSK1 "brassinosteroid-signalin | 0.908 | 0.660 | 0.659 | 1.3e-121 | |
| TAIR|locus:2142315 | 489 | BSK2 "brassinosteroid-signalin | 0.989 | 0.752 | 0.6 | 1.1e-119 | |
| TAIR|locus:2083499 | 477 | BSK9 "brassinosteroid-signalin | 0.916 | 0.714 | 0.601 | 4.8e-110 | |
| TAIR|locus:2150074 | 499 | BSK10 "brassinosteroid-signali | 0.997 | 0.743 | 0.555 | 1.3e-107 |
| TAIR|locus:2031279 BSK7 "brassinosteroid-signaling kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1578 (560.5 bits), Expect = 4.5e-162, P = 4.5e-162
Identities = 302/373 (80%), Positives = 330/373 (88%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAME 59
MGCE SKL A C S+ E + +E++ G N +P F E+SIETLR ATSGFA E
Sbjct: 1 MGCEVSKLCAFCCVSD-PEGSNHGVTGLDEDRRGEGNDLPQFREFSIETLRNATSGFATE 59
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
NIVSEHGEKAPNVVYKGKL+NQ RIAVKRFNR AWPD+RQFLEEA+AVGQLRN R+ANLL
Sbjct: 60 NIVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRKAWPDSRQFLEEAKAVGQLRNYRMANLL 119
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
GCC EG+ERLLVAE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCT K RALY
Sbjct: 120 GCCYEGEERLLVAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTGKGRALY 179
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
HDLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESVMYS+G
Sbjct: 180 HDLNAYRVLFDDDSNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYSYG 239
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
TLLLDLLSGKHIPPSHALDLIRDRNIQ L DSCLEGQFSSD+GTEL+RLASRCLQYEPRE
Sbjct: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQMLIDSCLEGQFSSDDGTELIRLASRCLQYEPRE 299
Query: 300 RPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLG 359
RPNP+SLVTA++ LQKD E PSH LMGIP A+ PLSPLG+ACLR DLTAIHEILEKL
Sbjct: 300 RPNPKSLVTAMIPLQKDLETPSHQLMGIPSSASTTPLSPLGEACLRTDLTAIHEILEKLS 359
Query: 360 YKDDEGAATEVCF 372
YKDDEGAATE+ F
Sbjct: 360 YKDDEGAATELSF 372
|
|
| TAIR|locus:2155115 BSK8 "brassinosteroid-signaling kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1571 (558.1 bits), Expect = 2.5e-161, P = 2.5e-161
Identities = 293/372 (78%), Positives = 331/372 (88%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MGCE SKLSA C SE G + P+ ++ E + +++P F E+SIET+R ATSGFA EN
Sbjct: 1 MGCEVSKLSALCCVSESGRSNPDVTGLDEEGRGESNDLPQFREFSIETIRNATSGFAAEN 60
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGE+APNVVYKGKLENQ RIAVKRFNR +WPD+RQFLEEA+AVGQLRN R+ANLLG
Sbjct: 61 IVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMANLLG 120
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CC E +ERLL+AE+MPN+TLAKHLFHWE+QPMKWAMRLRVALHIA+ALEYCTSK RALYH
Sbjct: 121 CCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGRALYH 180
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FDDD NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV+YSFGT
Sbjct: 181 DLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 240
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRNIQ L DS LEGQFSSD+GTEL+RLASRCLQYEPRER
Sbjct: 241 LLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYEPRER 300
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PNP+SLV+A++ LQKD E+ SH L+G+P+ A LSPLG+ACLR DLTAIHEI+EKLGY
Sbjct: 301 PNPKSLVSAMIPLQKDLEIASHQLLGVPNSATTTALSPLGEACLRSDLTAIHEIIEKLGY 360
Query: 361 KDDEGAATEVCF 372
KDDEGA TE+ F
Sbjct: 361 KDDEGATTELSF 372
|
|
| TAIR|locus:2127118 BSK3 "brassinosteroid-signaling kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1524 (541.5 bits), Expect = 2.4e-156, P = 2.4e-156
Identities = 286/372 (76%), Positives = 323/372 (86%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG +CS LS CC + + A EA DV+N E + +VP F EY++E L+ ATSGFA+E
Sbjct: 1 MGGQCSSLS-CCRNTSHKTAVLEAPDVDNGESSEITDVPNFREYTLEQLKAATSGFAVEY 59
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHGEKAPNVVYKGKLENQ +IAVKRF R AWPD+RQFLEEAR+VGQLR+ R+ANLLG
Sbjct: 60 IVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDSRQFLEEARSVGQLRSERMANLLG 119
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCCEGDERLLVAE+MPN+TLAKHLFHWETQPMKW MRLRV L++A+ALEYCTSK R LYH
Sbjct: 120 CCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRTLYH 179
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FD++ NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGR+TPESV+YSFGT
Sbjct: 180 DLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYSFGT 239
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIRDRN+QTLTDSCL+GQFS +GTELVRLASRCLQYE RER
Sbjct: 240 LLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEARER 299
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLGY 360
PN +SLVTAL LQK+TEV SHVLMG+PH + PLSPLG+AC R DLTA+ EILEKLGY
Sbjct: 300 PNTKSLVTALTPLQKETEVLSHVLMGLPHSGSVSPLSPLGEACSRRDLTAMLEILEKLGY 359
Query: 361 KDDEGAATEVCF 372
KDDEG E+ F
Sbjct: 360 KDDEGVTNELSF 371
|
|
| TAIR|locus:2154538 BSK5 "brassinosteroid-signaling kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1439 (511.6 bits), Expect = 2.4e-147, P = 2.4e-147
Identities = 275/376 (73%), Positives = 317/376 (84%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG CSKLS C + EA D++N G D++P F E+S + LR AT GF+ ++
Sbjct: 1 MGPRCSKLSLCWWPTHLKSTHNEASDLDN----GTDDLPSFTEFSFDQLRAATCGFSTDS 56
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
IVSEHG KAPNVVYKG+LE+ IAVKRFNRSAWPD RQFLEEA+AVGQLRN RLANL+G
Sbjct: 57 IVSEHGVKAPNVVYKGRLEDDRWIAVKRFNRSAWPDTRQFLEEAKAVGQLRNERLANLIG 116
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCEGDERLLVAE+MP +TL+KHLFHW++QPMKW+MRLRVAL++A+ALEYC+SK RALYH
Sbjct: 117 FCCEGDERLLVAEFMPFETLSKHLFHWDSQPMKWSMRLRVALYLAQALEYCSSKGRALYH 176
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYRI+FD D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRV PESV+YSFGT
Sbjct: 177 DLNAYRILFDQDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVIPESVVYSFGT 236
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLLSGKHIPPSHALDLIR +N L DSCL+G FS+D+GT+LVRLASRCLQYE RER
Sbjct: 237 LLLDLLSGKHIPPSHALDLIRGKNFLMLMDSCLDGHFSNDDGTDLVRLASRCLQYEARER 296
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAA----LPLSPLGDACLRMDLTAIHEILE 356
PN +SLV++L LQK+T++PSHVLMGIPHGAA+ L+PLGDAC R DLTAIHEILE
Sbjct: 297 PNVKSLVSSLAPLQKETDIPSHVLMGIPHGAASPKETTSLTPLGDACSRHDLTAIHEILE 356
Query: 357 KLGYKDDEGAATEVCF 372
K+GYKDDEG A E+ F
Sbjct: 357 KVGYKDDEGVANELSF 372
|
|
| TAIR|locus:2198160 BSK4 "brassinosteroid-signaling kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1394 (495.8 bits), Expect = 1.4e-142, P = 1.4e-142
Identities = 266/365 (72%), Positives = 309/365 (84%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMEN 60
MG + SK+ CCS + A EA DVEN+E V+ V F EYS+E L+ ATS FA+EN
Sbjct: 1 MGGQSSKIGTCCS---HKTTALEAPDVENKENGEVNGVHSFREYSLEQLKIATSCFALEN 57
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
+VSEHGE APNVVY+GKLEN +IA+KRF+ +AWPD RQFLEEAR VGQLR++R+ANLLG
Sbjct: 58 VVSEHGETAPNVVYQGKLENHMKIAIKRFSGTAWPDPRQFLEEARLVGQLRSKRMANLLG 117
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
CCEG ERLLVAE+MPN+TLAKHLFHW+T+PMKWAMRLRVAL+I+EALEYC++ LYH
Sbjct: 118 YCCEGGERLLVAEFMPNETLAKHLFHWDTEPMKWAMRLRVALYISEALEYCSNNGHTLYH 177
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
DLNAYR++FD++ NPRLS FGLMKNSRDG+SYSTNLAFTPPEYLRTGR+T ESV+YSFGT
Sbjct: 178 DLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITAESVIYSFGT 237
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
LLLDLL+GKHIPPSHALDLIRDRN+QTLTDSCLEGQFS +GTELVRL S CLQYE RER
Sbjct: 238 LLLDLLTGKHIPPSHALDLIRDRNLQTLTDSCLEGQFSDSDGTELVRLTSCCLQYEARER 297
Query: 301 PNPRSLVTALVTLQKDTEVPSHVLMGIPH-GAAALPLSPLGDACLRMDLTAIHEILEKLG 359
PN +SLVTAL++LQKDTEV SHVLMG+P G A P SP +AC DLT++ EILEK+G
Sbjct: 298 PNIKSLVTALISLQKDTEVLSHVLMGLPQSGTFASPPSPFAEACSGKDLTSMVEILEKIG 357
Query: 360 YKDDE 364
YKDDE
Sbjct: 358 YKDDE 362
|
|
| TAIR|locus:2084475 BSK6 "brassinosteroid-signaling kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
Identities = 263/378 (69%), Positives = 311/378 (82%)
Query: 1 MGCECSKLSACCSGSEYGEAAP-EAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAME 59
MG CSK S C S + A+ E+ D+EN K P F E+ +E L++AT GF+ +
Sbjct: 1 MGARCSKFSFCLFPSHFKSASVLESPDIENGGKVW----PTFKEFKLEQLKSATGGFSSD 56
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
NIVSEHGEKAPNVVY+G+L++ IAVKRFNR AW D RQFL+EA+AVG LR+ RLANL+
Sbjct: 57 NIVSEHGEKAPNVVYRGRLDDGRLIAVKRFNRLAWADHRQFLDEAKAVGSLRSDRLANLI 116
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
GCC EG+ERLLVAE+MP++TLAKHLFHWE PMKWAMRLRVAL +A+ALEYC++K RALY
Sbjct: 117 GCCFEGEERLLVAEFMPHETLAKHLFHWENNPMKWAMRLRVALCLAQALEYCSNKGRALY 176
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
HDLNAYR++FD D NPRLSCFGLMKNSRDG+SYSTNLAFTPPEYLRTGRVTPESV++SFG
Sbjct: 177 HDLNAYRVLFDKDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVVFSFG 236
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
T+LLDL+SGKHIPPSHALDLIR +N L DS LEG FS+++GTELVRLA+RCLQYE RE
Sbjct: 237 TVLLDLMSGKHIPPSHALDLIRGKNCAMLMDSALEGHFSNEDGTELVRLATRCLQYEARE 296
Query: 300 RPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAA-----LPLSPLGDACLRMDLTAIHEI 354
RPN +SLVT+LVTLQK+++V S+VLMGIPH A L L+P GDACLR+DLTAI EI
Sbjct: 297 RPNVKSLVTSLVTLQKESDVASYVLMGIPHETEAEEESPLSLTPFGDACLRVDLTAIQEI 356
Query: 355 LEKLGYKDDEGAATEVCF 372
L K+GYKDDEG A E+ F
Sbjct: 357 LSKIGYKDDEGIANELSF 374
|
|
| TAIR|locus:2122058 BSK1 "brassinosteroid-signaling kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1196 (426.1 bits), Expect = 1.3e-121, P = 1.3e-121
Identities = 227/344 (65%), Positives = 277/344 (80%)
Query: 34 GVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA 93
G +P F E+S L+ AT+ F+ +NIVSE GEKAPN+VYKG+L+N+ IAVK+F + A
Sbjct: 51 GGGGIPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMA 110
Query: 94 WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMK 153
WP+ +QF EEA VG+LR+ RLANL+G CC+GDERLLVAE+MPNDTLAKHLFHWE Q ++
Sbjct: 111 WPEPKQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIE 170
Query: 154 WAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213
WAMRLRV +IAEAL+YC+++ R LYHDLNAYR++FD+D +PRLSCFGLMKNSRDG+SYS
Sbjct: 171 WAMRLRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYS 230
Query: 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273
TNLA+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +NI L DS L
Sbjct: 231 TNLAYTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHL 290
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAA 333
EG+FS++E T +V LAS+CLQYEPRERPN + LV L LQ ++VPS+V++GI A
Sbjct: 291 EGKFSTEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDVPSYVMLGIKKQEEA 350
Query: 334 -----LPLSPLGDACLRMDLTAIHEILEKLGYKDDEGAATEVCF 372
PLSPLG+AC RMDLTAIH+IL Y+DDEG E+ F
Sbjct: 351 PSTPQRPLSPLGEACSRMDLTAIHQILVMTHYRDDEGT-NELSF 393
|
|
| TAIR|locus:2142315 BSK2 "brassinosteroid-signaling kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
Identities = 225/375 (60%), Positives = 288/375 (76%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN-VPVFCEYSIETLRTATSGFAME 59
MGC SK + S + +AP + N ++ VD + F E+ + LR AT+GF+
Sbjct: 1 MGCLHSKTANLPSSDD--PSAPNKPESVNGDQ--VDQEIQNFKEFELNELRKATNGFSPS 56
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
IVSE GEKAPNVVY+GKLE +A+KRF+R +WPDA+QF+ EA VG+LRN+R+ +L+
Sbjct: 57 CIVSEGGEKAPNVVYRGKLEGNHLVAIKRFSRQSWPDAQQFVVEATGVGKLRNKRIVSLI 116
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
GCC EGDERLLVAEYMPNDTL+KHLFHWE QP+ W MR+R+A +IAEAL+YC + R +Y
Sbjct: 117 GCCAEGDERLLVAEYMPNDTLSKHLFHWEKQPLPWDMRVRIADYIAEALDYCNIENRKIY 176
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239
HDLNAYRI+FD++ +PRLS FGLMKNSRDG+SYSTNLA+TPPE+LRTGRV PESV++S+G
Sbjct: 177 HDLNAYRILFDEEGDPRLSTFGLMKNSRDGKSYSTNLAYTPPEFLRTGRVIPESVIFSYG 236
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
T+LLDLLSGKHIPPSHALD+IR +N L DS LEGQ+++D+ T+LV LAS+CLQ E ++
Sbjct: 237 TILLDLLSGKHIPPSHALDIIRGKNALLLMDSSLEGQYANDDATKLVDLASKCLQSEAKD 296
Query: 300 RPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALP--LSPLGDACLRMDLTAIHEILEK 357
RP+ + L++A+ LQK EV SHVLMG+P LP LSPLG AC +MDL H+IL K
Sbjct: 297 RPDTKFLLSAVAPLQKQEEVASHVLMGLPKNTVILPTMLSPLGKACAKMDLATFHDILLK 356
Query: 358 LGYKDDEGAATEVCF 372
GY+D+EGA E+ F
Sbjct: 357 TGYRDEEGAENELSF 371
|
|
| TAIR|locus:2083499 BSK9 "brassinosteroid-signaling kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 4.8e-110, P = 4.8e-110
Identities = 210/349 (60%), Positives = 262/349 (75%)
Query: 28 ENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVK 87
+N+E+ P F E+S+E LR AT GF+ +NIVSEH E+ PN+VYKG+L + +IAVK
Sbjct: 13 DNKEEDEGSTCPNFLEFSLEQLRVATDGFSADNIVSEHNERVPNIVYKGQLNDGRKIAVK 72
Query: 88 RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW 147
RF R +WPD+ +F+EEA+AVG+ R+ +ANL+GCC EG ERLLVAEYMPN+TLAKHLFHW
Sbjct: 73 RFQRLSWPDSLEFIEEAQAVGRCRSEHMANLIGCCSEGHERLLVAEYMPNETLAKHLFHW 132
Query: 148 ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207
E +PMKW MRLRVALH A ALEYC LYHDLN YRI+FD NPRLSCFGLMK SR
Sbjct: 133 EKRPMKWEMRLRVALHTATALEYCNDWGIDLYHDLNTYRILFDKVGNPRLSCFGLMKCSR 192
Query: 208 DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT 267
+G+SYSTNLAF PPEYLR G V PESV +SFGTLLLDL+SG+HIPP+HALDL R +N
Sbjct: 193 EGKSYSTNLAFAPPEYLRLGTVIPESVTFSFGTLLLDLMSGRHIPPNHALDLFRGKNYLV 252
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV-PSHVLMG 326
L DS L+GQFS ++ TEL+ LASRCL+ EP ERP+ + L++AL L+K E+ P+
Sbjct: 253 LMDSALDGQFSDEDRTELIHLASRCLRPEPDERPSIKFLMSALSRLEKRAELWPNVKEEN 312
Query: 327 IPHGAAA-------LPLSPLGDACLRMDLTAIHEILEKLGYKDDEGAAT 368
IP + LPL+P G+AC R+DL+ +HE+LEKLGY +D+ T
Sbjct: 313 IPTPSYTEPATKEPLPLTPFGEACWRVDLSGMHELLEKLGYGEDDVVVT 361
|
|
| TAIR|locus:2150074 BSK10 "brassinosteroid-signaling kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 216/389 (55%), Positives = 267/389 (68%)
Query: 1 MGCECSKLSACCSGSEYGEAAPEAQDVENEEKPGVDN----VP-VFCEYSIETLRTATSG 55
MGC C K S S S + D+EN + D+ P +F E+S+E LR AT G
Sbjct: 1 MGCICFK-SWRRSSSSPSITSTVIDDLENVREYDADDDGGHYPLIFREFSLEQLRIATDG 59
Query: 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL 115
F+ NIVSEH + PN+VYKGKL + RIAVKRF R +WPD +F+ EA+AVG+LR+ +
Sbjct: 60 FSAGNIVSEHNDSVPNIVYKGKLGDGRRIAVKRFQRLSWPDPFEFINEAQAVGRLRSEHM 119
Query: 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
ANL+GCCC+ +ERLLVAEYMPN TLAKHLFHWE +PMKW MRL+VALH A ALEYC K
Sbjct: 120 ANLIGCCCDDNERLLVAEYMPNGTLAKHLFHWEKRPMKWEMRLKVALHTARALEYCNDKG 179
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVM 235
LYHDLN YRI+FD P+LSCFGLMKNS +G+ YSTNLAF PPEYLR G V ESV
Sbjct: 180 IDLYHDLNPYRIMFDKTGIPKLSCFGLMKNSHEGKIYSTNLAFAPPEYLRLGTVIAESVT 239
Query: 236 YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+SFGTLLLDL+SG+HIPP+HALDL R +N L DS L+GQFS ++ TEL+ +ASRC +
Sbjct: 240 FSFGTLLLDLMSGRHIPPNHALDLFRGKNYLVLMDSALDGQFSDEDRTELIHVASRCFKT 299
Query: 296 EPRERPNPRSLVTALVTLQKDTEV-PSHVLM-------GIPH----GAAALPLSPLGDAC 343
EP ERP+ + L L LQK ++ P +V +P +L L+P GDAC
Sbjct: 300 EPEERPSIKFLKATLSRLQKRAKLCPINVKRPMSPPSKNLPEKTKPATESLKLTPFGDAC 359
Query: 344 LRMDLTAIHEILEKLGYKDDEGAATEVCF 372
R DL++IHE+LEKLGY++D G E F
Sbjct: 360 SRADLSSIHELLEKLGYEEDNGVGNEFSF 388
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FHD7 | Y5126_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7876 | 1.0 | 0.7638 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 372 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-19 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-08 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-04 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.001 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.002 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.002 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 0.002 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.003 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.003 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 55/245 (22%), Positives = 91/245 (37%), Gaps = 49/245 (20%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VY + + ++A+K + + L E + +L + + L G + +
Sbjct: 8 TVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLY 67
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI- 187
LV EY +L L E + LR+ L I E LEY S + H DL I
Sbjct: 68 LVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENIL 124
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST----NLAFTPPEYLR-TGRVTPESVMYSFGTLL 242
+ D+ +L+ FGL K +S A+ PE L G + +S ++S G +L
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+L DLIR + LQ +P +RP+
Sbjct: 185 YEL--------PELKDLIR-----------------------------KMLQKDPEKRPS 207
Query: 303 PRSLV 307
+ ++
Sbjct: 208 AKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-23
Identities = 71/260 (27%), Positives = 114/260 (43%), Gaps = 36/260 (13%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG L + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73
Query: 126 DERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
+ ++V EYMP D L K+ + + + L AL IA +EY SK H
Sbjct: 74 EPLMIVMEYMPGGDLLDYLRKN----RPKELSLSDLLSFALQIARGMEYLESKN--FIHR 127
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVM 235
DL A + +++ ++S FGL ++ D Y + PE L+ G+ T +S +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDV 187
Query: 236 YSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+SFG LL ++ + G+ + + L+ ++ +C EL +L
Sbjct: 188 WSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP---------ELYKLML 238
Query: 291 RCLQYEPRERPNPRSLVTAL 310
+C +P +RP LV L
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 3e-22
Identities = 70/260 (26%), Positives = 111/260 (42%), Gaps = 37/260 (14%)
Query: 72 VVYKGKLE-----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKGKL+ + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE 73
Query: 126 DERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
+ +V EYM L K+ + + L AL IA +EY SK H
Sbjct: 74 EPLYIVMEYMEGGDLLSYLRKN-----RPKLSLSDLLSFALQIARGMEYLESKN--FIHR 126
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVM 235
DL A + +++ ++S FGL ++ D Y + PE L+ G+ T +S +
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186
Query: 236 YSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+SFG LL ++ + G+ + L+ +++ +C EL L
Sbjct: 187 WSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP---------ELYDLML 237
Query: 291 RCLQYEPRERPNPRSLVTAL 310
+C +P +RP LV L
Sbjct: 238 QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 3e-21
Identities = 74/262 (28%), Positives = 113/262 (43%), Gaps = 33/262 (12%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGD 126
VYKGKL +AVK A + R FL+EAR + +L + + LLG C E +
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE 69
Query: 127 ERLLVAEYMPNDTLAKHL-------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
LV EYM L +L E + L A+ IA+ +EY SK + ++
Sbjct: 70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVH 128
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
DL A + +D+ ++S FGL ++ D Y + + PE L+ G T +S
Sbjct: 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188
Query: 234 VMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
++SFG LL ++ + G + L+ +R + C + EL L
Sbjct: 189 DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD---------ELYEL 239
Query: 289 ASRCLQYEPRERPNPRSLVTAL 310
C Q +P +RP LV L
Sbjct: 240 MLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 7e-21
Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 30/257 (11%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG L + ++AVK A + R+ FLEEA + +L + + LLG C +G
Sbjct: 14 EVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
+ +V EYMP L L + + L++AL IA+ +EY SK H DL A
Sbjct: 74 EPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAA 130
Query: 185 YRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTP-----PEYLRTGRVTPESVMYSF 238
+ +++ ++S FGL ++ D P PE L+ G+ T +S ++SF
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190
Query: 239 GTLLLDLLSG-----KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G LL ++ + + L+L+ D ++C + EL L +C
Sbjct: 191 GVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPD---------ELYELMLQCW 241
Query: 294 QYEPRERPNPRSLVTAL 310
Y+P +RP LV L
Sbjct: 242 AYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-19
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 4/181 (2%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V G Q ++AVK + A+ FL EA + LR+ L LLG +G+ +V
Sbjct: 22 VMLGDYRGQ-KVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L +L + A +L AL + E +EY K ++ DL A ++ +D
Sbjct: 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN-FVHRDLAARNVLVSED 138
Query: 193 VNPRLSCFGLMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251
+ ++S FGL K + G+ + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 LVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 252 P 252
P
Sbjct: 199 P 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 16/247 (6%)
Query: 72 VVYKGKLEN-QFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
VYK K + +AVK + + E R + +L + + L+ + D
Sbjct: 14 TVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHL 73
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI 187
LV EY L +L P+ ++AL I LEY S + H DL I
Sbjct: 74 YLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHS--NGIIHRDLKPENI 129
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGR-VTPESVMYSFGTLL 242
+ D++ +++ FGL K S T TP PE L G P+ ++S G +L
Sbjct: 130 LLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVIL 189
Query: 243 LDLLSGKHIPPSHALD--LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+LL+GK + L R I + S E L +CL +P +R
Sbjct: 190 YELLTGKPPFSGENILDQLQLIRRILG-PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 301 PNPRSLV 307
P ++
Sbjct: 249 PTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 19/239 (7%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VYKG L+ +AVK + PD ++ FL+EA + Q + + L+G C + +V
Sbjct: 11 VYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E +P +L L + + + L+++L A +EY SK ++ DL A + +
Sbjct: 71 MELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVGE 128
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ ++S FG M +G Y+ + + +T PE L GR T ES ++S+G LL +
Sbjct: 129 NNVLKISDFG-MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRERP 301
S P N QT + + + E+ RL +C Y+P RP
Sbjct: 188 TFSLGDTPYPGM------SNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 51/252 (20%), Positives = 84/252 (33%), Gaps = 34/252 (13%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS-AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VY + + +A+K + D + L E + + +L++ + L + D+
Sbjct: 14 KVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLY 73
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYR-- 186
LV EY L L A I ALEY H +R
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYL--------HSKGIVHRDL 123
Query: 187 ----IVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESVMYSFG 239
I+ D+D + +L+ FGL + G +T + PE L ++S G
Sbjct: 124 KPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG 183
Query: 240 TLLLDLLSGK-----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
+L +LL+GK I S E +L+R + L
Sbjct: 184 VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD----ISPEAKDLIR---KLLV 236
Query: 295 YEPRERPNPRSL 306
+P +R
Sbjct: 237 KDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 20/251 (7%)
Query: 66 GEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125
GE V +G+ Q ++AVK N A+ FLEE + +L ++ L LLG
Sbjct: 15 GEGEFGAVLQGEYTGQ-KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH- 70
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
+ +V E M L L + L+ +L +AE +EY SK + ++ DL A
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAAR 129
Query: 186 RIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
I+ +D ++S FGL + S + + +T PE L+ + + +S ++S+G LL +
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
Query: 245 LLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRE 299
+ S G+ P +L +++ C+E + + EG ++ L + C + EP++
Sbjct: 190 VFSYGRAPYPKMSLKEVKE---------CVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 300 RPNPRSLVTAL 310
RP+ L L
Sbjct: 241 RPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 14/236 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+KG L+++ +AVK + + +FL EAR + Q + + L+G C + +V
Sbjct: 11 VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E +P L + +K ++ AL A + Y SK ++ DL A + +
Sbjct: 71 MELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGE 128
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ ++S FG+ + DG S+ L +T PE L GR + ES ++S+G LL +
Sbjct: 129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188
Query: 247 SGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
S P P R++ + SC Q D ++ ++ RC Y+P RP
Sbjct: 189 SLGVCPYPGMTNQQAREQVEKGYRMSC--PQKCPD---DVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARA 106
T+ S EN++S + A YKGK ++N + VK N + + +
Sbjct: 684 TINDILSSLKEENVISRGKKGAS---YKGKSIKNGMQFVVKEINDVNSIPSSEIAD---- 736
Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE 166
+G+L++ + L+G C L+ EY+ L++ L + + W R ++A+ IA+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAK 791
Query: 167 ALEY--CTSKERALYHDLNAYRIVFDDDVNPRLSCFGL-----MKNSRDGRSYSTNLAFT 219
AL + C + +L+ +I+ D P L L S A+
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYV 845
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA--------LDLIR----DRNIQT 267
PE T +T +S +Y FG +L++LL+GK P+ A ++ R D ++
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKS--PADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 268 LTDSCLEGQFSSD--EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
D + G S + E E++ LA C +P RP ++ L + + +
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 63/253 (24%), Positives = 113/253 (44%), Gaps = 24/253 (9%)
Query: 73 VYKGKLE-NQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
V+ G+L + +AVK + PD + +FL+EAR + Q + + L+G C + +
Sbjct: 11 VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V E + L E +K +++ + A +EY SK ++ DL A +
Sbjct: 71 VMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH-CIHRDLAARNCLVT 128
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ ++S FG+ + DG ST + +T PE L GR + ES ++SFG LL +
Sbjct: 129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
Query: 245 LLSGKHIPPSHALDLIRDRNIQT-----LTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
S +P ++ + I+ + C + + RL RC +Y+P +
Sbjct: 189 AFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPD---------AVYRLMERCWEYDPGQ 239
Query: 300 RPNPRSLVTALVT 312
RP+ ++ L +
Sbjct: 240 RPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 61 IVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNR 113
+ E GE A V+ G+ + + +AVK +A DAR+ F EA + ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHL------------FHWETQPMKWAMRLRVA 161
+ G C EGD ++V EYM + L K L + + L++A
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 162 LHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------ 215
+ IA + Y S + ++ DL + D+ ++ FG+ SRD Y+T+
Sbjct: 129 VQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVVKIGDFGM---SRD--VYTTDYYRVGG 182
Query: 216 -----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GK 249
+ + PPE + + T ES ++SFG +L ++ + GK
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 56/243 (23%), Positives = 110/243 (45%), Gaps = 19/243 (7%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V++G +N+ R+A+K + F +E +A+ +LR++ L +L C G+ ++
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
E M +L L E Q + A + +A +AE + Y + +++ DL A I+ +D
Sbjct: 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGED 140
Query: 193 VNPRLSCFGLMKNSRDG--RSYSTNLAF--TPPEYLRTGRVTPESVMYSFGTLLLDLLSG 248
+ +++ FGL + ++ S + + T PE G + +S ++SFG LL ++ +
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 249 KHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
+P D I C + E+ ++ C EP +RP+
Sbjct: 201 GQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ---------EIYKIMLECWAAEPEDRPSF 251
Query: 304 RSL 306
++L
Sbjct: 252 KAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 54/297 (18%)
Query: 56 FAMENI--VSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARA 106
+ + + E GE A VYKG+L + +A+K +A P +Q F +EA
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF-------------HWETQPMK 153
+ L++ + LLG C + ++ EY+ + L + L +
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 154 WAMR-LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
L +A+ IA +EY +S ++ DL A + + + ++S FGL SRD Y
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLTVKISDFGL---SRDI--Y 175
Query: 213 STN-----------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHA 256
S + + + PPE + G+ T ES ++SFG +L ++ S P
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 257 LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
+++IR R + + C + L C P RP + + T L +
Sbjct: 236 IEMIRSRQLLPCPEDC---------PARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 10/181 (5%)
Query: 74 YKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVA 132
Y+G ++AVK A A+ FL EA + QLR+ L LLG E L +V
Sbjct: 27 YRGN-----KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L +L + L+ +L + EA+EY + ++ DL A ++ +D
Sbjct: 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSED 138
Query: 193 VNPRLSCFGLMKNSRDGRSYST-NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251
++S FGL K + + + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 252 P 252
P
Sbjct: 199 P 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 67.1 bits (162), Expect = 2e-12
Identities = 58/274 (21%), Positives = 95/274 (34%), Gaps = 29/274 (10%)
Query: 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLR-NRRL 115
I+ + GE + VY + ++ +A+K + +FL E + + L +
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSK 174
L + LV EY+ +L L P+ + L + I ALEY SK
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 175 ERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDGRSYSTN----------LAFTPPEY 223
++ D+ I+ D D +L FGL K D S S+ + PE
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 224 LR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---RNIQTLTDSCLEGQF 277
L + S ++S G L +LL+G + I L L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 278 SSDEG----TELVRLASRCLQYEPRERPNPRSLV 307
S L + L +P+ R + S +
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 36/277 (12%)
Query: 60 NIVSEHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRN 112
++ E G+ + +VY+G K E + R+AVK N SA R +FL EA +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLR----VALHI 164
+ LLG +G L+V E M + L +L E P + L+ +A I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAF 218
A+ + Y +K + ++ DL A + D ++ FG+ ++ R G + +
Sbjct: 129 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCL 273
PE L+ G T S M+SFG +L ++ S P L + D D+C
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 247
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
E + L C Q+ P+ RP +V L
Sbjct: 248 E---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 28/242 (11%)
Query: 73 VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++A+K + S P+A FL EA + QL++ RL L + + ++
Sbjct: 22 VWMGYYNGHTKVAIKSLKQGSMSPEA--FLAEANLMKQLQHPRLVRLYAVVTQ-EPIYII 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM N +L L E + + +A IAE + + K ++ DL A I+ +
Sbjct: 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSE 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ +++ FGL + +R+G + + +T PE + G T +S ++SFG LL +
Sbjct: 138 TLCCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIPPSHALDLIRDRNIQTL-----TDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
+++ IP + +N++ D+C E EL L C + +P E
Sbjct: 196 IVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE---------ELYELMRLCWKEKPEE 246
Query: 300 RP 301
RP
Sbjct: 247 RP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 33/269 (12%)
Query: 73 VYKGKLENQF-----RIAVKRFNRSAWPDARQFLEEARAVGQLRN---RRLANLLGCCCE 124
V + + ++AVK N S R E R + LR + G C +
Sbjct: 20 VELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE--REIEILRTLDHENIVKYKGVCEK 77
Query: 125 GDER--LLVAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
R L+ EY+P+ +L +L H + +K L + I + ++Y S+ R ++ D
Sbjct: 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQ-RYIHRD 134
Query: 182 LNAYRIVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFTP-----PEYLRTGRVTPESV 234
L A I+ + + ++S FGL K Y +P PE LRT + + S
Sbjct: 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASD 194
Query: 235 MYSFGTLLLDLLS-GKH--IPPSHALDLI---RDRNIQT-LTDSCLEGQ-FSSDEG--TE 284
++SFG L +L + G PP+ L +I + + I T L + EG+ E
Sbjct: 195 VWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDE 254
Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313
+ L C + EP++RP+ L+ + L
Sbjct: 255 VYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 24/260 (9%)
Query: 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC 121
+ E G VV+ GK + +A+K A + F+EEA+ + +L + L L G
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALY 179
C + +V EYM N L +L + K L + + EA+EY S ++
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG-FIH 123
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESV 234
DL A + +D ++S FGL + D + S+ + + PPE R + +S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE----GTELVRLAS 290
++SFG L+ ++ S +P R N + + +S G + TE+ +
Sbjct: 184 VWSFGVLMWEVFSEGKMPYE------RFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMY 235
Query: 291 RCLQYEPRERPNPRSLVTAL 310
C +P +RP + L++ L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 58/256 (22%), Positives = 115/256 (44%), Gaps = 34/256 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK Q+ +A+K + + +F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77
Query: 132 AEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
EYM N + L +H ++ + L + + E + Y SK+ ++ DL A
Sbjct: 78 TEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESKQ-FIHRDLAARNC 131
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLL 242
+ DD ++S FGL + D S+ + ++PPE L + + +S +++FG L+
Sbjct: 132 LVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM 191
Query: 243 LDLLSGKHIPPSHALDLIRDR-NIQTLTDSCLEG------QFSSDEGTELVRLASRCLQY 295
++ S +P +R N + +G +S+ ++ + C
Sbjct: 192 WEVYSLGKMP--------YERFNNSETVEKVSQGLRLYRPHLASE---KVYAIMYSCWHE 240
Query: 296 EPRERPNPRSLVTALV 311
+ ERP + L++++
Sbjct: 241 KAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 64 EHGEKAPNVVYKG------KLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLA 116
E G+ + +VY+G K E + R+A+K N +A R +FL EA + + +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHL--FHWETQ------PMKWAMRLRVALHIAEAL 168
LLG +G L++ E M L +L E + P +++A IA+ +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPPE 222
Y + + ++ DL A + +D ++ FG+ ++ R G + + PE
Sbjct: 133 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQF 277
L+ G T S ++SFG +L ++ + P L + + + D+C + F
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF 251
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
EL+R+ C QY P+ RP+ +++++
Sbjct: 252 ------ELMRM---CWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 61/254 (24%), Positives = 109/254 (42%), Gaps = 32/254 (12%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV+ GK Q ++A+K N A + F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E+M N L +L + + K M L + + E +EY + ++ DL A +
Sbjct: 78 TEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEY-LERNSFIHRDLAARNCLVSS 135
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++S FG+ + D S++ A ++PPE + + +S ++SFG L+ ++
Sbjct: 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR--LAS--------RCLQYE 296
+ +P + N + + G L R LAS C +
Sbjct: 196 TEGKMP------FEKKSNYEVVE--------MISRGFRLYRPKLASMTVYEVMYSCWHEK 241
Query: 297 PRERPNPRSLVTAL 310
P RP L+ A+
Sbjct: 242 PEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 24/250 (9%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMPNDTL 140
+AVK R + +E + L + + GCC E + L+ EY+P +L
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200
+L + A L A I E + Y S+ ++ DL A ++ D+D ++ F
Sbjct: 96 RDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDF 151
Query: 201 GLMKNSRDGRSY-------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS---GKH 250
GL K +G Y + + + E L+ + + S ++SFG L +LL+ K
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
Query: 251 IPPSHALDLIRDRNIQT----LTDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNP 303
PP ++I + Q L + G + E+ L C + E + RP
Sbjct: 212 SPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271
Query: 304 RSLVTALVTL 313
RSL+ L +
Sbjct: 272 RSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL-FHWETQPMKWAMRL 158
F E A + QL ++ L G C GDE ++V EY+ +L +L + + W +L
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103
Query: 159 RVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST--- 214
VA +A AL + +++ L H ++ A ++ + + + +K S G S +
Sbjct: 104 EVAKQLAWALHFL--EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161
Query: 215 -----NLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
+ + PPE + + ++ + +SFGT L ++ SG P S ALD + +Q
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS-ALD--SQKKLQFY 218
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
D Q + + TEL L ++C+ YEP RP+ R+++ L
Sbjct: 219 ED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 50/187 (26%), Positives = 93/187 (49%), Gaps = 11/187 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G ++AVK + FL+EA+ + +LR+ +L L C E + +V
Sbjct: 22 VWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L L E + ++ + +A IAE + Y S+ ++ DL A I+ ++
Sbjct: 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGEN 139
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ +++ FGL + +R+G + + +T PE GR T +S ++SFG LL ++
Sbjct: 140 LVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
Query: 246 LSGKHIP 252
++ +P
Sbjct: 198 VTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 20/238 (8%)
Query: 73 VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++AVK P++ FLEEA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGNTKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM +L L E + +K + +A +A + Y + ++ DL + I+ D
Sbjct: 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY-IERMNYIHRDLRSANILVGD 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
+ +++ FGL + +R G + + +T PE GR T +S ++SFG LL +
Sbjct: 138 GLVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L++ +P P + +R + + D L L +C + +P ERP
Sbjct: 196 LVTKGRVPYPG-----MNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 37/272 (13%)
Query: 66 GEKAPNVVYKGKLE----NQFRIAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
GE V +G+L +Q ++AVK + + + + +FL EA + + + L+
Sbjct: 8 GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLI 67
Query: 120 GCCCEGDER------LLVAEYMPNDTLAKHLFH--WETQPMKWA--MRLRVALHIAEALE 169
G C E +++ +M + L L + P K L+ + IA +E
Sbjct: 68 GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EY 223
Y +++ ++ DL A + +D+ ++ FGL K G Y P E
Sbjct: 128 YLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 224 LRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFS 278
L T +S +++FG + ++ + P D +R N + CL+
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD---- 242
Query: 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
EL L C + +P++RP L L
Sbjct: 243 -----ELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 60/238 (25%), Positives = 111/238 (46%), Gaps = 20/238 (8%)
Query: 73 VYKGKLENQFRIAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++A+K + P+A FL+EA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGTTKVAIKTLKPGTMMPEA--FLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E+M +L L + + +K + +A IA+ + Y + ++ DL A I+ D
Sbjct: 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY-IERMNYIHRDLRAANILVGD 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
++ +++ FGL + +R G + + +T PE GR T +S ++SFG LL +
Sbjct: 138 NLVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L++ +P P + ++ + C +G S L L C + +P ERP
Sbjct: 196 LVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPES-----LHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 45/187 (24%), Positives = 88/187 (47%), Gaps = 11/187 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G N ++AVK + + FLEEA + L++ +L L + + ++
Sbjct: 22 VWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
EYM +L L E + + + IAE + Y ++ ++ DL A ++ +
Sbjct: 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY-IERKNYIHRDLRAANVLVSES 139
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ +++ FGL + +R+G + + +T PE + G T +S ++SFG LL ++
Sbjct: 140 LMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLYEI 197
Query: 246 LSGKHIP 252
++ IP
Sbjct: 198 VTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 73 VYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G R+A+K P+A FL+EA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y + ++ DL A I+ +
Sbjct: 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGE 137
Query: 192 DVNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
++ +++ FGL + +R G + + +T PE GR T +S ++SFG LL +
Sbjct: 138 NLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 245 LLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L + +P P + D+ + C + L L +C + EP ERP
Sbjct: 196 LTTKGRVPYPGMVNREVLDQVERGYRMPC-----PPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC 121
V E G +V+ G + ++A+K A + F+EEA+ + +L + +L L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALY 179
C E LV E+M + L+ +L Q K++ L + L + E + Y S ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN-VIH 123
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESV 234
DL A + ++ ++S FG+ + D + S+ + ++ PE + + +S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 235 MYSFGTLLLDLLSGKHIP 252
++SFG L+ ++ S P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 42/268 (15%)
Query: 79 ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
+++ +AVK ++ + F EA + L++ + G C EGD ++V EYM +
Sbjct: 33 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 139 TLAKHL--------FHWETQP---MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
L K L E + + L +A IA + Y S + ++ DL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNC 151
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPESVMY 236
+ +++ ++ FG+ SRD YST+ + + PPE + + T ES ++
Sbjct: 152 LVGENLLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206
Query: 237 SFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291
S G +L ++ + GK + + ++ I + +C + E+ L
Sbjct: 207 SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK---------EVYDLMLG 257
Query: 292 CLQYEPRERPNPRSLVTALVTLQKDTEV 319
C Q EP R N + + + L L K + V
Sbjct: 258 CWQREPHMRLNIKEIHSLLQNLAKASPV 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 57/240 (23%), Positives = 109/240 (45%), Gaps = 21/240 (8%)
Query: 84 IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
+AVK +FL+EA + ++++ L LLG C ++ E+M L +
Sbjct: 34 VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203
L Q + + L +A I+ A+EY K ++ DL A + ++ +++ FGL
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLS 151
Query: 204 KNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL 257
+ G +Y+ + + +T PE L + + +S +++FG LL ++ + + P +
Sbjct: 152 RLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 209
Query: 258 DLIRDRNIQTLTDSCLEGQFSSD--EG--TELVRLASRCLQYEPRERPNPRSLVTALVTL 313
DL + L LE + + EG ++ L C Q+ P +RP+ + A T+
Sbjct: 210 DL---SQVYEL----LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 45/271 (16%)
Query: 79 ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138
+++ +AVK + F EA + L++ + G C +GD ++V EYM +
Sbjct: 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 92
Query: 139 TLAKHL--------FHWETQPMK------WAMRLRVALHIAEALEYCTSKERALYHDLNA 184
L K L + QP + + L +A IA + Y S + ++ DL
Sbjct: 93 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLAT 151
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPES 233
+ ++ ++ FG+ SRD YST+ + + PPE + + T ES
Sbjct: 152 RNCLVGANLLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206
Query: 234 VMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
++SFG +L ++ + GK + + ++ I + C + E+ +
Sbjct: 207 DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK---------EVYDI 257
Query: 289 ASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
C Q EP++R N + + L L K T +
Sbjct: 258 MLGCWQREPQQRLNIKEIYKILHALGKATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 5e-09
Identities = 55/182 (30%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 126 DERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
+E+L LV EY P L HL + A R A I ALEY S +Y DL
Sbjct: 65 EEKLYLVLEYAPGGELFSHLSKEGRFSEERA-RFYAA-EIVLALEYLHSL-GIIYRDLKP 121
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D D + +L+ FGL K S + TP PE L +S G
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSDEGTELVRLASRCLQYEPR 298
LL ++L+GK PP +A + + + + L+ F E L S LQ +P
Sbjct: 182 LLYEMLTGK--PPFYA------EDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233
Query: 299 ER 300
+R
Sbjct: 234 KR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 40/267 (14%)
Query: 64 EHGEKAPNVVYKGKLENQFR----IAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANL 118
E GE V +G+L+ + +A+K + R FL EA +GQ + + L
Sbjct: 16 EFGE-----VCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
G + +++ EYM N +L K L + + + + IA ++Y + E
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLS--EMNY 127
Query: 179 YH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTN-----LAFTPPEYLRTGRVTP 231
H DL A I+ + ++ ++S FGL + D + Y+T + +T PE + + T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187
Query: 232 ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD--------SCLEGQFSSDEGT 283
S ++SFG ++ +++S P D+ I+ + D C
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP---YWDMSNQDVIKAVEDGYRLPPPMDCPSA-------- 236
Query: 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310
L +L C Q + ERP +V+ L
Sbjct: 237 -LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 48/279 (17%)
Query: 56 FAMENIV--SEHGEKAPNVVYKGKLEN------QFRIAVKRFN-RSAWPDARQFLEEARA 106
E I E G+ + +VY+G + + R+A+K N ++ + +FL EA
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62
Query: 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------FHWETQPMKWAMRL 158
+ + + LLG G L+V E M L +L + P +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 159 RVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--- 215
++A IA+ + Y +K + ++ DL A + +D+ ++ FG+ +RD Y T+
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGM---TRD--IYETDYYR 176
Query: 216 --------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP---PSH--ALDLIRD 262
+ + PE L+ G T +S ++SFG +L ++ + P S+ L + D
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236
Query: 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L ++C + +L+ L C QY P+ RP
Sbjct: 237 GGHLDLPENCPD---------KLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 44/187 (23%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V++G N +AVK + D + FL EA+ + +LR+ +L L C + +V
Sbjct: 22 VWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
E M +L ++L + +K + +A +A + Y + + ++ DL A ++ ++
Sbjct: 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGEN 139
Query: 193 VNPRLSCFGLMK-------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+++ FGL + +R+G + + +T PE R + +S ++SFG LL ++
Sbjct: 140 NICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
Query: 246 LSGKHIP 252
++ +P
Sbjct: 198 VTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 42/265 (15%)
Query: 66 GEKAPNVVYKGKL---ENQFRIAVKRF-----NRSAWPDARQFLEEARAVGQLRNRRLAN 117
GE V +G+L ++ ++AVK RS D FL EA + + + +
Sbjct: 8 GEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED---FLSEAVCMKEFDHPNVMR 64
Query: 118 LLGCCCEGDER------LLVAEYMPNDTLAKHLFHWE--TQP--MKWAMRLRVALHIAEA 167
L+G C + E +++ +M + L L + P + M ++ IA
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN------SRDGRSYSTNLAFTPP 221
+EY +SK ++ DL A + ++++N ++ FGL K R GR + +
Sbjct: 125 MEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQ 276
E L T +S ++SFG + ++ + P S D +R N CL+G
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGL 243
Query: 277 FSSDEGTELVRLASRCLQYEPRERP 301
+S L S C P++RP
Sbjct: 244 YS---------LMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 19/252 (7%)
Query: 66 GEKAPNVVYKGKLENQFRI-AVKRFNRSAWPDARQ--FLEEARAVGQLRNRRLANLLGCC 122
G+ + VV+K + R+ A+K+ + S + ++EAR + +L + +
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68
Query: 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
+ + +V EY N L K L +P+ R + I L + SK + L+ D+
Sbjct: 69 LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDI 127
Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSF 238
+ + D N ++ G+ K D +++ + TP PE +S +++
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQY 295
G +L + +GKH P A N L + G F S +L +L +CL
Sbjct: 188 GVVLYECCTGKH--PFDA------NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239
Query: 296 EPRERPNPRSLV 307
+ R+RP+ L+
Sbjct: 240 DYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 53/241 (21%), Positives = 93/241 (38%), Gaps = 23/241 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VYK + +A+K + + + E + + + ++ + G + DE +
Sbjct: 15 EVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V E+ +L K L Q + + V + + LEY S ++ D+ A I+
Sbjct: 75 VMEFCSGGSL-KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLT 132
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
D +L FGL D ++ + TP PE + ++ ++S G ++L
Sbjct: 133 SDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191
Query: 247 SGKHIPPSH------ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
GK PP AL I L + SDE + + +CLQ P +R
Sbjct: 192 EGK--PPYSELPPMKALFKIATNGPPGL----RNPEKWSDEFKDFL---KKCLQKNPEKR 242
Query: 301 P 301
P
Sbjct: 243 P 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 19/156 (12%)
Query: 158 LRVALHIAEALEYC----TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213
R+ + AL C L+ DL I D + N +L FGL K S++
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 214 TNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQ 266
TP PE L +S ++S G L+ +L + PP A L L I+
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS--PPFTARNQLQLA--SKIK 223
Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+ ++SS EL + L +P +RP+
Sbjct: 224 EGKFRRIPYRYSS----ELNEVIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 44/261 (16%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK AR FL+E + + +L+N + LLG C D ++ EYM N L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 143 HLFHWETQP----------MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192
L E + + A L +A+ IA ++Y S ++ DL + +
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGNH 165
Query: 193 VNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLLLDLL 246
+++ FG+ +N G Y P E + G+ T S +++FG L ++
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTE------------LVRLASR 291
+ L +++ L+D + G+F ++G + + +L R
Sbjct: 226 T-----------LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR 274
Query: 292 CLQYEPRERPNPRSLVTALVT 312
C + ++RP + L
Sbjct: 275 CWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 96 DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWA 155
D+ F E A + QL ++ L L G C DE ++V EY+ L L H E +
Sbjct: 44 DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLH 101
Query: 156 MRLRVALHIAEALEYCTSKE--------RALY---HDLNAYRIVFDDDVNPRLSCFGLMK 204
+L VA +A AL Y K+ + + + LN + F +P + L +
Sbjct: 102 WKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 205 NSRDGRSYSTNLAFTPPEYLRTGRVTPESVM--YSFGTLLLDLLSGKHIP-----PSHAL 257
R R + PE +R G+ + +SFGT LL++ S P S
Sbjct: 162 EERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216
Query: 258 DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
+D++ + D EL L ++C Y+P +RP+ R+++ L
Sbjct: 217 RFYQDQHRLPMPDC-----------AELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 54/253 (21%), Positives = 100/253 (39%), Gaps = 46/253 (18%)
Query: 84 IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL-- 140
+AVK +A + R L E + Q+ + + L G C + LL+ EY +L
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 141 --------------------AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
+ +L + + + + + A I+ ++Y E L H
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVH 150
Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPES 233
DL A ++ + ++S FGL ++ + SY + + E L T +S
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS 210
Query: 234 VMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
++SFG LL ++++ G + I P +L++ ++C E E+ L
Sbjct: 211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSE---------EMYNL 261
Query: 289 ASRCLQYEPRERP 301
C + EP +RP
Sbjct: 262 MLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 52/268 (19%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK A +AR FL+E + + +L++ + LLG C + D ++ EYM N L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 143 HLFHWETQ-----------------PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L + ++ L VAL IA ++Y +S ++ DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRDLATR 167
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFG 239
+ +++ +++ FG+ +N G Y P E + G+ T S +++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTE------------ 284
L ++L L +++ LTD + G+F D+G +
Sbjct: 228 VTLWEILM-----------LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQG 276
Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVT 312
L L +C + RERP S + A +T
Sbjct: 277 LYELMLQCWSRDCRERP-SFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 98 RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157
R FL EA +GQ + + L G G+ ++V EYM N L L E Q + A +
Sbjct: 51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV--AGQ 108
Query: 158 LRVALH-IAEALEYCTSKERALYHD-LNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
L L +A ++Y + E H L A++++ + D+ ++S F ++ + Y+T
Sbjct: 109 LMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM 166
Query: 216 -----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
+ + PE ++ + S ++SFG ++ +++S
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLR 159
FL EA + L++ +L L + + ++ E+M +L L E +
Sbjct: 48 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-------NSRDGRSY 212
+ IAE + + + ++ DL A I+ + +++ FGL + +R+G +
Sbjct: 107 FSAQIAEGMAF-IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 165
Query: 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQ 266
+ +T PE + G T +S ++SFG LL+++++ IP P L R +
Sbjct: 166 P--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
++C E EL + RC + P ERP
Sbjct: 224 R-PENCPE---------ELYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 32/257 (12%)
Query: 72 VVYKGKL--ENQFRI--AVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
VY G L + +I AVK NR + + QFL+E + + + +LLG C +
Sbjct: 10 CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE 69
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L+V YM + L ++ ET + L +A+ +EY SK + ++ DL A
Sbjct: 70 GSPLVVLPYMKHGDL-RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAAR 127
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYS 237
+ D+ +++ FGL ++ D YS + + + E L+T + T +S ++S
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG------QFSSDEGTELVRLASR 291
FG LL +L++ + PP D + +T L+G ++ D L +
Sbjct: 188 FGVLLWELMT-RGAPP------YPDVDSFDITVYLLQGRRLLQPEYCPD---PLYEVMLS 237
Query: 292 CLQYEPRERPNPRSLVT 308
C +P RP LV+
Sbjct: 238 CWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 49/268 (18%)
Query: 68 KAPNVVYKGKLENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGD 126
+AP ++ E +AVK A D + F EA + + + + LLG C G
Sbjct: 25 RAPGLL---PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81
Query: 127 ERLLVAEYMPNDTLAKHLFH----WETQ----------------PMKWAMRLRVALHIAE 166
L+ EYM L + L H + P+ +L +A +A
Sbjct: 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141
Query: 167 ALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN--SRDGRSYSTNLA----FT 219
+ Y + ER H DL + +++ +++ FGL +N S D S N A +
Sbjct: 142 GMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM 199
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD------LIRDRNIQTLTDSCL 273
PPE + R T ES ++++G +L ++ S + P + + +RD N+ + D+C
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAHEEVIYYVRDGNVLSCPDNC- 257
Query: 274 EGQFSSDEGTELVRLASRCLQYEPRERP 301
EL L C P +RP
Sbjct: 258 --------PLELYNLMRLCWSKLPSDRP 277
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 63/284 (22%), Positives = 118/284 (41%), Gaps = 48/284 (16%)
Query: 62 VSEHGEKAPNVVYKGKL-----ENQFRIAVKRF----NRSAWPDARQFLEEARAVGQLRN 112
+ E GE A +YKG L ++ +A+K N W + F +EA + +L +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---FQQEASLMAELHH 66
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-----------ETQPMKWAMR---- 157
+ LLG + ++ EY+ L + L E +K ++
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-- 215
L +A+ IA +EY +S ++ DL A I+ + ++ ++S GL + Y
Sbjct: 127 LHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 216 ----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQ 266
+ + PPE + G+ + +S ++SFG +L ++ S P ++++R R +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL 245
Query: 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
++ C +S L + C Q P RP + + T L
Sbjct: 246 PCSEDCPPRMYS---------LMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 23/198 (11%)
Query: 64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANL 118
E GE V++G L+ + +A+K RQ FL EA +GQ + + L
Sbjct: 17 EFGE-----VFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 119 LGCCCEGDERLLVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
G + +++ EYM N L K+L E + LR IA ++Y S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKY-LSDMN 127
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN-----LAFTPPEYLRTGRV 229
++ DL A I+ + ++ ++S FGL + D +Y+T+ + +T PE + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 230 TPESVMYSFGTLLLDLLS 247
T S ++SFG ++ +++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 56/256 (21%), Positives = 102/256 (39%), Gaps = 35/256 (13%)
Query: 73 VYKGKL-------ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
VY+G R+AVK + A + +FL+EA + + + LLG C
Sbjct: 11 VYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAM-----RLRVALHIAEALEYCTSKERALY 179
+ + ++ E M L +L + + L + L +A+ Y + ++
Sbjct: 71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY-LEQMHFIH 129
Query: 180 HDLNAYRIV-----FDDDVNPRLSCFGLMKNSRDGRSYST------NLAFTPPEYLRTGR 228
DL A + +D D ++ FGL ++ Y + + PE L G+
Sbjct: 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189
Query: 229 VTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--EL 285
T +S ++SFG L+ ++L+ P P+ N + L G+ E ++
Sbjct: 190 FTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTAGGRLQKPENCPDKI 242
Query: 286 VRLASRCLQYEPRERP 301
+L + C +P ERP
Sbjct: 243 YQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 54/244 (22%), Positives = 104/244 (42%), Gaps = 24/244 (9%)
Query: 76 GKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135
E + ++ +K + S + F E A + Q+ ++ + L G C E ++V E++
Sbjct: 27 YSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFV 86
Query: 136 PNDTLAKHLF-HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH------DLNAYRIV 188
L LF H ++ + + +VA +A AL Y K+ L H ++ R
Sbjct: 87 EFGPL--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREG 142
Query: 189 FDDDVNP--RLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDL 245
D + P +LS G+ + + + PE + + + + +SFGT L ++
Sbjct: 143 IDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF--SSDEGTELVRLASRCLQYEPRERPNP 303
IP ++D+ + + EGQ + EL L + C+ Y+P +RP
Sbjct: 203 CYNGEIP-------LKDKTLAE-KERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFF 254
Query: 304 RSLV 307
R+++
Sbjct: 255 RAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 12/183 (6%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VY K + +AVK + ++FL EA + QL + + L+G C+G+ +LV
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCKGEPLMLV 73
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E P L K+L + + + + +A +A + Y SK ++ DL A ++ +
Sbjct: 74 MELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVN 130
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
++S FG+ + G Y L + PE + G+ + +S ++S+G L +
Sbjct: 131 RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190
Query: 245 LLS 247
S
Sbjct: 191 AFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 68/273 (24%), Positives = 110/273 (40%), Gaps = 52/273 (19%)
Query: 64 EHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLA 116
E GE A V+ + N + +AVK + A ARQ F EA + L+++ +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIV 70
Query: 117 NLLGCCCEGDERLLVAEYMPNDTL----------AKHLFHWETQP---MKWAMRLRVALH 163
G C EG L+V EYM + L AK L E + L +A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 164 IAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------- 215
IA + Y S ++ DL + + ++ FG+ SRD YST+
Sbjct: 131 IASGMVYLASLH-FVHRDLATRNCLVGQGLVVKIGDFGM---SRD--IYSTDYYRVGGRT 184
Query: 216 ---LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQT 267
+ + PPE + + T ES ++SFG +L ++ + GK + + A++ I
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+C E+ + C Q EP++R
Sbjct: 245 RPRTC---------PPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 26/226 (11%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLR 159
FL+EA + L + L L G ++V E P +L L +
Sbjct: 43 FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 160 VALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---- 215
A+ IA + Y SK R ++ DL A I+ D ++ FGLM+ +
Sbjct: 102 YAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 216 ---LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-----GKHIPPSHALDLIRDRNIQT 267
A+ PE LRT + S ++ FG L ++ + + S L I D+ +
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DKEGER 219
Query: 268 LT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311
L ++C + ++ + +C + P +RP +L L
Sbjct: 220 LERPEACPQ---------DIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 34/247 (13%)
Query: 81 QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140
+ R+ +K + S A F E A + Q+ + LA + G C G E ++V E++ + L
Sbjct: 44 ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 141 AKHLFHWETQ-PMKWAMRLRVALHIAEALEYCTSKERALYH------DLNAYRIVFDDDV 193
L + + P+ W ++ VA +A AL Y K L H ++ R+ +
Sbjct: 104 DVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGT 159
Query: 194 NP--RLS--CFGLMKNSRDGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSG 248
+P +LS SR+ R + + PE + G ++ + +SFGT LL++
Sbjct: 160 SPFIKLSDPGVSFTALSREERV--ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217
Query: 249 KHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
+P PS + ++ + SC EL L S+CL YEP +RP+
Sbjct: 218 GEVPLKERTPSEK-ERFYEKKHRLPEPSC----------KELATLISQCLTYEPTQRPSF 266
Query: 304 RSLVTAL 310
R+++ L
Sbjct: 267 RTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 53/253 (20%), Positives = 104/253 (41%), Gaps = 37/253 (14%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR--- 157
+E + +G+ +N + NLLG C + ++ EY L ++L M ++
Sbjct: 68 MEMMKMIGKHKN--IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 158 -----------LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
+ A +A +EY S+ + ++ DL A ++ +D +++ FGL ++
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 207 RDGRSY--STN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-----KHIPPSH 255
+ Y +TN + + PE L T +S ++SFG LL ++ + IP
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315
L+++ + +C EL + C P +RP + LV L +
Sbjct: 245 LFKLLKEGHRMDKPANCTH---------ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
Query: 316 DTEVPSHVLMGIP 328
T ++ + +P
Sbjct: 296 VTSTDEYLDLSVP 308
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 23/249 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VY + +AVK P R+ FL+EA + Q + + L+G E + +V
Sbjct: 26 VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E P L +L + A + + ++ AL Y SK R ++ D+ A ++
Sbjct: 85 MELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSS 142
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PEYLRTGRVTPESVMYSFGTLLLDLL 246
+L FGL + D Y + P PE + R T S ++ FG + ++L
Sbjct: 143 PDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
Query: 247 S-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
G + + + I + + +C L L ++C Y+P +RP
Sbjct: 203 MLGVKPFQGVKNNDVIGRIENGERLPMPPNC---------PPTLYSLMTKCWAYDPSKRP 253
Query: 302 NPRSLVTAL 310
L L
Sbjct: 254 RFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 59/266 (22%), Positives = 100/266 (37%), Gaps = 27/266 (10%)
Query: 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLAN 117
++ G A VVY L N ++A+KR + + +E +A+ Q + +
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 118 LLGCCCEGDERLLVAEYMPNDTLA---KHLFHWETQPMKW-AMRLRVALHIAEALEYCTS 173
GDE LV Y+ +L K + A L+ L + LEY S
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHS 120
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFG----LMKNSRDGRSYSTNLAFTP----PEYLR 225
+ ++ D+ A I+ +D + +++ FG L R TP PE +
Sbjct: 121 NGQ-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 226 TGRVTPESV-MYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280
++SFG ++L +G PP L L + +L ++S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK- 238
Query: 281 EGTELVRLASRCLQYEPRERPNPRSL 306
++ S CLQ +P +RP L
Sbjct: 239 ---SFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 53/250 (21%), Positives = 97/250 (38%), Gaps = 42/250 (16%)
Query: 84 IAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK S D FL EA + + ++ + L+G E R ++ E M L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 143 HLFHWE---TQPMKWAMR--LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
L +P M+ L A +A+ +Y ++ D+ A + L
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCL--------L 149
Query: 198 SC-----------FGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSFGT 240
+C FG+ ++ Y + + PPE G T ++ ++SFG
Sbjct: 150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209
Query: 241 LLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEG--TELVRLASRCLQYEP 297
LL ++ S ++P P N + + G+ +G + R+ + C Q+ P
Sbjct: 210 LLWEIFSLGYMPYPGR-------TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTP 262
Query: 298 RERPNPRSLV 307
+RPN +++
Sbjct: 263 EDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 48/223 (21%), Positives = 92/223 (41%), Gaps = 16/223 (7%)
Query: 100 FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF-------HWETQPM 152
F E +L ++ + LLG C E + ++ EY L + L + P+
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 153 KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
++ + IA +++ S R ++ DL A + ++S L K+ + Y
Sbjct: 115 STKQKVALCTQIALGMDH-LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 213 STN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT 267
L + PE ++ + +S ++SFG L+ ++ + +P L + +
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY---GLSDEEVLNR 230
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
L LE + L +L +RC P++RP+ LV+AL
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 50/201 (24%), Positives = 97/201 (48%), Gaps = 27/201 (13%)
Query: 64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLAN 117
E GE V +G+L+ + +A+K +S + + R FL EA +GQ + + +
Sbjct: 16 EFGE-----VCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQ--PMKWAMRLRVALHIAEALEYCTSKE 175
L G + +++ E+M N L L + Q ++ LR IA ++Y S+
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKY-LSEM 125
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---YSTNLA------FTPPEYLRT 226
++ DL A I+ + ++ ++S FGL + D S Y+++L +T PE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 227 GRVTPESVMYSFGTLLLDLLS 247
+ T S ++S+G ++ +++S
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 53/243 (21%), Positives = 104/243 (42%), Gaps = 19/243 (7%)
Query: 73 VYKGKLENQFR--IAVKRFN-RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VYKG ++N+ + +A+K + A + +E + Q + + G +G +
Sbjct: 20 VYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
++ EY+ + L + P++ + I + L+Y S ER ++ D+ A ++
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLL 134
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
+ + +L+ FG+ D + TP PE ++ ++ ++S G ++L
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
Query: 246 LSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
G+ PP+ L +R I + LEGQ+S CL +PR RP +
Sbjct: 195 AKGE--PPNSDLHPMRVLFLIPKNSPPTLEGQYSK----PFKEFVEACLNKDPRFRPTAK 248
Query: 305 SLV 307
L+
Sbjct: 249 ELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK A +AR FL+E + + +L++ + LL C D ++ EYM N L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 143 HLFHWETQP---------MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193
L E Q + ++ + +A IA ++Y +S ++ DL + +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-FVHRDLATRNCLVGKNY 167
Query: 194 NPRLSCFGLMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLLLDLLS 247
+++ FG+ +N G Y P E + G+ T S +++FG L ++L+
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
Query: 248 -GKHIPPSHALD---------LIRDRNIQT 267
K P S D RD+ Q
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQV 257
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 10/174 (5%)
Query: 84 IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143
+A+K+ N P + E + +L+N + N L GDE +V EY+ +L
Sbjct: 47 VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV 106
Query: 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203
+ + A R L +ALE+ + + ++ D+ + ++ D + +L+ FG
Sbjct: 107 VTETCMDEAQIAAVCRECL---QALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFC 162
Query: 204 KNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
+S + + TP PE + P+ ++S G + ++++ G+ PP
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 40/246 (16%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL---------FHWET-- 149
+E + +G+ +N + NLLG C + ++ EY L ++L + ++
Sbjct: 71 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 150 ---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK-- 204
+ M + + +A +EY S ++ ++ DL A ++ ++ +++ FGL +
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 205 NSRDGRSYSTN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGK---HIPPSH 255
N+ D +TN + + PE L T +S ++SFG L+ ++ L G IP
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL---VT 312
L+++ + +C EL + C P RP + LV L +T
Sbjct: 248 LFKLLKEGHRMDKPANCT---------NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298
Query: 313 LQKDTE 318
L + E
Sbjct: 299 LTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 37/235 (15%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------------FH 146
+E + +G+ +N + NLLG C + ++ EY L ++L
Sbjct: 74 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
+ + + + A +A +EY SK + ++ DL A ++ +D +++ FGL ++
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 207 R--DGRSYSTN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGK---HIPPSH 255
D +TN + + PE L T +S ++SFG LL ++ L G +P
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
L+++ + +C EL + C P +RP + LV L
Sbjct: 251 LFKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 16/228 (7%)
Query: 77 KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LVAEYM 135
KLE + RI KR S + +Q LE+ N R L E + L LV M
Sbjct: 32 KLEKK-RIK-KRKGESMALNEKQILEKV-------NSRFVVSLAYAYETKDALCLVLTLM 82
Query: 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
L H++H + + A I LE +ER +Y DL I+ DD +
Sbjct: 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED-LHQERIVYRDLKPENILLDDHGHI 141
Query: 196 RLSCFGLMKNSRDGRSYS---TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
R+S GL + +G++ + + PE ++ R T ++ G LL ++++G+ P
Sbjct: 142 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS-P 200
Query: 253 PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
I+ ++ L E ++S + L L +P+ER
Sbjct: 201 FQQRKKKIKREEVERLVKEVQE-EYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 30/247 (12%)
Query: 84 IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER--LLVAEYMP----N 137
+AVK+ S R F E + L++ + G C R LV EY+P
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197
D L KH + + + L A I + +EY SK R ++ DL I+ + + ++
Sbjct: 96 DYLQKHRERLDHRKL-----LLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKI 149
Query: 198 SCFGLMKNSRDGRSYST-------NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKH 250
FGL K + Y + + PE L + + S ++SFG +L +L +
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSD 209
Query: 251 I---PPSHALDLI-RDRNIQTLTDSCLE-----GQFSSDEG--TELVRLASRCLQYEPRE 299
PP+ + ++ D+ Q + +E G+ + G E+ + C +P +
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQ 269
Query: 300 RPNPRSL 306
RP+ L
Sbjct: 270 RPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 44/200 (22%), Positives = 82/200 (41%), Gaps = 41/200 (20%)
Query: 73 VYKG-----KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
VYKG + + +A+K P A + L+EA + + + + LLG C
Sbjct: 23 VYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SS 81
Query: 127 ERLLVAEYMP-----------NDTL-AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK 174
+ L+ + MP D + +++L +W Q IA+ + Y +
Sbjct: 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-------------IAKGMSYL--E 126
Query: 175 ERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTP-----PEYLRTG 227
E+ L H DL A ++ + +++ FGL K D + Y P E +
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 228 RVTPESVMYSFGTLLLDLLS 247
T +S ++S+G + +L++
Sbjct: 187 IYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 66 GEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLL 119
G A VYKG + +A+K N + P A +F++EA + + + L LL
Sbjct: 16 GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 75
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
G C + LV + MP+ L ++ H + + L + IA+ + Y +ER L
Sbjct: 76 GVCLSPTIQ-LVTQLMPHGCLLDYV-HEHKDNIGSQLLLNWCVQIAKGMMYL--EERRLV 131
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAFTPPEYL-----RTGRVTPE 232
H DL A ++ + +++ FGL + D + Y+ + P +++ + T +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 233 SVMYSFGTLLLDLLS 247
S ++S+G + +L++
Sbjct: 192 SDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 98 RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT----LAKHLFHWETQPMK 153
R FL EA +GQ + + +L G + ++V EYM N + L KH + +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109
Query: 154 WAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211
+R IA ++Y S ++ DL A I+ + ++ ++S FGL + D +
Sbjct: 110 GMLR-----GIASGMKY-LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163
Query: 212 YSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
Y+T + +T PE + + T S ++S+G ++ +++S
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66 GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + + A R L +ALE+ S + ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 144
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 241 LLLDLLSGKHIPP 253
+ ++++ G+ PP
Sbjct: 205 MAIEMIEGE--PP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 159 RVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL---MKNSRDGRSYSTN 215
++A+ + E L Y + R ++ D+ I+ + +L FG+ + NS T+
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS 166
Query: 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK------------HIPPSHALDLIRDR 263
+ PE ++ G+ T +S ++S G +++L GK P LDL++ +
Sbjct: 167 -TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-Q 224
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
+Q F D L CL +P ERP P+ L
Sbjct: 225 IVQEPPPRLPSSDFPED----LRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 43/146 (29%), Positives = 63/146 (43%), Gaps = 23/146 (15%)
Query: 130 LVAEYMPND---TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
+V EYM +D L + +K M+ + E L+Y S L+ D+
Sbjct: 77 MVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-----QLLEGLQYLHSN-GILHRDIKGSN 130
Query: 187 IVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFT----PPEYLRTG--RVTPESVMYSF 238
I+ ++D +L+ FGL + R+ Y TN T PPE L G R PE M+S
Sbjct: 131 ILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPELL-LGATRYGPEVDMWSV 188
Query: 239 GTLLLDLLSGKHIPP----SHALDLI 260
G +L +L GK I L+ I
Sbjct: 189 GCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 42/193 (21%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66 GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+K+ N P + E + + +N + N L
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 87
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + + A R L +AL++ S + ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQ-VIHRDIKS 143
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 241 LLLDLLSGKHIPP 253
+ ++++ G+ PP
Sbjct: 204 MAIEMVEGE--PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 35/225 (15%)
Query: 111 RNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAM 156
+++ + NLLG C + ++ EY L + L + + +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--ST 214
+ A +A +EY S+ R ++ DL A ++ +D +++ FGL + D Y ++
Sbjct: 136 LVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 215 N----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGKH---IPPSHALDLIRDRNI 265
N + + PE L T +S ++SFG L+ ++ L G IP L+R+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254
Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
+C EL L C P +RP + LV AL
Sbjct: 255 MDKPSNCTH---------ELYMLMRECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 50/231 (21%), Positives = 101/231 (43%), Gaps = 34/231 (14%)
Query: 110 LRNRRLANLL---GCCCEGDER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHI 164
LRN N++ G C E L+ E++P+ +L ++L + +L+ A+ I
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQI 118
Query: 165 AEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-------NLA 217
+ ++Y S++ ++ DL A ++ + + ++ FGL K + Y T +
Sbjct: 119 CKGMDYLGSRQY-VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177
Query: 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSG------------KHIPPSHALDLIRDRNI 265
+ PE L + S ++SFG L +LL+ K I P+H + R +
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG-QMTVTRLV 236
Query: 266 QTLTDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313
+ L EG+ + E+ +L +C +++P +R ++L+ +
Sbjct: 237 RVLE----EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 26/182 (14%)
Query: 126 DERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
D LV ++ L H+ + E +WA + VAL +AL +E + D
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL---DALH----REGIVCRD 110
Query: 182 LNAYRIVFDDDVNPRLSCFGL---MKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSF 238
LN I+ DD + +L+ F +++S DG + + PE T +S
Sbjct: 111 LNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN--MYCAPEVGGISEETEACDWWSL 168
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
G +L +LL+GK + H I T T + ++ S+E L+ + LQ+ P
Sbjct: 169 GAILFELLTGKTLVECHP------SGINTHTTLNIP-EWVSEEARSLL---QQLLQFNPT 218
Query: 299 ER 300
ER
Sbjct: 219 ER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 20/247 (8%)
Query: 76 GKLENQFRIAVKRFNRSAWPDARQFL-EEARAVGQLRNR-RLANLLGCCCEGDERLLVAE 133
K + ++AVK +A R+ L E + + L N + NLLG C G L++ E
Sbjct: 60 SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119
Query: 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193
Y L L + L + +A+ + + SK ++ DL A ++
Sbjct: 120 YCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGK 178
Query: 194 NPRLSCFGLMKNSRDGRSY-STNLAFTP-----PEYLRTGRVTPESVMYSFGTLLLDLLS 247
++ FGL ++ + +Y A P PE + T ES ++S+G LL ++ S
Sbjct: 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
Query: 248 -GKHIPPSHALDLIRDRNIQTLTDS---CLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
G + P + D L + + + E ++++ C +P +RP
Sbjct: 239 LGSNPYP----GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK---TCWDADPLKRPTF 291
Query: 304 RSLVTAL 310
+ +V +
Sbjct: 292 KQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 30/210 (14%)
Query: 83 RIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141
R+ VK SA PD + FL+E + +L + + LG C E LLV E+ P L
Sbjct: 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83
Query: 142 KHL------FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195
+L Q + R+A +A L + + ++ DL D++
Sbjct: 84 NYLRSNRGMVAQMAQKD---VLQRMACEVASGLLW-LHQADFIHSDLALRNCQLTADLSV 139
Query: 196 RLSCFGLMKNSRDGRSYSTN------LAFTPPEY-------LRTGRVTPESVMYSFGTLL 242
++ +GL Y T L + PE L T +S ++S G +
Sbjct: 140 KIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199
Query: 243 LDLLSGKHIPPSHALDL------IRDRNIQ 266
+L + P D +R+++I+
Sbjct: 200 WELFTAADQPYPDLSDEQVLKQVVREQDIK 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 45/202 (22%), Positives = 77/202 (38%), Gaps = 26/202 (12%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
+VY + L Q RIA+K + EE L++R + LG E +
Sbjct: 23 IVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82
Query: 131 VAEYMPNDTLAKHL-FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYRIV 188
E +P +L+ L W + I E L+Y HD +R +
Sbjct: 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY--------LHDNQIVHRDI 134
Query: 189 FDDDV--NP-----RLSCFGLMKN----SRDGRSYSTNLAFTPPEYLRTGR--VTPESVM 235
D+V N ++S FG K + +++ L + PE + G + +
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194
Query: 236 YSFGTLLLDLLSGKHIPPSHAL 257
+S G ++++ +GK PP L
Sbjct: 195 WSLGCTIVEMATGK--PPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 57/283 (20%), Positives = 111/283 (39%), Gaps = 42/283 (14%)
Query: 62 VSEHGEKAPNVVYKGKL------ENQFRIAVKRF-NRSAWPDARQFLEEARAVGQLRNRR 114
+ E GE VYKG L E +A+K +++ P +F EA +L++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLF----HWET------QPMKWAMR----LRV 160
+ LLG + ++ Y + L + L H + + +K + + +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST------ 214
IA +E+ +S ++ DL ++ D +N ++S GL + Y
Sbjct: 130 VTQIAAGMEFLSS-HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLT 269
+ + PE + G+ + +S ++S+G +L ++ S P +++IR+R +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248
Query: 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312
D C + L C P RP + + + L T
Sbjct: 249 DDC---------PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 36/174 (20%), Positives = 67/174 (38%), Gaps = 6/174 (3%)
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
LV M L H+++ A + A I LE+ + R +Y DL ++
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH-LHQRRIVYRDLKPENVLL 128
Query: 190 DDDVNPRLSCFGL---MKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
DD N R+S GL +K + + + + PE L+ ++ G L +++
Sbjct: 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+G P + + ++ T + ++ E L LQ +P +R
Sbjct: 189 AG-RSPFRQRKEKVEKEELKRRTLE-MAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 43/193 (22%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 66 GEKAPNVVYKG-KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+K+ N P + E + + ++ + N L
Sbjct: 28 GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV 87
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + ET M V +ALE+ S + ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVT--ETC-MDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKS 143
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 241 LLLDLLSGKHIPP 253
+ ++++ G+ PP
Sbjct: 204 MAIEMVEGE--PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 57/263 (21%), Positives = 108/263 (41%), Gaps = 19/263 (7%)
Query: 66 GEKAPNVVYKGKL----EN-QFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLL 119
G A VYKG EN + +A+K + P A ++ L+EA + + + + LL
Sbjct: 16 GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLL 75
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
G C +L V + MP L ++ + + + L + IA+ + Y + R ++
Sbjct: 76 GICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSY-LEEVRLVH 132
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKN-SRDGRSYSTNLAFTPPEYLRTG-----RVTPES 233
DL A ++ + +++ FGL + D Y + P +++ R T +S
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
++S+G + +L++ P D I R I L + ++ + +C
Sbjct: 193 DVWSYGVTVWELMTFGAKP----YDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCW 248
Query: 294 QYEPRERPNPRSLVTALVTLQKD 316
+ RP R LV + +D
Sbjct: 249 MIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 37/235 (15%)
Query: 101 LEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM--------------PNDTLAKHLFH 146
+E + +G+ +N + NLLG C + +V EY P + +
Sbjct: 66 MEMMKMIGKHKN--IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206
+ + + A +A +E+ SK + ++ DL A ++ +D +++ FGL ++
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 207 RDGRSY--STN----LAFTPPEYLRTGRVTPESVMYSFGTLLLDL--LSGKHIP--PSHA 256
Y +TN + + PE L T +S ++SFG LL ++ L G P P
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 257 L-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
L L+++ +C + EL L C P +RP + LV L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQ---------ELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 34/186 (18%)
Query: 103 EARAVGQLRNRRLANLLGCCCEGDERLL--VAEYMPNDTLAKHLFHWETQPMKWAMRLRV 160
E R + ++ + + L E D+R L + EY+P L +L + + L
Sbjct: 51 EKRVLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFY 106
Query: 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP 220
A I ALEY SKE +Y DL I+ D + + +L+ FG K RD R+++ L T
Sbjct: 107 ASEIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT--LCGT- 161
Query: 221 PEYLRTGRVTPESVM----------YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD 270
PEYL PE + ++ G L+ ++L G PP D N + +
Sbjct: 162 PEYL-----APEVIQSKGHNKAVDWWALGILIYEMLVG--YPP------FFDDNPFGIYE 208
Query: 271 SCLEGQ 276
L G+
Sbjct: 209 KILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 16/147 (10%)
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEY 223
LEY S + ++ D+ A I+ +++ +L+ FG+ D + + TP PE
Sbjct: 112 LEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 224 LRTGRVTPESVMYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279
++ ++ ++S G +++ GK I P A+ +I ++ TL+D ++S
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP---EKWS- 226
Query: 280 DEGTELVRLASRCLQYEPRERPNPRSL 306
E +CL +P ERP+ L
Sbjct: 227 ---PEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 23/199 (11%)
Query: 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG 120
+V + G +Y K+ + I K RQ LE R R L L
Sbjct: 18 LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-----RCPFLVTLH- 71
Query: 121 CCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSKER 176
+ D +L L+ +Y+ L HL+ E V ++IAE AL+ +
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYIAEIVLALD-HLHQLG 125
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMK-----NSRDGRSYSTNLAFTPPEYLRTGRVTP 231
+Y D+ I+ D + + L+ FGL K S+ + + PE +R G
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 232 ESVM--YSFGTLLLDLLSG 248
+ + +S G L +LL+G
Sbjct: 186 DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 13/164 (7%)
Query: 96 DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL-VAEYMPNDTLAKHLFHWETQPMKW 154
D + E R + RN L CC + +RL V E++ L +FH +
Sbjct: 38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD 94
Query: 155 AMRLRV-ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS-RDGRSY 212
R R A I AL + K +Y DL ++ D + + +L+ FG+ K +G++
Sbjct: 95 EARARFYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153
Query: 213 STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252
ST TP PE L+ P ++ G LL ++L G H P
Sbjct: 154 ST-FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 57/252 (22%), Positives = 99/252 (39%), Gaps = 49/252 (19%)
Query: 84 IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVK A +AR+ FL+E + + +L + +A LLG C ++ EYM N L +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 143 HLFHWETQPMKWAMRLR---------VALHIAEALEYCTSKERALYH-DLNAYRIVFDDD 192
L + A + +A IA + Y S H DL + +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKN 166
Query: 193 VNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLR--------TGRVTPESVMYSFGTLLLD 244
+++ FG M + Y + P +R G+ T +S +++FG L +
Sbjct: 167 YTIKIADFG-MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTD-SCLE--GQFSSDEGT------------ELVRLA 289
+L+ L R++ + LTD +E G F D+G ++ L
Sbjct: 225 ILT-----------LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELM 273
Query: 290 SRCLQYEPRERP 301
C + + +RP
Sbjct: 274 LECWRRDEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 372 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.17 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.7 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.41 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.29 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.1 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.1 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.84 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.82 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.78 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.75 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.58 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.44 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.41 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.3 | |
| PLN02236 | 344 | choline kinase | 97.13 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.98 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.92 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.68 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.58 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.47 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.45 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.43 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.38 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.98 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.74 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.35 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=387.72 Aligned_cols=252 Identities=17% Similarity=0.250 Sum_probs=211.8
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC-eeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e 133 (372)
++.+.++.||+|..|+|||+. ..+++.+|+|.+...... ..+++.+|+++++.++||+||.+||.|.... ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 356677889999999999999 567999999999654333 3678999999999999999999999999998 4999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--Cc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 211 (372)
||++|||.++++. .+.+++....+|+.+|++||.|||...+||||||||+|||++..|.+||||||.++...+. .+
T Consensus 159 YMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 159 YMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred hcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhccc
Confidence 9999999999973 3679999999999999999999996339999999999999999999999999999876554 56
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh-ccccccccccccCCCChH-HHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQFSSD-EGTELVRLA 289 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~l~~li 289 (372)
+.||..|||||.+.+..|+.++||||||++++|+.+|+.|++........- ..+..++.. ..+.+|.. +++++++|+
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcccCCHHHHHHH
Confidence 889999999999999999999999999999999999998876531000000 011112221 22345554 889999999
Q ss_pred HHHccCCCCCCCChHHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..||++||.+|||+.++++|-.
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred HHHhcCCcccCCCHHHHhcCHH
Confidence 9999999999999999999943
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-54 Score=397.55 Aligned_cols=274 Identities=35% Similarity=0.621 Sum_probs=236.6
Q ss_pred cccccCHHHHHHHhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEe
Q 017395 40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119 (372)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 119 (372)
..+.|++.+++.+|++|+..+++ |+|+||.||+|...+++.||||++.........+|.+|+++|.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~i---g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLI---GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcce---ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence 56779999999999999998888 999999999999988899999988765543145699999999999999999999
Q ss_pred eEEEeCC-eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CcccccccCcceeecCCCCce
Q 017395 120 GCCCEGD-ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE--RALYHDLNAYRIVFDDDVNPR 196 (372)
Q Consensus 120 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--~iiH~Dikp~Nill~~~~~~k 196 (372)
|||.+.+ +.+||+||+++|+|.++++.....+++|.++.+|+.++|.||+|||... .||||||||+|||+|+++++|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999988 5999999999999999998643338999999999999999999999963 599999999999999999999
Q ss_pred eeccCCcccCCC-CCcc----cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCc-----------hhhHHh
Q 017395 197 LSCFGLMKNSRD-GRSY----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS-----------HALDLI 260 (372)
Q Consensus 197 l~Dfg~~~~~~~-~~~~----~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~-----------~~~~~~ 260 (372)
|+|||+++.... .... .||.+|+|||++..+..+.++|||||||+|+||+||+.+... +....+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999977654 3322 789999999999999999999999999999999999975542 122344
Q ss_pred hhcccccccccccc-CCCCh-HHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 261 RDRNIQTLTDSCLE-GQFSS-DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 261 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.+....+++++.+. ..++. .....+..++.+|++.+|..||+|.+|++.|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 45577788888766 55554 5777899999999999999999999999999665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=387.95 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=215.8
Q ss_pred ccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCC-eeEEEEecCC
Q 017395 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAEYMP 136 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~ 136 (372)
.+...+|.|+||+||+|.+.+...||||++....... .+.|.+|+.+|.+++|||||+++|+|.... ..+|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3444579999999999999665559999998655433 458999999999999999999999998887 7999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-cccccccCcceeecCCC-CceeeccCCcccCCC----CC
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-ALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD----GR 210 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~-iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~----~~ 210 (372)
+|+|.++++......+++..++.|+.||+.||.|||+. + ||||||||+|||++.++ ++||+|||+++.... ..
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~ 202 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMT 202 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeecccccccc
Confidence 99999999864467899999999999999999999999 8 99999999999999997 999999999986553 23
Q ss_pred cccCCCCcCCccccc--CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLR--TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~--~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
...||+.|||||++. ...|+.++|||||||++|||+||+.||...... .....+.....+..++..+++.+..+
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 367899999999999 558999999999999999999999998754321 12222333334445566688999999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
+.+||+.||..||++.+|+..|+.+.....
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 999999999999999999999998876443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=375.82 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=209.1
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
...+|.+.++||.|+||+||+|+ ..++..||||.+.+.. ....+.+..|+++|+.++|||||.+++++..++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 35678888999999999999999 5568999999998764 23356689999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC------CCceeeccCCccc
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD------VNPRLSCFGLMKN 205 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~------~~~kl~Dfg~~~~ 205 (372)
||||.||+|.++|+ ..+.+++..+..++.|++.||++||++ +||||||||+||||+.. -.+||+|||+++.
T Consensus 88 MEyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999998 445799999999999999999999999 99999999999999754 4589999999998
Q ss_pred CCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
...+ .+.+|++.|||||++..+.|+.|+|+||+|++||+|++|+.||.......+..... ........++...+
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~---k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK---KGNEIVPVLPAELS 241 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---ccccccCchhhhcc
Confidence 8765 35689999999999999999999999999999999999999987554333322110 01111223344556
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+.+++...++.+|.+|.+..+...+
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhh
Confidence 677789999999999999888777666
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=376.74 Aligned_cols=250 Identities=17% Similarity=0.230 Sum_probs=207.9
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc-------HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-------ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
+.|.+.+.||+|+||.|-+|. ..+++.||||++++..... .....+|+++|++|+|||||+++++|......
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 446666889999999999999 7789999999998643322 22367999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC---CCceeeccCCccc
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKN 205 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~ 205 (372)
||||||++||.|.+++- .++.+.+..-+.+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+++.
T Consensus 252 YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999997 456688888999999999999999999 99999999999999765 6699999999998
Q ss_pred CCCC---CcccCCCCcCCcccccCCC---CCCCCceeehHHHHHHHHhCCCCCCchhhHH-hhhccccccccccccCCCC
Q 017395 206 SRDG---RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 278 (372)
.... .+.+||+.|.|||++.+.. +..+.|+||+||+||-+++|.+||.+...+. ..++....-.. ..+...
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~--f~p~~w 406 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA--FGPLQW 406 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc--ccChhh
Confidence 7644 4678999999999998765 3347899999999999999999987654333 22222111110 111224
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...+.+..+||.+||..||+.|||+.|+++|-|
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 567899999999999999999999999999955
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=387.41 Aligned_cols=244 Identities=17% Similarity=0.220 Sum_probs=214.0
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
..|..-+.||+|||+.||.++. .+|+.||+|++.+.. ....+...+|+++.++|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4677777889999999999995 889999999998643 234667999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~---- 208 (372)
|+|..++|..+++ .++++++.++..++.||+.||.|||++ +|||||||..|++++++.++||+|||+|.....
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999997 567899999999999999999999999 999999999999999999999999999987663
Q ss_pred CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh-ccccccccccccCCCChHHHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
..+.+||+.|+|||++.....+..+||||+|||+|.|++|++||........-. .+.. .-.+|...+.++.+
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------~Y~~P~~ls~~A~d 247 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------EYSMPSHLSAEAKD 247 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------CcccccccCHHHHH
Confidence 346789999999999998889999999999999999999999987653222211 1111 11245677899999
Q ss_pred HHHHHccCCCCCCCChHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l 310 (372)
||.++|+.||.+|||+++|+.|=
T Consensus 248 LI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 248 LIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred HHHHHhcCCcccCCCHHHHhcCH
Confidence 99999999999999999999983
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=360.91 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=210.1
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEee-EEEeCCe-eEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLG-CCCEGDE-RLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~-~~lv 131 (372)
.+|.++++||+|+||+||++. ..+|..||.|.++..... ..++...|+.+|++|+|||||++++ -|.+.+. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999999 788999999999854332 3567899999999999999999998 4555555 8999
Q ss_pred EecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcC-CC--cccccccCcceeecCCCCceeeccCCcccC
Q 017395 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK-ER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~~--iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
||||.+|+|...|++. .++.+++..+|+++.|++.||..+|++ .+ ++||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999764 345699999999999999999999993 14 899999999999999999999999999988
Q ss_pred CCCC----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC-hHH
Q 017395 207 RDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDE 281 (372)
Q Consensus 207 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 281 (372)
.... +..||+.||+||.+.+..|+.+|||||+||++|||+.-++||.+.....+.....+.-. +..| ...
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-----~~~p~~~Y 253 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-----PPLPDEHY 253 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-----CCCcHHHh
Confidence 7664 56899999999999999999999999999999999999999987754433322222111 1234 567
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.++..++..|+..||.+||+.-.++..+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 899999999999999999998655555543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=376.30 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=215.2
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
.+.++++||+|-||.||+|.++....||+|.++.... ..+.|.+|+++|++|+|+|||+++++|..+..++||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 4567789999999999999998888999999986543 346899999999999999999999999998899999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc--c---
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--Y--- 212 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~--- 212 (372)
|+|.++|+...+..+...+.+.++.|||+|++||+++ ++|||||...|||++++..+||+|||+++...++.- .
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 9999999876677899999999999999999999999 999999999999999999999999999996544321 1
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (372)
.-.+.|.|||.+..+.++.+||||||||+||||+|-...++.. +.+....+.+....+-..|..|+.++.+++..|
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~----msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG----MSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC----CCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 1246899999999999999999999999999999865444322 112222333334444455788999999999999
Q ss_pred ccCCCCCCCChHHHHHHHHhhhcC
Q 017395 293 LQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 293 l~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
|+.+|++|||++.+...|+.+...
T Consensus 441 W~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred hhCCcccCCCHHHHHHHHHHhhhc
Confidence 999999999999999999877653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=350.03 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=202.2
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|+.++++|+|+||+||+++ .++|+.||||++..+.... .+-.+||+++|++++|+|+|.++++|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 58899999999999999999 6679999999998655322 33478999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-C---C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-G---R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~-~---~ 210 (372)
|+.. +.+-+.+.. ..++...+..+++|++.|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.... + +
T Consensus 83 ~dhT-vL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 83 CDHT-VLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred cchH-HHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 9884 545554433 4589999999999999999999999 999999999999999999999999999998763 2 4
Q ss_pred cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchh-hH-Hhh------------------hccccccc
Q 017395 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LD-LIR------------------DRNIQTLT 269 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~-~~-~~~------------------~~~~~~~~ 269 (372)
.+..|.+|.|||.+.| .+|....||||+||++.||++|.+.|++.. .+ .+. +.....+.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 5677999999999998 579999999999999999999998887641 11 000 00001110
Q ss_pred cccccC-----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 270 DSCLEG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 270 ~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
-+.... .--+..+.-+.+|+..||+.||++|++.++++.|
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 000000 0113456789999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=355.55 Aligned_cols=247 Identities=20% Similarity=0.245 Sum_probs=212.0
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
+.+++++++.||+|+||.||.++ .++++.+|+|++++.... +.+....|..+|.+++||.||+++..|++...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45678899999999999999999 567999999999865432 34568899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC---
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--- 207 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~--- 207 (372)
|+||+.||.|..+|. +.+.+++..+.-++.+|+.||.|||++ |||||||||+|||+|++|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999997 456799999999999999999999999 99999999999999999999999999998533
Q ss_pred -CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 208 -DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 208 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
...+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||.......+.+.....- ....+.-.+.+.+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----LPLPPGYLSEEAR 254 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----CCCCCccCCHHHH
Confidence 2345789999999999999999999999999999999999999998765444433332221 1122334678999
Q ss_pred HHHHHHccCCCCCCC----ChHHHHHH
Q 017395 287 RLASRCLQYEPRERP----NPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rp----s~~~il~~ 309 (372)
+++.++|..||.+|. ++.+|-+|
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 999999999999995 56676666
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=367.52 Aligned_cols=248 Identities=18% Similarity=0.284 Sum_probs=207.7
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHH--HHHHHHHHhcCC-CcceeeEeeEEEeCC-eeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ--FLEEARAVGQLR-NRRLANLLGCCCEGD-ERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~~lv 131 (372)
.+|.++++||.|.||.||+|+ ..++..||||.++..-.. +++ -+||++.|++|+ ||||+++.+++.+.+ .+|+|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 479999999999999999999 778999999999865432 333 478999999998 999999999998887 99999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
||||+. +|+++++++ ++.|++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+.....
T Consensus 89 fE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCCC
Confidence 999976 899999886 78899999999999999999999999 9999999999999999999999999999987654
Q ss_pred -CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhh--HHhh--------------h---------
Q 017395 210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIR--------------D--------- 262 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~~~~--------------~--------- 262 (372)
+.+..|.+|.|||++.. +.|+.+.||||+|||++|+.+-++.|++... +.++ .
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 56778999999999865 5689999999999999999999998886421 1110 0
Q ss_pred ccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
-.........+...+ +.++.++.++|.+||++||++||||.+++++
T Consensus 246 f~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000111111111122 3378999999999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=357.76 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=207.2
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC--eeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e~ 134 (372)
.+...+.||+|+||.||++. .++|+..|||.+...+....+.+.+|+.+|.+++|||||+++|...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 45566778999999999999 4558999999998764444677899999999999999999999854444 68999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-CCCceeeccCCcccCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRD----- 208 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~~----- 208 (372)
+++|+|.+++....+ .|++..+..+.+|++.||+|||++ |+|||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999999986544 799999999999999999999999 9999999999999998 79999999999886552
Q ss_pred --CCcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 --GRSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 --~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.....||+.|||||++..+. ...++|||||||++.||+||+.||... . ........+......+.+|...+.++
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~--~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F--EEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c--chHHHHHHHhccCCCCCCCcccCHHH
Confidence 23467899999999999643 446999999999999999999887642 0 00000111111112225677788999
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+|+.+|+..||++||||.++++|......
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999654443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=368.50 Aligned_cols=248 Identities=18% Similarity=0.296 Sum_probs=214.7
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+....|....++|+|+-|.||.|. ..+++.||||++........+-+++|+.+|+..+|+|||++++.|...+.+|+||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 344567777889999999999999 6778899999999887777777899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||++||+|.+.+. ...+++.++..|.++++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 9999999999994 45599999999999999999999999 9999999999999999999999999999876544
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccc-cccccCCCChHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-DSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 287 (372)
.+..||++|||||++....|.++.||||||++++||+-|++||..+.. ++ .+..+. ...+.-..+...++.+++
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lr--AlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LR--ALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HH--HHHHHhhcCCCCcCCccccCHHHHH
Confidence 456799999999999999999999999999999999999998864311 00 001111 111222346678899999
Q ss_pred HHHHHccCCCCCCCChHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (372)
|+.+||..|+.+|+++.|+|+|
T Consensus 502 FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcC
Confidence 9999999999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=330.72 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=205.8
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
++|..++.+|+|.||.||+|+ ..+|+.||||+++.....+ ....+||++.|+.++|+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 367888999999999999999 6789999999998765433 3457899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
|++. +|...|++ +...++..++..|+.+++.||+|||++ .|+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9977 79999975 456799999999999999999999999 99999999999999999999999999999876442
Q ss_pred -cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhh-HH---------------hhh-------ccc
Q 017395 211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-DL---------------IRD-------RNI 265 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~~---------------~~~-------~~~ 265 (372)
....|.+|.|||.+.|.. |+...||||.|||+.||+-|.+.+++... +. |.+ .++
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 235689999999998865 99999999999999999999976664310 00 000 000
Q ss_pred cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.....+.. ...-..++.++.+|+..+|..||.+|+|+.|++++
T Consensus 239 ~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 10111111 11234556788999999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=348.21 Aligned_cols=255 Identities=17% Similarity=0.213 Sum_probs=212.2
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.+-++|++...||.|.-++||+|. ...++.||||+++...... .+.+.+|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 456789999999999999999999 7788999999998665443 57899999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|.||.+||+.++++..-...+++..+..|+++++.||.|||++ |.||||||+.||||+++|.+||+|||.+..+...
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999999876666799999999999999999999999 9999999999999999999999999976543221
Q ss_pred ------CcccCCCCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccc----ccccCCC
Q 017395 210 ------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD----SCLEGQF 277 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 277 (372)
..+.||++|||||++.. ..|+.|+||||||++..||.+|..||..-......-..+..-.. ..+..+-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 44578999999999654 34999999999999999999999988643222111112221111 1111112
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
....+..+++++..||++||.+|||+.+++++
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 23456799999999999999999999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=353.70 Aligned_cols=250 Identities=21% Similarity=0.257 Sum_probs=203.2
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 130 (372)
-+.|+.+.+||+|.||.||+|+ ..+|..||+|++..+.... ..-..+||.+|++|+||||++|.+..... ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3568899999999999999999 7789999999998766332 33467999999999999999999998876 68999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
|+|||+. +|..++.. ..-.|++.+++.++.||+.||.|||++ |++|||||.+|||||.+|.+||+|||+++......
T Consensus 196 VFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9999988 69888853 445699999999999999999999999 99999999999999999999999999999665433
Q ss_pred -----cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhH----------------Hhhhcccc--
Q 017395 211 -----SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD----------------LIRDRNIQ-- 266 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~----------------~~~~~~~~-- 266 (372)
....|.+|.|||++.|.. |+.+.|+||.||||.||++|++++++...- .|...++.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 345589999999999864 999999999999999999999887653211 11101111
Q ss_pred ccccc------cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTDS------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+.+ .+.. .....+....+|+..+|..||.+|.|+.+++..
T Consensus 353 ~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00000 0000 012346789999999999999999999999876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=358.58 Aligned_cols=248 Identities=19% Similarity=0.221 Sum_probs=210.6
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCC----CC-ccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS----AW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 127 (372)
....|.+.+.||+|+||.|+.|. ..+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45578899999999999999998 567899999988764 11 22445778999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-CCceeeccCCcccC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNS 206 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~ 206 (372)
.++||||+.||+|.+++.. .+++.+..+..+++|+++|++|||++ ||+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999974 56799999999999999999999999 99999999999999999 99999999999977
Q ss_pred C----CCCcccCCCCcCCcccccCCC-CC-CCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 207 R----DGRSYSTNLAFTPPEYLRTGR-VT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 207 ~----~~~~~~~t~~y~aPE~~~~~~-~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
. ......||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+......... +... .-.+|..
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----i~~~--~~~~p~~ 245 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----IRKG--EFKIPSY 245 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----HhcC--CccCCCC
Confidence 2 235678999999999999977 75 689999999999999999999976432222211 1111 1123444
Q ss_pred H-HHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 281 E-GTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 281 ~-~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
. +.++..|+.+||..||.+|+|+.+|+.+=+
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 5 899999999999999999999999997644
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=360.97 Aligned_cols=242 Identities=19% Similarity=0.263 Sum_probs=211.5
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|.+.+.||+|+||.||||+ ..+.+.||+|.+.+....+ .+.+.+|+++++.++||||+.++++|++..++|+|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 46677777999999999999 6678999999998765443 56789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+.| +|..++. .++.++++.+..|+.+++.||.|||++ +|+|||+||.|||++.+|.+|+||||+++.....+
T Consensus 83 a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 83 AVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 987 9999997 556799999999999999999999999 99999999999999999999999999999877654
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...||+.|||||++.+++|+..+|+||+||++||+++|++||.....-.+...... ++ ..+|...+..+.+|+.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---d~---v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---DP---VKPPSTASSSFVNFLQ 232 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---CC---CCCcccccHHHHHHHH
Confidence 35689999999999999999999999999999999999999875432222111111 11 1245678899999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
..|.+||.+|.|..+++.|
T Consensus 233 gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHhhcChhhcccHHHHhcC
Confidence 9999999999999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=353.54 Aligned_cols=247 Identities=21% Similarity=0.247 Sum_probs=211.4
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCee
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 128 (372)
....+|.+.+.||.|+|++|++|+ ..++..||||++.+.-.- ..+.+.+|-++|.+| .||.|++|+-.|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345567788888999999999999 677999999999754322 234467899999999 799999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|+|+||+++|+|.++|++ -+.|++..+..++.||++||+|||++ |||||||||+|||+|++|++||+|||.++.+..
T Consensus 150 YFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999999984 46799999999999999999999999 999999999999999999999999999886532
Q ss_pred C-----------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccc
Q 017395 209 G-----------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 209 ~-----------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
. .+++||..|.+||++..+..+..+|||+||||||.|+.|++||.+...-.+ -+.+..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-FqkI~~---- 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-FQKIQA---- 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-HHHHHH----
Confidence 1 347889999999999999999999999999999999999988866432222 222222
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.-.+++..++.+.+|+.++|..||.+|+|+.+|.+|
T Consensus 302 -l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 -LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1224567777999999999999999999999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=332.03 Aligned_cols=258 Identities=17% Similarity=0.208 Sum_probs=209.6
Q ss_pred HHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeC--
Q 017395 51 TATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG-- 125 (372)
Q Consensus 51 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 125 (372)
...++.+.|+.+.+|++|.||.||+|+ .++++.||+|+++...... .-..+||+.+|.+++|||||.+-.+....
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 345677789999999999999999999 6779999999998765322 22468999999999999999999887543
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
+.+|||||||+. +|..++.. ..+++...+++-++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhh
Confidence 579999999988 79999975 346899999999999999999999999 999999999999999999999999999998
Q ss_pred CCCC----CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh------------------
Q 017395 206 SRDG----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD------------------ 262 (372)
Q Consensus 206 ~~~~----~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------------------ 262 (372)
.... +....|.+|.|||.+.+.. |+.+.|+||+|||+.||+++++.|++...-...+
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 7655 3455689999999999866 9999999999999999999998887542110000
Q ss_pred -------ccccccccccccCCCChH-HHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 263 -------RNIQTLTDSCLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 263 -------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..........++..|+.. .+....+|+..+|..||.+|.|+.+.++|=.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 001111111122223222 5688999999999999999999999999944
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=329.30 Aligned_cols=236 Identities=18% Similarity=0.212 Sum_probs=206.9
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.++|++++.||.|+||.|.+++ ..+|..+|+|++++...-. .+...+|..+|+.+.||.++++++.|.+.+++|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4567888999999999999999 5678999999998765544 34578899999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-C
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 210 (372)
|||++||.|..+++ +.+++++..+.-++.||+.||+|||++ +|++|||||+|||+|.+|.+||+|||+++..... -
T Consensus 123 meyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred EeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 99999999999997 456799999999999999999999999 9999999999999999999999999999987655 3
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
+.+||+.|+|||++....++.++|.|||||++|||+.|.+||..+....+-+ .++... -.+|.-.+.++++|+.
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~----KI~~~~--v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE----KILEGK--VKFPSYFSSDAKDLLK 273 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH----HHHhCc--ccCCcccCHHHHHHHH
Confidence 5689999999999999999999999999999999999999998765422222 122111 1467778899999999
Q ss_pred HHccCCCCCC
Q 017395 291 RCLQYEPRER 300 (372)
Q Consensus 291 ~cl~~dp~~R 300 (372)
.+|+.|-.+|
T Consensus 274 ~LL~vD~t~R 283 (355)
T KOG0616|consen 274 KLLQVDLTKR 283 (355)
T ss_pred HHHhhhhHhh
Confidence 9999999999
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=348.42 Aligned_cols=244 Identities=15% Similarity=0.256 Sum_probs=209.9
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|..+..||+|+||.||+|. ..+++.||+|++......+ .+++.+|+.+|.+++++||.++|+.+..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 45666788999999999999 5679999999998765444 677899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
.||++.+.++ .+..+.+..+.-++++++.||.|||.. +.+|||||+.|||+..+|.+||+|||++...... ..
T Consensus 94 ~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 94 GGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred cCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9999999996 445568999999999999999999999 9999999999999999999999999998765443 56
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
+.||+.|||||++.+..|+.++||||||++.+||.+|.+|+..... ....-++.....+.+...+++.+++|+..
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----mrvlflIpk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----MRVLFLIPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----ceEEEeccCCCCCccccccCHHHHHHHHH
Confidence 7899999999999988999999999999999999999987654211 22222233333334445677899999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||.+||+.||||.++++|
T Consensus 246 CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HhhcCcccCcCHHHHhhh
Confidence 999999999999999998
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=352.56 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=202.7
Q ss_pred CccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC-Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~ 127 (372)
++|++.+.||+|+||.||+|.. .++..||||++...... ..+.+.+|+.+|..+ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3678889999999999999973 23568999999754322 245689999999999 899999999988764 45
Q ss_pred eEEEEecCCCCCHHhhhhcCC-----------------------------------------------------------
Q 017395 128 RLLVAEYMPNDTLAKHLFHWE----------------------------------------------------------- 148 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 148 (372)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 899999999999999986421
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC------cccCCCCcCCc
Q 017395 149 -TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPP 221 (372)
Q Consensus 149 -~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aP 221 (372)
..++++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++...... ...++..|+||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 13478889999999999999999999 99999999999999999999999999997643221 22345789999
Q ss_pred ccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCC
Q 017395 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300 (372)
Q Consensus 222 E~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 300 (372)
|++.+..++.++|||||||++|||++ |..||............ .........+...++++.+++.+||+.||.+|
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----LKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99998889999999999999999997 88887653211100000 00001112244556789999999999999999
Q ss_pred CChHHHHHHHHhhhc
Q 017395 301 PNPRSLVTALVTLQK 315 (372)
Q Consensus 301 ps~~~il~~l~~~~~ 315 (372)
||+.++++.|+.+..
T Consensus 322 Ps~~el~~~l~~~~~ 336 (338)
T cd05102 322 PTFSALVEILGDLLQ 336 (338)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=342.23 Aligned_cols=253 Identities=16% Similarity=0.169 Sum_probs=206.9
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--------------cHHHHHHHHHHHhcCCCcceeeEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--------------DARQFLEEARAVGQLRNRRLANLL 119 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~l~ 119 (372)
-...|+++++||+|.||.|-+|. ..+++.||||++.+.... ..++..+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 45678999999999999999999 567999999999753321 245788999999999999999999
Q ss_pred eEEEeC--CeeEEEEecCCCCCHHhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCce
Q 017395 120 GCCCEG--DERLLVAEYMPNDTLAKHLFHWETQP-MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (372)
Q Consensus 120 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~k 196 (372)
++..+. +.+|||+|||..|.+...- ...+ +++.+++.++++++.||+|||.+ |||||||||+|+|++++|++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEE
Confidence 998765 5799999999988765433 4455 99999999999999999999999 999999999999999999999
Q ss_pred eeccCCcccCCCC---------CcccCCCCcCCcccccCCC----CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc
Q 017395 197 LSCFGLMKNSRDG---------RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR 263 (372)
Q Consensus 197 l~Dfg~~~~~~~~---------~~~~~t~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~ 263 (372)
|+|||.+.....+ ....||+.|+|||.+.++. .+.+.||||+||+||+|+.|+.||.+...-..-
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~-- 328 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF-- 328 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH--
Confidence 9999998765322 1357899999999998743 356889999999999999999999876432222
Q ss_pred cccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
..++...+.-...++..+++++||.++|.+||.+|.+..+|..|.+....
T Consensus 329 --~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 --DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 12222222212223567899999999999999999999999999876544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=345.46 Aligned_cols=251 Identities=16% Similarity=0.150 Sum_probs=207.5
Q ss_pred hcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
....++|++|..||+|+||.||+|+ ..+|..+|+|+++++..-. .+.++.|-.+|...++|+||+++..|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3467889999999999999999999 6679999999999765433 45678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
||||||++||++..+|. ..+.|++..+..++.+++.|+..||+. |+|||||||+|+|||..|++||+||||+.....
T Consensus 217 YLiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999997 556799999999999999999999999 999999999999999999999999999752110
Q ss_pred -------------------------------C--------------------CcccCCCCcCCcccccCCCCCCCCceee
Q 017395 209 -------------------------------G--------------------RSYSTNLAFTPPEYLRTGRVTPESVMYS 237 (372)
Q Consensus 209 -------------------------------~--------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S 237 (372)
. .+..||+-|+|||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 0245789999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCC---ChHHHHHH
Q 017395 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP---NPRSLVTA 309 (372)
Q Consensus 238 lGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~il~~ 309 (372)
||||+|||+.|.+||.+......-..... .. ..+...-....+.++.+||.+||. ||.+|. .++||-+|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~n-wr-~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVN-WR-ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHH-Hh-hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999976543221111100 00 001111123345899999999998 999996 58888777
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=351.70 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=207.3
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
....+...||+|+||+||+|.+.+ .||||+++.....+ .+.|.+|+.++++-+|.||+-+.|+|..+.. .||+.+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 344566789999999999999755 49999998766544 6679999999999999999999999988776 999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC------
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------ 208 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 208 (372)
|+|-+|+.+|+.. ...|...+...|++|++.|+.|||.+ +|||||||..||++.++++|||+|||++.....
T Consensus 469 CeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred ccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 9999999999763 35699999999999999999999999 999999999999999999999999999875332
Q ss_pred CCcccCCCCcCCcccccCC---CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.....+...|||||+++.+ +|+..+||||||+++|||+||..|+.....+.+.-..-.....+.+ ......++.++
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~-s~~~s~~pk~m 625 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL-SKIRSNCPKAM 625 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc-hhhhccCHHHH
Confidence 1223456889999999853 5899999999999999999999988644333222222111111111 11235677899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+|+..||..++++||.+.+|+..|+.+.+
T Consensus 626 k~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 626 KRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 999999999999999999999999888766
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=352.33 Aligned_cols=248 Identities=17% Similarity=0.225 Sum_probs=216.0
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
....|++-+.||.|+-|.|-+|+ ..+|+.+|||++.+... .....+.+|+-+|+.+.||||+++++++.+..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 44567777889999999999999 67899999999986522 123458899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
|.||++||.|++++. .++++++..+.++++||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|.....+
T Consensus 90 vlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999997 667899999999999999999999999 9999999999999999999999999999876665
Q ss_pred --CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
.+.+|++.|.+||++.|.+| ..++||||.|||||.|+||+.||.++....+........+ .+|..++.+++
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------~MPs~Is~eaQ 240 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------EMPSNISSEAQ 240 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------cCCCcCCHHHH
Confidence 35689999999999999997 5689999999999999999999986654333322222211 34677889999
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+||.+||..||..|.|+++|++|.+
T Consensus 241 dLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 241 DLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHHHhccCccccccHHHHhhCch
Confidence 9999999999999999999999965
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=347.31 Aligned_cols=247 Identities=19% Similarity=0.200 Sum_probs=220.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCe-eEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDE-RLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lv~ 132 (372)
+.|..++++|+|+||.+++.+ ..++..+++|.+....... .+...+|+.++++++|||||.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578899999999999999998 5567899999998655443 4468899999999999999999999999888 99999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
+||+||+|.+.|.+.++..+++..+..|+.|++.|+.|||++ +|+|||||+.||+++.++.+||+|||+++......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999999999999887777899999999999999999999988 99999999999999999999999999999877653
Q ss_pred --cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
+..||+.|+.||.+.+.+|..++|||||||++|||++-+++|.......+..........+ .|...+.++..+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P-----lp~~ys~el~~l 237 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP-----LPSMYSSELRSL 237 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC-----CCccccHHHHHH
Confidence 5789999999999999999999999999999999999999887766555554444444333 467788999999
Q ss_pred HHHHccCCCCCCCChHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (372)
+..||..+|..||++.+++.+
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999988
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=336.23 Aligned_cols=245 Identities=16% Similarity=0.242 Sum_probs=202.6
Q ss_pred ccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEe----CCeeEEEEecCC
Q 017395 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMP 136 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~ 136 (372)
.+|+|++|.||+|.+ +++.||||.+....... .+.|.+|+.+|++++||||+++++++.+ ....++||||++
T Consensus 27 ~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred EEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 469999999999998 67899999998654333 4668899999999999999999999876 356899999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-CcccCC
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTN 215 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~t 215 (372)
+|+|.+++.. .+.+++.....++.|++.||.|||+..+++||||||+||++++++.+||+|||+++..... ....++
T Consensus 106 ~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 183 (283)
T PHA02988 106 RGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183 (283)
T ss_pred CCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence 9999999974 4568999999999999999999998448899999999999999999999999998865433 234578
Q ss_pred CCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 216 LAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 216 ~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
..|+|||++.+ ..++.++|||||||++|||++|+.||........... +.........+..++..+.+++.+||
T Consensus 184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 89999999976 6799999999999999999999999865432222111 11111122334456789999999999
Q ss_pred cCCCCCCCChHHHHHHHHhhhc
Q 017395 294 QYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.||++|||+.++++.|+.++.
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999988753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=366.30 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=212.2
Q ss_pred ccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
+....++||+|+||.||+|+.. +.+.||||.++..... ..++|.+|+++|..++|||||+++|+|..++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4556788999999999999842 3578999999987766 57789999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcC--------CC----CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceee
Q 017395 131 VAEYMPNDTLAKHLFHW--------ET----QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~--------~~----~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~ 198 (372)
|+|||..|+|.++|+.. .+ .+|+..+.+.|+.|||.|+.||-++ .+|||||-..|+||.++..+||+
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEec
Confidence 99999999999999743 11 2388999999999999999999999 99999999999999999999999
Q ss_pred ccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccc
Q 017395 199 CFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 199 Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
|||+++...... ...-.++|||||.+..+++|.+||||||||+|||+++ |+.|+.+...+... ..+...
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI----e~i~~g 721 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI----ECIRAG 721 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH----HHHHcC
Confidence 999998754432 1222579999999999999999999999999999997 55666543222111 111111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.+ -..|..++.++.+||..||+.+|.+||++.||-..|+......
T Consensus 722 ~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 722 QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 11 2347788999999999999999999999999999999876654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=338.91 Aligned_cols=248 Identities=17% Similarity=0.220 Sum_probs=203.7
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
|++++.||+|+||.||+|. ..+++.||||.+...... ....+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 5677788999999999999 567999999998754322 234578999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---Cc
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS 211 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 211 (372)
+++|+|.+++.......+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||++...... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999999888654445699999999999999999999999 9999999999999999999999999998865432 23
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..||..|+|||++.+..++.++|||||||++|||++|+.||...............+.. ....++...+.++.+|+.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHH
Confidence 46789999999999999999999999999999999999988653211111000001111 1112345567899999999
Q ss_pred HccCCCCCCCC-----hHHHHHH
Q 017395 292 CLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps-----~~~il~~ 309 (372)
||+.||.+||+ ++++++|
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999997 8899887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=346.22 Aligned_cols=246 Identities=15% Similarity=0.167 Sum_probs=206.7
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+.+|.+++.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 456789999999999999999995 5688999999975321 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ |++||||||+|||++.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999999973 45689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|+|||++.+..++.++|||||||++|||++|..||............ ... ...++...+..+.+|+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~--~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI----LAG--RLKFPNWFDGRARDLV 246 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH----hcC--CcCCCCCCCHHHHHHH
Confidence 3456889999999999988999999999999999999999998654322111111 111 1123444567899999
Q ss_pred HHHccCCCCCCCC-----hHHHHHH
Q 017395 290 SRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps-----~~~il~~ 309 (372)
.+||+.||.+||+ +.+++.|
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999996 6888888
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=346.25 Aligned_cols=244 Identities=20% Similarity=0.315 Sum_probs=208.8
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|....-++=||.|+-|-||+|++. ++.||||+++... ..+++-|++|+||||+.+.|+|....-+|||||||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred HHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 333334455799999999999984 4679999987432 36788999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC---CCcc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---GRSY 212 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~ 212 (372)
..|-|..+|+ .+++++......|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++.... ..++
T Consensus 195 a~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence 9999999998 566799999999999999999999999 999999999999999999999999999886544 3467
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (372)
.||..|||||+++..+.+.|.||||||||||||+||.-|+.+-.. ...+..+-...+.-..|..++.-|.-|+++|
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVGsNsL~LpvPstcP~GfklL~Kqc 347 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQC 347 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEeccCCcccccCcccCchHHHHHHHHH
Confidence 899999999999999999999999999999999999988754321 2223333344444456788889999999999
Q ss_pred ccCCCCCCCChHHHHHHHHhhh
Q 017395 293 LQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 293 l~~dp~~Rps~~~il~~l~~~~ 314 (372)
|+..|..||++++|+.||+-..
T Consensus 348 w~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 348 WNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HhcCCCCCccHHHHHHHHhhcC
Confidence 9999999999999999987543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=333.64 Aligned_cols=245 Identities=17% Similarity=0.233 Sum_probs=214.4
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHH---HHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+|++.+.||+|.||.|-+|. ...|+.||||.++++...+.+ .+.+|+++|..|+||||+.++++|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 368899999999999999999 678999999999887665544 4789999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||..+|.|++++. ..+.|++..+.++++||++|+.|+|.+ +++|||||.+|||+|.|+++||+|||++..+...
T Consensus 133 EYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 9999999999997 456799999999999999999999999 9999999999999999999999999999887665
Q ss_pred CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
.+++|++.|.+||++.|.+| .+..|-|||||+||.|+.|..||.+.....+..+...... ..+..+.+..-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY-------rEP~~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY-------REPETPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc-------cCCCCCchHHHH
Confidence 46889999999999999997 5789999999999999999999987655444322222111 122334678899
Q ss_pred HHHHccCCCCCCCChHHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~ 311 (372)
|++||..||.+|.|+.+|..|.+
T Consensus 283 IRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhhe
Confidence 99999999999999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=345.05 Aligned_cols=237 Identities=18% Similarity=0.226 Sum_probs=200.1
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
.||+|+||.||+|. ..+++.||||++.... ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 47999999999999 4578999999997532 1234568899999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccCC
Q 017395 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYSTN 215 (372)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~t 215 (372)
|.+++. ..+.+++..+..++.||+.||+|||++ |++||||||+||+++.++.+||+|||+++.... .....||
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 82 LFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999986 345689999999999999999999999 999999999999999999999999999875322 1234689
Q ss_pred CCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccC
Q 017395 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (372)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (372)
+.|+|||++.+..++.++|||||||++|||++|+.||............... ...++...+.++.+|+.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999989999999999999999999999998654333222111111 1134555678999999999999
Q ss_pred CCCCCC-----ChHHHHHH
Q 017395 296 EPRERP-----NPRSLVTA 309 (372)
Q Consensus 296 dp~~Rp-----s~~~il~~ 309 (372)
||++|| ++.++++|
T Consensus 233 dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHcCCCCCCCHHHHHcC
Confidence 999999 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.04 Aligned_cols=245 Identities=18% Similarity=0.177 Sum_probs=205.7
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|++++.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 578889999999999999994 4689999999865322 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-Ccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 212 (372)
|+++++|.+++.. .+.+++..+..++.|++.||+|||++ |++||||||+|||+++++.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 82 YVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 9999999999973 45689999999999999999999999 9999999999999999999999999998865443 235
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (372)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||.............. . ...++...+..+.+|+.+|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~----~--~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----G--KLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CcCCCccCCHHHHHHHHHH
Confidence 688999999999988899999999999999999999998865432221111111 0 1123445568899999999
Q ss_pred ccCCCCCCCC-----hHHHHHHHH
Q 017395 293 LQYEPRERPN-----PRSLVTALV 311 (372)
Q Consensus 293 l~~dp~~Rps-----~~~il~~l~ 311 (372)
|+.||.+||+ +.++++|-+
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCcc
Confidence 9999999995 999998843
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=340.36 Aligned_cols=254 Identities=18% Similarity=0.228 Sum_probs=206.0
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.++|++++.||+|+||.||++.. .++..||+|.+...... ..+.+.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 35788999999999999999994 56889999999764322 24579999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--Cc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 211 (372)
|+++++|.+++.. ...+++..+..++.|++.||.|||++.+++||||||+||+++.++.+||+|||++...... ..
T Consensus 84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 84 HMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence 9999999999973 3468999999999999999999998636999999999999999999999999998765432 33
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc-----------c------------
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----------L------------ 268 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-----------~------------ 268 (372)
..++..|+|||++.+..++.++|||||||++|||++|+.||.......+....... .
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccc
Confidence 56789999999999888999999999999999999999988543211111000000 0
Q ss_pred ---------------cc---ccccCCC-ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 269 ---------------TD---SCLEGQF-SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 269 ---------------~~---~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.. ....... ....+.++.+|+.+||+.||++|||+.++++|.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00 0000001 1235678999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=341.22 Aligned_cols=250 Identities=17% Similarity=0.162 Sum_probs=205.7
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|.+++.||.|+||.||+|+. .+++.||||++.... ......+.+|++++..++||||+++++++...+..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 688899999999999999995 468899999997532 1234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-CCcc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-GRSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~ 212 (372)
|+++++|.+++. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 999999999996 345689999999999999999999999 999999999999999999999999999886544 2345
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc--ccccccccccCCCChHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN--IQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
.||+.|+|||++.+..++.++|||||||++|||++|..||............ .................+.++.+++.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 6899999999999989999999999999999999999998654322111100 00011110000001245688999999
Q ss_pred HHccCCCCCCCChHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l 310 (372)
+||..+|.+||++.++++|-
T Consensus 239 ~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHhhChhhhcCCHHHHHhCc
Confidence 99999999999999999983
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=356.91 Aligned_cols=305 Identities=20% Similarity=0.286 Sum_probs=239.9
Q ss_pred ccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
...|-+.||.|.||+|++|.++. ...||||.++...... ..+|+.|+.+|.+++||||++|.|+......++||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34455678999999999999532 5689999998765433 557999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS- 211 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 211 (372)
|||++|+|+.+|+.+++ .+++.+..-++++|+.|++||-+. ++|||||...|||++.+..+|++|||+++...++..
T Consensus 710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999999999988664 499999999999999999999999 999999999999999999999999999998765432
Q ss_pred cc----C--CCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 212 YS----T--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 212 ~~----~--t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
.. | .++|.|||.+...++|.+||||||||++||.++ |..|+.+.. +++...-+....+-..|.+|+..
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----NQdVIkaIe~gyRLPpPmDCP~a 862 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVIKAIEQGYRLPPPMDCPAA 862 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----hHHHHHHHHhccCCCCCCCCcHH
Confidence 11 1 368999999999999999999999999999664 666654322 22222223333344457789999
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCCCcccccCCCCCCCCCCCCCCCCcccccchhhHHHHHHHcC---Cc
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLTAIHEILEKLG---YK 361 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~ 361 (372)
+.+|+..||++|-.+||.+.+|+..|+.+...+..-.......+.+..+... ...+.-....++-+||+.++ |.
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld---~~~~~~~~f~sv~~WL~aIkm~rY~ 939 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLD---RSGSDFTPFRSVGDWLEAIKMGRYK 939 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccC---CCCCCCcccCCHHHHHHHhhhhHHH
Confidence 9999999999999999999999999999988765533222211111111111 11222334568889999998 78
Q ss_pred CCCCccccccC
Q 017395 362 DDEGAATEVCF 372 (372)
Q Consensus 362 ~~~~~~~~~~~ 372 (372)
+.+.+++--||
T Consensus 940 ~~F~~ag~~s~ 950 (996)
T KOG0196|consen 940 EHFAAAGYTSF 950 (996)
T ss_pred HHHHhcCcccH
Confidence 88877775543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.14 Aligned_cols=246 Identities=17% Similarity=0.199 Sum_probs=205.7
Q ss_pred CCCccccccccCCCCCCeEEEEEeC-C-CcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE-N-QFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
.+.+|.+++.||+|+||.||+|... + +..||+|.+.... ....+.+.+|+++++.++||||+++++++...+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4567899999999999999999843 3 3689999986432 223456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999973 45699999999999999999999999 9999999999999999999999999999865433
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....||+.|+|||++.+..++.++|||||||++|||++|..||................ ..++...+..+.++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~l 258 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------IYFPKFLDNNCKHL 258 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHH
Confidence 34568999999999998889999999999999999999999987543222111111111 12344556789999
Q ss_pred HHHHccCCCCCCC-----ChHHHHHH
Q 017395 289 ASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
+.+||+.||.+|+ +++++++|
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999995 89999888
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.06 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=212.6
Q ss_pred ccccccccCCCCCCeEEEEEeCC--C---cEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLEN--Q---FRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
+..+.++||+|+||+||+|++.. + ..||||...... .....+|++|+++|++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34455889999999999999432 2 238999998533 334667999999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
||||+|.||+|.++|++... .++..+...++.+.+.||+|||++ ++|||||-.+|+|++.++.+||+|||+++.....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999999986433 699999999999999999999999 9999999999999999999999999998866422
Q ss_pred Ccc----cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 210 RSY----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 210 ~~~----~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
... .-...|+|||.+..+.|+.++|||||||++||+++ |..|+++.......... .....+...+...+.+
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI----~~~~~r~~~~~~~p~~ 391 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI----VKNGYRMPIPSKTPKE 391 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH----HhcCccCCCCCCCHHH
Confidence 211 23478999999999999999999999999999999 77777665433222222 1222333445567789
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCCC
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVP 320 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~~ 320 (372)
+..++.+||..||++||||.++.+.|+.+......+
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999999998776654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=326.94 Aligned_cols=248 Identities=20% Similarity=0.294 Sum_probs=202.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcC--CCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe-----CCeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFN--RSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE-----GDERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~ 129 (372)
.|..++.||+|+||.|..|. ..+|+.||||++. .....+.++..+|+++|+.++|+||+.+.+++.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 34457889999999999999 6779999999998 4555567889999999999999999999999865 35699
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
+|+|+|+. +|...++ .++.|+...+..+++|++.||+|+|+. +++||||||+|++++.+..+||+|||+++....
T Consensus 103 iV~elMet-DL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELMET-DLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHHhh-HHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeecccc
Confidence 99999954 8999997 445599999999999999999999999 999999999999999999999999999998743
Q ss_pred ----C-CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhh-------------------HHhhhc
Q 017395 209 ----G-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------------------DLIRDR 263 (372)
Q Consensus 209 ----~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-------------------~~~~~~ 263 (372)
. +.+..|.+|.|||++.. ..||.+.||||.|||+.||++|++.|++... ..+...
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 1 34567999999999865 4599999999999999999999998875411 011101
Q ss_pred cccccccc---ccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 264 NIQTLTDS---CLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 264 ~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.....+.. ... ...-+..++.+.+|+.+||..||.+|+|++|.++|
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111110 000 01113567899999999999999999999999998
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=337.19 Aligned_cols=236 Identities=18% Similarity=0.204 Sum_probs=197.3
Q ss_pred cCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 65 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999994 568899999987432 23345688999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----CcccCCC
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~t~ 216 (372)
.+++.. .+.+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++..... ....||+
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999973 45699999999999999999999999 9999999999999999999999999998753222 2346889
Q ss_pred CcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCC
Q 017395 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (372)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (372)
.|+|||++.+..++.++|||||||++|||++|+.||.............. . ...++...+.++.+++.+||+.|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----E--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----C--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 99999999998899999999999999999999999865433222211111 1 11344556789999999999999
Q ss_pred CCCCCC---hHHHHHH
Q 017395 297 PRERPN---PRSLVTA 309 (372)
Q Consensus 297 p~~Rps---~~~il~~ 309 (372)
|.+||+ +.+++.|
T Consensus 232 p~~R~~~~~~~e~l~h 247 (312)
T cd05585 232 PTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCCCHHHHHcC
Confidence 999975 6777776
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=339.37 Aligned_cols=237 Identities=18% Similarity=0.234 Sum_probs=199.4
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
.||+|+||.||++. ..+++.||||++.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 47999999999999 4568999999997532 2234568899999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----CcccCC
Q 017395 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (372)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~t 215 (372)
|.+++. ..+.+++..+..++.||+.||+|||++ |++||||||+|||++.++.+||+|||+++..... ....||
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 82 LFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 999886 345699999999999999999999999 9999999999999999999999999998753221 234588
Q ss_pred CCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccC
Q 017395 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (372)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (372)
+.|+|||++.+..++.++|||||||++|+|++|+.||.............. ....++...+.++.+|+.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EDIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------CCccCCCCCCHHHHHHHHHHcCC
Confidence 999999999988899999999999999999999999865433222211111 01123455678899999999999
Q ss_pred CCCCCC-----ChHHHHHH
Q 017395 296 EPRERP-----NPRSLVTA 309 (372)
Q Consensus 296 dp~~Rp-----s~~~il~~ 309 (372)
||++|+ ++.++++|
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=345.28 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=203.4
Q ss_pred CccccccccCCCCCCeEEEEEe-C-----CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcC-CCcceeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-E-----NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~-----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 128 (372)
.+|.+.+.||+|+||.||+|.. . ++..||||++......+ .+.+.+|+++++.+ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3677889999999999999973 1 23579999997654332 45688999999999 899999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCC------------------------------------------------------------
Q 017395 129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------ 148 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 148 (372)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc------ccC
Q 017395 149 --------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YST 214 (372)
Q Consensus 149 --------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~ 214 (372)
..++++..+++++.|++.||.|||++ |++||||||+||++++++.+||+|||+++....... ..+
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 12478899999999999999999999 999999999999999999999999999876543221 223
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
+..|+|||++.+..++.++|||||||++|||++ |+.||........ .............+...++++.+++.+||
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 467999999998889999999999999999997 9988765322111 11111111111223334688999999999
Q ss_pred cCCCCCCCChHHHHHHHHhhh
Q 017395 294 QYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~l~~~~ 314 (372)
+.||.+|||+.+|++.|+.+.
T Consensus 353 ~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 353 NLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=326.60 Aligned_cols=251 Identities=19% Similarity=0.266 Sum_probs=204.2
Q ss_pred CCccccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
...|++.+.||+|+||.||+|++. .+..||+|.++...... ...|.+|+..+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 446788889999999999999742 36789999998653322 4568999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.++++|||.........
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999998642 34689999999999999999999999 99999999999999999999999999876543221
Q ss_pred -----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
...++..|+|||.+.+..++.++|||||||++||+++ |..||............. .......+..++..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 236 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-----DGFRLPAPRNCPNL 236 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----CCCCCCCCCCCCHH
Confidence 1233568999999998899999999999999999775 888875432221111110 11111234456788
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+.+++.+||+.+|.+|||+.+|++.|..+
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=339.19 Aligned_cols=237 Identities=18% Similarity=0.239 Sum_probs=198.4
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
.||+|+||.||++. ..++..||+|++.... ......+.+|+++++.++||||+++++++...+..|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 47999999999999 4578999999997532 2234567889999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----CcccCC
Q 017395 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (372)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~t 215 (372)
|..++.. ...+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...... ....||
T Consensus 82 L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 82 LFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 9998863 45689999999999999999999999 9999999999999999999999999998753221 234588
Q ss_pred CCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccC
Q 017395 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (372)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (372)
+.|+|||++.+..++.++|||||||++|||++|+.||............... ...++...++++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999889999999999999999999999988654322221111110 1123455678999999999999
Q ss_pred CCCCCC-----ChHHHHHH
Q 017395 296 EPRERP-----NPRSLVTA 309 (372)
Q Consensus 296 dp~~Rp-----s~~~il~~ 309 (372)
||.+|| ++.++++|
T Consensus 233 dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHhCCCCCCCHHHHHcC
Confidence 999998 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=343.93 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=200.4
Q ss_pred ccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
+|++.+.||+|+||.||+|+. .++..||||+++.... ...+.+.+|+.+|..+ +||||++++++|...+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 577889999999999999973 2466899999975432 2345789999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC-------------------------------------------------------------
Q 017395 130 LVAEYMPNDTLAKHLFHWE------------------------------------------------------------- 148 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 148 (372)
+||||+++|+|.++++...
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999986422
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-----
Q 017395 149 ------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----- 211 (372)
Q Consensus 149 ------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 211 (372)
...+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||+++.......
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 12478899999999999999999999 999999999999999999999999999876543221
Q ss_pred -ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 212 -~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
..++..|+|||++.+..++.++|||||||++|||++ |..||........ .............+...+.++.+|+
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK----FYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH----HHHHHHhCccCCCCCCCCHHHHHHH
Confidence 223467999999999999999999999999999998 7766643221110 0001111111112333457899999
Q ss_pred HHHccCCCCCCCChHHHHHHHHh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.+||+.||++|||+.+|++.|+.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHh
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=332.24 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=198.9
Q ss_pred CccccccccCCCCCCeEEEEEeCC-----------------CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANL 118 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l 118 (372)
.+|.+.++||+|+||.||+|.+.+ +..||+|.+...... ...+|.+|+++|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997432 347999999764332 24579999999999999999999
Q ss_pred eeEEEeCCeeEEEEecCCCCCHHhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccc
Q 017395 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE-----------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181 (372)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~D 181 (372)
++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. |++|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~ivH~d 163 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NFVHRD 163 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-CccccC
Confidence 999999999999999999999999885421 12468889999999999999999999 999999
Q ss_pred ccCcceeecCCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhC--CCCCC
Q 017395 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG--KHIPP 253 (372)
Q Consensus 182 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg--~~p~~ 253 (372)
|||+|||++.++.+||+|||+++...... ...++..|+|||++.++.++.++||||||+++|||+++ ..|+.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999987653321 22346789999999988899999999999999999875 44443
Q ss_pred chhhHHhhhcccc--ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 254 SHALDLIRDRNIQ--TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 254 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
............. ...........+..++..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 3211111110000 000000111123455688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=324.10 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=208.0
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.++|+++++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45788999999999999999998788889999987543 23567999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 210 (372)
++++|.++++......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 999999999765556789999999999999999999999 99999999999999999999999999998654322
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|+|||++.+..++.++||||||+++|+|++ |..||............... .........+.++.+++
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li 237 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-----YRMPRMENCPDELYDIM 237 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHH
Confidence 1224567999999998889999999999999999998 88777543222111111111 11112234567899999
Q ss_pred HHHccCCCCCCCChHHHHHHHHh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.+||..+|++|||++++.+.|+.
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=344.34 Aligned_cols=247 Identities=18% Similarity=0.277 Sum_probs=211.3
Q ss_pred hcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCe
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 127 (372)
.-+..++++++.||+|.||.|++|. ..+++.+|||.+++... .+.+..+.|.+++... +||.+++++.+|++..+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 4466788899999999999999999 56689999999987653 3466788899888877 59999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+|+||||+.||++..+. ..+.+++..+.-++..|+.||.|||++ ||||||||.+|||+|.+|.+||+|||+++..-
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999955544 445699999999999999999999999 99999999999999999999999999998643
Q ss_pred ----CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 208 ----DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 208 ----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
...+++||+.|||||++.+..|+.+.|.|||||+||||+.|+.||+++..+.+-+..... ...+|..++.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~~~yP~~ls~ 593 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSK 593 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------CCCCCCcccH
Confidence 335688999999999999999999999999999999999999999876544433322221 1245777889
Q ss_pred HHHHHHHHHccCCCCCCCC-----hHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps-----~~~il~~ 309 (372)
+..+++.++|..||.+|.- +.+|..|
T Consensus 594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 9999999999999999974 5666665
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.27 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=205.7
Q ss_pred CCccccccccCCCCCCeEEEEEeCC-C-----cEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN-Q-----FRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
+.+|++++.||+|+||.||+|.... + ..||+|.+....... ...|.+|++++.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3467889999999999999998533 2 579999997544322 45689999999999999999999999988899
Q ss_pred EEEEecCCCCCHHhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~ 194 (372)
+++|||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+||++++++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCc
Confidence 999999999999999964321 4588999999999999999999999 9999999999999999999
Q ss_pred ceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 017395 195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (372)
Q Consensus 195 ~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 267 (372)
++|+|||++...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~---- 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM---- 238 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 999999998764322 12334678999999998889999999999999999998 8888764332222111
Q ss_pred cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+........+..++.++.+|+.+||+.||.+||++.+|+++|+.
T Consensus 239 -i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111122355677899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=331.19 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=199.7
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|++++.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 578899999999999999995 4688999999975432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
++++.|..+.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99987765543 335689999999999999999999999 9999999999999999999999999998865432
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh--cc------------------ccccc
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD--RN------------------IQTLT 269 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~--~~------------------~~~~~ 269 (372)
....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .. .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 23457889999999998889999999999999999999998886532110000 00 00000
Q ss_pred ccccc------CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 270 DSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 270 ~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+... .......+.++.+|+.+||+.||++|||++++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 01112356789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=341.40 Aligned_cols=249 Identities=16% Similarity=0.169 Sum_probs=199.1
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
..+.+|++++.||.|+||.||+|+ ..+++.||||++...... ....+.+|+++++.++|+||+++++++...+..++|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 346678888999999999999999 456899999999654322 245689999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|||+++++|.+.. ..++..+..++.||+.||.|||++ |++||||||+|||+++++.+||+|||+++.....
T Consensus 151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999986543 356788899999999999999999 9999999999999999999999999998765432
Q ss_pred --CcccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 --RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
....||..|+|||++.. ...+.++|||||||++|||++|+.||.......+.... .... .......+...+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~ 301 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM-CAIC-MSQPPEAPATAS 301 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-HHHh-ccCCCCCCCccC
Confidence 34568899999998853 22456899999999999999999988632111110000 0000 001112344566
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.++.+|+.+||+.||++|||+.++++|-+
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 88999999999999999999999999843
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=306.53 Aligned_cols=248 Identities=20% Similarity=0.251 Sum_probs=214.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+++++-+.||+|-||.||+|+ ..++..||+|++.++... -..++.+|+++-+.|+||||++++++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 355677888999999999999 677889999999765432 2457899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC--CCC
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGR 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~--~~~ 210 (372)
||..+|+|...|.......+++...+.++.|++.||.|+|.+ ++|||||||+|+|++..+.+||+|||-+.... ...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~ 180 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRK 180 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCce
Confidence 999999999999877777899999999999999999999999 99999999999999999999999999876653 335
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..+||.-|.+||...+...+...|+|++|++.||++.|.+||.....+.. ...+.. .+-.+|..++.++.++|.
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----YkrI~k--~~~~~p~~is~~a~dlI~ 254 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----YKRIRK--VDLKFPSTISGGAADLIS 254 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH----HHHHHH--ccccCCcccChhHHHHHH
Confidence 67899999999999999999999999999999999999999876532211 111111 122356777899999999
Q ss_pred HHccCCCCCCCChHHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~ 311 (372)
+|+.++|.+|.+..++++|-+
T Consensus 255 ~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 255 RLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHhccCccccccHHHHhhhHH
Confidence 999999999999999999865
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=342.33 Aligned_cols=247 Identities=17% Similarity=0.159 Sum_probs=198.7
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|.+++.||+|+||+||+|. ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57889999999999999998 56688999999975432 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----- 208 (372)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999863 45689999999999999999999999 999999999999999999999999998753210
Q ss_pred ----------------------------------------------CCcccCCCCcCCcccccCCCCCCCCceeehHHHH
Q 017395 209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (372)
Q Consensus 209 ----------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil 242 (372)
.....||..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0124588999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH--ccCCCCCCCChHHHHHH
Q 017395 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC--LQYEPRERPNPRSLVTA 309 (372)
Q Consensus 243 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dp~~Rps~~~il~~ 309 (372)
|||++|..||.............. . ............++++.+|+.+| +..++..||++.+++.|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVIN-W-ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHc-c-ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999865432111111100 0 00001011123567899999984 45566679999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=321.13 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=202.5
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.++|.++++||+|+||.||++.+.++..+|+|.+.... ....++.+|+++|++++||||+++++++......++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 45678889999999999999998777889999987443 33567999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 210 (372)
++|+|.+++.... ..+++..+..++.|++.||.|||++ |++|+||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 9999999986432 3589999999999999999999999 99999999999999999999999999987643321
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|+|||++.+..++.++||||||+++|||++ |+.|+............... .....+...+..+.+++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~li 234 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRLYRPKLASMTVYEVM 234 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHH
Confidence 1223467999999998889999999999999999999 78776543221111111110 01112333457899999
Q ss_pred HHHccCCCCCCCChHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l 310 (372)
.+||+.||++|||+.++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=329.88 Aligned_cols=252 Identities=17% Similarity=0.231 Sum_probs=200.3
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
...+|.++++||.|+||.||+|. ..++..||+|.+...... ....+.+|++++++++||||+++++++......++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35678999999999999999999 456889999999754322 2456789999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+++ +|.+++.. ....+++..+..++.|++.||+|||++ |++||||||+||++++++.+||+|||+++.....
T Consensus 83 e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 89998864 234588999999999999999999999 9999999999999999999999999998764322
Q ss_pred -CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-------ccc-------------
Q 017395 210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-------IQT------------- 267 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-------~~~------------- 267 (372)
....++..|+|||++.+ ..++.++||||+||++|+|++|+.||............ ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 23456889999999876 45899999999999999999999888653221111000 000
Q ss_pred cccccccC----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 LTDSCLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...+.... ......+.++.+|+.+||+.||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0112346789999999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=335.55 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=203.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.+|+++++||.|+||.||+|.. .++..+|+|.+...... ..+.+.+|++++++++||||++++++|...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 5788999999999999999995 46889999998764322 245689999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--Ccc
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 212 (372)
+++++|.+++.. .+.+++..+..++.|++.||.|||++.+++|+||||+||++++++.+||+|||++...... ...
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 85 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 999999999963 4568999999999999999999997537999999999999999999999999998754332 334
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc---cc-----------------------
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQ----------------------- 266 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~---~~----------------------- 266 (372)
.++..|+|||++.+..++.++|||||||++|+|++|+.||............ ..
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 6788999999999888999999999999999999999987643211110000 00
Q ss_pred ----------cccccc---ccCCCC-hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 267 ----------TLTDSC---LEGQFS-SDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 267 ----------~~~~~~---~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+.... .....+ ...+.++.+|+.+||+.||++|||+.+++.+-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000 000011 124578999999999999999999999998843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=305.18 Aligned_cols=256 Identities=19% Similarity=0.186 Sum_probs=210.7
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----Cee
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER 128 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 128 (372)
|-.+|++.++||+|||+.||+++ ..++..+|+|++......+.+..++|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 55689999999999999999999 778999999999988877888999999999999999999999886543 348
Q ss_pred EEEEecCCCCCHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeecCCCCceeeccCCcc
Q 017395 129 LLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
||+++|...|||.+.+.... +..+++.+++.|+.+|++||.+||.. . ++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999997643 34699999999999999999999998 5 9999999999999999999999999887
Q ss_pred cCCCC-------------CcccCCCCcCCcccccC---CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc-
Q 017395 205 NSRDG-------------RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT- 267 (372)
Q Consensus 205 ~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~- 267 (372)
...-. ....-|..|.|||.+.- ...+.++|||||||+||+|+.|..||.... -.++.+.-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---~~GgSlaLA 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---QQGGSLALA 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---hcCCeEEEe
Confidence 54321 11234789999999863 447999999999999999999999885331 12222221
Q ss_pred cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
+......-.-....++.+.+++++||+.||.+||++.+++.+++.+.
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 12211111112347899999999999999999999999999988653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=322.65 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=208.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.++.+.+.||.|+||.||+|. ..+++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457788889999999999999 4568899999987543 34567999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---- 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 211 (372)
++++|.+++.......+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 999999999765556689999999999999999999999 999999999999999999999999999876544321
Q ss_pred -ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 212 -~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...+..|+|||.+.+..++.++||||||+++|||++ |..|++........... ........+...+.++.+++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----HCCCCCCCCCCCCHHHHHHH
Confidence 123467999999998889999999999999999998 88777654322221111 11112234455678999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.+||+.||++|||+.++++.|+.+
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=342.46 Aligned_cols=246 Identities=15% Similarity=0.135 Sum_probs=200.0
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|.+++.||.|+||+||+|+. .+++.||||++.... ......+.+|+++|..++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 678889999999999999994 568999999997532 1224457889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ |++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999973 45699999999999999999999999 9999999999999999999999999998653211
Q ss_pred --------------------------------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCC
Q 017395 210 --------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251 (372)
Q Consensus 210 --------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p 251 (372)
....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 013578999999999988899999999999999999999999
Q ss_pred CCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCC---hHHHHHH
Q 017395 252 PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (372)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (372)
|............. ..... .........++++.+++.+|+. +|.+|++ +.++++|
T Consensus 239 f~~~~~~~~~~~i~-~~~~~-~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKII-NWKET-LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHH-cCCCc-cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 86543211111100 00000 0000112346789999999996 9999997 9999887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.09 Aligned_cols=247 Identities=18% Similarity=0.200 Sum_probs=205.1
Q ss_pred CccccccccCCCCCCeEEEEEe-CC-CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-EN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
..|.+.+.||+|+||.||+|.. .+ ++.||+|.+..........+.+|+.+|+.++||||+++++++...+..||||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3588999999999999999983 34 678999988665544455688899999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
+++|+|.+++... ...++++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999987542 345689999999999999999999999 9999999999999999999999999999865432
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||................. ..++..++.++.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~ 300 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-----DPFPCPVSSGMK 300 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCccCCHHHH
Confidence 234588999999999988899999999999999999999998865432211111111111 122345568899
Q ss_pred HHHHHHccCCCCCCCChHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+++.+||+.||++||++.+++.+
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhC
Confidence 99999999999999999999765
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.26 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=210.6
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
+|.+++.||.|+||.||+|...++..+|+|.+........+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 57888999999999999999777899999999876655567899999999999999999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----ccc
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYS 213 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~ 213 (372)
++|.+++.......+++..+..++.|++.||.|||++ |++|+||||+||++++++.+||+|||++....... ...
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 165 (261)
T cd05148 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165 (261)
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCC
Confidence 9999999865566799999999999999999999999 99999999999999999999999999987654322 223
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (372)
++..|+|||.+.+..++.++||||||+++|+|++ |+.|+............. .......+..++..+.+++.+|
T Consensus 166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHHHHHHHHHH
Confidence 4567999999988889999999999999999998 777775432111111111 1112223455678899999999
Q ss_pred ccCCCCCCCChHHHHHHHHhh
Q 017395 293 LQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 293 l~~dp~~Rps~~~il~~l~~~ 313 (372)
|+.||.+|||+.++++.|+.+
T Consensus 241 l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 241 WAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=323.86 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=197.9
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC-----eeEEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLLVA 132 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~ 132 (372)
|.-.+.+|.|+||.||+|. ..+++.||||++..+.. ---+|+++|+.++|||||++.-+|.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4444566999999999999 55679999999865432 2237999999999999999999886542 346899
Q ss_pred ecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeeccCCcccCCCC
Q 017395 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 209 (372)
||++. +|.++++.. .++.++.-.++-+..||++||+|||+. ||+||||||+|+|+| +.|.+||||||.|+....+
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 99987 899999753 345688888999999999999999998 999999999999999 5599999999999987655
Q ss_pred C---cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhH----------------Hhhhcc-----
Q 017395 210 R---SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD----------------LIRDRN----- 264 (372)
Q Consensus 210 ~---~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~----------------~~~~~~----- 264 (372)
. ++.-|..|.|||.+.|.. |+.+.||||.|||+.||+-|++.|++.... .+....
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 4 455688999999999865 999999999999999999999988764211 111111
Q ss_pred --ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH--HHhhhc
Q 017395 265 --IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (372)
Q Consensus 265 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--l~~~~~ 315 (372)
...+....+...+....++++.+|+.++|+.+|.+|.++.+++.| ++.+..
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111111111112345567899999999999999999999999988 455544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.18 Aligned_cols=250 Identities=18% Similarity=0.200 Sum_probs=196.7
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++|++++.||.|+||.||+|.. .+++.||||++...... ....+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 5788999999999999999995 46889999999754322 234678999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
+. ++|.+++.. ....+++..+..++.|++.||+|||++ |++||||||+||++++++.+||+|||++...... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 96 578888754 335689999999999999999999999 9999999999999999999999999998754322 2
Q ss_pred cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhh--HHhhhc-----c-c----------cccccc
Q 017395 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDR-----N-I----------QTLTDS 271 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~~~~~~-----~-~----------~~~~~~ 271 (372)
...++..|+|||++.+. .++.++|||||||++|+|++|..||..... +..... . . ......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 34568899999998764 478899999999999999999998864211 000000 0 0 000000
Q ss_pred cccCCCC---------hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 272 CLEGQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 272 ~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
......+ ...+.++.+|+.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000 0123578999999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=340.11 Aligned_cols=247 Identities=20% Similarity=0.202 Sum_probs=203.9
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|.+++.||+|+||+||+|.. .+++.||||++..... .....+.+|++++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 678899999999999999995 4689999999975321 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
|+++++|.+++... ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999743 5799999999999999999999998 99999999999999999999999999987654322
Q ss_pred ------------------------------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh
Q 017395 211 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI 260 (372)
Q Consensus 211 ------------------------------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~ 260 (372)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 34578999999999999999999999999999999999999865432211
Q ss_pred hhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCC-hHHHHHHH
Q 017395 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN-PRSLVTAL 310 (372)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~il~~l 310 (372)
...... .... .........++++.+|+.+||. ||.+||+ +.++++|.
T Consensus 239 ~~~i~~-~~~~-~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 239 YNKIIN-WKES-LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHhc-cCCc-ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 111111 0000 0001111257899999999997 9999999 99999983
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=328.41 Aligned_cols=248 Identities=17% Similarity=0.209 Sum_probs=203.9
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
|++++.||+|+||+||++.. .+++.||||.+...... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 66778889999999999994 56899999999754322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---c
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---S 211 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 211 (372)
+++|+|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 9999999988654445699999999999999999999999 99999999999999999999999999988654332 2
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++||||+|+++|||++|..||...............+. . ....++...+..+.+|+.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK-E-DQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-h-cccccCcccCHHHHHHHHH
Confidence 4678899999999988899999999999999999999998865322111111111111 1 1122344567889999999
Q ss_pred HccCCCCCCC-----ChHHHHHH
Q 017395 292 CLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rp-----s~~~il~~ 309 (372)
||+.||.+|| ++.+++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999 88899887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=333.11 Aligned_cols=239 Identities=18% Similarity=0.238 Sum_probs=197.8
Q ss_pred ccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCC----CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 62 VSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
++.||+|+||.||+++. .+++.||||++.... ......+.+|+++|+.++||||+++++++...+..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 35689999999999984 357899999987432 1224457899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++++|.+++.. .+.+.+..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999999863 45688999999999999999999999 9999999999999999999999999998743221
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ... ...++...+.++.+++
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~----~~~--~~~~~~~~~~~~~~li 231 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI----LKG--KLNLPPYLTPEARDLL 231 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH----HcC--CCCCCCCCCHHHHHHH
Confidence 2345789999999999888999999999999999999999988654322111111 111 1123445668899999
Q ss_pred HHHccCCCCCCC-----ChHHHHHH
Q 017395 290 SRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
.+||+.||++|| ++.++++|
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcC
Confidence 999999999999 89998887
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.57 Aligned_cols=244 Identities=13% Similarity=0.110 Sum_probs=197.0
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|++++.||+|+||+||+|. ..+++.||||++..... .....+.+|+.++.+++||||+++++.+.+....|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 57888999999999999998 45689999999975321 223567889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999973 45699999999999999999999999 9999999999999999999999999998753211
Q ss_pred -----------------------------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCc
Q 017395 210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (372)
Q Consensus 210 -----------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~ 254 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 124688999999999998999999999999999999999999865
Q ss_pred hhhHHhhhccccccccccccCCCC--hHHHHHHHHHHHHHccCCCC---CCCChHHHHHH
Q 017395 255 HALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYEPR---ERPNPRSLVTA 309 (372)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~---~Rps~~~il~~ 309 (372)
............ .... ..++ ...+.++.+++.+++. +|. .||++.+|++|
T Consensus 239 ~~~~~~~~~i~~-~~~~---~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMN-WKET---LIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHc-CcCc---ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 432211111110 0000 0111 1245788899988664 344 56899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=336.65 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=198.0
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
.||+|+||.||++. ..+++.||+|++.... ......+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 47999999999999 4578999999997532 2234567889999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCCCceeeccCCcccCCCC----CcccC
Q 017395 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (372)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~ 214 (372)
|..++. ..+.+++..+..++.||+.||.|||+ + |++||||||+|||++.++.+||+|||+++..... ....|
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 82 LFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 999886 34569999999999999999999997 6 9999999999999999999999999998753221 23458
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|+.|+|||++.+..++.++|||||||++|||++|..||............... ...++...++++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHhh
Confidence 89999999999889999999999999999999999998654332222111110 112344566889999999999
Q ss_pred CCCCCCC-----ChHHHHHH
Q 017395 295 YEPRERP-----NPRSLVTA 309 (372)
Q Consensus 295 ~dp~~Rp-----s~~~il~~ 309 (372)
.||++|+ ++.++++|
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999996 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=334.03 Aligned_cols=241 Identities=19% Similarity=0.284 Sum_probs=197.2
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHH---hcCCCcceeeEeeEEEeCCeeEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAV---GQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
|++++.||+|+||.||+|. ..+++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5678899999999999999 4568999999997432 12234566676654 567899999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC---
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--- 208 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 208 (372)
|||+++++|...+. ...+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999998884 34699999999999999999999999 999999999999999999999999999875322
Q ss_pred -CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 209 -GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 209 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.............. . ...++...+.++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~ 230 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN----D--EVRYPRFLSREAIS 230 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCCCCCHHHHH
Confidence 1235678999999999988899999999999999999999999865432222111111 0 11234456788999
Q ss_pred HHHHHccCCCCCCC-----ChHHHHHH
Q 017395 288 LASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
++.+||+.||.+|| ++.+++++
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999999999999 57888776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=338.36 Aligned_cols=244 Identities=20% Similarity=0.246 Sum_probs=207.7
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
|.-++.||.|+||-||-|. ..+.+.||||.+.-++.. .++++++|+.+|++++|||++.+.|+|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4556788999999999999 678899999999865544 377899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccC
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 214 (372)
|-| |-.|++.- .++++.+-.+..|..+.+.||+|||+. +.||||||..|||+++.|.+||+|||.+.......++.|
T Consensus 108 ClG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvG 184 (948)
T KOG0577|consen 108 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVG 184 (948)
T ss_pred Hhc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCchhcccC
Confidence 965 77777743 356799999999999999999999999 999999999999999999999999999999999999999
Q ss_pred CCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 215 t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
|++|||||++. .+.|+-++||||||++..||...++|.+.-+.... +..+........-...++..|++|+..
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA----LYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH----HHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 99999999986 46799999999999999999999988664321111 111111111111245788999999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||++-|.+|||..++++|
T Consensus 261 CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhhCcccCCcHHHHhhc
Confidence 999999999999999987
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.70 Aligned_cols=252 Identities=15% Similarity=0.136 Sum_probs=205.4
Q ss_pred HHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC
Q 017395 51 TATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126 (372)
Q Consensus 51 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 126 (372)
....+..+|.+++.||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 344466789999999999999999999 4568899999996422 123445789999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999999853 4588999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC-----CcccCCCCcCCcccccCC----CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 207 RDG-----RSYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~-----~~~~~t~~y~aPE~~~~~----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||........... +........+
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~~~~~ 268 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK----IMDHKNSLTF 268 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH----HHcCCCcCCC
Confidence 432 234688999999998753 378999999999999999999999876432211111 1111001112
Q ss_pred C--hHHHHHHHHHHHHHccCCCCC--CCChHHHHHHH
Q 017395 278 S--SDEGTELVRLASRCLQYEPRE--RPNPRSLVTAL 310 (372)
Q Consensus 278 ~--~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~l 310 (372)
+ ...+.++.+|+.+||..+|.+ |+|+.++++|-
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 2 235789999999999999987 99999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=333.15 Aligned_cols=243 Identities=19% Similarity=0.232 Sum_probs=199.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCC-cceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 132 (372)
+|++++.||+|+||.||+|.. .+++.||||++.... ....+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999999994 567899999997532 2335568899999999976 46888999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~---- 208 (372)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999999863 45689999999999999999999999 999999999999999999999999999864321
Q ss_pred CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
.....||..|+|||++.+..++.++|||||||++|||++|+.||............. . ....++...+.++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~----~--~~~~~~~~~~~~~~~l 231 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM----E--HNVSYPKSLSKEAVSI 231 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----c--CCCCCCCCCCHHHHHH
Confidence 123457899999999999899999999999999999999999886543221111111 1 1123345567889999
Q ss_pred HHHHccCCCCCCCCh-----HHHHHH
Q 017395 289 ASRCLQYEPRERPNP-----RSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~-----~~il~~ 309 (372)
+.+||..||.+|++. +++++|
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=328.68 Aligned_cols=253 Identities=18% Similarity=0.272 Sum_probs=204.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCc----EEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+|++++.||+|+||.||+|.+ .+++ .||||.+..... ...+++.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCcee
Confidence 4688889999999999999984 3443 489999975432 235678999999999999999999999876 46789
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||+++......
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 99999999999999753 34588999999999999999999999 99999999999999999999999999998654322
Q ss_pred c------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 S------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 ~------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
. ...+..|+|||++.+..++.++||||||+++|||++ |..|+.......+.. +.........+..++.
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQPPICTI 238 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHhCCCCCCCCCCCCH
Confidence 1 123567999999998899999999999999999998 887775432221111 1111111122334567
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
++.+++.+||..||.+|||+.+++..|..+.++.
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 8999999999999999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.22 Aligned_cols=247 Identities=17% Similarity=0.168 Sum_probs=200.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
++|++++.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++|++++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368899999999999999999 55689999999964321 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~---- 208 (372)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999963 45689999999999999999999999 999999999999999999999999999742210
Q ss_pred -------------------------------------------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHH
Q 017395 209 -------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245 (372)
Q Consensus 209 -------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el 245 (372)
.....||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0123588999999999998899999999999999999
Q ss_pred HhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCC---ChHHHHHH
Q 017395 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP---NPRSLVTA 309 (372)
Q Consensus 246 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~il~~ 309 (372)
++|+.||.............. . ............+.++.+++.+|+ .+|.+|+ |+.++++|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN-W-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc-c-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999865432211111100 0 000111112245678899999977 5999999 89999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=319.03 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=203.2
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..+|.+++.||+|+||.||+|...++..+|||.+.... ...+.|.+|+.++++++||||+++++++......++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35688999999999999999997777779999987543 33567999999999999999999999999888999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 210 (372)
.+++|.+++.... ..+++..++.++.|++.||.|||+. |++|+||||+||++++++.+||+|||.++......
T Consensus 82 ~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 82 SNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 9999999996532 3689999999999999999999999 99999999999999999999999999987543322
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|++||.+.+..++.++||||||+++|+|++ |..|+............... .....+...+..+.+++
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li 234 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-----LRLYRPHLASEKVYAIM 234 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-----CCCCCCCCCCHHHHHHH
Confidence 1223567999999998889999999999999999998 88776533221111111111 11112233468899999
Q ss_pred HHHccCCCCCCCChHHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+||+.||.+|||+.+|++.|+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=340.21 Aligned_cols=246 Identities=17% Similarity=0.165 Sum_probs=198.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|.+++.||+|+||+||+|. ..+++.||||++..... ...+.+.+|++++++++||||+++++.+...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57889999999999999999 56688999999975332 224568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----- 208 (372)
|+++|+|.+++.+ .+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999863 35689999999999999999999999 999999999999999999999999999743210
Q ss_pred ----------------------------------------------CCcccCCCCcCCcccccCCCCCCCCceeehHHHH
Q 017395 209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (372)
Q Consensus 209 ----------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil 242 (372)
.....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0123578999999999988999999999999999
Q ss_pred HHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCC---hHHHHHH
Q 017395 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (372)
Q Consensus 243 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (372)
|||++|+.||.............. .. ...........++++.+++.+|+ .+|.+|++ +.++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~-~~-~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVIN-WQ-TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHc-cC-CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999865432111111100 00 00011112345678899998876 59999987 8888887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=329.37 Aligned_cols=245 Identities=27% Similarity=0.454 Sum_probs=194.6
Q ss_pred ccccccCCCCCCeEEEEEeC-----CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 60 NIVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
++.+.||.|.||.||+|.+. .+..|+||.++..... ..+.|.+|++.+++++||||++++|++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35577899999999999965 3678999999754333 36789999999999999999999999998888999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++|+|.+++.......+++.+++.|+.|++.||.|||++ +++|+||+++||++++++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 99999999999876566799999999999999999999999 9999999999999999999999999999876322
Q ss_pred --CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
........|+|||.+.+..++.++||||||+++||+++ |+.|+.......+.... ........+..++..+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-----KQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-----HTTEETTSBTTSBHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccceeccchhHHHH
Confidence 12234578999999998889999999999999999999 56665443221111111 11111223445678899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+++.+||+.||++|||+.+|++.|
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=323.36 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=204.6
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
.+|.+++.||+|+||.||+|... ++..||||.+...... ..+.+.+|+++|+.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46788899999999999999853 2578999999865544 3567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCcee
Q 017395 130 LVAEYMPNDTLAKHLFHWE------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl 197 (372)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEE
Confidence 9999999999999996431 23578999999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccc
Q 017395 198 SCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD 270 (372)
Q Consensus 198 ~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 270 (372)
+|||++...... ....+++.|+|||++.+..++.++||||||+++|||++ |..||..............
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~---- 239 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ---- 239 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----
Confidence 999998754321 12234578999999999999999999999999999998 9888754332221111111
Q ss_pred ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
......+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 -GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111223445688999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=338.11 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=203.8
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 128 (372)
..|.+.+.||+|+||.||+|+.. .+..||||++...... ..+.+.+|+++|+++. ||||++++++|......
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 46778899999999999999842 1346999999754332 2457999999999996 99999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCC------------------------------------------------------------
Q 017395 129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------ 148 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 148 (372)
|||||||++|+|.+++....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999999999999886421
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC
Q 017395 149 ----------------------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (372)
Q Consensus 149 ----------------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~ 194 (372)
...+++..++.++.|++.||.|||++ +++||||||+||++++++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCE
Confidence 12478889999999999999999999 9999999999999999999
Q ss_pred ceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 017395 195 PRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (372)
Q Consensus 195 ~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 267 (372)
+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..|++....+......
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~--- 352 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK--- 352 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH---
Confidence 9999999987643321 2234578999999998889999999999999999997 88777643211110000
Q ss_pred cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.........+...+.++.+++.+||+.||++|||+.+|.+.|..+.+
T Consensus 353 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 -IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 01111112344566889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=331.36 Aligned_cols=237 Identities=17% Similarity=0.234 Sum_probs=196.1
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|+. .+++.||||++.... ....+.+..|.+++..+ +||||+++++++...+..|+||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 579999999999994 568899999997532 22345678899998866 7999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|...+. ..+.+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9999886 345689999999999999999999999 999999999999999999999999999875322 123457
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|..|+|||++.+..++.++|||||||++|||++|+.||.............. . ...++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH----D--DVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHHHHhc
Confidence 8999999999988899999999999999999999999865432222211111 0 012234456889999999999
Q ss_pred CCCCCCC-------ChHHHHHH
Q 017395 295 YEPRERP-------NPRSLVTA 309 (372)
Q Consensus 295 ~dp~~Rp-------s~~~il~~ 309 (372)
.||++|| ++.++++|
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999 88888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=324.62 Aligned_cols=242 Identities=19% Similarity=0.240 Sum_probs=196.8
Q ss_pred cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 65 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
||+|+||+||++. ..+++.||+|.+...... ..+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999 457889999998754322 235678899999999999999999999999999999999999999
Q ss_pred HhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----cccC
Q 017395 141 AKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYST 214 (372)
Q Consensus 141 ~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~ 214 (372)
.+++... ....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++....... ...+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 9887432 335689999999999999999999999 99999999999999999999999999987654332 3467
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|+.|+|||++.+..++.++||||||+++|||++|+.||................... ...++...+..+.+++.+||+
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhc
Confidence 889999999999999999999999999999999999886432111000001111111 112345567889999999999
Q ss_pred CCCCCCC-----ChHHHHHH
Q 017395 295 YEPRERP-----NPRSLVTA 309 (372)
Q Consensus 295 ~dp~~Rp-----s~~~il~~ 309 (372)
.||++|| +++++++|
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcC
Confidence 9999999 77888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=331.98 Aligned_cols=237 Identities=19% Similarity=0.257 Sum_probs=195.7
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||+||+|+. .+++.||||++.... ....+.+.+|..++..+ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 579999999999994 568899999987432 22345678899988877 6999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|.+++.. ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 82 DLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred hHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 99998863 45699999999999999999999999 999999999999999999999999999875322 123457
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|+.|+|||++.+..++.++|||||||++|||++|+.||............... ...++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999998654332222111111 012334456889999999999
Q ss_pred CCCCCCCCh------HHHHHH
Q 017395 295 YEPRERPNP------RSLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~------~~il~~ 309 (372)
.||.+||++ .+++.|
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcC
Confidence 999999998 667666
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=325.43 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=195.0
Q ss_pred ccccccccCCCCCCeEEEEEe-C-CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcC---CCcceeeEeeEEEe-----C
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-E-NQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCCE-----G 125 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~ 125 (372)
+|++++.||+|+||.||+|.. . ++..||||.+...... ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 588899999999999999985 3 4678999998754322 234567788777765 69999999999852 3
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
...++||||+. ++|.+++.......+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 56899999996 5899998765556699999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc--------c------c
Q 017395 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------T------L 268 (372)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~--------~------~ 268 (372)
.... ....++..|+|||++.+..++.++|||||||++|||++|+.||.............. . .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 5432 234578899999999988899999999999999999999988764321110000000 0 0
Q ss_pred cccccc-------CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 TDSCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 ~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...... ....+..+..+.+|+.+||+.||++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000000 00112356788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=339.39 Aligned_cols=245 Identities=16% Similarity=0.123 Sum_probs=198.3
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|.+++.||.|+||.||++. ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 57888999999999999998 5678999999986432 1224568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++|+|.+++.. .+.+++..+..++.|++.||+|||+. |++||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999963 45689999999999999999999999 9999999999999999999999999998532110
Q ss_pred -----------------------------------------------CcccCCCCcCCcccccCCCCCCCCceeehHHHH
Q 017395 210 -----------------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (372)
Q Consensus 210 -----------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil 242 (372)
....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 023578999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHhhhccccccccccccCCCC--hHHHHHHHHHHHHHccCCCCCC---CChHHHHHHH
Q 017395 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYEPRER---PNPRSLVTAL 310 (372)
Q Consensus 243 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~R---ps~~~il~~l 310 (372)
|||++|..||............. ..... ..++ ...+.++.+|+.+||. +|.+| +|+.+++.|-
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~-~~~~~---~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKII-NWRET---LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHH-ccCCc---cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 99999999886533211111000 00000 0111 2356789999999997 67765 5999999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.18 Aligned_cols=247 Identities=18% Similarity=0.208 Sum_probs=199.0
Q ss_pred ccccccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCC----CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCee
Q 017395 58 MENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 128 (372)
+|++++.||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999974 357899999986432 12245678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999863 45699999999999999999999999 999999999999999999999999999875432
Q ss_pred C-----CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 209 G-----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 209 ~-----~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
. ....||..|+|||++.+.. ++.++|||||||++|||++|+.||...............+.. ....++...+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCC
Confidence 2 2346889999999998754 788999999999999999999988532110000000000110 1122344567
Q ss_pred HHHHHHHHHHccCCCCCCC-----ChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
..+.+++.+||+.||++|| +++++++|
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 8899999999999999999 77888887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=322.53 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=203.6
Q ss_pred CCccccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
+++++++++||+|+||.||+|.. .++..||+|.+...... ....+.+|++++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 46788999999999999999983 24678999999754332 2457889999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWE---------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~ 194 (372)
+||||+++++|.+++.... ...+++.++..++.|++.||.|||++ |++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCc
Confidence 9999999999999985321 23478899999999999999999999 9999999999999999999
Q ss_pred ceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 017395 195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (372)
Q Consensus 195 ~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 267 (372)
+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++ |..||...............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998764322 12334567999999988889999999999999999998 87776543222111111111
Q ss_pred cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.....+..++..+.+++.+||+.||.+||++.+|+++|..
T Consensus 243 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 243 -----QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1112334456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.16 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=206.4
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
..|++++.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4578889999999999999997777889999997654 345679999999999999999999999999999999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc--ccC
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--YST 214 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 214 (372)
+++|.+++.......+++..+..++.|++.||.|||++ |++|+||||+||++++++.+||+|||++........ ..+
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 99999999754445689999999999999999999999 999999999999999999999999999876543211 112
Q ss_pred ---CCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 215 ---NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 215 ---t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
+..|+|||.+.+..++.++||||||+++|||++ |+.|+.............. ......+...+..+.+++.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-----GYRMPCPPGCPKELYDIML 238 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCCcCCHHHHHHHH
Confidence 347999999998889999999999999999999 8877754322211111111 1111223445688999999
Q ss_pred HHccCCCCCCCChHHHHHHHHh
Q 017395 291 RCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+||+.+|.+||++.++++.|+.
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=314.75 Aligned_cols=252 Identities=17% Similarity=0.203 Sum_probs=201.7
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCC-----
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRR-LANLLGCCCEGD----- 126 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----- 126 (372)
...|..+++||+|+||+||+|+ ..+|+.||+|++...... -.....+|+.+|+.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3457778889999999999999 678999999999865442 2345789999999999999 999999998877
Q ss_pred -eeEEEEecCCCCCHHhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 127 -ERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
..++|+||++. +|..++..... +.++...++.++.|++.||+|||++ +|+||||||+|||++++|.+||+|||++
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchH
Confidence 78999999966 79999976443 4688899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCC----CCcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh-----------ccccc
Q 017395 204 KNSRD----GRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-----------RNIQT 267 (372)
Q Consensus 204 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-----------~~~~~ 267 (372)
+...- ..+..+|.+|.|||++.+. .|+...||||+|||+.||+++++.|++........ .....
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 86552 2345678999999999987 59999999999999999999998887542111000 00000
Q ss_pred cc---------cccc-cCCCC---hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 LT---------DSCL-EGQFS---SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 ~~---------~~~~-~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+. .... ...+. +....+..+++.+||+.+|..|.|+..++.|
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 0000 00000 1122589999999999999999999999998
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=322.37 Aligned_cols=243 Identities=16% Similarity=0.204 Sum_probs=195.1
Q ss_pred cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 65 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
||+|+||.||++. ..+++.||+|.+..... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999 45689999999964322 1233466799999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---cccCCCC
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SYSTNLA 217 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~t~~ 217 (372)
.+++.......+++..+..++.|++.||+|||+. |++||||||+||++++++.++|+|||++....... ...++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 9988655555689999999999999999999999 99999999999999999999999999987654432 3457889
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCC
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (372)
|+|||++.+..++.++|||||||++|||++|+.||...................... ......+.++.+|+.+||+.||
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCH
Confidence 999999998889999999999999999999999876432111111111111111110 0112456789999999999999
Q ss_pred CCCCChHHHHHH
Q 017395 298 RERPNPRSLVTA 309 (372)
Q Consensus 298 ~~Rps~~~il~~ 309 (372)
.+||+++++++.
T Consensus 239 ~~R~~~~~~~~~ 250 (277)
T cd05607 239 EDRLGSREKNDD 250 (277)
T ss_pred hhCCCCccchhh
Confidence 999999766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=318.43 Aligned_cols=255 Identities=16% Similarity=0.198 Sum_probs=207.4
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
++|.+.+.||.|+||.||+|+ ..+++.||||.+..... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 467888999999999999999 55789999998864322 22446899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||+++++|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999888532 234588999999999999999999999 99999999999999999999999999987654322
Q ss_pred ----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
...++..|+|||.+.+..++.++|+||||+++|||++|+.|+.......... ...+.........+...+..+.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL--CQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH--HHHHhcCCCCCCChhhcCHHHH
Confidence 2457788999999998889999999999999999999999875432111100 0000000111112234567899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
+++.+||+.+|++|||+.++++.+++++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=319.88 Aligned_cols=251 Identities=17% Similarity=0.183 Sum_probs=203.8
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
...+|++++.||+|+||.||+|+ ..+++.||+|++..........+.+|+.++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 44578999999999999999999 46788999999976554455678899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 87 YCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 9999999999863 45689999999999999999999999 9999999999999999999999999998765322
Q ss_pred CcccCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH-hhhccccccccccccCCCChHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+....... ...........+.. ......+..+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL--KDKTKWSSTF 241 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC--ccccccCHHH
Confidence 2345778999999985 3447889999999999999999998875322110 00000000111101 1123456789
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+++.+||+.||++|||+++++++|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=335.56 Aligned_cols=254 Identities=17% Similarity=0.147 Sum_probs=203.8
Q ss_pred HHHhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC
Q 017395 50 RTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125 (372)
Q Consensus 50 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 125 (372)
.........|++++.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34444557899999999999999999994 568899999986422 12344588999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
...|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999999953 3589999999999999999999999 999999999999999999999999999886
Q ss_pred CCCC-----CcccCCCCcCCcccccCCC----CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCC
Q 017395 206 SRDG-----RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (372)
Q Consensus 206 ~~~~-----~~~~~t~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (372)
.... ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... .+........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~----~i~~~~~~~~ 267 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS----KIMDHKNSLN 267 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCcccC
Confidence 5432 2346899999999997543 7889999999999999999999986543221111 1111111111
Q ss_pred CC--hHHHHHHHHHHHHHccCCCCC--CCChHHHHHHHH
Q 017395 277 FS--SDEGTELVRLASRCLQYEPRE--RPNPRSLVTALV 311 (372)
Q Consensus 277 ~~--~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~l~ 311 (372)
++ ...+..+.+++..||..++.. |+|+.++++|-+
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 22 234688999999999865543 899999999843
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=322.96 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=206.8
Q ss_pred CccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
..|.+.+.+|.|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3577888899999999999974 2356799999986655556679999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeec
Q 017395 131 VAEYMPNDTLAKHLFHWE-----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~D 199 (372)
||||+++++|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEecc
Confidence 999999999999986321 13489999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccc
Q 017395 200 FGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 200 fg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
||++....... ...++..|+|||++.+..++.++||||||+++|+|++ |..||.................
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~--- 240 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--- 240 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc---
Confidence 99987543221 2233568999999998889999999999999999998 7777654322211111111110
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
...+...+.++.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 241 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 241 --LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 112234557899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=332.98 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=195.0
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----CeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 129 (372)
.|++.+.||+|+||.||+|. ..+++.||||.+.... .....++.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47888999999999999999 4578999999987432 22345689999999999999999999988543 2489
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+. ++|.+++. ....+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 58999886 344699999999999999999999999 9999999999999999999999999998754321
Q ss_pred -------CcccCCCCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh-------------------h
Q 017395 210 -------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-------------------R 261 (372)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~-------------------~ 261 (372)
....+|..|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 23467899999999876 5689999999999999999999988854321100 0
Q ss_pred hcccccccc---ccccCC---CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 262 DRNIQTLTD---SCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 262 ~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
......... ...... ..+..++.+.+++.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 000000 011245678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=330.17 Aligned_cols=243 Identities=18% Similarity=0.227 Sum_probs=199.5
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+|++++.||+|+||.||+|.. .+++.||||++..... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477888999999999999994 4678999999875321 2234577788888877 5899999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~---- 208 (372)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++ |++||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999999863 35689999999999999999999999 999999999999999999999999999875332
Q ss_pred CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ... ...++...+.++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i----~~~--~~~~p~~~s~~~~~l 231 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----MEH--NVAYPKSMSKEAVAI 231 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH----HhC--CCCCCCcCCHHHHHH
Confidence 22356789999999999999999999999999999999999998654322221111 111 112345567899999
Q ss_pred HHHHccCCCCCCCCh-----HHHHHH
Q 017395 289 ASRCLQYEPRERPNP-----RSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~-----~~il~~ 309 (372)
+.+||+.||.+|++. .++++|
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 999999999999985 666655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=329.65 Aligned_cols=237 Identities=19% Similarity=0.210 Sum_probs=194.6
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|+. .+++.||||+++... ....+.+..|..++... +||||+++++++...+..|+||||+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 579999999999994 568899999997532 12345577788888755 8999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|..++.. ...+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 82 DLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 99999863 45689999999999999999999999 999999999999999999999999999874321 233567
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|..|+|||++.+..++.++|||||||++|||++|+.||.............. ....++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV------DTPHYPRWITKESKDILEKLFE 232 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCCCHHHHHHHHHHcc
Confidence 8999999999998999999999999999999999999865433222211110 0112344456889999999999
Q ss_pred CCCCCCCChH-HHHHH
Q 017395 295 YEPRERPNPR-SLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~~-~il~~ 309 (372)
.||.+||++. ++++|
T Consensus 233 ~dP~~R~~~~~~~~~h 248 (316)
T cd05620 233 RDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCHHHcCCChHHHHcC
Confidence 9999999984 66655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=322.35 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=203.7
Q ss_pred CCCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
++.+|+++++||.|+||.||+|... ++..||||++....... .+.+.+|+.++.+++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 4557889999999999999999852 25789999998654332 4568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
.++++||+.+++|.+++... ....+++..+..++.|++.||.|||++ |++||||||+||++++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEecCCC
Confidence 99999999999999998521 123588899999999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 017395 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 266 (372)
.+||+|||+++...... ...+++.|+|||.+.++.++.++||||||+++|||++ |..|+..............
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987643221 2234578999999988889999999999999999998 6666544322211111111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
......+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 242 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 -----RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11112345567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=317.12 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=204.3
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
++|+++++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46888999999999999999987888899999976443 3567999999999999999999999874 467899999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----c
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~ 211 (372)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 99999999754455689999999999999999999999 99999999999999999999999999987654321 1
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ........+...+..+.+++.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-----ERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCHHHHHHHH
Confidence 233567999999988889999999999999999999 77776543221111111 111112234456688999999
Q ss_pred HHccCCCCCCCChHHHHHHHHh
Q 017395 291 RCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+||..||++|||++++.+.|+.
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=335.73 Aligned_cols=247 Identities=16% Similarity=0.168 Sum_probs=197.4
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.-..|.+++.||+|+||.||+|. ..+++.||+|.... +.+.+|+++|++++||||+++++++......++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 34579999999999999999999 56789999997542 357899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----- 208 (372)
++. ++|..++.. ...+++..++.|+.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 164 ~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 164 RYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred cCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 995 589888863 35689999999999999999999999 999999999999999999999999999865322
Q ss_pred CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-----------HHhhh--c------------
Q 017395 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----------DLIRD--R------------ 263 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-----------~~~~~--~------------ 263 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+.. +
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 1234689999999999988899999999999999999999977643210 00000 0
Q ss_pred cccccc----c-----ccccCCC--ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 264 NIQTLT----D-----SCLEGQF--SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 264 ~~~~~~----~-----~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...... . +.....+ ....+.++.+|+.+||+.||.+|||+.|++++-.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000000 0 0000000 0134678999999999999999999999998743
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=316.51 Aligned_cols=243 Identities=17% Similarity=0.240 Sum_probs=210.3
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
+.++++||+|+||.||+|. ..+|+.+|||.+... .+.+++.+|+.+|++++.|++|++||.+.....+|||||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 5688999999999999999 567999999999865 4688999999999999999999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCccc
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYS 213 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~ 213 (372)
|++.+.++. ++++|++..+..+++..+.||+|||.. .-||||||..|||++.+|.+||+|||.+..+.. .....
T Consensus 113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 999999975 567899999999999999999999998 889999999999999999999999999887654 34678
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccc-cccccCCCChHHHHHHHHHHHHH
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-DSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c 292 (372)
||+.|||||++..-.|+.++||||||++..||..|++|+.+-- ..+.+.-+. .+...-.-|...+.++.+++++|
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH----PMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH----PMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc----ccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 9999999999998889999999999999999999998765421 111111111 11111233667899999999999
Q ss_pred ccCCCCCCCChHHHHHH
Q 017395 293 LQYEPRERPNPRSLVTA 309 (372)
Q Consensus 293 l~~dp~~Rps~~~il~~ 309 (372)
|.++|++|-|+-++++|
T Consensus 267 LiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEH 283 (502)
T ss_pred hcCCHHHHHHHHHHhhh
Confidence 99999999999999988
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=316.60 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=204.1
Q ss_pred CccccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.+|.+.+.||+|+||.||+|.+. +...||||.++..... ....|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 35677888899999999999863 2468999998754433 245789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
|||+++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 84 TEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999999999653 34689999999999999999999999 99999999999999999999999999988764211
Q ss_pred -----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
...++..|+|||.+.+..++.++||||||+++|+|++ |..|+............... .....+..++..
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 236 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-----YRLPPPMDCPSA 236 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHH
Confidence 1223567999999998889999999999999999998 88777543322211111110 111223445688
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+.+++.+||+.+|++||++.+++++|..+
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=316.01 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=205.0
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
..|+++++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++ ..+..+++|||+.
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 46888999999999999999987888999999975443 456899999999999999999999987 4567899999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----c
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~ 211 (372)
+++|.+++.......+++.++..++.|++.||+|||+. |++|+||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 99999998765556789999999999999999999999 99999999999999999999999999987654221 2
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||++.+..++.++||||||+++||+++ |+.||............ ........+...+.++.+++.
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCCCCCCHHHHHHHH
Confidence 234568999999998889999999999999999999 88877543221111110 111111223345678999999
Q ss_pred HHccCCCCCCCChHHHHHHHHh
Q 017395 291 RCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+||..+|++|||+++++..|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 238 LCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=330.66 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=201.7
Q ss_pred ccccccccCCCCCCeEEEEEe-C-----CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC-Cee
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-E-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER 128 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~ 128 (372)
+|++++.||.|+||.||+|.. . +++.||+|++...... ..+.+.+|+.++.++ +|+||++++++|... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 688999999999999999973 2 2478999999754322 245688999999999 899999999988654 568
Q ss_pred EEEEecCCCCCHHhhhhcCC-----------------------------------------------------------C
Q 017395 129 LLVAEYMPNDTLAKHLFHWE-----------------------------------------------------------T 149 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------~ 149 (372)
+++|||+++++|.+++.... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999985321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC------cccCCCCcCCccc
Q 017395 150 QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEY 223 (372)
Q Consensus 150 ~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~ 223 (372)
.++++..+..++.|++.||+|||++ |++||||||+||++++++.++|+|||++....... ...++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 2689999999999999999999999 99999999999999999999999999998653221 2234568999999
Q ss_pred ccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhh-HHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCC
Q 017395 224 LRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301 (372)
Q Consensus 224 ~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 301 (372)
+.+..++.++|||||||++|||++ |..||..... +.... ..........+...+.++.+++.+||+.+|++||
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR-----RLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH-----HHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999998 8877754211 11110 0111111122344567899999999999999999
Q ss_pred ChHHHHHHHHhhhc
Q 017395 302 NPRSLVTALVTLQK 315 (372)
Q Consensus 302 s~~~il~~l~~~~~ 315 (372)
++.+++++|..+.+
T Consensus 322 s~~ell~~l~~~~~ 335 (337)
T cd05054 322 TFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=328.49 Aligned_cols=237 Identities=19% Similarity=0.252 Sum_probs=193.4
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|.. .+++.||||+++... ....+.+..|..++..+ +||||+++++++......++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 579999999999994 568899999997532 12344566777777654 8999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 82 DLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 99999863 44699999999999999999999999 999999999999999999999999999875432 123467
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|+.|+|||++.+..++.++|||||||++|||++|+.||............. . ....++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~--~~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL----N--DRPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----c--CCCCCCCCCCHHHHHHHHHHcc
Confidence 999999999998889999999999999999999999986543222211111 1 1122344566889999999999
Q ss_pred CCCCCCCChH-HHHHH
Q 017395 295 YEPRERPNPR-SLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~~-~il~~ 309 (372)
.||.+||++. +++++
T Consensus 233 ~~P~~R~~~~~~l~~h 248 (316)
T cd05592 233 RDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCHHHcCCChHHHHcC
Confidence 9999999875 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=332.33 Aligned_cols=238 Identities=17% Similarity=0.184 Sum_probs=196.2
Q ss_pred cccCCCCCCeEEEEEe----CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 63 SEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
+.||+|+||.||+++. .+++.||+|++..... .....+.+|+++|++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5689999999999874 3578999999975332 234457889999999999999999999999999999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Ccc
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY 212 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~ 212 (372)
+|+|.+++. ....+++..++.++.|++.||.|||+. |++||||||+||++++++.+||+|||++...... ...
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999986 345699999999999999999999999 9999999999999999999999999998765433 234
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (372)
.|+..|+|||++.+..++.++|||||||++|||++|+.||............ ... ...++...+.++.+|+.+|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i----~~~--~~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI----LKA--KLGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH----HcC--CCCCCCCCCHHHHHHHHHH
Confidence 5789999999999888999999999999999999999988654322111111 111 1123445668899999999
Q ss_pred ccCCCCCCCCh-----HHHHHH
Q 017395 293 LQYEPRERPNP-----RSLVTA 309 (372)
Q Consensus 293 l~~dp~~Rps~-----~~il~~ 309 (372)
|+.||.+||++ .+++.+
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCC
Confidence 99999999994 445554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=318.35 Aligned_cols=252 Identities=18% Similarity=0.203 Sum_probs=212.1
Q ss_pred hcCCCccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
.-++..+++++.||.|.-|+||++... ++..+|+|++.+..... ..+...|-++|+.++||.++.||..|+.....
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 346778899999999999999999954 46899999998765443 44577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC-
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR- 207 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~- 207 (372)
|++||||+||+|..+.++..++.+++..+.-++.+|+.||+|||.. |||+|||||+||||.++|++.|+||.++....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999999988888999999999999999999999999 99999999999999999999999998743210
Q ss_pred -----------------------------------C------------------------CCcccCCCCcCCcccccCCC
Q 017395 208 -----------------------------------D------------------------GRSYSTNLAFTPPEYLRTGR 228 (372)
Q Consensus 208 -----------------------------------~------------------------~~~~~~t~~y~aPE~~~~~~ 228 (372)
. ..++.||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 01245678899999999999
Q ss_pred CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCC----hH
Q 017395 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN----PR 304 (372)
Q Consensus 229 ~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ 304 (372)
.+.+.|.|+|||++|||+.|..||.+..... .+..++...+.-.-.+..+..+++||+++|.+||.+|.. +.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh----hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 9999999999999999999999997653222 222222222221122367789999999999999999997 88
Q ss_pred HHHHH
Q 017395 305 SLVTA 309 (372)
Q Consensus 305 ~il~~ 309 (372)
||-+|
T Consensus 388 eIK~H 392 (459)
T KOG0610|consen 388 EIKRH 392 (459)
T ss_pred HhhcC
Confidence 98888
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=321.51 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=207.7
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++.+++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46778889999999999999732 355799999976665556679999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCce
Q 017395 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~k 196 (372)
||||+++++|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEE
Confidence 999999999999996421 23489999999999999999999999 999999999999999999999
Q ss_pred eeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccc
Q 017395 197 LSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLT 269 (372)
Q Consensus 197 l~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 269 (372)
|+|||++...... ....++..|+|||.+.+..++.++||||||+++|||+| |..|+.........+....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--- 240 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ--- 240 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC---
Confidence 9999998754332 22334678999999998889999999999999999999 8877654322211111111
Q ss_pred cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
......+...+..+.+++.+||+.||.+|||+.++++.|..+.+.
T Consensus 241 --~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 241 --GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111112334567899999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=339.76 Aligned_cols=247 Identities=18% Similarity=0.224 Sum_probs=208.8
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+.++||+.||.|+||.||+|. ..++-..|-|++...+....++|+-|+++|..++||+||++++.|...+.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457899999999999999999 5556677889998877777889999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC----CCCc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----DGRS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~----~~~~ 211 (372)
.||....++.. -+..|++.++..+++|+++||.|||++ +|||||||..|||++-+|.++|+|||.+.... ...+
T Consensus 112 ~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 99999888765 456799999999999999999999999 99999999999999999999999999875432 3457
Q ss_pred ccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccc-ccCCCChHHHHHH
Q 017395 212 YSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-LEGQFSSDEGTEL 285 (372)
Q Consensus 212 ~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 285 (372)
+.||++|||||++. ..+|+.++||||||++|.||..+.+|........ .+..+...- +.-.-|..++..+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR----VllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH----HHHHHhhcCCCcccCcchhhhHH
Confidence 89999999999875 3569999999999999999999997643322111 111111111 1112367788999
Q ss_pred HHHHHHHccCCCCCCCChHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+++.+||.+||..||++.++++|
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999999988
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=331.05 Aligned_cols=241 Identities=15% Similarity=0.219 Sum_probs=195.4
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|. ..+++.||||+++.... ...+.+.+|..++..+ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999 45688999999975322 2345578899999988 6999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|.+++. ..+.+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9999886 345699999999999999999999999 999999999999999999999999999874221 223567
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH-----hhhccccccccccccCCCChHHHHHHHHHH
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
|..|+|||++.+..++.++|||||||++|+|++|+.||....... ........+... ...++...+.++.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li 236 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 899999999999889999999999999999999999885211000 000000001111 1123455678899999
Q ss_pred HHHccCCCCCCCC------hHHHHHH
Q 017395 290 SRCLQYEPRERPN------PRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps------~~~il~~ 309 (372)
.+||+.||.+|+| +.++++|
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999997 6788877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=355.05 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=208.4
Q ss_pred CCccccccccCCCCCCeEEEEEeCC--C----cEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN--Q----FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
.....+...||+|+||.||.|...+ + ..||||.+.+.. .+...+|++|..+|+.++|||||+++|+|......
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3344566778999999999999533 3 249999998654 34466899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 129 LLVAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
+|++|||+||+|..+|++.+ ...++....+.++.|||.|+.||+++ ++|||||..+|+|+++...+||+|||++
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999998642 34588999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc-cccccccCC
Q 017395 204 KNSRDGRS------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-LTDSCLEGQ 276 (372)
Q Consensus 204 ~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 276 (372)
+......- ..-...|||||.+..+.+|.++|||||||+|||++|...+++... .+..+.. +.... +-.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~----~n~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR----SNFEVLLDVLEGG-RLD 924 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc----chHHHHHHHHhCC-ccC
Confidence 95433221 122468999999999999999999999999999999765544321 1111111 11111 334
Q ss_pred CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.|..|+..+.++|.+||+.+|++||++..|++.+..+...
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 5778889999999999999999999999999988877654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=314.69 Aligned_cols=246 Identities=20% Similarity=0.259 Sum_probs=205.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|.+.+.||+|++|.||+|+. .+++.|++|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 366778899999999999994 568999999987543 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+++++|.+++.......+++..++.++.|++.||.|||+. |++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999999999765556799999999999999999999999 99999999999999999999999999987654432
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...++..|+|||++.+..++.++|+||||+++++|++|+.|+................ ....+...+.++.+++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~ 234 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-----FPPVSQMYSQQLAQLID 234 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCccccCHHHHHHHH
Confidence 2356788999999998889999999999999999999999886543222111111111 11223355688999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 235 QCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHccCCcccCcCHHHHhhC
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=315.99 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=202.0
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..++.+.+.||+|+||.||+|...++..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 345778889999999999999977777899999875432 3457889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---- 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 211 (372)
++++|.+++... ...+++..+..++.|++.||+|||++ |++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 82 ANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999999643 23689999999999999999999999 999999999999999999999999999876543221
Q ss_pred -ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 212 -~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ........+...+.++.+++
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-----SAGYRLYRPKLAPTEVYTIM 234 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-----HcCCcCCCCCCCCHHHHHHH
Confidence 112357999999998889999999999999999999 67666432211111111 11111223344678999999
Q ss_pred HHHccCCCCCCCChHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l 310 (372)
.+||..+|++|||+.++++.|
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=330.52 Aligned_cols=241 Identities=16% Similarity=0.211 Sum_probs=194.7
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 47999999999999 45688999999975422 2344577899888877 7999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|..++. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9999886 345699999999999999999999999 999999999999999999999999999875322 223567
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh-----hccccccccccccCCCChHHHHHHHHHH
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-----DRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
|..|+|||++.+..++.++|||||||++|||++|+.||......... ......+... ...+|...+..+.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll 236 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 89999999999999999999999999999999999987421100000 0000001111 1234556678899999
Q ss_pred HHHccCCCCCCCC------hHHHHHH
Q 017395 290 SRCLQYEPRERPN------PRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps------~~~il~~ 309 (372)
.+||+.||.+||+ +.++++|
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999998 4688777
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=314.69 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=203.2
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.+|+++++||+|+||.||+|...+...||+|++.... ...++|.+|+++++.++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3688999999999999999997666679999997543 23567999999999999999999999874 456899999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----c
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~ 211 (372)
+++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 99999999754445689999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||+..+..++.++||||||+++|+|++ |..||.............. ......+...+..+.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLMC 237 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-----CCCCCCccccCHHHHHHHH
Confidence 234567999999988889999999999999999999 6666644322211111100 0111223456688999999
Q ss_pred HHccCCCCCCCChHHHHHHHHhh
Q 017395 291 RCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+||+.||++||++.++++.|+..
T Consensus 238 ~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 238 QCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=328.85 Aligned_cols=237 Identities=20% Similarity=0.228 Sum_probs=192.2
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHH-HHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||+||+|.. .+++.||||++..... ....++.+|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 579999999999994 5789999999975321 12334555655 567899999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|..++.. ...+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 82 ELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 99999863 45689999999999999999999999 999999999999999999999999999875322 123457
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|+.|+|||++.+..++.++|||||||++|||++|+.||................ ...+...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------LRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhh
Confidence 899999999999899999999999999999999999986543222211111110 11233456889999999999
Q ss_pred CCCCCCCChH----HHHHH
Q 017395 295 YEPRERPNPR----SLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~~----~il~~ 309 (372)
.||.+||++. +++++
T Consensus 233 ~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred cCHHhCCCCCCCHHHHHcC
Confidence 9999999884 66655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=344.96 Aligned_cols=249 Identities=17% Similarity=0.205 Sum_probs=205.1
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC-----
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD----- 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 126 (372)
.-..|.+.+.||+|+||+||+|+ ..+++.||||++..... .....+.+|+..+..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34588899999999999999998 56789999999975433 23456889999999999999999988775432
Q ss_pred ---eeEEEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 127 ---ERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
..++||||+++|+|.++++.. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 368999999999999998643 235689999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccC
Q 017395 202 LMKNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 202 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (372)
+++.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||................ ..
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-----~~ 263 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-----YD 263 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-----CC
Confidence 9876432 233568899999999999889999999999999999999999886543322221111111 11
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+...++++.+++.+||+.||.+||++.+++++
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2345567899999999999999999999999886
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.03 Aligned_cols=251 Identities=21% Similarity=0.287 Sum_probs=203.8
Q ss_pred CCCccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
++.++.+.++||+|+||.||++.. .++..+|+|.+........+.+.+|+++++.++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 345678889999999999999963 23668999998876655567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCc
Q 017395 129 LLVAEYMPNDTLAKHLFHWET-------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~ 195 (372)
+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+. |++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCE
Confidence 999999999999999864321 3488999999999999999999999 99999999999999999999
Q ss_pred eeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccc
Q 017395 196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL 268 (372)
Q Consensus 196 kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 268 (372)
||+|||++....... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.............
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---
Confidence 999999987543221 1223578999999998889999999999999999998 777764322111111000
Q ss_pred ccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.......+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 239 --~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 --QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 10111223445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=328.23 Aligned_cols=237 Identities=18% Similarity=0.249 Sum_probs=196.5
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||.|+||+||+|.. .+++.||||++.... ......+.+|.+++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 579999999999994 458899999997532 22345678899999888 6999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|..++.. ...+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||+++.... .....+
T Consensus 82 ~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 82 DLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 99998863 44699999999999999999999999 999999999999999999999999999865321 123457
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
+..|+|||++.+..++.++|||||||++|+|++|+.||............. .. ...++...+.++.+|+.+||+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~----~~--~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL----ED--EVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH----cC--CCCCCCcCCHHHHHHHHHHcc
Confidence 899999999999999999999999999999999999886543222211111 10 112344566889999999999
Q ss_pred CCCCCCCCh-----HHHHHH
Q 017395 295 YEPRERPNP-----RSLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~-----~~il~~ 309 (372)
.||.+|||+ .+++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcC
Confidence 999999999 888877
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=332.54 Aligned_cols=247 Identities=16% Similarity=0.141 Sum_probs=201.0
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|.+++.||+|+||+||++. ..+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 57888999999999999999 45789999999975432 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
|+++|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 82 YQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 99999999999753 35699999999999999999999999 99999999999999999999999999997654332
Q ss_pred --cccCCCCcCCccccc------CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 211 --SYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
...+|+.|+|||++. +..++.++|||||||++|||++|+.||.............. .. ...........+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-~~-~~~~~~~~~~~~ 237 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN-FQ-RFLKFPEDPKVS 237 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc-CC-CccCCCCCCCCC
Confidence 235789999999987 45578999999999999999999999865432211111100 00 000001112356
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.++.+|+..||. ||.+|||+.+++.|
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 889999999997 99999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=322.04 Aligned_cols=252 Identities=17% Similarity=0.234 Sum_probs=209.0
Q ss_pred HhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 52 ATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 52 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
..+....|.+++.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 34455688999999999999999999 45688999999987666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++++|.+++. ...+++.++..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 95 VMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred eecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999999985 34589999999999999999999999 9999999999999999999999999998754332
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....+++.|+|||.+.+..++.++|||||||++|+|++|+.||............ ..........+...+..+.
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHH
Confidence 2345778999999999888999999999999999999999988643221110000 0011111112345567899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+++.+||..||++|||+.+++++-
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhCh
Confidence 999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=327.15 Aligned_cols=237 Identities=19% Similarity=0.226 Sum_probs=194.0
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||+||+|.. .+++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 579999999999995 558899999997532 12345577788888764 8999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|.+++.. ...+++.++..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 82 DLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 99999963 35689999999999999999999999 999999999999999999999999999875322 223467
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|..|+|||++.+..++.++|||||||++|||++|+.||.............. ....++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM------DNPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCccCCHHHHHHHHHHhc
Confidence 8999999999988899999999999999999999998865432211111100 0112334456789999999999
Q ss_pred CCCCCCCChH-HHHHH
Q 017395 295 YEPRERPNPR-SLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~~-~il~~ 309 (372)
.||.+||++. ++++|
T Consensus 233 ~~P~~R~~~~~~l~~h 248 (316)
T cd05619 233 REPERRLGVKGDIRQH 248 (316)
T ss_pred cCHhhcCCChHHHHcC
Confidence 9999999997 66655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=314.14 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=195.7
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHH
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 141 (372)
.||+|+||.||+|.. .+++.||+|.+...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 579999999999994 57889999998654322 2456999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc------ccCC
Q 017395 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTN 215 (372)
Q Consensus 142 ~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~t 215 (372)
+++.. ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++........ ...+
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99864 234689999999999999999999999 999999999999999999999999999875443211 1123
Q ss_pred CCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
..|+|||.+.++.++.++||||||+++|||++ |..|+.......... ..........+...+..+.+++.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-----AIEQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-----HHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence 56999999998889999999999999999998 666654322111111 111111122344556889999999999
Q ss_pred CCCCCCCChHHHHHHHH
Q 017395 295 YEPRERPNPRSLVTALV 311 (372)
Q Consensus 295 ~dp~~Rps~~~il~~l~ 311 (372)
.||++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=308.17 Aligned_cols=248 Identities=20% Similarity=0.227 Sum_probs=208.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|.+-..||+|.|+.||++. ..+|+.+|+|+++.... .+.+++.+|+++.+.|+||||+++++...+....|||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 46666778999999999998 67799999999874322 3577899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC---CCceeeccCCcccCCCCC-
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~~~~~~- 210 (372)
+.|++|..-|-. +..+++..+-..++||++||.|+|.+ +|||||+||+|+|+.+. .-+||+|||++.....+.
T Consensus 92 m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 92 VTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 999999876653 24578999999999999999999999 99999999999999633 348999999999887543
Q ss_pred --cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
...||+.|||||++...+|+..+|||+.||+||-|+.|.+||.+.....+-++....-.+- .+...+..+++.++|
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~--~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY--PSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC--CCcccCcCCHHHHHH
Confidence 3568999999999999999999999999999999999999998854444433333322211 122345677999999
Q ss_pred HHHHccCCCCCCCChHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l 310 (372)
+.+||..||.+|.|+.|.++|-
T Consensus 247 vrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred HHHHhccChhhhccHHHHhCCc
Confidence 9999999999999999999873
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=334.30 Aligned_cols=244 Identities=12% Similarity=0.118 Sum_probs=198.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|++++.||+|+||.||++. ..+++.||||++.... ......+.+|+.++.+++||||+++++.+...+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 57888999999999999999 4568999999997432 2234568889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++|+|.+++. ..+.+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999996 345699999999999999999999999 9999999999999999999999999998643211
Q ss_pred -----------------------------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCc
Q 017395 210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (372)
Q Consensus 210 -----------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~ 254 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 123578999999999999999999999999999999999999865
Q ss_pred hhhHHhhhccccccccccccCCCC--hHHHHHHHHHHHHHccCCCCCCCC---hHHHHHH
Q 017395 255 HALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (372)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (372)
............ .... ..++ ...+.++.+++.+++. ||.+|++ +.++++|
T Consensus 239 ~~~~~~~~~i~~-~~~~---~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMN-WKET---LVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHc-CCCc---eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 432221111110 0000 0111 1246789999999874 9999984 6788877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.82 Aligned_cols=250 Identities=18% Similarity=0.227 Sum_probs=203.8
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-C-----cceeeEeeEEEeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-N-----RRLANLLGCCCEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~l 130 (372)
+|.+++.||+|.||.|-+|+ ..+++.||||+++... .-..+-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 67889999999999999999 6779999999998643 23456678999999997 4 489999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC--CCceeeccCCcccCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--VNPRLSCFGLMKNSRD 208 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~--~~~kl~Dfg~~~~~~~ 208 (372)
|+|.+.. +|+++++.+.-.+|+...+..++.||+.||.+||.. +|||+||||+||||.+- ..+||+|||.+.....
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 9999955 899999988888899999999999999999999999 99999999999999743 4699999999987665
Q ss_pred CC-cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH----------------hhh-cccccccc
Q 017395 209 GR-SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----------------IRD-RNIQTLTD 270 (372)
Q Consensus 209 ~~-~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~----------------~~~-~~~~~~~~ 270 (372)
.. .+..+..|.|||++.|.+|+.+.||||||||+.||++|.+.|++..... +.. .......+
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~ 423 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT 423 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence 43 5667889999999999999999999999999999999998776541100 000 00000000
Q ss_pred c-----------------------------cc-----------cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 271 S-----------------------------CL-----------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 271 ~-----------------------------~~-----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
. .. ...........+.+|+.+||..||.+|+|..+.++|-
T Consensus 424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence 0 00 0011123457899999999999999999999999993
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.45 Aligned_cols=254 Identities=17% Similarity=0.149 Sum_probs=210.2
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCC-cEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeE-EEe------C
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGC-CCE------G 125 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~------~ 125 (372)
+-..+.|.+.|.+|||+.||+|....+ ..||+|++...+....+...+|+++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 334677888999999999999996554 999999998777777888999999999997 9999999993 221 1
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
-+++|.||||.||+|-+++..+....|++.++++|+.++++|+++||.. ..|||||||-+||||..+|+.||||||.+.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 3578999999999999999877667799999999999999999999987 459999999999999999999999999876
Q ss_pred cCCCCC-------------cccCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccc
Q 017395 205 NSRDGR-------------SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268 (372)
Q Consensus 205 ~~~~~~-------------~~~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 268 (372)
..-... ...+|+.|+|||.+. +..++.|+|||+|||+||-|+....||.....- .+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------aI 266 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------AI 266 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------eE
Confidence 432211 124689999999874 567999999999999999999999998654221 22
Q ss_pred ccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
+.....-.-.+.++..+.+||..||+.||++||++.+++..+..+...
T Consensus 267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 222111112357889999999999999999999999999998887653
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=315.86 Aligned_cols=255 Identities=17% Similarity=0.215 Sum_probs=208.1
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
++|++.+.||+|+||.||+|. ..++..+|||.+..... ....++.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 567888999999999999999 56789999998865332 22457889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||+++++|.+++... ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999988632 235689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
...++..|+|||++.+..++.++|+||||+++|+|++|..|+.....+.... ...+.........+...+..+.
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH--hhhhhcCCCCCCCcccccHHHH
Confidence 2457789999999998889999999999999999999999875432211110 0000000111111234678999
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
+++.+||+.||++|||+.+|++.+.++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=317.78 Aligned_cols=253 Identities=19% Similarity=0.253 Sum_probs=201.2
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCc----EEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+|++++.||.|+||+||+|.+ .+++ .+++|.+...... ...++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4677888999999999999985 3444 4788888643322 2456788888999999999999999875 456789
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
++||+++|+|.+++.. ..+.+++..+..|+.|++.||.|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999964 335689999999999999999999999 99999999999999999999999999987643221
Q ss_pred ------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
...++..|+|||.+.++.++.++||||||+++|||++ |..|+.+........ +.........+..++.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-----LLEKGERLAQPQICTI 238 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHCCCcCCCCCCCCH
Confidence 2235678999999998889999999999999999998 888775532221111 1111111112233456
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
++.+++.+||..||++|||+.++++.|..+..++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 7899999999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=322.46 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=205.3
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCc--EEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQF--RIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
.+.+|.+.+.||+|+||.||+|.. .++. .+|+|.+..... .....+.+|++++.++ +||||+++++++...+..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 456788889999999999999995 3443 468887764322 2345788999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCc
Q 017395 130 LVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~ 195 (372)
+||||+++++|.+++.... ...+++.+++.++.|++.||+|||++ |++||||||+|||+++++.+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcE
Confidence 9999999999999996432 23578999999999999999999999 99999999999999999999
Q ss_pred eeeccCCcccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccc
Q 017395 196 RLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 196 kl~Dfg~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
||+|||++...... .....+..|+|||++.+..++.++|||||||++|||+| |..||............ ..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-----~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQ 238 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hc
Confidence 99999998643221 11223567999999988889999999999999999998 88877543222111111 11
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
......+...+.++.+|+.+||+.+|++||++.+++..|..+.....
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11112233456789999999999999999999999999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=318.22 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=202.0
Q ss_pred ccccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 130 (372)
+|++++.||+|+||.||++.. .++..||+|.+........+.+.+|++++++++||||+++++++... ...++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 678889999999999999974 24789999999876655567899999999999999999999987543 46899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||++++++.+||+|||++.......
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 99999999999999642 34589999999999999999999999 99999999999999999999999999988654332
Q ss_pred c-------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh---ccc--------ccccccc
Q 017395 211 S-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---RNI--------QTLTDSC 272 (372)
Q Consensus 211 ~-------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~---~~~--------~~~~~~~ 272 (372)
. ..++..|+|||++.+..++.++||||||+++|||++|..++.......... ... .......
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 1 112345999999998889999999999999999999876543322111110 000 0001111
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.....+...+.++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11112344567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=312.98 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=204.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEE-eCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e 133 (372)
+..+|.+.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 3457888999999999999999874 6789999986543 3467899999999999999999999764 4567899999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-cc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 212 (372)
|+++++|.++++......+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 159 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceeccccCCCC
Confidence 99999999999765555689999999999999999999999 99999999999999999999999999987654332 23
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..+..|+|||++.+..++.++||||||+++|+|++ |+.|+............. .......+..++..+.+++.+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----KGYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----cCCCCCCCCCCCHHHHHHHHH
Confidence 34567999999998889999999999999999997 887765433222211111 111122344567889999999
Q ss_pred HccCCCCCCCChHHHHHHHHhh
Q 017395 292 CLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~ 313 (372)
||+.+|++|||+.++++.|+.+
T Consensus 235 ~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 235 CWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=318.11 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=204.8
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 128 (372)
.+|++++.||+|+||.||++... ....+|+|.+..... ....++.+|+++++++ +|+||+++++++...+..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 35778889999999999999853 246899999875432 2345688999999999 799999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~ 194 (372)
+++|||+++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCe
Confidence 9999999999999998642 235689999999999999999999999 9999999999999999999
Q ss_pred ceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccc
Q 017395 195 PRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (372)
Q Consensus 195 ~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 267 (372)
+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..|+............
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--- 247 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL--- 247 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH---
Confidence 9999999988654321 1223567999999988889999999999999999997 87777543322211111
Q ss_pred cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
........+...+..+.+|+.+||..||++|||+.++++.|..+.
T Consensus 248 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 248 --KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111234455678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=312.85 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=208.3
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..+|++.+.+|.|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 346778889999999999999974 67899999986543 4678999999999999999999999999889999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-ccC
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YST 214 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 214 (372)
++++|.+++.......+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||.++....... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 161 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL 161 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccccCCC
Confidence 999999999765545799999999999999999999999 999999999999999999999999999887643322 233
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
+..|+|||.+.++.++.++||||||+++||+++ |..|+.............. ......+...++.+.+++.+||
T Consensus 162 ~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-----GYRMEAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred cccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----CCCCCCccCCCHHHHHHHHHHh
Confidence 567999999998889999999999999999997 8877654432222111111 1112233445688999999999
Q ss_pred cCCCCCCCChHHHHHHHHhh
Q 017395 294 QYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~l~~~ 313 (372)
..+|++|||+.++++.|+.+
T Consensus 237 ~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 237 ELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ccChhhCcCHHHHHHHHhcC
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=319.90 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=205.2
Q ss_pred CCccccccccCCCCCCeEEEEEeC-CC--cEEEEEEcCCCC-CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE-NQ--FRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 130 (372)
+++|.+.+.||.|+||.||+|... ++ ..+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 457888899999999999999853 33 357899887432 23356789999999999 79999999999999899999
Q ss_pred EEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCce
Q 017395 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~k 196 (372)
||||+++++|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||++++++.+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEE
Confidence 999999999999996421 13588999999999999999999999 999999999999999999999
Q ss_pred eeccCCcccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccc
Q 017395 197 LSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 197 l~Dfg~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
|+|||++...... .....+..|+|||++.+..++.++|||||||++|||++ |..||.............. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-----~ 234 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-----G 234 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-----C
Confidence 9999998643321 11222457999999998889999999999999999997 8888765432222111111 1
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.....+..++..+.+|+.+||+.+|.+|||+.++++.|..+....
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111233456688999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=313.75 Aligned_cols=240 Identities=20% Similarity=0.267 Sum_probs=195.8
Q ss_pred ccCCCCCCeEEEEEe---CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
+||+|+||.||+|.+ .++..+|+|++...... ..+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 579999999999964 35788999998754322 2457899999999999999999999875 45679999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-------
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------- 211 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~------- 211 (372)
+|.+++.. ...+++..+..++.|++.||+|||++ |++||||||.||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999963 34689999999999999999999999 999999999999999999999999999876543321
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||.+....++.++||||||+++|||++ |..||.......... ..........+..++.++.+++.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~i~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-----MIESGERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHCCCCCCCCCCCCHHHHHHHH
Confidence 123468999999988889999999999999999998 888775432211111 11111122344556789999999
Q ss_pred HHccCCCCCCCChHHHHHHHHh
Q 017395 291 RCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+||+.||++||++.+|...|+.
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHhccCchhCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=325.65 Aligned_cols=249 Identities=18% Similarity=0.159 Sum_probs=211.3
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 131 (372)
..|.+.+.||+|.||.||+++ ..+|+.+|+|++.+..... .+.+.+|+.+|++++ |||||.+++.|.....+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 357777899999999999999 4559999999998765433 457999999999998 99999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC----CCceeeccCCcccCC
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD----VNPRLSCFGLMKNSR 207 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~----~~~kl~Dfg~~~~~~ 207 (372)
||+|.||.|.+.+... .+++..+..++.|++.|++|||+. |++||||||+|+|+... +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999764 399999999999999999999999 99999999999999632 579999999999877
Q ss_pred CC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
.. ....||+.|+|||++.+..|+..+||||+||++|.|++|..||................. .......+..+..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFTSEPWDDISES 268 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCCCCCccccCHH
Confidence 63 346799999999999999999999999999999999999999876543322221111111 1122234566899
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.+++..++..||..|+|+.++++|-|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 999999999999999999999999854
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=312.72 Aligned_cols=246 Identities=16% Similarity=0.201 Sum_probs=205.2
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|.+++.||.|+||.||++. ..+++.+|+|.++... ....+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 46788999999999999999 4568899999986432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
++++|.+++.......+++..++.++.|++.||.|||++ |++|+||||+||++++++.++|+|||.+...... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999999998755556689999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++|+||||+++|+|++|..||............... .....+...+..+.+++.+
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-----SYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-----CCCCCCcccCHHHHHHHHH
Confidence 45778899999999888999999999999999999999988654322221111111 1112234456789999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||+.||++|||+.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=330.92 Aligned_cols=257 Identities=17% Similarity=0.148 Sum_probs=203.9
Q ss_pred HHHHhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEe
Q 017395 49 LRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCE 124 (372)
Q Consensus 49 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 124 (372)
+.........|++++.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 444455667899999999999999999994 568899999986422 1224457899999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
....++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999999853 3588999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC-----CcccCCCCcCCcccccCCC----CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccC
Q 017395 205 NSRDG-----RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 205 ~~~~~-----~~~~~t~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (372)
..... ....||+.|+|||++.+.. ++.++|||||||++|||++|..||............... ... ...
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~-~~~ 268 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH-KNS-LTF 268 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCc-ccC
Confidence 65432 2346899999999997543 788999999999999999999998754322111111100 000 000
Q ss_pred CCChHHHHHHHHHHHHHccCCCCC--CCChHHHHHHHH
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRE--RPNPRSLVTALV 311 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~l~ 311 (372)
......+..+.+++.+||..++.+ |+++.++++|..
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 112346788999999999844433 789999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=317.12 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=200.1
Q ss_pred ccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEEE
Q 017395 60 NIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLV 131 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 131 (372)
.+++.||+|+||+||++.. .++..||+|.+..... .....+.+|+++|+.++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7888999999999988652 3577899999976532 2356788999999999999999999988653 458999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
|||+++++|.+++.. ..+++.+++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999953 3599999999999999999999999 99999999999999999999999999987654322
Q ss_pred ------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhH---Hhhhc-------ccccccccccc
Q 017395 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD---LIRDR-------NIQTLTDSCLE 274 (372)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~---~~~~~-------~~~~~~~~~~~ 274 (372)
...++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 123456799999998888999999999999999999999876432111 00000 00011111111
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
...+...+.++.+++.+||+.||++|||++++++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1234456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=326.53 Aligned_cols=232 Identities=19% Similarity=0.234 Sum_probs=189.0
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHH-HHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|+. .+++.||+|++..... .....+.+|.. +++.++||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 579999999999995 5688999999874321 12334555654 578899999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|...+. ....+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||+++.... .....+
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9998886 345688999999999999999999999 999999999999999999999999999875322 123457
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|+.|+|||++.+..++.++|||||||++|||++|..||............... ...++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK------PLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999998654322222111111 112344556789999999999
Q ss_pred CCCCCCCChH
Q 017395 295 YEPRERPNPR 304 (372)
Q Consensus 295 ~dp~~Rps~~ 304 (372)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (321)
T cd05603 233 KDQRRRLGAK 242 (321)
T ss_pred CCHhhcCCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.61 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=202.9
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.+|++.++||.|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3578888999999999999997676789999987543 23467899999999999999999999874 466899999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----c
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~ 211 (372)
+++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 99999999765555689999999999999999999999 99999999999999999999999999987653322 1
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+.............. ......+...+..+.+++.
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-----GYRMPCPQGCPESLHELMK 237 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCcccCHHHHHHHH
Confidence 234567999999998889999999999999999999 7777654322211111111 1111234456688999999
Q ss_pred HHccCCCCCCCChHHHHHHHHh
Q 017395 291 RCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+||+.||++||+++++++.|+.
T Consensus 238 ~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 238 LCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.37 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=199.0
Q ss_pred ccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
+|++.+.||+|+||.||+|... ++..||||.+..... ....++.+|+.+++.++||||+++++++..+...++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 5778888999999999999742 256799999865332 234568999999999999999999999999899999
Q ss_pred EEecCCCCCHHhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 131 VAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
||||+++++|.+++.... ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||+
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCC
Confidence 999999999999986422 12467889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccC
Q 017395 203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 203 ~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (372)
+....... ...++..|+|||++.++.++.++|||||||++|||++ |..|+.............. . ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~-~~~ 240 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----G-GLL 240 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----C-CcC
Confidence 87543321 1234668999999998889999999999999999999 5666654322211111101 0 011
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 223445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=327.55 Aligned_cols=237 Identities=17% Similarity=0.196 Sum_probs=192.0
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHH-HHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||+||+|. ..+++.||+|++..... .....+.+|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 57999999999999 55789999999975321 22345566655 467789999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|..++. ....+++..+..++.||+.||.|||++ |++||||||+|||+++++.+||+|||+++.... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 9999886 345699999999999999999999999 999999999999999999999999999875322 223458
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|..|+|||++.+..++.++|||||||++|||++|..||................ ...++..+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------LVLRPGASLTAWSILEELLE 232 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------ccCCCCCCHHHHHHHHHHhc
Confidence 899999999999899999999999999999999999986543222211111110 11233456789999999999
Q ss_pred CCCCCCCChH----HHHHH
Q 017395 295 YEPRERPNPR----SLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~~----~il~~ 309 (372)
.||.+||+++ ++++|
T Consensus 233 ~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred cCHHhcCCCCCCHHHHhcC
Confidence 9999999875 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=317.97 Aligned_cols=256 Identities=17% Similarity=0.198 Sum_probs=206.6
Q ss_pred HHHHhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 49 LRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 49 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
+++--...+.|+++++||.|+||.||+|.. .++..||+|.+........+.+.+|+++++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK 83 (292)
T ss_pred hhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence 344444556799999999999999999995 5588999999987665556779999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+++++|..++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred EEEEEecCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999888754 235689999999999999999999999 99999999999999999999999999876533
Q ss_pred CC----CcccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 208 DG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|..|+.............. ... .....+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~--~~~~~~ 238 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEP--PTLSQP 238 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCC--ccCCCC
Confidence 22 23456789999999853 3468899999999999999999988754321111100000 000 011123
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...+.++.+++.+||..||++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 4556789999999999999999999999887
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=319.15 Aligned_cols=250 Identities=15% Similarity=0.165 Sum_probs=194.9
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcC---CCcceeeEeeEEEe-----CC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCCE-----GD 126 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~~ 126 (372)
.|++++.||+|+||+||+|. ..+++.||+|.+...... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999999 457899999998754322 234566777777665 69999999998864 24
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++||||+.+ +|.+++.......+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 58999999975 899988765555699999999999999999999999 9999999999999999999999999998865
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc--------cccc------
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI--------QTLT------ 269 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~--------~~~~------ 269 (372)
... ....++..|+|||++.+..++.++|||||||++|+|++|++||............. ....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 433 23456889999999998889999999999999999999998775432111000000 0000
Q ss_pred ccccc-------CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 270 DSCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 270 ~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..... ....+..+..+.+++.+||+.||++|||+.+++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 01112356788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.87 Aligned_cols=248 Identities=20% Similarity=0.256 Sum_probs=193.7
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--------Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--------DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------~~ 127 (372)
..|.+++.||+|+||.||+|.. .+++.||||++.... ....+|+.+|+.++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 4688999999999999999994 568899999986432 2345799999999999999999987432 24
Q ss_pred eEEEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcc
Q 017395 128 RLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMK 204 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~ 204 (372)
+++||||+++ +|.+++... ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 6799999976 687776432 345699999999999999999999999 999999999999999654 69999999998
Q ss_pred cCCCC---CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc----------------
Q 017395 205 NSRDG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---------------- 264 (372)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~---------------- 264 (372)
..... ....+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+..........
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 65432 345678999999998764 5899999999999999999999888654211100000
Q ss_pred -------ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 265 -------IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 265 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
...+....+...++...+.++.+|+.+||..||.+|||+.++++|-
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0000001111123334567899999999999999999999999883
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.28 Aligned_cols=249 Identities=19% Similarity=0.259 Sum_probs=202.3
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
|++.+.||+|+||+||++. ..+++.||||.+....... ...+.+|+.++++++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 4556677999999999999 5568899999987543222 34578899999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---c
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---S 211 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 211 (372)
+++++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++....... .
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 9999999998654445699999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......... ......... ....++...+.++.+|+.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-VQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhh-hhhhcCccCCHHHHHHHHH
Confidence 46789999999999888999999999999999999999988643211000 001111111 1112344556789999999
Q ss_pred HccCCCCCCCC-----hHHHHHHH
Q 017395 292 CLQYEPRERPN-----PRSLVTAL 310 (372)
Q Consensus 292 cl~~dp~~Rps-----~~~il~~l 310 (372)
||+.||.+||| +.++++|-
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcCh
Confidence 99999999999 88999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=315.94 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=202.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCc----EEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.++++++.||.|+||+||+|+ ..++. .||+|.+...... ....+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 367788899999999999998 44444 4899998754332 35578899999999999999999999865 45789
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
++||+++|+|.++++.. ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 99999999999999642 34689999999999999999999999 99999999999999999999999999988654322
Q ss_pred c------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 S------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 ~------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
. ..++..|+|||.+.+..++.++|||||||++|||++ |..|+.......... ..........+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-----LLEKGERLPQPPICTI 238 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHCCCcCCCCccCCH
Confidence 1 223567999999998889999999999999999998 777764322111111 1111111122344567
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
++.+++.+||+.||++||++.++++.|..+....
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 8999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=320.09 Aligned_cols=253 Identities=17% Similarity=0.239 Sum_probs=209.6
Q ss_pred HHHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 50 RTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 50 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
....+....|.+++.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++......
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 3344555789999999999999999999 467899999999876655567789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++. ...+++.++..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 92 WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEeecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999999985 34589999999999999999999999 999999999999999999999999999876543
Q ss_pred CC----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 209 GR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 209 ~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
.. ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ..............+...+..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeeeccCCCCCCCCccccCHH
Confidence 22 34567899999999988899999999999999999999988754321100 000000111111223455678
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+++.+||..||++||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=316.44 Aligned_cols=248 Identities=19% Similarity=0.227 Sum_probs=201.3
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
|+..+.||.|+||+||+|. ..+++.||+|.+...... ....+.+|+++|++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 4455677999999999999 457889999998754322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---Cc
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS 211 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 211 (372)
+++++|.+++.......+++..+..++.|++.||.|||+. |++||||||+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9999999988654445699999999999999999999999 9999999999999999999999999998764332 23
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++|+||||+++|+|++|..||...............+... ...++...+.++.+|+..
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHHHHH
Confidence 467899999999998889999999999999999999999886532211111111111110 112344556789999999
Q ss_pred HccCCCCCCCC-----hHHHHHH
Q 017395 292 CLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps-----~~~il~~ 309 (372)
||+.||++||+ +.+++.+
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcC
Confidence 99999999999 7788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.70 Aligned_cols=254 Identities=19% Similarity=0.238 Sum_probs=207.6
Q ss_pred CccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
..|.+.+.||.|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46788889999999999999954 789999998864322 22557899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||+++++|.+++... ....+++.+++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999998642 235689999999999999999999999 9999999999999999999999999998765432
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh-HHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS-DEGTEL 285 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 285 (372)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......... ............+. ..+.++
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---HhhhhcCCCCCCChhhcCHHH
Confidence 22456788999999998889999999999999999999998875432111100 00000001111222 556789
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
.+++.+||..+|++|||+.+|++.|+.+.
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.20 Aligned_cols=254 Identities=18% Similarity=0.255 Sum_probs=209.5
Q ss_pred HHHHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 49 LRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 49 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
+.........|.+++.||.|++|.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 33444455679999999999999999998 56789999999986655556778999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++|+||+++++|.+++. ...+++.++..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999999999999985 34589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 208 DGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 208 ~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||........... ... ........+...+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~ 243 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT--NGTPELQNPEKLSP 243 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh--cCCcccCCcccCCH
Confidence 322 23567899999999988899999999999999999999988764321111000 000 00001112344567
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+.+++.+||..||.+|||+.+++.+
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 89999999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=312.60 Aligned_cols=238 Identities=19% Similarity=0.343 Sum_probs=191.5
Q ss_pred ccCCCCCCeEEEEEeCC-------------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 64 EHGEKAPNVVYKGKLEN-------------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.||+|+||.||+|+..+ ...|++|.+..........|.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 57999999999998432 23589999876554445678899999999999999999999999889999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC-------ceeeccCCc
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-------PRLSCFGLM 203 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~-------~kl~Dfg~~ 203 (372)
||||+++++|..++.. ....+++..++.++.|++.||+|||++ +++||||||+|||++.++. ++++|||++
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999998864 335689999999999999999999999 9999999999999986664 899999998
Q ss_pred ccCCCCCcccCCCCcCCccccc-CCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 204 KNSRDGRSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 204 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
..........++..|+|||++. +..++.++|||||||++|||++ |..|+.......... ...... ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-----~~~~~~--~~~~~~ 232 (262)
T cd05077 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-----FYEGQC--MLVTPS 232 (262)
T ss_pred ccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----HHhcCc--cCCCCC
Confidence 7766555566788999999987 4568999999999999999984 666554332111110 000000 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+.++.+|+.+||+.||.+||++.+|++.|
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 56899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=325.24 Aligned_cols=242 Identities=17% Similarity=0.239 Sum_probs=197.2
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEe
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 133 (372)
|++++.||+|+||+||+|. ..+++.||||++.... ....+.+..|..++..+. |++|+++++++...+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 5667888999999999999 4568999999997532 223456788999998885 5788889999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----C
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----G 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~ 209 (372)
|+++|+|.+++. ....+++.++..++.|++.||.|||++ |++||||||+|||+++++.+||+|||+++.... .
T Consensus 82 y~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999999999986 345699999999999999999999999 999999999999999999999999999875332 1
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||..|+|||++.+..++.++|||||||++|||++|+.||........... +... ...++...+.++.+++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~~~--~~~~p~~~~~~~~~li 232 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEH--NVSYPKSLSKEAVSIC 232 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHhC--CCCCCccCCHHHHHHH
Confidence 234578999999999988899999999999999999999998865432221111 1111 1123445668899999
Q ss_pred HHHccCCCCCCCCh-----HHHHHH
Q 017395 290 SRCLQYEPRERPNP-----RSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~-----~~il~~ 309 (372)
.+||+.||.+|++. .++++|
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcC
Confidence 99999999999974 455555
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=314.01 Aligned_cols=248 Identities=15% Similarity=0.168 Sum_probs=201.6
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|.+++.||+|+||.||+|. ..+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 467888999999999999999 4568999999997665455567889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
++++|.+++. ..+.+++.+++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++...... ..
T Consensus 89 ~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 89 GGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 9999999986 345699999999999999999999999 9999999999999999999999999998654322 23
Q ss_pred ccCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh-hccccccccccccCCCChHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-DRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 212 ~~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
..++..|+|||++. ...++.++|+|||||++|+|++|..|+......... .........+... ....++..+.+
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 243 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--DKMKWSNSFHH 243 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--ccCCCCHHHHH
Confidence 46788999999985 445888999999999999999999887543211110 0000011111110 01134568999
Q ss_pred HHHHHccCCCCCCCChHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (372)
++.+||+.||++|||+.+++++
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=317.42 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=203.8
Q ss_pred cccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
|++.+.||+|+||.||+|... ....+|+|.+..... ...+++.+|+.+++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 567788999999999999842 235799999875443 2356789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee
Q 017395 132 AEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill 189 (372)
|||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill 160 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVLV 160 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheEEE
Confidence 99999999999886421 13588999999999999999999999 99999999999999
Q ss_pred cCCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhh
Q 017395 190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRD 262 (372)
Q Consensus 190 ~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~ 262 (372)
++++.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||++ |..|+.......+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999987543221 1234568999999988889999999999999999998 887775433222211
Q ss_pred ccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
. .........+...+.++.+++.+||+.||++||++.++++.|+.+..
T Consensus 241 ~-----~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 L-----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-----HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111122344556889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=316.07 Aligned_cols=239 Identities=24% Similarity=0.363 Sum_probs=193.8
Q ss_pred ccCCCCCCeEEEEEeC-C-------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 64 EHGEKAPNVVYKGKLE-N-------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.||.|+||.||+|... . ...||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5799999999999843 2 2348899987655444567899999999999999999999999989999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC--------ceeeccCCcccCC
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--------PRLSCFGLMKNSR 207 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~--------~kl~Dfg~~~~~~ 207 (372)
++|+|.+++... ...+++..+..++.|++.||+|||++ |++||||||+||+++.++. ++++|||++....
T Consensus 82 ~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 82 KFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999999743 33689999999999999999999999 9999999999999987765 5999999987766
Q ss_pred CCCcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 208 DGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 208 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
......++..|+|||++.+. .++.++||||||+++|||++|..++........... .... ...++...+.++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~ 233 (258)
T cd05078 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FYED--RHQLPAPKWTELA 233 (258)
T ss_pred CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HHHc--cccCCCCCcHHHH
Confidence 65566778899999999874 479999999999999999999654432211111000 0000 1123444557899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+++.+||+.||++|||++++++.|
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHhc
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=320.08 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=206.1
Q ss_pred CccccccccCCCCCCeEEEEEeC--------CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 126 (372)
+.|.+.+.||+|+||.||+|... +...+|+|.+.... .....++.+|+++++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46889999999999999999742 23579999998543 23355688999999999 7999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~ 192 (372)
..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+. |++||||||+||+++.+
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTED 176 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCC
Confidence 9999999999999999997532 13488999999999999999999999 99999999999999999
Q ss_pred CCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccc
Q 017395 193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (372)
Q Consensus 193 ~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~ 265 (372)
+.+||+|||++....... ...++..|+|||++.+..++.++|||||||++|||++ |..|+............
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~- 255 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL- 255 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-
Confidence 999999999987654321 1223467999999998889999999999999999998 77776543322211111
Q ss_pred cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
........+...+.++.+++.+||..+|.+|||+.++++.|+.+.+.
T Consensus 256 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 256 ----KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ----HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111233445678999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=312.57 Aligned_cols=246 Identities=17% Similarity=0.218 Sum_probs=201.9
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-----cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.|.+.+.||.|++|.||+|. ..+++.||+|.+...... ..+.+.+|++++++++||||+++++++......++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 45667778999999999999 456899999998643221 234688999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||++++++.++|+|||+++.....
T Consensus 83 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999863 45689999999999999999999999 9999999999999999999999999998754322
Q ss_pred -----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
....++..|+|||++.+..++.++||||||+++|||++|+.||......... ...........++...+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----FKIATQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----HHHhccCCCCCCCccCCHH
Confidence 2234677899999999888999999999999999999999887543111110 0111111122345556788
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+.+++.+||..+|.+|||+.+++++.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.52 Aligned_cols=254 Identities=18% Similarity=0.302 Sum_probs=200.6
Q ss_pred ccccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 129 (372)
-|.+++.||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 367889999999999999973 3578899999975432 2345789999999999999999999998775 5689
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++++|.+++... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++......
T Consensus 85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 999999999999998642 33589999999999999999999999 9999999999999999999999999998765432
Q ss_pred C-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh-------cc---cccccccc
Q 017395 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------RN---IQTLTDSC 272 (372)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-------~~---~~~~~~~~ 272 (372)
. ...++..|+|||++.+..++.++||||||+++|||++++.|........... .. ........
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 1 2334567999999998889999999999999999999876542211000000 00 00000000
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.....+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11122344678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=315.45 Aligned_cols=248 Identities=17% Similarity=0.197 Sum_probs=201.7
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
|++++.||.|+||.||+|.. .++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67889999999999999995 45788999999766555567799999999999999999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cccc
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~ 213 (372)
++|..++.. ...++++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++...... ....
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999988754 345699999999999999999999999 9999999999999999999999999998654322 2345
Q ss_pred CCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 214 TNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 214 ~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
++..|+|||++. +..++.++|||||||++|||++|+.||................ . .....+...+.++.++
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~l 241 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-P--PTLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC-C--CCCCCccccCHHHHHH
Confidence 788999999984 3457889999999999999999998875432111110000000 0 0111233456789999
Q ss_pred HHHHccCCCCCCCChHHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.+||+.||.+||++.+++++-.
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCC
Confidence 99999999999999999988743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.09 Aligned_cols=242 Identities=20% Similarity=0.290 Sum_probs=195.5
Q ss_pred ccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
+||+|+||.||+|.+. ++..||+|++....... .+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4799999999999753 35579999997654322 456899999999999999999999875 457899999999999
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-------c
Q 017395 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-------Y 212 (372)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~ 212 (372)
|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........ .
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999864 234689999999999999999999999 999999999999999999999999999875433211 1
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
.++..|+|||++.+..++.++||||||+++||+++ |..||......... ...........+..++.++.+++.+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-----SFIEQGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-----HHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 22467999999988889999999999999999996 88777543211111 1111111223445567899999999
Q ss_pred HccCCCCCCCChHHHHHHHHhh
Q 017395 292 CLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~ 313 (372)
||..||++||++.+|.+.|+.+
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=324.97 Aligned_cols=233 Identities=20% Similarity=0.222 Sum_probs=188.7
Q ss_pred ccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHH-HHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||+||+|+. .+++.||+|++..... .....+.+|.. +++.++||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 579999999999994 5678899999875321 12234455544 567889999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|.+++.. ...+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 82 ELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 99999963 45688999999999999999999999 999999999999999999999999999875322 223468
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
|+.|+|||++.+..++.++|||||||++|||++|+.||.............. . ...++...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~--~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----K--PLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh----C--CcCCCCCCCHHHHHHHHHHcc
Confidence 8999999999998999999999999999999999999865432221111111 1 012234556889999999999
Q ss_pred CCCCCCCChHH
Q 017395 295 YEPRERPNPRS 305 (372)
Q Consensus 295 ~dp~~Rps~~~ 305 (372)
.||.+||++.+
T Consensus 233 ~~p~~R~~~~~ 243 (325)
T cd05602 233 KDRTKRLGAKD 243 (325)
T ss_pred cCHHHCCCCCC
Confidence 99999998773
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.82 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=199.4
Q ss_pred cccccccCCCCCCeEEEEEeC-C---CcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe-----
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE----- 127 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 127 (372)
|.+.+.||+|+||.||+|... + +..||||.+..... .....+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456778899999999999853 2 36899999975432 234578999999999999999999998866544
Q ss_pred -eEEEEecCCCCCHHhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 128 -RLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 128 -~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
.+++|||+++++|..++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988532 223689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccC
Q 017395 203 MKNSRDGRS------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 203 ~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (372)
++....... ...+..|+|||.+.+..++.++||||||+++|||++ |..|+............. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~ 234 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-----HGNRL 234 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCC
Confidence 886543221 223567999999988889999999999999999999 776665432211111111 11111
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
..+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 23455678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.37 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=206.5
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
++|.+.+.||.|+||.||+|...+++.||||.+.... ...+++.+|+.++++++||||+++++++......++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4678889999999999999998777889999997544 345679999999999999999999999998889999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----c
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~ 211 (372)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||++....... .
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 99999999765556799999999999999999999999 99999999999999999999999999987654321 1
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...+..|+|||.+.+..++.++||||||+++|+|++ |+.||.............. ......+...+.++.+++.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-----GYRMPRPPNCPEELYDLML 238 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHH
Confidence 223467999999998889999999999999999998 8877754322111111111 0111223344678999999
Q ss_pred HHccCCCCCCCChHHHHHHHHh
Q 017395 291 RCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+||+.+|++||++.++.+.|+.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=315.58 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=200.9
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
..|.+++.||+|+||.||+|... .+..||+|.+...... ....|.+|+.+++.++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 35678888999999999999853 4678999998754433 2456999999999999999999999999888999
Q ss_pred EEEecCCCCCHHhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC---CceeeccC
Q 017395 130 LVAEYMPNDTLAKHLFHWET-----QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFG 201 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~---~~kl~Dfg 201 (372)
+||||+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .+||+|||
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999865321 2589999999999999999999999 999999999999998654 59999999
Q ss_pred CcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccc
Q 017395 202 LMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 202 ~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||........... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-----~~~~~~ 239 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-----VTGGGR 239 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCCc
Confidence 988653221 1122457999999998889999999999999999997 8877754332221111 111112
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2334556688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=323.62 Aligned_cols=249 Identities=18% Similarity=0.136 Sum_probs=197.2
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|++++.||+|+||+||+++ ..+++.||||++.... ....+.+.+|+.++..++|+||+++++++...+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 68899999999999999999 4568899999986421 1234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
|+++|+|.+++.+ ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999999999964 244689999999999999999999999 99999999999999999999999999987544322
Q ss_pred --cccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 --SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||................ ............+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 238 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-EHFQFPPDVTDVSE 238 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CcccCCCccCCCCH
Confidence 2357899999999873 447889999999999999999999986543211111110000 00000011123567
Q ss_pred HHHHHHHHHccCCCC--CCCChHHHHHH
Q 017395 284 ELVRLASRCLQYEPR--ERPNPRSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~--~Rps~~~il~~ 309 (372)
++.+++.+||..++. .|+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 899999998865443 47899999999
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=318.15 Aligned_cols=253 Identities=17% Similarity=0.239 Sum_probs=203.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|++++.||+|+||.||++. ..++..+|+|.+...... ...++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 57888999999999999999 456888999998754332 2456889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--Cccc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 213 (372)
++++|.++++. .+.+++..+..++.|++.||.|||+..+++|+||||+||++++++.+||+|||++...... ....
T Consensus 82 ~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 82 DGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 99999999974 3568999999999999999999997438999999999999999999999999998754332 3456
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh---cccccccc--------------------
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---RNIQTLTD-------------------- 270 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~---~~~~~~~~-------------------- 270 (372)
++..|+|||++.+..++.++|+||||+++|+|++|+.|+.......... ........
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhH
Confidence 7889999999988889999999999999999999998875432111110 00000000
Q ss_pred -----c---cccCCCC-hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 271 -----S---CLEGQFS-SDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 271 -----~---~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
. ......+ ...+.++.+++.+||..||++|||+.+++++..-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred HHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0 0000111 1245689999999999999999999999999553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=319.04 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=203.4
Q ss_pred CccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 128 (372)
++|.+.+.||+|+||.||+|.. .++..||||.++..... ..+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3577888899999999999973 12457999998754322 245689999999999 799999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+.+|+|.++++......+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++....
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999999754444589999999999999999999999 999999999999999999999999999876543
Q ss_pred CC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 209 GR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 209 ~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |..|+.......... ...........+...
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~ 269 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY----KLIKEGYRMAQPEHA 269 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH----HHHHcCCcCCCCCCC
Confidence 22 1234567999999998889999999999999999998 887765432111100 011111111123344
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+.++.+++.+||+.+|++|||+.++++.|..+
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 67899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=308.79 Aligned_cols=242 Identities=30% Similarity=0.431 Sum_probs=202.2
Q ss_pred ccCCCCCCeEEEEEeC-C---CcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|... . +..||+|.+....... .+.+.+|++.++.++|+||+++++++......++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 5799999999999953 3 7899999998665443 677999999999999999999999999989999999999999
Q ss_pred CHHhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 139 TLAKHLFHWE-------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 139 sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999997532 36699999999999999999999999 9999999999999999999999999999876543
Q ss_pred ----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
....++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. ......+..++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 235 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----GYRLPKPEYCPDE 235 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccCChH
Confidence 23445788999999998889999999999999999999 5777654422211111111 1122334556789
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.+++.+||..||.+|||+.+++++|+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 236 LYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=319.92 Aligned_cols=254 Identities=19% Similarity=0.296 Sum_probs=205.1
Q ss_pred CccccccccCCCCCCeEEEEEe--------CCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 126 (372)
.+|.+.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 4677889999999999999973 124579999987543 23356789999999999 8999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~ 192 (372)
..++||||+++++|.+++.... ...+++.++..++.|++.||.|||++ |++||||||+||+++++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~ 173 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTEN 173 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCC
Confidence 9999999999999999997532 23478889999999999999999999 99999999999999999
Q ss_pred CCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccc
Q 017395 193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNI 265 (372)
Q Consensus 193 ~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~ 265 (372)
+.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|+|++ |..|+.............
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999999988654321 1234567999999998889999999999999999998 666665432222211111
Q ss_pred cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.......+..++.++.+++.+||+.+|++|||+.++++.|+++...
T Consensus 254 -----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 254 -----EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -----cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111122445678899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=321.25 Aligned_cols=254 Identities=17% Similarity=0.248 Sum_probs=200.4
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
....|.++++||+|+||.||+|+. .+++.||+|.+...... ....+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 345789999999999999999994 46889999999754322 2346789999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+++ +|.+++.. ....+++..+..++.|++.||.|||++ |++||||||+||++++++.+||+|||++......
T Consensus 84 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99976 78888754 234589999999999999999999999 9999999999999999999999999998754322
Q ss_pred -CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc-----------ccc------c-
Q 017395 210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-----------QTL------T- 269 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~-----------~~~------~- 269 (372)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||............. ..+ .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 22456789999999875 458899999999999999999998886542211100000 000 0
Q ss_pred --cccccC----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 270 --DSCLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 270 --~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+.... ......+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000 011235678999999999999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.10 Aligned_cols=238 Identities=24% Similarity=0.379 Sum_probs=190.0
Q ss_pred ccCCCCCCeEEEEEeCC-------------------------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeE
Q 017395 64 EHGEKAPNVVYKGKLEN-------------------------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL 118 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 118 (372)
.||+|+||.||+|.... ...||+|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 57999999999997411 24589999876544345578899999999999999999
Q ss_pred eeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-----
Q 017395 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----- 193 (372)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~----- 193 (372)
++++......++||||+++|+|..++.. ..+.+++..+..++.|++.||+|||++ +++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999999998864 345689999999999999999999999 999999999999997644
Q ss_pred --CceeeccCCcccCCCCCcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHH-hCCCCCCchhhHHhhhccccccc
Q 017395 194 --NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLL-SGKHIPPSHALDLIRDRNIQTLT 269 (372)
Q Consensus 194 --~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~-tg~~p~~~~~~~~~~~~~~~~~~ 269 (372)
.+|++|||++..........++..|+|||.+.+ ..++.++||||||+++|||+ +|..|+.......... ..
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~ 234 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-----FY 234 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-----HH
Confidence 379999998865544445567788999999876 45899999999999999985 6777664332111100 00
Q ss_pred cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.. ....+...+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 235 ~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 00 0112223346799999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=324.83 Aligned_cols=241 Identities=18% Similarity=0.217 Sum_probs=194.5
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 57999999999999 45688999999975432 2345588999999888 6999999999999999999999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcccC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~ 214 (372)
+|..++. ..+.+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 82 DLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9999886 345699999999999999999999999 999999999999999999999999999875321 223568
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh---hhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI---RDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
|+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+... ...++...+..+.+++.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 8999999999998999999999999999999999998843110000 00000001111 112345566889999999
Q ss_pred HccCCCCCCCCh------HHHHHH
Q 017395 292 CLQYEPRERPNP------RSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~------~~il~~ 309 (372)
||+.||.+|+++ .++++|
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcC
Confidence 999999999985 577766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.81 Aligned_cols=250 Identities=15% Similarity=0.186 Sum_probs=196.6
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC------
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ 126 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 126 (372)
..+|.+++.||+|+||.||++.. .++..||||.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46789999999999999999994 568999999997532 223556889999999999999999999986443
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999976 5777663 2488999999999999999999999 9999999999999999999999999998764
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc------------------cc
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR------------------NI 265 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------------------~~ 265 (372)
... ....+|..|+|||++.+..++.++|||||||++|+|++|+.||........... ..
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 332 234678899999999998999999999999999999999998864321100000 00
Q ss_pred ccccc--cccc----------------CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 266 QTLTD--SCLE----------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 266 ~~~~~--~~~~----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..... +... .......+.++.+|+.+||+.||++|||+.|+++|-+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000 0000 0011123567899999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=311.62 Aligned_cols=246 Identities=14% Similarity=0.202 Sum_probs=197.7
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeC------CeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG------DERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~------~~~~ 129 (372)
.|++++.||.|+||.||+|. ..+++.||+|++.... .....+.+|+.+++++ +||||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 45677788999999999999 4568899999997544 3446788999999999 699999999998753 4689
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+.+++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 999999999999999764456789999999999999999999999 9999999999999999999999999998764322
Q ss_pred ----CcccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 210 ----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
....++..|+|||++.+ ..++.++|||||||++|||++|+.|+............ ............
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~ 240 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPAPRLKSKK 240 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hcCCCCCCCCCC
Confidence 23457889999999863 35788999999999999999999887532211111100 001111111234
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+.++.+|+.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 55789999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=315.39 Aligned_cols=251 Identities=16% Similarity=0.215 Sum_probs=205.4
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
..+.|.++++||.|+||.||++.. .++..||+|.+........+.+.+|++++++++||||+++++++..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456789999999999999999995 5688999999986655556789999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999864 234699999999999999999999999 9999999999999999999999999987654322
Q ss_pred CcccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 210 RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
....++..|+|||.+. +..++.++|+||||+++|+|++|+.|+.............. . .......+...+.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~ 237 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-S--EPPTLDQPSKWSSS 237 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-C--CCCCcCCcccCCHH
Confidence 2345788999999985 33477899999999999999999988754321111100000 0 00011123445678
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+.+++.+||+.+|.+||++.+++++-
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcCh
Confidence 99999999999999999999999883
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=329.39 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=202.2
Q ss_pred ccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 129 (372)
++.+.+.||+|+||.||+|++. .+..||||+++...... .+.+.+|+++|.++. ||||+++++++...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 5667788999999999999853 24689999998653332 446899999999997 999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCC------------------------------------------------------------
Q 017395 130 LVAEYMPNDTLAKHLFHWET------------------------------------------------------------ 149 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 149 (372)
+||||+.+|+|.++++....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999999964321
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 150 ------------------------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 150 ------------------------------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
..+++..++.++.|++.||.|||+. +++||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCC
Confidence 2367788899999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 017395 194 NPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 266 (372)
.+||+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||++ |..|+......... .
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~----~ 352 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF----Y 352 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH----H
Confidence 9999999998754321 12335678999999998889999999999999999998 77776532211110 0
Q ss_pred ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
...........+..++.++.+++.+||..+|.+||++++|++.|+.+.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 001111112234456789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=300.85 Aligned_cols=250 Identities=20% Similarity=0.222 Sum_probs=206.4
Q ss_pred HhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc----c----HHHHHHHHHHHhcCC-CcceeeEeeE
Q 017395 52 ATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP----D----ARQFLEEARAVGQLR-NRRLANLLGC 121 (372)
Q Consensus 52 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l~-hpniv~l~~~ 121 (372)
+...|..|.--+.+|+|..++|-++. ..++..+|+|++...... . .+.-.+|+.+|+++. ||||+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34455566666667999999999988 667889999999643221 1 334578999999995 9999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
++.+..+++|+|.|+.|.|+|++. ..-.+++....+|++|+.+|+.|||.+ +||||||||+|||+++|.++||+|||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999999996 556799999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCC---cccCCCCcCCcccccC------CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh----hhcccccc
Q 017395 202 LMKNSRDGR---SYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----RDRNIQTL 268 (372)
Q Consensus 202 ~~~~~~~~~---~~~~t~~y~aPE~~~~------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~----~~~~~~~~ 268 (372)
++.....+. ..+||++|+|||.+.- ..|+...|+||+|||+|.|+.|.+||.......+ .+++..
T Consensus 169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq-- 246 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ-- 246 (411)
T ss_pred eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc--
Confidence 999887764 4689999999998863 2388899999999999999999988754322211 111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
....-..+.+....+||.+||+.||.+|.|+.|++.|-
T Consensus 247 ----F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 247 ----FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred ----cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 11112356678999999999999999999999999993
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.76 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=202.4
Q ss_pred CCccccccccCCCCCCeEEEEEeC-CC---cEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
..+|++.+.||+|+||.||+|... ++ ..||||.+..... ...++|.+|+.++++++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 346788899999999999999853 33 3699999975432 235679999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++++|.+++... .+.+++.+++.++.|++.||+|||++ |++|+||||+||+++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999998653 34689999999999999999999999 99999999999999999999999999987543321
Q ss_pred c-------cc--CCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 211 S-------YS--TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 211 ~-------~~--~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
. .. .+..|+|||.+.+..++.++||||||+++||+++ |..||.............. ......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~ 235 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-----DYRLPPPMD 235 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-----CCcCCCccc
Confidence 1 11 1346999999998889999999999999999886 8877754322211111110 011122344
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
++..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.97 Aligned_cols=249 Identities=15% Similarity=0.167 Sum_probs=194.2
Q ss_pred cccccCCC--CCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 61 IVSEHGEK--APNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 61 ~~~~lG~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+++.||+| +|++||++. ..+++.||||.+...... ..+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45678888 788999998 567899999999764322 2345778999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC------
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------ 209 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~------ 209 (372)
++|+|.+++.......+++..++.++.|++.||+|||++ +++||||||+||+++.++.++++||+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999654445699999999999999999999999 9999999999999999999999999864332110
Q ss_pred -----CcccCCCCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh----hccccccccc-------
Q 017395 210 -----RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----DRNIQTLTDS------- 271 (372)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~----~~~~~~~~~~------- 271 (372)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ........+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11234667999999976 35899999999999999999999988542111100 0000000000
Q ss_pred -----------------------------cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 272 -----------------------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 272 -----------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
..........++++.+|+.+||+.||++|||+++++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 000011223467899999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=308.68 Aligned_cols=247 Identities=18% Similarity=0.187 Sum_probs=205.6
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|++++.||.|+||.||.++ ..+++.+++|.+.... ....+++.+|++++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 37788899999999999998 5668899999987543 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+++++|.+++.......+++..+..++.|++.||.|||+. |++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999999765456689999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...++..|+|||.+.+..++.++||||||+++|+|++|..|+.............. ... ...+...+.++.+++.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GNY-TPVVSVYSSELISLVH 234 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CCC-CCCccccCHHHHHHHH
Confidence 34578899999999988889999999999999999999988754322211111111 101 1122445688999999
Q ss_pred HHccCCCCCCCChHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l 310 (372)
+||..+|.+||++.++++++
T Consensus 235 ~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHcccCcccCCCHHHHhhCc
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.24 Aligned_cols=247 Identities=18% Similarity=0.243 Sum_probs=198.9
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|++++.||+|+||.||+|. ..+++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 56788899999999999998 56788999999875432 23456899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--Cccc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 213 (372)
++++|..+. .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++...... ....
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 999997653 378889999999999999999999 9999999999999999999999999998765432 3346
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH---hhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---IRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
++..|+|||++.+..++.++|+||||+++|+|++|+.||....... ........+.............+.++.+++.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 7889999999998889999999999999999999998875321000 0000000000010011112234578999999
Q ss_pred HHccCCCCCCCChHHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~ 311 (372)
+||+.||++||++.+++++.+
T Consensus 235 ~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 235 QCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHhhCChhhCCCHHHHhcCcc
Confidence 999999999999999998844
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=330.48 Aligned_cols=250 Identities=18% Similarity=0.203 Sum_probs=197.2
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC-----eeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 129 (372)
++++++.||+|+||.||+|.. .+++.||||.+.... ....+++.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 356788899999999999994 578999999986532 223467899999999999999999999998776 789
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+.+ +|.+.+. ....+++..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQS-DLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeecccc-CHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999964 7888875 345699999999999999999999999 9999999999999999999999999998764332
Q ss_pred -----CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-------------------
Q 017395 210 -----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------- 264 (372)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------------------- 264 (372)
....++..|+|||++.+.. ++.++|||||||++|||++|+.||............
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1234678899999998754 789999999999999999999888643211100000
Q ss_pred cccccccccc-------CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 265 IQTLTDSCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 265 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...+...... .......+.++.+|+.+||+.||.+|||+.++++|-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0000000000 0112234678999999999999999999999999843
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=326.91 Aligned_cols=249 Identities=15% Similarity=0.207 Sum_probs=197.1
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------C
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 126 (372)
..+|.+++.||+|+||.||+|. ..+++.||||.+..... .....+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4578899999999999999998 45688999999975432 2345788999999999999999999988643 3
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 57999999976 6777764 2488999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc------------------c
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------I 265 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------------------~ 265 (372)
... ....+|..|+|||++.+..++.++|||||||++|+|++|+.||............ .
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 443 2346789999999999888999999999999999999999988643211100000 0
Q ss_pred ccccc---------------ccc---cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 266 QTLTD---------------SCL---EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 266 ~~~~~---------------~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
..... ... ....+...+.++.+|+.+||+.||++|||+.++++|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00000 000 0011122356789999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=314.28 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=200.4
Q ss_pred CccccccccCCCCCCeEEEEEeCC-----------------CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANL 118 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l 118 (372)
.+|+++++||+|+||.||+|.... +..||+|.+...... ..+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 478899999999999999998432 246899998865432 35678999999999999999999
Q ss_pred eeEEEeCCeeEEEEecCCCCCHHhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee
Q 017395 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (372)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill 189 (372)
++++......+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+. |++|+||||+||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili 163 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATRNCLV 163 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccchhceee
Confidence 999999999999999999999999986432 12689999999999999999999999 99999999999999
Q ss_pred cCCCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh--CCCCCCchhhHHhh
Q 017395 190 DDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIR 261 (372)
Q Consensus 190 ~~~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~p~~~~~~~~~~ 261 (372)
++++.++|+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||++ +..|+.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 99999999999998754322 12234668999999998889999999999999999998 45554332111110
Q ss_pred hccccc--cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 262 DRNIQT--LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 262 ~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...... ..........+..++.++.+++.+||+.||.+|||+.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 000000 00000111123345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=312.54 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=202.3
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
++|.+++.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46788899999999999999853 246899999875432 23456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 130 LVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999986422 22478899999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccc
Q 017395 202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 202 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
+++..... ....++..|+|||.+.++.++.++||||||+++||+++ |..|+............. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-----~~~~ 239 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-----DGGH 239 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-----cCCC
Confidence 98754332 12334678999999988889999999999999999998 787765432221111111 1111
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1234445789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=311.37 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=195.5
Q ss_pred ccccccCCCCCCeEEEEEeCC-Cc--EEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------Cee
Q 017395 60 NIVSEHGEKAPNVVYKGKLEN-QF--RIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DER 128 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~ 128 (372)
.+.+.||+|+||.||+|...+ +. .||+|.++... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 355778999999999999544 33 69999987543 23356789999999999999999999987532 247
Q ss_pred EEEEecCCCCCHHhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 129 LLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
+++|||+++|+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCccc
Confidence 8999999999999887421 224589999999999999999999999 99999999999999999999999999988
Q ss_pred cCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCC
Q 017395 205 NSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 205 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
...... ...++..|++||.+.+..++.++||||||+++|||++ |..||............. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~ 235 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-----QGNRLKQ 235 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----cCCCCCC
Confidence 654322 2234568999999998889999999999999999999 677765432111111100 0011122
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.92 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=200.0
Q ss_pred CccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC-Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~ 127 (372)
++|++.+.||.|+||.||+|.. .+++.||||+++..... ....+.+|+.+|.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3688999999999999999973 34678999999754322 245688999999999 689999999988654 46
Q ss_pred eEEEEecCCCCCHHhhhhcCC-----------------------------------------------------------
Q 017395 128 RLLVAEYMPNDTLAKHLFHWE----------------------------------------------------------- 148 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 148 (372)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986421
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC------cccCCC
Q 017395 149 ------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNL 216 (372)
Q Consensus 149 ------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~t~ 216 (372)
...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++....... ...++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 12367888999999999999999999 99999999999999999999999999987643221 123356
Q ss_pred CcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccC
Q 017395 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (372)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 295 (372)
.|+|||++.+..++.++||||||+++|+|++ |..|+.......... ...........+...++++.+++.+||+.
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH----HHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 7999999998889999999999999999997 777765421110000 00001111112233457899999999999
Q ss_pred CCCCCCChHHHHHHHHhhhc
Q 017395 296 EPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 296 dp~~Rps~~~il~~l~~~~~ 315 (372)
||++|||+.+|+++|+.+.+
T Consensus 322 ~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 322 EPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=307.91 Aligned_cols=250 Identities=14% Similarity=0.156 Sum_probs=205.1
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
++|++.+.+|.|+||.||+|.. .+++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4678889999999999999994 567899999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++...... ..
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 999999998642 25699999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred ccCCCCcCCcccccCC---CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.|+................... .....+...+.++.++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 239 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-PKLKDKEKWSPVFHDF 239 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-ccccchhhhhHHHHHH
Confidence 4567889999999876 78999999999999999999998875432111110000000000 0111234567889999
Q ss_pred HHHHccCCCCCCCChHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+||..+|.+|||+.+++.+
T Consensus 240 i~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=318.46 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=204.8
Q ss_pred ccccccccCCCCCCeEEEEEeC--------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCe
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 127 (372)
.|.+.+.||+|+||.||+|... .+..||+|.+..... ...+++.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 5788999999999999999732 123699999875432 2356789999999999 79999999999999899
Q ss_pred eEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
.+++|||+++|+|.+++.... ...+++.++..++.|++.||.|||++ |++||||||+||++++++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~~ 171 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDN 171 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC
Confidence 999999999999999986432 23478899999999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 017395 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 266 (372)
.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..|+..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 251 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999987654321 1223457999999998889999999999999999998 7777654332222111111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
......+...+.++.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 252 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 252 -----GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111233455678999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=307.70 Aligned_cols=242 Identities=22% Similarity=0.297 Sum_probs=197.6
Q ss_pred ccCCCCCCeEEEEEeCC--C--cEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKLEN--Q--FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 57999999999998533 3 3699999987665 446679999999999999999999999988 8899999999999
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-------c
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S 211 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-------~ 211 (372)
+|.+++.......+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 999999764435689999999999999999999999 99999999999999999999999999987654321 2
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+.............. .......+...+..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK----EGERLERPEACPQDIYNVML 235 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCcCCCCccCCHHHHHHHH
Confidence 345678999999998889999999999999999998 8887743221111111000 00111123345678999999
Q ss_pred HHccCCCCCCCChHHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~ 311 (372)
+||+.+|++|||+.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=306.56 Aligned_cols=241 Identities=25% Similarity=0.398 Sum_probs=198.4
Q ss_pred ccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHh
Q 017395 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~ 142 (372)
.||.|+||.||+|...++..||+|.+....... ...+.+|+++++.++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 479999999999997788899999987654332 3468899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----cccCCCC
Q 017395 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SYSTNLA 217 (372)
Q Consensus 143 ~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~t~~ 217 (372)
++... ...+++..+..++.|++.||.|||++ |++|+||||+||++++++.+||+|||++....... ...++..
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 82 FLRKK-KDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 98643 34589999999999999999999999 99999999999999999999999999987543321 1223467
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCC
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (372)
|+|||++.+..++.++||||||+++|++++ |..||............ ........+..++..+.+++.+||+.+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-----EKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 999999998889999999999999999998 88777543222111111 111112234456789999999999999
Q ss_pred CCCCCChHHHHHHHH
Q 017395 297 PRERPNPRSLVTALV 311 (372)
Q Consensus 297 p~~Rps~~~il~~l~ 311 (372)
|++|||+.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=345.55 Aligned_cols=255 Identities=19% Similarity=0.187 Sum_probs=203.8
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+|++++.||+|+||.||+|.. .+++.||||++...... ..++|.+|++++++++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5788999999999999999994 56899999999754322 2457999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 133 EYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
||++|++|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999886321 12356778899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC----------------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh
Q 017395 204 KNSRDG----------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR 261 (372)
Q Consensus 204 ~~~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~ 261 (372)
+..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 765110 1235789999999999999999999999999999999999988643211111
Q ss_pred hccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCC-ChHHHHHHHHhhhc
Q 017395 262 DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP-NPRSLVTALVTLQK 315 (372)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~il~~l~~~~~ 315 (372)
.. .....+. ........++.+.+++.+||+.||++|| +++++++.|+....
T Consensus 241 ~~--~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 YR--DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 0011110 0001124567899999999999999996 67778787877654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=327.61 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=219.8
Q ss_pred cccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
..+-.+||-|.||.||.|.|+ -...||||.++.+.. ..++|+.|+.+|+.++|||+|+++|+|.....+|||+|||.+
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 334568899999999999964 478899999986653 467899999999999999999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--cccC-
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--SYST- 214 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~- 214 (372)
|+|.++|++..+..++.-..+.++.||..|+.||..+ ++|||||...|.|+.++..+|++|||+++.+...+ ...|
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA 426 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA 426 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc
Confidence 9999999988888888889999999999999999999 99999999999999999999999999999876543 2223
Q ss_pred --CCCcCCcccccCCCCCCCCceeehHHHHHHHHhCC-CCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 215 --NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 215 --t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
.+.|.|||-+....++.++|||+|||+|||+.|-. .|+++... -....++....+-.-|..|++.+.+|+.+
T Consensus 427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----SqVY~LLEkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYGLLEKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence 47899999999999999999999999999998744 56655322 12233444445556688899999999999
Q ss_pred HccCCCCCCCChHHHHHHHHhhhcCCCCC
Q 017395 292 CLQYEPRERPNPRSLVTALVTLQKDTEVP 320 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~~~~~~~~ 320 (372)
||+++|.+||+++|+-+.++.+..+..+.
T Consensus 502 CW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred HhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 99999999999999999999998776654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=308.10 Aligned_cols=246 Identities=16% Similarity=0.182 Sum_probs=202.7
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe-CCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e 133 (372)
.|++++.||.|++|.||++. ..+++.||+|.+..... ...+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 37888999999999999999 45678999999975432 234568899999999999999999998764 446899999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++++|.+++.......+++.+++.++.|++.||.+||++ |++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99999999999765556799999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....+++.|+|||++.+..++.++||||||+++++|++|+.||................ ....+...+..+.+++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li 234 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-----LPPMPKDYSPELGELI 234 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----CCCCccccCHHHHHHH
Confidence 23456789999999998889999999999999999999998876433222111111111 1123445668999999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+||+.||.+|||+.+++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHhccCcccCCCHHHHhcC
Confidence 99999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=321.25 Aligned_cols=250 Identities=16% Similarity=0.138 Sum_probs=198.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
++|++++.||+|+||+||+++. .+++.||+|++.... ......+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688999999999999999994 568899999987422 122345788999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
||++||+|.+++... ...+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999742 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ---cccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 211 ---SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 211 ---~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
...||+.|+|||++.+ +.++.++|||||||++|||++|+.||................... .........+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~~~ 237 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF-QFPSHITDVS 237 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-cCCCccccCC
Confidence 2458899999999875 457889999999999999999999986543221111111000000 0011112356
Q ss_pred HHHHHHHHHHccCCCCC--CCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRE--RPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (372)
.++.+++.+||..++++ |++++++++|
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 88999999999876554 4689999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=315.90 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred ccccccccCCCCCCeEEEEEeC--------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCe
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 127 (372)
+|.+.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 5678889999999999999731 245799999875432 2355688999999999 69999999999998889
Q ss_pred eEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+||++++++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCC
Confidence 999999999999999996532 23588999999999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 017395 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 266 (372)
.+||+|||+++...... ...++..|+|||++.++.++.++||||||+++|+|++ |..||.............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~- 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR- 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999997654321 1123457999999998889999999999999999999 777765432221111111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.......+..++.++.+++.+||+.||++|||+.++++.|..+....
T Consensus 251 ----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 251 ----EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11111234455678999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=310.62 Aligned_cols=243 Identities=15% Similarity=0.230 Sum_probs=203.0
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|++++.||.|++|.||+|.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++++......++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 578888999999999999994 568899999997653 334567889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++..... ..
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 82 GGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999999963 3789999999999999999999999 9999999999999999999999999998766543 23
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH-HHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 290 (372)
..++..|+|||.+.+..++.++||||||+++|+|++|..|+........... .........+.. .+.++.+++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-----IPKNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-----hhhcCCCCCcccccCHHHHHHHH
Confidence 4567889999999988899999999999999999999988754321111100 001111112222 5678999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||..||++|||+++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 233 LCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=308.41 Aligned_cols=247 Identities=21% Similarity=0.253 Sum_probs=190.4
Q ss_pred cccCCCCCCeEEEEEeCC---CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 63 SEHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
+.||+|+||.||+|...+ +..+|+|.+...... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 357999999999998533 457999998765432 2346889999999999999999999999888999999999999
Q ss_pred CHHhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----
Q 017395 139 TLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (372)
Q Consensus 139 sL~~~l~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 210 (372)
+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 9999986422 23467788889999999999999999 99999999999999999999999999987543221
Q ss_pred -cccCCCCcCCcccccCC-------CCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 211 -SYSTNLAFTPPEYLRTG-------RVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
...++..|+|||++.+. .++.++||||||+++|||++ |..||......................+......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 23356789999998642 35789999999999999996 9888754322111111111111111111222234
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+..+.+++..|| .+|++|||+++|+..|.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 577899999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=309.70 Aligned_cols=246 Identities=20% Similarity=0.277 Sum_probs=188.7
Q ss_pred cccCCCCCCeEEEEEeCC---CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 63 SEHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
++||+|+||.||+|...+ ...+|+|.+...... ....|.+|++.++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997432 457899987654322 2456889999999999999999999999999999999999999
Q ss_pred CHHhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC------
Q 017395 139 TLAKHLFHWET---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------ 209 (372)
Q Consensus 139 sL~~~l~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~------ 209 (372)
+|.+++..... ...++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999965322 2356788899999999999999999 9999999999999999999999999998653221
Q ss_pred CcccCCCCcCCcccccC-------CCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 210 RSYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
....++..|+|||++.. ..++.++|||||||++|||++ |..|+.........................+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 12234567999998753 346889999999999999999 5656543321111111111111111122334456
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+..+.+++..|| .||++|||+.+|++.|
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 678889999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.45 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=206.6
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.++|++++.||+|+||+||++. ..+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 4578899999999999999999 45688999999875432 235678999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--Cc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 211 (372)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+..+++|+||||+||++++++.++|+|||++...... ..
T Consensus 84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~ 161 (284)
T cd06620 84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161 (284)
T ss_pred cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence 9999999999863 4568999999999999999999997438999999999999999999999999998654322 23
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh---h----ccccccccccccCCCC-hHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---D----RNIQTLTDSCLEGQFS-SDEGT 283 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~---~----~~~~~~~~~~~~~~~~-~~~~~ 283 (372)
..++..|+|||++.+..++.++|||||||++|+|++|..||......... . .......... ...++ ...+.
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCCchhcCH
Confidence 46788999999998888999999999999999999999988643221000 0 0011111110 11112 22567
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
++.+|+.+||+.||++|||+.+++++..-+.
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 8999999999999999999999999855443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=306.63 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=203.3
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
..|++.++||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4678889999999999999997777789999987543 235678999999999999999999999877 77899999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----c
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~ 211 (372)
+++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 99999999764555688999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||++.++.++.++|+||||+++|++++ |..|+............... .....+...+.++.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENCPEELYNIMM 237 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----CCCCCcccCCHHHHHHHH
Confidence 223467999999998889999999999999999999 78777543222111111111 111123345678999999
Q ss_pred HHccCCCCCCCChHHHHHHHHh
Q 017395 291 RCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~ 312 (372)
+||+.+|++||++.++++.|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 238 RCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.93 Aligned_cols=240 Identities=18% Similarity=0.302 Sum_probs=205.0
Q ss_pred cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhh
Q 017395 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (372)
Q Consensus 65 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (372)
||+|.||+||-|+ ..++..+|||.+........+-+..|+.+.++++|.|||+++|.+.+++++-|.||-++||||.++
T Consensus 583 LGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsL 662 (1226)
T KOG4279|consen 583 LGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSL 662 (1226)
T ss_pred eecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHH
Confidence 6999999999999 667889999999987766777799999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeeccCCcccCCC----CCcccCCC
Q 017395 144 LFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD----GRSYSTNL 216 (372)
Q Consensus 144 l~~~~~~~l--~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~----~~~~~~t~ 216 (372)
++. .=+++ .+.++..+.+||++||.|||.+ .|||||||-+|||++ -.|.+||+|||-++.... ..++.||.
T Consensus 663 Lrs-kWGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 663 LRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence 974 33567 7899999999999999999999 999999999999997 678999999998876543 35678999
Q ss_pred CcCCcccccCCC--CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 217 AFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 217 ~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
.|||||++..++ |..++|||||||++.||.||++||..-....... ..+---...+.+|...+.+.+.+|.+|+.
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 999999998765 8999999999999999999998885322111110 00101112346788999999999999999
Q ss_pred CCCCCCCChHHHHHH
Q 017395 295 YEPRERPNPRSLVTA 309 (372)
Q Consensus 295 ~dp~~Rps~~~il~~ 309 (372)
+||.+||++.+++..
T Consensus 818 pd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcccCccHHHhccC
Confidence 999999999999986
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.44 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=198.1
Q ss_pred CccccccccCCCCCCeEEEEEeCC---------------CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLEN---------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLG 120 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~ 120 (372)
.+|++.++||+|+||.||++.... ...||+|.+...... ..+.|.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 378899999999999999987532 235899999754322 2456999999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCCHHhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec
Q 017395 121 CCCEGDERLLVAEYMPNDTLAKHLFHWE----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (372)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~ 190 (372)
++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~ 163 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLVG 163 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhhEEEc
Confidence 9999999999999999999999985421 12478899999999999999999999 999999999999999
Q ss_pred CCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhC--CCCCCchhhHHhhh
Q 017395 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG--KHIPPSHALDLIRD 262 (372)
Q Consensus 191 ~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg--~~p~~~~~~~~~~~ 262 (372)
+++.+||+|||++....... ...++..|+|||++.++.++.++||||||+++|+|+++ ..|+..........
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 99999999999987543321 12335689999999988899999999999999999984 44443321111111
Q ss_pred cccc--ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 263 RNIQ--TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 263 ~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.... ...........+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0000 000000011123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=306.30 Aligned_cols=247 Identities=21% Similarity=0.328 Sum_probs=201.9
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..++.+.+.||.|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 45678889999999999999997667889999987543 23567999999999999999999999999989999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 210 (372)
++++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 82 EHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999864 234689999999999999999999999 99999999999999999999999999987543321
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|+|||.+.++.++.++||||||+++|||++ |..|+.............. ......+...+..+.+|+
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-----GFRLYKPRLASQSVYELM 234 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-----CCCCCCCCCCCHHHHHHH
Confidence 1223568999999998889999999999999999998 7877654322211111100 001111223457899999
Q ss_pred HHHccCCCCCCCChHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l 310 (372)
.+||+.+|++|||+.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=313.32 Aligned_cols=256 Identities=22% Similarity=0.322 Sum_probs=205.0
Q ss_pred CCccccccccCCCCCCeEEEEEeC-----CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEe--CCe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCE--GDE 127 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~ 127 (372)
...|.+++.||+|+||.||+|.+. ++..||||.+...... ..+.|.+|+++++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 346778899999999999999853 3688999999865543 45679999999999999999999999877 557
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 89999999999999999643 23589999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCc-------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh----------hcccccccc
Q 017395 208 DGRS-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTD 270 (372)
Q Consensus 208 ~~~~-------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~----------~~~~~~~~~ 270 (372)
.... ...+..|++||.+.+..++.++||||||++++||++|..|+......... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3211 22345699999998888999999999999999999999876543211100 000001111
Q ss_pred ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.......+..++.++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=312.27 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=200.8
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
.+|.+++.||+|+||.||+|... .+..||+|.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 46888999999999999999742 2458999998754322 2346889999999999999999999999989999
Q ss_pred EEEecCCCCCHHhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 130 LVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCC
Confidence 9999999999999996422 13356778899999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccc
Q 017395 202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 202 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
+++..... ....++..|+|||.+.++.++.++|||||||++|||++ |..|+............ ... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~~-~~ 239 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----MDG-GY 239 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcC-CC
Confidence 98754321 12234567999999998889999999999999999998 56666443222111111 000 01
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1223344678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=312.98 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=201.3
Q ss_pred CCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
..+|++++.||+|+||.||+|... ++..||+|.+....... ..++.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 346888999999999999999853 46789999997544322 45689999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCccee
Q 017395 129 LLVAEYMPNDTLAKHLFHWE--------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nil 188 (372)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil 162 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLATRNCL 162 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CeecccccHhheE
Confidence 99999999999999996421 12478889999999999999999999 9999999999999
Q ss_pred ecCCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhh
Q 017395 189 FDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIR 261 (372)
Q Consensus 189 l~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~ 261 (372)
+++++.++|+|||++....... ....+..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987543221 1223567999999998889999999999999999997 76676433211111
Q ss_pred hccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 262 DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.. +.... ....+...+.++.+|+.+||+.||.+|||+.|+++.|+
T Consensus 243 ~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 243 YY----VRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HH----HhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 10 00000 01123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=310.10 Aligned_cols=252 Identities=17% Similarity=0.245 Sum_probs=202.0
Q ss_pred HHHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 50 RTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 50 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
+..++++....+ ||+|+||.||+|. ..++..||+|.+........+.+.+|+.++++++|+||+++++++..++..
T Consensus 4 ~~~~~~~~~~~~---lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 4 EYEYDENGERVV---LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccccccCCceEE---EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 345566665544 5999999999999 556889999999877666677899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-CCCceeeccCCccc
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~ 205 (372)
++|+||+++++|.+++... ...+ ++..+..++.|++.||+|||++ |++||||||+||+++. ++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999999742 2345 7888999999999999999999 9999999999999985 67899999999875
Q ss_pred CCCC----CcccCCCCcCCcccccCCC--CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh
Q 017395 206 SRDG----RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (372)
Q Consensus 206 ~~~~----~~~~~t~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (372)
.... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.|+.......... ...........++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~ 235 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMFKIHPEIPE 235 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhhccCCCCCc
Confidence 4322 2245678999999987644 7889999999999999999998875321110000 00000011123455
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+.++.+++.+||+.+|.+|||+.+++.+
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 567889999999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=307.13 Aligned_cols=246 Identities=17% Similarity=0.191 Sum_probs=204.8
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|.+++.||+|+||.||++. ..+++.||+|.+.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 37788999999999999999 5578899999987532 22345789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+.+++|.+++.......+++.++..|+.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999999999754445689999999999999999999999 99999999999999999999999999987654432
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...++..|+|||++.+..++.++|+||||+++++|++|+.|+................ ....+...+.++.+++.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~ 234 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-----YPPVSSHYSYDLRNLVS 234 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-----CCCCcccCCHHHHHHHH
Confidence 2356788999999998889999999999999999999998875432221111111111 11234455688999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||+.+|.+||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 235 QLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=308.13 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=202.3
Q ss_pred CccccccccCCCCCCeEEEEEeC-C---CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.+|++.+.||+|+||.||+|... + +..+|+|.++..... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999842 2 347999998754322 245789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 211 (372)
|||+++++|.+++... ...+++.++..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++........
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 9999999999999643 34689999999999999999999999 999999999999999999999999999886543221
Q ss_pred -------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 212 -------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 212 -------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
...+..|+|||.+.+..++.++|+||||+++||+++ |..|+............... .....+...+.
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 236 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-----YRLPAPMDCPA 236 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----CcCCCCCCCCH
Confidence 112457999999998889999999999999999886 88887543221111111110 11122334567
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.+.+++.+||+.+|.+||++.++++.|..+
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=324.55 Aligned_cols=249 Identities=15% Similarity=0.197 Sum_probs=196.7
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------C
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 126 (372)
..+|.+++.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4578899999999999999999 4568899999997532 22345788999999999999999999987543 3
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999976 6877774 2488999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc----------------
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT---------------- 267 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~---------------- 267 (372)
... ....+|..|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 443 2346789999999999989999999999999999999999988643211100000000
Q ss_pred -----------------cccccc---cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 268 -----------------LTDSCL---EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 268 -----------------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
...... ....+...+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000 0001112346789999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=321.43 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=208.3
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
...+.++||+|-||+|.++....+..||||.++.....+ ..+|.+|+++|.+++||||++++|+|..++.+++|+||++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 345678999999999999998888999999999766544 4789999999999999999999999999999999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcc----
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---- 212 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---- 212 (372)
+|+|.+++..............+|+.||+.|++||.+. ++|||||.+.|+|++.++++||+|||+++....+..+
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 99999999764333345556778999999999999998 9999999999999999999999999999966554332
Q ss_pred --cCCCCcCCcccccCCCCCCCCceeehHHHHHHHH--hCCCCCCchhhHHhhhcccccccccccc---CCCChHHHHHH
Q 017395 213 --STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL--SGKHIPPSHALDLIRDRNIQTLTDSCLE---GQFSSDEGTEL 285 (372)
Q Consensus 213 --~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 285 (372)
.-.++|||+|.+.-+++|.++|+|+||+++||++ +...|+.....+... .+...+.+.... ...|.-++..+
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-en~~~~~~~~~~~~~l~~P~~cp~~l 776 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-ENAGEFFRDQGRQVVLSRPPACPQGL 776 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-HhhhhhcCCCCcceeccCCCcCcHHH
Confidence 2257999999999999999999999999999975 455666543222221 112222222111 12356678899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.+++.+||..+-.+|||++++..+|.+.
T Consensus 777 yelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 777 YELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=306.61 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=196.1
Q ss_pred cccCCCCCCeEEEEEe-CC---CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 63 SEHGEKAPNVVYKGKL-EN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~-~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
++||+|+||.||+|.+ .. +..+|+|.+...... ..+++.+|++++++++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 3679999999999974 22 268999999865543 3557899999999999999999999875 5678999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcc-----
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----- 212 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----- 212 (372)
++|.+++.. ...+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 999999974 33689999999999999999999999 9999999999999999999999999998765433221
Q ss_pred --cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 213 --STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 213 --~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||........... .........+..++..+.+++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-----LESGERLPRPEECPQEIYSIM 231 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----HHcCCcCCCCCCCCHHHHHHH
Confidence 12357999999998889999999999999999998 8877643221111110 001111123445568899999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
.+||..+|++|||+.++++.|+.+.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=308.18 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=200.6
Q ss_pred ccccccccCCCCCCeEEEEEeC-CC---cEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+|...+.||+|+||.||+|... ++ ..+|+|.+..... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 4456677899999999999953 33 3799999975532 23567999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS- 211 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 211 (372)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. |++|+||||+||++++++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 86 EYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999999864 235689999999999999999999999 999999999999999999999999999876543211
Q ss_pred ------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 212 ------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
...+..|+|||++.+..++.++||||||+++|||++ |..|+............. .......+...+.+
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~ 238 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-----DGFRLPAPMDCPSA 238 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-----cCCCCCCCCCCCHH
Confidence 112346999999998889999999999999999997 888875432211111111 01111123345678
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+.+++.+||+.+|++||++.+|++.|.++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=306.80 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=201.7
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+.+|.+.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence 45688889999999999999985 56789999986533 34678999999999999999999999865 4579999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-cccC
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYST 214 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 214 (372)
++++|.+++.......+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCC
Confidence 999999999765555689999999999999999999999 99999999999999999999999999987654332 2233
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
+..|+|||.+.++.++.++|+||||+++|+|++ |..||.............. ......+...+..+.+++.+||
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-----GYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-----CCCCCCCCcCCHHHHHHHHHHc
Confidence 567999999998889999999999999999998 8877754432222111111 1111223445688999999999
Q ss_pred cCCCCCCCChHHHHHHHH
Q 017395 294 QYEPRERPNPRSLVTALV 311 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~l~ 311 (372)
+.+|++||++.++++.|+
T Consensus 235 ~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 235 ETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCChhhCcCHHHHHHHHc
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=304.73 Aligned_cols=242 Identities=27% Similarity=0.406 Sum_probs=198.7
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHH
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 141 (372)
+.||.|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 357999999999999766899999998765443 3567999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc------ccCC
Q 017395 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTN 215 (372)
Q Consensus 142 ~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~t 215 (372)
+++... ...+++..+..++.+++.||.|||++ +++||||||+||+++.++.++|+|||++........ ...+
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 998642 34688999999999999999999999 999999999999999999999999999876542211 1224
Q ss_pred CCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
..|+|||.+.++.++.++|+||||+++|||++ |..|+............. .......+...+.++.+++.+||.
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-----SGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-----cCCCCCCCccCCHHHHHHHHHHhc
Confidence 56999999998889999999999999999999 666665433222111111 111112234556789999999999
Q ss_pred CCCCCCCChHHHHHHHH
Q 017395 295 YEPRERPNPRSLVTALV 311 (372)
Q Consensus 295 ~dp~~Rps~~~il~~l~ 311 (372)
.+|++|||+.++++.|+
T Consensus 234 ~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 234 YDPENRPSFSEIYNELQ 250 (251)
T ss_pred cChhhCcCHHHHHHHhh
Confidence 99999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=306.63 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=203.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|++.+.||.|+||+||+|. ..++..+|+|++..... ...+.+.+|++.++.++|+||+++++.+......++||||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 57888999999999999999 45688999999975432 24567999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 136 PNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
++++|.+++..... ..+++..+..++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999975332 5689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccC-CCChHHHHH
Q 017395 211 ----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG-QFSSDEGTE 284 (372)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 284 (372)
...++..|+|||.+... .++.++|+||||+++|+|++|+.|+................ ...... ......+..
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSKS 239 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccccHH
Confidence 23467889999999876 68999999999999999999998875432111111111110 011111 111355688
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+++.+||..||++|||+.++++|
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=323.11 Aligned_cols=236 Identities=17% Similarity=0.179 Sum_probs=189.2
Q ss_pred cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcC---CCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL---RNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 65 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
||+|+||+||+|+ ..+++.||||++...... ....+..|..++... +||||+++++++......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999 456899999998643221 233456677777665 699999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCccc
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYS 213 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~ 213 (372)
|+|.+++. ..+.+++..+..++.||+.||+|||++ |++||||||+|||++.++.+||+|||++..... .....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99999986 345699999999999999999999999 999999999999999999999999999875322 12356
Q ss_pred CCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC-hHHHHHHHHHHHH
Q 017395 214 TNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTELVRLASR 291 (372)
Q Consensus 214 ~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~ 291 (372)
||..|+|||++.+. .++.++|||||||++|+|++|+.||................. .++ ...+.++.+++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~~~~li~~ 231 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV------RFPKNVLSDEGRQFVKG 231 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC------CCCCccCCHHHHHHHHH
Confidence 88999999999765 489999999999999999999999865432222111110000 111 2346789999999
Q ss_pred HccCCCCCCC----ChHHHHHH
Q 017395 292 CLQYEPRERP----NPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rp----s~~~il~~ 309 (372)
||+.||.+|| ++.++++|
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcC
Confidence 9999999998 57777776
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=312.40 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=197.0
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|.+++.||.|++|.||+|+. .+++.||||.+..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477889999999999999995 5689999999875432 2245688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 135 MPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
++ ++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 97 58988886433 25689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc--------------------ccccc
Q 017395 210 RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR--------------------NIQTL 268 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--------------------~~~~~ 268 (372)
....++..|+|||++.+. .++.++||||||+++|+|+||+.||........... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 223457889999998764 478899999999999999999988754311000000 00000
Q ss_pred cccccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 ~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...... .......+.++.+++.+||..||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=318.81 Aligned_cols=249 Identities=17% Similarity=0.154 Sum_probs=197.2
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|++++.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++..++|+||+++++++...+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 678899999999999999994 457889999986422 1123458889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++|+|.+++.+. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 99999999999742 34689999999999999999999999 9999999999999999999999999998754322
Q ss_pred -CcccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||................ ...........++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~s~ 238 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-ERFQFPAQVTDVSE 238 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-ccccCCCccccCCH
Confidence 12468899999999863 458899999999999999999999986543211111111100 00001111234578
Q ss_pred HHHHHHHHHccCCCCC--CCChHHHHHH
Q 017395 284 ELVRLASRCLQYEPRE--RPNPRSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~--Rps~~~il~~ 309 (372)
++.+|+.+|+..+++. |+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 8999999999665444 6899999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=310.44 Aligned_cols=253 Identities=19% Similarity=0.236 Sum_probs=204.4
Q ss_pred CccccccccCCCCCCeEEEEEeCC-----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEe-CCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~ 129 (372)
+.|.+.+.||+|+||.||+|...+ +..|++|.+..... ...+.+.+|+.++++++||||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 467778889999999999999654 68899999875432 235568899999999999999999998766 46789
Q ss_pred EEEecCCCCCHHhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 130 LVAEYMPNDTLAKHLFHWET------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
+++||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 99999999999999864322 4589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCC
Q 017395 204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (372)
Q Consensus 204 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (372)
+...... ...++..|+|||++.+..++.++||||||+++||+++ |+.|+.......+...... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~ 239 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-----GYRLA 239 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-----CCCCC
Confidence 7653321 2234567999999998889999999999999999999 8887754322111111111 11111
Q ss_pred CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+..++.++.+++.+||..||++|||+.++++.|..+.+
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 233456789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=307.03 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=195.2
Q ss_pred ccCCCCCCeEEEEEeC-CCc--EEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 64 EHGEKAPNVVYKGKLE-NQF--RIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.||+|+||.||+|... ++. .+|+|.+..... ...+.+.+|++++.++ +||||+++++++...+..++||||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 4699999999999953 443 578898875332 2345789999999999 7999999999999999999999999999
Q ss_pred CHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 139 TLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 139 sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
+|.+++.... ...+++.++..++.|++.||+|||++ |++||||||+||++++++.+||+|||++.
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCcc
Confidence 9999986432 12478999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
..... .....+..|+|||++.+..++.++||||||+++|||++ |..||............ ........+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~ 235 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRLEKPLN 235 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-----hCCCCCCCCCc
Confidence 43221 11223457999999988889999999999999999997 88777543221111111 11111122334
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
.+.++.+++.+||+.||.+|||+.+++..|..+.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 5678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=309.19 Aligned_cols=245 Identities=16% Similarity=0.258 Sum_probs=204.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|..++.||.|+||.||+|.. .++..||+|.+..... ...+.+.+|+++++.++||||+++++++......++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 577888899999999999995 5688999999875432 33567899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----c
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 211 (372)
++++|.+++. ..++++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9999999985 34689999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++|+||||+++|||++|..|+......... ...........+...+..+.+++.+
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----FLIPKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----hhhhcCCCCCCchhhhHHHHHHHHH
Confidence 35678899999999888999999999999999999999887543211111 1111111223455677899999999
Q ss_pred HccCCCCCCCChHHHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~ 311 (372)
||+.+|++||++.+++.+-.
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 236 CLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred HcccCcccCcCHHHHHhChH
Confidence 99999999999999999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=306.90 Aligned_cols=243 Identities=19% Similarity=0.287 Sum_probs=199.6
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc---------HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---------ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
|.+.+.||.|++|.||+|.. .+++.||+|.+....... .+.+.+|++++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 44567789999999999984 568899999887543221 24588999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. |++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999963 35689999999999999999999999 999999999999999999999999999876542
Q ss_pred C----------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 209 G----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 209 ~----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ...... ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~ 233 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----IFKIGE-NASPEIP 233 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----HHHHhc-cCCCcCC
Confidence 1 123467889999999988899999999999999999999998864321110 001101 1122334
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...+..+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 5567899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=312.05 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=198.0
Q ss_pred ccccccccCCCCCCeEEEEEeC-----------------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE-----------------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLL 119 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~ 119 (372)
+|.+.+.||+|+||.||++... +...||+|.+...... ..++|.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788899999999999998532 2457999999754332 346799999999999999999999
Q ss_pred eEEEeCCeeEEEEecCCCCCHHhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec
Q 017395 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWET---------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (372)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~ 190 (372)
+++...+..++||||+++++|.+++..... ..+++.++..++.|++.||+|||+. |++|+||||+||+++
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~ 164 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVG 164 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCChheEEEc
Confidence 999999999999999999999999864321 2477889999999999999999999 999999999999999
Q ss_pred CCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh--CCCCCCchhhHHhhh
Q 017395 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIRD 262 (372)
Q Consensus 191 ~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~p~~~~~~~~~~~ 262 (372)
+++.++|+|||++....... ...++..|++||...++.++.++|||||||++|||++ |..|+..........
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999999987643321 1223567999999888889999999999999999998 555554322111111
Q ss_pred cccccccc---ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 263 RNIQTLTD---SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 263 ~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.. ..... .......+..++..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 245 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 245 NT-GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH-HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 00000 00001123345688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=312.44 Aligned_cols=252 Identities=17% Similarity=0.244 Sum_probs=203.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|++++.||+|+||.||++.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 688999999999999999995 478999999987542 223467899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--Ccc
Q 017395 136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (372)
Q Consensus 136 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 212 (372)
++++|..++.... ...+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence 9999999886421 2368999999999999999999996339999999999999999999999999998765332 234
Q ss_pred cCCCCcCCcccccCCC------CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~------~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
.++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||........... ...+.. ......+..++.++.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~ 239 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIVD-GDPPTLPSGYSDDAQ 239 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHhh-cCCCCCCcccCHHHH
Confidence 5678899999986543 58899999999999999999998854322211110 111111 111234555778999
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+++.+||+.+|++||++.+++.+-+
T Consensus 240 ~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 240 DFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHHcccCcccCCCHHHHhcChh
Confidence 9999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.59 Aligned_cols=243 Identities=18% Similarity=0.212 Sum_probs=192.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.|.+.+.||.|+||.||+|.. .+++.||||.... ..+.+|+++|++++|+||+++++++...+..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 488889999999999999995 4588999996432 346789999999999999999999999999999999995
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC------C
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------R 210 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~------~ 210 (372)
++|.+++.. ....+++.+++.|+.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..... .
T Consensus 244 -~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 -SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred -CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 689888864 234699999999999999999999999 9999999999999999999999999998764332 1
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh------------hHHhhhccc--cccccc-----
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------------LDLIRDRNI--QTLTDS----- 271 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~------------~~~~~~~~~--~~~~~~----- 271 (372)
...||..|+|||++.+..++.++|||||||++|||++|..+++... ...+..... ......
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 2458999999999999899999999999999999999886543211 111111000 000000
Q ss_pred ----------cccCC-----CC--hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 272 ----------CLEGQ-----FS--SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 272 ----------~~~~~-----~~--~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..... +. ...+.++.+|+.+||+.||.+|||+.|+++|
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00 0234578999999999999999999999998
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=306.38 Aligned_cols=245 Identities=24% Similarity=0.319 Sum_probs=191.9
Q ss_pred ccCCCCCCeEEEEEeC----CCcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEE-eCCeeEEEEecCCC
Q 017395 64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLLVAEYMPN 137 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~ 137 (372)
.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5799999999999842 24579999986432 233567889999999999999999999875 34568999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--------
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-------- 209 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-------- 209 (372)
++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 82 GDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999999642 33467888899999999999999999 9999999999999999999999999998754321
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCch-hhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+... ........ +. .......+...+..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LL-QGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hh-cCCCCCCCCcCCHHHHHH
Confidence 1223456899999998888999999999999999999966554322 11111100 00 000111223345789999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.+||+.+|++||++.++++.|+.+..
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=307.90 Aligned_cols=246 Identities=17% Similarity=0.229 Sum_probs=200.8
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
+|.+.+.||.|+||+||+|...+++.+|||.+...... ....+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 35677888999999999999878889999998754321 134588999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC---
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--- 208 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 208 (372)
|||+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999963 35689999999999999999999999 999999999999999999999999998875321
Q ss_pred -------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 209 -------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 209 -------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
.....++..|+|||++.+..++.++||||||+++|+|++|..||........... .. .........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~--~~~~~~~~~~~~~ 234 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IG--AHRGLMPRLPDSF 234 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hh--hccCCCCCCCCCC
Confidence 1234567899999999988899999999999999999999988754211100000 00 0001112234456
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.++.+++.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 7889999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=311.11 Aligned_cols=244 Identities=16% Similarity=0.270 Sum_probs=201.7
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|..++.||.|+||.||+|. ..+++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46677888999999999998 45688999999875432 23456899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----c
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 211 (372)
++++|.+++. ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999884 35689999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++||||||+++|||++|+.|+.......... ..........+...+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPKNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhcCCCCCCCcccCHHHHHHHHH
Confidence 346788999999998889999999999999999999998865321111100 011111122334456789999999
Q ss_pred HccCCCCCCCChHHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l 310 (372)
||+.+|++||++.+++.+-
T Consensus 236 ~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 236 CLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred HccCCcccCcCHHHHHHhH
Confidence 9999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.27 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=204.7
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCc----EEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+|++++.||+|+||.||+|.. .++. .||+|.+...... ....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 3678889999999999999984 3333 6899998765432 34578999999999999999999999877 78999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999999653 34589999999999999999999998 99999999999999999999999999988654332
Q ss_pred c------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 S------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 ~------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
. ..++..|+|||.+....++.++|+||||+++||+++ |+.|+.......+...... ......+..++.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 238 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-----GERLPQPPICTI 238 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-----CCCCCCCCCCCH
Confidence 1 112457999999988889999999999999999998 8888765432222211111 111122334557
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.+.+++.+||..||+.||++.++++.|..+.++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=343.13 Aligned_cols=250 Identities=17% Similarity=0.203 Sum_probs=197.8
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 129 (372)
.+.+|.+++.||.|+||+||+|. ..++..||+|.+...... ....|.+|+.+|++++||||++++++|... ..+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 45689999999999999999999 456889999998754322 345789999999999999999999988653 5689
Q ss_pred EEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcC------CCcccccccCcceeecC----------
Q 017395 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK------ERALYHDLNAYRIVFDD---------- 191 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~------~~iiH~Dikp~Nill~~---------- 191 (372)
|||||+++++|.++|... ....+++..++.|+.||+.||.|||+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998642 235699999999999999999999984 15999999999999964
Q ss_pred -------CCCceeeccCCcccCCCC---CcccCCCCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCCCchhhHH
Q 017395 192 -------DVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL 259 (372)
Q Consensus 192 -------~~~~kl~Dfg~~~~~~~~---~~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~ 259 (372)
.+.+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||+||||++|..||.......
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 234899999998865432 23468999999999864 348899999999999999999999885432110
Q ss_pred hhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.....+.... . ......+.++.+||..||+.+|.+||++.+++.+
T Consensus 251 qli~~lk~~p-~----lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 251 QLISELKRGP-D----LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHhcCC-C----CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 0000000000 0 0012345789999999999999999999999976
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=304.68 Aligned_cols=246 Identities=18% Similarity=0.207 Sum_probs=203.6
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|++++.||+|+||.||++. ..+++.+|||.+..... ...+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 37788899999999999998 45788999999975432 2355789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-CCceeeccCCcccCCCCC---
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~--- 210 (372)
+++++|.+++.......+++..+..++.|++.||.|||++ |++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 9999999999765555689999999999999999999999 99999999999999855 458999999988665432
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+............... .....+...+.++.+++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~ 234 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----TFAPISDRYSPDLRQLIL 234 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----CCCCCCCCcCHHHHHHHH
Confidence 245678999999999888999999999999999999999887544322111111111 111233446688999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||+.||++|||+.+++.+
T Consensus 235 ~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 235 SMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHccCChhhCCCHHHHhhC
Confidence 9999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=304.87 Aligned_cols=246 Identities=16% Similarity=0.206 Sum_probs=203.3
Q ss_pred CccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
++|++.+.||.|+||.||+|... ++..+++|.+..... .+++.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 36778888999999999999954 478999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----c
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 211 (372)
++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999999864 345689999999999999999999999 99999999999999999999999999988654432 2
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++||||||+++|+|++|+.|+............ .. ........+...+.++.+++.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-PN--KPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-cc--CCCCCCCchhhcCHHHHHHHHH
Confidence 34678999999999888999999999999999999999887543211110000 00 0001111234456789999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||+.||++|||+.+++.+
T Consensus 236 ~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 236 CLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHhcChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=314.06 Aligned_cols=252 Identities=17% Similarity=0.255 Sum_probs=200.4
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+..|.++++||.|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 456899999999999999999984 46889999998754322 2446789999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+.+ +|.+++... ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.+||+|||++......
T Consensus 84 e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 99974 899888643 34689999999999999999999999 9999999999999999999999999998764322
Q ss_pred -CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc-----------ccccccc------
Q 017395 210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR-----------NIQTLTD------ 270 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----------~~~~~~~------ 270 (372)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||........... ....+..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 223457889999998764 478899999999999999999988865322111000 0000000
Q ss_pred ---ccccC----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 ---SCLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ---~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.... ......+..+.+|+.+||+.||.+|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0112346789999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=310.39 Aligned_cols=247 Identities=14% Similarity=0.208 Sum_probs=198.2
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEe------CCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE------GDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------~~~~ 128 (372)
..|++++.+|.|+||.||+|.. .+++.+|+|++.... ....++..|+.+++++ +||||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 4667778889999999999994 668899999986543 2345688999999999 69999999999853 4578
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
+++|||+++|+|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999999999999765556689999999999999999999999 999999999999999999999999999875432
Q ss_pred ----CCcccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh
Q 017395 209 ----GRSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (372)
Q Consensus 209 ----~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (372)
.....++..|+|||.+. +..++.++|||||||++|||++|..||....... ................
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----ALFLIPRNPPPKLKSK 249 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----hhhhHhhCCCCCCccc
Confidence 22345788999999986 3457889999999999999999998875432110 0111111111111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.++.++.+++.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 456789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=312.71 Aligned_cols=252 Identities=19% Similarity=0.297 Sum_probs=200.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCc----EEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
+++.++.||+|+||.||+|.. .++. .||+|.+....... ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCceee
Confidence 456778899999999999984 4444 57999887544322 3468899999999999999999999865 457799
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
+||+++|+|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 87 TQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred ehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccCccc
Confidence 9999999999998642 34589999999999999999999999 99999999999999999999999999998654322
Q ss_pred -----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
...++..|+|||.+.+..++.++||||||+++|||++ |+.|+........... .........+..++..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEKGERLPQPPICTID 239 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHCCCCCCCCCCCCHH
Confidence 1223568999999998889999999999999999997 7877754322211111 1111111122334578
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
+.+++.+||..+|++||++.++++.|..+..+.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 999999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=321.86 Aligned_cols=250 Identities=17% Similarity=0.225 Sum_probs=196.2
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------C
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 126 (372)
...|.+++.||.|+||.||+|. ..+++.||||.+..... ...+.+.+|+++|++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 3578899999999999999999 45788999999975422 2245678999999999999999999987543 3
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++++|++ +++|.+++. ...+++..+..++.|++.||.|||++ |++||||||+||++++++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 578999998 779998874 35699999999999999999999999 9999999999999999999999999998875
Q ss_pred CCC-CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh-------cccccccccc-----
Q 017395 207 RDG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------RNIQTLTDSC----- 272 (372)
Q Consensus 207 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-------~~~~~~~~~~----- 272 (372)
... ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ..........
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence 543 34567899999999987 468999999999999999999998886432110000 0000000000
Q ss_pred ---c--cCCC--------ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 273 ---L--EGQF--------SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 273 ---~--~~~~--------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
. .... ....++.+.+|+.+||..||.+|||+.+++.|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0 0000 012345688999999999999999999999983
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=315.53 Aligned_cols=247 Identities=18% Similarity=0.177 Sum_probs=202.9
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|++++.||.|+||.||+|.. .+++.||+|.+...... ..+.+.+|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 578888999999999999995 45899999999765433 34568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+.+++|.+++.......+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999765556799999999999999999999999 9999999999999999999999999987653221
Q ss_pred -----------------------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh
Q 017395 210 -----------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI 260 (372)
Q Consensus 210 -----------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~ 260 (372)
....++..|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 123467789999999988899999999999999999999998864432211
Q ss_pred hhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCC----hHHHHHH
Q 017395 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN----PRSLVTA 309 (372)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~il~~ 309 (372)
.. .+.............+..+.+++.+||..||++||| +.+++.+
T Consensus 241 ~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 241 FS----NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH----HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11 111111110111225689999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=313.19 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=200.0
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHH--HHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDAR--QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|++++.||+|+||+||++.. .+++.||+|++......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999999994 55778999999876544322 3456999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC----CCCCc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGRS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~----~~~~~ 211 (372)
++++|.+++. ....+++..++.++.|++.||.+||++ +++|+||||+||++++++.++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 9999999996 356689999999999999999999999 9999999999999999999999999998753 11234
Q ss_pred ccCCCCcCCccccc-CCCCCCCCceeehHHHHHHHHhCCCCCCchh----hHHhhhccccccccccccCCCChHHHHHHH
Q 017395 212 YSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHA----LDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 212 ~~~t~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
..++..|+|||++. +..++.++||||+|+++|+|++|..|+.... ................ .........+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 234 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---QQSREKSEELR 234 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---TSHTTSHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---cccchhHHHHH
Confidence 56788999999998 7789999999999999999999998887541 1111111111111110 00111238999
Q ss_pred HHHHHHccCCCCCCCChHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+++.+||+.||++|||+.+++++
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.20 Aligned_cols=236 Identities=25% Similarity=0.382 Sum_probs=189.9
Q ss_pred ccCCCCCCeEEEEEeCC-C----------cEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 64 EHGEKAPNVVYKGKLEN-Q----------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.||+|+||.||+|...+ + ..|++|.+...... ...|.+|+.++++++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 57999999999999643 3 35888887654433 5779999999999999999999999988 7789999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-------CceeeccCCccc
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-------NPRLSCFGLMKN 205 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-------~~kl~Dfg~~~~ 205 (372)
||+++++|.+++.... ..+++..+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++..
T Consensus 80 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 80 EYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 9999999999997432 2689999999999999999999999 999999999999999887 799999999987
Q ss_pred CCCCCcccCCCCcCCcccccCC--CCCCCCceeehHHHHHHHHhC-CCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 206 SRDGRSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 206 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
........++..|+|||++.+. .++.++||||||+++|||++| ..|+.......... ... . ....+....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~---~---~~~~~~~~~ 230 (259)
T cd05037 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQ---D---QHRLPMPDC 230 (259)
T ss_pred cccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHh---c---CCCCCCCCc
Confidence 6655555667889999999876 689999999999999999996 44443221110000 000 0 001112223
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
..+.+++.+||..+|.+|||+.++++.|
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 7899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=318.41 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=208.9
Q ss_pred cccCCCCCCeEEEEEeCC-----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 63 SEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
+.||.|-||.||+|.+.+ .-.||||..+.+.. .+.+.|+.|+.+|++++||||++++|+|.+ ...|||||+++
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~ 473 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAP 473 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEeccc
Confidence 567999999999998533 34689999987543 346789999999999999999999999965 67999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccC--
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST-- 214 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 214 (372)
.|.|..+++.+ +..|+......++.||+.||+|||++ ++|||||...|||+.+...+||+|||+++......-+..
T Consensus 474 ~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 474 LGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred chhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 99999999864 44589999999999999999999999 999999999999999999999999999998776543322
Q ss_pred ---CCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 215 ---NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 215 ---t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
.+.|||||.+....+|.+||||-|||++||++. |..||.+ ..+......+...-+...|+.|++.+..|+.
T Consensus 552 ~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg-----vkNsDVI~~iEnGeRlP~P~nCPp~LYslms 626 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG-----VKNSDVIGHIENGERLPCPPNCPPALYSLMS 626 (974)
T ss_pred cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc-----ccccceEEEecCCCCCCCCCCCChHHHHHHH
Confidence 467999999999999999999999999999875 6667654 3344444444555555678899999999999
Q ss_pred HHccCCCCCCCChHHHHHHHHhhhc
Q 017395 291 RCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+||+++|.+||.+.+|...|..+..
T Consensus 627 kcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 627 KCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999998877654
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=313.44 Aligned_cols=246 Identities=18% Similarity=0.276 Sum_probs=208.0
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
-|.+-+.||+|.|..|-+|+ .=+|+.||||++.+....+ ...+.+|++.|+.++|||||++|++..+...+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 35566678999999999998 5689999999998766544 34688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeeccCCcccCCCCC---
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
-++|+|+++|-+.. ..+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||+|||++..+..+.
T Consensus 99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 99999999997533 4599999999999999999999999 999999999999886 56889999999998777664
Q ss_pred cccCCCCcCCcccccCCCCC-CCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
..+|+..|.|||++.|..|+ ++.||||||||||-|++|+.||....... .+..+++ + .-..|..++.++++||
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTmImD-C-KYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTMIMD-C-KYTVPSHVSKECRDLI 250 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhhhhc-c-cccCchhhhHHHHHHH
Confidence 56788999999999999886 47899999999999999999886432110 1111111 1 1135788999999999
Q ss_pred HHHccCCCCCCCChHHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..||..||.+|.|.++|..+-|
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred HHHHhcCchhhccHHHHhcccc
Confidence 9999999999999999988743
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=310.13 Aligned_cols=249 Identities=20% Similarity=0.274 Sum_probs=198.2
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|++++.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++|||++++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 578889999999999999995 4689999999864432 2235688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+++++|..++. ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 82 CDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred cCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99998888775 334589999999999999999999998 99999999999999999999999999988654432
Q ss_pred cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhH-Hhhh--cccc-----------------ccc
Q 017395 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRD--RNIQ-----------------TLT 269 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~--~~~~-----------------~~~ 269 (372)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .... .... ...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3456788999999876 45789999999999999999999887643211 0000 0000 000
Q ss_pred cccccCCC-----ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 270 DSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 270 ~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+...... ....+..+.+|+.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000 12346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=311.04 Aligned_cols=250 Identities=18% Similarity=0.218 Sum_probs=202.6
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
-...|.+++.||.|+||+||+|.. .+++.||+|.+...... ..+.+.+|+++++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 345678888999999999999994 56889999998644322 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 93 v~e~~~g-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 93 VMEYCLG-SASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred EHHhhCC-CHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 9999975 77777643 234699999999999999999999999 99999999999999999999999999998776666
Q ss_pred cccCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
...++..|+|||++. .+.++.++||||||+++|||++|+.|+........... +.........+..++..+.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHHHHH
Confidence 677888999999885 35588999999999999999999988754321111000 00000011112345678999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
++.+||+.||++||++.+++.+..
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChh
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=323.29 Aligned_cols=245 Identities=16% Similarity=0.194 Sum_probs=196.6
Q ss_pred ccccccccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|.+++.||.|+||.||++... .+..||+|.+... ..+.+|+++|++++||||+++++++......++|||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 6899999999999999999742 3578999998643 2356899999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
+. ++|.+++. ....+++..++.|+.||+.||.|||++ |++||||||+|||++.++.++|+|||++......
T Consensus 168 ~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 168 YK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred cC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 96 57888884 446799999999999999999999999 9999999999999999999999999998765432
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH----hhh----cc--cccc----------
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IRD----RN--IQTL---------- 268 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~----~~~----~~--~~~~---------- 268 (372)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... +.. .. ....
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 13468899999999998899999999999999999999999986532110 000 00 0000
Q ss_pred ----ccccccCC--CC-----hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 269 ----TDSCLEGQ--FS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 269 ----~~~~~~~~--~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.....+.. .+ ...+.++.++|.+||..||++|||+.+++.+-.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 00000000 01 123567899999999999999999999999843
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=316.58 Aligned_cols=243 Identities=13% Similarity=0.179 Sum_probs=191.3
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.|++++.||+|+||.||+|.. .++..||+|+.... ....|+.++++++||||+++++++......++||||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 688999999999999999995 45788999985432 23579999999999999999999999999999999995
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---Cccc
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS 213 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~ 213 (372)
++|.+++.. ....+++..+..|+.||+.||.|||++ |++||||||+|||++.++.+||+|||+++..... ....
T Consensus 141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 588888864 345699999999999999999999999 9999999999999999999999999998754322 2346
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh----HHhh--hccccc------cccccc--------
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIR--DRNIQT------LTDSCL-------- 273 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~----~~~~--~~~~~~------~~~~~~-------- 273 (372)
||..|+|||++.+..++.++|||||||++|||+++..+++.... .... ...+.. ......
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 297 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL 297 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence 78999999999998999999999999999999987665532100 0000 000000 000000
Q ss_pred -----------cCCC-------ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 274 -----------EGQF-------SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 274 -----------~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...+ ....+.++.+||.+||+.||.+|||+.++++|
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 01234567789999999999999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=303.42 Aligned_cols=246 Identities=18% Similarity=0.222 Sum_probs=186.6
Q ss_pred ccCCCCCCeEEEEEeCC---CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 64 EHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
+||+|+||.||+|...+ ...+++|.+..... ...+.|.+|+..++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 58999999999997433 23566777764432 235679999999999999999999999999899999999999999
Q ss_pred HHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC------CCc
Q 017395 140 LAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRS 211 (372)
Q Consensus 140 L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~------~~~ 211 (372)
|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||++..... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999997532 23467778899999999999999999 999999999999999999999999998764221 123
Q ss_pred ccCCCCcCCcccccC-------CCCCCCCceeehHHHHHHHHhCCC-CCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 212 YSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
..++..|+|||++.. ..++.++||||||+++|||+++.. |+......................+..+...+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 456788999999853 235789999999999999997644 443221111111111111111122233344567
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+.+++..|| .+|++||++++|++.|.
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 8999999999 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=305.41 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=200.9
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
.+|.+++.||.|+||.||+|+.. +...|++|.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999853 2467999998765443 3567999999999999999999999998888999
Q ss_pred EEEecCCCCCHHhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 130 LVAEYMPNDTLAKHLFHWET-------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
+||||+++++|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999975431 1589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCC
Q 017395 203 MKNSRDG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (372)
Q Consensus 203 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (372)
+...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~----~~~~~~~ 239 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----AGKLELP 239 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH----cCCcCCC
Confidence 8654321 12234567999999988888999999999999999999 565654322111111111 0111111
Q ss_pred CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+...+..+.+++.+||+.||.+|||+.+++..|.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 23345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=305.71 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=202.4
Q ss_pred CccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.+|.+.+.||.|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 456777889999999999998533 3479999987654 2335679999999999999999999998865 567899
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999999999643 33589999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
...++..|+|||.+.+..++.++||||||+++||+++ |..||........... . ........+..++..+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-I----ENGERLPMPPNCPPTL 237 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-H----HcCCcCCCCCCCCHHH
Confidence 1223457999999988889999999999999999986 8888754322111110 0 0001112344556899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.+++.+||..+|++|||+.++++.|..+...
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=312.13 Aligned_cols=246 Identities=16% Similarity=0.220 Sum_probs=200.8
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
|.....||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445689999999999994 56889999999765555566789999999999999999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cccc
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~ 213 (372)
++|..++. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...... ....
T Consensus 103 ~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 103 GALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 99999874 34689999999999999999999999 9999999999999999999999999998654332 2345
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
++..|+|||++.+..++.++||||||+++|||++|+.||........... ....... ........+..+.+++.+||
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPP--KLKNAHKISPVLRDFLERML 255 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhccCCC--CccccCCCCHHHHHHHHHHh
Confidence 78899999999988899999999999999999999988754321111000 0000000 01112334578999999999
Q ss_pred cCCCCCCCChHHHHHHHH
Q 017395 294 QYEPRERPNPRSLVTALV 311 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~l~ 311 (372)
+.+|.+||++.+++++-.
T Consensus 256 ~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 256 TREPQERATAQELLDHPF 273 (297)
T ss_pred cCCcccCcCHHHHhhChh
Confidence 999999999999999744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=312.48 Aligned_cols=241 Identities=17% Similarity=0.240 Sum_probs=198.3
Q ss_pred ccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 62 VSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
...||.|+||.||++.. .++..||||.+........+.+.+|+..++.++||||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 45679999999999984 56889999998765555566789999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----CcccCCC
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~t~ 216 (372)
.+++. .+.+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++...... ....++.
T Consensus 107 ~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 182 (292)
T cd06658 107 TDIVT---HTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182 (292)
T ss_pred HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCc
Confidence 99884 34589999999999999999999999 9999999999999999999999999998654322 2345778
Q ss_pred CcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCC
Q 017395 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (372)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (372)
.|+|||.+.+..++.++||||||+++|||++|+.|+........... ......... ......+..+.+++.+||..|
T Consensus 183 ~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNLPPRV--KDSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCcc--ccccccCHHHHHHHHHHccCC
Confidence 99999999888899999999999999999999998764322111100 111111111 112234578999999999999
Q ss_pred CCCCCChHHHHHH
Q 017395 297 PRERPNPRSLVTA 309 (372)
Q Consensus 297 p~~Rps~~~il~~ 309 (372)
|.+|||+.+++++
T Consensus 260 P~~Rpt~~~il~~ 272 (292)
T cd06658 260 PSQRATAQELLQH 272 (292)
T ss_pred hhHCcCHHHHhhC
Confidence 9999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=308.88 Aligned_cols=243 Identities=19% Similarity=0.241 Sum_probs=203.3
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|.+++.||.|+||.||++.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 578889999999999999994 5689999999875332 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-Ccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 212 (372)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||++++++.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 82 YVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 9999999999974 35699999999999999999999999 9999999999999999999999999998876544 234
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (372)
.+++.|+|||.+.+...+.++||||||+++|+|++|+.|+............. .. ...++...+..+.+++.+|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~--~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL----EG--KVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cC--CccCCccCCHHHHHHHHHH
Confidence 57889999999988888999999999999999999998876543211111111 00 1123444568999999999
Q ss_pred ccCCCCCCC-----ChHHHHHH
Q 017395 293 LQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 293 l~~dp~~Rp-----s~~~il~~ 309 (372)
|..||.+|+ +++++++|
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcC
Confidence 999999999 78888877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=305.15 Aligned_cols=248 Identities=19% Similarity=0.236 Sum_probs=198.0
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc----------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP----------DARQFLEEARAVGQLRNRRLANLLGCCCEGD 126 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 126 (372)
.|.+.+.||.|+||.||+|. ..+++.||+|.+...... ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 35667788999999999998 456889999988642111 1235788999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999743 5689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC------CcccCCCCcCCcccccCCC--CCCCCceeehHHHHHHHHhCCCCCCchhhH-HhhhccccccccccccCCC
Q 017395 207 RDG------RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~------~~~~~t~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 277 (372)
... ....++..|+|||.+.... ++.++|+||||+++|++++|..|+...... ........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK-RSAPPIPPDV 237 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc-ccCCcCCccc
Confidence 432 1234678899999987654 789999999999999999999887532211 11110000 0011111122
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
....+.++.+++.+||..+|++|||+.++++|
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 23456899999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.99 Aligned_cols=243 Identities=15% Similarity=0.230 Sum_probs=184.3
Q ss_pred cccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeEEEEecCCC
Q 017395 63 SEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPN 137 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~ 137 (372)
.+||+|+||+||+|... +++.||+|.+..... ...+.+|+++|++++||||+++++++.. ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 57899999999999853 467899999975432 3457899999999999999999998854 4568999999965
Q ss_pred CCHHhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee----cCCCCceeeccCCcccC
Q 017395 138 DTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 138 gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill----~~~~~~kl~Dfg~~~~~ 206 (372)
+|.+++... ....+++..+..++.|++.||.|||++ |++||||||+|||+ +.++.+||+|||+++..
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 788877532 123589999999999999999999999 99999999999999 45678999999999765
Q ss_pred CCC-------CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHH----------hh-------
Q 017395 207 RDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----------IR------- 261 (372)
Q Consensus 207 ~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~----------~~------- 261 (372)
... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.....+. ..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 432 234568899999999874 58999999999999999999998875321100 00
Q ss_pred --------hc-ccc---ccccccccCC------------CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 262 --------DR-NIQ---TLTDSCLEGQ------------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 262 --------~~-~~~---~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.. ... .......... .....+.++.+|+.+||+.||.+|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000 0000000000 000123568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=298.01 Aligned_cols=248 Identities=17% Similarity=0.131 Sum_probs=201.2
Q ss_pred ccccc-cccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeC----CeeEE
Q 017395 58 MENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEG----DERLL 130 (372)
Q Consensus 58 ~~~~~-~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~----~~~~l 130 (372)
+|.+- +.||-|-.|.|-.+. ..+++.+|+|++.. .+...+|+++....+ |||||.++++|... ..+.+
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 34433 457999999999998 67799999999964 355679999988885 99999999998543 45789
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec---CCCCceeeccCCcccCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~~~~ 207 (372)
|||.++||.|++.|..+..+.+++.++..|+.||+.|+.|||+. +|.||||||+|+|.. .|-.+||+|||+++...
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999999999999988888899999999999999999999999 999999999999997 44569999999999766
Q ss_pred CCC---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccc--cCCCChHHH
Q 017395 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL--EGQFSSDEG 282 (372)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 282 (372)
... +..-|+.|.|||++...+|+..+|+||+||++|-|++|.+||++.....+..+-...+..... ...-...++
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS 295 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS 295 (400)
T ss_pred CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence 432 334589999999999999999999999999999999999998764221111111111111111 011124678
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
++.+++|+.+|..+|.+|.|+.++++|-+
T Consensus 296 e~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 296 EAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred HHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 99999999999999999999999999855
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=303.69 Aligned_cols=244 Identities=16% Similarity=0.177 Sum_probs=197.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-----ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 129 (372)
.|++.+.||+|+||.||+|.. .++..||||.+..... ...+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 567778889999999999994 5689999998864221 1245688999999999999999999988763 4688
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999863 34588999999999999999999999 999999999999999999999999999875432
Q ss_pred ------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 209 ------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 209 ------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......... ............+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI----FKIATQPTNPVLPPHVS 235 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH----HHHhcCCCCCCCchhhC
Confidence 12345778999999998888999999999999999999999887543211111 11111111233456667
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+.+++.+||. +|++||++++|+++
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 889999999994 99999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=313.73 Aligned_cols=248 Identities=17% Similarity=0.189 Sum_probs=200.0
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 131 (372)
+-..|+++++||+||.+.||++.-.+.+.+|+|.+..... ....-|.+|+..|.+|+ |.+||++++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3467999999999999999999987778899888864332 23566999999999995 99999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
|||-+. +|..+|+.+......| .+..+..|++.|+.++|+. ||||.||||.|+|+- .|.+||+|||++......+
T Consensus 439 mE~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 999755 8999998654443444 7788899999999999999 999999999999998 6799999999999877654
Q ss_pred -----cccCCCCcCCcccccCC-----------CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc
Q 017395 211 -----SYSTNLAFTPPEYLRTG-----------RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
+..||+.||+||.+... +.++++||||||||||+|+.|+.||..-... -.++..+.++...
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---IAKLHAITDPNHE 591 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---HHHHHhhcCCCcc
Confidence 46799999999998632 2578999999999999999999887542211 1223334444322
Q ss_pred CCCChHH-HHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 275 GQFSSDE-GTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 275 ~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
-+||..- ..++.++++.||+.||++|||+.++|+|
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2333221 2349999999999999999999999998
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.78 Aligned_cols=244 Identities=18% Similarity=0.223 Sum_probs=196.0
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-----ccHHHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 129 (372)
.|.+.+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 456677789999999999994 5688999999864321 123468899999999999999999998865 35789
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
++|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999999963 34589999999999999999999998 9999999999999999999999999998754321
Q ss_pred -------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ ............++...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 235 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA----IFKIATQPTNPQLPSHIS 235 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH----HHHHhcCCCCCCCchhcC
Confidence 123467889999999988899999999999999999999988754321111 111111111233455566
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+.+++ +||..+|++||++++|++|
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 7888888 7888999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=309.41 Aligned_cols=249 Identities=17% Similarity=0.251 Sum_probs=205.4
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.....|.+++.||.|+||.||++. ..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 344678899999999999999998 4568899999997655555667899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
||+++++|.+++. ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 9999999999985 34588999999999999999999999 99999999999999999999999999876543322
Q ss_pred --cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccc-cccccCCCChHHHHHHHH
Q 017395 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT-DSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 287 (372)
...++..|++||.+.+..++.++|+||||+++|++++|+.||........ ...+. ........+...+..+.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----eeehhcCCCCCCCCccccCHHHHH
Confidence 23567889999999888899999999999999999999998864321110 00000 000011123345678999
Q ss_pred HHHHHccCCCCCCCChHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l 310 (372)
++.+||+.+|++||++.+++.|-
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCH
Confidence 99999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=305.53 Aligned_cols=250 Identities=14% Similarity=0.154 Sum_probs=196.9
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEE-----eCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCC-----EGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-----~~~~~ 128 (372)
..+|++++.||+|+||.||++. ..+++.+|+|++.... ....++.+|+.+++.+ +||||+++++++. .++..
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 3467788999999999999998 4568899999986533 2235688999999999 6999999999874 34568
Q ss_pred EEEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 129 LLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
++||||+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++...
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999999987532 335689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC----CcccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 207 RDG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
... ....++..|+|||++.. ..++.++|||||||++|||++|+.|+.......... ........ ....
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~--~~~~ 251 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPP--TLHQ 251 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccccCCC--cccC
Confidence 432 23457889999999853 347889999999999999999998875432111100 00000000 0111
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+...+..+.+++.+||+.||++|||+.++++++
T Consensus 252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 233457899999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=309.48 Aligned_cols=247 Identities=17% Similarity=0.138 Sum_probs=198.0
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+|++++.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999994 5578999999875532 224568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|++|++|.+++.. .+.+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999964 35689999999999999999999999 9999999999999999999999999987632100
Q ss_pred ---------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc
Q 017395 210 ---------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 210 ---------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
....++..|+|||.+.+..++.++|+||||+++|||++|..||.+................ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~---~ 235 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---W 235 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---C
Confidence 1124567899999998888999999999999999999999988654322222111111000 0
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.......+.++.+++.+||+.||++||++.++.+.|
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 011124567899999999999999999854444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=309.30 Aligned_cols=252 Identities=17% Similarity=0.235 Sum_probs=204.3
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
|..++.||+|+||.||+|+ ..++..||+|.+...... ....+.+|++++++++|||++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 5677889999999999999 456889999998754322 245688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccC
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 214 (372)
+.+ +|.+.+.. ...++++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++..........+
T Consensus 107 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 107 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred CCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 975 78777753 345689999999999999999999999 999999999999999999999999999887766666778
Q ss_pred CCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 215 t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
+..|+|||++. ++.++.++|||||||++|||++|+.|+........... +.............+..+.+++.+
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~ 259 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDYFRNFVDS 259 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCCccccHHHHHHHHH
Confidence 88999999974 35688999999999999999999988754321111110 111101111123456789999999
Q ss_pred HccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 292 CLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
||+.+|.+||++.++++++..+....
T Consensus 260 ~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 260 CLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HccCCcccCcCHHHHHhChhhhccCc
Confidence 99999999999999999987655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=328.78 Aligned_cols=251 Identities=18% Similarity=0.175 Sum_probs=189.9
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC------cceeeEeeEEEeC-Cee
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEG-DER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~-~~~ 128 (372)
.+|++++.||+|+||+||+|+ ..+++.||||+++... .....+..|++++..++| .+++++++++... .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 568899999999999999999 4568899999996432 123345667777776654 4588999988764 578
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC---------------
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV--------------- 193 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~--------------- 193 (372)
++|||++ +++|.+++.+ .+.+++..+..|+.||+.||.|||++.|||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9999998 6789998863 456999999999999999999999733999999999999998665
Q ss_pred -CceeeccCCcccCCC-CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh---ccc---
Q 017395 194 -NPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---RNI--- 265 (372)
Q Consensus 194 -~~kl~Dfg~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~---~~~--- 265 (372)
.+||+|||.+..... .....+|..|+|||++.+..++.++|||||||++|||++|+.||.......... ...
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 499999998765433 234678999999999999999999999999999999999999886432110000 000
Q ss_pred -------------ccccccc--ccCCC---------------ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 266 -------------QTLTDSC--LEGQF---------------SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 266 -------------~~~~~~~--~~~~~---------------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..+.... +.... .......+.+||.+||+.||.+|||+.|+++|-+
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 0000000 00000 0012456889999999999999999999999833
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.62 Aligned_cols=248 Identities=19% Similarity=0.280 Sum_probs=202.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|++++.||.|++|.||++.. .+++.||+|.+..... ....++.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 567788899999999999995 4688999999876543 23457899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCCCceeeccCCcccCCCC--Ccc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 212 (372)
++++|.+++.... ..+++..+..++.|++.||.|||+ . |++|+||||+||++++++.++|+|||.+...... ...
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 9999999997432 678999999999999999999999 7 9999999999999999999999999998754322 125
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh--HHhhhccccccccccccCCCChH-HHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLA 289 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li 289 (372)
.++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ..... ........ .....+.. .+.++.+++
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNE-PPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH-HHHHHhcC-CCCCCChhhcCHHHHHHH
Confidence 677899999999988899999999999999999999988754310 00000 00000111 11112222 678899999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+||..||.+|||+.+++.+
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHcCCCchhCcCHHHHhhC
Confidence 99999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.56 Aligned_cols=251 Identities=18% Similarity=0.211 Sum_probs=196.6
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++..++.||.|+||.||++. ..+++.||+|.+...... ....+.+|+.++.++. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45567788999999999999 456899999999754432 3456889999999996 99999999999998999999999
Q ss_pred CCCCCHHhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 135 MPNDTLAKHL---FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 135 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
+.. +|.++. .......+++..+..++.|++.||+|||+..+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 864 555543 22234679999999999999999999997448999999999999999999999999998754332
Q ss_pred -CcccCCCCcCCcccccCC---CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||..................+......+...+.++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence 234568899999999876 5899999999999999999999887643211000000000011111122233467899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+|+.+||+.||++|||+.+|+++
T Consensus 244 ~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 244 VNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=310.58 Aligned_cols=249 Identities=18% Similarity=0.209 Sum_probs=195.5
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|.+++.||+|+||.||+|.. .+|+.||+|.+...... ....+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 367888999999999999994 56889999999754322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
+.+ +|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 975 78887754 235699999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhh-H-Hhhhc-------------ccccccccc--
Q 017395 211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-D-LIRDR-------------NIQTLTDSC-- 272 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~-~~~~~-------------~~~~~~~~~-- 272 (372)
...++..|+|||++.+.. ++.++|||||||++|+|++|+.|+..... . ..... .........
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 234578899999987754 78999999999999999999988542211 0 00000 000000000
Q ss_pred --cc-----CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 273 --LE-----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 273 --~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.. .......+.++.+++.+||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 01112356889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=304.17 Aligned_cols=247 Identities=18% Similarity=0.274 Sum_probs=200.5
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
|...+.||+|++|.||+|. ..+++.||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 4555678999999999999 567899999999753311 245689999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcccCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~~- 209 (372)
|||+++++|.+++.. .+++++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999999973 45689999999999999999999999 999999999999998776 5999999998765432
Q ss_pred -------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
....++..|+|||.+.+..++.++||||+|+++++|++|..|+.......... ..............+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhC
Confidence 12346788999999988889999999999999999999998875322110000 0111111112234455677
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.++.+++.+||..+|.+|||+.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=301.68 Aligned_cols=246 Identities=18% Similarity=0.235 Sum_probs=203.5
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeEEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVA 132 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~ 132 (372)
+|++++.||.|+||.||++. ..+++.||+|.+..... ...+++.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47788999999999999998 55788999999875433 234568899999999999999999998754 45689999
Q ss_pred ecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCT-----SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH-----~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
||+++++|.+++... ....+++..++.++.|++.||.||| +. +++|+||||+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998643 2457899999999999999999999 87 999999999999999999999999999887
Q ss_pred CCCCC----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 206 SRDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 206 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
..... ...++..|+|||.+.+..++.++|+||||+++++|++|+.|+............ .......++...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~ 234 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-----KEGKFRRIPYRY 234 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-----hcCCCCCCcccc
Confidence 65433 345788999999999888999999999999999999999887654322111111 111112345566
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.++.+++.+||+.+|++||++.+|+++
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 7899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.79 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=199.3
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|++.+.||.|+||.||+|.. .++..||||++..... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999994 5689999999976543 2246799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+ +++|.+++... ...+++.+++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999998643 35699999999999999999999999 99999999999999999999999999988654432
Q ss_pred -cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc--------------------ccc
Q 017395 211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI--------------------QTL 268 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~--------------------~~~ 268 (372)
...++..|+|||.+.+.. ++.++||||+|++++||++|.+++............. ..+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345678999999987654 6899999999999999999976664322110000000 000
Q ss_pred ccccc----cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 TDSCL----EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 ~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..... .....+..+..+.+++.+||+.||++|||+++++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 001112345899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=291.98 Aligned_cols=251 Identities=18% Similarity=0.250 Sum_probs=203.5
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 131 (372)
+..+.+.++.||.|..|.|+++. ..+|..+|||.+.+.+.. ..++++..++++...+ +|.||+.+|||..+..++|.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 44566788899999999999999 556899999999876543 3567888888877664 89999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
||.|.. .+..++++ -.+++++..+-++...++.||.||..+.+|||||+||+|||+|+.|++||||||++..+-..
T Consensus 170 MelMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 170 MELMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 999843 45555543 55679999999999999999999998889999999999999999999999999998766544
Q ss_pred -CcccCCCCcCCcccccCC---CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
+...|.+.|||||.+.-. .|+.++||||||++|+||.||+.|+.....+...-.++..-.++.+.. ....++.+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~--~~gFSp~F 325 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG--HMGFSPDF 325 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc--ccCcCHHH
Confidence 334677899999999743 489999999999999999999999887543333222222211222221 12368999
Q ss_pred HHHHHHHccCCCCCCCChHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
++|+..||.+|+.+||...++++|
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999988
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=300.56 Aligned_cols=249 Identities=17% Similarity=0.265 Sum_probs=199.9
Q ss_pred cccccccCCCCCCeEEEEEeCC--CcEEEEEEcCCCCC----------ccHHHHHHHHHHHhc-CCCcceeeEeeEEEeC
Q 017395 59 ENIVSEHGEKAPNVVYKGKLEN--QFRIAVKRFNRSAW----------PDARQFLEEARAVGQ-LRNRRLANLLGCCCEG 125 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~ 125 (372)
|.+++.||.|+||.||+|.... ++.+|+|.+..... ....++.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6678889999999999999544 78899998864221 123457789988875 7999999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+..+++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999999987532 34568999999999999999999996338999999999999999999999999998
Q ss_pred ccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 204 KNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 204 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
...... ....++..|++||.+.+..++.++|+||||+++|+|++|+.|+..................+ .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~ 237 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP----LPEGM 237 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc----CCccc
Confidence 865543 23456788999999998889999999999999999999998875432222111111111111 11123
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+..+.+++.+||+.||++||++.++..++.
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 4578999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=304.15 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=195.1
Q ss_pred ccCCCCCCeEEEEEeCC-------CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 64 EHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.||.|+||.||+|+..+ ++.+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 47999999999998532 25799999865432 33567899999999999999999999999888999999999
Q ss_pred CCCCHHhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-----CceeeccCCccc
Q 017395 136 PNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-----NPRLSCFGLMKN 205 (372)
Q Consensus 136 ~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-----~~kl~Dfg~~~~ 205 (372)
++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999996421 23478999999999999999999999 999999999999999877 899999999875
Q ss_pred CCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 206 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
..... ....+..|+|||++.++.++.++||||||+++|||++ |..||........... .........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~ 235 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-----VTAGGRLQKP 235 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-----HhcCCccCCc
Confidence 43221 2234578999999998889999999999999999998 8877754321111110 0111111234
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 456788999999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=299.25 Aligned_cols=245 Identities=28% Similarity=0.430 Sum_probs=199.1
Q ss_pred ccccccCCCCCCeEEEEEeCC-----CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 60 NIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.+++.||.|+||.||++...+ +..||+|.+...... ..+.+.+|++.++.++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456788999999999999543 388999999765543 46689999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc--
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-- 211 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 211 (372)
|+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999753333389999999999999999999999 999999999999999999999999999876554311
Q ss_pred ---ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 212 ---~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
..++..|+|||.+.+..++.++||||||+++++|++ |..|+.............. ......+...+.++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-----GYRLPKPENCPPEIYK 235 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCCCcCCHHHHH
Confidence 225678999999988889999999999999999998 6666543221111111111 0111223346788999
Q ss_pred HHHHHccCCCCCCCChHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l 310 (372)
++.+||..||++|||+.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=306.15 Aligned_cols=251 Identities=18% Similarity=0.261 Sum_probs=195.5
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.+.|++++.||.|++|.||+|.. .+++.||||.+...... ....+.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 45788999999999999999995 46889999998754322 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+.+ +|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9975 899988643 34689999999999999999999999 9999999999999999999999999998654321
Q ss_pred CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhh--HHhhh------ccccccc----------c
Q 017395 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRD------RNIQTLT----------D 270 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~~~~~------~~~~~~~----------~ 270 (372)
....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||..... +.... ....... .
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 12235778999999876 4588999999999999999999988754320 00000 0000000 0
Q ss_pred ---cccc-C---CCChHHH--HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 ---SCLE-G---QFSSDEG--TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ---~~~~-~---~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... . ....... .++.+++.+||+.||.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0 0001122 678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=303.18 Aligned_cols=243 Identities=16% Similarity=0.248 Sum_probs=201.5
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|.++++||.|+||.||+|.. .+++.||||.+..... ...+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466788899999999999984 5688999999875432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
++++|.+++. ...+++..+..++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 9999999985 34689999999999999999999999 9999999999999999999999999998765432 22
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||.+.+..++.++|+|||||++|+|++|..|+........... .........+...+.++.+++.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----IPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-----HhcCCCCCCCcccCHHHHHHHHH
Confidence 3567889999999888889999999999999999999988754321111110 01111122334456889999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=302.15 Aligned_cols=248 Identities=15% Similarity=0.182 Sum_probs=198.9
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCC------ee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD------ER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~------~~ 128 (372)
++|++++.||.|++|.||+|.. .+++.+++|++..... ..+++.+|+++++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5788889999999999999995 4678999999876543 346799999999999 6999999999997644 48
Q ss_pred EEEEecCCCCCHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 129 LLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
++||||+++++|.+++.... +..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 99999999999999986433 46799999999999999999999999 9999999999999999999999999998754
Q ss_pred CCC----CcccCCCCcCCcccccCC-----CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 207 RDG----RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
... ....++..|+|||++... .++.++||||||+++|+|++|+.||.................. ....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 240 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP---TLKS 240 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC---CCCc
Confidence 332 234567889999988642 3678999999999999999999887543211111111111000 1111
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+...+.++.+++.+||..||++|||+.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 23356789999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=306.29 Aligned_cols=244 Identities=17% Similarity=0.237 Sum_probs=199.7
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
+...+.||.|++|.||++. ..+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 3444567999999999999 457889999998765544556789999999999999999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cccc
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~ 213 (372)
++|.+++.. ..+++..+..++.|++.||+|||++ |++||||+|+||+++.++.++|+|||++...... ....
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999863 5689999999999999999999999 9999999999999999999999999987654332 2245
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
++..|+|||.+.+..++.++||||||+++|+|++|+.|+............... ..... ..+...+..+.+++.+||
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKL--KNLHKVSPRLRSFLDRML 253 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCC--cccccCCHHHHHHHHHHc
Confidence 788999999999888999999999999999999999887543211111111110 00100 112235678999999999
Q ss_pred cCCCCCCCChHHHHHH
Q 017395 294 QYEPRERPNPRSLVTA 309 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~ 309 (372)
+.+|++|||+.+++++
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=306.55 Aligned_cols=252 Identities=17% Similarity=0.225 Sum_probs=199.2
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 129 (372)
++..|.+++.||.|+||.||+|.. .+++.+|+|.++...... ...+.+|++++++++||||+++++++... ...+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 456788999999999999999995 468899999997544322 33577899999999999999999998877 8899
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+.+ +|.+++... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCc-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99999975 899988642 33689999999999999999999999 9999999999999999999999999998865443
Q ss_pred ----CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc---------------------
Q 017395 210 ----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR--------------------- 263 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--------------------- 263 (372)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 2234578899999987654 68899999999999999999988753321110000
Q ss_pred ----cccccccccccCCCChH-HHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 264 ----NIQTLTDSCLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 264 ----~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.........+...++.. .+..+.+++.+||+.||++|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000001111122222 46789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=299.32 Aligned_cols=245 Identities=18% Similarity=0.261 Sum_probs=200.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|.+.+.||.|+||.||+|.. .+++.||+|.++..... ..+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 467788899999999999994 56889999999865543 466799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999973 34588999999999999999999999 99999999999999999999999999987654322
Q ss_pred ----cccCCCCcCCcccccCCC---CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh--HH
Q 017395 211 ----SYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS--DE 281 (372)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 281 (372)
...++..|+|||++.+.. .+.++||||||+++|++++|+.||............... .....++. ..
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 233 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----GHKPPIPDSLQL 233 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----CCCCCCCccccc
Confidence 134578999999998766 889999999999999999999987533111100000000 01111222 23
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 6789999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=304.25 Aligned_cols=246 Identities=19% Similarity=0.259 Sum_probs=194.9
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHH-HhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARA-VGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|.+++.||+|+||.||+|.. .+++.||+|.++..... ...++..|+.. ++.++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 578889999999999999994 56999999999765322 23456667765 5667899999999999999999999999
Q ss_pred CCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
++ ++|.+++... ....+++..++.++.|++.||.|||++.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 96 5888887542 234689999999999999999999985589999999999999999999999999987654322
Q ss_pred -cccCCCCcCCcccccC----CCCCCCCceeehHHHHHHHHhCCCCCCchhh--HHhhhccccccccccccCCC-ChHHH
Q 017395 211 -SYSTNLAFTPPEYLRT----GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNIQTLTDSCLEGQF-SSDEG 282 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~ 282 (372)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.|+..... +.... .... ....+ ....+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~ 234 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-----VVEE-PSPQLPAEKFS 234 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-----HHhc-CCCCCCccccC
Confidence 2456788999998865 3468899999999999999999988753211 11111 1111 01111 12356
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.++.+++.+||..+|++||++.+++++-
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 7899999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=306.97 Aligned_cols=249 Identities=17% Similarity=0.236 Sum_probs=197.5
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|++++.||.|++|.||+|+. .+++.||||.+...... ....+.+|++++++++||||+++++++......++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 67888999999999999994 56889999998754322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
. ++|.+++.......+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++...... ..
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 6 5899988765566799999999999999999999999 9999999999999999999999999998755432 22
Q ss_pred ccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------c-------------ccc
Q 017395 212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------T-------------LTD 270 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------~-------------~~~ 270 (372)
..++..|+|||++.+.. ++.++||||||+++|||+||+.||.............. . ...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 34577899999987654 68899999999999999999988754321110000000 0 000
Q ss_pred cccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 SCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... .......+.++.+++.+||+.||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 00112345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=302.43 Aligned_cols=243 Identities=21% Similarity=0.244 Sum_probs=203.3
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|++++.||.|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 367888999999999999995 4688999999975432 235678999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---C
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~ 210 (372)
|+.+++|.+++.. ..++++..+..|+.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... .
T Consensus 81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999999964 35799999999999999999999999 9999999999999999999999999998765543 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh---HHhhhccccccccccccCCCChHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL---DLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+..... ...... ... .....+...+..+.+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~ 231 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-----QET-ADVLYPATWSTEAID 231 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-----hcc-ccccCcccCcHHHHH
Confidence 34567889999999988899999999999999999999998765432 111111 000 122345556789999
Q ss_pred HHHHHccCCCCCCCCh--HHHHHH
Q 017395 288 LASRCLQYEPRERPNP--RSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~--~~il~~ 309 (372)
++.+||..||.+||++ ++++++
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHHHHccCChhHcCCccHHHHhcC
Confidence 9999999999999999 666543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.17 Aligned_cols=253 Identities=17% Similarity=0.223 Sum_probs=200.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e 133 (372)
.|+.+++||.|++|.||++.. .+++.+|+|.+..... ....++.+|++++++++||||++++++|... +.+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 567888999999999999995 5688999999975433 2355789999999999999999999998653 46899999
Q ss_pred cCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 134 YMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999887532 345689999999999999999999999 9999999999999999999999999998754432
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh----HHhhhccccccccccccCCCC--hHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTDSCLEGQFS--SDEGT 283 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~--~~~~~ 283 (372)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ...............+..... ...++
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHH
Confidence 234567889999999988899999999999999999999988764311 000000000000011111111 23467
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+.+++.+||..||.+|||+.+++++-+
T Consensus 241 ~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 8999999999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=301.26 Aligned_cols=242 Identities=16% Similarity=0.157 Sum_probs=192.7
Q ss_pred ccccccc--cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSE--HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~--lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|.+++. +|.|+||.||++. ..++..+|+|.+........ |+.....+ +||||+++++++...+..++|||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 3344444 5999999999999 56788999999875432221 22222222 79999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcccCCCCCcc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDGRSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 212 (372)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++.........
T Consensus 90 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 166 (267)
T PHA03390 90 YIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166 (267)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccC
Confidence 9999999999974 34799999999999999999999999 999999999999999888 9999999999877766667
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 292 (372)
.++..|+|||++.+..++.++||||||+++|+|++|+.|+.................. .....+...++.+.+++.+|
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 244 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--KKLPFIKNVSKNANDFVQSM 244 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--ccCCcccccCHHHHHHHHHH
Confidence 7889999999999888999999999999999999999988643211111001111011 11122345678999999999
Q ss_pred ccCCCCCCCC-hHHHHHH
Q 017395 293 LQYEPRERPN-PRSLVTA 309 (372)
Q Consensus 293 l~~dp~~Rps-~~~il~~ 309 (372)
|+.||.+||+ ++++++|
T Consensus 245 l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 245 LKYNINYRLTNYNEIIKH 262 (267)
T ss_pred hccChhhCCchHHHHhcC
Confidence 9999999995 6999876
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.72 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=197.4
Q ss_pred ccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|++++.||.|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5788899999999999999954 5899999998654322 245688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
+++++|..+... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 82 VDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 999999887753 34589999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHh-hh-----ccc----------cccccccc
Q 017395 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-RD-----RNI----------QTLTDSCL 273 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~-~~-----~~~----------~~~~~~~~ 273 (372)
...++..|+|||++.+. .++.++||||||+++|||++|+.|+........ .. ... ..+.....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 23467889999998764 478899999999999999999977754321000 00 000 00000000
Q ss_pred cC---------CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 274 EG---------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 274 ~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.. ...+..+..+.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 0112456789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.72 Aligned_cols=251 Identities=19% Similarity=0.274 Sum_probs=216.7
Q ss_pred hcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
.+.+..|.+++.||+|.|+.|.+|+ ..++..||||.+.+..... .+.+.+|+++|+.++|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 4567788999999999999999999 5568999999998766443 456899999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+.+|.+++++. ..+.+.+..+..++.|+.+|++|||++ +|+|||||.+||||+.+.++||+|||++..+...
T Consensus 132 lV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999998 445577799999999999999999999 9999999999999999999999999999877644
Q ss_pred ---CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.+.+|++.|.|||++.+..| .+.+|+||+|++||.|+.|..||.+......+...+.... .++--.+.++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~------rIp~~ms~dc 282 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY------RIPFYMSCDC 282 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee------cccceeechh
Confidence 46789999999999999875 6799999999999999999999876654433333322211 2344556789
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.++|+++|..+|.+|+++++|.++-+.
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhccc
Confidence 999999999999999999999998553
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=299.90 Aligned_cols=244 Identities=20% Similarity=0.213 Sum_probs=200.0
Q ss_pred cccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCC-----ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
|...+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|+++++.++|+||+++++++......+++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455577899999999999954 788999999865432 13457899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 82 ELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 99999999999963 34689999999999999999999999 9999999999999999999999999998765433
Q ss_pred CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....++..|++||.+.... ++.++|+||||+++|+|++|+.||......... ...........++...+.++.++
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHHhcccCCCcCCCcCHHHHHH
Confidence 2345778899999998766 899999999999999999999887543211100 00001011123344567889999
Q ss_pred HHHHccCCCCCCCChHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+||+.+|++||++.+++.+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcC
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.38 Aligned_cols=252 Identities=17% Similarity=0.223 Sum_probs=205.2
Q ss_pred cCCCccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.....|.+...+|.|++|.||+|... ++..|++|++..... ..+.+.+|++.+++++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 33445777788899999999999964 688999999986543 4667899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 9999999999997532 3799999999999999999999998 9999999999999999999999999987654432
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....++..|++||.+.+..++.++|+||||+++|+|++|+.|+.................. ....+..++.++.++
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~l 249 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP---PLKNPEKWSPEFKDF 249 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---CCcchhhCCHHHHHH
Confidence 2334678899999999888999999999999999999999887543221111110000000 011122356789999
Q ss_pred HHHHccCCCCCCCChHHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.+||+.+|.+|||+.+++++..
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChH
Confidence 99999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=299.40 Aligned_cols=245 Identities=17% Similarity=0.252 Sum_probs=201.8
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|.+.+.||.|+||.||++.. .++..||+|.+..... ...+.+.+|+++++.++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 66778899999999999994 5688999999875432 23457889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC-ceeeccCCcccCCCCC----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-PRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~-~kl~Dfg~~~~~~~~~---- 210 (372)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++. +||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 999999999764455689999999999999999999999 9999999999999998754 6999999987655432
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...+++.|+|||++.+..++.++|+||||+++++|++|..|+................. ...+...+.++.+++.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-----APISPNFSRDLRSLIS 235 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-----CCCCCCCCHHHHHHHH
Confidence 23467889999999888899999999999999999999988764322211111111111 1123345678999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||..+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 236 QLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=308.12 Aligned_cols=243 Identities=15% Similarity=0.230 Sum_probs=183.8
Q ss_pred cccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeEEEEecCCC
Q 017395 63 SEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPN 137 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~ 137 (372)
.+||+|+||+||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 46899999999999854 357899999875432 3467899999999999999999998854 4578999999965
Q ss_pred CCHHhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee----cCCCCceeeccCCcccC
Q 017395 138 DTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 138 gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill----~~~~~~kl~Dfg~~~~~ 206 (372)
+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+++..
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 787776421 123588999999999999999999999 99999999999999 46678999999999865
Q ss_pred CCC-------CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHh------------------
Q 017395 207 RDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI------------------ 260 (372)
Q Consensus 207 ~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~------------------ 260 (372)
... ....+|..|+|||++.+. .++.++|||||||++|||+||+.||.....+..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 432 223568899999999764 479999999999999999999988743211000
Q ss_pred -------hhc-cc---cccccccccC------------CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 261 -------RDR-NI---QTLTDSCLEG------------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 261 -------~~~-~~---~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
... .. .......... .........+.+|+.+||..||.+|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00 0000000000 0011123568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=302.40 Aligned_cols=249 Identities=14% Similarity=0.112 Sum_probs=197.2
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeC-----Cee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG-----DER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-----~~~ 128 (372)
-.+|.+++.||.|+||.||++.. .+++.+|+|.+..... ....+.+|+.+++++ +|||++++++++... +..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 34577888899999999999994 6788999999875432 245678899999999 799999999998754 358
Q ss_pred EEEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 129 LLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
++||||+++++|.++++.. ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 9999999999999988532 345689999999999999999999999 9999999999999999999999999998764
Q ss_pred CCC----CcccCCCCcCCcccccCCC-----CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 207 RDG----RSYSTNLAFTPPEYLRTGR-----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~~~~-----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
... ....++..|+|||.+.... ++.++|||||||++|||++|+.|+................. .....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 255 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP---PTLLH 255 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC---CCCCc
Confidence 432 2345678899999986532 68899999999999999999988754321111000000000 00111
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+...+..+.+++.+||+.||++||++.++++|
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 33455789999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=298.92 Aligned_cols=247 Identities=19% Similarity=0.282 Sum_probs=204.6
Q ss_pred ccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|++++.||.|++|.||+|+.. +++.|+||++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5678888999999999999954 589999999986654 33567999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
++++|.+++.. ...+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 82 DGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 99999999974 3669999999999999999999999 8 99999999999999999999999999988665433
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH-HHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li 289 (372)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+......... .....+... .....+.. .+..+.+++
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF-ELMQAICDG-PPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH-HHHHHHhcC-CCCCCCcccCCHHHHHHH
Confidence 234678899999999888999999999999999999999887544200000 000111111 11122333 668999999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+||..+|++|||+.+++++
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHccCChhhCCCHHHHHhC
Confidence 99999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=305.04 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=198.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|++++.||+|+||.||+|.. .+++.||||.++.... ...+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 578889999999999999995 4688999999875322 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
++++.|..+.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99877766554 334589999999999999999999999 99999999999999999999999999987654432
Q ss_pred -cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhH-Hhhh-c------------------ccc--
Q 017395 211 -SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRD-R------------------NIQ-- 266 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~-~------------------~~~-- 266 (372)
...++..|+|||++.+. .++.++||||||+++|+|++|+.|+...... .... . ...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34567889999999888 7899999999999999999999877532110 0000 0 000
Q ss_pred ccccc----cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTDS----CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..... .....++..++.++.+|+.+||..+|++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00011223347889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=298.83 Aligned_cols=244 Identities=18% Similarity=0.254 Sum_probs=199.6
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~ 132 (372)
.|++++.||.|+||.||+|. ..+++.||+|.+..... ...+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 46778889999999999999 46789999999875432 33567889999999996 999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 99999999999853 3689999999999999999999999 9999999999999999999999999998765433
Q ss_pred -CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh-HHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS-DEGTELV 286 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 286 (372)
....++..|+|||.+.++ .++.++|+||||+++|+|++|..|+........... .... ....++. ..+.++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~ 232 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKS----KPPRLEDNGYSKLLR 232 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccC----CCCCCCcccCCHHHH
Confidence 234577889999998754 478999999999999999999988754322111110 0000 1111222 2567899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+++.+||..||++||++.+++.+-
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhCh
Confidence 999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=301.89 Aligned_cols=242 Identities=18% Similarity=0.240 Sum_probs=195.7
Q ss_pred cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 65 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
||+|+||+||++. ..+++.||+|.+..... .....+.+|+++|++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 5999999999998 45688999999865322 2244578899999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---CcccCCCC
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA 217 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~t~~ 217 (372)
.+++.......+++..+..++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++...... ....++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 9999754445799999999999999999999999 9999999999999999999999999998765432 22346778
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCC
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (372)
|+|||.+.+..++.++||||||+++|+|++|+.||.................. .....+...++.+.+++.+||+.||
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999887543210000000000010 1112344557889999999999999
Q ss_pred CCCC-----ChHHHHHH
Q 017395 298 RERP-----NPRSLVTA 309 (372)
Q Consensus 298 ~~Rp-----s~~~il~~ 309 (372)
.+|| ++.+++.|
T Consensus 238 ~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 238 EKRLGCRGGSADEVREH 254 (277)
T ss_pred hHccCCCcccHHHHHhC
Confidence 9999 77778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=293.73 Aligned_cols=247 Identities=18% Similarity=0.245 Sum_probs=204.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
+|.+.+.||.|++|.||++.. .++..+++|++........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 367778899999999999995 4688999999987655456789999999999999999999999999999999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---Cccc
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS 213 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~ 213 (372)
+++|.+++.... ..+++..+..++.|++.||.+||+. |++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 999999986432 5699999999999999999999998 9999999999999999999999999998876554 3456
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
++..|++||.+.+..++.++|+||||+++++|++|+.|+.................... ..+...+..+.+++.+||
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL---RNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc---CcccccCHHHHHHHHHHc
Confidence 77899999999988899999999999999999999988764421111111110101000 011223678999999999
Q ss_pred cCCCCCCCChHHHHHH
Q 017395 294 QYEPRERPNPRSLVTA 309 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~ 309 (372)
+.||++|||+.+++++
T Consensus 236 ~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 236 QKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=297.89 Aligned_cols=240 Identities=16% Similarity=0.186 Sum_probs=197.6
Q ss_pred cCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 65 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
||.|++|.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 59999999999995 4588999999975432 2245689999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---CcccCCCC
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA 217 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~t~~ 217 (372)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 999963 34589999999999999999999998 9999999999999999999999999998876543 23456789
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCC
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (372)
|++||.+.+..++.++|+||||+++|+|++|..|+.....+... ....+........++...+.++.+++.+||+.||
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME--IYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH--HHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999887644310000 0111111111223344457899999999999999
Q ss_pred CCCCC-----hHHHHHH
Q 017395 298 RERPN-----PRSLVTA 309 (372)
Q Consensus 298 ~~Rps-----~~~il~~ 309 (372)
++||+ +.+++++
T Consensus 236 ~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 236 EERLGNLKGGIKDIKKH 252 (262)
T ss_pred hhCcCCcccCHHHHhcC
Confidence 99999 8888876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.56 Aligned_cols=248 Identities=21% Similarity=0.206 Sum_probs=196.1
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-----cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
|++++.||.|+||.||+|.. .+++.||||.+...... ....+.+|++++++++|+||+++++++...+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 66778899999999999994 56889999999765433 2345778999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
||+ +++|.+++.... ..+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 999 889999996432 3699999999999999999999999 99999999999999999999999999987654432
Q ss_pred --cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhh-HHhhhc----------------ccccccc
Q 017395 211 --SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDR----------------NIQTLTD 270 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~~~~~~----------------~~~~~~~ 270 (372)
...++..|+|||.+.+ ..++.++|||||||++|||++|.+++..... +..... .......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 2335678999999865 4578999999999999999999766543211 000000 0000000
Q ss_pred cccc-----CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 SCLE-----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... .......+.++.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 01113346789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=296.79 Aligned_cols=242 Identities=17% Similarity=0.166 Sum_probs=192.1
Q ss_pred cccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc---HHHHHHHHHHH-hcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAV-GQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
+.||.|+||.||+|.. .+++.||||.+....... ...+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5679999999999994 568899999997543221 22344555444 455899999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccCCCC
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~t~~ 217 (372)
++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..........++..
T Consensus 82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158 (260)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcC
Confidence 999999963 35689999999999999999999999 999999999999999999999999999887665556678889
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCC
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (372)
|++||.+.+..++.++||||||+++|+|++|..|+.................. ........++.++.+++.+||+.||
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCCcccccCCHHHHHHHHHHccCCH
Confidence 99999998888899999999999999999999887543322211111000000 1111223456889999999999999
Q ss_pred CCCCChH---HHHHH
Q 017395 298 RERPNPR---SLVTA 309 (372)
Q Consensus 298 ~~Rps~~---~il~~ 309 (372)
++||++. +++.|
T Consensus 237 ~~R~~~~~~~~~l~~ 251 (260)
T cd05611 237 AKRLGANGYQEIKSH 251 (260)
T ss_pred HHccCCCcHHHHHcC
Confidence 9999764 55544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=297.40 Aligned_cols=249 Identities=20% Similarity=0.295 Sum_probs=195.3
Q ss_pred cccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC------
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ 126 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 126 (372)
|.+.+.||+|+||.||+|.+. +++.||||++..... ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678899999999999842 368899999975432 23567899999999999999999999886532
Q ss_pred eeEEEEecCCCCCHHhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
..++++||+.+|+|.+++... ....+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887421 123578999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccC
Q 017395 203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 203 ~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (372)
++...... ...++..|++||.+.+..++.++||||||+++|||++ |+.|+.............. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~ 234 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-----GNRL 234 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-----CCcC
Confidence 88654321 2223467999999998889999999999999999999 7766643322111111000 0011
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 12234557899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=301.88 Aligned_cols=240 Identities=17% Similarity=0.226 Sum_probs=197.2
Q ss_pred cccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHH
Q 017395 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 141 (372)
..||+|+||.||++.. .+++.||||.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5679999999999984 578999999987555445567999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----CcccCCCC
Q 017395 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (372)
Q Consensus 142 ~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~t~~ 217 (372)
+++. ...+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06657 106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence 9874 34589999999999999999999999 9999999999999999999999999987654332 23456788
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCC
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (372)
|+|||.+.+..++.++|+||||+++|+|++|..|+............ ........ ......+..+.+++.+||+.||
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKL--KNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCccc--CCcccCCHHHHHHHHHHHhCCc
Confidence 99999998888899999999999999999999887643221111100 00011100 0122345789999999999999
Q ss_pred CCCCChHHHHHH
Q 017395 298 RERPNPRSLVTA 309 (372)
Q Consensus 298 ~~Rps~~~il~~ 309 (372)
.+||++.+++.+
T Consensus 259 ~~R~~~~~ll~~ 270 (292)
T cd06657 259 AQRATAAELLKH 270 (292)
T ss_pred ccCcCHHHHhcC
Confidence 999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=315.87 Aligned_cols=243 Identities=21% Similarity=0.284 Sum_probs=203.6
Q ss_pred cccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 61 IVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+.++||+|.||.|++|.|.. .-.||||++...... ...+|++|+.+|.+|+|||+++|||+..+ ....||||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 34567999999999999743 346899999876655 57789999999999999999999999877 7889999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCccc--
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS-- 213 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 213 (372)
+.|||.+.|++.....|-......++.||+.|+.||.++ ++|||||-..|+|+.....+||+|||+.+.+.......
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999999875566788899999999999999999999 99999999999999999999999999999876554321
Q ss_pred -----CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCC-CCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 214 -----TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 214 -----~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
..+.|.|||.+....++.++|||+|||++|||+|+. .||.+..- ..+.+.++...+-.-|..|++++.+
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----~qIL~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----IQILKNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----HHHHHhccccccCCCCCCChHHHHH
Confidence 246799999999999999999999999999999865 46554321 1122222332333347788999999
Q ss_pred HHHHHccCCCCCCCChHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l 310 (372)
++..||+.+|++|||+..|.+.+
T Consensus 347 imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHhccCCccccccHHHHHHhH
Confidence 99999999999999999998554
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=299.74 Aligned_cols=240 Identities=18% Similarity=0.186 Sum_probs=189.6
Q ss_pred cCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHh---cCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVG---QLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 65 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
||+|+||.||++.. .+++.+|+|.+...... ....+.+|..+++ ..+||||+.+++++...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 69999999999994 56889999998654321 1223445544443 34799999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--CcccCC
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN 215 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~t 215 (372)
++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++...... ....++
T Consensus 82 ~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 82 GDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 99999986 345699999999999999999999999 9999999999999999999999999998754332 234578
Q ss_pred CCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 216 LAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 216 ~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... ..... .......+...+.++.+++.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT-LTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh-hcCCcCCccccCHHHHHHHHHHhc
Confidence 99999999874 458999999999999999999999885432111100 00000 011123455567899999999999
Q ss_pred CCCCCCC-----ChHHHHHHH
Q 017395 295 YEPRERP-----NPRSLVTAL 310 (372)
Q Consensus 295 ~dp~~Rp-----s~~~il~~l 310 (372)
.||.+|| |++++++|.
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCc
Confidence 9999999 699999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=305.69 Aligned_cols=249 Identities=17% Similarity=0.202 Sum_probs=192.8
Q ss_pred CCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHh
Q 017395 66 GEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (372)
Q Consensus 66 G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~ 142 (372)
|.|+||+||+|.. .+++.||||++...... ..+.+.+|+.+++.++||||++++++|..++..++||||+.+++|.+
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS 88 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence 4459999999994 57899999998754322 24568899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----------Cc
Q 017395 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RS 211 (372)
Q Consensus 143 ~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----------~~ 211 (372)
++.......+++..+..++.|++.||+|||++ |++||||||+||+++.++.++++||+.+...... ..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (328)
T cd08226 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167 (328)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccc
Confidence 99765445689999999999999999999999 9999999999999999999999999754322110 01
Q ss_pred ccCCCCcCCcccccCC--CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-----------------------
Q 017395 212 YSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------------- 266 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~----------------------- 266 (372)
..++..|+|||++.+. .++.++|||||||++|+|++|+.||..............
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (328)
T cd08226 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQ 247 (328)
T ss_pred ccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccch
Confidence 1234679999999764 478999999999999999999988754321110000000
Q ss_pred ------------------ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH--HHhhhc
Q 017395 267 ------------------TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (372)
Q Consensus 267 ------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--l~~~~~ 315 (372)
.+.........+..++..+.+|+.+||+.||++|||+.+++++ +..+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 248 SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000011111234467889999999999999999999999988 344443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=324.90 Aligned_cols=253 Identities=16% Similarity=0.185 Sum_probs=186.0
Q ss_pred CCccccccccCCCCCCeEEEEEeCC--CcEEEEEEcC--------------C---CCCccHHHHHHHHHHHhcCCCccee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN--QFRIAVKRFN--------------R---SAWPDARQFLEEARAVGQLRNRRLA 116 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~--------------~---~~~~~~~~~~~E~~~l~~l~hpniv 116 (372)
...|+++++||+|+||+||++.... +...++|.+. . ........+.+|+++|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3579999999999999999987422 2222222111 0 1111244688999999999999999
Q ss_pred eEeeEEEeCCeeEEEEecCCCCCHHhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 117 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
++++++...+..|+|+|++.+ +|.+++.... ........+..|+.||+.||.|||++ |||||||||+|||++.++
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC
Confidence 999999999999999999954 6777764321 12234567888999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCCC-----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh----HHhhh-c
Q 017395 194 NPRLSCFGLMKNSRDGR-----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRD-R 263 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~----~~~~~-~ 263 (372)
.+||+|||+++...... ...||..|+|||++.+..++.++|||||||++|||++|..++..... ..+.. .
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 99999999998654322 34689999999999998999999999999999999999865432110 00000 0
Q ss_pred cc-----ccc----------cccc-c---cCCCC-----hHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 264 NI-----QTL----------TDSC-L---EGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 264 ~~-----~~~----------~~~~-~---~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.. ... .... . ...++ ...+.++.+++.+||+.||.+|||+.|++.+-
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 00 000 0000 0 00000 11345788889999999999999999999983
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=299.57 Aligned_cols=250 Identities=18% Similarity=0.206 Sum_probs=194.1
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
..|.+++.||+|+||.||+|. ..++..||+|.+....... ...+.+|+++++.++|+||+++++++..+...++||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 468889999999999999998 4568899999997544322 34678999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
+. ++|.+++... ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||+++..... .
T Consensus 85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 85 MH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred cc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 96 5777776532 34578889999999999999999999 9999999999999999999999999998754322 2
Q ss_pred cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhH--Hhhhc----------------ccc----c
Q 017395 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDR----------------NIQ----T 267 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~--~~~~~----------------~~~----~ 267 (372)
...++..|+|||++.+. .++.++||||||+++|+|++|..||...... .+... ... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 23457889999998764 4788999999999999999999887532210 00000 000 0
Q ss_pred cccccccCCCC-----hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 LTDSCLEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 ~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
........... ...+.++.+++.+|+..||.+|||+.+++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000 0124688999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=300.68 Aligned_cols=251 Identities=19% Similarity=0.222 Sum_probs=196.4
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.+|++++.||.|++|.||+|.. .+++.||+|.+...... ..+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5688999999999999999995 46889999998754322 23568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-CCCceeeccCCcccCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~~~--- 209 (372)
|+++ +|.+++.......+++..++.++.|++.||+|||++ +++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9964 788888654444578899999999999999999999 9999999999999985 567999999998754322
Q ss_pred -CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhH-Hhhh------cccccc----------cc
Q 017395 210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRD------RNIQTL----------TD 270 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~------~~~~~~----------~~ 270 (372)
....++..|+|||++.+. .++.++||||||+++|+|+||..||...... .... ...... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 223457889999998764 4789999999999999999999887543211 0000 000000 00
Q ss_pred c--cccC----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 S--CLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ~--~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
. .... ......+.++.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 0122346789999999999999999999999987
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=293.28 Aligned_cols=246 Identities=20% Similarity=0.241 Sum_probs=206.2
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|.+++.||.|+||.||++.. .++..||+|++..... ...+.+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 367888899999999999995 4688999999986543 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 135 MPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
+++++|.+++.... ...+++..+..++.+++.||.|||+. |++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999997543 46799999999999999999999999 99999999999999999999999999987654432
Q ss_pred --cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
...++..|+|||.+.+..++.++|+||+|+++++|++|+.|+................ ....+...+.++.++
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 234 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-----YPPIPSQYSSELRNL 234 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----CCCCCCCCCHHHHHH
Confidence 2356788999999988889999999999999999999998875443222221111111 122344566889999
Q ss_pred HHHHccCCCCCCCChHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+||..+|++|||+.+++++
T Consensus 235 i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 235 VSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.80 Aligned_cols=251 Identities=19% Similarity=0.220 Sum_probs=201.7
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
..|..++.||.|+||.||+|. ..+++.+|+|.+..... ...+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 346677889999999999999 45688999999864322 22456889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcc
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 212 (372)
||+. |+|.+.+.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 95 e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (308)
T cd06634 95 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171 (308)
T ss_pred EccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecCcccc
Confidence 9996 578877753 345689999999999999999999999 9999999999999999999999999998877666666
Q ss_pred cCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 213 ~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
.++..|+|||.+. .+.++.++|||||||++|+|++|..|+.............. ...........+..+.+++
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh----cCCCCcCcccccHHHHHHH
Confidence 7888999999975 34578899999999999999999988754321111110000 0001111234567899999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
.+||+.+|++||++.+++.+.....
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCccccc
Confidence 9999999999999999999855433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=302.10 Aligned_cols=256 Identities=20% Similarity=0.234 Sum_probs=198.3
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeC--Cee
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DER 128 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 128 (372)
++.+.|++++.||.|+||.||+|.. .+++.||+|.+....... ...+.+|+.++++++|+||+++++++... +..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3567889999999999999999994 568999999987543222 23567899999999999999999998754 568
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+.+ +|.+++... ...+++..++.++.|++.||.|||+. |++||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999999975 788888642 35699999999999999999999999 999999999999999999999999999886543
Q ss_pred C----CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc-------cccc-------
Q 017395 209 G----RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QTLT------- 269 (372)
Q Consensus 209 ~----~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~-------~~~~------- 269 (372)
. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 2 12234678999999876 457899999999999999999998875432111100000 0000
Q ss_pred --ccc-cc-CCC------ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 270 --DSC-LE-GQF------SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 270 --~~~-~~-~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
... .. ... ....++++.+++.+||+.||++|||+.+++.|-+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 000 00 000 01246788999999999999999999999988543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=307.36 Aligned_cols=248 Identities=15% Similarity=0.191 Sum_probs=196.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 127 (372)
..|.+++.||+|+||.||+|. ..+++.||||.+.... ......+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 578889999999999999999 4578999999986432 22345688999999999999999999988643 35
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 7999999965 88888752 289999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc--------------------
Q 017395 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-------------------- 264 (372)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-------------------- 264 (372)
... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 432 235678899999999989999999999999999999999887643210000000
Q ss_pred -------------cccccccccc----CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 265 -------------IQTLTDSCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 265 -------------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
...+...... ...+...+..+.+++.+||+.||++|||+.+++.+-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000000000 000123467789999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.96 Aligned_cols=244 Identities=19% Similarity=0.219 Sum_probs=197.3
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
|..+++||.|+||+||+|+. .+++.||+|.+...... ..+.+.+|+++++.++|||++++++++......|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567789999999999994 56889999998754322 245688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccC
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 214 (372)
+. ++|.+++.. ...++++..+..++.|++.||.|||++ |++|+||+|+||+++.++.+||+|||++..........+
T Consensus 103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~ 179 (313)
T cd06633 103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVG 179 (313)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccc
Confidence 96 478887754 345689999999999999999999999 999999999999999999999999999876655556678
Q ss_pred CCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 215 t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
+..|+|||++. .+.++.++||||||+++|+|++|..|+................. ........+..+.+|+.+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS----PTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----CCCCccccCHHHHHHHHH
Confidence 88999999985 35588899999999999999999988765321111111000000 111122345679999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||+.+|.+||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=294.33 Aligned_cols=244 Identities=17% Similarity=0.198 Sum_probs=198.9
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC-----CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 129 (372)
.|++.+.||+|+||.||+|. ..++..||+|.+.... ......+.+|++++++++||||+++++++... ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 56778889999999999999 4568999999875321 12245788999999999999999999998664 4688
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
++|||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999863 34588999999999999999999999 9999999999999999999999999998754321
Q ss_pred -------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
....++..|+|||++.+..++.++|+|||||++|+|++|+.||........ ............++...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----IFKIATQPTKPMLPDGVS 235 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----HHHHHcCCCCCCCCcccC
Confidence 224577899999999988899999999999999999999988754321111 111111112234566777
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+.+++.+||. +|..||++.+++.|
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 899999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=299.36 Aligned_cols=249 Identities=18% Similarity=0.228 Sum_probs=196.6
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|++++.||.|++|.||+|.. .++..||+|++...... ....+.+|++.++.++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778899999999999994 57899999998754322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
+ ++|.+++.......+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 5 5899998754444689999999999999999999999 9999999999999999999999999998754322 22
Q ss_pred ccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-----------------ccccc---c
Q 017395 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------------IQTLT---D 270 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-----------------~~~~~---~ 270 (372)
..++..|+|||++.+. .++.++||||||+++|+|++|+.||............ ..... .
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 3457889999988764 4788999999999999999999887543211000000 00000 0
Q ss_pred cc---ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 SC---LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.. .........+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0001123345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=291.44 Aligned_cols=245 Identities=18% Similarity=0.233 Sum_probs=203.7
Q ss_pred cccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEEEEe
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e 133 (372)
|.+.+.||+|++|.||+|... ++..|++|++..... ...+.+.+|++.+++++||||+++++.+... ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 556677899999999999954 688999999976543 3356789999999999999999999999888 88999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
|+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 99999999999743 3799999999999999999999998 99999999999999999999999999988665432
Q ss_pred ---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
...++..|++||.+.+...+.++||||||+++++|++|..|+........ ....+.........+...+..+.+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHHH
Confidence 24567899999999988899999999999999999999988754321100 011111111122344555789999
Q ss_pred HHHHHccCCCCCCCChHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (372)
++.+||+.||++||++.+++.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhC
Confidence 9999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=290.80 Aligned_cols=244 Identities=19% Similarity=0.260 Sum_probs=203.7
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|.+.+.||.|++|.||+|.. .+++.|++|.+..... ...+.+.+|++++++++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 367788899999999999984 4678999999987654 3456799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc---
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--- 211 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 211 (372)
+++++|.+++.. ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999974 35699999999999999999999999 999999999999999999999999999887654332
Q ss_pred -ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 -~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..++..|+|||.+.+..++.++||||+|+++|+|++|..|+............. ......++...+..+.+++.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----ccCCCCCCCCCCHHHHHHHH
Confidence 456788999999988778999999999999999999998875432111000000 01112334556789999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||..+|++|||+.+++.+
T Consensus 233 ~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHhCChhhCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.31 Aligned_cols=239 Identities=16% Similarity=0.221 Sum_probs=194.8
Q ss_pred cccCCCCCCeEEEEEe-CCCcEEEEEEcCCC----CCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe--eEEEEecC
Q 017395 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE--RLLVAEYM 135 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~lv~e~~ 135 (372)
..||+|+|-+||+|.+ .+|-.||.-.++.. .....++|..|+.+|+.|+||||++++.++.+... .-+|+|++
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 3479999999999994 45778886655432 22336789999999999999999999999987655 78999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccccccCcceeec-CCCCceeeccCCcccCCCC--Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG--RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~~--~~ 211 (372)
..|+|..|++ +.+.++...+..|++||+.||.|||++ +.|||||||.+||+|+ .-|.+||+|+|+|...... .+
T Consensus 126 TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks 203 (632)
T KOG0584|consen 126 TSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS 203 (632)
T ss_pred cCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce
Confidence 9999999998 455689999999999999999999987 7899999999999998 4589999999999876654 45
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhH-HhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
..||+.|||||... ..|+...||||||++++||+|+..|+...... .+-......+.+. .+..--.+++++||.
T Consensus 204 vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~----sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA----ALSKVKDPEVREFIE 278 (632)
T ss_pred eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH----HhhccCCHHHHHHHH
Confidence 78999999999988 78999999999999999999999987542111 1111112222221 122222478999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||.. ..+|||+.|+|++
T Consensus 279 kCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHhcC-chhccCHHHHhhC
Confidence 99999 9999999999998
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=296.93 Aligned_cols=247 Identities=18% Similarity=0.211 Sum_probs=192.4
Q ss_pred cccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCC-CcceeeEeeEEEeC--CeeEEEEe
Q 017395 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEG--DERLLVAE 133 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e 133 (372)
|++++.||+|+||.||+|. ..+++.||+|.+..... .......+|+..+.++. |+|++++++++... +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5678899999999999999 55688999999875422 22234567999999985 99999999999887 88999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---C
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~ 210 (372)
|+++ +|.+.+... ...+++..+..++.|++.||.|||+. |++||||+|+||+++. +.+||+|||++...... .
T Consensus 81 ~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 9975 788888642 34689999999999999999999999 9999999999999999 99999999998765433 2
Q ss_pred cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh-h---h---cccc---------ccccccc
Q 017395 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-R---D---RNIQ---------TLTDSCL 273 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~-~---~---~~~~---------~~~~~~~ 273 (372)
...++..|+|||++.+ +.++.++|||||||++|||++|..||........ . . .... .......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 3456789999998754 4578899999999999999999988864321110 0 0 0000 0000000
Q ss_pred cC-------CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 274 EG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 274 ~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.. ......+.++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 0112457899999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=298.64 Aligned_cols=250 Identities=17% Similarity=0.231 Sum_probs=197.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+|+++++||.|++|.||+|+. .++..||||.+...... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 377889999999999999995 56889999999765432 3456789999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
++ +|.+++.... ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++...... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 86 8888876432 34689999999999999999999999 9999999999999999999999999998754322 2
Q ss_pred cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc-----------------ccccccc
Q 017395 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-----------------QTLTDSC 272 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~-----------------~~~~~~~ 272 (372)
...++..|++||++.+. .++.++||||||+++|+|++|+.||............. .......
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 33457889999998764 47889999999999999999998875432111100000 0000000
Q ss_pred c------cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 273 L------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 273 ~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
. .....+..+..+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 001112346789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=298.10 Aligned_cols=248 Identities=21% Similarity=0.246 Sum_probs=196.3
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEEEEe
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e 133 (372)
|+++++||.|+||.||+|+. .+++.+|+|.+.... ......+.+|++++++++|||++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56788999999999999995 458899999998653 22345688999999999999999999999887 78999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. |++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 899888642 24699999999999999999999999 99999999999999999999999999988665432
Q ss_pred --cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc--------------cc-----
Q 017395 211 --SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------TL----- 268 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~--------------~~----- 268 (372)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+.............. .+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23456789999988754 578999999999999999999988754332111100000 00
Q ss_pred ------ccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 ------TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 ------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
........+...++..+.+++.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111136789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=292.26 Aligned_cols=246 Identities=16% Similarity=0.231 Sum_probs=204.5
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+|++++.+|.|+||.||++. ..+++.+|+|.+..... .....+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 36788899999999999998 55788999999875432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--C
Q 017395 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 210 (372)
+++++|.+++.+. ....+++..++.++.|++.||+|||+. |++|+||+|+||++++++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 9999999998642 135689999999999999999999999 9999999999999999999999999998765443 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...++..|++||.+.+..++.++|+||||+++|+|++|+.|+.............. ......+...+.++.+++.
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-----GKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----CCCCCCchhhCHHHHHHHH
Confidence 23467899999999988899999999999999999999988765432222111111 1112234466788999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||+.+|++|||+.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 235 SMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHcCCCcccCCCHHHHhcC
Confidence 9999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=299.45 Aligned_cols=250 Identities=16% Similarity=0.166 Sum_probs=193.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCe-----e
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR-NRRLANLLGCCCEGDE-----R 128 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~-----~ 128 (372)
.|++.+.||+|+||.||+|.. .+++.||||.+...... ....+.+|+.+++.++ ||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 577888899999999999994 56899999998754322 2456889999999995 6999999999877655 8
Q ss_pred EEEEecCCCCCHHhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-CCCceeeccCCcc
Q 017395 129 LLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMK 204 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~ 204 (372)
|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++ |++||||||+||+++. ++.+||+|||++.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 999999986 7988876432 24689999999999999999999999 9999999999999998 8899999999987
Q ss_pred cCCCC----CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-------ccccc---
Q 017395 205 NSRDG----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-------IQTLT--- 269 (372)
Q Consensus 205 ~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-------~~~~~--- 269 (372)
..... ....+++.|+|||++.+. .++.++||||||+++|+|++|..||............ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 223457789999988754 4789999999999999999999887643211100000 00000
Q ss_pred ------------cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 270 ------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 270 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+.......+..+.++.++|.+||..||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000112356789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.87 Aligned_cols=255 Identities=16% Similarity=0.210 Sum_probs=197.6
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCC----CcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEe-C
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LEN----QFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCE-G 125 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~----~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 125 (372)
+....|++++.||+|.||.||+|. .++ ...+|+|.++.....+ .....+|+.+++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 344579999999999999999996 322 2379999998653322 3467899999999999999999999887 7
Q ss_pred CeeEEEEecCCCCCHHhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC----CCceee
Q 017395 126 DERLLVAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD----VNPRLS 198 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~----~~~kl~ 198 (372)
..+++++||.+. +|...|+.. ..+.++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEee
Confidence 789999999988 698888642 235689999999999999999999999 99999999999999877 999999
Q ss_pred ccCCcccCCCC-------CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhH------------
Q 017395 199 CFGLMKNSRDG-------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD------------ 258 (372)
Q Consensus 199 Dfg~~~~~~~~-------~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~------------ 258 (372)
|||+++.+.+. .....|++|.|||.+.|.. ||.+.||||+|||..||+|-++.|.+...+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999976543 2345689999999999876 999999999999999999998766432111
Q ss_pred ----------------Hhhhcc-ccccccccccCCC-C----------hHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 259 ----------------LIRDRN-IQTLTDSCLEGQF-S----------SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 259 ----------------~~~~~~-~~~~~~~~~~~~~-~----------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+++.. ....+.......+ + ..-++...+|+.++|..||-+|.|+.+.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 000000 0000000000000 0 00134588999999999999999999999984
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=306.59 Aligned_cols=248 Identities=17% Similarity=0.263 Sum_probs=193.8
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----CeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 129 (372)
++|.+++.||+|+||.||+|. ..+++.||||.+..... .....+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 468889999999999999998 55789999999864322 2345688999999999999999999987544 3589
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+|+||+.+ +|.+++. .+.+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999965 8888874 45699999999999999999999999 9999999999999999999999999998764332
Q ss_pred C-------cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh-----------ccccccc-
Q 017395 210 R-------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-----------RNIQTLT- 269 (372)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-----------~~~~~~~- 269 (372)
. ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... .....+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 1 2356788999998765 458899999999999999999998885432110000 0000000
Q ss_pred -------cccc-cCC-----CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 270 -------DSCL-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 270 -------~~~~-~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... ... ..+..+.++.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000 012345789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=338.06 Aligned_cols=239 Identities=17% Similarity=0.202 Sum_probs=202.3
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
.||.|.||.||.|. ..+|+..|||-+...... ..+.+.+|+.++..++|||+|+++|+-.+....+|.||||++|+|
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence 57999999999999 788999999998755432 245678999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--------cc
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--------SY 212 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--------~~ 212 (372)
.+.+. .++..++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.+....... ..
T Consensus 1322 a~ll~--~gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~ 1398 (1509)
T KOG4645|consen 1322 ASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSM 1398 (1509)
T ss_pred HHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhh
Confidence 99997 344577778888999999999999999 99999999999999999999999999998765442 45
Q ss_pred cCCCCcCCcccccCCC---CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
.||+.|||||++.+.. -..++||||+|||++||+||+.||..-..++. +.--+...-.+.+|...+.+-.+|+
T Consensus 1399 ~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1399 MGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred cCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHhccCCCCCchhhhHhHHHHH
Confidence 7899999999998754 56789999999999999999999753322211 1111222233467778999999999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+||..||.+|.++.+++++
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999887
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=289.14 Aligned_cols=245 Identities=18% Similarity=0.224 Sum_probs=209.4
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccH---HHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
..++..++.||+|.||.|-+++ ..+++.+|+|++++.-.-.. ..-+.|-++|+..+||.+..+...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3456678888999999999999 77899999999987554332 2356789999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC----
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR---- 207 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~---- 207 (372)
|||..||.|.-++. +.+.+++.....+...|+.||.|||++ +||+||||.+|.++|.+|++||+|||+++..-
T Consensus 247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999998886 456699999999999999999999999 99999999999999999999999999998532
Q ss_pred CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 208 DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 208 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
....++||+.|+|||++....|..+.|.|.+||++|||++|+.||.....+.+-+-.... .-.+|...+++...
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------d~kFPr~ls~eAkt 397 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------DLKFPRTLSPEAKT 397 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------hccCCccCCHHHHH
Confidence 235688999999999999999999999999999999999999999865444332222111 12467788899999
Q ss_pred HHHHHccCCCCCCC-----ChHHHHHH
Q 017395 288 LASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
|+..+|.+||.+|. .+.||.+|
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 99999999999995 47777776
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.15 Aligned_cols=253 Identities=17% Similarity=0.216 Sum_probs=193.2
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC----
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD---- 126 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 126 (372)
...+.|+++++||+|+||.||+|.. .+++.||||.+...... ....+.+|++++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 3456789999999999999999994 56899999998643322 2345678999999999999999999986653
Q ss_pred ----eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 127 ----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 127 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
..++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999965 78888754 234689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC--------cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhh----h---cccc
Q 017395 203 MKNSRDGR--------SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----D---RNIQ 266 (372)
Q Consensus 203 ~~~~~~~~--------~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~----~---~~~~ 266 (372)
+....... ...++..|+|||.+.+.. ++.++||||||+++|||++|..|+......... . ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 87553321 234567899999987654 788999999999999999999877543211100 0 0000
Q ss_pred cccccc----------ccCC---------CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTDSC----------LEGQ---------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~~~----------~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+.... .... .+...+..+.+++.+||..||.+|||++++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000 001124577899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=303.77 Aligned_cols=252 Identities=18% Similarity=0.274 Sum_probs=197.6
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----CeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 129 (372)
.|.+++.||.|+||+||+|+ ..+++.||||.+.... ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 57888899999999999999 5578999999987532 22345678999999999999999999987644 3589
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 589988863 45699999999999999999999999 9999999999999999999999999998865433
Q ss_pred ----CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHH-------------------hhhccc
Q 017395 210 ----RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------------------IRDRNI 265 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~-------------------~~~~~~ 265 (372)
....++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... ......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 23456788999998875 458899999999999999999998875431100 000000
Q ss_pred ccccc---cccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH--HHhh
Q 017395 266 QTLTD---SCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTL 313 (372)
Q Consensus 266 ~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--l~~~ 313 (372)
..... .... .......+.++.+++.+||+.||++|||+.++++| +..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 0000 01123456889999999999999999999999999 5444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=302.06 Aligned_cols=249 Identities=16% Similarity=0.213 Sum_probs=193.5
Q ss_pred cccccccCCCCCCeEEEEEe-C--CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-E--NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 130 (372)
|++++.||+|+||.||+|.. . ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 67888999999999999995 4 57899999998633 23346688999999999999999999999888 78999
Q ss_pred EEecCCCCCHHhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC----CCCceeeccCCc
Q 017395 131 VAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLM 203 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~----~~~~kl~Dfg~~ 203 (372)
||||+++ +|.+.+... ....+++..++.++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999976 677766432 123689999999999999999999999 9999999999999999 899999999998
Q ss_pred ccCCCCC-------cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHh-----hhc-------
Q 017395 204 KNSRDGR-------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-----RDR------- 263 (372)
Q Consensus 204 ~~~~~~~-------~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~-----~~~------- 263 (372)
....... ...++..|+|||++.+. .++.++||||||+++++|++|+.|+........ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 7653321 23457889999988764 478999999999999999999988753321110 000
Q ss_pred -----------------cccccccccccCCCC---------h--HHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 264 -----------------NIQTLTDSCLEGQFS---------S--DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 264 -----------------~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.............++ . ..+.++.+++.+||+.||++|||+.+++.+
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000000011 0 345679999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=292.94 Aligned_cols=236 Identities=21% Similarity=0.227 Sum_probs=192.8
Q ss_pred cCCCCCCeEEEEEeC-CCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 65 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
||.|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999964 589999999976543 2355788999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----------
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----------- 209 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----------- 209 (372)
.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999974 23689999999999999999999999 9999999999999999999999999998754332
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH--HHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EGTELV 286 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~ 286 (372)
....++..|++||.+.....+.++||||||+++|+|++|..|+................ ...+.. .+..+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 231 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK------IEWPEDVEVSDEAI 231 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------cCCCccccCCHHHH
Confidence 12345778999999988889999999999999999999998876443222111111100 011222 268899
Q ss_pred HHHHHHccCCCCCCCChHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+++.+||+.+|.+|||+..+.+.
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHH
Confidence 99999999999999999444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.50 Aligned_cols=250 Identities=12% Similarity=0.060 Sum_probs=184.6
Q ss_pred CccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCccH-----------HHHHHHHHHHhcCCCcceeeEeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDA-----------RQFLEEARAVGQLRNRRLANLLGC 121 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~l~~~ 121 (372)
..|.+.+.||+|+||.||+|...+ +..+|+|+......... .....++..+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 478899999999999999999543 45677776543322110 112334455667789999999997
Q ss_pred EEeCC----eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCcee
Q 017395 122 CCEGD----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (372)
Q Consensus 122 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl 197 (372)
+.... ..++++|++.. ++.+.+.. ....++..+..|+.|++.||.|||++ +++||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEE
Confidence 65543 45788888744 67777653 23467888999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCC-----------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-HHhhhccc
Q 017395 198 SCFGLMKNSRD-----------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNI 265 (372)
Q Consensus 198 ~Dfg~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~~~~~~~~ 265 (372)
+|||+++.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99999875421 1224588999999999999999999999999999999999998864311 10000000
Q ss_pred cccccccccCC-CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 266 QTLTDSCLEGQ-FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 266 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.........+. .....+.++.+++..||..+|++||++.++++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00111100010 1233468899999999999999999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.80 Aligned_cols=241 Identities=18% Similarity=0.211 Sum_probs=188.1
Q ss_pred CCCeEEEEE-eCCCcEEEEEEcCCC--CCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhh
Q 017395 69 APNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF 145 (372)
Q Consensus 69 ~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 145 (372)
++|.||.++ ..+++.||||++... .....+.+.+|++++++++||||+++++++......+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 445555555 336889999999754 23345679999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----------CcccC
Q 017395 146 HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RSYST 214 (372)
Q Consensus 146 ~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----------~~~~~ 214 (372)
......+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||.+...... ....+
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 65455689999999999999999999999 9999999999999999999999999987643211 12345
Q ss_pred CCCcCCcccccCC--CCCCCCceeehHHHHHHHHhCCCCCCchhhHHh-hh---ccccccc-------------------
Q 017395 215 NLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-RD---RNIQTLT------------------- 269 (372)
Q Consensus 215 t~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~-~~---~~~~~~~------------------- 269 (372)
+..|+|||++.+. .++.++|||||||++|||++|+.||........ .. .......
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 6789999998763 488999999999999999999998864321110 00 0000000
Q ss_pred -----cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 -----DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 -----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
............+.++.+|+.+||..||++|||+.+++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00001112234567899999999999999999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=293.18 Aligned_cols=240 Identities=19% Similarity=0.187 Sum_probs=189.5
Q ss_pred cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHH---HHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEAR---AVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 65 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~---~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
||+|+||.||+|. ..+++.||+|.+....... ...+..|.. .++...||||+++++++...+..++||||+.|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 6999999999998 4568899999987543221 222444444 34445799999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--CcccCC
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN 215 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~t 215 (372)
++|.+++. ....+++..+..|+.|++.||.|||+. +++||||||+||+++.++.++|+|||++...... ....++
T Consensus 82 ~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (278)
T cd05606 82 GDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (278)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence 99999886 345699999999999999999999999 9999999999999999999999999998754332 234678
Q ss_pred CCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHcc
Q 017395 216 LAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (372)
Q Consensus 216 ~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 294 (372)
..|+|||++.++ .++.++||||+|+++|+|++|+.||.......... .... .......++...+.++.+++.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~~~~-~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRM-TLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--HHHH-hhccCCCCCCcCCHHHHHHHHHHhh
Confidence 999999999754 58999999999999999999998876431110000 0000 0011123344557899999999999
Q ss_pred CCCCCCC-----ChHHHHHHH
Q 017395 295 YEPRERP-----NPRSLVTAL 310 (372)
Q Consensus 295 ~dp~~Rp-----s~~~il~~l 310 (372)
.+|.+|| ++.+++++-
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCc
Confidence 9999999 999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=337.29 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=197.1
Q ss_pred cccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 61 IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
....||+|+||.||+|.. .++..||||.+...... ...|++.+++++||||++++++|......++||||+++|+
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 344569999999999995 67899999999754322 2356889999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh---cCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccCCC
Q 017395 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCT---SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNL 216 (372)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~t~ 216 (372)
|.++++ .++|..+..|+.|++.||+||| +. +++||||||+||+++.++..++. ||............++.
T Consensus 770 L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~ 842 (968)
T PLN00113 770 LSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842 (968)
T ss_pred HHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccc
Confidence 999995 2899999999999999999999 55 99999999999999998888876 66655444444456789
Q ss_pred CcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh------hHHh----hhccccccccccccC--CCChHHHHH
Q 017395 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------LDLI----RDRNIQTLTDSCLEG--QFSSDEGTE 284 (372)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~------~~~~----~~~~~~~~~~~~~~~--~~~~~~~~~ 284 (372)
.|+|||++.+..++.++|||||||++|||+||+.|+.... ..+. .........++.... ..+.....+
T Consensus 843 ~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (968)
T PLN00113 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922 (968)
T ss_pred cccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence 9999999999899999999999999999999998874211 0000 011112222232222 233456678
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 899999999999999999999999999886644
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=296.05 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=198.8
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|++++.||.|++|.||+|.. .+++.+++|.+...... ....+.+|++++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778899999999999994 57899999998755433 3567889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----c
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 211 (372)
++ +|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 76 888888642 35799999999999999999999999 99999999999999999999999999987655432 3
Q ss_pred ccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-----------cccccc---------
Q 017395 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------IQTLTD--------- 270 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-----------~~~~~~--------- 270 (372)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||............ ......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4467789999999876 6899999999999999999999887543211100000 000000
Q ss_pred ----ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 ----SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...........+.++.+++.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000001123457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=299.89 Aligned_cols=250 Identities=18% Similarity=0.228 Sum_probs=207.5
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
+.|..|+++ |+|+||.||-+. ..+|..+|.|.+.+.... ...-.++|-.+|.+++.+.||.+-..|.+.+.++
T Consensus 185 n~F~~~Rvl---GkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 185 NTFRVYRVL---GKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cceeeeEEE---ecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 456667666 999999999998 667999999998653321 2234688999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+|+..|.||+|.-+|.......+++..+..++.+|+.||.+||+. +||+||+||+|||+|+.|++.|+|+|++..+..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999999765556799999999999999999999999 9999999999999999999999999999987765
Q ss_pred C---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 R---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ~---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
. ...||.+|||||++.++.|+...|.|||||+||||+.|+.||.......-.+..-+.+.. ....++...++++.
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHH
Confidence 4 347899999999999999999999999999999999999998654221111111111111 11246778889999
Q ss_pred HHHHHHccCCCCCCCC-----hHHHHHH
Q 017395 287 RLASRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps-----~~~il~~ 309 (372)
++....|++||.+|.. ++++.+|
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 9999999999999974 5577666
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=303.32 Aligned_cols=253 Identities=20% Similarity=0.292 Sum_probs=201.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC-----eeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 129 (372)
+|.+.+.||.|++|.||+|.. .+++.||||.+.... ....+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 367888999999999999995 458999999997643 233567899999999999999999999987765 789
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++ +|.+++.. ...+++..++.++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999975 89998863 34799999999999999999999999 9999999999999999999999999998875543
Q ss_pred C-------cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc----------------
Q 017395 210 R-------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI---------------- 265 (372)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~---------------- 265 (372)
. ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 23467889999999887 78999999999999999999998886443211100000
Q ss_pred ---ccccc------ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH--HHhhh
Q 017395 266 ---QTLTD------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ 314 (372)
Q Consensus 266 ---~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--l~~~~ 314 (372)
..... ...........+.++.+++.+||+.+|.+|||+.+++.+ ++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000 000000112346789999999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=281.88 Aligned_cols=243 Identities=20% Similarity=0.208 Sum_probs=197.2
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecCCCCCHH
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 141 (372)
.||+|+|+.|-.++ ..++..+|||++.+.......++.+|++++.+++ |+||++++++|++...+|||||-|.||+|.
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL 164 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL 164 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence 36999999999998 8899999999999887667888999999999996 999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC---ceeeccCCcccCCCC---------
Q 017395 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNSRDG--------- 209 (372)
Q Consensus 142 ~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~~~~~~~--------- 209 (372)
.+|+ .++.+++.++.++.++|+.||.|||.+ ||.|||+||+|||-..-.. +|||||.+.......
T Consensus 165 shI~--~~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 165 SHIQ--KRKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9998 456699999999999999999999999 9999999999999975544 899999886543221
Q ss_pred --CcccCCCCcCCccccc---C--CCCCCCCceeehHHHHHHHHhCCCCCCchhhH--Hhhhccccc-----cccccccC
Q 017395 210 --RSYSTNLAFTPPEYLR---T--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDRNIQT-----LTDSCLEG 275 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~---~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~--~~~~~~~~~-----~~~~~~~~ 275 (372)
.+..|+..|||||+.. + ..|+.++|.||||||||-|++|.+||.+.-.. -|..+..-. +...+..+
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 1234566799999874 2 34899999999999999999999998653110 011111111 11111111
Q ss_pred --CCC----hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 276 --QFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 276 --~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+|| ..++.+..++++.+|..|+.+|.++..+++|
T Consensus 322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 233 3568999999999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.99 Aligned_cols=251 Identities=16% Similarity=0.251 Sum_probs=196.0
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe----CCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 129 (372)
..|.+.+.||.|+||.||+|. ..+++.||+|++..... ...+.+.+|+.+|++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 357778889999999999999 55689999999875432 235568899999999999999999998753 35689
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+. ++|.+++. ....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999996 58999886 345599999999999999999999999 9999999999999999999999999998754322
Q ss_pred --------CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh----h---h-----------
Q 017395 210 --------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----R---D----------- 262 (372)
Q Consensus 210 --------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~----~---~----------- 262 (372)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ . .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 12356788999999865 4588999999999999999999988854321100 0 0
Q ss_pred -cccccccccc-ccCC-----CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 263 -RNIQTLTDSC-LEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 263 -~~~~~~~~~~-~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.......... .... .....+.++.+++.+||+.+|++|||+.+++.+-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0000000000 0000 11234688999999999999999999999999844
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=291.22 Aligned_cols=249 Identities=19% Similarity=0.208 Sum_probs=194.4
Q ss_pred cccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcC---CCcceeeEeeEEEeCCe-----
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD--ARQFLEEARAVGQL---RNRRLANLLGCCCEGDE----- 127 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~----- 127 (372)
|++++.||.|+||.||+|+.. +++.||+|.+....... ...+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567788999999999999964 58999999997543222 33566788777666 59999999999988766
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.+++|||+.+ +|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 899988754445699999999999999999999999 99999999999999999999999999987754
Q ss_pred CCC---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc-----------------
Q 017395 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT----------------- 267 (372)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~----------------- 267 (372)
... ...++..|+|||++.+..++.++|+||||+++|+|++|..|+...............
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 332 234678899999999888999999999999999999998776543211110000000
Q ss_pred -ccccccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 -LTDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 -~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
....... .......+..+.+++.+||+.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 01122456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=294.96 Aligned_cols=252 Identities=19% Similarity=0.272 Sum_probs=197.3
Q ss_pred cCCCccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 130 (372)
.++++|.+++.||.|+||.||+|... +++.||||.+...... ....+.+|+.++.+.. ||||+++++++......++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 35567889999999999999999965 4889999999754332 2445777888777775 9999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+..|++||||+|+||++++++.+||+|||++.......
T Consensus 92 v~e~~~~-~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 92 CMELMST-CLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EeeccCc-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9999854 77777654 234799999999999999999999973399999999999999999999999999987654322
Q ss_pred ---cccCCCCcCCcccccCCC----CCCCCceeehHHHHHHHHhCCCCCCchhh--HHhhhccccccccccccCCCChHH
Q 017395 211 ---SYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... +..... ....... ......+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~ 245 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-LQEEPPS---LPPNEGF 245 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-hcCCCCC---CCCCCCC
Confidence 234567899999987653 78899999999999999999998754211 111100 0000000 0111234
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.++.+|+.+||+.||.+||++.+++.+..
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 678999999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.44 Aligned_cols=243 Identities=21% Similarity=0.245 Sum_probs=201.3
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 132 (372)
+|.+.+.||.|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 578888999999999999994 5789999999975322 22456889999999998 999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
||+++++|.+++.. ...+++..++.|+.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999974 34699999999999999999999999 99999999999999999999999999987644322
Q ss_pred ----------------------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccc
Q 017395 211 ----------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268 (372)
Q Consensus 211 ----------------------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 268 (372)
...++..|+|||++.+..++.++|+||||++++++++|..|+......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~ 234 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF----QKI 234 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHH
Confidence 124567899999998888999999999999999999999887643211111 111
Q ss_pred ccccccCCCChHHHHHHHHHHHHHccCCCCCCCCh----HHHHHH
Q 017395 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP----RSLVTA 309 (372)
Q Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~il~~ 309 (372)
. .....++...++.+.+++.+||+.||.+|||+ .++++|
T Consensus 235 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 01112344557889999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=294.03 Aligned_cols=246 Identities=17% Similarity=0.230 Sum_probs=196.2
Q ss_pred cccccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCCC----ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
|++.+.||.|+||.||++.. .+|..||+|++..... ...+.+.+|++++.++ +|+||+++++++......+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 67788899999999999985 3688999999975322 2245688999999999 5999999999999989999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+||++++++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999974 35689999999999999999999999 9999999999999999999999999998765432
Q ss_pred C-----cccCCCCcCCcccccCC--CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 R-----SYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 ~-----~~~~t~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
. ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+................... ...++...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--CCCCCccCC
Confidence 1 24467899999998753 46889999999999999999998875321100000000001000 112344566
Q ss_pred HHHHHHHHHHccCCCCCCC-----ChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
..+.+++.+||+.||++|| ++.+++.+
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 8899999999999999997 67777776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.92 Aligned_cols=252 Identities=17% Similarity=0.270 Sum_probs=197.1
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHh--cCCCcceeeEeeEEEeCC----eeE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVG--QLRNRRLANLLGCCCEGD----ERL 129 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~hpniv~l~~~~~~~~----~~~ 129 (372)
....++++.+|+|+||.||||.+. ++.||||++... +.+.|.+|-++.. .++|+||++++++-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 344556778899999999999984 479999999853 3566777766655 558999999999866554 799
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCcccccccCcceeecCCCCceeeccC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--------ERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--------~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
||++|.+.|+|.++|+ ...++|....+|+..+++||+|||.. +.|+|||||..|||+.++++..|+|||
T Consensus 285 LVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999995 45699999999999999999999982 579999999999999999999999999
Q ss_pred CcccCCCCC------cccCCCCcCCcccccCCC-CC-----CCCceeehHHHHHHHHhCCCCCC-------ch-------
Q 017395 202 LMKNSRDGR------SYSTNLAFTPPEYLRTGR-VT-----PESVMYSFGTLLLDLLSGKHIPP-------SH------- 255 (372)
Q Consensus 202 ~~~~~~~~~------~~~~t~~y~aPE~~~~~~-~~-----~~~Dv~SlGvil~el~tg~~p~~-------~~------- 255 (372)
++..+..+. ...||.+|||||++.+.- +. .+.||||+|.|||||+++-.... .-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998765442 357899999999998753 22 36899999999999998653221 00
Q ss_pred ---hhHHhhhccccccccccccCCCCh-----HHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 256 ---ALDLIRDRNIQTLTDSCLEGQFSS-----DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 256 ---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
..+.++.... ....++.++. ....-+++.+..||+.|++.|.|+.-+.+++..+.....
T Consensus 442 ~hPt~e~mq~~VV----~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQELVV----RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHHHH----hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111111111 1222223332 345789999999999999999999999999988876543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=293.33 Aligned_cols=249 Identities=16% Similarity=0.277 Sum_probs=195.6
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|.+++.||.|++|+||+|+. .+++.||||.+...... +.....+|+..+++++ ||||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 56778899999999999995 45889999998754322 2334567999999999 999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---Ccc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY 212 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~ 212 (372)
+++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++...... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 77999988754445789999999999999999999999 9999999999999999999999999998765543 234
Q ss_pred cCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh----------------hc-----ccccccc
Q 017395 213 STNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------------DR-----NIQTLTD 270 (372)
Q Consensus 213 ~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~----------------~~-----~~~~~~~ 270 (372)
.++..|+|||++.+ ..++.++|+||||++++||++|+.||+........ +. .......
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 56788999998864 45789999999999999999999887543211000 00 0000000
Q ss_pred cccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 SCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... .......+.++.+++.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 00111225789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=294.08 Aligned_cols=248 Identities=18% Similarity=0.217 Sum_probs=196.7
Q ss_pred cccccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCCC----ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
|.+.+.||.|++|.||+++. .+++.||||.+..... ...+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 67788899999999999984 3568899999874321 2245688999999999 5999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999863 35689999999999999999999998 9999999999999999999999999998764432
Q ss_pred C-----cccCCCCcCCcccccCCC--CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 R-----SYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 ~-----~~~~t~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
. ...++..|+|||.+.+.. .+.++||||||+++|+|++|..|+................... ....+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccC
Confidence 2 234678999999987655 7889999999999999999998875321110000000011111 112344456
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..+.+++.+||+.||++|||+.++.+.|.
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 78999999999999999999877766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=324.13 Aligned_cols=255 Identities=17% Similarity=0.144 Sum_probs=212.8
Q ss_pred HHHHHHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCC---CCccHHHHHHHHHHHhcCCCcceeeEeeEE
Q 017395 47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCC 122 (372)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 122 (372)
..++...-+-++|++++.||+|+||.|...+ ..+++.||+|++++. ...+..-|..|-++|.--+.+-|+.++-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 4556666677899999999999999999999 567899999999862 233455689999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
++..++|+|||||+||+|-.++.+.. ++++..+..++..|+.||.-||+- |+|||||||+|||||..|++||+|||.
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999999997543 699999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCC-----CcccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccc
Q 017395 203 MKNSRDG-----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 203 ~~~~~~~-----~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
+-.+... ....|||-|++||++.. +.|...+|.||+||++|||+.|..||+.+..-... ..+++..
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY----~KIm~hk 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY----GKIMNHK 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH----HHHhchh
Confidence 8766633 24579999999999962 45999999999999999999999999865432211 1122221
Q ss_pred ccCCCC--hHHHHHHHHHHHHHccCCCCCCCC---hHHHHHH
Q 017395 273 LEGQFS--SDEGTELVRLASRCLQYEPRERPN---PRSLVTA 309 (372)
Q Consensus 273 ~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps---~~~il~~ 309 (372)
-.-.|| ..++.++.+||.+.+ -+|..|.. +.++..|
T Consensus 298 ~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 111334 447899999999988 56888887 9999888
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.46 Aligned_cols=248 Identities=16% Similarity=0.220 Sum_probs=193.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC----------
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG---------- 125 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---------- 125 (372)
.+|.+++.||.|+||.||+|. ..+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 468889999999999999999 456899999999776655567789999999999999999999876543
Q ss_pred ----CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeecc
Q 017395 126 ----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCF 200 (372)
Q Consensus 126 ----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Df 200 (372)
...++||||+++ +|.+++. ...+++..++.++.|++.||.|||+. |++||||||+||+++ +++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCc
Confidence 357999999974 8988884 34689999999999999999999999 999999999999998 5567899999
Q ss_pred CCcccCCCC-------CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc------
Q 017395 201 GLMKNSRDG-------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------ 266 (372)
Q Consensus 201 g~~~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~------ 266 (372)
|++...... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998764322 12245778999998764 4578899999999999999999998854311000000000
Q ss_pred ------------cccc-ccccC-----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 ------------TLTD-SCLEG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ------------~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... ..... ......+.++.+|+.+||+.||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00000 0112345789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=300.05 Aligned_cols=252 Identities=15% Similarity=0.227 Sum_probs=195.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 127 (372)
..|.+++.||.|+||.||+|. ..+++.||||.+..... .....+.+|+++++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 467888999999999999999 45789999999875321 1245688999999999999999999998654 24
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++|+||+.. +|..++ +..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6999999965 777665 23589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC-cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-------------------cc
Q 017395 208 DGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-------------------IQ 266 (372)
Q Consensus 208 ~~~-~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-------------------~~ 266 (372)
... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 332 3456788999999876 45889999999999999999999988653211100000 00
Q ss_pred cc---ccccccCCC---ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH--HHhhh
Q 017395 267 TL---TDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ 314 (372)
Q Consensus 267 ~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--l~~~~ 314 (372)
.. ........+ .+..+..+.+|+.+||+.||.+||++.+++.| ++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 000000000 11345678999999999999999999999987 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=299.63 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=193.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCC--CCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeC--CeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS--AWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG--DERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~l 130 (372)
..|.+.+.||.|+||.||+|.. .+++.+|||.+... .......+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 3677888899999999999995 46889999988642 223345678899999999 999999999998653 46899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+.+ +|..++.. ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eeccccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 9999975 89998853 2689999999999999999999999 99999999999999999999999999987543321
Q ss_pred ---------cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh------------------
Q 017395 211 ---------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD------------------ 262 (372)
Q Consensus 211 ---------~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------------------ 262 (372)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 2346788999998865 457889999999999999999998875321110000
Q ss_pred -ccccccccccc------cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 263 -RNIQTLTDSCL------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 263 -~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.....+..... ........+.++.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 001112256789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=294.29 Aligned_cols=249 Identities=22% Similarity=0.241 Sum_probs=193.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC-------
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------- 126 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------- 126 (372)
..|.+.+.||.|+||.||+|.. .+++.||+|.++.... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 4677888999999999999995 4688999999975432 22356788999999999999999999987654
Q ss_pred ---eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 127 ---ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
..++|+||+++ +|...+... ...+++..+..++.|++.||+|||+. |++|+||||+||++++++.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 677777542 34689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC-----cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHH----hhh---ccc----c
Q 017395 204 KNSRDGR-----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IRD---RNI----Q 266 (372)
Q Consensus 204 ~~~~~~~-----~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~----~~~---~~~----~ 266 (372)
....... ...++..|+|||.+.+. .++.++|||||||++|||++|+.|+....... +.. ... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 7654322 12346789999988754 47889999999999999999998775321110 000 000 0
Q ss_pred ccccc--------------cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTDS--------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+... ... ......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 000 0011246789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.38 Aligned_cols=244 Identities=18% Similarity=0.187 Sum_probs=203.8
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 131 (372)
..+..|.+..++|.|+|+.|..+. ..+++..+||++..... +-.+|+.++... +||||+++++.+..+.+.|+|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 346789999999999999999998 66788999999987622 233677666666 699999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee-cCCCCceeeccCCcccCCCCC
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF-DDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill-~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||++.|+-|.+.+.. .. .....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++......
T Consensus 395 ~e~l~g~ell~ri~~--~~-~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS--KP-EFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred ehhccccHHHHHHHh--cc-hhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence 999999998888852 22 33378888999999999999998 99999999999999 589999999999998877652
Q ss_pred -cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...-|..|.|||++....|++++|+||||++||+|++|+.|+.....+ ..+......+.+...++.++++|+
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFSECVSDEAKDLL 543 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccccccCHHHHHHH
Confidence 224578899999999888999999999999999999999988655433 122222233445577889999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.+||+.||.+||++.++..|-+-
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999998554
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=298.31 Aligned_cols=251 Identities=18% Similarity=0.168 Sum_probs=194.3
Q ss_pred Cccccc-cccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--------------HHHHHHHHHHHhcCCCcceeeEee
Q 017395 57 AMENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--------------ARQFLEEARAVGQLRNRRLANLLG 120 (372)
Q Consensus 57 ~~~~~~-~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l~~ 120 (372)
..|..+ +.||.|+||+||+|. ..+++.||||.+....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 356555 458999999999999 4568999999987543221 124789999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeecc
Q 017395 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (372)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Df 200 (372)
++...+..++||||+. ++|.+++. ....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 58999986 345689999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC------------------CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhh
Q 017395 201 GLMKNSRDG------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR 261 (372)
Q Consensus 201 g~~~~~~~~------------------~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~ 261 (372)
|++...... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.|+.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998755410 1123467899999997654 688999999999999999999887643211100
Q ss_pred hc-------cccc-cc-----------cccccC---CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 262 DR-------NIQT-LT-----------DSCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 262 ~~-------~~~~-~~-----------~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.. .... .. ...... ......+.++.+++.+||+.+|++|||+.+++.+-+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 00 0000 00 000000 011234578999999999999999999999998744
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=289.85 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=196.9
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
|++++.||+|++|.||+|+. .+++.||+|.+.... ....+.+.+|++++++++|+|++++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45677889999999999994 558999999998653 223456889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----c
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 211 (372)
++ +|.+++.... ..+++..+..++.|++.||.|||++ |++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~-~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 75 8999997432 4699999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred ccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-----------------c---ccccc
Q 017395 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------------I---QTLTD 270 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-----------------~---~~~~~ 270 (372)
...+..|+|||.+.+. .++.++||||||+++|||++|..||............ . .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3346789999999776 7899999999999999999998877543221110000 0 00000
Q ss_pred ccccC---CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 SCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..... ...+..+..+.+++.+||..||++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 0011236789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.05 Aligned_cols=247 Identities=17% Similarity=0.258 Sum_probs=194.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe-CCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e 133 (372)
.|.+++.||.|+||.||+|. ..+++.||||.+..... ...+.+.+|++++++++||||++++++|.. ....++|||
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 47788889999999999998 55789999998864322 234678899999999999999999999865 457899999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-Ccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 212 (372)
|+ +++|.++++ ..++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... ...
T Consensus 91 ~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (328)
T cd07856 91 LL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY 165 (328)
T ss_pred hh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence 99 568998884 34588899999999999999999999 9999999999999999999999999998765433 234
Q ss_pred cCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh----hh---------------cccccccccc
Q 017395 213 STNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI----RD---------------RNIQTLTDSC 272 (372)
Q Consensus 213 ~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~----~~---------------~~~~~~~~~~ 272 (372)
.++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .+ ..........
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 56788999999876 4689999999999999999999988754321000 00 0000000000
Q ss_pred c-cCC-----CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 273 L-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 273 ~-~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
. ... .....+..+.+++.+||+.+|++|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 112345789999999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=296.82 Aligned_cols=249 Identities=18% Similarity=0.220 Sum_probs=194.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 127 (372)
+.|.+++.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 457788889999999999998 56789999999975321 2245688999999999999999999988643 34
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.+++++++ +++|.+++. ...+++..+..++.|++.||+|||+. |++||||||+||++++++.+||+|||++....
T Consensus 97 ~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 97 VYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred EEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 78888887 779998884 34599999999999999999999999 99999999999999999999999999988654
Q ss_pred CCC-cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc-------cccccc---------
Q 017395 208 DGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR-------NIQTLT--------- 269 (372)
Q Consensus 208 ~~~-~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-------~~~~~~--------- 269 (372)
... ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... ....+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 432 3456889999999876 4588899999999999999999988754321110000 000000
Q ss_pred ------cccccC---CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 ------DSCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 ------~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
...... ......+.++.+++.+||+.||.+|||+.+++.+-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000000 00112457899999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=298.41 Aligned_cols=248 Identities=15% Similarity=0.207 Sum_probs=195.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC------e
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~ 127 (372)
..|.+++.||.|+||.||+|. ..++..||||.+...... ..+.+.+|+++|++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 458889999999999999998 567899999998643222 2346889999999999999999999986543 3
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+ +++|.+++. ...+++..+..++.|++.||.|||+. |++||||||+||++++++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 779998884 35699999999999999999999999 99999999999999999999999999988654
Q ss_pred CCC-cccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc--c-----------------cc
Q 017395 208 DGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR--N-----------------IQ 266 (372)
Q Consensus 208 ~~~-~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--~-----------------~~ 266 (372)
... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........... . ..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 432 3456789999999876 3588899999999999999999988754321100000 0 00
Q ss_pred cccc---cccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTD---SCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... .... .......+..+.+++.+||+.||++|||+.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 01112345679999999999999999999999977
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.06 Aligned_cols=236 Identities=22% Similarity=0.244 Sum_probs=195.6
Q ss_pred cCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 65 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
||.|+||.||++.. .+++.+|+|.+...... ....+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 59999999999995 45889999998765432 345789999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----CcccCCC
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~t~ 216 (372)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ....++.
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999963 34689999999999999999999998 9999999999999999999999999998765442 2345678
Q ss_pred CcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCC
Q 017395 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (372)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (372)
.|++||...+...+.++|+||||+++|++++|..||.............. ....++...+..+.+++.+||..|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------DPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence 89999999888889999999999999999999988854432111111111 111234445688999999999999
Q ss_pred CCCCCCh---HHHHHH
Q 017395 297 PRERPNP---RSLVTA 309 (372)
Q Consensus 297 p~~Rps~---~~il~~ 309 (372)
|++||++ .+++++
T Consensus 232 p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 232 PTKRLGSGGAEEIKAH 247 (250)
T ss_pred HhhCCCcccHHHHHhC
Confidence 9999999 565543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=285.76 Aligned_cols=245 Identities=16% Similarity=0.191 Sum_probs=195.9
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC-----CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
+|.+.+.||+|+||.||++.. ..+..+++|.++... .....++.+|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 367888999999999999984 334556666655321 12234577899999999999999999999988999999
Q ss_pred EecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
|||+++++|.+++... ....+++..++.++.|++.||.|||+. |++|+||+|+||++++ +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999988642 345699999999999999999999999 9999999999999975 56999999998765332
Q ss_pred ----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.............. ......+...+.++
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 233 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-----GPTPSLPETYSRQL 233 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-----CCCCCCcchhcHHH
Confidence 234567889999999888889999999999999999999988754322111111111 11222345667899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+++.+||..||++||++.+++++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=293.40 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=191.7
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeC-------
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG------- 125 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 125 (372)
..+|.+++.||.|+||.||+|.. .+++.||||.+......+ ...+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 56889999999999999999994 568899999986543222 34578999999999999999999987543
Q ss_pred -CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 126 -DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
..+++||||+.+ +|...+.. ....+++..+..++.|++.||.|||++ |++|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999976 67777653 345699999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCC---------------cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc-----
Q 017395 205 NSRDGR---------------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR----- 263 (372)
Q Consensus 205 ~~~~~~---------------~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~----- 263 (372)
...... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 543221 12346779999988754 478999999999999999999988754321110000
Q ss_pred ------------cccccccccccCCCC-------hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 264 ------------NIQTLTDSCLEGQFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 264 ------------~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..............+ ......+.+++.+||+.||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000000000001 1233678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=283.03 Aligned_cols=247 Identities=17% Similarity=0.207 Sum_probs=197.3
Q ss_pred ccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
+-++.||+|+||+|+|-. ...|+..|||+++.... ...++++.|.+...+- +.||||+++|.+...+..||.||+|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 445788999999999998 56799999999987665 3456799999876655 69999999999999999999999995
Q ss_pred CCCHHhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---C
Q 017395 137 NDTLAKHLF---HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (372)
Q Consensus 137 ~gsL~~~l~---~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~ 210 (372)
- ||..+.+ .-.+..+++..+-.|....+.||.||.....|||||+||+|||++..|.+||||||++..+..+ +
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 4 6665443 2234568999999999999999999998779999999999999999999999999998765543 3
Q ss_pred cccCCCCcCCcccccCC--CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC---hHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS---SDEGTEL 285 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l 285 (372)
.-.|...|||||.+... .|+.+|||||||++|||+.||+.|+..|.. ..++...-+......-..+ .+.+..+
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 34577899999999743 489999999999999999999988776643 2222211111111111112 3467899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..++.-||.+|.+.||...+++++
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhcC
Confidence 999999999999999999999887
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=256.88 Aligned_cols=249 Identities=18% Similarity=0.256 Sum_probs=199.0
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|...++||+|.||+||+|+ +.+++.||+|.++.+...+ ....++|+-+|+.++|.|||+++++......+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667789999999999999 7789999999998654322 45688999999999999999999999899999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
|.. +|..++.. -++.++.+.+..++.|++.||.|+|++ ++.|||+||+|.||+.||.+||+|||+++.++-. .
T Consensus 83 cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 965 79888854 456799999999999999999999999 9999999999999999999999999999876643 2
Q ss_pred cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcc--------------cccccccccc
Q 017395 211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN--------------IQTLTDSCLE 274 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~--------------~~~~~~~~~~ 274 (372)
....|.+|.+|.++.|.. |+...|+||-||++.|+.. |++.|++...+...... +..+.+-..-
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 345689999999999876 8999999999999999986 45556654332221111 0011111111
Q ss_pred CCCC---------hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 275 GQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 275 ~~~~---------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.++ +.....-++++.+.|.-+|.+|.+++..+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 2334567899999999999999999998876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=303.84 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=194.2
Q ss_pred cccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------CeeEEEE
Q 017395 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLLVA 132 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~lv~ 132 (372)
.-+.||+|+||.||+|+ ..+|+.||||.++... ....+...+|+++|++++|||||+++++=.+. ....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 33567999999999999 7789999999998644 33467799999999999999999999975443 3578999
Q ss_pred ecCCCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec--CCCC--ceeeccCCcccCC
Q 017395 133 EYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVN--PRLSCFGLMKNSR 207 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~--~~~~--~kl~Dfg~~~~~~ 207 (372)
|||.||+|...+.+-. ...|++.+.+.++..++.||.|||.+ ||+||||||.||++- ++|. .||+|||.++...
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 9999999999997543 35699999999999999999999999 999999999999994 3344 8999999999887
Q ss_pred CCC---cccCCCCcCCccccc-CCCCCCCCceeehHHHHHHHHhCCCCCCchhhH-----Hhh---hccccccc---c--
Q 017395 208 DGR---SYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----LIR---DRNIQTLT---D-- 270 (372)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-----~~~---~~~~~~~~---~-- 270 (372)
+.. +..||..|++||... .+.|+..+|.|||||++|+++||..||-..... ... .++...+. .
T Consensus 176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~ 255 (732)
T KOG4250|consen 176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEE 255 (732)
T ss_pred CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecc
Confidence 764 567999999999998 478999999999999999999999998432111 000 00000000 0
Q ss_pred ---cc-ccCCC------ChHHHHHHHHHHHHHccCCCCCCC--ChHHHHHHHHhhh
Q 017395 271 ---SC-LEGQF------SSDEGTELVRLASRCLQYEPRERP--NPRSLVTALVTLQ 314 (372)
Q Consensus 271 ---~~-~~~~~------~~~~~~~l~~li~~cl~~dp~~Rp--s~~~il~~l~~~~ 314 (372)
+. ....+ .......+-..+..+|..+|++|- ...+....+..+.
T Consensus 256 eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 256 ENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred cCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 00 00111 223345666777788888999987 5555555544443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=318.32 Aligned_cols=248 Identities=19% Similarity=0.224 Sum_probs=189.6
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEe-------
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCE------- 124 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 124 (372)
..+.+++.++.||+||||.||+++ .-||+.||||++.... ........+|+.+|.+|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 344566777788999999999999 6689999999998664 1224568899999999999999999754200
Q ss_pred -----------------------------------------------------------------------C--------
Q 017395 125 -----------------------------------------------------------------------G-------- 125 (372)
Q Consensus 125 -----------------------------------------------------------------------~-------- 125 (372)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 017395 126 ---------------------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172 (372)
Q Consensus 126 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH 172 (372)
..+||-||||+..+|.++++++.... .....|+++++|+.||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 11488999999988888886432211 46789999999999999999
Q ss_pred cCCCcccccccCcceeecCCCCceeeccCCcccCC----------------------CCCcccCCCCcCCcccccCCC--
Q 017395 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----------------------DGRSYSTNLAFTPPEYLRTGR-- 228 (372)
Q Consensus 173 ~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~----------------------~~~~~~~t~~y~aPE~~~~~~-- 228 (372)
+. |+|||||||.||++++++.+||+|||++.... ..+...||..|+|||++.+..
T Consensus 715 ~~-giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 715 DQ-GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred hC-ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99 99999999999999999999999999987611 113456889999999998754
Q ss_pred -CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc--CCCChHHHHHHHHHHHHHccCCCCCCCChHH
Q 017395 229 -VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDEGTELVRLASRCLQYEPRERPNPRS 305 (372)
Q Consensus 229 -~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 305 (372)
|+.|+|+||||||++||+. ||.... +.. ..+..+.+..+. ..+..+..+.-..+|.++++.||.+||||.|
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsM-ERa--~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSM-ERA--SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchH-HHH--HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999999999996 343221 111 111111111111 2234445567789999999999999999999
Q ss_pred HHHH
Q 017395 306 LVTA 309 (372)
Q Consensus 306 il~~ 309 (372)
+|+.
T Consensus 868 LL~s 871 (1351)
T KOG1035|consen 868 LLNS 871 (1351)
T ss_pred Hhhc
Confidence 9875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=288.02 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=197.8
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCC-CCcc------HHHHHHHHHHHhcCCCcceeeEeeEEEeC-Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS-AWPD------ARQFLEEARAVGQLRNRRLANLLGCCCEG-DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~ 127 (372)
++|-++..||+|||+.||+|. +..++.||||+-... +|.+ .+...+|.++.+.|+||.||++|++|.-+ ..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456778889999999999999 667889999986532 2322 22367899999999999999999999754 56
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCcccccccCcceeec---CCCCceeeccCCc
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFD---DDVNPRLSCFGLM 203 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~ 203 (372)
+|-|+|||+|.+|.-+|+ ..+.+++..+..|+.||+.||.||... ..|||-||||.|||+. ..|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 899999999999999997 456699999999999999999999875 6899999999999995 4578999999999
Q ss_pred ccCCCCC-----------cccCCCCcCCcccccCC----CCCCCCceeehHHHHHHHHhCCCCCCchhh--HHhhhcccc
Q 017395 204 KNSRDGR-----------SYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNIQ 266 (372)
Q Consensus 204 ~~~~~~~-----------~~~~t~~y~aPE~~~~~----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~~~~~~~~~ 266 (372)
+.+.... ...||.+|++||++.-+ .++.+.||||+|||+|.++.|+.||..... +.+....+.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9876432 34689999999998754 378999999999999999999999864321 112211111
Q ss_pred ccccccccCCCC--hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTDSCLEGQFS--SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... -.|| +.++.+...||++||++.-++|....++..+
T Consensus 701 kAtE----VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 701 KATE----VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ccee----ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1111 1222 4567899999999999999999988887765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.05 Aligned_cols=247 Identities=18% Similarity=0.224 Sum_probs=190.2
Q ss_pred cccccccCCCCCCeEEEEEe-CC--CcEEEEEEcCCCCC--ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeC----Cee
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-EN--QFRIAVKRFNRSAW--PDARQFLEEARAVGQL-RNRRLANLLGCCCEG----DER 128 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~~ 128 (372)
|++.+.||+|+||.||++.. .+ +..||+|.+..... ...+.+.+|+++++++ +||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 67788899999999999994 34 78899999874321 2245688999999999 599999999975432 457
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++++||+. ++|.+++. ....+++..+..++.|++.||.|||++ |++||||||+||++++++.+||+|||++.....
T Consensus 82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 89999986 58999886 345699999999999999999999999 999999999999999999999999999875432
Q ss_pred C--------CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh-----------------
Q 017395 209 G--------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD----------------- 262 (372)
Q Consensus 209 ~--------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~----------------- 262 (372)
. ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 1 12357889999998866 458999999999999999999998775422100000
Q ss_pred --cccccc------ccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 263 --RNIQTL------TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 263 --~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...... .............+..+.+|+.+||+.||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000001112235789999999999999999999999988
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=298.42 Aligned_cols=249 Identities=18% Similarity=0.233 Sum_probs=196.3
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe-----
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE----- 127 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 127 (372)
...|.+++.||.|++|.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 45688899999999999999995 568899999987532 2234567889999999999999999998765544
Q ss_pred -eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 128 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
.++|+||+ +++|.+++. ...+++..++.++.|++.||.|||+. |++|+||||+||++++++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 669999985 35699999999999999999999999 9999999999999999999999999998865
Q ss_pred CCC-CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------cc---------
Q 017395 207 RDG-RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TL--------- 268 (372)
Q Consensus 207 ~~~-~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------~~--------- 268 (372)
... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.............. .+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 443 334567889999998753 578899999999999999999988864322111000000 00
Q ss_pred ---cc---ccccCC---CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 ---TD---SCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 ---~~---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.. ...... .....+.++.+++.+||+.||.+|||+.+|+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 000000 011236789999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=315.72 Aligned_cols=146 Identities=21% Similarity=0.227 Sum_probs=131.3
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
+..|.++++||.|+||.||+|.. .+++.||||++....... ...+.+|+.++..++||||+++++++......|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 56789999999999999999995 468899999997543222 35688999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
|||+.+++|.+++.. .+.+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999963 34689999999999999999999999 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=279.33 Aligned_cols=218 Identities=20% Similarity=0.210 Sum_probs=178.3
Q ss_pred CCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhc
Q 017395 68 KAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (372)
Q Consensus 68 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (372)
|.+|.||++. ..+++.||+|.+.... .+.+|...+....||||+++++++......++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 7899999999 5678999999997643 233455556666799999999999999999999999999999999864
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-CcccCCCCcCCccccc
Q 017395 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLR 225 (372)
Q Consensus 147 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~ 225 (372)
...+++..+..++.|++.||.|||++ |++||||||+||++++++.++++|||.+...... ....++..|+|||.+.
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence 34599999999999999999999999 9999999999999999999999999987655432 2234567799999998
Q ss_pred CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCCh
Q 017395 226 TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303 (372)
Q Consensus 226 ~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (372)
+..++.++|+||+|+++|||++|..|+...... .. .......+...+..+.+++.+||+.||++||++
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG------IN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 888999999999999999999999765322110 00 001112344566889999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=300.84 Aligned_cols=248 Identities=15% Similarity=0.210 Sum_probs=207.3
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEe-----CCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE-----GDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-----~~~~ 128 (372)
-+.++++..+|.|.+|.||+++ .++++..|+|+....... .++...|.++|+.. .|||++.++|+|.. ++.+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 3456677788999999999999 778999999999865533 45678889999988 59999999999864 4679
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|||||||.|||..|+++...+..+.|..+..|++.++.||.+||.+ .++|||||-.|||++.++.+||+|||++.....
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999999887788899999999999999999999999 999999999999999999999999999877554
Q ss_pred C----CcccCCCCcCCcccccCC-----CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccc-ccccCCCC
Q 017395 209 G----RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD-SCLEGQFS 278 (372)
Q Consensus 209 ~----~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 278 (372)
. ....||+.|||||++.-. .|+..+|+||||++..||.-|.+|+.+- .....+..+.. +.+.-.-|
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm----HPmraLF~IpRNPPPkLkrp 251 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM----HPMRALFLIPRNPPPKLKRP 251 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc----chhhhhccCCCCCCccccch
Confidence 3 457789999999999743 3788999999999999999999776432 22222222222 22222336
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...+.++.++|..||.+|..+||++.++++|
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 7889999999999999999999999999877
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=290.76 Aligned_cols=240 Identities=20% Similarity=0.224 Sum_probs=201.1
Q ss_pred cccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
+.||.|.||+||-|+ .++|+.||||++.+..... ..++.+|+.+|+++.||.||.+.-.|++.+.+|+|||-+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 457999999999999 6789999999998765443 45789999999999999999999999999999999999966 4
Q ss_pred HHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC---CCceeeccCCcccCCCC---Cccc
Q 017395 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDG---RSYS 213 (372)
Q Consensus 140 L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~~~~~---~~~~ 213 (372)
..+.|.....+.|++.....++.||+.||+|||.+ +|+|+||||+|||+.+. -.+||||||+++.+... .+..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 55555555778899999999999999999999999 99999999999999755 35999999999987754 5678
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh--hHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
||+.|+|||+++.+.|+..-|+||.|||+|.-++|..||..+. .+.+.+.... .+ ..-..+.+.+..+||..
T Consensus 728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM--yP----p~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM--YP----PNPWSEISPEAIDLINN 801 (888)
T ss_pred CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc--cC----CCchhhcCHHHHHHHHH
Confidence 9999999999999999999999999999999999998875331 1112211111 11 12235677899999999
Q ss_pred HccCCCCCCCChHHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l 310 (372)
+|+..-.+|-|....+.|.
T Consensus 802 LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred HHHHHHHHhcchHhhccch
Confidence 9999999999999888773
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=280.46 Aligned_cols=251 Identities=17% Similarity=0.208 Sum_probs=194.2
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhc--CCCcceeeEeeEEEeC----CeeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEG----DERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~----~~~~lv 131 (372)
+..+++.+|+|.||+||+|.+ .|+.||||++.... .+.+.+|.++.+. |+|+||+.+++.-... .++|||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 455778899999999999999 56789999997543 4567888888775 4999999998875433 268999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-------CCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-------~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
++|.+.|||+|+|. ...++....++++..++.||++||. ++.|.|||||..|||+..++...|+|+|++.
T Consensus 288 TdYHe~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eecccCCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999995 4679999999999999999999997 3679999999999999999999999999997
Q ss_pred cCCCC--------CcccCCCCcCCcccccCCC----C--CCCCceeehHHHHHHHHhCC----------CCCCchh----
Q 017395 205 NSRDG--------RSYSTNLAFTPPEYLRTGR----V--TPESVMYSFGTLLLDLLSGK----------HIPPSHA---- 256 (372)
Q Consensus 205 ~~~~~--------~~~~~t~~y~aPE~~~~~~----~--~~~~Dv~SlGvil~el~tg~----------~p~~~~~---- 256 (372)
..... ....||.+|||||++...- + -..+||||||.|+||+..+- .||.+..
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 65543 3457899999999997542 2 23589999999999997532 2433221
Q ss_pred -hHHhhhccccccccccccCC-CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 257 -LDLIRDRNIQTLTDSCLEGQ-FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 257 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+.+++-.-.+...+..... ...++...+.++++.||..||.-|.|+--|.+.|.++.+
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11111111111111111111 234667899999999999999999999999999888764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=300.13 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=209.4
Q ss_pred ccccccCCCCCCeEEEEE-eCC----CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 60 NIVSEHGEKAPNVVYKGK-LEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~-~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+..++||.|+||+||+|. ... .-+||+|++...... ...+++.|+-.|.+++|||+++++++|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 455778999999999998 444 457899998755433 3567999999999999999999999997754 899999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcc-
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY- 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 212 (372)
|++.|+|.++++. .+..+.....+.|..||++||.|||.+ +++||||-..|||+.+-..+||.|||+++........
T Consensus 778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999986 445688899999999999999999999 9999999999999999999999999999987654322
Q ss_pred -----cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 213 -----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 213 -----~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
...+.|||-|.+....|+.++|||||||++||++| |..|+.... ...+..++....+-.-|+.++-++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----AEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----HHHhhHHHhccccCCCCCCccHHHH
Confidence 12467999999999999999999999999999987 555654432 2334444444444456788899999
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.++.+||..|+..||+++++...+.++.+++
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 9999999999999999999999988876654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.32 Aligned_cols=237 Identities=19% Similarity=0.254 Sum_probs=199.9
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 131 (372)
.+++++..||+|+||.|.+|. ..+.+.+|||+++++-.- +.+--+.|-++|..- +-|.+++++.+|++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 367788889999999999998 556889999999875432 233345677788777 578899999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC----
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR---- 207 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~---- 207 (372)
|||+.||+|--.|+. -+.+.+..+..++.+|+-||-|||++ |||+||||.+||+++.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999999999998873 45689999999999999999999999 99999999999999999999999999998532
Q ss_pred CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 208 DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 208 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
...++.||+.|+|||++...+|..+.|.|||||+||||+.|++||.++..+.+-.. +.+. .-.+|...+.++.+
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a----I~eh--nvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA----IMEH--NVSYPKSLSKEAVA 579 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHHc--cCcCcccccHHHHH
Confidence 23467899999999999999999999999999999999999999987654433221 2211 12467888999999
Q ss_pred HHHHHccCCCCCCCC
Q 017395 288 LASRCLQYEPRERPN 302 (372)
Q Consensus 288 li~~cl~~dp~~Rps 302 (372)
+....|.+.|.+|..
T Consensus 580 ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHhhcCCccccC
Confidence 999999999999963
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=269.17 Aligned_cols=253 Identities=18% Similarity=0.237 Sum_probs=195.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeC--------
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG-------- 125 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------- 125 (372)
+.|+.+.++|+|.||+||+|+ ..+++.||+|++-..+.. -....++|+++|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 467778889999999999999 566888999987643321 134578999999999999999999988543
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
..+|+||.+|+. +|..++.. ....++..++.+++.++..||.|+|+. .|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999987 79998854 345699999999999999999999999 999999999999999999999999999976
Q ss_pred CCCC--------CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhH----------------Hh
Q 017395 206 SRDG--------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD----------------LI 260 (372)
Q Consensus 206 ~~~~--------~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~----------------~~ 260 (372)
+... +....|.+|.+||.+.|.. |+++.|||.-|||+.||.||.+.+.+.... .|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 5432 2233489999999998854 999999999999999999999776543110 01
Q ss_pred hhccccccccc-----cccCCC--------ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 261 RDRNIQTLTDS-----CLEGQF--------SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 261 ~~~~~~~~~~~-----~~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.+.....+... ...+.+ |-.-..+..+|+.++|..||.+|++++++++|-.-
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 11110011100 000000 11113588999999999999999999999998543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=274.98 Aligned_cols=250 Identities=16% Similarity=0.177 Sum_probs=198.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC--Cc----ceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--NR----RLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp----niv~l~~~~~~~~~~~ 129 (372)
..|.+++.+|+|.||.|-.+. ...+..||||+++.-. .-.+..+-|+++|.++. .| -+|.+.++|...++.|
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 478899999999999999999 4457899999997432 12345677999999994 23 3788889999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC------------------
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD------------------ 191 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~------------------ 191 (372)
||+|.+ |-|+++++..+.-.+++..++..+++|++.+++|||+. +++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 999998 77999999887778899999999999999999999999 9999999999999932
Q ss_pred --CCCceeeccCCcccCCCCC-cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh--h-----HHhh
Q 017395 192 --DVNPRLSCFGLMKNSRDGR-SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA--L-----DLIR 261 (372)
Q Consensus 192 --~~~~kl~Dfg~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~--~-----~~~~ 261 (372)
+..++|+|||-+....... ....|..|.|||++.+-.++..+||||+||||+|+.||...|+... . +.+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl 325 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL 325 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence 2347899999998776654 4567899999999999999999999999999999999998876542 0 0000
Q ss_pred hccccccccc-----------------------------ccc----CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHH
Q 017395 262 DRNIQTLTDS-----------------------------CLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (372)
Q Consensus 262 ~~~~~~~~~~-----------------------------~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (372)
+.....++.. +.. -........++.+|+.+||..||.+|+|+.|++.
T Consensus 326 Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 326 GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 0000000000 000 0012344568999999999999999999999998
Q ss_pred H
Q 017395 309 A 309 (372)
Q Consensus 309 ~ 309 (372)
|
T Consensus 406 H 406 (415)
T KOG0671|consen 406 H 406 (415)
T ss_pred C
Confidence 8
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=302.77 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=203.5
Q ss_pred cccCCCCCCeEEEEEeC--------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEE
Q 017395 63 SEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+.||+|.||.|++|... ....||||.++..... +.+.+..|+++|+.+ +|+||+.++|+|...+..++|+
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 47899999999999732 1567999999865433 456799999999999 6999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceee
Q 017395 133 EYMPNDTLAKHLFHWE------------T--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~ 198 (372)
||+..|+|.+++++.+ . ..++....+.++.||+.|++||++. ++|||||-..|||+.++..+||+
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~~kIa 460 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKVIKIA 460 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCEEEEc
Confidence 9999999999998644 0 1388999999999999999999999 99999999999999999999999
Q ss_pred ccCCcccCCCCCcc-----c--CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccc
Q 017395 199 CFGLMKNSRDGRSY-----S--TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 199 Dfg~~~~~~~~~~~-----~--~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
|||+++.......+ . -...|||||.+....|+.++|||||||+|||++|...++.... .....+.+....
T Consensus 461 DFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~---~~~~~l~~~l~~ 537 (609)
T KOG0200|consen 461 DFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI---PPTEELLEFLKE 537 (609)
T ss_pred cccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC---CcHHHHHHHHhc
Confidence 99999965443222 1 1345999999999889999999999999999998665443220 001111223333
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
..+...|..++.++.+++..||+.+|.+||++.++.+.|.....
T Consensus 538 G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 538 GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 34445677788999999999999999999999999999988543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=288.15 Aligned_cols=254 Identities=16% Similarity=0.160 Sum_probs=214.4
Q ss_pred HhcCCCccccccccCCCCCCeEEEEEeCCCc-EEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 52 ATSGFAMENIVSEHGEKAPNVVYKGKLENQF-RIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 52 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
+...+++.+++..||-|+||.|-+....+.. .+|+|++++...-+ .+.+..|-.+|..++.|.||++|..|.+...
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 3445667788899999999999999965433 48999998655433 3457889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+|++||-|-||.|...++ +++.++..+...++..+++|++|||++ |||+|||||+|.+++.+|-+||.|||+++...
T Consensus 495 vYmLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999997 567799999999999999999999999 99999999999999999999999999999877
Q ss_pred CCC---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
.+. +++||+.|.|||++.....+.++|.||||+++|||++|.+||.+......-+ .++...-.-.+|......
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn----~ILkGid~i~~Pr~I~k~ 647 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN----LILKGIDKIEFPRRITKT 647 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH----HHHhhhhhhhcccccchh
Confidence 654 5789999999999999999999999999999999999999987643222211 122222222467777889
Q ss_pred HHHHHHHHccCCCCCCCC-----hHHHHHHHHh
Q 017395 285 LVRLASRCLQYEPRERPN-----PRSLVTALVT 312 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps-----~~~il~~l~~ 312 (372)
..+|+++++..+|.+|.. +.+|.+|-+-
T Consensus 648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 648 ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred HHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 999999999999999975 7888888553
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=284.63 Aligned_cols=259 Identities=16% Similarity=0.166 Sum_probs=202.7
Q ss_pred CHHHHHHHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEee
Q 017395 45 SIETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLG 120 (372)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~ 120 (372)
.+-.|+.+.-+=+.+-.|+.||-|+||+|.++. .++...+|+|.+.+.+.-. ......|-++|..-+++-||+||-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 444566666677778889999999999999998 5667889999998655332 234678999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeecc
Q 017395 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (372)
Q Consensus 121 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Df 200 (372)
.|.+++.+|+||+|++||++-.+|. +.+.|.+..+..++.++..|+++.|.- |+|||||||+|||||.+|++||+||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeec
Confidence 9999999999999999999999886 456799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCC---------CC-------------------------------------CcccCCCCcCCcccccCCCCCCCCc
Q 017395 201 GLMKNSR---------DG-------------------------------------RSYSTNLAFTPPEYLRTGRVTPESV 234 (372)
Q Consensus 201 g~~~~~~---------~~-------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~D 234 (372)
||+.-+. .+ ....||..|+|||++....++..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9976321 00 1235789999999999999999999
Q ss_pred eeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCC---ChHHHHHH
Q 017395 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP---NPRSLVTA 309 (372)
Q Consensus 235 v~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~il~~ 309 (372)
.||.|||||||+.|+.||-....... +.........+.-.+..+.+.++.++|.+++ .+++.|. -+++|..|
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~t--q~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGET--QYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAH 928 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcc--eeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcC
Confidence 99999999999999998854321100 0000011112222233456778888887765 3466675 35556555
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=261.73 Aligned_cols=235 Identities=21% Similarity=0.246 Sum_probs=193.2
Q ss_pred CCCeEEEEEeC-CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhc
Q 017395 69 APNVVYKGKLE-NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (372)
Q Consensus 69 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (372)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57899999964 58999999998765544 67899999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---CcccCCCCcCCccc
Q 017395 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEY 223 (372)
Q Consensus 147 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~t~~y~aPE~ 223 (372)
. ..+++..++.++.+++.++.+||+. +++|+||+|+||++++++.++|+|||.+...... ....++..|++||.
T Consensus 81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 R--GRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 2 2389999999999999999999999 9999999999999999999999999998876553 34556789999999
Q ss_pred ccCCCCCCCCceeehHHHHHHHHhCCCCCCc-hhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCC
Q 017395 224 LRTGRVTPESVMYSFGTLLLDLLSGKHIPPS-HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302 (372)
Q Consensus 224 ~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 302 (372)
+.+..++.++||||||++++++++|..|+.. ................. .......+.++.+++.+||..+|++||+
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---PPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---ccccccCCHHHHHHHHHHccCCchhccC
Confidence 9988889999999999999999999988754 22111111111100000 0000115578999999999999999999
Q ss_pred hHHHHHH
Q 017395 303 PRSLVTA 309 (372)
Q Consensus 303 ~~~il~~ 309 (372)
+.+++++
T Consensus 235 ~~~~~~~ 241 (244)
T smart00220 235 AEEALQH 241 (244)
T ss_pred HHHHhhC
Confidence 9999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=295.57 Aligned_cols=251 Identities=18% Similarity=0.194 Sum_probs=169.0
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CC----CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeE------EE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-EN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC------CC 123 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------~~ 123 (372)
..++|.+.+.||+|+||.||+|++ .+ +..||||++..... .+.+..+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 556888999999999999999995 45 68999999864332 1222222 1222222232222221 23
Q ss_pred eCCeeEEEEecCCCCCHHhhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCc
Q 017395 124 EGDERLLVAEYMPNDTLAKHLFHWETQ------------------PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (372)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~ 185 (372)
.....++||||+.+++|.+++...... ......+..++.|++.||.|||++ +|+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHH
Confidence 456799999999999999998642210 112345678999999999999999 9999999999
Q ss_pred ceeecC-CCCceeeccCCcccCCCC-----CcccCCCCcCCcccccCC----------------------CCCCCCceee
Q 017395 186 RIVFDD-DVNPRLSCFGLMKNSRDG-----RSYSTNLAFTPPEYLRTG----------------------RVTPESVMYS 237 (372)
Q Consensus 186 Nill~~-~~~~kl~Dfg~~~~~~~~-----~~~~~t~~y~aPE~~~~~----------------------~~~~~~Dv~S 237 (372)
|||+++ ++.+||+|||+++..... ....+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 689999999999765432 345678899999976432 2344669999
Q ss_pred hHHHHHHHHhCCCCCCchhhHHhhh---cc--ccc---cccccccCC------CChHHHHHHHHHHHHHccCCCCCCCCh
Q 017395 238 FGTLLLDLLSGKHIPPSHALDLIRD---RN--IQT---LTDSCLEGQ------FSSDEGTELVRLASRCLQYEPRERPNP 303 (372)
Q Consensus 238 lGvil~el~tg~~p~~~~~~~~~~~---~~--~~~---~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (372)
|||++|||+++..+........... .. ... ......... ..........+|+.+||+.||++|||+
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 9999999999875543322111110 00 000 000000000 001112345689999999999999999
Q ss_pred HHHHHHH
Q 017395 304 RSLVTAL 310 (372)
Q Consensus 304 ~~il~~l 310 (372)
.++++|-
T Consensus 445 ~e~L~Hp 451 (566)
T PLN03225 445 KAALAHP 451 (566)
T ss_pred HHHhCCc
Confidence 9999983
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=252.15 Aligned_cols=257 Identities=18% Similarity=0.245 Sum_probs=202.9
Q ss_pred cCHHHHHHHhcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeE
Q 017395 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGC 121 (372)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~ 121 (372)
++++.......+.++|++++++|+|-|++||.|. ..+++.++||+++.- ..+.+.+|+.+|..|+ ||||++++++
T Consensus 25 WdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~Di 101 (338)
T KOG0668|consen 25 WDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDI 101 (338)
T ss_pred cchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhh
Confidence 3444444455678899999999999999999999 678899999999753 3467899999999997 9999999999
Q ss_pred EEeC--CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceee
Q 017395 122 CCEG--DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLS 198 (372)
Q Consensus 122 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~ 198 (372)
..++ ....+|+||+.+.+...+. ..|+...+..++.+++.||.|+|+. ||+|||+||.|++|| +.-.++|+
T Consensus 102 V~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlI 175 (338)
T KOG0668|consen 102 VKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLI 175 (338)
T ss_pred hcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeee
Confidence 8765 3578999999998777665 2477888999999999999999999 999999999999999 55679999
Q ss_pred ccCCcccCCCCCcc---cCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhh--H--------------
Q 017395 199 CFGLMKNSRDGRSY---STNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHAL--D-------------- 258 (372)
Q Consensus 199 Dfg~~~~~~~~~~~---~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~--~-------------- 258 (372)
|+|++.....+..+ ..+..|-.||.+..- .|+.+-|+|||||++..|+..+.||+.... +
T Consensus 176 DWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 176 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred ecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 99999988776554 346789999999764 589999999999999999999999864210 0
Q ss_pred --Hhhh------cccccccccccc--------CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 259 --LIRD------RNIQTLTDSCLE--------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 259 --~~~~------~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+.. .....++....+ ..-..-.++++.+|+.++|..|-++|+|++|...|
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0000 000111100000 01111235899999999999999999999999988
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=281.59 Aligned_cols=254 Identities=15% Similarity=0.159 Sum_probs=180.3
Q ss_pred CCccccccccCCCCCCeEEEEEe-----------------CCCcEEEEEEcCCCCCccHHHH--------------HHHH
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-----------------ENQFRIAVKRFNRSAWPDARQF--------------LEEA 104 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~ 104 (372)
.++|.+.++||+|+||+||+|.. ..++.||||.+........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45677888899999999999963 2356899999976443333333 3466
Q ss_pred HHHhcCCCcce-----eeEeeEEEe--------CCeeEEEEecCCCCCHHhhhhcCC----------------------C
Q 017395 105 RAVGQLRNRRL-----ANLLGCCCE--------GDERLLVAEYMPNDTLAKHLFHWE----------------------T 149 (372)
Q Consensus 105 ~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------~ 149 (372)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677777653 356899999999999999886321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-----ccCCCCcCCcccc
Q 017395 150 QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----YSTNLAFTPPEYL 224 (372)
Q Consensus 150 ~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~t~~y~aPE~~ 224 (372)
..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ..+++.|+|||.+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1246778999999999999999999 999999999999999999999999999875433221 2336889999988
Q ss_pred cCCCC----------------------CCCCceeehHHHHHHHHhCCCCCCchhh---HHhhh--cccc---cccccccc
Q 017395 225 RTGRV----------------------TPESVMYSFGTLLLDLLSGKHIPPSHAL---DLIRD--RNIQ---TLTDSCLE 274 (372)
Q Consensus 225 ~~~~~----------------------~~~~Dv~SlGvil~el~tg~~p~~~~~~---~~~~~--~~~~---~~~~~~~~ 274 (372)
..... ..+.||||+||++++|++|..++..... ..... .... ........
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 64321 1246999999999999999853322100 00000 0000 00001111
Q ss_pred CCCChHHHHHHHHHHHHHccCCC---CCCCChHHHHHHH
Q 017395 275 GQFSSDEGTELVRLASRCLQYEP---RERPNPRSLVTAL 310 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~il~~l 310 (372)
-......+....+|+.++|..+| .+|+|+.++++|-
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 11223456889999999999766 6899999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=243.82 Aligned_cols=201 Identities=17% Similarity=0.195 Sum_probs=169.9
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+..-+.+||+|++|.|-+-+ ..+|+..|+|.+...-.. ..++.++|+++..+. .+|.+|+++|.......+||.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 34456788999999999888 578999999999865433 345688999987766 699999999999899999999999
Q ss_pred CCCCCHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc-
Q 017395 135 MPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS- 211 (372)
Q Consensus 135 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 211 (372)
|.- ||..+-++ ..++.+++..+-+|+..++.||.|||++..+||||+||+|||++.+|.+|+||||++-.+.++..
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 955 78776543 24567999999999999999999999988999999999999999999999999999887765432
Q ss_pred --ccCCCCcCCcccccC----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHH
Q 017395 212 --YSTNLAFTPPEYLRT----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL 259 (372)
Q Consensus 212 --~~~t~~y~aPE~~~~----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~ 259 (372)
..|...|||||.+.. ..|+.++||||||+++.||.+++.|+..|..+.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 457789999998864 358999999999999999999999988775443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.73 Aligned_cols=242 Identities=17% Similarity=0.233 Sum_probs=195.6
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
...++++++.||+|+|..|-+++ ..+.+.+|+|++++.-..+ .+=...|-.+..+- +||.+|-++.+|++...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 45678888999999999999999 6678899999998643332 22245566665555 6999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC--
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-- 207 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~-- 207 (372)
+|.||++||+|--.++ ..+.++++.+..+..+|+.||.|||++ |||+||||.+|||+|..|.+||+|+|+++..-
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999987776 455699999999999999999999999 99999999999999999999999999998532
Q ss_pred --CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh----hccccccccccccCCCChHH
Q 017395 208 --DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----DRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 208 --~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 281 (372)
...++.||+.|+|||++++..|....|.|+|||+++||+.|+.||.--..+... +...+-++... -.+|...
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--iriprsl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPRSL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cccccee
Confidence 235678999999999999999999999999999999999999998532111111 11111122221 1345566
Q ss_pred HHHHHHHHHHHccCCCCCCC
Q 017395 282 GTELVRLASRCLQYEPRERP 301 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rp 301 (372)
+-....+++..|.+||.+|.
T Consensus 483 svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhc
Confidence 67788899999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=281.97 Aligned_cols=234 Identities=21% Similarity=0.230 Sum_probs=178.4
Q ss_pred CCCCCCe-EEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCCCHHhh
Q 017395 66 GEKAPNV-VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (372)
Q Consensus 66 G~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (372)
|.|+.|+ ||+|.. +++.||||++-... ..-..+|+..|+.- +|||||++++.-.+..+.||..|.|.. +|.++
T Consensus 518 G~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dl 592 (903)
T KOG1027|consen 518 GYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDL 592 (903)
T ss_pred ccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHH
Confidence 6776655 799998 56799999986433 23457999999998 599999999998888999999999965 99999
Q ss_pred hhcC-CCCC-CCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---C--CCceeeccCCcccCCCCC------
Q 017395 144 LFHW-ETQP-MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---D--VNPRLSCFGLMKNSRDGR------ 210 (372)
Q Consensus 144 l~~~-~~~~-l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~--~~~kl~Dfg~~~~~~~~~------ 210 (372)
+... .... ..-...+.++.|++.||++||+. +||||||||+||||+. + ..++|+|||+++....+.
T Consensus 593 ie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~ 671 (903)
T KOG1027|consen 593 IESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRL 671 (903)
T ss_pred HhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcc
Confidence 9752 1111 11145678899999999999998 9999999999999974 3 468999999999765543
Q ss_pred -cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...||.+|+|||++....-+.+.||||+||++|+.++|..-+++...+...+.......-..+.. ..++ ++.+||
T Consensus 672 s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~--~~d~--eA~dLI 747 (903)
T KOG1027|consen 672 SGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEP--LPDC--EAKDLI 747 (903)
T ss_pred cCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeecc--CchH--HHHHHH
Confidence 35689999999999998888899999999999999998543333332221111111000000110 1111 899999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+|++++|..||++.+|+.|
T Consensus 748 ~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 748 SRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHhcCCCcccCCCHHHHhCC
Confidence 99999999999999999988
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=278.24 Aligned_cols=252 Identities=15% Similarity=0.143 Sum_probs=210.0
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+.-++|+++.++|.|.||.||||+ ..+++..|||+++.....+..-..+|+-+++.++|||||-++|.+......|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 556789999999999999999999 6779999999999877667777789999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC----C
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----D 208 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~----~ 208 (372)
|||.+|+|.+.-+ ..+++++.++..+.+..+.||+|||+. |-+|||||-.|||+++.|.+|++|||.+-.+. .
T Consensus 92 EycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999999876 567899999999999999999999999 99999999999999999999999999876543 4
Q ss_pred CCcccCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
..++.||++|||||+.. .+.|...+|||++|+...|+-.-++|.++...............++. .-.-....++.+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp-~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP-TLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC-cccCCccchHHH
Confidence 46789999999999875 45699999999999999999888876543211111000001111111 111234567899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+|++.||.++|++|||+..++.|
T Consensus 248 h~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheec
Confidence 999999999999999999988776
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=253.25 Aligned_cols=246 Identities=18% Similarity=0.264 Sum_probs=190.8
Q ss_pred ccccCCCCCCeEEEEE-eCCCcEEEEEEcCC--CCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----CeeEEEEe
Q 017395 62 VSEHGEKAPNVVYKGK-LENQFRIAVKRFNR--SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLLVAE 133 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~e 133 (372)
-+.||.|+||.||..+ -++|+.||+|++.. .+....+++.+|+++|.-++|.|++..++...-. ..+|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 3567999999999999 56799999999863 2233456789999999999999999998876543 24788999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc--
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-- 211 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 211 (372)
++.. +|...|- ..+.++...++-+++||++||+|||+. +|.||||||.|.|+++|..+||||||+++.......
T Consensus 138 LmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 9966 6888775 567799999999999999999999999 999999999999999999999999999997655432
Q ss_pred ---ccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchh----hHHhh---------------hcccccc
Q 017395 212 ---YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHA----LDLIR---------------DRNIQTL 268 (372)
Q Consensus 212 ---~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~----~~~~~---------------~~~~~~~ 268 (372)
...|.+|.|||.+.|.. |+.+.||||.|||+.||+..+-.|.... .+.+. ++....+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 23478999999999865 9999999999999999998886654321 11110 1111111
Q ss_pred cccccc-CC--------CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 269 TDSCLE-GQ--------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 269 ~~~~~~-~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.....+ +. -+.....+...++.+++..||+.|.+..+.+.++.
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111 11 11233457788899999999999999999988853
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=247.63 Aligned_cols=245 Identities=17% Similarity=0.207 Sum_probs=191.4
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCC--CCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------Cee
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DER 128 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~ 128 (372)
+|.-++.+|.|+- .|-.|. .-.++.||+|.+... .....++..+|..++..++|+||++++.+|.-. ..+
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4556677788886 666666 345889999988643 334466788999999999999999999998543 358
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|+|||||.. +|...+. -.++-.++..|+.|++.|++|||+. ||+||||||+||++..+..+||.|||+++....
T Consensus 97 y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCc
Confidence 999999955 8999886 3477889999999999999999999 999999999999999999999999999987655
Q ss_pred C---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-HHh------------------------
Q 017395 209 G---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLI------------------------ 260 (372)
Q Consensus 209 ~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~~~------------------------ 260 (372)
. +.+..|..|.|||++.+..+.+.+||||+||++.||++|...|++... +.+
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 4 446678899999999998899999999999999999999987764310 000
Q ss_pred --------hhcccccccccc-ccC--CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 261 --------RDRNIQTLTDSC-LEG--QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 261 --------~~~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.........+.. ... +.+...+..+++++.+||..||++|.|++++|.|
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000111100 000 1122345679999999999999999999999998
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=253.44 Aligned_cols=132 Identities=16% Similarity=0.185 Sum_probs=115.9
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-----C---cceeeEeeEEEe---
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----N---RRLANLLGCCCE--- 124 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~--- 124 (372)
.+|.++++||=|-|++||+|+ ..+.+.||+|+++... .-.+..+.|+++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 489999999999999999999 5678899999997433 22456789999999994 3 469999999975
Q ss_pred -CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec
Q 017395 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (372)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~ 190 (372)
+.++|||+|++ |.+|..+|+...-+.++...++.|++||+.||.|||...||||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 45899999999 779999998877788999999999999999999999999999999999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=262.46 Aligned_cols=250 Identities=16% Similarity=0.162 Sum_probs=197.8
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC------cceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~~~~~ 129 (372)
+.|.+.+-.|.|-|++|..|.. ..|+.||||+|.... .-.+.=++|+++|++|+. -|.++++..|.+.+++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 4788999999999999999994 447899999997533 223445789999999962 58999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-CCceeeccCCcccCC
Q 017395 130 LVAEYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR 207 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~~ 207 (372)
||+|-+ ..+|.++|++.. +-.|....+..++.|+.-||..|..- |++|.||||+|||+++. ..+||||||.+....
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCccccccc
Confidence 999998 558999998743 34688899999999999999999988 99999999999999954 569999999987665
Q ss_pred CC--CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh------------------------
Q 017395 208 DG--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR------------------------ 261 (372)
Q Consensus 208 ~~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~------------------------ 261 (372)
.. +.+..+..|.|||++.|-+|+...|+||.||+||||.||+-.|++.....+.
T Consensus 589 eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqH 668 (752)
T KOG0670|consen 589 ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQH 668 (752)
T ss_pred cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhh
Confidence 43 3455677899999999999999999999999999999999888754111000
Q ss_pred ----------------hccccccc---cc------ccc--CCCC---hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 262 ----------------DRNIQTLT---DS------CLE--GQFS---SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 262 ----------------~~~~~~~~---~~------~~~--~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.....++ .+ .+. ..++ ......|.+|+.+||..||++|.|..+.|.|
T Consensus 669 FD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 669 FDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred cccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 00000000 00 000 0122 2345789999999999999999999999987
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=234.57 Aligned_cols=207 Identities=26% Similarity=0.383 Sum_probs=183.5
Q ss_pred cCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHh
Q 017395 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (372)
Q Consensus 65 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~ 142 (372)
||.|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 589999999999964 4889999999865533 24679999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-CCCceeeccCCcccCCCC----CcccCCCC
Q 017395 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (372)
Q Consensus 143 ~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~~~----~~~~~t~~ 217 (372)
++.... ..+++..++.++.+++.++.+||+. |++|+||+|.||+++. ++.++|+|||.+...... ....+...
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 996422 4689999999999999999999999 9999999999999998 899999999998876553 23456788
Q ss_pred cCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCC
Q 017395 218 FTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (372)
Q Consensus 218 y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 296 (372)
|++||.+... ..+.++|+|++|++++++ ..+.+++.+|++.|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 9999999877 788999999999999998 57899999999999
Q ss_pred CCCCCChHHHHHHH
Q 017395 297 PRERPNPRSLVTAL 310 (372)
Q Consensus 297 p~~Rps~~~il~~l 310 (372)
|++||++.++++++
T Consensus 202 p~~R~~~~~l~~~~ 215 (215)
T cd00180 202 PEKRPSAKEILEHL 215 (215)
T ss_pred cccCcCHHHHhhCC
Confidence 99999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=261.82 Aligned_cols=202 Identities=14% Similarity=0.167 Sum_probs=174.9
Q ss_pred HHHHhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-----c---cHHHHHHHHHHHhcCC---Cccee
Q 017395 49 LRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-----P---DARQFLEEARAVGQLR---NRRLA 116 (372)
Q Consensus 49 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~---~~~~~~~E~~~l~~l~---hpniv 116 (372)
.+....+|++|..++.+|.|+||.|++|.+ .+...|+||.+.+... - +.-..-.|+.+|..++ |+||+
T Consensus 553 ~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl 632 (772)
T KOG1152|consen 553 CEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL 632 (772)
T ss_pred ceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence 345567899999999999999999999994 4567899999875431 1 1112457999999997 99999
Q ss_pred eEeeEEEeCCeeEEEEecC-CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCc
Q 017395 117 NLLGCCCEGDERLLVAEYM-PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (372)
Q Consensus 117 ~l~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~ 195 (372)
+++++|++.+.+||+||-. +|-+|+++|. .+..+++..+..|++||+.|+++||+. ||||||||-+||+++.+|-+
T Consensus 633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred hhhheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCCeE
Confidence 9999999999999999975 5679999996 456699999999999999999999999 99999999999999999999
Q ss_pred eeeccCCcccCCCC--CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCC
Q 017395 196 RLSCFGLMKNSRDG--RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPP 253 (372)
Q Consensus 196 kl~Dfg~~~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~ 253 (372)
||+|||.+.....+ ..+.||..|.|||++.|.+| ...-|||++|++||.++....|++
T Consensus 710 klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999998776554 46889999999999999887 556899999999999999888864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=232.46 Aligned_cols=241 Identities=20% Similarity=0.232 Sum_probs=188.8
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeE-EEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGC-CCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~~~lv~e~ 134 (372)
.|.|.+.+|+|.||.+-++. ..+++.+++|-+.... ....+|.+|..---.| .|.||+.-+++ |++.+..++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 68899999999999999999 4568899999998654 4567899998876666 48999988765 6677788899999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec--CCCCceeeccCCcccCCCCCcc
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGRSY 212 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~ 212 (372)
++.|+|.+-+. ...+.+....+++.|+++||.|+|++ ++||||||.+||||- +..++||||||+.+..+.....
T Consensus 104 aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 104 APRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred CccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 99999999884 45688999999999999999999999 999999999999994 4457999999998766554333
Q ss_pred c-CCCCcCCcccccCC---C--CCCCCceeehHHHHHHHHhCCCCCCch--------hhHHhhhccccccccccccCCCC
Q 017395 213 S-TNLAFTPPEYLRTG---R--VTPESVMYSFGTLLLDLLSGKHIPPSH--------ALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 213 ~-~t~~y~aPE~~~~~---~--~~~~~Dv~SlGvil~el~tg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
. -+..|.+||++... . ..+.+|+|.||++++.++||+.|+... .+..+..+....+.+. -
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~------F 253 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK------F 253 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh------h
Confidence 2 35679999987642 2 578899999999999999999988632 2222333333222111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...++.+..+.++-|..++++|--..++.+.
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2345778889999999999999655555444
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=242.89 Aligned_cols=251 Identities=19% Similarity=0.224 Sum_probs=198.0
Q ss_pred cccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeC-CeeEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLL 130 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~l 130 (372)
.+....+-+|.||.||.|.+. +.+.|-||.++....+ +...++.|.-.+..+.|||+..+.+++.+. ...++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 444555688999999999643 3566778888754432 245688999999999999999999998764 56889
Q ss_pred EEecCCCCCHHhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 131 VAEYMPNDTLAKHLFHW------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
++.++.-|+|..++... ..+.++..+...++.|++.|++|||+. |+||.||...|.+|++...+||+|-.+++
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999999722 234578889999999999999999999 99999999999999999999999999988
Q ss_pred cCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 205 NSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 205 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
..-... .......||+||.+....|+.++|+|||||+||||+|-...+..+. .............+-.-|
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI----DPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI----DPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc----CHHHHHHHHhccceecCC
Confidence 654321 2234578999999999999999999999999999998554333221 111112222223333446
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
-+|+.++..++.-||+.+|++||+++++..-|....
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 778899999999999999999999999999887653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=241.65 Aligned_cols=245 Identities=23% Similarity=0.292 Sum_probs=193.3
Q ss_pred CccccccccCCCCCCeEEEEEe-C---CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-E---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 131 (372)
..|.++.++|.|.|++||+|++ . .++.||+|.+...+.. .++.+|+++|..+. +.||+++.+++..++.+.+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 4577888999999999999983 3 4789999999876543 56889999999995 89999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeeccCCcccC----
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNS---- 206 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~---- 206 (372)
+||++.....++.. .++...+..+++.++.||.++|.+ |||||||||+|+|.+ ..+.-.|.|||++...
T Consensus 114 lp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999999884 377889999999999999999999 999999999999998 5577899999997610
Q ss_pred -------------CC--C-----------------------------CcccCCCCcCCcccccCCC-CCCCCceeehHHH
Q 017395 207 -------------RD--G-----------------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTL 241 (372)
Q Consensus 207 -------------~~--~-----------------------------~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvi 241 (372)
.. + ....||++|.|||++...+ .+.+.||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 0 0234789999999998654 7899999999999
Q ss_pred HHHHHhCCCCCCchhhH--------------Hhh------hc-------c----------cccc-cccccc--------C
Q 017395 242 LLDLLSGKHIPPSHALD--------------LIR------DR-------N----------IQTL-TDSCLE--------G 275 (372)
Q Consensus 242 l~el~tg~~p~~~~~~~--------------~~~------~~-------~----------~~~~-~~~~~~--------~ 275 (372)
++.+++++.||+....+ .+. +. . ...+ ...+.. .
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999998632100 000 00 0 0000 000000 0
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
......+..+.+|+.+||..||.+|.|+++.|+|
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1112234589999999999999999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=229.14 Aligned_cols=194 Identities=23% Similarity=0.254 Sum_probs=170.5
Q ss_pred cccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
|.+...+|.|++|.||++... +++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 345677899999999999965 4889999999876554 56789999999999999999999999998899999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----Cc
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RS 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----~~ 211 (372)
+++|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 9999999964222 289999999999999999999999 9999999999999999999999999998876554 34
Q ss_pred ccCCCCcCCcccc-cCCCCCCCCceeehHHHHHHHHhCCCCCCc
Q 017395 212 YSTNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (372)
Q Consensus 212 ~~~t~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~p~~~ 254 (372)
..++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 5567889999998 566688899999999999999999998855
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=267.37 Aligned_cols=192 Identities=17% Similarity=0.143 Sum_probs=141.3
Q ss_pred cCCC-cceeeEeeEE-------EeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc
Q 017395 109 QLRN-RRLANLLGCC-------CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180 (372)
Q Consensus 109 ~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~ 180 (372)
.++| +||.+++++| .+...+++++||+ +++|.+++.. ....+++.+++.++.||+.||.|||++ ||+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ-GIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC-Ceeec
Confidence 4456 5888888877 2234577888988 5599999964 345699999999999999999999999 99999
Q ss_pred cccCcceeecC-------------------CCCceeeccCCcccCCCC--------------------CcccCCCCcCCc
Q 017395 181 DLNAYRIVFDD-------------------DVNPRLSCFGLMKNSRDG--------------------RSYSTNLAFTPP 221 (372)
Q Consensus 181 Dikp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~--------------------~~~~~t~~y~aP 221 (372)
||||+||||+. ++.+|++|||+++..... ....+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 455677777776532110 013467889999
Q ss_pred ccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCC
Q 017395 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301 (372)
Q Consensus 222 E~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 301 (372)
|++.+..++.++|||||||+||||++|..|+..... ..... ......+ . ..........++.+||+.||.+||
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~-~~~~~~~----~-~~~~~~~~~~~~~~~L~~~P~~Rp 257 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSL-RHRVLPP----Q-ILLNWPKEASFCLWLLHPEPSCRP 257 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHH-HHhhcCh----h-hhhcCHHHHHHHHHhCCCChhhCc
Confidence 999999999999999999999999998866542211 11100 0011111 0 111234567889999999999999
Q ss_pred ChHHHHHHH
Q 017395 302 NPRSLVTAL 310 (372)
Q Consensus 302 s~~~il~~l 310 (372)
|+.+++++-
T Consensus 258 s~~eil~h~ 266 (793)
T PLN00181 258 SMSELLQSE 266 (793)
T ss_pred ChHHHhhch
Confidence 999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=210.89 Aligned_cols=167 Identities=16% Similarity=0.109 Sum_probs=128.1
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccCCCC
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~t~~ 217 (372)
|+|.+++.. .+..+++.+++.|+.|++.||.|||++ + ||+||+++.++.+|+ ||++....... ..+|+.
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g~~~ 69 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRVDPY 69 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc-CCCccc
Confidence 689999964 245699999999999999999999998 6 999999999999999 99988765433 367899
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhH-Hhhhcccccccccccc-CCCChHHHH--HHHHHHHHHc
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLE-GQFSSDEGT--ELVRLASRCL 293 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~--~l~~li~~cl 293 (372)
|+|||++.+..++.++|||||||++|||++|+.||...... ................ ...+...+. ++.+++.+||
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 99999999999999999999999999999999887532110 0000001111111000 011223333 6999999999
Q ss_pred cCCCCCCCChHHHHHHHHhhhc
Q 017395 294 QYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~l~~~~~ 315 (372)
..||.+|||+.++++++..+..
T Consensus 150 ~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 150 SRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=217.34 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=206.7
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
++++.+++.+|.....|+.|+|+++.+ .+++|+++...... ..+|..|.-.|+-+.||||+.+++.|..+.++.++.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 566778888999999999999998554 68888887655433 346999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc-cccCcceeecCCCCceeeccCCcccCCCCCc
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~-Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 211 (372)
.||+.|||+..+++...-.++..++.+++.++++|++|||+...++-| -|....|++|++.+++|+ .+-.+..-+...
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe~g 345 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG 345 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeeccc
Confidence 999999999999876666678899999999999999999998677766 899999999999998875 222222222233
Q ss_pred ccCCCCcCCcccccCCCC---CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRV---TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~---~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
..-.+.||+||.+...+- -.++|+|||.+++|||.|...||.+...... -..+.-..++..+|+..+..+..|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----gmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----GMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----hhhhhhccccccCCCCccHHHHHH
Confidence 344688999999987652 3578999999999999999999865432211 123334456667888999999999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
+.-|+..||.+||.++.|+-.|+.+.
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=216.91 Aligned_cols=257 Identities=16% Similarity=0.129 Sum_probs=199.4
Q ss_pred ccccccccCCCCCCeEEEEEeCC--CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC----cceeeEeeEE-EeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLEN--QFRIAVKRFNRSAWPDARQFLEEARAVGQLRN----RRLANLLGCC-CEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l 130 (372)
.|.+.++||+|+||.||++.... ...+|+|............+..|+.++..+.. +++..+++.+ ......||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999544 35799998876543333367889999998873 6899999998 47778999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-----CCceeeccCCcc-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-----VNPRLSCFGLMK- 204 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-----~~~kl~Dfg~~~- 204 (372)
||+.+ |.+|.++......+.++..++..|+.|++.+|.+||+. |++||||||+|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99998 78999988665567899999999999999999999999 99999999999999854 359999999998
Q ss_pred -cCC---------C---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccc
Q 017395 205 -NSR---------D---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 205 -~~~---------~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
... . ...+.||..|+++.+..+...+.+.|+||++.++.+++.|..|+........ ..........
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHhhh
Confidence 311 0 1124489999999999999999999999999999999999988744221000 0111111111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
..........+.++.++...+-..+...+|....+...|+......
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111022334567888888888899999999999999988776554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=199.79 Aligned_cols=255 Identities=16% Similarity=0.165 Sum_probs=202.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC-cceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~ 134 (372)
..|+++++||.|+||.+|.|. ..+|+.||||+-.... ...++..|.++.+.|++ ..|+.+..++.+...-.+||++
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 479999999999999999999 7889999999976433 34567889999999974 7888888999899999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec---CCCCceeeccCCcccCCC---
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRD--- 208 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~~~~~--- 208 (372)
. |.||.+++.- ..+.++..+++-++-|++.-++|+|.+ ++|||||||+|+|.. ....+.|+|||+++...+
T Consensus 93 L-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 93 L-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred c-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 8 8899998853 456699999999999999999999999 999999999999997 335689999999986543
Q ss_pred --------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccc---cccCCC
Q 017395 209 --------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS---CLEGQF 277 (372)
Q Consensus 209 --------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 277 (372)
+....||..|.+-....+...+.+.|+-|+|.+|..+.-|..||.+-... .+.++...+.+. .....+
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-tk~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-TKKQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-hHHHHHHHHHHhhcCCCHHHH
Confidence 24457889999988888878899999999999999999999998753211 111111111111 111122
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
....+.++.-.+..|-..--++-|...-+.+.++-+....
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 3445688999999999999999999887777766655443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=212.98 Aligned_cols=166 Identities=16% Similarity=0.032 Sum_probs=127.9
Q ss_pred CccccccccCCCCCCeEEEEEeC--CCcEEEEEEcCCCC-----CccHHHHHHHHHHHhcCCCcceee-EeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE--NQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLAN-LLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~ 128 (372)
..|.+.+.||+|+||+||+|... +++.||||++.... ....+.|.+|+++|++++|+|++. ++++ +..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence 35788888999999999999853 57788999875331 112456899999999999999985 4432 457
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc-cCcceeecCCCCceeeccCCcccCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Di-kp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
|+||||++|++|... . .. . ...++.|++.||.|||+. ||+|||| ||+|||++.++.+||+|||+++...
T Consensus 94 ~LVmE~~~G~~L~~~-~--~~---~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R--PH---G---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHHh-C--cc---c---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999999999732 1 11 1 146789999999999999 9999999 9999999999999999999998654
Q ss_pred CCC------------cccCCCCcCCcccccCCC------CCCCCcee
Q 017395 208 DGR------------SYSTNLAFTPPEYLRTGR------VTPESVMY 236 (372)
Q Consensus 208 ~~~------------~~~~t~~y~aPE~~~~~~------~~~~~Dv~ 236 (372)
... ...++..|+|||.+.... .+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 322 234567799999987432 23446666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=200.41 Aligned_cols=253 Identities=17% Similarity=0.174 Sum_probs=203.3
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|++-++||+|+||.++.|+ +-+++.||||.-...+ +..++..|.+..+.|. .++|..++-|..++.+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57888999999999999999 7789999999987654 3456788888888884 799999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-----CCceeeccCCcccCCCC-
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-----VNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-----~~~kl~Dfg~~~~~~~~- 209 (372)
|.||.|++. ..++.|+..++..++.|++.-++|+|++ .+|+|||||+|+||..- ..+.++|||+++...+.
T Consensus 107 -GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 -GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred -CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 889999874 4677899999999999999999999999 99999999999999743 34899999999875432
Q ss_pred ----------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh--ccccccccccccCCC
Q 017395 210 ----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD--RNIQTLTDSCLEGQF 277 (372)
Q Consensus 210 ----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~ 277 (372)
.+..||.+||+-....|...+.+.|+-|+|-+++..+-|..||.+...+..+. .++-+.........+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 35678999999999999999999999999999999999999987642221111 111111111111122
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
....+.++...+.-.-..+-.+-|..+-+...+..+..
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 34457889999998889999999998877777665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=199.89 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=194.4
Q ss_pred cccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCc-ceeeEeeEEEeCCeeEEEEec
Q 017395 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNR-RLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~ 134 (372)
|.+...||.|+||.||++... ..+++|.+....... ...+.+|+.++..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788899999999999976 689999998655433 56799999999999988 799999999777778999999
Q ss_pred CCCCCHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcccCCCC---
Q 017395 135 MPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~~--- 209 (372)
+.+++|.+++..... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999977753221 2689999999999999999999999 999999999999999888 6999999998754332
Q ss_pred -------CcccCCCCcCCcccccC---CCCCCCCceeehHHHHHHHHhCCCCCCchhh----HHhhhccccccccccccC
Q 017395 210 -------RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 275 (372)
....++..|++||.+.+ ..++...|+||+|++++++++|..|+..... ...... ......+....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI-ILELPTPSLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH-HHhcCCccccc
Confidence 34567899999999988 5788999999999999999999988654321 111110 00000000000
Q ss_pred CCC----hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 276 QFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 276 ~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
... ......+.+++..++..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 1223678999999999999999998887775
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=185.37 Aligned_cols=140 Identities=16% Similarity=0.162 Sum_probs=109.7
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--c-------HHH-----------------HHHHHHHHhcCCCcce
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--D-------ARQ-----------------FLEEARAVGQLRNRRL 115 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~hpni 115 (372)
.+.||.|+||.||+|...+|+.||||+++..... . ..+ ..+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4678999999999999778999999999754211 1 112 2349999999988776
Q ss_pred eeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCcccccccCcceeecCCCC
Q 017395 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAYRIVFDDDVN 194 (372)
Q Consensus 116 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~l-H~~~~iiH~Dikp~Nill~~~~~ 194 (372)
.....+... ..+|||||++|++|..... ...++++..+..++.|++.+|.++ |+. |++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-CCc
Confidence 443333222 2389999999887765432 345689999999999999999999 688 999999999999998 478
Q ss_pred ceeeccCCcccCC
Q 017395 195 PRLSCFGLMKNSR 207 (372)
Q Consensus 195 ~kl~Dfg~~~~~~ 207 (372)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-26 Score=221.76 Aligned_cols=243 Identities=16% Similarity=0.092 Sum_probs=180.7
Q ss_pred cccCCCCCCeEEEEE-eCCCcEEEEEEcCCC--CCccHH----HHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDAR----QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..+|.|++|.|+.+. .......+.|.+... ...... .+..|+-+-..++|||++..+..+.+.....-+||||
T Consensus 324 ~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~ 403 (601)
T KOG0590|consen 324 RVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYC 403 (601)
T ss_pred ceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcc
Confidence 456999999888887 444445555544311 111111 2566777788889999988887776666555569999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC------
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------ 209 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~------ 209 (372)
++ +|..++.. ...++...+-.++.|++.|++|+|+. |+.|||+|++|++++.+|.+||+|||.+......
T Consensus 404 ~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 404 PY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred cH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99 99999963 34688899999999999999999999 9999999999999999999999999998765432
Q ss_pred --CcccCCCCcCCcccccCCCCCC-CCceeehHHHHHHHHhCCCCCCchhhHHhh---hccccccccccccCCCChHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPPSHALDLIR---DRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~-~~Dv~SlGvil~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......... ...........-...+....+.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 2356788999999999999876 579999999999999999887432111000 0000000000000112245578
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+.+|.++|+.||.+|.|+.+|++.
T Consensus 560 ~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hHHHHHHHHccCChhheecHHHHhhC
Confidence 89999999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=188.23 Aligned_cols=169 Identities=11% Similarity=0.038 Sum_probs=132.0
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHH---H------HHHHHHHHhcCCCcceeeEeeEEEeC--
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR---Q------FLEEARAVGQLRNRRLANLLGCCCEG-- 125 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~hpniv~l~~~~~~~-- 125 (372)
..|++++.+|.|+||.||++.. ++..+|||++......... . +.+|++.+.+++|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 3688999999999999999766 5668999999754433322 2 67999999999999999999886543
Q ss_pred ------CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeec
Q 017395 126 ------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (372)
Q Consensus 126 ------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~D 199 (372)
+..+|||||++|.+|.++.. +++ ....+++.+|..+|+. |++|||+||+||+++.+| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999988742 333 2456999999999999 999999999999999888 99999
Q ss_pred cCCcccCCCCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHH
Q 017395 200 FGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246 (372)
Q Consensus 200 fg~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~ 246 (372)
||........... ...+....+..++|+||||+++.-+.
T Consensus 178 fg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 9987655322111 11333445677999999999987543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=177.78 Aligned_cols=142 Identities=15% Similarity=0.157 Sum_probs=112.7
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc---------------------c-----HHHHHHHHHHHhcCCCcc
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP---------------------D-----ARQFLEEARAVGQLRNRR 114 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~hpn 114 (372)
+.+.||+|++|.||+|...+|+.||||+++..... . ...+.+|.+.+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678999999999999768999999999764211 0 112357899999999998
Q ss_pred eeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCC
Q 017395 115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 115 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~ 193 (372)
+.....+... ..+|||||++|+++..... ....++...+..++.|++.++.++|+ . |++||||||+||+++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CC
Confidence 7554444333 2489999999886544322 23457888999999999999999999 8 999999999999999 88
Q ss_pred CceeeccCCcccCCC
Q 017395 194 NPRLSCFGLMKNSRD 208 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~ 208 (372)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-24 Score=202.03 Aligned_cols=224 Identities=16% Similarity=0.166 Sum_probs=187.2
Q ss_pred cCCCCCCeEEEEEe----CCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 65 HGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 65 lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
+|.|+||.|++... +.+..+|+|++++..... ......|..++..++ ||.+++++..++.....++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 59999999998752 347889999997644322 224667888888887 99999999999999999999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccCCCC
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~t~~ 217 (372)
|.|...+. ....+.+.....+...++-|++++|+. +++|||+|++||+++.+|.+++.|||+++..-.....+||.-
T Consensus 82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYE 158 (612)
T ss_pred chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchh
Confidence 99998886 344578888888999999999999999 999999999999999999999999999998766666689999
Q ss_pred cCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCC
Q 017395 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (372)
Q Consensus 218 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 297 (372)
|||||++. ....++|.||||++++||+||..||.......+.. .....|...+..+.+++..++..+|
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~----------~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILK----------AELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhh----------hccCCchhhhHHHHHHHHHHHhhCH
Confidence 99999998 56779999999999999999999987632221111 1123577888999999999999999
Q ss_pred CCCCCh
Q 017395 298 RERPNP 303 (372)
Q Consensus 298 ~~Rps~ 303 (372)
..|.-.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 999643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-24 Score=209.54 Aligned_cols=243 Identities=16% Similarity=0.184 Sum_probs=178.1
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCC-CccHHHHHHHHHH--HhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA-WPDARQFLEEARA--VGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++...+.||.+.|=.|.+|+++.|. |+||++-+.. .-....|.++++- ...++|||.+.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667788999999999999988886 9999987654 2234444444333 4556899999987776677778999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
..+ +|+|++.. +.-+...+.+.|+.|++.||.-+|.. ||+|+|||.+||||+.-+-+.|+||.-.+...-. .
T Consensus 103 vkh-nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 965 89999952 33367788889999999999999999 9999999999999999889999999876643211 1
Q ss_pred cc-------cCCCCcCCcccccCC----------C-CCCCCceeehHHHHHHHHhCCCCCCc-hhhHHhhhccccccccc
Q 017395 211 SY-------STNLAFTPPEYLRTG----------R-VTPESVMYSFGTLLLDLLSGKHIPPS-HALDLIRDRNIQTLTDS 271 (372)
Q Consensus 211 ~~-------~~t~~y~aPE~~~~~----------~-~~~~~Dv~SlGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~ 271 (372)
.+ ..-.+|+|||.+... . .+++.||||+||++.||++-..|.+. ...-.++.+. ......
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-~~~~e~ 257 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-ADDPEQ 257 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-ccCHHH
Confidence 11 112479999987531 1 67899999999999999987555432 2111122221 111111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+ ..++ ...+++++..|++.||.+|.|+++.|+.-
T Consensus 258 ~L-e~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 258 LL-EKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HH-HhCc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11 0111 24789999999999999999999999983
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=168.41 Aligned_cols=133 Identities=14% Similarity=0.104 Sum_probs=105.6
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-----CCcceeeEeeEEEeCC---e-eEEEEe
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-----RNRRLANLLGCCCEGD---E-RLLVAE 133 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~-~~lv~e 133 (372)
..||+|+||.||. ...+.. .+||++........+.+.+|++.++.+ +||||++++|++.+.. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4579999999996 333444 479998765555567899999999999 5799999999998863 3 337899
Q ss_pred c--CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCcccccccCcceeecC----CCCceeeccCCc
Q 017395 134 Y--MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLM 203 (372)
Q Consensus 134 ~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al-~~lH~~~~iiH~Dikp~Nill~~----~~~~kl~Dfg~~ 203 (372)
| +.+++|.+++++ ..+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 557999999964 236665 35678888888 999999 9999999999999973 347999995443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=166.02 Aligned_cols=179 Identities=15% Similarity=0.088 Sum_probs=136.9
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc----HHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecC
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD----ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+...|++|+||+||.+.. .+..++.+.+....+-- ...+.+|+++|++|. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 445679999999997776 67788888887655421 224789999999995 5889999886 3469999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc-cCcceeecCCCCceeeccCCcccCCCCCc---
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSRDGRS--- 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Di-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 211 (372)
.|.+|...+. .. ...++.|++.+|.++|+. |++|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~---~~------~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPP---RG------DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhh---hh------hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9999976542 11 135788999999999999 9999999 79999999999999999999986543321
Q ss_pred --------------ccCCCCcCCcccccCC-CCC-CCCceeehHHHHHHHHhCCCCCCc
Q 017395 212 --------------YSTNLAFTPPEYLRTG-RVT-PESVMYSFGTLLLDLLSGKHIPPS 254 (372)
Q Consensus 212 --------------~~~t~~y~aPE~~~~~-~~~-~~~Dv~SlGvil~el~tg~~p~~~ 254 (372)
...++.|+.|+...-- ..+ ...+.++.|.-+|.++|++.+...
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0125667777654432 233 456778999999999999976543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=177.98 Aligned_cols=228 Identities=20% Similarity=0.175 Sum_probs=146.9
Q ss_pred cccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCC----------cceeeEeeEE----
Q 017395 61 IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRN----------RRLANLLGCC---- 122 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------pniv~l~~~~---- 122 (372)
.-+.||.|+++.||.+++ .+++.+|||++..... ...+++.+|.-....+.+ -.++.-++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 335679999999999995 5599999999864332 236677777765555432 1222222222
Q ss_pred -----EeCC--------eeEEEEecCCCCCHHhhhhc---CCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccC
Q 017395 123 -----CEGD--------ERLLVAEYMPNDTLAKHLFH---WET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184 (372)
Q Consensus 123 -----~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp 184 (372)
.... +.+++|+-+.+ +|.+++.. ... ..+.......+..|++..+++||+. |++|+||+|
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi~~ 173 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDIKP 173 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-SG
T ss_pred CCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEecccce
Confidence 1111 24778888744 78887642 111 1233455677779999999999999 999999999
Q ss_pred cceeecCCCCceeeccCCcccCCCCCc-ccCCCCcCCcccccCC--------CCCCCCceeehHHHHHHHHhCCCCCCch
Q 017395 185 YRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTNLAFTPPEYLRTG--------RVTPESVMYSFGTLLLDLLSGKHIPPSH 255 (372)
Q Consensus 185 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~t~~y~aPE~~~~~--------~~~~~~Dv~SlGvil~el~tg~~p~~~~ 255 (372)
+|++++.+|.++|+||+.....+.... ...+..|.+||..... .++.+.|.|+||+++|.|.++..||...
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999988766554433 3445779999977432 3788999999999999999999887643
Q ss_pred hhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCC
Q 017395 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300 (372)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 300 (372)
........ ... ... +.++.++.||..+|+.||.+|
T Consensus 254 ~~~~~~~~----~f~-----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 254 SPEADPEW----DFS-----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGGSTSGG----GGT-----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred Cccccccc----cch-----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 21111111 111 223 677899999999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=185.84 Aligned_cols=210 Identities=22% Similarity=0.328 Sum_probs=162.7
Q ss_pred HhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcc
Q 017395 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (372)
Q Consensus 107 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~N 186 (372)
|+.+.|.|+.+++|.+..+...++|.+||..|+|.+.+.. ....+++.-...++++++.||.|||....-.|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4678999999999999999999999999999999999975 456689999999999999999999998333899999999
Q ss_pred eeecCCCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCC-------CCCCCceeehHHHHHHHHhCCCCCC
Q 017395 187 IVFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGR-------VTPESVMYSFGTLLLDLLSGKHIPP 253 (372)
Q Consensus 187 ill~~~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~-------~~~~~Dv~SlGvil~el~tg~~p~~ 253 (372)
.+++.++.+||+|||+....... .......-|.|||.+++.. .+.+.||||||++++|+++.+.||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998766421 1112235699999998742 4677999999999999999999986
Q ss_pred chhhHHhhhcccccc---ccccccCCCC-h-HHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 254 SHALDLIRDRNIQTL---TDSCLEGQFS-S-DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 254 ~~~~~~~~~~~~~~~---~~~~~~~~~~-~-~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
...........+..+ .....++... . ...+++..++..||..+|.+||+++.|...+..+.+..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 532111110011111 1111222221 1 34457999999999999999999999999988776643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-22 Score=175.03 Aligned_cols=191 Identities=16% Similarity=0.169 Sum_probs=145.7
Q ss_pred CCcceeeEeeEEEeC---------------------------CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHH
Q 017395 111 RNRRLANLLGCCCEG---------------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALH 163 (372)
Q Consensus 111 ~hpniv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q 163 (372)
+|||||++.++|.+. ..+|+||.-++. +|.+++. .+..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~---~~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW---TRHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh---cCCCchHHHHHHHHH
Confidence 599999999887432 347999998866 8999994 455778888889999
Q ss_pred HHHHHHHhhcCCCcccccccCcceeec--CCCC--ceeeccCCcccCCC----------CCcccCCCCcCCcccccCCC-
Q 017395 164 IAEALEYCTSKERALYHDLNAYRIVFD--DDVN--PRLSCFGLMKNSRD----------GRSYSTNLAFTPPEYLRTGR- 228 (372)
Q Consensus 164 i~~al~~lH~~~~iiH~Dikp~Nill~--~~~~--~kl~Dfg~~~~~~~----------~~~~~~t~~y~aPE~~~~~~- 228 (372)
+++|+.|||++ |+.|||+|.+|||+. +++. +.|+|||.+--... .....|.-.-||||+....+
T Consensus 350 lLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 350 LLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 999999999999994 4443 78999998653222 22334566789999987532
Q ss_pred -----CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCCh
Q 017395 229 -----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303 (372)
Q Consensus 229 -----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (372)
.-.++|.|+.|.+.||+++...||+......+.....++- ..+..|..+++.+++++...|+.||++|++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~----qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES----QLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh----hCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 2458999999999999999999998754333333332221 1224566778899999999999999999987
Q ss_pred HHHHHHH
Q 017395 304 RSLVTAL 310 (372)
Q Consensus 304 ~~il~~l 310 (372)
.-..+.|
T Consensus 505 ~iAANvl 511 (598)
T KOG4158|consen 505 NIAANVL 511 (598)
T ss_pred cHHHhHH
Confidence 6655553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=166.73 Aligned_cols=155 Identities=14% Similarity=0.077 Sum_probs=118.7
Q ss_pred CHHHHHHHhcCCCccccccccCCCCCCeEEEEE--eCCCcEEEEEEcCCCCCc-------------------c-----HH
Q 017395 45 SIETLRTATSGFAMENIVSEHGEKAPNVVYKGK--LENQFRIAVKRFNRSAWP-------------------D-----AR 98 (372)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------~-----~~ 98 (372)
+..++.+.-+.-..|.+.+.||.|+||.||+|. ..+|+.||||+++..... + ..
T Consensus 16 ~~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (237)
T smart00090 16 TRLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRL 95 (237)
T ss_pred HHHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHH
Confidence 344444444444467888999999999999998 567999999998754211 0 12
Q ss_pred HHHHHHHHHhcCCCc--ceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 017395 99 QFLEEARAVGQLRNR--RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER 176 (372)
Q Consensus 99 ~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~ 176 (372)
.+.+|++.+.++.+. .+++++++ ...++||||++|++|..... ....+....+..++.|++.++.+||+. |
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-g 168 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE-G 168 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc-C
Confidence 356899999999753 34455543 23489999999988876543 233466677889999999999999999 8
Q ss_pred -cccccccCcceeecCCCCceeeccCCcccCC
Q 017395 177 -ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 177 -iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
++||||||+||+++ ++.++|+|||.+....
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999999 8899999999876543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=178.81 Aligned_cols=236 Identities=19% Similarity=0.259 Sum_probs=154.3
Q ss_pred cccccCCCCCCeEEEEE-eCC---CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEee-------EEEe-----
Q 017395 61 IVSEHGEKAPNVVYKGK-LEN---QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG-------CCCE----- 124 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~-~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-------~~~~----- 124 (372)
+.+..+.++++.++... ..+ .+.++.+..............+++-.+....|-+..-+.+ .+..
T Consensus 248 ~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~ 327 (516)
T KOG1033|consen 248 ISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGK 327 (516)
T ss_pred ccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccc
Confidence 33444555556665554 222 2334444444333223333445555555554433333322 1111
Q ss_pred CCeeEEEEecCCCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 125 GDERLLVAEYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
...+||.|++|...+|.++|.+++ ....++...+.|+.|++.|+.| + +.+|+|+||.||++..+..+||.|||+.
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhhe
Confidence 125789999999999999997433 3457788999999999999999 6 9999999999999999999999999998
Q ss_pred ccCCCCC----------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccc
Q 017395 204 KNSRDGR----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273 (372)
Q Consensus 204 ~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (372)
....... ...||..||+||++.+..|+.++||||||++|+||++-- .... ........+-+..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f---~T~~---er~~t~~d~r~g~i 477 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQF---STQF---ERIATLTDIRDGII 477 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHh---ccHH---HHHHhhhhhhcCCC
Confidence 7544332 356899999999999999999999999999999999821 1110 11111111111111
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHH
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il 307 (372)
.+.+- ...++-..|+.+++...|.+||++.+..
T Consensus 478 p~~~~-~d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 478 PPEFL-QDYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ChHHh-hcCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 11110 1124556899999999999999555443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=159.30 Aligned_cols=134 Identities=16% Similarity=0.164 Sum_probs=113.0
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc--------HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+.||+|++|.||+|.. ++..|+||+........ ...+.+|++++..++|++++....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5679999999999987 66689999866433211 23578899999999999988877777777888999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
++|++|.+.+... .+ .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998531 22 7889999999999999999 999999999999999 78899999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=186.00 Aligned_cols=242 Identities=16% Similarity=0.123 Sum_probs=173.2
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCCeeEEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~ 132 (372)
-..|.|-+.+|+|+||.||+|...+|+.||||+-+....-. |.==.+++.+|+ -+-|..+...+.-.+.-++|+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 34677888999999999999997779999999977544211 222234444555 233444444444556679999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-------CCCCceeeccCCccc
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-------DDVNPRLSCFGLMKN 205 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-------~~~~~kl~Dfg~~~~ 205 (372)
||.+.|+|.+++. ..+.++|..+..++.|++..+..||.. +|||+||||+|.||. ++..++|+|||.+..
T Consensus 774 ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999999997 556799999999999999999999999 999999999999994 234589999998764
Q ss_pred C---CCCC---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh
Q 017395 206 S---RDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (372)
Q Consensus 206 ~---~~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (372)
+ .++. ...+|-.+-.+|...|.+++...|.|.|..+++.|+.|+..- ..++....+... ++..+..
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~~~~~~~-~~Ry~~~ 922 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSSWMVKTN-FPRYWKR 922 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcceecccc-chhhhhH
Confidence 3 3332 234678899999999999999999999999999999998421 111111111111 1111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
.-..++...+|..|-..=|...++...|+...
T Consensus 923 ---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 923 ---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred ---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 22344555666655555577888877776654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=152.97 Aligned_cols=138 Identities=17% Similarity=0.138 Sum_probs=109.5
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc----------------------cHHHHHHHHHHHhcCCCc--
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----------------------DARQFLEEARAVGQLRNR-- 113 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp-- 113 (372)
.|.+.+.||.|+||.||++...+++.||||++...... ....+.+|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 36777889999999999999878999999987643210 011356789999999877
Q ss_pred ceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 114 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
.++..++. ...++||||++|++|..... ......++.+++.++.++|+. |++|+||||+||++++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCC
Confidence 44444442 34589999999999877542 134567889999999999998 999999999999999999
Q ss_pred CceeeccCCcccCCC
Q 017395 194 NPRLSCFGLMKNSRD 208 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~ 208 (372)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=154.20 Aligned_cols=129 Identities=18% Similarity=0.212 Sum_probs=105.7
Q ss_pred cCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 65 HGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 65 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
||+|+||.||+|.+ ++..|++|........ ...++.+|++++..++|+++.....++......++||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 69999999999996 5678999986543211 12457789999999998876655555556677899999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
|++|.+.+... . . .++.+++.+|.+||+. |++|+|++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~--~-~------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEG--N-D------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhc--H-H------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999987421 1 1 7899999999999999 999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-20 Score=181.98 Aligned_cols=201 Identities=19% Similarity=0.166 Sum_probs=144.7
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
+++.|+.+..|+||.||..++ .+.+.+|+| ++++.. +.+. ++....+|. .|
T Consensus 84 df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npf---------------vv----- 135 (1205)
T KOG0606|consen 84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPF---------------VV----- 135 (1205)
T ss_pred ccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCcc---------------ee-----
Confidence 566778889999999999985 457789984 443221 1111 222222333 33
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC--------
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-------- 208 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~-------- 208 (372)
|+-...++. -++++.. ++.+++|||+. ||+|||+||+|.+|+.-|.+|++|||+.+....
T Consensus 136 -gDc~tllk~--~g~lPvd--------mvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 -GDCATLLKN--IGPLPVD--------MVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred -chhhhhccc--CCCCcch--------hhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 344444542 2334322 27889999999 999999999999999999999999999774321
Q ss_pred -----------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 209 -----------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 209 -----------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
.....||+.|.|||++.-..|....|.|++|+|+||.+-|..||+++..+.+....+...+... +-
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp---E~ 280 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP---EE 280 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc---cc
Confidence 1234689999999999988999999999999999999999999998755544444433322211 11
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCC
Q 017395 278 SSDEGTELVRLASRCLQYEPRERP 301 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rp 301 (372)
....++++++++.++|+.+|..|-
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhc
Confidence 334468999999999999999994
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=174.56 Aligned_cols=134 Identities=19% Similarity=0.175 Sum_probs=108.9
Q ss_pred ccccccCCCCCCeEEEEEeCCCcEEEEEEc-CCC-CCc------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRF-NRS-AWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
...+.||+|+||+||+|.+.+.. +++|+. ... ... ..+++.+|++++..++|++++....++......++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 44567899999999999875543 444432 211 111 134688999999999999999888887777788999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
|||++|++|.+++. ....++.+++.+|.+||+. |++||||||+||++ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999884 3567899999999999999 99999999999999 6789999999998653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=140.26 Aligned_cols=135 Identities=15% Similarity=0.037 Sum_probs=113.9
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC--cceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
+++.+|.|.++.||++...+ ..+++|....... ...+.+|+.++..++| .+++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45678999999999999755 6799999875443 4578999999999976 58999999888778899999999988
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.+..+ +......++.+++.+++++|.. .+++|+|++|+||+++..+.+++.|||.+....
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 76543 5567788899999999999984 279999999999999998999999999886543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=145.86 Aligned_cols=133 Identities=17% Similarity=0.149 Sum_probs=103.2
Q ss_pred cC-CCCCCeEEEEEeCCCcEEEEEEcCCCCC-------------ccHHHHHHHHHHHhcCCCcce--eeEeeEEEeCC--
Q 017395 65 HG-EKAPNVVYKGKLENQFRIAVKRFNRSAW-------------PDARQFLEEARAVGQLRNRRL--ANLLGCCCEGD-- 126 (372)
Q Consensus 65 lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~-- 126 (372)
+| .|+.|+||.+... +..++||.+..... ....++.+|++++..++|++| ++.+++.....
T Consensus 39 lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~ 117 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL 117 (239)
T ss_pred eecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence 46 6777889999874 56799998854221 123468899999999998774 67777654332
Q ss_pred --eeEEEEecCCC-CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 127 --ERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 127 --~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
..++||||++| .+|.+++.. ..++... +.+++.+|.+||+. ||+||||||.|||++.++.++|+|||.+
T Consensus 118 ~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 118 FYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 23599999997 699998853 3455543 57899999999999 9999999999999998889999999987
Q ss_pred ccC
Q 017395 204 KNS 206 (372)
Q Consensus 204 ~~~ 206 (372)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.2e-18 Score=142.53 Aligned_cols=137 Identities=16% Similarity=0.146 Sum_probs=99.0
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHH----------------------HHHHHHHhcCCCc--ce
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQF----------------------LEEARAVGQLRNR--RL 115 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~hp--ni 115 (372)
.+.||+|+||.||+|...+++.||||++...... ....+ ..|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4568999999999999778999999998753321 11111 3566666666443 34
Q ss_pred eeEeeEEEeCCeeEEEEecCCCCCHHhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCC
Q 017395 116 ANLLGCCCEGDERLLVAEYMPNDTLAKH-LFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 116 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~ 193 (372)
.+.+++ ...++||||++++++... +.. .... ..+..++.+++.++.++|. . +++|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYREA-GLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-CC
Confidence 444443 245999999999543221 111 0011 5678899999999999999 7 999999999999999 89
Q ss_pred CceeeccCCcccCCC
Q 017395 194 NPRLSCFGLMKNSRD 208 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~ 208 (372)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999865433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-19 Score=175.65 Aligned_cols=252 Identities=13% Similarity=0.104 Sum_probs=193.1
Q ss_pred CCccccccccCCCCCCeEEEEEe--CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 130 (372)
...|.+++.||.|+|+.|-.... .....+|+|.+.... .....+...|..+-+.+. |+|++++++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 44678888899999999998874 335677788776543 111334455777777776 9999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCcccccccCcceeecCCC-CceeeccCCcccCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT-SKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD 208 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~ 208 (372)
+++|..|+++.+.+........+......++.|+..++.|+| .. ++.|+||||+|.+++.++ .++++|||++.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999883222225677788889999999999999 77 999999999999999999 999999999987665
Q ss_pred -CC------cccC-CCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc--CCC
Q 017395 209 -GR------SYST-NLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQF 277 (372)
Q Consensus 209 -~~------~~~~-t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 277 (372)
.. ...| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....+...... ...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGRFTQLP 254 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccccccCc
Confidence 21 2456 8999999999985 45778999999999999999998875432111 111112211111 112
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
....+....+++.+++..+|..|.+.+++...-+
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred cccCChhhhhcccccccCCchhcccccccccccc
Confidence 3445677889999999999999999998877643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1e-15 Score=145.93 Aligned_cols=140 Identities=18% Similarity=0.110 Sum_probs=98.6
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccH----------------------------------------HHHHH
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA----------------------------------------RQFLE 102 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 102 (372)
..||.|++|.||+|++.+|+.||||+.+..-.... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 45899999999999988999999999864321100 02555
Q ss_pred HHHHHhcCC----CcceeeEeeEE-EeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHhhcCCC
Q 017395 103 EARAVGQLR----NRRLANLLGCC-CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE-ALEYCTSKER 176 (372)
Q Consensus 103 E~~~l~~l~----hpniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~-al~~lH~~~~ 176 (372)
|++.+.++. |.+-+.+-.++ ......+|||||++|++|.++...... ..+ ...++.+++. .+..+|.. |
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~-g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD-G 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC-C
Confidence 666666652 22222322222 223456999999999999887642111 122 3456666665 46788988 9
Q ss_pred cccccccCcceeecCCCCceeeccCCcccCC
Q 017395 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 177 iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
++|+|+||.||+++.++.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.3e-16 Score=146.21 Aligned_cols=241 Identities=20% Similarity=0.236 Sum_probs=182.7
Q ss_pred ccccccCC--CCCCeEEEEEe---CCCcEEEEEEcC--CCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEE
Q 017395 60 NIVSEHGE--KAPNVVYKGKL---ENQFRIAVKRFN--RSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 60 ~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 131 (372)
.+.+.+|. |.+|.||.+.. .++..+|+|.-+ .........=.+|+.....++ |+|.++.+..+...+..|+-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 45567899 99999999985 457889999843 222223334467888888884 99999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCcccccccCcceeecCC-CCceeeccCCcccC
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE----ALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNS 206 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~----al~~lH~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~ 206 (372)
+|++. .+|..+.+. ....++...++.++.+... ||.++|+. +++|-|+||.||++..+ ...+++|||+...+
T Consensus 197 tE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred ecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCcceeEEc
Confidence 99995 688888764 2334778888888888888 99999999 99999999999999988 88999999998876
Q ss_pred CCCCc---------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 207 RDGRS---------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~~~---------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
....- ..+...|++||... +.++..+|+||+|.+..+..++..++.......|.. +-......++
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----~r~~~ip~e~ 347 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----LRQGYIPLEF 347 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----cccccCchhh
Confidence 65431 13556799999987 567889999999999999999887654321111111 0000111223
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
....+.++...+.++++.+|..|++++.+..+
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 33445667779999999999999999888766
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-15 Score=132.87 Aligned_cols=199 Identities=18% Similarity=0.197 Sum_probs=142.0
Q ss_pred HHHHhcCCCcceeeEeeEEEeC-----CeeEEEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcC-C
Q 017395 104 ARAVGQLRNRRLANLLGCCCEG-----DERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK-E 175 (372)
Q Consensus 104 ~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ 175 (372)
+..|.++-|.|||+++.|+.+. ....+++||+..|+|..+|++. ....+......+|+-||+.||.|||+- +
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 4556677899999999998654 3578999999999999999863 335688888999999999999999986 5
Q ss_pred CcccccccCcceeecCCCCceeeccCCcccCC--------CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh
Q 017395 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--------DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247 (372)
Q Consensus 176 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t 247 (372)
.++|+++..+.|++..+|-+|+..--...... ......+.++|.+||.=...+.+.++|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 78999999999999999888875422111100 0111234578999998777778889999999999999988
Q ss_pred CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 248 GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 248 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+..-..........+..+....-. -....-+.++..|+...|..||+|++++.|.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~--------len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIG--------LENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhhhhhhheee--------ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 873221111000111111111100 0112235688899999999999999999883
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.2e-15 Score=142.23 Aligned_cols=144 Identities=15% Similarity=0.098 Sum_probs=96.5
Q ss_pred CCccccccccCCCCCCeEEEEEeCC-CcEEEEEEcCCCCCc--------------------------c--------H---
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWP--------------------------D--------A--- 97 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~--- 97 (372)
|..|+. ..+|.|++|.||+|++.+ |+.||||+++..-.. + .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455555 678999999999999766 999999999743110 0 0
Q ss_pred ---HHHHHHHHHHhcCC----CcceeeEeeEEEe-CCeeEEEEecCCCCCHHhhhhcCCCC----CCCHHHHHHHHHHHH
Q 017395 98 ---RQFLEEARAVGQLR----NRRLANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQ----PMKWAMRLRVALHIA 165 (372)
Q Consensus 98 ---~~~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~qi~ 165 (372)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++-.-...+ .+....+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 12445555555552 3333443333322 34568999999999998742111111 244444455555554
Q ss_pred HHHHHhhcCCCcccccccCcceeecCCC----CceeeccCCcccCCC
Q 017395 166 EALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNSRD 208 (372)
Q Consensus 166 ~al~~lH~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg~~~~~~~ 208 (372)
.. |++|+|+||.||+++.++ .+++.|||++.....
T Consensus 278 -------~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999887 899999999876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-13 Score=130.47 Aligned_cols=174 Identities=14% Similarity=0.147 Sum_probs=134.7
Q ss_pred CCCCCCeEE-EEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhh
Q 017395 66 GEKAPNVVY-KGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (372)
Q Consensus 66 G~G~~g~Vy-~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (372)
+-++.+ +| .|. ..++.+|.|...+.......+...+-++.|+.++||||+++++.+...+..|||+|-+. .|..+
T Consensus 21 ~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~ 97 (690)
T KOG1243|consen 21 AFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETV 97 (690)
T ss_pred cCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHH
Confidence 333333 44 344 66788999999987765334567788999999999999999999999999999999974 47777
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc----ccCCCCcC
Q 017395 144 LFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----YSTNLAFT 219 (372)
Q Consensus 144 l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~t~~y~ 219 (372)
+++ +....+...+.||+.||.|||+..+++|++|.-+.|+++..|..||++|.++........ ...-..|.
T Consensus 98 lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~ 172 (690)
T KOG1243|consen 98 LKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFD 172 (690)
T ss_pred HHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhccc
Confidence 753 446677788999999999999776999999999999999999999999988765443321 11112456
Q ss_pred CcccccCCCCCCCCceeehHHHHHHHHhCC
Q 017395 220 PPEYLRTGRVTPESVMYSFGTLLLDLLSGK 249 (372)
Q Consensus 220 aPE~~~~~~~~~~~Dv~SlGvil~el~tg~ 249 (372)
.|+.+.... -..|.|-||++++|++.|.
T Consensus 173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 173 DPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 666544222 3569999999999999994
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.9e-14 Score=115.69 Aligned_cols=128 Identities=15% Similarity=0.038 Sum_probs=96.2
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
++.++.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.+ +++++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356788999999999974 66899999865432 1234678999999886544 44555543 2345899999999887
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccccccCcceeecCCCCceeeccCCccc
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-----ALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~-----iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
...- . ....++.+++.+|+.||+. + ++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6431 1 1134568999999999998 6 49999999999999 66899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.1e-13 Score=112.51 Aligned_cols=138 Identities=10% Similarity=0.109 Sum_probs=101.1
Q ss_pred ccccCCCCCCeEEEEEeCC-------CcEEEEEEcCCCCC---------------------cc-HHHH----HHHHHHHh
Q 017395 62 VSEHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAW---------------------PD-ARQF----LEEARAVG 108 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~-~~~~----~~E~~~l~ 108 (372)
.+.||.|--+.||.|...+ +..+|||+.+.... .. .+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3567999999999998442 47899998852110 01 1122 37999999
Q ss_pred cCC--CcceeeEeeEEEeCCeeEEEEecCCCCCHHh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCcccccccC
Q 017395 109 QLR--NRRLANLLGCCCEGDERLLVAEYMPNDTLAK-HLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNA 184 (372)
Q Consensus 109 ~l~--hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~al~~l-H~~~~iiH~Dikp 184 (372)
++. .-++++.+++ ..-+|||||+.++.+.. .++ ...++......+..+++.+|..| |.. |+||+||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~-glVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC-NLVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC-CeecCCCCH
Confidence 995 3567777765 34589999997754422 232 22355667778889999999999 788 999999999
Q ss_pred cceeecCCCCceeeccCCcccCCC
Q 017395 185 YRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 185 ~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
.||++. ++.+.|+|||.+.....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCCC
Confidence 999997 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.5e-14 Score=131.77 Aligned_cols=246 Identities=15% Similarity=0.104 Sum_probs=181.3
Q ss_pred CCccccccccCCCCCCeEEEEEe--CCCcEEEEEEcCCCCCccHHH--HHHHHHHHhcC-CCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWPDARQ--FLEEARAVGQL-RNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 130 (372)
..++..+..||.|.|+.|+.... .++..+++|.+.........+ -+.|+-+...+ .|.+++..+..+....+.|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 34567888999999999999874 468899999987654333222 35677777766 59999998888888888889
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-CCceeeccCCcccCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~~~~ 209 (372)
--|||+++++...+. -...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||....+...
T Consensus 344 p~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhcccccccccccee
Confidence 999999998887663 345688889999999999999999999 99999999999999876 88899999998653322
Q ss_pred C-cccCCCCcC--CcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 R-SYSTNLAFT--PPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ~-~~~~t~~y~--aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
. ......++. +++......+..+.|++|||..+.+.+++........ ....+... .....+ .....+.
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~~i~~~-~~p~~~-~~~~~~q 491 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSLTIRSG-DTPNLP-GLKLQLQ 491 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cceeeecc-cccCCC-chHHhhh
Confidence 2 222233344 4555555668889999999999999999985432211 11111111 011112 2237888
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.+...+...++..||.+.++..+....
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhh
Confidence 899999999999999998887775443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.8e-12 Score=116.09 Aligned_cols=215 Identities=18% Similarity=0.175 Sum_probs=155.7
Q ss_pred CCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe----CCeeEEEEecCCC-CCHHhh
Q 017395 70 PNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMPN-DTLAKH 143 (372)
Q Consensus 70 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 143 (372)
..+.|+++ ..+|..|++|+++.........-..-++.++++.|+|+|++.++|.. ...+++|++|+++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789998 66899999999954332222233455788999999999999999873 3468999999986 678776
Q ss_pred hhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 144 LFHW-------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 144 l~~~-------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
.... .+...++..+|.++.|+..||.++|+. |+..+-|.+.+||++.+.+++|+..|+........
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 5322 122467899999999999999999999 99999999999999999999999888876554433
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
. |-+.+ ..+-|.=.||.+++.|.||..- ++..+... ......+....+.++++++.
T Consensus 448 --------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n--s~~~d~~~---------~s~~~~I~~~yS~D~rn~v~ 503 (655)
T KOG3741|consen 448 --------T--EPLES---QQQNDLRDLGLLLLALATGTEN--SNRTDSTQ---------SSHLTRITTTYSTDLRNVVE 503 (655)
T ss_pred --------C--cchhH---HhhhhHHHHHHHHHHHhhcccc--cccccchH---------HHHHHHhhhhhhHHHHHHHH
Confidence 1 11111 2357888999999999999632 11101010 00011234566788999999
Q ss_pred HHccCCCCCCCChHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l 310 (372)
.....++++ -++.+++.++
T Consensus 504 yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 504 YLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHhcCccc-ccHHHHHHHH
Confidence 999998887 6777777663
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.9e-12 Score=110.15 Aligned_cols=140 Identities=17% Similarity=0.176 Sum_probs=108.6
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCC--cceeeEeeEEEeCC---eeEEEEecCC
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRN--RRLANLLGCCCEGD---ERLLVAEYMP 136 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~---~~~lv~e~~~ 136 (372)
+.+|.|..+.||++...+|..+++|....... .....+.+|+++++.+.+ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45689999999999976667899999865432 134568899999999975 45677888766542 5689999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------ 174 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------------ 174 (372)
|.+|.+.+. ...+++.....++.+++.+|..||+.
T Consensus 84 G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998877652 13477777888888888888888741
Q ss_pred -------------CCcccccccCcceeecC--CCCceeeccCCccc
Q 017395 175 -------------ERALYHDLNAYRIVFDD--DVNPRLSCFGLMKN 205 (372)
Q Consensus 175 -------------~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~ 205 (372)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24689999999999998 56689999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-11 Score=101.31 Aligned_cols=130 Identities=17% Similarity=0.162 Sum_probs=96.6
Q ss_pred ccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc--------HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.+++|+-+.+|.+.+-+. .+++|.=....... ..+-.+|++++.+++--.|.--.=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 358899999999976443 46666443222211 234678999999987545444444455677789999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
+|..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++.+.+ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999988532 255677777778889999 999999999999998654 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-11 Score=100.16 Aligned_cols=144 Identities=17% Similarity=0.132 Sum_probs=104.7
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+..+-+|+-+.|+++.+ .|+...||.-...... ...+-.+|++.|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 344557788889999998 4566666654322221 1345778999999987555555555566777779999
Q ss_pred ecCCC-CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC---ceeeccCCcccC
Q 017395 133 EYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNS 206 (372)
Q Consensus 133 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~~~~ 206 (372)
||++| .++.+++...............++..+-..+.-||.+ ++||+||..+||++..++. +.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 5788888654333333344478899999999999999 9999999999999975543 589999997543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.2e-13 Score=132.20 Aligned_cols=244 Identities=15% Similarity=0.110 Sum_probs=172.4
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.++...+++-+-+|+++.++.+. -..+...+.|+...... .+.+....+-.++-..++|-++....-+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45566677788899999999887 33454455554433221 122223333333333345656655444555678899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC---
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--- 207 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~--- 207 (372)
+++|+.+++|...++. .+..+..-....+..+..++++||.. .++|+|++|.|.++..++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999999873 34566666777788899999999998 79999999999999999999999998422110
Q ss_pred --------------------------------CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCch
Q 017395 208 --------------------------------DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH 255 (372)
Q Consensus 208 --------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~ 255 (372)
......+|+.|.+||...+......+|.|++|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 001234678999999999999999999999999999999999888665
Q ss_pred hhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChH
Q 017395 256 ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304 (372)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 304 (372)
......+....... ....-+...+.+..+++...+..+|.+|..+.
T Consensus 1039 tpq~~f~ni~~~~~---~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDI---PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhhhccccCCC---CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 43333322222111 11223455678899999999999999998765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.6e-10 Score=102.73 Aligned_cols=132 Identities=11% Similarity=0.090 Sum_probs=99.0
Q ss_pred eEEEEEeCCCcEEEEEEcCCCCCcc-----------HHHHHHHHHHHhcCCC--cceeeEeeEEEe-----CCeeEEEEe
Q 017395 72 VVYKGKLENQFRIAVKRFNRSAWPD-----------ARQFLEEARAVGQLRN--RRLANLLGCCCE-----GDERLLVAE 133 (372)
Q Consensus 72 ~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h--pniv~l~~~~~~-----~~~~~lv~e 133 (372)
.|.+... +|+.|.||......+.. ...+.+|+..+.++.. -.++..++++.. ....+||||
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3667666 56789999775443221 1147899999988853 334455666543 235789999
Q ss_pred cCCCC-CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-------CCCceeeccCCccc
Q 017395 134 YMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-------DVNPRLSCFGLMKN 205 (372)
Q Consensus 134 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-------~~~~kl~Dfg~~~~ 205 (372)
++++. +|.+++......+.+......++.+++..+.-||.. |++|+|+++.|||++. +..+.|+||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99886 899998643344566778889999999999999999 9999999999999974 46789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.5e-10 Score=97.18 Aligned_cols=127 Identities=18% Similarity=0.147 Sum_probs=84.2
Q ss_pred eEEEEEeCCCcEEEEEEcCCCCC----------------------cc----HHHHHHHHHHHhcCCCc--ceeeEeeEEE
Q 017395 72 VVYKGKLENQFRIAVKRFNRSAW----------------------PD----ARQFLEEARAVGQLRNR--RLANLLGCCC 123 (372)
Q Consensus 72 ~Vy~~~~~~~~~vavK~~~~~~~----------------------~~----~~~~~~E~~~l~~l~hp--niv~l~~~~~ 123 (372)
.||.|...++..+|||+.+.... .. .....+|++.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988899999998853210 00 12356899999999754 577777653
Q ss_pred eCCeeEEEEecCC--CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCcccccccCcceeecCCCCceeecc
Q 017395 124 EGDERLLVAEYMP--NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY-CTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (372)
Q Consensus 124 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~-lH~~~~iiH~Dikp~Nill~~~~~~kl~Df 200 (372)
.-+|||||++ |..+..+.. ..++......++.+++..+.. +|.. |++|+||.+.||+++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~----~~~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD----VDLSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH----CGGGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHh----ccccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEec
Confidence 2389999998 655544332 112234566778888886655 4687 99999999999999977 9999999
Q ss_pred CCcccCCC
Q 017395 201 GLMKNSRD 208 (372)
Q Consensus 201 g~~~~~~~ 208 (372)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 98876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.7e-11 Score=114.15 Aligned_cols=147 Identities=20% Similarity=0.270 Sum_probs=104.4
Q ss_pred HHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcc-------------cCCCCcCCcccccCC
Q 017395 161 ALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-------------STNLAFTPPEYLRTG 227 (372)
Q Consensus 161 ~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------~~t~~y~aPE~~~~~ 227 (372)
+.++++|+.|+|+..++||++|.|++|.++.++..||+.|+++........+ .....|.|||++.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3455599999999889999999999999999999999999987655442221 123579999999998
Q ss_pred CCCCCCceeehHHHHHHHHhCCCC-CCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHH
Q 017395 228 RVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306 (372)
Q Consensus 228 ~~~~~~Dv~SlGvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 306 (372)
..+.++|+||+|+++|.+..|+.+ +......... ............-++...+.++++=+.+++..++..||++.++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh--hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 889999999999999999844433 2211100000 0111111111112335667899999999999999999987776
Q ss_pred HHH
Q 017395 307 VTA 309 (372)
Q Consensus 307 l~~ 309 (372)
...
T Consensus 263 ~~~ 265 (700)
T KOG2137|consen 263 LSI 265 (700)
T ss_pred hcc
Confidence 543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.5e-09 Score=91.07 Aligned_cols=152 Identities=16% Similarity=0.130 Sum_probs=105.8
Q ss_pred cCHHHHHHHhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCC--------------------Ccc--HHHHH
Q 017395 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--------------------WPD--ARQFL 101 (372)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------------~~~--~~~~~ 101 (372)
++.-.|......-.-+.+-.+||-|--+.||.|....|..+|||.=+... +.. .....
T Consensus 78 yD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~ 157 (304)
T COG0478 78 YDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAE 157 (304)
T ss_pred hhHHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHH
Confidence 34444444444444455667889999999999999899999999643211 000 22356
Q ss_pred HHHHHHhcCCCc--ceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccc
Q 017395 102 EEARAVGQLRNR--RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179 (372)
Q Consensus 102 ~E~~~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH 179 (372)
+|.++|.+|.-. .+++.+++- .-.+||||++|-.|...- ++......++..|+.-+.-+-.. |+||
T Consensus 158 rEf~~L~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~-GiVH 225 (304)
T COG0478 158 REFEALQRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR-GIVH 225 (304)
T ss_pred HHHHHHHHhhhcCCCCCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc-Cccc
Confidence 899999999754 778777753 348999999997665432 23334444455555555444455 9999
Q ss_pred ccccCcceeecCCCCceeeccCCcccCC
Q 017395 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 180 ~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+|+++-||+++++|.+.++||-.+....
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccCC
Confidence 9999999999999999999998765443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.3e-08 Score=83.72 Aligned_cols=137 Identities=13% Similarity=0.047 Sum_probs=103.0
Q ss_pred CCCCCCeEEEEEeCCCcEEEEEEcCCCC------CccHHHHHHHHHHHhcCCC--cceeeEeeEEE-eC----CeeEEEE
Q 017395 66 GEKAPNVVYKGKLENQFRIAVKRFNRSA------WPDARQFLEEARAVGQLRN--RRLANLLGCCC-EG----DERLLVA 132 (372)
Q Consensus 66 G~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~-~~----~~~~lv~ 132 (372)
|+||.+-|+.-...+. .+=+|.-...- ......|.+|+..|.++.. -.+++.. ++. .. ...+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 7788889999887444 67788765211 1135679999999999953 3355555 332 21 2468999
Q ss_pred ecCCC-CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC--ceeeccCCccc
Q 017395 133 EYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKN 205 (372)
Q Consensus 133 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~--~kl~Dfg~~~~ 205 (372)
|-+.| -+|.+++....-.+.+......++.+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 6899988654444567888889999999999999999 9999999999999986667 99999976553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=9.5e-09 Score=88.40 Aligned_cols=107 Identities=20% Similarity=0.201 Sum_probs=85.2
Q ss_pred HHHHHHHHHHHhcCC--CcceeeEeeEEEeCC----eeEEEEecCCC-CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 017395 97 ARQFLEEARAVGQLR--NRRLANLLGCCCEGD----ERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169 (372)
Q Consensus 97 ~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~ 169 (372)
..+..+|...+..+. .=.+++.+++..... ..++|+|++++ .+|.+++..... ++......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788999888885 334566677765532 45899999988 489999864222 667778899999999999
Q ss_pred HhhcCCCcccccccCcceeecCCC---CceeeccCCcccC
Q 017395 170 YCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNS 206 (372)
Q Consensus 170 ~lH~~~~iiH~Dikp~Nill~~~~---~~kl~Dfg~~~~~ 206 (372)
-||.. |++|+|+++.|||++.++ .+.++||+-++..
T Consensus 133 ~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999776 7999999877643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.5e-08 Score=87.68 Aligned_cols=248 Identities=16% Similarity=0.148 Sum_probs=154.7
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeE------EEeCC-eeEEEEec
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGC------CCEGD-ERLLVAEY 134 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~------~~~~~-~~~lv~e~ 134 (372)
..||+|+-+.+|..-.-.+ .+-|+..........+ -+..|... .||-+-.=+.+ .-.++ ...++|..
T Consensus 17 r~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 17 RPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred ccccCCccceeeecchhhc--hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 4679999999997642122 3346665443322222 22333333 56644331111 11222 36788888
Q ss_pred CCCCC-HHhhhhc---C-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 135 MPNDT-LAKHLFH---W-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 135 ~~~gs-L~~~l~~---~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+.+.. +..+..- + .-....|.-.+++++.++.+.+.||.. |.+-+|+.++|+|+.+++.+.|.|-.....-.++
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceeeccCC
Confidence 77642 2222221 1 112468999999999999999999999 9999999999999999999999886544333333
Q ss_pred C---cccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhC-CCCCCchh--------hH-Hhhhccccccccc
Q 017395 210 R---SYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSG-KHIPPSHA--------LD-LIRDRNIQTLTDS 271 (372)
Q Consensus 210 ~---~~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~--------~~-~~~~~~~~~~~~~ 271 (372)
. ...|...|++||.-. +-..+...|.|.||+++++++.| ++||.+-. .+ .+..+....-.+.
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~ 250 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQ 250 (637)
T ss_pred ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhc
Confidence 3 345678899999765 33467889999999999999988 66664321 00 0111100000000
Q ss_pred -----cccCCCC-hHHHHHHHHHHHHHccC--CCCCCCChHHHHHHHHhhhcC
Q 017395 272 -----CLEGQFS-SDEGTELVRLASRCLQY--EPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 272 -----~~~~~~~-~~~~~~l~~li~~cl~~--dp~~Rps~~~il~~l~~~~~~ 316 (372)
.....+| .-.++++..|..+|+.. ++.-|||++.-+..|..+..+
T Consensus 251 ~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 251 RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0011122 23467889999999964 356899999988888777554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.7e-08 Score=85.40 Aligned_cols=160 Identities=19% Similarity=0.213 Sum_probs=116.0
Q ss_pred ccccCHHHHHHHhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc-------------------cHHH--
Q 017395 41 FCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-------------------DARQ-- 99 (372)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-- 99 (372)
+...+++.+....+.-..-.+.+.|+.|--+.||+|...++..+|||+++..... +..+
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3345677788887777777788899999999999999878899999998643211 1111
Q ss_pred ---HHHHHHHHhcCC--CcceeeEeeEEEeCCeeEEEEecCCCC-CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 017395 100 ---FLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS 173 (372)
Q Consensus 100 ---~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 173 (372)
..+|+..|+++. +-.+++-+++.. -.|||||+... .-.-.| ..-++.......+..++++.+.-|-.
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 246788888874 555666666543 38999999553 111122 22234444677888899999988877
Q ss_pred CCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 174 ~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
..++||+||+.-|||+. ++.+.|+|||.+....+
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 44999999999999999 88999999998876553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.9e-09 Score=98.90 Aligned_cols=140 Identities=13% Similarity=0.062 Sum_probs=92.0
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc------------------------------H----------HHHHH
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD------------------------------A----------RQFLE 102 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~----------~~~~~ 102 (372)
..++.++-|.||+|++.+|+.||||+.+..-... . -+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 3568899999999999899999999986421110 0 02445
Q ss_pred HHHHHhcCC-----CcceeeEeeEE-EeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCC
Q 017395 103 EARAVGQLR-----NRRLANLLGCC-CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKE 175 (372)
Q Consensus 103 E~~~l~~l~-----hpniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al-~~lH~~~ 175 (372)
|+..+.+++ .+++ ++-.++ .-.+...|+|||++|-.+.+...... ..++...+. ..++.+. .-+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhc-
Confidence 666666553 2332 222222 23456699999999998888743212 335533332 2222222 112224
Q ss_pred CcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 176 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|+.|.|.+|.||+++.+|.+.+.|||+......
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-07 Score=80.00 Aligned_cols=134 Identities=14% Similarity=0.073 Sum_probs=85.0
Q ss_pred cccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHH---------HHHHHHHhcCCCc---ceeeEeeEEE---
Q 017395 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF---------LEEARAVGQLRNR---RLANLLGCCC--- 123 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~hp---niv~l~~~~~--- 123 (372)
|.+++.+-......|.+-.. ++..+++|..........+.| .+.+..+.+++.. ....++.+..
T Consensus 33 ~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 33 YKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred ceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 44444445555556666666 567899999876443222222 2344444444322 2222222221
Q ss_pred --eCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 124 --EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 124 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
-....+++|||++|..|.+... +++ .+...+..++.-||+. |+.|+|.+|.|++++++ .++++||+
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC-cEEEEECc
Confidence 1234578999999988877542 333 2456677889999999 99999999999999955 59999998
Q ss_pred Cccc
Q 017395 202 LMKN 205 (372)
Q Consensus 202 ~~~~ 205 (372)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.9e-08 Score=92.84 Aligned_cols=141 Identities=14% Similarity=0.060 Sum_probs=92.1
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc-------------------------------------HHHHHHHHH
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-------------------------------------ARQFLEEAR 105 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 105 (372)
..||.-+.|.||+|++++|+.||||+-+..-... .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 3578899999999999899999999876422110 002455655
Q ss_pred HHhcC----CCcc------eeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017395 106 AVGQL----RNRR------LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175 (372)
Q Consensus 106 ~l~~l----~hpn------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 175 (372)
...++ .|-+ |++++-.+ .....|+||||+|..+.+.-.- ....++...+..-+.+...-+-+- .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~~qIf~--~- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYLEQIFK--T- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHHHHHHh--c-
Confidence 44433 3444 44444333 2456999999999877765322 333466554444444333322222 3
Q ss_pred CcccccccCcceeecC----CCCceeeccCCcccCCCC
Q 017395 176 RALYHDLNAYRIVFDD----DVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 176 ~iiH~Dikp~Nill~~----~~~~kl~Dfg~~~~~~~~ 209 (372)
|++|.|-+|.||++.. ++.+.+.|||+.......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999983 677999999998766543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.1e-07 Score=79.30 Aligned_cols=136 Identities=11% Similarity=0.109 Sum_probs=84.0
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc--ceeeEeeEEEeCCeeEEEEecCCCCC-
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLGCCCEGDERLLVAEYMPNDT- 139 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~gs- 139 (372)
..+|.|..+.||+. .+..+++|...... ......+|.++++.+..- .+++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 35699999999984 23457889886533 334578999999998643 35777888777777889999999863
Q ss_pred HHhhh---------------------hcCCCCCCCHHHH-HHHHH----------HHHHH-HHHhh---cCCCccccccc
Q 017395 140 LAKHL---------------------FHWETQPMKWAMR-LRVAL----------HIAEA-LEYCT---SKERALYHDLN 183 (372)
Q Consensus 140 L~~~l---------------------~~~~~~~l~~~~~-~~i~~----------qi~~a-l~~lH---~~~~iiH~Dik 183 (372)
+...+ +............ ..+.. .+... ..+|. ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 1100011111110 00100 01111 12222 12356899999
Q ss_pred CcceeecCCCCceeeccCCcc
Q 017395 184 AYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 184 p~Nill~~~~~~kl~Dfg~~~ 204 (372)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.1e-06 Score=77.83 Aligned_cols=135 Identities=16% Similarity=0.106 Sum_probs=84.0
Q ss_pred CCCCC-CeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecCCCCCHHhh
Q 017395 66 GEKAP-NVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (372)
Q Consensus 66 G~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (372)
-.|.. +.||+....+ ..+.||+..... ..++.+|+++++.+. +--+++++++....+..++|||+++|.+|...
T Consensus 7 ~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 34444 7899998644 678899886543 335678999888883 45577788877766678999999999877643
Q ss_pred h-------------------hcCC--CCCCCHH--HHHHH-----------------------HHHHHHHHHHhh---cC
Q 017395 144 L-------------------FHWE--TQPMKWA--MRLRV-----------------------ALHIAEALEYCT---SK 174 (372)
Q Consensus 144 l-------------------~~~~--~~~l~~~--~~~~i-----------------------~~qi~~al~~lH---~~ 174 (372)
. +... ..++... ..... ..++...|.... ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 1101 0011100 00000 111111111111 11
Q ss_pred CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 175 ~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
..++|+|+.|.||++++++...|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 358999999999999987778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.7e-08 Score=94.31 Aligned_cols=180 Identities=9% Similarity=-0.027 Sum_probs=132.0
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEEEecCCCC-
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYMPND- 138 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~g- 138 (372)
.....++|+++.++|.+-.-......+.+... ....-++++|.+++||| .+..++-+......+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34456889999999998423333446766533 33456889999999999 777777777778899999999877
Q ss_pred CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---CcccCC
Q 017395 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTN 215 (372)
Q Consensus 139 sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~t 215 (372)
+-..... ...-.+..-+...+.+.-+++++++|+. --+|+| ||+..+ +..+..||+....+... ....++
T Consensus 321 s~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~ 393 (829)
T KOG0576|consen 321 SSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGT 393 (829)
T ss_pred cccccCC-hhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-cccccccccCCcccCcccccccCCCC
Confidence 2211110 0111244455667777888999999987 568888 776664 78899999988766554 456678
Q ss_pred CCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCC
Q 017395 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP 252 (372)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~ 252 (372)
+.|+|||+...+.+....|.|++|+-..++.-|.+|-
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 9999999999999999999999999877777777553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.8e-06 Score=75.54 Aligned_cols=78 Identities=21% Similarity=0.285 Sum_probs=56.8
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc--ceeeEeeEEEe---CCeeEEEEecCC
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLGCCCE---GDERLLVAEYMP 136 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~---~~~~~lv~e~~~ 136 (372)
++.++.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+++++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4567889999999999867 58999997654 3345678899888888532 45677765433 335799999999
Q ss_pred CCCHHh
Q 017395 137 NDTLAK 142 (372)
Q Consensus 137 ~gsL~~ 142 (372)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.41 E-value=4e-06 Score=86.90 Aligned_cols=80 Identities=15% Similarity=0.258 Sum_probs=59.0
Q ss_pred cccccCCCCCCeEEEEEeCCC---cEEEEEEcCCCCC-ccHHHHHHHHHHHhcCC-Ccce--eeEeeEEEeC---CeeEE
Q 017395 61 IVSEHGEKAPNVVYKGKLENQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRL--ANLLGCCCEG---DERLL 130 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~~~l 130 (372)
-+.+++.|.++.+|+....++ ..+++|+...... .....+.+|+++|+.+. |.++ ++++.+|.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 367789999999999886553 4678887654322 23456889999999995 6654 7888887654 46799
Q ss_pred EEecCCCCCH
Q 017395 131 VAEYMPNDTL 140 (372)
Q Consensus 131 v~e~~~~gsL 140 (372)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5e-06 Score=67.80 Aligned_cols=131 Identities=17% Similarity=0.159 Sum_probs=89.7
Q ss_pred cccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCccee-eEeeEEEeCCeeEEEEecCCC
Q 017395 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~~ 137 (372)
.++.+.||+|.+|.||++.+.++ .+|+|+-..++ ....+..|+++|..+.-.++. +++.|.. .++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 34557789999999999998555 79999876544 356789999999999866553 4444432 2566999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccc-CcceeecCCCCceeeccCCcccC
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dik-p~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..|.+.-.. .+..++. .++..---|... ||-|..|. |..+++..++.+.|+||.-++..
T Consensus 97 ~~L~~~~~~-----~~rk~l~----~vlE~a~~LD~~-GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG-----GDRKHLL----RVLEKAYKLDRL-GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc-----ccHHHHH----HHHHHHHHHHHh-ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 888776531 1233333 344443334444 89899775 55555555569999999987743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.1e-06 Score=72.40 Aligned_cols=101 Identities=21% Similarity=0.243 Sum_probs=77.9
Q ss_pred HHHHHHhcCCC-cceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcC-C-Cc
Q 017395 102 EEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSK-E-RA 177 (372)
Q Consensus 102 ~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~-~-~i 177 (372)
.|.-+|+.+++ +++++++|+|-+ ++|.||...+++...-... .-...+|..+.+|+.++++.+.+++.. . .+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57788888876 699999999933 7799999877664321000 112368999999999999999999873 2 34
Q ss_pred ccccccCcceeecCCCCceeeccCCcccC
Q 017395 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 178 iH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
.-.|++++|+-+++++++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 55599999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.3e-05 Score=68.04 Aligned_cols=126 Identities=18% Similarity=0.105 Sum_probs=89.2
Q ss_pred ccCCCCCCeEEEEEeCCCcEEEEEEcCCCC----------------CccHHHHHHHHHHHhcCC------CcceeeEeeE
Q 017395 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSA----------------WPDARQFLEEARAVGQLR------NRRLANLLGC 121 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~l~~~ 121 (372)
.||.|+.-.||.-- +.....||+..... .....++.+|+.-...+. +.+|.+++|+
T Consensus 8 ~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 45999888888653 44458899987655 222456677776655555 8899999999
Q ss_pred EEeCCeeEEEEecCCC------CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC--C
Q 017395 122 CCEGDERLLVAEYMPN------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--V 193 (372)
Q Consensus 122 ~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~--~ 193 (372)
..+..-..+|+|.+.+ .+|.++++ ...++. .... .+-+-..||-+. +|+.+|++|.||++..+ +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~---~L~~f~~~l~~~-~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQ---ALDEFKRYLLDH-HIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHH---HHHHHHHHHHHc-CCeecCCCcccEEEEecCCC
Confidence 9999889999998733 47888884 334655 3333 333444666777 99999999999999632 2
Q ss_pred --Cceeec
Q 017395 194 --NPRLSC 199 (372)
Q Consensus 194 --~~kl~D 199 (372)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.3e-05 Score=82.19 Aligned_cols=194 Identities=19% Similarity=0.146 Sum_probs=136.9
Q ss_pred HHHHHHHHhcCCCcceeeEeeEEEeCCe----eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017395 100 FLEEARAVGQLRNRRLANLLGCCCEGDE----RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175 (372)
Q Consensus 100 ~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 175 (372)
..-|.+.+..+.|+|++.++.|...... ..+..+++...++...+. .-...+..+.+.+..++..||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 3456677888899999999998765533 234567888888888886 445678889999999999999999997
Q ss_pred CcccccccCc---ceeecCCCCceee--ccCCcccCCCCC---cccCCCCcCCcccccCCCCCC--CCceeehHHHHHHH
Q 017395 176 RALYHDLNAY---RIVFDDDVNPRLS--CFGLMKNSRDGR---SYSTNLAFTPPEYLRTGRVTP--ESVMYSFGTLLLDL 245 (372)
Q Consensus 176 ~iiH~Dikp~---Nill~~~~~~kl~--Dfg~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~--~~Dv~SlGvil~el 245 (372)
...|.-+..+ +...+..+...++ ||+..+...... ....+..|.++|......+.. ..|+|.+|..+..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 5555544444 4444556666666 888777655432 223345678888887665544 47999999999999
Q ss_pred HhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 246 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..|..+... .......+. ........+...+|+..++++|+++.+++.+.-
T Consensus 386 ~~~~~i~~~-----------~~~~~~~l~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 386 SQGEDISEK-----------SAVPVSLLD----VLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhcCccccc-----------ccchhhhhc----cccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 998854311 111111111 111126888999999999999999999999843
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.9e-05 Score=70.68 Aligned_cols=79 Identities=11% Similarity=0.024 Sum_probs=58.3
Q ss_pred cccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC---cceeeEeeEEEe---CCeeEEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN---RRLANLLGCCCE---GDERLLVA 132 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~---~~~~~lv~ 132 (372)
..-++.||.|..+.||.....++ .+.+|..+.. .....+.+|++.|+.+.- -.++++++++.. .+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33456789999999999986566 4777775431 123578999999998852 468888887754 35689999
Q ss_pred ecCCCCCH
Q 017395 133 EYMPNDTL 140 (372)
Q Consensus 133 e~~~~gsL 140 (372)
|+++|+++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.4e-05 Score=68.77 Aligned_cols=73 Identities=15% Similarity=0.119 Sum_probs=45.4
Q ss_pred cccCCCCCC-eEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc---ceeeEeeEEEeC---CeeEEEEecC
Q 017395 63 SEHGEKAPN-VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCCEG---DERLLVAEYM 135 (372)
Q Consensus 63 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~---~~~~lv~e~~ 135 (372)
..++.|+.. .||+.. ..+++|...... ...++.+|+++|..+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 345655554 588752 247788765422 245788999999887532 345555544322 2358999999
Q ss_pred CCCCHH
Q 017395 136 PNDTLA 141 (372)
Q Consensus 136 ~~gsL~ 141 (372)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.7e-05 Score=64.83 Aligned_cols=125 Identities=19% Similarity=0.215 Sum_probs=88.5
Q ss_pred CccccccccCCCCC-CeEEEEEeCCCcEEEEEEcCC---CCC-------c-----------cHHHHHHHHHHHhcCC---
Q 017395 57 AMENIVSEHGEKAP-NVVYKGKLENQFRIAVKRFNR---SAW-------P-----------DARQFLEEARAVGQLR--- 111 (372)
Q Consensus 57 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~-------~-----------~~~~~~~E~~~l~~l~--- 111 (372)
.+.+.++.||.|.- |.||++.. +|+.+|+|++.. ... . -...|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57778888999999 99999998 566999999321 100 0 0124778888777774
Q ss_pred Ccce--eeEeeEEEeC------------------CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 017395 112 NRRL--ANLLGCCCEG------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171 (372)
Q Consensus 112 hpni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~l 171 (372)
+.++ |+.+||..-. ....||.||++... .++... +.++.+-+..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHH
Confidence 4566 9999997432 12357888776543 233333 45666667889
Q ss_pred hcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 172 TSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 172 H~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
|.. ||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~-gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL-GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC-CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999976 4589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.3e-05 Score=65.94 Aligned_cols=135 Identities=12% Similarity=0.062 Sum_probs=77.8
Q ss_pred cCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEEEecCCCCCHHhh
Q 017395 65 HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (372)
Q Consensus 65 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (372)
+..|-.+.+|+... ++..+++|........-.-+..+|.++++.+.... .++++..+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45577789999884 55678899865432221113577888888885432 344454432 3799999998765421
Q ss_pred -----------------hhcCC--CCCCCHH-HHHHHHHHH---------HHHHHHhhc-------CCCcccccccCcce
Q 017395 144 -----------------LFHWE--TQPMKWA-MRLRVALHI---------AEALEYCTS-------KERALYHDLNAYRI 187 (372)
Q Consensus 144 -----------------l~~~~--~~~l~~~-~~~~i~~qi---------~~al~~lH~-------~~~iiH~Dikp~Ni 187 (372)
++... ..+++.. .+..+..++ ...+..+-. ...++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 1122211 111211111 111111111 12579999999999
Q ss_pred eecCCCCceeeccCCccc
Q 017395 188 VFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 188 ll~~~~~~kl~Dfg~~~~ 205 (372)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00013 Score=64.11 Aligned_cols=73 Identities=18% Similarity=0.112 Sum_probs=48.2
Q ss_pred cccCCCCCCeEEEEEeCC--CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC-cceeeEeeEEEeCCeeEEEEecCCCCC
Q 017395 63 SEHGEKAPNVVYKGKLEN--QFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
+.|..|-.+.+|+....+ +..|++|+....... .-+..+|+.+++.+.. .-.+++++.+. -.+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456778888999998654 678999987643221 1223478888888843 33455554432 248999999876
Q ss_pred H
Q 017395 140 L 140 (372)
Q Consensus 140 L 140 (372)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00035 Score=65.78 Aligned_cols=76 Identities=16% Similarity=0.147 Sum_probs=55.3
Q ss_pred ccccCCCCCCeEEEEEeCCC-cEEEEEEcCC------CCC-ccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCCeeEE
Q 017395 62 VSEHGEKAPNVVYKGKLENQ-FRIAVKRFNR------SAW-PDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~------~~~-~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 130 (372)
++.+|-|.++.||+....+| +.|+||.-.. ..+ -..+++..|.+.|..+. -.++++++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 45789999999999997676 5899998541 111 23567788888888873 24677887763 355789
Q ss_pred EEecCCCCC
Q 017395 131 VAEYMPNDT 139 (372)
Q Consensus 131 v~e~~~~gs 139 (372)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00032 Score=63.82 Aligned_cols=139 Identities=14% Similarity=0.161 Sum_probs=83.2
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc--ceeeEeeE------EEeCCeeEEEEe
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLGC------CCEGDERLLVAE 133 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~------~~~~~~~~lv~e 133 (372)
++.+..|....+|+....++ .+++|+... ....+...|++++..+.+. .+++++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 55677787789999876444 688998864 2335567788887777432 24444432 123456789999
Q ss_pred cCCCCCHHh-----------h---hhcC----CC-----CCCCHHHHH----------HHHHHHHHHHHHhhc------C
Q 017395 134 YMPNDTLAK-----------H---LFHW----ET-----QPMKWAMRL----------RVALHIAEALEYCTS------K 174 (372)
Q Consensus 134 ~~~~gsL~~-----------~---l~~~----~~-----~~l~~~~~~----------~i~~qi~~al~~lH~------~ 174 (372)
|++|..+.. . ++.. .. ....|.... .....+..++.++.+ .
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 0 1100 00 001111110 011112333444432 1
Q ss_pred CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 175 ~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
.+++|+|+.|.||++++++...|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999987777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00015 Score=66.10 Aligned_cols=151 Identities=15% Similarity=0.154 Sum_probs=104.9
Q ss_pred HhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCC--CccHH-------------------H-----HHHHHH
Q 017395 52 ATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDAR-------------------Q-----FLEEAR 105 (372)
Q Consensus 52 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~-------------------~-----~~~E~~ 105 (372)
..+.-..-++-++|..|--+.||.|+-.+|..+|||+++-+- ..+.+ . ..+|++
T Consensus 139 ll~RG~i~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~R 218 (520)
T KOG2270|consen 139 LLNRGVIVEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMR 218 (520)
T ss_pred HHhcCeeeecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHH
Confidence 333444456778899999999999998889999999885211 00111 0 346888
Q ss_pred HHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCH-HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccC
Q 017395 106 AVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL-AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184 (372)
Q Consensus 106 ~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp 184 (372)
.|++++.-.|+----+... .-.|||+++..... .-.| ....++...+..+-.|++.-+.-|-+..++||.||.-
T Consensus 219 NLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE 293 (520)
T KOG2270|consen 219 NLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE 293 (520)
T ss_pred HHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence 8888876554433222222 23789999854221 1122 3445788888888899999998888777999999999
Q ss_pred cceeecCCCCceeeccCCcccCCC
Q 017395 185 YRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 185 ~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
-|+|+. +|.+.|+|.+.+.....
T Consensus 294 fN~Lyh-dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 294 FNLLYH-DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred hhheEE-CCEEEEEEccccccCCC
Confidence 999997 57899999887654433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00062 Score=62.73 Aligned_cols=157 Identities=12% Similarity=0.083 Sum_probs=83.7
Q ss_pred cCHHHHHHHhcCCCc--cccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc--ceeeEe
Q 017395 44 YSIETLRTATSGFAM--ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLL 119 (372)
Q Consensus 44 ~~~~~~~~~~~~~~~--~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~ 119 (372)
.+..++...-..|.. ..-++.++.|....+|+....+| .+++|++... ..+....|+.++..|... .+++.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 455555554444432 22345567787789999886555 6889987621 223344455555554311 233333
Q ss_pred e------EEEeCCeeEEEEecCCCCCHH-----------hhh---hcC-CC--------CCCCH-HHHHH----------
Q 017395 120 G------CCCEGDERLLVAEYMPNDTLA-----------KHL---FHW-ET--------QPMKW-AMRLR---------- 159 (372)
Q Consensus 120 ~------~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~-~~--------~~l~~-~~~~~---------- 159 (372)
. +....+..+++++|++|..+. ..+ +.. .. ..+.+ .....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 122345679999999986431 111 110 00 01111 11111
Q ss_pred --HHHH-HHHHHHHhhc------CCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 160 --VALH-IAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 160 --i~~q-i~~al~~lH~------~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
.+.+ +...+..+.. ..+++|+|++|.||+++++...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 1111222221 1389999999999999966556899998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00076 Score=61.82 Aligned_cols=157 Identities=13% Similarity=0.164 Sum_probs=87.8
Q ss_pred CHHHHHHHhcCC--CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc--ceeeEee
Q 017395 45 SIETLRTATSGF--AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLG 120 (372)
Q Consensus 45 ~~~~~~~~~~~~--~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~ 120 (372)
+.+++...-..| .....++.++.|....+|+....++ .+++|+..... ..+....|++++..|... .+++++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 344454443333 3333466778887789999876555 57789875432 233455667777766422 2444443
Q ss_pred EE------EeCCeeEEEEecCCCCCHHh-----------h---hhcC-CC--C------CC-CHHHHH------------
Q 017395 121 CC------CEGDERLLVAEYMPNDTLAK-----------H---LFHW-ET--Q------PM-KWAMRL------------ 158 (372)
Q Consensus 121 ~~------~~~~~~~lv~e~~~~gsL~~-----------~---l~~~-~~--~------~l-~~~~~~------------ 158 (372)
.. ...+..+++++|++|..+.. . ++.. .+ . .+ .|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 12356789999998854321 1 1110 00 0 00 111100
Q ss_pred HHHHHHHHHHHHhhc------CCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 159 RVALHIAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 159 ~i~~qi~~al~~lH~------~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
.....+...++++.. ..+++|+|+++.||++++++...|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001122334444432 1489999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00015 Score=64.95 Aligned_cols=151 Identities=14% Similarity=0.089 Sum_probs=105.2
Q ss_pred cCHHHHHHHhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCC--------------------CccH--HHHH
Q 017395 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--------------------WPDA--RQFL 101 (372)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------------~~~~--~~~~ 101 (372)
+++-.|.+..+.-.-+.+-.+||-|--+.||.+....|+..++|.=+... |--. -...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 55666777776666777888999999999999999889999999543110 0001 1235
Q ss_pred HHHHHHhcCCC--cceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccc
Q 017395 102 EEARAVGQLRN--RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179 (372)
Q Consensus 102 ~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH 179 (372)
+|+..|+.|.- =-+++.+++..+ ++|||++.|-.|...-+ ..+..++. ..+..-+.-|-.+ |+||
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~RH----~Vvmelv~g~Pl~~v~~-----v~d~~~ly---~~lm~~Iv~la~~-GlIH 225 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHNRH----CVVMELVDGYPLRQVRH-----VEDPPTLY---DDLMGLIVRLANH-GLIH 225 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccccce----eeHHHhhcccceeeeee-----cCChHHHH---HHHHHHHHHHHHc-Ccee
Confidence 78888888842 346666665543 89999999988766432 12233333 3333334455566 9999
Q ss_pred ccccCcceeecCCCCceeeccCCcccCC
Q 017395 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 180 ~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+|..-=||++++++.++++||-.+....
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred cccchheeEEecCCCEEEeechHhhccC
Confidence 9999999999999999999997655443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00075 Score=61.67 Aligned_cols=74 Identities=22% Similarity=0.263 Sum_probs=48.7
Q ss_pred cccCCCCCCeEEEEEeCC-------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEEEec
Q 017395 63 SEHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~ 134 (372)
+.+..|--..+|+....+ ++.+++|+..... ....+..+|++++..+...+ .+++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345557677899998654 5789999976543 22234567888888885322 3455665532 468999
Q ss_pred CCCCCHH
Q 017395 135 MPNDTLA 141 (372)
Q Consensus 135 ~~~gsL~ 141 (372)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0019 Score=58.79 Aligned_cols=154 Identities=14% Similarity=0.121 Sum_probs=86.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcC-CCCCccHHHHHHHHHHHhcCC--CcceeeEeeEEEeCC--eeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFN-RSAWPDARQFLEEARAVGQLR--NRRLANLLGCCCEGD--ERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~--~~~ 129 (372)
.+....++..+..|.-..+|..... ++.++|..-. ........+..+|+++++.+. -.-+...+++|..+. ..|
T Consensus 23 ~~~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 23 GYAGLLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CcCCCceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 3444555655544444455655543 7788888221 122223445667888887774 234556677776665 679
Q ss_pred EEEecCCCCCHHh------------------hhhcC---C-------C--CCCCHHHHHHHHHHH--------------H
Q 017395 130 LVAEYMPNDTLAK------------------HLFHW---E-------T--QPMKWAMRLRVALHI--------------A 165 (372)
Q Consensus 130 lv~e~~~~gsL~~------------------~l~~~---~-------~--~~l~~~~~~~i~~qi--------------~ 165 (372)
.||+|++|..+.+ +|..- . . ......++..+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 9999998832222 11100 0 0 000111111111111 1
Q ss_pred HHHHHhhcC-------CCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 166 EALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 166 ~al~~lH~~-------~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
.-..+++.+ ..++|+|+++.|++++.++-+-+.||+++......
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 122333332 35899999999999998888999999998765543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0028 Score=59.60 Aligned_cols=81 Identities=19% Similarity=0.160 Sum_probs=54.4
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCC-----CC-C-ccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCCeeEE
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNR-----SA-W-PDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----~~-~-~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 130 (372)
..+.+|-|....||+.... +..++||.-.. .. + .+..+-..|++.|+.+. -.++++++.++. ...++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 4567899999999998864 45699998751 11 1 13344455677777664 257888888876 34588
Q ss_pred EEecCCC--CCHHhhh
Q 017395 131 VAEYMPN--DTLAKHL 144 (372)
Q Consensus 131 v~e~~~~--gsL~~~l 144 (372)
+|||+++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 9999976 3344433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0016 Score=58.65 Aligned_cols=31 Identities=23% Similarity=0.213 Sum_probs=25.4
Q ss_pred CcccccccCcceeecCCCC-ceeeccCCcccC
Q 017395 176 RALYHDLNAYRIVFDDDVN-PRLSCFGLMKNS 206 (372)
Q Consensus 176 ~iiH~Dikp~Nill~~~~~-~kl~Dfg~~~~~ 206 (372)
.++|+|++|.||++++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5799999999999997555 469999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=1.2e-05 Score=84.31 Aligned_cols=169 Identities=10% Similarity=-0.051 Sum_probs=121.6
Q ss_pred EEEEEcCCCCCccH-----HHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeEEEEecCCCCCHHhhhhcCCC--CCCCH
Q 017395 84 IAVKRFNRSAWPDA-----RQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPNDTLAKHLFHWET--QPMKW 154 (372)
Q Consensus 84 vavK~~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~ 154 (372)
+.+|+.+....+.. +-.+.|.+.++...|+++.....-... ....+.+++|+.+|.+++.|-++.. .++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45565554333322 223445556666789998876554432 2457899999999999999875432 33455
Q ss_pred HHHHHHHHHHHHHHHHhhcCC----CcccccccCcceeecCCCCceeeccCCcccCCCCCcc----cCCCCcCCcccccC
Q 017395 155 AMRLRVALHIAEALEYCTSKE----RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----STNLAFTPPEYLRT 226 (372)
Q Consensus 155 ~~~~~i~~qi~~al~~lH~~~----~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~~t~~y~aPE~~~~ 226 (372)
.-+.....+.+.+..-+|+.. -.+|+++|+-|.+|..+.++|++++|+.+...+.... .+++.|+.|++...
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence 555555555577777777642 3589999999999999999999999999965554443 34667888988887
Q ss_pred CCCCCCCceeehHHHHHHHHhCCCCC
Q 017395 227 GRVTPESVMYSFGTLLLDLLSGKHIP 252 (372)
Q Consensus 227 ~~~~~~~Dv~SlGvil~el~tg~~p~ 252 (372)
-.++.++|+|+.|+-+|++..|..++
T Consensus 1415 ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1415 IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 77888899999999999999888654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0035 Score=57.96 Aligned_cols=72 Identities=14% Similarity=0.045 Sum_probs=48.5
Q ss_pred ccCCCCCCeEEEEEeCCC-cEEEEEEcC----C--CC-CccHHHHHHHHHHHhcCC--Cc-ceeeEeeEEEeCCeeEEEE
Q 017395 64 EHGEKAPNVVYKGKLENQ-FRIAVKRFN----R--SA-WPDARQFLEEARAVGQLR--NR-RLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~----~--~~-~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~lv~ 132 (372)
++|-|....||++...++ +.|+||.-. . .+ .-..++..-|.+.|+... -| .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997554 589999653 1 12 223455667888887763 34 45565554 445567999
Q ss_pred ecCCC
Q 017395 133 EYMPN 137 (372)
Q Consensus 133 e~~~~ 137 (372)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0041 Score=57.93 Aligned_cols=138 Identities=14% Similarity=0.126 Sum_probs=81.5
Q ss_pred ccccCCCCCCeEEEEEeCC-----CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEEEecC
Q 017395 62 VSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~ 135 (372)
+..+-.|-...+|+....+ +..|++|+.........+ -.+|..+++.+..-+ -+++++.+..+ .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455557888999987532 367999988754422222 367888888885333 34556665332 589999
Q ss_pred CCCCHHhh-----------------hhcCC--CC--CCCHHHHHHHHHHHH-----------------HHHHH----hhc
Q 017395 136 PNDTLAKH-----------------LFHWE--TQ--PMKWAMRLRVALHIA-----------------EALEY----CTS 173 (372)
Q Consensus 136 ~~gsL~~~-----------------l~~~~--~~--~l~~~~~~~i~~qi~-----------------~al~~----lH~ 173 (372)
++.+|... ++... .. ...+.++..++.++. ..+.. +..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 88766421 11111 00 112334434432221 11111 111
Q ss_pred ---CCCcccccccCcceeecC-CCCceeeccCCcc
Q 017395 174 ---KERALYHDLNAYRIVFDD-DVNPRLSCFGLMK 204 (372)
Q Consensus 174 ---~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~ 204 (372)
...++|+|+++.||++++ ++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 126799999999999986 4679999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0023 Score=57.74 Aligned_cols=75 Identities=16% Similarity=0.158 Sum_probs=48.3
Q ss_pred ccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCCeeEEEEecCC
Q 017395 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.-++.++-|....+|+.. .+++.+-||+-.. .....|..|++-|+.|. --.+++++++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344556779899999988 5677899998762 22346888988888883 4568889998887778899999997
Q ss_pred CC
Q 017395 137 ND 138 (372)
Q Consensus 137 ~g 138 (372)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 66
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0015 Score=62.14 Aligned_cols=161 Identities=20% Similarity=0.272 Sum_probs=89.9
Q ss_pred HHHHHHHHHHHhcCCCcceeeEeeEEEeC-CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017395 97 ARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175 (372)
Q Consensus 97 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 175 (372)
..+.+..+..++.+.|+|...++++.... ....+|||++ +.||.+.+..+. +...... .+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s~~--------------~~- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDESLL--------------AH- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhhhc--------------cc-
Confidence 45677788899999999999999876543 2478899999 569999986432 2111100 11
Q ss_pred CcccccccCcceeecCCCCceeeccCCcccCCCCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCch
Q 017395 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH 255 (372)
Q Consensus 176 ~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~ 255 (372)
++.|- |++ +++| -++ .. | | ....+++||||+|.++.++.-|...+..-
T Consensus 87 ~~~~~-----~~~-------~~td-~~~---t~---------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 87 GVLHL-----NII-------YITD-HFL---TK---------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cccee-----hhh-------hccc-ccc---cc---------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 33222 222 2222 000 00 0 0 01114999999999999999988543321
Q ss_pred hhHHhhhcccccccccc------ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHH
Q 017395 256 ALDLIRDRNIQTLTDSC------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (372)
Q Consensus 256 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (372)
...........-...+. ....+.-.+...+.++...|+-..|..||...++.+
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 10000000000000000 000122345677888999999999998886555544
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.011 Score=54.27 Aligned_cols=29 Identities=14% Similarity=0.072 Sum_probs=25.2
Q ss_pred CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 175 ~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 37899999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.011 Score=54.63 Aligned_cols=137 Identities=17% Similarity=0.200 Sum_probs=78.0
Q ss_pred cccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcce-eeEeeEEEeCCeeEEEEecCCC
Q 017395 63 SEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~ 137 (372)
..+..|--..+|+....+ +..|++|+....... .-+-.+|..+++.+..-++ +++++++.. + +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 344446677899887533 237999988654322 1123578888888864444 456666532 2 58999987
Q ss_pred CCHHh--------------h---hhcCC---CC-CCCHHHHHHHHHHHH-------------------------HHHHHh
Q 017395 138 DTLAK--------------H---LFHWE---TQ-PMKWAMRLRVALHIA-------------------------EALEYC 171 (372)
Q Consensus 138 gsL~~--------------~---l~~~~---~~-~l~~~~~~~i~~qi~-------------------------~al~~l 171 (372)
.+|.. . ++... .. +--+..+..+..++- ..+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 1 11111 00 112333333333221 111111
Q ss_pred h-cC---CCcccccccCcceeecC-CCCceeeccCCcc
Q 017395 172 T-SK---ERALYHDLNAYRIVFDD-DVNPRLSCFGLMK 204 (372)
Q Consensus 172 H-~~---~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~ 204 (372)
. .. .-+.|+|+.+.||++++ ++.++++||..+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 11 13689999999999974 5789999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0097 Score=55.77 Aligned_cols=74 Identities=14% Similarity=0.092 Sum_probs=50.6
Q ss_pred ccccCCCCCCeEEEEEeC-CCcEEEEEEcCC-----CC-CccHHHHHHHHHHHhcCC--Cc-ceeeEeeEEEeCCeeEEE
Q 017395 62 VSEHGEKAPNVVYKGKLE-NQFRIAVKRFNR-----SA-WPDARQFLEEARAVGQLR--NR-RLANLLGCCCEGDERLLV 131 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~lv 131 (372)
+..||-|.-..||++... ++..|+||.-.. .+ .-+.++..-|.+.|+... -| ++++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999964 356799996531 12 123566777888888763 34 46666654 44556788
Q ss_pred EecCCC
Q 017395 132 AEYMPN 137 (372)
Q Consensus 132 ~e~~~~ 137 (372)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 988853
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0065 Score=55.64 Aligned_cols=73 Identities=16% Similarity=0.044 Sum_probs=58.3
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
...|++|++- |++|.. + ..-.+.++..++.+.+.-+.-+..+...=|||+.-.||||+ +|++.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3467778875 445432 2 12457899999999999888888777788999999999999 99999999999984
Q ss_pred C
Q 017395 206 S 206 (372)
Q Consensus 206 ~ 206 (372)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.18 Score=46.49 Aligned_cols=98 Identities=16% Similarity=0.103 Sum_probs=55.8
Q ss_pred cccccCHHHHHHHhcCCCcc--ccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc--e
Q 017395 40 VFCEYSIETLRTATSGFAME--NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--L 115 (372)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~--~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--i 115 (372)
++..++.+.+..+...+.-+ ..+..|+ +.-..||+....++..+++|+.+... ....+...|++.+..|.... +
T Consensus 7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~-s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv 84 (325)
T PRK11768 7 PFQTLTPDLILDALESLGLRVDGRLLALN-SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPV 84 (325)
T ss_pred CCCCCChHHHHHHHHHcCCCCccceEeec-cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCC
Confidence 34455555555554444221 2223333 33467999998778889999886433 23456677877777663211 2
Q ss_pred eeEe---e--EEEeCCeeEEEEecCCCCC
Q 017395 116 ANLL---G--CCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 116 v~l~---~--~~~~~~~~~lv~e~~~~gs 139 (372)
+... | ....++..+.++++++|..
T Consensus 85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 2211 1 1223456788999998754
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.036 Score=51.05 Aligned_cols=145 Identities=17% Similarity=0.276 Sum_probs=83.4
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc------eeeEeeE----EEeC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR------LANLLGC----CCEG 125 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~----~~~~ 125 (372)
+.....+..|.. .-..+|+....+|.. ++|+.... ....+...|...|.-+.-.+ +..+=|- ...+
T Consensus 25 ~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~ 100 (331)
T COG2334 25 YGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG 100 (331)
T ss_pred cCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence 333334444555 456799999877765 88988765 23455666777777663211 2222111 1112
Q ss_pred CeeEEEEecCCCCCHHh-h--------------hh----cCC--C----CCCCHHH-------------HHHHHHHHHHH
Q 017395 126 DERLLVAEYMPNDTLAK-H--------------LF----HWE--T----QPMKWAM-------------RLRVALHIAEA 167 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~-~--------------l~----~~~--~----~~l~~~~-------------~~~i~~qi~~a 167 (372)
...+-+++|++|..+.. . ++ ... + ....|.. ......++...
T Consensus 101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~ 180 (331)
T COG2334 101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA 180 (331)
T ss_pred ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence 37788999999987772 0 00 001 0 1122320 01123334444
Q ss_pred HHHhhcC-------CC--cccccccCcceeecCCCC-ceeeccCCcc
Q 017395 168 LEYCTSK-------ER--ALYHDLNAYRIVFDDDVN-PRLSCFGLMK 204 (372)
Q Consensus 168 l~~lH~~-------~~--iiH~Dikp~Nill~~~~~-~kl~Dfg~~~ 204 (372)
+..+.+. .+ +||+|+.|.||+++.+.. ..+.||+.+.
T Consensus 181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 4444431 23 899999999999998875 8899999764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.034 Score=47.87 Aligned_cols=67 Identities=22% Similarity=0.277 Sum_probs=47.2
Q ss_pred eEEEEE-eC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCCeeEEEEecCCCCCHH
Q 017395 72 VVYKGK-LE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (372)
Q Consensus 72 ~Vy~~~-~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 141 (372)
.|..|. .. +..++-||+-.. ....-|..|+.-|..+. .-++.+++.+.....+.|+||||++-+.+.
T Consensus 28 ~inea~~v~dg~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 28 DINEAWRLRDGTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cccceeEeecCCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 455554 22 355788888543 22456888888777763 456888888888899999999999876554
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.06 Score=49.32 Aligned_cols=31 Identities=10% Similarity=0.076 Sum_probs=27.6
Q ss_pred CCcccccccCcceeecCCCCceeeccCCccc
Q 017395 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 175 ~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
.+++|+|+.+.|||+++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3799999999999999998999999987654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.01 Score=55.14 Aligned_cols=61 Identities=16% Similarity=0.105 Sum_probs=44.7
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~ 190 (372)
...++-+|..|-++..+++. ...++....+++.=.+.|+--+---.+++|.|++|.||++-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 34677788999999999853 33555666777776667765444333899999999999995
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.15 Score=54.39 Aligned_cols=148 Identities=17% Similarity=0.215 Sum_probs=80.9
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-------CCcceeeEe-e----EE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-------RNRRLANLL-G----CC 122 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~l~-~----~~ 122 (372)
.|.-...++.|+ |..-.+|+....++..+++|+.+.... ......|...|..| .-|.+++-. | ..
T Consensus 23 ~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v 99 (1013)
T PRK06148 23 HFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASA 99 (1013)
T ss_pred HcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEe
Confidence 343333446675 346789999877788899999986432 22333444455433 234444322 1 11
Q ss_pred Ee-CC--eeEEEEecCCCCCHHhhhh---------------------cCC----CCCCCHHH-----------------H
Q 017395 123 CE-GD--ERLLVAEYMPNDTLAKHLF---------------------HWE----TQPMKWAM-----------------R 157 (372)
Q Consensus 123 ~~-~~--~~~lv~e~~~~gsL~~~l~---------------------~~~----~~~l~~~~-----------------~ 157 (372)
.. .+ ..+-+++|++|..|.+... ... .+.+.|.. .
T Consensus 100 ~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~ 179 (1013)
T PRK06148 100 QDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPED 179 (1013)
T ss_pred ecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHH
Confidence 11 12 4677899999987765110 000 11122211 1
Q ss_pred HHHHHHHHHHHH-----HhhcC-CCcccccccCcceeecCCC--Cce-eeccCCccc
Q 017395 158 LRVALHIAEALE-----YCTSK-ERALYHDLNAYRIVFDDDV--NPR-LSCFGLMKN 205 (372)
Q Consensus 158 ~~i~~qi~~al~-----~lH~~-~~iiH~Dikp~Nill~~~~--~~k-l~Dfg~~~~ 205 (372)
..++.++...+. .+.+. .++||+|+++.|||++.++ .+. |+|||.+..
T Consensus 180 r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 180 RALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 122223332222 12111 3799999999999999775 454 999998653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.041 Score=47.11 Aligned_cols=151 Identities=13% Similarity=0.062 Sum_probs=88.4
Q ss_pred CCCCeEEEEEeCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhc
Q 017395 68 KAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (372)
Q Consensus 68 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (372)
|+.++.-+++..-| +..+|++...... ...-|..+.+++.++. .|+++..- ..-...++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 33444444443233 4556666544433 3455788888888775 46666532 34457799999854211
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccCCCCcCCccccc
Q 017395 147 WETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLR 225 (372)
Q Consensus 147 ~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~ 225 (372)
+. ..++..=+.+|.-.|+ ..+.+|+|..|+||+-|..|.+||.|-+..- ..+..|.--|
T Consensus 142 -----~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------~~~V~~vN~~--- 201 (308)
T PF07387_consen 142 -----NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------ENQVNMVNIE--- 201 (308)
T ss_pred -----ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--------hheeeEEeee---
Confidence 11 1112222456777784 4689999999999999999999999975421 1111222211
Q ss_pred CCCCCCCCceeehHHHHHHHHhCC
Q 017395 226 TGRVTPESVMYSFGTLLLDLLSGK 249 (372)
Q Consensus 226 ~~~~~~~~Dv~SlGvil~el~tg~ 249 (372)
....|.++.+-+|=..+++++...
T Consensus 202 Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 202 YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred ccccChHHHHHHHHHHHHHHHHHH
Confidence 123466677666666666665543
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.07 Score=47.19 Aligned_cols=78 Identities=15% Similarity=0.110 Sum_probs=55.2
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC-CCCCHH
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM-PNDTLA 141 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~-~~gsL~ 141 (372)
+.+..|..+.|+.++..+|+++++|+.........+ ......|+..+-...|++++.- .....|++|.+ ++.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E--~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHE--ARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhh--hhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchh
Confidence 445668889999999889999999998754322111 1122558888888899999864 33457889998 556777
Q ss_pred hhh
Q 017395 142 KHL 144 (372)
Q Consensus 142 ~~l 144 (372)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 655
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.12 Score=48.67 Aligned_cols=76 Identities=12% Similarity=0.149 Sum_probs=46.1
Q ss_pred cccccCCCCCCeEEEEEeCCC--c-----EEEEEEcCCCCCccHHHHHHHHHHHhcCCCc-ceeeEeeEEEeCCeeEEEE
Q 017395 61 IVSEHGEKAPNVVYKGKLENQ--F-----RIAVKRFNRSAWPDARQFLEEARAVGQLRNR-RLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~ 132 (372)
.++.+..|--+.+|++...++ . .|.++...... ...-+-.+|+++++.+... --.++++.+.. ++|.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 345565688889999975432 1 24444432211 1111225788999999644 44556666643 7999
Q ss_pred ecCCCCCHH
Q 017395 133 EYMPNDTLA 141 (372)
Q Consensus 133 e~~~~gsL~ 141 (372)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 372 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-25 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-61
Identities = 87/310 (28%), Positives = 141/310 (45%), Gaps = 31/310 (10%)
Query: 26 DVENEEKPGVD--NVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFR 83
DV EE P V + F S+ L+ A+ F+ +NI+ G VYKG+L +
Sbjct: 3 DVPAEEDPEVHLGQLKRF---SLRELQVASDNFSNKNIL---GRGGFGKVYKGRLADGTL 56
Query: 84 IAVKRFNR-SAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142
+AVKR QF E + +R L L G C ERLLV YM N ++A
Sbjct: 57 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116
Query: 143 HLF--HWETQPMKWAMRLRVALHIAEALEY--CTSKERALYHDLNAYRIVFDDDVNPRLS 198
L P+ W R R+AL A L Y + ++ D+ A I+ D++ +
Sbjct: 117 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176
Query: 199 CFGLMKNSRDGRSY-STNLAFT----PPEYLRTGRVTPESVMYSFGTLLLDLLSGK---- 249
FGL K ++ +T + T PEYL TG+ + ++ ++ +G +LL+L++G+
Sbjct: 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
Query: 250 -HIPP--------SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
L++++ ++ L D L+G + +E +L+++A C Q P ER
Sbjct: 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296
Query: 301 PNPRSLVTAL 310
P +V L
Sbjct: 297 PKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-60
Identities = 81/318 (25%), Positives = 140/318 (44%), Gaps = 44/318 (13%)
Query: 28 ENEEKPGVD-NVPVFCEYSIETLRTATSGFAMENIVSEH---GEKAPNVVYKGKLENQFR 83
EN+ D F S L+ T+ F I GE VVYKG + N
Sbjct: 1 ENKSLEVSDTRFHSF---SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-T 56
Query: 84 IAVKRFNRSAWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139
+AVK+ +QF +E + + + ++ L LLG +GD+ LV YMPN +
Sbjct: 57 VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116
Query: 140 LAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR------IVFDDD 192
L L + T P+ W MR ++A A + + L+ + + +R I+ D+
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINF-------LHENHHIHRDIKSANILLDEA 169
Query: 193 VNPRLSCFGLMK-NSRDGRSY-STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
++S FGL + + + ++ ++ + T PE L G +TP+S +YSFG +LL+++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 247 SGK-----HIPPSHALD-----LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+G H P LD ++ I+ D + S + +AS+CL +
Sbjct: 229 TGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEK 287
Query: 297 PRERPNPRSLVTALVTLQ 314
+RP+ + + L +
Sbjct: 288 KNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 78/317 (24%), Positives = 140/317 (44%), Gaps = 28/317 (8%)
Query: 14 GSEYGEAAPEAQDVENEEKPGVDNVPVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVV 73
GS+Y +A D + + L AT+ F + ++ G V
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRV---PLVDLEEATNNFDHKFLI---GHGVFGKV 55
Query: 74 YKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133
YKG L + ++A+KR + +F E + R+ L +L+G C E +E +L+ +
Sbjct: 56 YKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115
Query: 134 YMPNDTLAKHLF--HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
YM N L +HL+ T M W RL + + A L Y RA+ H D+ + I+ D
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL--HTRAIIHRDVKSINILLD 173
Query: 191 DDVNPRLSCFGLMK-NSRDGRSY-STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLD 244
++ P+++ FG+ K + +++ ST + T PEY GR+T +S +YSFG +L +
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 245 LLSGK----HIPPSH-------ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
+L + P A++ + ++ + D L + + + A +CL
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 294 QYEPRERPNPRSLVTAL 310
+RP+ ++ L
Sbjct: 294 ALSSEDRPSMGDVLWKL 310
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 48/262 (18%), Positives = 95/262 (36%), Gaps = 34/262 (12%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
++KG+ + I VK W R F EE + + + +LG C
Sbjct: 25 ELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 130 L--VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+ +MP +L L + + ++ AL +A + + + E + LN+
Sbjct: 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSY-STNLAFTP----PEYLRTGRVTPESV---MYSF 238
++ D+D+ R+S + S+ S + P PE L+ M+SF
Sbjct: 144 VMIDEDMTARISMADV------KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197
Query: 239 GTLLLDLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCL 293
LL +L++ + + + ++ T+ + +L C+
Sbjct: 198 AVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP---------HVSKLMKICM 248
Query: 294 QYEPRERPNPRSLVTALVTLQK 315
+P +RP +V L +Q
Sbjct: 249 NEDPAKRPKFDMIVPILEKMQD 270
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 49/322 (15%), Positives = 105/322 (32%), Gaps = 57/322 (17%)
Query: 43 EYSIETLRTATSGFAMENIVSE--HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
+ E L + + + + G V+K +L N+ +AVK F D + +
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGC-----VWKAQLLNE-YVAVKIFPIQ---DKQSW 63
Query: 101 LEEA--RAVGQLRNRRLANLLGCCCEGD----ERLLVAEYMPNDTLAKHLFHWETQPMKW 154
E ++ +++ + +G G + L+ + +L+ L + W
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSW 120
Query: 155 AMRLRVALHIAEALEY--------CTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKN 205
+A +A L Y + A+ H D+ + ++ +++ ++ FGL
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 206 SRDGRSYSTNLAFT------PPEYLRTGRVTPESV-----MYSFGTLLLDLLSGK----- 249
G+S PE L MY+ G +L +L S
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 250 -----------HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT-ELVRLASRCLQYEP 297
I +L+ +++ + L + G L C ++
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 298 RERPNPRSLVTALVTLQKDTEV 319
R + + + +Q+ T +
Sbjct: 301 EARLSAGCVGERITQMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 51/264 (19%), Positives = 108/264 (40%), Gaps = 23/264 (8%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
V++ + +AVK + +FL E + +LR+ + +G +
Sbjct: 52 TVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 130 LVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRI 187
+V EY+ +L + L + + RL +A +A+ + Y ++ + H +L + +
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
+ D ++ FGL + S + A TP PE LR +S +YSFG +L
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 244 DLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
+L + + ++ P+ + + + + + + ++ + C EP
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP---------QVAAIIEGCWTNEPW 281
Query: 299 ERPNPRSLVTALVTLQKDTEVPSH 322
+RP+ +++ L L K P +
Sbjct: 282 KRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 55/266 (20%), Positives = 109/266 (40%), Gaps = 38/266 (14%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL- 129
VYKGK +AVK N +A + F E + + R+ + +G +L
Sbjct: 40 VYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLA 95
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIV 188
+V ++ +L HL H + + +A A ++Y +K + H DL + I
Sbjct: 96 IVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIF 152
Query: 189 FDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESV---MYSFG 239
+D ++ FGL K+ G L+ + PE +R P S +Y+FG
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 240 TLLLDLLSGK-----HIPPSHALDLI----RDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+L +L++G+ ++++ ++ + +C + + RL +
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK---------RMKRLMA 263
Query: 291 RCLQYEPRERPNPRSLVTALVTLQKD 316
CL+ + ERP+ ++ + L ++
Sbjct: 264 ECLKKKRDERPSFPRILAEIEELARE 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-21
Identities = 48/259 (18%), Positives = 102/259 (39%), Gaps = 31/259 (11%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV K K + +A+K+ + + F+ E R + ++ + + L G C + LV
Sbjct: 23 VVCKAKWRAK-DVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77
Query: 132 AEYMPNDTLAKHLFHWETQP-MKWAMRLRVALHIAEALEYC-TSKERALYH-DLNAYRIV 188
EY +L L E P A + L ++ + Y + + +AL H DL ++
Sbjct: 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 189 FDDD-VNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
++ FG + D +++ TN + PE + + ++S+G +L
Sbjct: 138 LVAGGTVLKICDFGT---ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 244 DLLSGK------HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
++++ + P + + + L + + + L +RC +P
Sbjct: 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK---------PIESLMTRCWSKDP 245
Query: 298 RERPNPRSLVTALVTLQKD 316
+RP+ +V + L +
Sbjct: 246 SQRPSMEEIVKIMTHLMRY 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 53/266 (19%), Positives = 95/266 (35%), Gaps = 40/266 (15%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY+ +AVK D +EA+ L++ + L G C +
Sbjct: 22 KVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYH-DLNAY 185
LV E+ L + L + + + + A+ IA + Y + H DL +
Sbjct: 81 LCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 186 RIVFDDDVNPRLSC--------FGLMKNSRD-GRSYSTNLAFTP----PEYLRTGRVTPE 232
I+ V FGL +R+ R+ + A PE +R +
Sbjct: 138 NILILQKVENGDLSNKILKITDFGL---AREWHRTTKMSAAGAYAWMAPEVIRASMFSKG 194
Query: 233 SVMYSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVR 287
S ++S+G LL +LL+G+ I + + + +C E +
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE---------PFAK 245
Query: 288 LASRCLQYEPRERPNPRSLVTALVTL 313
L C +P RP+ +++ L T+
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 55/266 (20%), Positives = 106/266 (39%), Gaps = 42/266 (15%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA-------RQFLEEARAVGQLRNRRLANLLGCCC 123
+V+KG+ ++++ +A+K ++F E + L + + L G
Sbjct: 34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93
Query: 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DL 182
+V E++P L L + P+KW+++LR+ L IA +EY ++ + H DL
Sbjct: 94 NPP--RMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 183 NAYRIVFDDDVNPRLSC-----FGLMKNSRDGRSYSTNLAFTP----PEYL--RTGRVTP 231
+ I C FGL S+ + L PE + T
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGL---SQQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 232 ESVMYSFGTLLLDLLSGK----HIPPSHA--LDLIRDRNIQ-TLTDSCLEGQFSSDEGTE 284
++ YSF +L +L+G+ +++IR+ ++ T+ + C
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP---------R 258
Query: 285 LVRLASRCLQYEPRERPNPRSLVTAL 310
L + C +P++RP+ +V L
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 47/276 (17%), Positives = 89/276 (32%), Gaps = 39/276 (14%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VY G+ + +A++ + + + F E A Q R+ + +G C
Sbjct: 48 QVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIV 188
++ TL + + ++A I + + Y +K + H DL + +
Sbjct: 106 IITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVF 162
Query: 189 FDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTP-------PEYLRTGRVTPESVM---- 235
+D+ ++ FGL + L PE +R E
Sbjct: 163 YDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221
Query: 236 -----YSFGTLLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286
++ GT+ +L + + P + + L+ G E+
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--------IGMGKEIS 273
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSH 322
+ C +E ERP L+ L L K SH
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 58/343 (16%), Positives = 107/343 (31%), Gaps = 68/343 (19%)
Query: 43 EYSIETLRTATSGFAMENIVSE--HGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF 100
E + + ++ +G VYKG L+ + +AVK F+ + + + F
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGA-----VYKGSLDERP-VAVKVFS---FANRQNF 52
Query: 101 LEEAR--AVGQLRNRRLANLLGCCCEGD-----ERLLVAEYMPNDTLAKHLFHWETQPMK 153
+ E V + + +A + E LLV EY PN +L K+L
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSD 109
Query: 154 WAMRLRVALHIAEALEY-------CTSKERALYH-DLNAYRIVFDDDVNPRLSCFGL--- 202
W R+A + L Y + A+ H DLN+ ++ +D +S FGL
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 203 -----MKNSRDGRSYSTNLAFTP----PEYLR-------TGRVTPESVMYSFGTLLLDLL 246
+ + + + + T PE L + MY+ G + ++
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 247 SGK------HIPPSHAL----DLIRDRNIQTLTDS-CLEGQ-------FSSDEGT--ELV 286
P + + ++ + + E Q + + L
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPH 329
C + R + + L E V H
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 48/272 (17%), Positives = 91/272 (33%), Gaps = 38/272 (13%)
Query: 73 VYKGKLENQFR-IAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
K + +K R R FL+E + + L + + +G + +
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EY+ TL + W+ R+ A IA + Y S + H DLN++ +
Sbjct: 86 TEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR 142
Query: 191 DDVNPRLSCFGL--------------MKNSRDGRSYSTNLAFTP----PEYLRTGRVTPE 232
++ N ++ FGL + R + P PE + +
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202
Query: 233 SVMYSFGTLLLDLLSGKHIPP-----SHALDLIRDRNI-QTLTDSCLEGQFSSDEGTELV 286
++SFG +L +++ + P + L + + +C
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP---------SFF 253
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ RC +P +RP+ L L TL+
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-18
Identities = 57/260 (21%), Positives = 109/260 (41%), Gaps = 24/260 (9%)
Query: 72 VVYKGKLENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 28 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
+ E+M L +L Q + + L +A I+ A+EY K H DL A +
Sbjct: 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV 144
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLD 244
++ +++ FGL + + A +T PE L + + +S +++FG LL +
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 245 LLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
+ + P S +L+ + C E ++ L C Q+ P +
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSD 255
Query: 300 RPNPRSLVTALVTLQKDTEV 319
RP+ + A T+ +++ +
Sbjct: 256 RPSFAEIHQAFETMFQESSI 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 56/259 (21%), Positives = 109/259 (42%), Gaps = 24/259 (9%)
Query: 73 VYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VY+G + +AVK + +FL+EA + ++++ L LLG C ++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
E+M L +L Q + + L +A I+ A+EY K H +L A +
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG 352
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
++ +++ FGL + + A +T PE L + + +S +++FG LL ++
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 246 LSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+ P S +L+ + C E ++ L C Q+ P +R
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSDR 463
Query: 301 PNPRSLVTALVTLQKDTEV 319
P+ + A T+ +++ +
Sbjct: 464 PSFAEIHQAFETMFQESSI 482
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 26/258 (10%)
Query: 73 VYKGKLENQ-FRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
V+ G+L +AVK + PD + FL+EAR + Q + + L+G C + +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
V E + L E ++ L++ A +EY SK H DL A +
Sbjct: 190 VMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV 246
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAF------TPPEYLRTGRVTPESVMYSFGTLLL 243
+ ++S FG+ + DG ++ T PE L GR + ES ++SFG LL
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 244 DLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
+ S P + + + C + + RL +C YEP
Sbjct: 307 ETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD---------AVFRLMEQCWAYEPG 357
Query: 299 ERPNPRSLVTALVTLQKD 316
+RP+ ++ L +++K
Sbjct: 358 QRPSFSTIYQELQSIRKR 375
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 24/257 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G R+A+K FL+EA+ + +LR+ +L L E + +V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y H DL A I+ +
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 315
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + A +T PE GR T +S ++SFG LL +L
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ +P LD + C E L L +C + EP ERP
Sbjct: 376 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEERP 426
Query: 302 NPRSLVTALVTLQKDTE 318
L L TE
Sbjct: 427 TFEYLQAFLEDYFTSTE 443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 28/255 (10%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-LV 131
V G ++AVK A A+ FL EA + QLR+ L LLG E L +V
Sbjct: 209 VMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EYM +L +L + L+ +L + EA+EY H DL A ++
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS 323
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+D ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 324 EDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 247 S-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
S G+ IP + + D C + + C + RP
Sbjct: 381 SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYDVMKNCWHLDAATRP 431
Query: 302 NPRSLVTALVTLQKD 316
L L ++
Sbjct: 432 TFLQLREQLEHIRTH 446
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 64/250 (25%), Positives = 99/250 (39%), Gaps = 28/250 (11%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-L 130
V G ++AVK A A+ FL EA + QLR+ L LLG E L +
Sbjct: 36 DVMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVF 189
V EYM +L +L + L+ +L + EA+EY H DL A ++
Sbjct: 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 150
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDL 245
+D ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 151 SEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 246 LS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
S G+ IP + + D C + + C + R
Sbjct: 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMR 258
Query: 301 PNPRSLVTAL 310
P+ L L
Sbjct: 259 PSFLQLREQL 268
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 24/257 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G R+A+K FL+EA+ + +LR+ +L L E + +V
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y H DL A I+ +
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 398
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + A +T PE GR T +S ++SFG LL +L
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ +P LD + C E L L +C + EP ERP
Sbjct: 459 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE---------SLHDLMCQCWRKEPEERP 509
Query: 302 NPRSLVTALVTLQKDTE 318
L L TE
Sbjct: 510 TFEYLQAFLEDYFTSTE 526
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 38/264 (14%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ ++AVK + FL EA + L++ +L L + + ++
Sbjct: 204 VWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 261
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
E+M +L L E + + IAE + + + H DL A I+
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSA 319
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ +++ FGL + D + A +T PE + G T +S ++SFG LL++++
Sbjct: 320 SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 247 SGKHIP-PSHALDLIRDRNIQTLT-----------DSCLEGQFSSDEGTELVRLASRCLQ 294
+ IP P + N + + ++C E EL + RC +
Sbjct: 380 TYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPE---------ELYNIMMRCWK 423
Query: 295 YEPRERPNPRSLVTALVTLQKDTE 318
P ERP + + L TE
Sbjct: 424 NRPEERPTFEYIQSVLDDFYTATE 447
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 50/256 (19%), Positives = 109/256 (42%), Gaps = 24/256 (9%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK + Q+ +AVK + +F +EA+ + +L + +L G C + +V
Sbjct: 23 VVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EY+ N L +L + ++ + L + + E + + S + H DL A + D
Sbjct: 82 TEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD 138
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
D+ ++S FG+ + D + S+ ++ PE + + +S +++FG L+ ++
Sbjct: 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198
Query: 246 LSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
S +P S + + + + + ++ C P +R
Sbjct: 199 FSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD---------TIYQIMYSCWHELPEKR 249
Query: 301 PNPRSLVTALVTLQKD 316
P + L++++ L++
Sbjct: 250 PTFQQLLSSIEPLREK 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 60/280 (21%), Positives = 107/280 (38%), Gaps = 37/280 (13%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
++KG ++ + +K +++ + F E A + +L ++ L G C
Sbjct: 24 IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
GDE +LV E++ +L +L + +L VA +A A+ + L H ++
Sbjct: 84 GDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVC 140
Query: 184 AYRI-VFDDDVNPR-------LSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TPESV 234
A I + ++ LS G+ + + PPE + + +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATD 200
Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
+SFGT L ++ SG P L DR Q + + EL L
Sbjct: 201 KWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-----------HQLPAPKAAELANLI 249
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPH 329
+ C+ YEP RP+ R+++ L +L VP H
Sbjct: 250 NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH 289
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 24/257 (9%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132
V+ G ++AVK + + FL EA + QL+++RL L + + ++
Sbjct: 29 VWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86
Query: 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDD 191
EYM N +L L + L +A IAE + + + H DL A I+ D
Sbjct: 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSD 144
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + A +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ IP + + D+C E EL +L C + P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255
Query: 302 NPRSLVTALVTLQKDTE 318
L + L TE
Sbjct: 256 TFDYLRSVLEDFFTATE 272
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 32/259 (12%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
+V+ G N+ ++A+K A F+EEA + +L + +L L G C E LV
Sbjct: 23 LVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
E+M + L+ +L + L + L + E + Y + H DL A +
Sbjct: 82 TEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC--VIHRDLAARNCL-- 136
Query: 191 DDVNPRLSC----FGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTL 241
V FG+ + D + S+ + PE R + +S ++SFG L
Sbjct: 137 --VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194
Query: 242 LLDLLSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++ S IP S ++ I + ++ + C +
Sbjct: 195 MWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST---------HVYQIMNHCWRER 245
Query: 297 PRERPNPRSLVTALVTLQK 315
P +RP L+ L + +
Sbjct: 246 PEDRPAFSRLLRQLAEIAE 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK Q+ +A+K + +F+EEA+ + L + +L L G C + ++
Sbjct: 39 VVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFD 190
EYM N L +L + + L + + EA+EY SK+ H DL A + +
Sbjct: 98 TEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN 154
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTLLLDL 245
D ++S FGL + D S+ + ++PPE L + + +S +++FG L+ ++
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214
Query: 246 LSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
S +P S + I E ++ + C + ER
Sbjct: 215 YSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE---------KVYTIMYSCWHEKADER 265
Query: 301 PNPRSLVTALVTL 313
P + L++ ++ +
Sbjct: 266 PTFKILLSNILDV 278
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 29/263 (11%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V++G +A+K R+ FL+EA + Q + + L+G +
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITENP 464
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
++ E L L + + A + A ++ AL Y SK H D+ A
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 521
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGTL 241
++ + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581
Query: 242 LLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 632
Query: 297 PRERPNPRSLVTALVTLQKDTEV 319
P RP L L T+ ++ ++
Sbjct: 633 PSRRPRFTELKAQLSTILEEEKL 655
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 69/319 (21%), Positives = 117/319 (36%), Gaps = 52/319 (16%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V G+L + + +A+K R+ FL EA +GQ + + L G +
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY-H-DLNAY 185
++V EYM N +L L + Q + + IA ++Y + Y H DL A
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQF-TVIQLVGMLRGIASGMKYLSDMG---YVHRDLAAR 176
Query: 186 RIVFDDDVNPRLSC----FGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESV 234
I+ +N L C FGL + D + T PE + + T S
Sbjct: 177 NIL----INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232
Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++S+G +L +++S P + + + C L +L
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA---------ALYQLM 283
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSPLGDACLRMDLT 349
C Q + RP +V+ L L ++ + I AAA P + L D +D+T
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGS-----LKIITSAAARPSNLLLDQS-NVDIT 337
Query: 350 A---IHEILEKLG---YKD 362
+ L + K+
Sbjct: 338 TFRTTGDWLNGVWTAHCKE 356
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 32/266 (12%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY G+ +N+ + A+K +R + FL E + L + + L+G +
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96
Query: 128 RLL-VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+ YM + L + + + P + + L +A +EY ++ H DL A
Sbjct: 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYLAEQK--FVHRDLAAR 153
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--------TPPEYLRTGRVTPESVMYS 237
+ D+ +++ FGL ++ D YS T E L+T R T +S ++S
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213
Query: 238 FGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
FG LL +LL+ G HI P + + C + L ++ +C
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD---------SLYQVMQQC 264
Query: 293 LQYEPRERPNPRSLVTALVTLQKDTE 318
+ +P RP R LV + +
Sbjct: 265 WEADPAVRPTFRVLVGEVEQIVSALL 290
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 39/286 (13%)
Query: 73 VYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
VYKG L + + +A+K R FL EA +GQ + + L G +
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+++ EYM N L K L + + + + + IA ++Y + H DL A
Sbjct: 120 PMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAGMKYLANM--NYVHRDLAAR 176
Query: 186 RIVFDDDVNPRLSC----FGL---MKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESV 234
I+ VN L C FGL +++ + ++ T PE + + T S
Sbjct: 177 NIL----VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 232
Query: 235 MYSFGTLLLDLLSGKHIP-P----SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG ++ ++++ P + I D C + +L
Sbjct: 233 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS---------AIYQLM 283
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALP 335
+C Q E RP +V+ L L + + + P + LP
Sbjct: 284 MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLP 329
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 51/263 (19%), Positives = 96/263 (36%), Gaps = 29/263 (11%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V++G +A+K R+ FL+EA + Q + + L+G +
Sbjct: 30 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITEN 88
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
++ E L L + ++ + A ++ AL Y SK H D+ A
Sbjct: 89 PVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYAYQLSTALAYLESKR--FVHRDIAAR 145
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGT 240
++ + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+ ++L P + + I + + +C L L ++C Y
Sbjct: 206 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAY 256
Query: 296 EPRERPNPRSLVTALVTLQKDTE 318
+P RP L L T+ ++ +
Sbjct: 257 DPSRRPRFTELKAQLSTILEEEK 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 57/261 (21%), Positives = 100/261 (38%), Gaps = 38/261 (14%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY G L + AVK NR FL E + + + +LLG C +
Sbjct: 41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
L+V YM + L + + P + + L +A+ ++Y SK+ H DL A
Sbjct: 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYLASKK--FVHRDLAAR 157
Query: 186 RIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAF-----TPPEYLRTGRVTPESV 234
+ D+ +++ FGL +RD ++ A E L+T + T +S
Sbjct: 158 NCMLDEKFTVKVADFGL---ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSD 214
Query: 235 MYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG LL +L++ G + + + C + L +
Sbjct: 215 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 265
Query: 290 SRCLQYEPRERPNPRSLVTAL 310
+C + RP+ LV+ +
Sbjct: 266 LKCWHPKAEMRPSFSELVSRI 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 53/280 (18%), Positives = 101/280 (36%), Gaps = 45/280 (16%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V + +L + ++AVK D +FL EA + + + +A L+G
Sbjct: 39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98
Query: 127 ER------LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
+ +++ +M + L + +R + IA +EY +S+
Sbjct: 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157
Query: 177 ALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
H DL A + +D+ ++ FGL SR Y E L
Sbjct: 158 -FIHRDLAARNCMLAEDMTVCVADFGL---SRKIYSGDYYRQGCASKLPVKWLALESLAD 213
Query: 227 GRVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
T S +++FG + ++++ G+ I + + + N C+E
Sbjct: 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME------- 266
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPS 321
E+ L +C +P++RP+ L L + V S
Sbjct: 267 --EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 56/271 (20%), Positives = 107/271 (39%), Gaps = 38/271 (14%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VY+G + R+A+K N +A R FL EA + + + LLG +G
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100
Query: 126 DERLLVAEYMPNDTLAKHL--------FHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
L++ E M L +L + P + +++A IA+ + Y + +
Sbjct: 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158
Query: 178 LYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRTGRVT 230
H DL A + +D ++ FG+ ++ + Y PE L+ G T
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218
Query: 231 PESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
S ++SFG +L ++ + + + L + + + D+C + L
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 269
Query: 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
L C QY P+ RP+ +++++ +
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 55/269 (20%), Positives = 96/269 (35%), Gaps = 38/269 (14%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V G+L + +A+K R FL EA +GQ + + L G G
Sbjct: 64 EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
++V EYM N +L L + Q + + + + Y + H DL A
Sbjct: 124 LAMIVTEYMENGSLDTFLRTHDGQF-TIMQLVGMLRGVGAGMRYLSDL--GYVHRDLAAR 180
Query: 186 RIVFDDDVNPRLSC----FGL---MKNSRDGRSYSTNLAF----TPPEYLRTGRVTPESV 234
++ V+ L C FGL +++ D +T T PE + + S
Sbjct: 181 NVL----VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASD 236
Query: 235 MYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG ++ ++L+ P + + + C L +L
Sbjct: 237 VWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH---------ALHQLM 287
Query: 290 SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
C + +RP +V+ L L + E
Sbjct: 288 LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 59/278 (21%), Positives = 98/278 (35%), Gaps = 46/278 (16%)
Query: 73 VYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VY+G++ ++AVK FL EA + + ++ + +G +
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 126 DERLLVAEYMPNDTLAKHL---FHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYH 180
R ++ E M L L +QP AM L VA IA +Y H
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 204
Query: 181 -DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
D+ A R P FG+ +RD Y PPE
Sbjct: 205 RDIAA-RNCLLTCPGPGRVAKIGDFGM---ARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260
Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
G T ++ +SFG LL ++ S G L+ + +C
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG------- 313
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
+ R+ ++C Q++P +RPN ++ + +D +V
Sbjct: 314 --PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 54/279 (19%), Positives = 97/279 (34%), Gaps = 41/279 (14%)
Query: 72 VVYKGKLE-----NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V + + +AVK+ S R F E + L++ + G C
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 127 ER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
R L+ EY+P +L +L + + + L+ I + +EY +K H DL
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA 172
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
I+ +++ ++ FGL K + Y PE L + + S ++
Sbjct: 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232
Query: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RLA--- 289
SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 233 SFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPRPD 286
Query: 290 ----------SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ C +RP+ R L + ++
Sbjct: 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 56/278 (20%), Positives = 96/278 (34%), Gaps = 46/278 (16%)
Query: 73 VYKGKLEN------QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VY+G++ ++AVK FL EA + + ++ + +G +
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105
Query: 126 DERLLVAEYMPNDTLAKHL-----FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
R ++ E M L L + + L VA IA +Y H
Sbjct: 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 163
Query: 181 -DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----TPPEYLRT 226
D+ A R P FG+ +RD SY PPE
Sbjct: 164 RDIAA-RNCLLTCPGPGRVAKIGDFGM---ARDIYRASYYRKGGCAMLPVKWMPPEAFME 219
Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
G T ++ +SFG LL ++ S G L+ + +C
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG------- 272
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
+ R+ ++C Q++P +RPN ++ + +D +V
Sbjct: 273 --PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 72 VVYKGKLE-----NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V + + +AVK+ S R F E + L++ + G C
Sbjct: 25 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84
Query: 127 ER--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
R L+ EY+P D L KH + + L+ I + +EY +K H
Sbjct: 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGTKR--YIH 137
Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPE 232
DL I+ +++ ++ FGL K + + PE L + +
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RL 288
S ++SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRL 251
Query: 289 A-------------SRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ C +RP+ R L + ++ +
Sbjct: 252 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 60/278 (21%), Positives = 96/278 (34%), Gaps = 43/278 (15%)
Query: 73 VYKGKLEN-----QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V + +AVK A P R + +E + L + + GCC +
Sbjct: 47 VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106
Query: 127 ER--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
LV EY+P D L +H L A I E + Y ++ H
Sbjct: 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQL-------LLFAQQICEGMAYLHAQH--YIH 157
Query: 181 -DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPE 232
DL A ++ D+D ++ FGL K +G Y + PE L+ +
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA 217
Query: 233 SVMYSFGTLLLDLLS--GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG-------- 282
S ++SFG L +LL+ P + +T L + G
Sbjct: 218 SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL--ERGERLPRPDK 275
Query: 283 --TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
E+ L C + E RP +L+ L T+ + +
Sbjct: 276 CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 30/264 (11%)
Query: 72 VVYKGKLEN---QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V +G Q +A+K + + + EA+ + QL N + L+G C+ +
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 409
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+LV E L K L + + + + ++ ++Y K H +L A
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARN 466
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFG 239
++ + ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526
Query: 240 TLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
+ + LS P + I C EL L S C
Sbjct: 527 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWI 577
Query: 295 YEPRERPNPRSLVTALVTLQKDTE 318
Y+ +RP+ ++ +
Sbjct: 578 YKWEDRPDFLTVEQRMRACYYSLA 601
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 53/276 (19%), Positives = 100/276 (36%), Gaps = 44/276 (15%)
Query: 73 VYKGKL----ENQFRIAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V +G L ++AVK + + S+ + +FL EA + + + LLG C E
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 127 -----ERLLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
+ +++ +M L + + L+ + IA +EY +++
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167
Query: 178 LYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLAF----TPPEYLRTG 227
H DL A + DD+ ++ FGL S+ Y E L
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGL---SKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224
Query: 228 RVTPESVMYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282
T +S +++FG + ++ + G + D + + + CL+
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD-------- 276
Query: 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
EL + C + +P +RP L L L +
Sbjct: 277 -ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 56/261 (21%), Positives = 100/261 (38%), Gaps = 38/261 (14%)
Query: 73 VYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY G L + AVK NR FL E + + + +LLG C +
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 128 -RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
L+V YM + L + + P + + L +A+ +++ SK+ H DL A
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFLASKK--FVHRDLAAR 221
Query: 186 RIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAF-----TPPEYLRTGRVTPESV 234
+ D+ +++ FGL +RD ++ A E L+T + T +S
Sbjct: 222 NCMLDEKFTVKVADFGL---ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 235 MYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289
++SFG LL +L++ G + + + C + L +
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 329
Query: 290 SRCLQYEPRERPNPRSLVTAL 310
+C + RP+ LV+ +
Sbjct: 330 LKCWHPKAEMRPSFSELVSRI 350
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 65/290 (22%), Positives = 103/290 (35%), Gaps = 56/290 (19%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V+ + N +AVK ++ + F EA + L+++ + G C EG
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 127 ERLLVAEYMPNDTLAKHL-------------FHWETQPMKWAMRLRVALHIAEALEYCTS 173
L+V EYM + L + L P+ L VA +A + Y
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176
Query: 174 KERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF----T 219
H DL R V L FG+ SRD Y
Sbjct: 177 LH--FVHRDLAT-RNCL---VGQGLVVKIGDFGM---SRDIYSTDYYRVGGRTMLPIRWM 227
Query: 220 PPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLE 274
PPE + + T ES ++SFG +L ++ + GK + + A+D I +C
Sbjct: 228 PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPP 287
Query: 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVL 324
E+ + C Q EP++R + + + L L + V VL
Sbjct: 288 ---------EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL 328
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 50/265 (18%), Positives = 96/265 (36%), Gaps = 31/265 (11%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG + + +A+K + P A + L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
L+ + MP L ++ + L + IA+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRTGRVTPESVMYSF 238
++ + +++ FGL K + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + +L++ G IP S ++ C ++ + +C
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI---------DVYMIMRKCW 256
Query: 294 QYEPRERPNPRSLVTALVTLQKDTE 318
+ RP R L+ + +D +
Sbjct: 257 MIDADSRPKFRELIIEFSKMARDPQ 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 51/281 (18%)
Query: 73 VYKGKLEN------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V+ + N + +AVK + F EA + L++ + G C +GD
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90
Query: 127 ERLLVAEYMPN--------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
++V EYM + L + + L +A IA + Y
Sbjct: 91 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 150
Query: 173 SKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSYS--TNLAF----TPP 221
S+ H DL R V L FG+ ++ Y + PP
Sbjct: 151 SQH--FVHRDLAT-RNCL---VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 204
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
E + + T ES ++SFG +L ++ + GK + + ++ I + C +
Sbjct: 205 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK-- 262
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
E+ + C Q EP++R N + + L L K T
Sbjct: 263 -------EVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 29/263 (11%)
Query: 72 VVYKGKLEN----QFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
VY+G N + +AVK + D ++ F+ EA + L + + L+G E +
Sbjct: 27 EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEE 85
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
++ E P L +L + + + +L I +A+ Y S H D+
Sbjct: 86 PTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYLESIN--CVHRDIAVR 142
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA-----FTPPEYLRTGRVTPESVMYSFGT 240
I+ +L FGL + D Y ++ + PE + R T S ++ F
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+ ++LS P + ++ + D C L L +RC Y
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP---------VLYTLMTRCWDY 253
Query: 296 EPRERPNPRSLVTALVTLQKDTE 318
+P +RP LV +L + + +
Sbjct: 254 DPSDRPRFTELVCSLSDVYQMEK 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 54/264 (20%), Positives = 98/264 (37%), Gaps = 32/264 (12%)
Query: 72 VVYKGKLENQFR---IAVK--RFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V KG + + +AVK + + + L EA + QL N + ++G CE +
Sbjct: 32 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAE 90
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+LV E L K+L + + +K + + ++ ++Y H DL A
Sbjct: 91 SWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 146
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMYSF 238
++ ++S FGL K R +Y T+ + PE + + + +S ++SF
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206
Query: 239 GTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G L+ + S P S ++ C E+ L + C
Sbjct: 207 GVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCW 257
Query: 294 QYEPRERPNPRSLVTALVTLQKDT 317
Y+ RP ++ L D
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDV 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 50/265 (18%), Positives = 97/265 (36%), Gaps = 31/265 (11%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG + + +A+K + P A + L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
L+ + MP L ++ + L + IA+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSF 238
++ + +++ FGL K + + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + +L++ G IP S ++ C ++ + +C
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI---------DVYMIMVKCW 256
Query: 294 QYEPRERPNPRSLVTALVTLQKDTE 318
+ RP R L+ + +D +
Sbjct: 257 MIDADSRPKFRELIIEFSKMARDPQ 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 50/268 (18%), Positives = 92/268 (34%), Gaps = 38/268 (14%)
Query: 72 VVYKGKL---ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V +G + Q +A+K + + + EA+ + QL N + L+G C+ +
Sbjct: 25 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 83
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+LV E L K L + + + + ++ ++Y K H DL A
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARN 140
Query: 187 IVFDDDVNPRLSC----FGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVM 235
++ + R FGL K SY + + PE + + + S +
Sbjct: 141 VL----LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196
Query: 236 YSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
+S+G + + LS P + I C EL L S
Sbjct: 197 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMS 247
Query: 291 RCLQYEPRERPNPRSLVTALVTLQKDTE 318
C Y+ +RP+ ++ +
Sbjct: 248 DCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 48/298 (16%), Positives = 103/298 (34%), Gaps = 35/298 (11%)
Query: 72 VVYKGKLENQFR-----IAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
V+KG + + +K + + Q + A+G L + + LLG C G
Sbjct: 28 TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPG 86
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
LV +Y+P +L H+ + + L + IA+ + Y + H +L A
Sbjct: 87 SSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAA 143
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESVMYSF 238
++ +++ FG+ + + E + G+ T +S ++S+
Sbjct: 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203
Query: 239 GTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + +L++ G + + DL+ C ++ + +C
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI---------DVYMVMVKCW 254
Query: 294 QYEPRERPNPRSLVTALVTLQKD----TEVPSHVLMGIPHGAAALPLSPLGDACLRMD 347
+ RP + L + +D + GI G L+ + ++
Sbjct: 255 MIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELE 312
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 52/292 (17%), Positives = 99/292 (33%), Gaps = 54/292 (18%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGDER- 128
V+ GK + ++AVK F + + E + Q R N+L +G
Sbjct: 53 VWMGKWRGE-KVAVKVFF---TTEEASWFRE-TEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 129 ---LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
L+ +Y N +L +L ++ + L++A L + T + A+
Sbjct: 108 TQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
H DL + I+ + ++ GL + ++ + T PE L +
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLN 223
Query: 231 PESV-------MYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNIQTLTDSCLEG 275
MYSFG +L ++ P H L C++
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 276 Q-------FSSDEGT-ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
+SSDE ++ +L + C + P R + L + + ++
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 45/278 (16%)
Query: 73 VYKGKLENQF---RIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCEGDE 127
V K +++ A+KR A D + F E + +L + + NLLG C
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100
Query: 128 RLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCTS 173
L EY P+ L L + + L A +A ++Y +
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160
Query: 174 KERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPEYLRT 226
K+ H DL A I+ ++ +++ FGL SR Y T E L
Sbjct: 161 KQ--FIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWMAIESLNY 215
Query: 227 GRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
T S ++S+G LL +++S G + + + + +C +
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD------- 268
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
E+ L +C + +P ERP+ ++ +L + ++ +
Sbjct: 269 --EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 54/275 (19%), Positives = 98/275 (35%), Gaps = 52/275 (18%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG L +A+K A R+ F EA +L++ + LLG +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84
Query: 126 DERLLVAEYMPN--------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171
++ Y + D + ++ + + IA +EY
Sbjct: 85 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 172 TSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSYSTNLA------FTP 220
+S + H DL A R V V +L+ GL + Y +
Sbjct: 145 SSHH--VVHKDL-ATRNVL---VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 198
Query: 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHA----LDLIRDRNIQTLTDSCLEG 275
PE + G+ + +S ++S+G +L ++ S P ++ +++IR+R + D C
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA- 257
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
+ L C P RP + + + L
Sbjct: 258 --------WVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 50/275 (18%), Positives = 101/275 (36%), Gaps = 45/275 (16%)
Query: 73 VYKGKLE-----NQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V + + ++AVK + + +E + L + + G C E
Sbjct: 37 VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96
Query: 127 ER--LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
L+ E++P+ +L ++L + + + +L+ A+ I + ++Y S++ H DL
Sbjct: 97 GNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA 153
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
A ++ + + ++ FGL K + Y + PE L + S ++
Sbjct: 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 237 SFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV----RLAS- 290
SFG L +LL+ AL L GQ + + RL
Sbjct: 214 SFGVTLHELLTYCDSDSSPMALFLKMIGPTH--------GQMTVTRLVNTLKEGKRLPCP 265
Query: 291 ------------RCLQYEPRERPNPRSLVTALVTL 313
+C +++P R + ++L+ L
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 55/292 (18%), Positives = 107/292 (36%), Gaps = 47/292 (16%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCC 122
V + + +AVK A + E + + +++ + NLLG C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
+ ++ EY L ++L + M + + +A +
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPP 221
EY S++ H DL A ++ ++ +++ FGL ++ + Y +TN P
Sbjct: 171 EYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
E L T +S ++SFG L+ ++ + G IP L+++ + +C
Sbjct: 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN-- 286
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIP 328
EL + C P +RP + LV L + T ++ + P
Sbjct: 287 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQP 331
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 47/282 (16%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCC 122
V + ++AVK A + E + + + + NLLG C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
+ ++ EY L ++L H + + + A +A +
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPP 221
EY SK+ H DL A ++ +D +++ FGL ++ Y +TN P
Sbjct: 205 EYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLTDSCLEGQ 276
E L T +S ++SFG LL ++ + G +P L+++ + +C
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTN-- 320
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
EL + C P +RP + LV L + T
Sbjct: 321 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 47/292 (16%), Positives = 99/292 (33%), Gaps = 54/292 (18%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGD--- 126
V++GK + +AVK F+ + R + E + Q R N+L + +
Sbjct: 58 VWRGKWRGE-EVAVKIFS---SREERSWFRE-AEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
+ LV++Y + +L +L + +++AL A L + T + A+
Sbjct: 113 TQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
H DL + I+ + ++ GL + + T PE L +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD-DSIN 228
Query: 231 PESV-------MYSFGTLLLDLLSGKHI---PPSHAL---DLI-RDRNIQTLTDS-CLEG 275
+ +Y+ G + ++ I + L DL+ D +++ + C +
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 276 Q--------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319
S + + ++ C R + L L + +
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 67/296 (22%), Positives = 105/296 (35%), Gaps = 60/296 (20%)
Query: 73 VYKGKLENQF------RIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
V++ + +AVK A D + F EA + + N + LLG C G
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122
Query: 126 DERLLVAEYMPNDTLAKHL----------------------FHWETQPMKWAMRLRVALH 163
L+ EYM L + L P+ A +L +A
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRDGRSY--STNL 216
+A + Y + ++ H DL A R V + FGL +N Y N
Sbjct: 183 VAAGMAYLSERK--FVHRDL-ATRNCL---VGENMVVKIADFGLSRNIYSADYYKADGND 236
Query: 217 AF----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQT 267
A PPE + R T ES ++++G +L ++ S G + + +RD NI
Sbjct: 237 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 296
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHV 323
++C EL L C P +RP+ S+ L + + E V
Sbjct: 297 CPENCPL---------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 55/274 (20%), Positives = 101/274 (36%), Gaps = 34/274 (12%)
Query: 73 VYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V + +AVK+ S R F E + + L + + G
Sbjct: 39 VELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98
Query: 128 R--LLVAEYMPN----DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181
+ LV EY+P+ D L +H + + L + I + +EY S+ R ++ D
Sbjct: 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGSR-RCVHRD 152
Query: 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESV 234
L A I+ + + + +++ FGL K + Y PE L + +S
Sbjct: 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG----------TE 284
++SFG +L +L + S + + +R + + +EG E
Sbjct: 213 VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAE 272
Query: 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ L C P++RP+ +L L L +
Sbjct: 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 58/281 (20%), Positives = 97/281 (34%), Gaps = 61/281 (21%)
Query: 73 VYKGKL--------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCC 122
V + + +AVK A + E + + +++ + NLLG C
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156
Query: 123 CEGDERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEAL 168
+ ++ EY L ++L + M + + +A +
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF 218
EY S++ H DL A R V V FGL +RD Y +TN
Sbjct: 217 EYLASQK--CIHRDL-AARNVL---VTENNVMKIADFGL---ARDINNIDYYKKTTNGRL 267
Query: 219 ----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTLT 269
PE L T +S ++SFG L+ ++ + G IP L+++ +
Sbjct: 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 327
Query: 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
+C EL + C P +RP + LV L
Sbjct: 328 ANCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 57/261 (21%), Positives = 97/261 (37%), Gaps = 36/261 (13%)
Query: 72 VVYKGKL----ENQFRIAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCE 124
VV +G+ +AVK + + + P+A F+ E A+ L +R L L G
Sbjct: 33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVL 91
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
+V E P +L L R A+ +AE + Y SK H DL
Sbjct: 92 TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLA 148
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSY---STNLAF----TPPEYLRTGRVTPESVMY 236
A ++ ++ FGLM+ + + PE L+T + S +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 237 SFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLT--DSCLEGQFSSDEGTELVRLA 289
FG L ++ + P S L I D+ + L + C + ++ +
Sbjct: 209 MFGVTLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDCPQ---------DIYNVM 258
Query: 290 SRCLQYEPRERPNPRSLVTAL 310
+C ++P +RP +L L
Sbjct: 259 VQCWAHKPEDRPTFVALRDFL 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-10
Identities = 36/199 (18%), Positives = 71/199 (35%), Gaps = 38/199 (19%)
Query: 73 VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL---GCCCEGD--- 126
V++G + + +AVK F+ D + + E + R N+L
Sbjct: 24 VWRGSWQGE-NVAVKIFS---SRDEKSWFRE-TELYNTVMLRHENILGFIASDMTSRHSS 78
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY------CTSKERALY 179
+ L+ Y +L +L + + LR+ L IA L + T + A+
Sbjct: 79 TQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 180 H-DLNAYRIVFDDDVNPRLSCFGL----MKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
H DL + I+ + ++ GL +++ + T PE L +
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD-ETIQ 194
Query: 231 PESV-------MYSFGTLL 242
+ +++FG +L
Sbjct: 195 VDCFDSYKRVDIWAFGLVL 213
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 62/282 (21%), Positives = 104/282 (36%), Gaps = 58/282 (20%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEG 125
V K +AVK +A P + L E + Q+ + + L G C +
Sbjct: 39 VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98
Query: 126 DERLLVAEYMPNDTLAKHL----------------------FHWETQPMKWAMRLRVALH 163
LL+ EY +L L H + + + + A
Sbjct: 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY---STNLA 217
I++ ++Y + L H DL A I+ + ++S FGL SRD +
Sbjct: 159 ISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGL---SRDVYEEDSYVKRSQGR 213
Query: 218 F----TPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNIQTL 268
E L T +S ++SFG LL ++++ G + IPP +L++ +
Sbjct: 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER 273
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
D+C E E+ RL +C + EP +RP + L
Sbjct: 274 PDNCSE---------EMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 52/285 (18%), Positives = 92/285 (32%), Gaps = 58/285 (20%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCCE 124
V + + ++AVK +A D ++ + E + + L + NLLG C
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121
Query: 125 GDERLLVAEYMPN------------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
G L++ EY F L + +A+ + +
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 173 SKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF---- 218
SK H D+ A R V + FGL +RD S N
Sbjct: 182 SKN--CIHRDVAA-RNVL---LTNGHVAKIGDFGL---ARDIMNDSNYIVKGNARLPVKW 232
Query: 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNIQTLTDSC 272
PE + T +S ++S+G LL ++ S P ++ L++D
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA 292
Query: 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317
+ + + C EP RP + + + L ++
Sbjct: 293 PK---------NIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 39/280 (13%), Positives = 68/280 (24%), Gaps = 49/280 (17%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNR---RLANLLGCCCE 124
VV+ + +E A+K F A + + E A +L +
Sbjct: 77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 125 GD-----------------------ERLLVAEYMPND--TLAKHLFHWETQ--PMKWAMR 157
D LL+ D L L
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 158 LRVALHIAEALEYCTSKERALYH-DL---NAYRIVFDDDVNPRLSCFGL-MKNSRDGRSY 212
+ + SK L H N + D L K G +
Sbjct: 197 HILTAQLIRLAANLQSKG--LVHGHFTPDN---LFIMPDGRLMLGDVSALWKVGTRGPAS 251
Query: 213 STNLAFTPPEYL--RTGRVTPESVMYSFGTLLLDLLSGK---HIPPSHALDLIRDRNIQT 267
S + + P E+L T T + G + + + + +++
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307
L + + L R L ++ R R P +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 44/249 (17%), Positives = 87/249 (34%), Gaps = 25/249 (10%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCC---CEGD 126
VYKG E +A + ++F EEA + L++ + +G
Sbjct: 42 VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101
Query: 127 ERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNA 184
+ + LV E M + TL +L + MK + I + L++ ++ + H DL
Sbjct: 102 KCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 185 YRIVFD-DDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGTL 241
I + ++ GL R + + F PE +Y+FG
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMC 218
Query: 242 LLDLLSGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
+L++ + ++ + + +T F E+ + C++
Sbjct: 219 MLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
Query: 298 RERPNPRSL 306
ER + + L
Sbjct: 272 DERYSIKDL 280
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 56/290 (19%), Positives = 95/290 (32%), Gaps = 62/290 (21%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCCE 124
V + + +AVK SA R+ + E + + L N + NLLG C
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98
Query: 125 GDERLLVAEYMPNDTLAKHL----------------FHWETQPMKWAMRLRVALHIAEAL 168
G L++ EY L L + + L + +A+ +
Sbjct: 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 169 EYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---STNLAF 218
+ SK H DL A R + + FGL +RD S N
Sbjct: 159 AFLASKN--CIHRDLAA-RNIL---LTHGRITKICDFGL---ARDIKNDSNYVVKGNARL 209
Query: 219 ----TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNIQTL 268
PE + T ES ++S+G L +L S P P + +I++
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS 269
Query: 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ E+ + C +P +RP + +V + ++
Sbjct: 270 PEHAPA---------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 48/282 (17%), Positives = 93/282 (32%), Gaps = 47/282 (16%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCE 124
V + +AVK A + + E + + + + + NLLG C +
Sbjct: 43 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102
Query: 125 GDE-RLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALE 169
+++ E+ L+ +L + + + +A+ +E
Sbjct: 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 162
Query: 170 YCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--STNLAF----TPPE 222
+ S++ H DL A I+ + ++ FGL ++ Y + PE
Sbjct: 163 FLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDRNIQTLTDSCLEGQ 276
+ T +S ++SFG LL ++ S P +++ D
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-- 278
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
E+ + C EP +RP LV L L +
Sbjct: 279 -------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 46/260 (17%), Positives = 85/260 (32%), Gaps = 53/260 (20%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLG--------CCC 123
+VY+G +N+ +AVKR + A + E + L C
Sbjct: 40 IVYRGMFDNR-DVAVKRILPECFSFADR---EVQL--------LRESDEHPNVIRYFCTE 87
Query: 124 EGDERL-LVAEYMP----NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178
+ + + E K H +P+ ++ L + S +
Sbjct: 88 KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQ-----QTTSGLAHLHSLN--I 139
Query: 179 YH-DLNAYRIVF-----DDDVNPRLSCFGLMKNSRDGRSYSTNLAF---TP----PEYLR 225
H DL + I+ + +S FGL K GR + + T PE L
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 226 ---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG-QFSSDE 281
T ++S G + ++S P +L + + + CL +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 282 GTELVRLASRCLQYEPRERP 301
EL+ + + +P++RP
Sbjct: 260 ARELIE---KMIAMDPQKRP 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 31/198 (15%), Positives = 56/198 (28%), Gaps = 36/198 (18%)
Query: 127 ERLLVAEYMPND--TLAKHLFHWETQ--PMKWAMRLRVALHIAEALEYCTSKERALYH-D 181
R + M ++ T + L + + RL++ L + L L H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231
Query: 182 L---NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYL-----------RTG 227
L + IV D L+ F + S + F PPE R
Sbjct: 232 LRPVD---IVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 228 RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTELV 286
+T ++ G ++ + P I ++ + L+
Sbjct: 289 LMTFSFDAWALGLVIYWIWCAD--LP------ITKDAALGGSEWIFRSCKNIPQPVRALL 340
Query: 287 RLASRCLQYEPRERPNPR 304
L+Y +R P
Sbjct: 341 E---GFLRYPKEDRLLPL 355
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 34/225 (15%), Positives = 59/225 (26%), Gaps = 35/225 (15%)
Query: 129 LLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DL--- 182
L T + L + + RL++ L + L L H L
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPV 240
Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYL----------RTGRVTPE 232
+ IV D L+ F + F PPE +T
Sbjct: 241 D---IVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLAS 290
++ G + + P+ + E F S + + L
Sbjct: 298 FDTWTLGLAIYWIWCAD--LPNTDDAALGG----------SEWIFRSCKNIPQPVRALLE 345
Query: 291 RCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALP 335
L+Y +R P + Q TE+ + + + G
Sbjct: 346 GFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTRE 390
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 60/295 (20%), Positives = 97/295 (32%), Gaps = 67/295 (22%)
Query: 73 VYKGKL------ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQL-RNRRLANLLGCCCE 124
V ++AVK A R+ + E + + QL + + NLLG C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120
Query: 125 GDERLLVAEYMPN---------------------DTLAKHLFHWETQPMKWAMRLRVALH 163
L+ EY + + + + + L A
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSC----FGLMKNSRD--GRSY---S 213
+A+ +E+ K H DL A R V V FGL +RD S
Sbjct: 181 VAKGMEFLEFKS--CVHRDLAA-RNVL---VTHGKVVKICDFGL---ARDIMSDSNYVVR 231
Query: 214 TNLAF----TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP------PSHALDLIRDR 263
N PE L G T +S ++S+G LL ++ S P ++ LI++
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
E E+ + C ++ R+RP+ +L + L D E
Sbjct: 292 FKMDQPFYATE---------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 3e-07
Identities = 55/353 (15%), Positives = 105/353 (29%), Gaps = 101/353 (28%)
Query: 15 SEYGEAAPEAQDVENEEKPGVDNVPVFCEYSI------ETLRTATSGFAMENIVSEHGEK 68
+E + + + + ++ VF +Y++ LR A V G
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 69 -------APNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC 121
A +V K++ + + F W + L
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKI--F----WLN----------------------LKN 191
Query: 122 CCEGDERL-----LVAEYMPNDT-LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175
C + L L+ + PN T + H + + + LR + ++ Y E
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR---RLLKSKPY----E 244
Query: 176 RALYHDLNAYRIVFDDDV-NPR------LSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGR 228
L +V + V N + LSC L+ +R + + L+ T
Sbjct: 245 NCL--------LVLLN-VQNAKAWNAFNLSCKILL-TTRF-KQVTDFLSAA-----TTTH 288
Query: 229 VTPESVMYSFG-----TLLLDLLSGK--HIPPS------HALDLI--RDRNIQTLTDSCL 273
++ + + +LLL L + +P L +I R+ D
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD--- 345
Query: 274 EGQFSSDEGTELVRLASRCLQY-EPRERPNPRSLVTALVTLQKDTEVPSHVLM 325
+ +L + L EP E R + L +P+ +L
Sbjct: 346 --NWKHVNCDKLTTIIESSLNVLEPAEY---RKMFDRLSVFPPSAHIPTILLS 393
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 44/244 (18%), Positives = 87/244 (35%), Gaps = 19/244 (7%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
K E+ + +K N S + E + +++ + E
Sbjct: 40 AILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+V +Y L K + + + L + I AL++ + + L+ D+ + I
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFL 158
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
D +L FG+ + + TP PE +S +++ G +L +L
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPN 302
+ K A +++ L + G F S +L L S+ + PR+RP+
Sbjct: 219 CTLK--HAFEA------GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 303 PRSL 306
S+
Sbjct: 271 VNSI 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 27/265 (10%), Positives = 62/265 (23%), Gaps = 45/265 (16%)
Query: 72 VVYKGK------LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG 125
VY+ +N+ + +K + + + +
Sbjct: 80 QVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139
Query: 126 DERLLVAEYMPNDTLAKHL-----FHWETQPMKWAMRLRVALHIAEALEYCTSKERA--- 177
+ +LV E TL + + P + A+ + +E E
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF--AMRMLYMIEQVHDCEIIHGD 197
Query: 178 -------LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEY--- 223
L + D L G S D + + FT +
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ---SIDMKLFPKGTIFTAKCETSGFQCV 254
Query: 224 -LRTGRVTPESV-MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
+ + + + + + +L G ++ +++ + + D
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-------VKNEGGECKPEGLFRRLPHLDM 307
Query: 282 GTELVRLASRCLQYEPRERPNPRSL 306
E L L
Sbjct: 308 WNEFFH---VMLNIPDCHHLPSLDL 329
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 53/285 (18%), Positives = 92/285 (32%), Gaps = 82/285 (28%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL--LGCCCEGDERL 129
VV++G + + +AVKR A E + + + + N+ C D L
Sbjct: 31 VVFQGSFQGR-PVAVKRMLIDFCDIALM---EIKLLTESDDH--PNVIRYYCSETTDRFL 84
Query: 130 -LVAEYMPNDTL-----AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
+ E N L +K++ + K + + IA + + H L
Sbjct: 85 YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL--------HSLK 135
Query: 184 --------------------AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP--- 220
A + +++ +S FGL K G+S P
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 221 -----PEYLR-------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
PE L R+T ++S G + +LS P R+ NI
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--KYSRESNI--- 250
Query: 269 TDSCLEGQFS------------SDEGTELVRLASRCLQYEPRERP 301
+ G FS E T+L+ + + ++P +RP
Sbjct: 251 ----IRGIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRP 288
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 47/209 (22%), Positives = 82/209 (39%), Gaps = 34/209 (16%)
Query: 164 IAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFT 219
I A++YC K + H DL A ++ D D+N +++ FG G +
Sbjct: 123 IVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 220 PPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277
PE + G+ PE ++S G +L L+SG +P +N++ L + L G++
Sbjct: 181 APELFQ-GKKYDGPEVDVWSLGVILYTLVSG-SLP-------FDGQNLKELRERVLRGKY 231
Query: 278 S--SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALP 335
T+ L R L P +R TL+ ++ + G
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRG----------TLE---QIMKDRWINA--GHEEDE 276
Query: 336 LSPLGDACLRMDLTAIHEILEKLGYKDDE 364
L P + L + +I+ +GY +E
Sbjct: 277 LKPFVEPELDISDQKRIDIMVGMGYSQEE 305
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 38/197 (19%), Positives = 68/197 (34%), Gaps = 37/197 (18%)
Query: 133 EYMPNDTLAKHLFH-WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL---NAYRIV 188
+ + L + + + + L + + IAEA+E+ SK ++ DL N I
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSN---IF 196
Query: 189 FDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TP---------------E 232
F D ++ FGL+ T L P TG+V T +
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLA 289
++S G +L +LL ++ +TD +F + + + +
Sbjct: 257 VDIFSLGLILFELLYSF--STQMER-------VRIITDVR-NLKFPLLFTQKYPQEHMMV 306
Query: 290 SRCLQYEPRERPNPRSL 306
L P ERP +
Sbjct: 307 QDMLSPSPTERPEATDI 323
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 45/250 (18%), Positives = 92/250 (36%), Gaps = 20/250 (8%)
Query: 66 GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
GE + +V + + ++AVK + E + ++ + +
Sbjct: 54 GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
G+E ++ E++ L + + V + +AL Y ++ ++ D+ +
Sbjct: 114 GEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKS 169
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D +LS FG +L TP PE + E ++S G
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
++++++ G+ P A+ +RD L +S + S L R L +
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS---HKVSP----VLRDFLERMLVRD 282
Query: 297 PRERPNPRSL 306
P+ER + L
Sbjct: 283 PQERATAQEL 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 50/273 (18%), Positives = 90/273 (32%), Gaps = 60/273 (21%)
Query: 73 VYKG--KLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL- 129
V K L++++ A+K+ + L E + L ++ + E +
Sbjct: 22 VVKARNALDSRYY-AIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79
Query: 130 ------------LVAEYMPNDTLAKHLFHWETQPMKW--AMRLRVALHIAEALEYCTSKE 175
+ EY N TL + ++ + R+ I EAL Y S+
Sbjct: 80 PMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYIHSQG 136
Query: 176 RALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--------------TP 220
+ H DL I D+ N ++ FGL KN + T
Sbjct: 137 --IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 221 ----PEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------LDLIRDRNIQTLT 269
E L TG + MYS G + +++ P S L +R +I+
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIE--- 247
Query: 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
F ++ ++ + ++P +RP
Sbjct: 248 ---FPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 51/250 (20%), Positives = 100/250 (40%), Gaps = 20/250 (8%)
Query: 66 GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE 124
G+ A VY + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
GDE +V EY+ +L + M V +ALE+ S + ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKS 144
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGT 240
I+ D + +L+ FG +S + + TP PE + P+ ++S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 241 LLLDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++++ G+ + P AL LI L + + S+ +RCL+ +
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---EKLSA----IFRDFLNRCLEMD 257
Query: 297 PRERPNPRSL 306
+R + + L
Sbjct: 258 VEKRGSAKEL 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 37/164 (22%), Positives = 57/164 (34%), Gaps = 46/164 (28%)
Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
+ E + H LN +R I+ DDD+N +L+ FG G
Sbjct: 132 ALLEVICAL--------HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182
Query: 216 LAFTP----PEYLRTGRV------TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265
+ TP PE + E M+S G ++ LL+G PP R
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFW------HRKQ 234
Query: 266 QTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRER 300
+ + G + SD +LV R L +P++R
Sbjct: 235 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKR 275
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 47/293 (16%), Positives = 86/293 (29%), Gaps = 57/293 (19%)
Query: 61 IVSEHGEKAPNVVYKGKLENQFR-IAVK--RFNRSAWPDARQ-FLEEARAVGQLRNRRLA 116
++ HG P ++ R +A+ D Q L + ++ +A
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER 176
+L L+VAE++ +L + +T P +R +A A + +
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA-IRAMQSLAAAADA--AHRA 148
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKN---SRDGRSYSTNLAFTPPEYLRTGRVTPES 233
+ +P S DG A P P+
Sbjct: 149 GVAL-----S-----IDHPS--------RVRVSIDGDVVLAYPATMPD-------ANPQD 183
Query: 234 VMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--------GQFSSDEGTEL 285
+ G L LL + P L L + + D ++
Sbjct: 184 DIRGIGASLYALLVNR--WP-----LPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLMGIPHGAAALPLSP 338
+A+R +Q + R T L +Q+ T V + P A + +P
Sbjct: 237 SAVAARSVQGDGGIRSAS----TLLNLMQQATAVADRTEVLGPIDEAPVSAAP 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 45/269 (16%)
Query: 72 VVYKG--KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDER 128
VV++ K+++ A+KR AR+ + E +A+ +L + + E +
Sbjct: 20 VVFEAKNKVDDCNY-AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 129 L------------LVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKE 175
+ + + L + T + + ++ L + L IAEA+E+ SK
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 176 RALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRV-TP-- 231
L H DL I F D ++ FGL+ T L P TG+V T
Sbjct: 139 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196
Query: 232 -------------ESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQF 277
+ ++S G +L +LL P S ++ +R +++ L L Q
Sbjct: 197 MSPEQIHGNSYSHKVDIFSLGLILFELL----YPFSTQMERVRTLTDVRNLKFPPLFTQK 252
Query: 278 SSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ L P ERP ++
Sbjct: 253 YP----CEYVMVQDMLSPSPMERPEAINI 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 37/174 (21%), Positives = 72/174 (41%), Gaps = 23/174 (13%)
Query: 86 VKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF 145
+KRF R E QL ++ + +++ E D LV EY+ TL++++
Sbjct: 55 LKRFER-----------EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE 103
Query: 146 HWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMK 204
P+ + I + +++ + + + H D+ I+ D + ++ FG+ K
Sbjct: 104 --SHGPLSVDTAINFTNQILDGIKH--AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
Query: 205 NSRDGRSYSTNLAF-TP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP 253
+ TN T PE + + +YS G +L ++L G+ PP
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE--PP 211
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 34/181 (18%), Positives = 69/181 (38%), Gaps = 16/181 (8%)
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+ E+ TL + + + + + L + I + ++Y SK + + DL I
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFL 155
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDL 245
D ++ FGL+ + ++ + + T PE + + E +Y+ G +L +L
Sbjct: 156 VDTKQVKIGDFGLVTSLKNDGKRTRSKG-TLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
L A + + L D + F + L + L +P +RPN
Sbjct: 215 LH----VCDTAFE--TSKFFTDLRDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSE 264
Query: 306 L 306
+
Sbjct: 265 I 265
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 36/161 (22%), Positives = 59/161 (36%), Gaps = 42/161 (26%)
Query: 164 IAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRDGRSYS 213
I EA+ Y H+ +R +++ D +++ FGL K
Sbjct: 157 ILEAVAYL--------HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 214 TNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT 269
T + TP PE LR PE M+S G + LL G P + +R Q +
Sbjct: 209 T-VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG--FEPFYD-----ERGDQFMF 260
Query: 270 DSCLEGQFS---------SDEGTELVRLASRCLQYEPRERP 301
L ++ S +LVR + + +P++R
Sbjct: 261 RRILNCEYYFISPWWDEVSLNAKDLVR---KLIVLDPKKRL 298
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 39/164 (23%), Positives = 59/164 (35%), Gaps = 46/164 (28%)
Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215
+ EA+ + H N +R I+ DD++ RLS FG + G
Sbjct: 208 SLLEAVSFL--------HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE- 258
Query: 216 LAFTP----PEYLRTGRV------TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265
L TP PE L+ E +++ G +L LL+G PP R
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPP------FWHRRQ 310
Query: 266 QTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRER 300
+ +EGQ+ S +L+ R LQ +P R
Sbjct: 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS---RLLQVDPEAR 351
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 21/190 (11%)
Query: 130 LVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH----DLN 183
+V EY LA + E Q + LRV + AL+ C + + DL
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFG 239
+ D N +L FGL + S++ TP PE + +S ++S G
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF---SSDEGTELVRLASRCLQYE 296
LL +L + PP A + + L EG+F EL + +R L +
Sbjct: 204 CLLYELCALM--PPFTA------FSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 297 PRERPNPRSL 306
RP+ +
Sbjct: 256 DYHRPSVEEI 265
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 42/259 (16%), Positives = 78/259 (30%), Gaps = 39/259 (15%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDE 127
V + L + A+KR D + EA + + L+ C E
Sbjct: 45 VDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMR--LRVALHIAEALEYCTSKERALYH-DLNA 184
L+ + TL + + + L + L I LE +K H DL
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKP 162
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG----------------R 228
I+ D+ P L G M + S +
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222
Query: 229 VTPESVMYSFGTLLLDLLSGKH-----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283
+ + ++S G +L ++ G+ ++ L + + SS
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP----RHSSA--- 275
Query: 284 ELVRLASRCLQYEPRERPN 302
L +L + + +P +RP+
Sbjct: 276 -LWQLLNSMMTVDPHQRPH 293
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 48/273 (17%), Positives = 104/273 (38%), Gaps = 33/273 (12%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCEGDER 128
VY+ L + +A+K+ DA+ ++E + QL + + E +E
Sbjct: 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 129 LLVAEYMPNDTLAKHL--FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
+V E L++ + F + + + + + + ALE+ S+ R ++ D+
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPAN 166
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLL 242
+ +L GL + + + +L TP PE + +S ++S G LL
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-------SDEGTELVRLASRCLQY 295
++ + + P + N+ +L + + S+E +LV + C+
Sbjct: 227 YEMAALQ--SPFYG----DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV---NMCINP 277
Query: 296 EPRERPNPRSL------VTALVTLQKDTEVPSH 322
+P +RP+ + + A + H
Sbjct: 278 DPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 45/241 (18%), Positives = 80/241 (33%), Gaps = 28/241 (11%)
Query: 73 VYKG-KLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128
V+K E+ AVKR D + L E + ++ ++ L EG
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132
Query: 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188
L E L +H W + A AL + S+ ++ D+ I
Sbjct: 133 YLQTELCGPS-LQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIF 189
Query: 189 FDDDVNPRLSCFGLMK--------NSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGT 240
+L FGL+ ++G + PE L+ + ++S G
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-----YMAPELLQGSY-GTAADVFSLGL 243
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+L++ P Q L L +F++ +EL + L+ +P+ R
Sbjct: 244 TILEVACNME-LPHGG------EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296
Query: 301 P 301
Sbjct: 297 A 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 43/254 (16%), Positives = 90/254 (35%), Gaps = 35/254 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
V++ E + A+K N + E + +L+ + ++ L D+
Sbjct: 43 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 101
Query: 128 RL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+ +V E D L L ++ ++ EA+ + H DL
Sbjct: 102 YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPA 156
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRS--YSTNLAFTP----PEYLR-----------TGR 228
+ D +L FG+ + + + T PE ++ +
Sbjct: 157 NFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
++P+S ++S G +L + GK P ++ I + + D E +F +L
Sbjct: 216 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 288 LASRCLQYEPRERP 301
+ CL+ +P++R
Sbjct: 272 VLKCCLKRDPKQRI 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 25/161 (15%), Positives = 55/161 (34%), Gaps = 43/161 (26%)
Query: 163 HIAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRDGRSY 212
+ AL Y H + ++ I+F ++ FGL + +
Sbjct: 132 QMMNALAYF--------HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 213 STNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268
+ T PE + VT + ++S G ++ LL+G P +++ +
Sbjct: 184 TNAAG-TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC--LPFT------GTSLEEV 233
Query: 269 TDSCLEGQFS--------SDEGTELVRLASRCLQYEPRERP 301
+ + + + +L++ + L +P RP
Sbjct: 234 QQKATYKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRP 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 48/246 (19%), Positives = 84/246 (34%), Gaps = 34/246 (13%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V++ K + F+ AVK+ R EE A L + R+ L G EG +
Sbjct: 74 VHRMKDKQTGFQCAVKKVRL---EVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIF 128
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E + +L + + + L E LEY ++ R L+ D+ A ++
Sbjct: 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSS 185
Query: 192 D-VNPRLSCFGLMKNSRDGRSYSTNLAF-----TP----PEYLRTGRVTPESVMYSFGTL 241
D L FG + + L T PE + + ++S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 242 LLDLLSGKH----IPPSHALDLIRDRN--IQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+L +L+G H I I+ + SC + + ++ L+
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC------APLTAQAIQ---EGLRK 296
Query: 296 EPRERP 301
EP R
Sbjct: 297 EPVHRA 302
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 35/244 (14%)
Query: 73 VYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-----RRLA--NLLG--CC 122
VY + +++F +A+K ++ LE+A QLR L N+L
Sbjct: 25 VYLAREKQSKFILALKVLFKAQ-------LEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 123 CEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH- 180
R+ L+ EY P T+ + L + +A AL YC SK + H
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHSKR--VIHR 133
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSF 238
D+ ++ +++ FG ++ R L + PPE + + ++S
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYE 296
G L + L GK PP Q +F+ L SR L++
Sbjct: 194 GVLCYEFLVGK--PP------FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 297 PRER 300
P +R
Sbjct: 246 PSQR 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 34/166 (20%), Positives = 59/166 (35%), Gaps = 44/166 (26%)
Query: 159 RVALHIAEALEYCTSKERALYHDLN-AYR------IVF---DDDVNPRLSCFGLMKNSRD 208
R+ + + Y H N +R I+ + D + ++ FGL +
Sbjct: 125 RIIKQVFSGITYM--------HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 209 GRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264
T PE LR G + ++S G +L LLSG PP + +N
Sbjct: 177 NTKMKD-RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT--PPFYG------KN 226
Query: 265 IQTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPRERP 301
+ G+++ SD+ +L+R + L + P R
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRI 269
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 38/193 (19%), Positives = 64/193 (33%), Gaps = 24/193 (12%)
Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSK 174
+ ++L + + M L HL + + AE LE+ ++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHNR 311
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVT 230
+Y DL I+ D+ + R+S GL + + ++ T PE L+ G
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAY 368
Query: 231 PESVMY-SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSDEGTELVR 287
S + S G +L LL G P ++ + L EL
Sbjct: 369 DSSADWFSLGCMLFKLLRGH--SPFRQHK---TKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 288 LASRCLQYEPRER 300
L LQ + R
Sbjct: 424 LLEGLLQRDVNRR 436
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 41/253 (16%), Positives = 86/253 (33%), Gaps = 33/253 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
V++ E + A+K N + E + +L+ + ++ L
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYR 186
+V E D L L ++ ++ EA+ + H DL
Sbjct: 131 IYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPAN 185
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRS--YSTNLAFTP----PEYLR-----------TGRV 229
+ D +L FG+ + + + PE ++ ++
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 230 TPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288
+P+S ++S G +L + GK P ++ I + + D E +F +L +
Sbjct: 245 SPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 289 ASRCLQYEPRERP 301
CL+ +P++R
Sbjct: 301 LKCCLKRDPKQRI 313
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 45/200 (22%), Positives = 72/200 (36%), Gaps = 35/200 (17%)
Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE---ALEYCTSK 174
L E + L LV M L H++H A R + AE LE +
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE 305
Query: 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TPPEYLRTGRVTPE 232
R +Y DL I+ DD + R+S GL + +G++ T Y+ PE
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RVGT-VGYM-----APE 355
Query: 233 SVMY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FSSD 280
V + G LL ++++G+ P + + + E +S
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRK--KKIKREEVERLVKEVPEEYSER 411
Query: 281 EGTELVRLASRCLQYEPRER 300
+ L S+ L +P ER
Sbjct: 412 FSPQARSLCSQLLCKDPAER 431
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 45/242 (18%), Positives = 78/242 (32%), Gaps = 51/242 (21%)
Query: 85 AVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN----DTL 140
A K D +E + + LR+ L NL + +E +++ E+M + +
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245
Query: 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYR------IVFDDDV 193
A MR + + L + H+ N + I+F
Sbjct: 246 ADEHNKMSEDEAVEYMR-----QVCKGLCHM--------HENNYVHLDLKPENIMFTTKR 292
Query: 194 NPRLSC--FGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLLS 247
+ L FGL + +S T PE V + M+S G L LLS
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKVTTG-TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 248 GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS---------SDEGTELVRLASRCLQYEPR 298
G + P N + ++ S++G + +R + L +P
Sbjct: 352 G--LSP------FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR---KLLLADPN 400
Query: 299 ER 300
R
Sbjct: 401 TR 402
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 35/198 (17%)
Query: 119 LGCCCEGDERL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
L + +RL V EY L HL E + R A I AL+Y S++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLHSEKNV 270
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMK-NSRDGRSYSTNLAF--TPPEYLRTGRVTPESV 234
+Y DL ++ D D + +++ FGL K +DG + T F T PEYL PE +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGT-PEYL-----APEVL 321
Query: 235 MY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG--QFSSDEG 282
G ++ +++ G+ P +++ + L + L +F G
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR--LP------FYNQDHEKLFELILMEEIRFPRTLG 373
Query: 283 TELVRLASRCLQYEPRER 300
E L S L+ +P++R
Sbjct: 374 PEAKSLLSGLLKKDPKQR 391
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 43/254 (16%), Positives = 90/254 (35%), Gaps = 35/254 (13%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127
V++ E + A+K N + E + +L+ + ++ L D+
Sbjct: 24 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-ITDQ 82
Query: 128 RL-LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAY 185
+ +V E D L L ++ ++ EA+ + H DL
Sbjct: 83 YIYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQH--GIVHSDLKPA 137
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TP----PEYLR-----------TGR 228
+ D +L FG+ + + + T PE ++ +
Sbjct: 138 NFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
++P+S ++S G +L + GK P ++ I + + D E +F +L
Sbjct: 197 ISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQD 252
Query: 288 LASRCLQYEPRERP 301
+ CL+ +P++R
Sbjct: 253 VLKCCLKRDPKQRI 266
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 372 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.66 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.15 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.39 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.81 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.54 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.03 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.31 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-62 Score=446.80 Aligned_cols=247 Identities=17% Similarity=0.201 Sum_probs=208.4
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
++|+++++||+|+||+||+|+ ..+++.||||++...... ..+.+.+|+++|++++|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 589999999999999999999 467999999999765432 35679999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
||+||+|.++|.......+++.+++.|+.||+.||.|||++ |||||||||+|||++.+|.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 99999999999765666789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|||||++.+..|+.++|||||||++|||+||+.||................. ...+..++.++.+||
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-----PPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----CCCCTTSCHHHHHHH
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CCCCccCCHHHHHHH
Confidence 235699999999999999999999999999999999999999976543322221111111 123455678999999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+||+.||++|||+.++++|
T Consensus 258 ~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-61 Score=434.93 Aligned_cols=256 Identities=18% Similarity=0.277 Sum_probs=207.9
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+++++.+.++||+|+||+||+|++.+ .||||+++.... ...+.|.+|+++|++++|||||+++|++.. +.++|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 45678889999999999999999754 599999975432 235679999999999999999999998854 6789999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
|||+||+|.++++. ....+++.++..|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+++.....
T Consensus 111 Ey~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 111 QWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp ECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999974 345699999999999999999999999 9999999999999999999999999999865422
Q ss_pred ---CcccCCCCcCCcccccC---CCCCCCCceeehHHHHHHHHhCCCCCCchhhH-HhhhccccccccccccCCCChHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
....||+.|||||++.+ +.|+.++|||||||+||||+||+.||...... ............+ .....+..++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~ 267 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP-DLSKLYKNCP 267 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-CSTTSCTTSC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-Ccccccccch
Confidence 23578999999999964 35899999999999999999999998653211 1111111111111 1123455677
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.++.+|+.+||+.||++|||+.+|+++|+.++..
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 8999999999999999999999999999988653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-61 Score=443.29 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=210.6
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.++.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667788999999999999864 478999999987665567789999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCcee
Q 017395 131 VAEYMPNDTLAKHLFHWE-------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl 197 (372)
|||||++|+|.++++... ..+++|.+++.|+.||+.||.|||++ +||||||||+|||+++++.+||
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECCCCcEEE
Confidence 999999999999997532 24699999999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccc
Q 017395 198 SCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD 270 (372)
Q Consensus 198 ~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 270 (372)
+|||+++..... ....||+.|||||++.+..++.++|||||||++|||+| |+.||............ .
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i-----~ 274 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-----T 274 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH-----H
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH-----H
Confidence 999999865332 23467899999999999999999999999999999999 89888654322211111 1
Q ss_pred ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
...+...|..+++++.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1112344666788999999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=439.06 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=213.6
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999853 478899999987665557789999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeec
Q 017395 131 VAEYMPNDTLAKHLFHW-----------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~D 199 (372)
|||||++|+|.++|+.. ....++|.+++.|+.||+.||.|||++ +||||||||+|||+++++.+||+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCCcEEECC
Confidence 99999999999999753 235699999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccc
Q 017395 200 FGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 200 fg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
||+++..... ....||+.|||||++.++.|+.++|||||||++|||+| |+.||.......+..... ..
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-----~~ 246 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-----QG 246 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----HT
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----cC
Confidence 9999864332 22357899999999999999999999999999999998 898886543222211111 11
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.....|..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 12234666788999999999999999999999999999988653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-61 Score=438.08 Aligned_cols=253 Identities=19% Similarity=0.271 Sum_probs=212.2
Q ss_pred CCCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
++++++++++||+|+||+||+|.+. +++.||||+++..... ..++|.+|+.+|++++|||||+++|+|.+.+.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 4456788999999999999999862 4678999999754433 35789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
.+||||||++|+|.++|.... ...++|..+..|+.||+.||.|||++ +||||||||+|||+++++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEECCCC
Confidence 999999999999999996432 24589999999999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 017395 194 NPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 266 (372)
++||+|||+++..... ....||+.|||||++.++.++.++|||||||+||||+| |..||.+.....+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~--- 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM--- 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH---
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 9999999999864322 23467899999999999999999999999999999998 7888765432222111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+........|..++.++.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 260 --i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 --IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122234667788999999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-61 Score=443.38 Aligned_cols=248 Identities=17% Similarity=0.219 Sum_probs=212.4
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|+++++||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4589999999999999999994 579999999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
+||+|.+++.+ +.+++.++..|+.||+.||.|||++ |||||||||+|||++.+|.+||+|||+++..... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 99999999963 4599999999999999999999999 9999999999999999999999999999876433 35
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..||+.|||||++.+..|+.++|||||||++|||++|+.||................ . .....+..+++++.+||.+
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~--~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-P--PRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-C--CCCSCGGGSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-C--CCCCccccCCHHHHHHHHH
Confidence 679999999999999999999999999999999999999987643222211111110 0 1112234667899999999
Q ss_pred HccCCCCCCCChHHHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~ 311 (372)
||+.||++|||+.|+++|-+
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGG
T ss_pred HcCCChhHCcCHHHHhcCHh
Confidence 99999999999999998733
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=437.25 Aligned_cols=260 Identities=17% Similarity=0.129 Sum_probs=215.6
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
....|.+.++||+|+||+||+|+ ..+|+.||||+++.... ..+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45678888999999999999999 45699999999976432 2479999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcccCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~~--- 209 (372)
||+||+|.+++++ .+.+++..+..|+.||+.||.|||++ |||||||||+|||++.+| .+||+|||+++.....
T Consensus 131 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999974 45699999999999999999999999 999999999999999887 5999999999875432
Q ss_pred ------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 210 ------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.............. .......+++.+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS---EPPPIREIPPSCAP 284 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH---SCCGGGGSCTTSCH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc---CCCCchhcCccCCH
Confidence 224689999999999999999999999999999999999999865321111111000 01111234566789
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCCCccccc
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEVPSHVLM 325 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~~~~~~~ 325 (372)
++.+||.+||+.||.+|||+.|++++|.........-.++|.
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 999999999999999999999999999887766554445444
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-60 Score=445.09 Aligned_cols=247 Identities=17% Similarity=0.218 Sum_probs=212.4
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|+++++||+|+||.||+|+ ..+|+.||||++........+.+.+|+++|++++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 459999999999999999999 4579999999998766666677999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
+||+|.++++. +.+++.++..|+.||+.||+|||++ |||||||||+||||+.+|.+||+|||+++..... ..
T Consensus 231 ~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 231 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 99999999963 4599999999999999999999999 9999999999999999999999999999876433 34
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.............. .. ....+..+++++.+||.+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~--~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PP--RLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC--CCSCTTSSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CC--CCcccccCCHHHHHHHHH
Confidence 678999999999999999999999999999999999999987643222211111111 11 112234567899999999
Q ss_pred HccCCCCCCCChHHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l 310 (372)
||+.||++|||+.|+++|-
T Consensus 384 ~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCG
T ss_pred HcCCChhHCcCHHHHhcCH
Confidence 9999999999999999873
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=431.06 Aligned_cols=244 Identities=17% Similarity=0.183 Sum_probs=210.6
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
++|++++.||+|+||+||+|+ ..+++.||||++.+.. ....+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 479999999999999999999 5679999999997432 234567999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
|||+||+|.+++++ .+.+++..+..|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+++.....
T Consensus 112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999973 45699999999999999999999999 9999999999999999999999999999875422
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
.+..||+.|||||++.+..|+.++||||+||++|||+||+.||............... ...+|...++++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 262 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------EYDFPEKFFPKAR 262 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCCCCTTCCHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCcccCHHHH
Confidence 3457999999999999999999999999999999999999999765433222211111 1134566778999
Q ss_pred HHHHHHccCCCCCCCChHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+|+.+||+.||.+|||+.|++.+
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHccCCHhHCcChHHHcCC
Confidence 99999999999999999987554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=419.03 Aligned_cols=246 Identities=19% Similarity=0.245 Sum_probs=197.9
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.++|++++.||+|+||+||+|. ..+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999 56799999999975432 2356799999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|||| +|+|.+++.+ .+.+++..+..++.||+.||+|||++ ||+||||||+|||+++++++||+|||+++.....
T Consensus 92 mEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999 6799999974 45699999999999999999999999 9999999999999999999999999999875443
Q ss_pred -CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
....||+.|+|||++.+..+ +.++||||+||++|||+||+.||.............. . ...++...++++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~----~--~~~~p~~~s~~~~~ 241 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN----G--VYTLPKFLSPGAAG 241 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----T--CCCCCTTSCHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHH
Confidence 34679999999999998876 5799999999999999999999976543322211111 1 11245566789999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
|+.+||+.||++|||++|+++|-+
T Consensus 242 li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 242 LIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred HHHHHccCChhHCcCHHHHHcCcc
Confidence 999999999999999999999843
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=422.77 Aligned_cols=244 Identities=18% Similarity=0.243 Sum_probs=199.6
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe----CCeeEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV 131 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv 131 (372)
|++..+||+|+||+||+|.+ .++..||||++..... ...+.|.+|+++|++++|||||+++++|.. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 45667799999999999994 5689999999975432 235679999999999999999999999865 3458999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeec-CCCCceeeccCCcccCCC
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~ 208 (372)
||||+||+|.+++++ .+.+++..+..|+.||+.||+|||++ + ||||||||+|||++ .++.+||+|||+++....
T Consensus 108 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999974 45799999999999999999999998 7 99999999999998 479999999999986544
Q ss_pred C--CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-HHhhhccccccccccccCCCChHHHHHH
Q 017395 209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
. ....||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ..+......... ...++...++++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~ 259 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEV 259 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----CCCCCccCCHHH
Confidence 3 34579999999999875 699999999999999999999999864321 111111111111 112233445789
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+|+.+||+.||++|||+.++++|-
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCc
Confidence 9999999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=424.57 Aligned_cols=244 Identities=17% Similarity=0.188 Sum_probs=201.9
Q ss_pred CccccccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
++|++++.||+|+||+||+|+. .+++.||||+++.... .+..++.+|+++|++++|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999985 2478999999975432 223468899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC--
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~-- 208 (372)
|||||+||+|.+++.+ .+.+++.++..++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+++....
T Consensus 104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999974 45699999999999999999999999 999999999999999999999999999986432
Q ss_pred --CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 209 --GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 209 --~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
.....||+.|||||++.+..|+.++|||||||++|||+||+.||.+............ . ...+|..+++++.
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~--~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----A--KLGMPQFLSPEAQ 254 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----C--CCCCCTTSCHHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc----C--CCCCCCcCCHHHH
Confidence 2356799999999999999999999999999999999999999976543322211111 1 1134566788999
Q ss_pred HHHHHHccCCCCCCCCh-----HHHHHH
Q 017395 287 RLASRCLQYEPRERPNP-----RSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~-----~~il~~ 309 (372)
+|+.+||+.||++|||+ +|+++|
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999999999999984 688776
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=427.73 Aligned_cols=257 Identities=20% Similarity=0.256 Sum_probs=212.9
Q ss_pred cCCCccccccccCCCCCCeEEEEEeCC------CcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCC-cceeeEeeEEEeC
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRN-RRLANLLGCCCEG 125 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h-pniv~l~~~~~~~ 125 (372)
-+.++|++.++||+|+||+||+|.+.. ++.||||.+....... .+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 355789999999999999999998532 3679999998655433 5679999999999965 8999999999764
Q ss_pred -CeeEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec
Q 017395 126 -DERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (372)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~ 190 (372)
+.++||||||++|+|.++|+... ...+++..+..|+.||+.||.|||++ +||||||||+|||++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLS 219 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccceeeC
Confidence 56899999999999999997532 24589999999999999999999999 999999999999999
Q ss_pred CCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhc
Q 017395 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDR 263 (372)
Q Consensus 191 ~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~ 263 (372)
+++.+||+|||+++...... ...||+.|||||++.+..|+.++|||||||+||||+| |+.||.+......
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~--- 296 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 296 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999999999998764432 2356889999999999999999999999999999998 8888865321111
Q ss_pred cccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+...+....+...|..+++++.+|+.+||+.||++|||+.+|+++|+.+.+
T Consensus 297 -~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 -FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp -HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 111111222334566677899999999999999999999999999998765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-57 Score=408.36 Aligned_cols=241 Identities=18% Similarity=0.249 Sum_probs=190.8
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC---------
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD--------- 126 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--------- 126 (372)
+|++++.||+|+||+||+|+ ..+++.||||+++..... ..+.+.+|+++|++++|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 68999999999999999999 457899999999765433 2467999999999999999999999987544
Q ss_pred ---eeEEEEecCCCCCHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 127 ---ERLLVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
.+|||||||++|+|.+++..... ...++..++.|+.||+.||+|||++ |||||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEccCcc
Confidence 37999999999999999975322 2356778899999999999999999 999999999999999999999999999
Q ss_pred cccCCCC----------------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc
Q 017395 203 MKNSRDG----------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ 266 (372)
Q Consensus 203 ~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 266 (372)
++..... ....||+.|||||++.+..|+.++|||||||++|||++ ||......... ..
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~---~~ 238 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT---LT 238 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH---HH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH---HH
Confidence 9865432 12468999999999999999999999999999999996 56543211110 00
Q ss_pred ccccccccCCCC---hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTDSCLEGQFS---SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+ ....+| ...++.+.+|+.+||+.||++|||+.++++|
T Consensus 239 ~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01 111222 3345678899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-57 Score=409.71 Aligned_cols=253 Identities=15% Similarity=0.191 Sum_probs=196.5
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHH--HHHHHHHhcCCCcceeeEeeEEEeCC----eeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQF--LEEARAVGQLRNRRLANLLGCCCEGD----ERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv 131 (372)
+|.+.++||+|+||+||+|++ +|+.||||+++... .+.+ ..|+..+.+++|||||+++++|...+ .+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 466678899999999999998 57899999997532 3334 44556667889999999999998654 57999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-------~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
||||++|+|.++++. .++++..+.+++.|++.||+|||++ .+||||||||+|||+++++++||+|||+++
T Consensus 80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999963 4699999999999999999999974 389999999999999999999999999998
Q ss_pred cCCCCC--------cccCCCCcCCcccccCC------CCCCCCceeehHHHHHHHHhCCCCCCchhhH-----Hh-----
Q 017395 205 NSRDGR--------SYSTNLAFTPPEYLRTG------RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----LI----- 260 (372)
Q Consensus 205 ~~~~~~--------~~~~t~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-----~~----- 260 (372)
...... ...||+.|||||++.+. .++.++|||||||++|||+||..|+...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 654321 24689999999999764 3678999999999999999998665321100 00
Q ss_pred -hhccccccccccccCCCC-----hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 261 -RDRNIQTLTDSCLEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 261 -~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.......+.....++.+| ..++..+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 000000111122222222 346678999999999999999999999999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=407.15 Aligned_cols=250 Identities=15% Similarity=0.232 Sum_probs=201.7
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEe------CCe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCE------GDE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 127 (372)
++|++++.||+|+||+||+|+ ..+|+.||||+++..... ..+++.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 469999999999999999999 467999999999754432 34578999999999999999999998764 357
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+|||||||+ |+|.+++. ..+.+++..+..|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 57999997 456799999999999999999999999 99999999999999999999999999998653
Q ss_pred C--------CCcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------ccc--
Q 017395 208 D--------GRSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TLT-- 269 (372)
Q Consensus 208 ~--------~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------~~~-- 269 (372)
. .....||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+............ ...
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 2 23467999999999988754 69999999999999999999999875432111100000 000
Q ss_pred ----------cccc-cC-----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 ----------DSCL-EG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 ----------~~~~-~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.... .. ...+..++++.+||.+||..||.+|||+.|+++|-
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 0000 00 00123467899999999999999999999999983
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=395.49 Aligned_cols=245 Identities=18% Similarity=0.227 Sum_probs=197.3
Q ss_pred CccccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 131 (372)
+.|+++++||+|+||+||+|+.+ +++.||||.+.... ...++.+|+++|+.+ +||||++++++|.+.+++|||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 45899999999999999999842 46889999987543 346788999999998 699999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-CCceeeccCCcccCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~~~~- 209 (372)
||||+||+|.+++. .+++.++..++.||+.||+|||++ |||||||||+|||++.+ +.+||+|||+++.....
T Consensus 99 mE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999983 499999999999999999999999 99999999999999876 79999999999754321
Q ss_pred -------------------------------CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhh
Q 017395 210 -------------------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL 257 (372)
Q Consensus 210 -------------------------------~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~ 257 (372)
....||+.|+|||++.+.. ++.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1246899999999998764 89999999999999999999999854321
Q ss_pred HHhhhccc-------------------------------ccccc---------c---------cccCCCChHHHHHHHHH
Q 017395 258 DLIRDRNI-------------------------------QTLTD---------S---------CLEGQFSSDEGTELVRL 288 (372)
Q Consensus 258 ~~~~~~~~-------------------------------~~~~~---------~---------~~~~~~~~~~~~~l~~l 288 (372)
+...-..+ ..... + ..........++++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 10000000 00000 0 00001123356789999
Q ss_pred HHHHccCCCCCCCChHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+||+.||++|||++|+++|
T Consensus 333 l~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=416.70 Aligned_cols=249 Identities=19% Similarity=0.149 Sum_probs=211.7
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
++|++++.||+|+||+||+|. ..+|+.||||++......+.+.+.+|+++|+.++|||||+++++|.+.+.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 578999999999999999999 4679999999998766556677999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC--CCceeeccCCcccCCCCC---
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--VNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~--~~~kl~Dfg~~~~~~~~~--- 210 (372)
+||+|.++|.. ....+++.++..++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++......
T Consensus 237 ~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 237 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred CCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999999964 345699999999999999999999999 99999999999999854 889999999999876543
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...||+.|||||++.+..|+.++|||||||++|||++|..||.+............... .........++.++.+||.
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW--NMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--CCCSGGGTTSCHHHHHHHH
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC--CCCcccccCCCHHHHHHHH
Confidence 35789999999999999999999999999999999999999876543222111111000 0111122345788999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||+.||.+|||+.|+++|
T Consensus 393 ~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999997
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=414.37 Aligned_cols=249 Identities=17% Similarity=0.138 Sum_probs=205.8
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC---ccHHHHH---HHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFL---EEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
..++|++++.||+|+||.||+|+ ..+|+.||||++.+... .....+. +++.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 45789999999999999999999 56799999999964221 1222333 44677788899999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+|||||||+||+|.++|.+ .+.+++..+..++.||+.||.|||++ |||||||||+||||+.+|.+||+|||+++...
T Consensus 267 lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999974 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CC--CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 208 DG--RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 208 ~~--~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
.. .+..||+.|||||++.. ..|+.++|||||||++|||++|..||.......... ....+.. ....+|...+++
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~--~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--MAVELPDSFSPE 420 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHH--CCCCCCTTSCHH
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcC--CCCCCCccCCHH
Confidence 43 45689999999999975 579999999999999999999999987542211100 0000111 112356667899
Q ss_pred HHHHHHHHccCCCCCCCC-----hHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps-----~~~il~~ 309 (372)
+.+||.+||+.||.+|++ +.+|++|
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 999999999999999998 7899988
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=366.68 Aligned_cols=262 Identities=24% Similarity=0.421 Sum_probs=222.1
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
....|++.+.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 33567788888999999999999878999999999877666678899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 135 MPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
+++|+|.+++.... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.....
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999996533 23589999999999999999999999 9999999999999999999999999998764321
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-----------HHhhhccccccccccccC
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----------DLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~ 275 (372)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ............++....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc
Confidence 223478999999999988999999999999999999999988754311 111122233334444445
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
..+...+..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 567888999999999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=369.00 Aligned_cols=256 Identities=19% Similarity=0.254 Sum_probs=214.9
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.++|.+.+.||+|+||+||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 45788899999999999999995 56899999999766655677899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+++++|.+++... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 9999999999753 45699999999999999999999999 99999999999999999999999999997654321
Q ss_pred --------------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCC
Q 017395 211 --------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (372)
Q Consensus 211 --------------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (372)
...||+.|+|||++.+..++.++||||||+++|||++|..|+......... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~ 243 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---FGLNVRGFLDRY 243 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---SSBCHHHHHHHT
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---Hhhhhhcccccc
Confidence 346889999999999999999999999999999999999877543211110 011111111122
Q ss_pred CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.+..+++.+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3455567899999999999999999999999999988764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=367.18 Aligned_cols=259 Identities=19% Similarity=0.297 Sum_probs=209.4
Q ss_pred hcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
...+.+|++++.||+|+||+||+|+. +++.||||++...... ..+.+.+|+++|++++||||+++++++......++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34567899999999999999999987 5778999999765433 24578999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeecCCCCceeeccCCcccCC
Q 017395 131 VAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ | ++||||||+||+++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999974321 2389999999999999999999999 8 9999999999999999999999999987544
Q ss_pred CC----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 208 DG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
.. ....+|+.|+|||++.+..++.++||||||+++|||++|+.||............ .........+..+++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV----GFKCKRLEIPRNLNP 266 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----HHSCCCCCCCTTSCH
T ss_pred ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcCCCCCCCccCCH
Confidence 32 3456899999999999999999999999999999999999988654322211111 111122234556778
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
++.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=369.77 Aligned_cols=250 Identities=19% Similarity=0.287 Sum_probs=212.2
Q ss_pred hcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
......|.+++.||+|+||.||+|.. .+++.||||++..... ...+++.+|+++|+.++||||+++++++...+..+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34467899999999999999999995 6799999999975432 23567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999999974 35699999999999999999999999 9999999999999999999999999999765443
Q ss_pred ---CcccCCCCcCCcccccCCCCC-CCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||............... ....|...+.++
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 241 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------KYRIPFYMSTDC 241 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHH
Confidence 345689999999999988765 7899999999999999999998765433332221111 112344567889
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+|+.+||+.||.+|||+.++++|-+
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 99999999999999999999999843
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=367.70 Aligned_cols=249 Identities=17% Similarity=0.236 Sum_probs=211.2
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
....|++++.||+|+||+||+|. ..+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34578999999999999999999 56789999999976665667789999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++|+|.+++.. ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 9999999999964 3599999999999999999999999 9999999999999999999999999998765433
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|+|||++.+..++.++||||||+++|||++|..||.............. ........+...+..+.+|+
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHH
Confidence 235689999999999999999999999999999999999999865422111110000 01111123455678899999
Q ss_pred HHHccCCCCCCCChHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l 310 (372)
.+||+.||.+|||+.++++|-
T Consensus 251 ~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTTCG
T ss_pred HHHccCChhHCcCHHHHhhCh
Confidence 999999999999999999873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=362.26 Aligned_cols=263 Identities=16% Similarity=0.196 Sum_probs=218.5
Q ss_pred cccCHHHHHHHhcCCCc-------cccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc
Q 017395 42 CEYSIETLRTATSGFAM-------ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR 113 (372)
Q Consensus 42 ~~~~~~~~~~~~~~~~~-------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp 113 (372)
..++.++++.+++.... |.....||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34788888888876432 556678899999999999954 7999999999876666677899999999999999
Q ss_pred ceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 114 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
||+++++++...+..++||||+++++|.+++. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999999985 35699999999999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCC----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccc
Q 017395 194 NPRLSCFGLMKNSRDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT 269 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 269 (372)
.+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||............ ....
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~-~~~~ 257 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSP 257 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSS
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCC
Confidence 9999999998765432 3456899999999999989999999999999999999999988654322111111 0000
Q ss_pred cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+ ....+...+..+.+++.+||+.||++|||+.+++++-.
T Consensus 258 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 258 PP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp CC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00 01122345688999999999999999999999999854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=370.77 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=211.9
Q ss_pred CCccccccccCCCCCCeEEEEEe--------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 125 (372)
.++|.+.+.||+|+||.||+|.. .++..||||+++..... ..+.+.+|+++|+++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788999999999999999984 23567999999865432 356799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~ 191 (372)
+..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ |++||||||+|||++.
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchhhEEECC
Confidence 99999999999999999997543 23589999999999999999999999 9999999999999999
Q ss_pred CCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 017395 192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~ 264 (372)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~-- 316 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-- 316 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH--
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--
Confidence 999999999999865432 22345678999999999999999999999999999999 888876533221111
Q ss_pred ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
..........+..++.++.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 317 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 317 ---LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ---HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111112223455677899999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=354.25 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=214.7
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+.++|++++.||+|+||.||+|...+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346799999999999999999998788899999998654 3457799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 87 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999999964 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....++..|+|||++.+..++.++||||||+++|+|++ |..||............... .....+...+.++.++
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQI 239 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHH
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----ccCCCCCcCCHHHHHH
Confidence 23345678999999998999999999999999999999 88777654322222111111 1122344456889999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
+.+||+.||.+|||+.+++++|+.+.+.
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999988653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=366.06 Aligned_cols=246 Identities=17% Similarity=0.224 Sum_probs=209.9
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCC---CCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
..++|++++.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+++|+.++||||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 346899999999999999999994 56899999999743 22345678999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC--
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~-- 208 (372)
||||++||+|.+++.. .+.+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++....
T Consensus 83 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999999973 45699999999999999999999999 999999999999999999999999999986432
Q ss_pred --CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 209 --GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 209 --~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............... ...++...+.++.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~ 233 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAK 233 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHH
Confidence 23456899999999999999999999999999999999999998754332222111111 1134556678999
Q ss_pred HHHHHHccCCCCCCC-----ChHHHHHH
Q 017395 287 RLASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
+|+.+||+.||.+|| ++.++++|
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999999 89999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=363.74 Aligned_cols=272 Identities=28% Similarity=0.464 Sum_probs=224.5
Q ss_pred CcccccCHHHHHHHhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceee
Q 017395 39 PVFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLAN 117 (372)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~ 117 (372)
.....+++.++...+++ |.+.+.||+|+||.||+|...+++.||||++...... ....+.+|++++++++||||++
T Consensus 15 ~~~~~~~~~~~~~~~~~---y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 15 GQLKRFSLRELQVASDN---FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CCCEECCTHHHHTTTTS---SCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred CccceecHHHHHHHhhc---cccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 34567888888766655 5567777999999999999878999999999865432 2336899999999999999999
Q ss_pred EeeEEEeCCeeEEEEecCCCCCHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCC--CcccccccCcceeecCCC
Q 017395 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKE--RALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 118 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~--~iiH~Dikp~Nill~~~~ 193 (372)
+++++......++||||+++|+|.+++.... ...+++..++.|+.|++.||.|||++. |++||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 9999999999999999999999999997643 235999999999999999999999863 899999999999999999
Q ss_pred CceeeccCCcccCCCC-----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-----------
Q 017395 194 NPRLSCFGLMKNSRDG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----------- 257 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~----------- 257 (372)
.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999999865432 224478999999999988899999999999999999999998853211
Q ss_pred --HHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 258 --DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 258 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
..........+........++...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 01112223334444445566788899999999999999999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=364.02 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=212.3
Q ss_pred CCCccccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
....|++.+.||+|+||.||+|... .+..||||++...... ..+.|.+|++++++++||||+++++++...+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3457899999999999999999963 3456999999865332 3567999999999999999999999999989999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++++|.++++. ....+++..++.|+.|++.||.|||++ |++||||||+|||++.++.+||+|||+++.....
T Consensus 127 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999964 345699999999999999999999999 9999999999999999999999999999876443
Q ss_pred C-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
. ...+|+.|+|||++.+..++.++||||||+++|||++ |..||............. .......+..+
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~ 279 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-----EGYRLPAPMGC 279 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-----TTCCCCCCTTC
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-----cCCCCCCCCCc
Confidence 2 1234667999999998889999999999999999999 888876543222211111 11122334566
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
+.++.+|+.+||+.||.+|||+.+|++.|+.+.+...
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 7899999999999999999999999999999877543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=356.65 Aligned_cols=258 Identities=17% Similarity=0.244 Sum_probs=210.4
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+|++++.||+|+||.||+|.. .+++.||+|.+....... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4689999999999999999994 568999999986543322 457899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+++++|.+++.. .+++++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999974 35699999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||................... .....+...+..+.+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-VTTDVRKDIPQSLSN 246 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-HHHHSCTTSCHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-cchhcccCCCHHHHH
Confidence 23457999999999999999999999999999999999999987653322211111111111 111123445688999
Q ss_pred HHHHHccCCCCCCC-ChHHHHHHHHhhhcCCC
Q 017395 288 LASRCLQYEPRERP-NPRSLVTALVTLQKDTE 318 (372)
Q Consensus 288 li~~cl~~dp~~Rp-s~~~il~~l~~~~~~~~ 318 (372)
++.+||+.||.+|| +++++.+.|..+.....
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 99999999999998 89999999988765443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=371.08 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=202.9
Q ss_pred CCccccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
...|.+.+.||+|+||.||+|+.. ++..||||+++..... ..+.|.+|++++++++||||+++++++......++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 346888899999999999999854 5778999999865332 35579999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++......
T Consensus 124 v~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999974 344699999999999999999999999 99999999999999999999999999998654332
Q ss_pred -------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 211 -------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
...++..|+|||++.+..++.++||||||+++|||++ |+.||............ ........+..++
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-----~~~~~~~~~~~~~ 276 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-----DEGYRLPPPMDCP 276 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-----HTTEECCCCTTCB
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCcccc
Confidence 1223568999999999999999999999999999998 88887643322221111 1111122344566
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 889999999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=366.97 Aligned_cols=248 Identities=18% Similarity=0.195 Sum_probs=206.9
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
+.|.+++.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.+|++++||||+++++++......+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 3588999999999999999994 56899999999754332 3567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC----CceeeccCCccc
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKN 205 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg~~~~ 205 (372)
+||||++||+|.+++. ....+++..++.++.||+.||.|||++ |++||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999996 345799999999999999999999999 999999999999998776 799999999987
Q ss_pred CCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.................. .........+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s 246 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD--FDEEFFSQTS 246 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSC
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCchhccCCC
Confidence 6543 3456899999999999989999999999999999999999998754322221111110000 0001112346
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.++.+||.+||..||.+|||+.++++|
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 789999999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=359.41 Aligned_cols=260 Identities=19% Similarity=0.288 Sum_probs=211.3
Q ss_pred CCccccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--Cee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 128 (372)
-.+|++++.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35789999999999999999984 35889999999876655567899999999999999999999998653 568
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999999753 34599999999999999999999999 999999999999999999999999999987543
Q ss_pred CC-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc-----------ccccccc
Q 017395 209 GR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR-----------NIQTLTD 270 (372)
Q Consensus 209 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----------~~~~~~~ 270 (372)
.. ...++..|+|||++.+..++.++||||||+++|||++|..|+........... .......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 32 23356679999999999999999999999999999999988765432211100 0111111
Q ss_pred ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.......+..++.++.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11222345667789999999999999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=351.47 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=212.7
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 130 (372)
++.+|++++.||+|+||.||+|+.. ++.||||++...... ..+.+.+|+.++++++||||+++++++... ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 5678999999999999999999984 788999999865432 355799999999999999999999999877 78899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
||||+++|+|.+++.......+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||+......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999999865555799999999999999999999998 8 99999999999999999999999888755333
Q ss_pred CCcccCCCCcCCcccccCCCCCC---CCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRVTP---ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~---~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
....+|+.|+|||++.+..++. ++||||||+++|||++|+.||........... ..........+..++.++
T Consensus 166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIPPGISPHV 240 (271)
T ss_dssp -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCCTTCCHHH
T ss_pred -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCCCCCCHHH
Confidence 3456789999999998766544 79999999999999999998865432222111 111112223455667899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=351.70 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=212.4
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..+|++++.||+|+||.||+|...++..||||++..... ..+++.+|++++++++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 357899999999999999999988888999999986543 4567999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 210 (372)
++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 999999999642 34599999999999999999999999 99999999999999999999999999998654432
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...+|..|+|||++.+..++.++||||||+++|+|++ |..||.............. ......+...+..+.+++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-----GHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-----TCCCCCCTTSCHHHHHHH
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-----CCCCCCCCcChHHHHHHH
Confidence 2334567999999998889999999999999999999 8888754332222111111 111122344567899999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.+||+.||.+|||+.+++++|+.+.+..
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 9999999999999999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=352.93 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=211.3
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+..+|++++.||+|+||.||+|...++..||||++.... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 445889999999999999999998888899999998654 3457799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 9999999999742 35699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.............. ......+...+..+.++
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-----GLRLYRPHLASEKVYTI 253 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-----TCCCCCCTTCCHHHHHH
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-----ccCCCCCCcCCHHHHHH
Confidence 23345678999999998899999999999999999998 8888765332222111111 11122334456889999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
+.+||+.||.+|||+.+++++|+.+...
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=358.34 Aligned_cols=246 Identities=17% Similarity=0.214 Sum_probs=210.2
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
...+|++++.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 456899999999999999999995 578999999997432 2235678899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||++||+|.+++.. ...+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 9999999999999974 45699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............. .. ...++...+.++.+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~--~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----NA--ELRFPPFFNEDVKDLL 234 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HC--CCCCCTTSCHHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hC--CCCCCCCCCHHHHHHH
Confidence 34678999999999999999999999999999999999999986543222211111 11 1124555678999999
Q ss_pred HHHccCCCCCCC-----ChHHHHHH
Q 017395 290 SRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
.+||..||.+|| ++.++++|
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999 89999988
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=374.66 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=212.5
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC-eeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e 133 (372)
+..+|++++.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|++++||||+++++++.... ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 5578899999999999999999984 6799999998654 4578999999999999999999999987765 7999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-Ccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 212 (372)
|+++|+|.+++.......+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..... ...
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 99999999999865445589999999999999999999999 9999999999999999999999999999865433 233
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
.++..|+|||++.+..++.++||||||+++|||++ |+.||.......... ..........+..+++++.+|+.+
T Consensus 347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-----~i~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-----HHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCcCCHHHHHHHHH
Confidence 56789999999999999999999999999999998 888876432211111 111112223456677899999999
Q ss_pred HccCCCCCCCChHHHHHHHHhhhcC
Q 017395 292 CLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
||+.||.+|||+.++++.|+.+...
T Consensus 422 cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=349.51 Aligned_cols=272 Identities=28% Similarity=0.475 Sum_probs=222.5
Q ss_pred cccccCHHHHHHHhcCCCcccc---ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCC----CccHHHHHHHHHHHhcCCC
Q 017395 40 VFCEYSIETLRTATSGFAMENI---VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRN 112 (372)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~---~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 112 (372)
....|++.++..++++|+...+ .+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4577899999999999976522 26689999999999997 57799999997532 2235679999999999999
Q ss_pred cceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC
Q 017395 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (372)
Q Consensus 113 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~ 191 (372)
|||+++++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDE 168 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECT
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcC
Confidence 999999999999999999999999999999986432 35699999999999999999999999 9999999999999999
Q ss_pred CCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH----hh
Q 017395 192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IR 261 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~----~~ 261 (372)
++.+||+|||++...... ....+|+.|+|||++.+ .++.++||||||+++|+|++|..||....... +.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999998765432 23467899999998875 58899999999999999999998875432110 00
Q ss_pred h------ccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 262 D------RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 262 ~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
. .......... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 0 0011111111 123466788999999999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=373.02 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=211.1
Q ss_pred CCCccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+..+|.+.+.||+|+||.||+|.+. +++.||||.+....... .+.|.+|+++|++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3457888999999999999999964 78999999997543322 346889999999999999999999999989999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
||+++|+|.++++. ....+++..++.++.|++.||+|||++ |++||||||+|||++.++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp ECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999974 234589999999999999999999999 99999999999999999999999999988654321
Q ss_pred ----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 211 ----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
...++..|+|||++.++.++.++|||||||++|||++ |..|+.......... ..........+..++.++
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-----FVEKGGRLPCPELCPDAV 344 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-----HHHTTCCCCCCTTCCHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCCCCHHH
Confidence 1223567999999998889999999999999999998 888776543222111 111111223345567899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus 345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=358.94 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=209.4
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCC-------cEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQ-------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
..+|.+.+.||+|+||.||+|.. .++ ..||+|++........+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 35788999999999999999984 334 4799999987665667789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC--------ceeec
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--------PRLSC 199 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~--------~kl~D 199 (372)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++. +||+|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999999999999999753 33499999999999999999999999 9999999999999998877 99999
Q ss_pred cCCcccCCCCCcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 200 FGLMKNSRDGRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 200 fg~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
||++..........+|..|+|||++.+ ..++.++||||||+++|||++|..|+.............. .....+
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~------~~~~~~ 238 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE------DRHQLP 238 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------TTCCCC
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh------ccCCCC
Confidence 999987666555667899999999987 6689999999999999999997666543321111111000 011223
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
...+.++.+|+.+||+.||.+|||+.+++++|+.+.....
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 3345679999999999999999999999999998876443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=360.85 Aligned_cols=258 Identities=15% Similarity=0.214 Sum_probs=204.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC----eeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD----ERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~l 130 (372)
+..+|++++.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3458999999999999999999974 7899999997543 23445677999999999999999999998754 4799
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCcccccccCcceeecCCCCceeeccC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK---------ERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---------~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
||||+++|+|.++++. ..+++..++.++.|++.||.|||+. .|++||||||+|||++.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999964 4599999999999999999999985 289999999999999999999999999
Q ss_pred CcccCCCC------CcccCCCCcCCcccccCC-----CCCCCCceeehHHHHHHHHhCCCCCCchhhH------------
Q 017395 202 LMKNSRDG------RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD------------ 258 (372)
Q Consensus 202 ~~~~~~~~------~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~------------ 258 (372)
+++..... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99764432 234679999999999873 3567889999999999999999887542110
Q ss_pred ----HhhhccccccccccccCC-CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 259 ----LIRDRNIQTLTDSCLEGQ-FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 259 ----~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.+..........+..... .....+.++.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000000000111111111 12345678999999999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=365.45 Aligned_cols=254 Identities=17% Similarity=0.114 Sum_probs=198.8
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+..+|++++.||+|+||+||+|+. .+++.||||++..... ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 456899999999999999999995 4789999999976443 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC--ceeeccCCcccCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNSRD--- 208 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~--~kl~Dfg~~~~~~~--- 208 (372)
|+++|+|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+||+++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999999999963 34699999999999999999999999 9999999999999987665 99999999874332
Q ss_pred CCcccCCCCcCCcccccCCCCCCC-CceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRVTPE-SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~-~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+.............+.++.+
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 234568999999999988877655 8999999999999999999865321111011111111111111111235688999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHHh
Q 017395 288 LASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
|+.+||+.||.+|||+.++++|-+-
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HHHHHccCChhHCcCHHHHHhCcch
Confidence 9999999999999999999999553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=352.97 Aligned_cols=248 Identities=15% Similarity=0.175 Sum_probs=200.4
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--------------------------cHHHHHHHHHHH
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--------------------------DARQFLEEARAV 107 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l 107 (372)
.+.+|.+++.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 456899999999999999999994 56899999999754321 134689999999
Q ss_pred hcCCCcceeeEeeEEEe--CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCc
Q 017395 108 GQLRNRRLANLLGCCCE--GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (372)
Q Consensus 108 ~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~ 185 (372)
++++||||+++++++.. ....++||||+++++|.+++ ....+++..++.++.|++.||.|||++ |++||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHH
Confidence 99999999999999986 56899999999999998876 345799999999999999999999999 9999999999
Q ss_pred ceeecCCCCceeeccCCcccCCCC----CcccCCCCcCCcccccCCC---CCCCCceeehHHHHHHHHhCCCCCCchhhH
Q 017395 186 RIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALD 258 (372)
Q Consensus 186 Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~t~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~ 258 (372)
||+++.++.+||+|||++...... ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 999999999999999999876543 2356899999999998765 377899999999999999999998754332
Q ss_pred HhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 259 LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.......... .........+.++.+|+.+||+.||++|||+.++++|-
T Consensus 247 ~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 247 CLHSKIKSQA----LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp HHHHHHHHCC----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred HHHHHHhccc----CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 2211111111 11111234567899999999999999999999998873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=352.06 Aligned_cols=250 Identities=17% Similarity=0.188 Sum_probs=201.5
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.+|++++.||+|+||+||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999995 56899999999754432 24678999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++ +|.+.+.. ..+.+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9976 56665543 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhH-Hhhhcccc--------------cccc---
Q 017395 210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQ--------------TLTD--- 270 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~--------------~~~~--- 270 (372)
....+|+.|+|||++.+.. ++.++|||||||++|+|++|..|+...... ........ ....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 3346789999999998766 799999999999999999998886432111 00000000 0000
Q ss_pred ------ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 271 ------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 271 ------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...........+.++.+|+.+||+.||++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000011223467889999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=361.03 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=215.4
Q ss_pred HHHhcCCCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEE
Q 017395 50 RTATSGFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCC 122 (372)
Q Consensus 50 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~ 122 (372)
.........|++++.||+|+||.||+|... +++.||||+++...... .+.+.+|++++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 334455678999999999999999999963 34889999998654333 56799999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCCHHhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc
Q 017395 123 CEGDERLLVAEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYH 180 (372)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~ 180 (372)
...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++ |++||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~ 198 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHR 198 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence 99999999999999999999997532 15699999999999999999999999 99999
Q ss_pred cccCcceeecCCCCceeeccCCcccCCC------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCC
Q 017395 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPP 253 (372)
Q Consensus 181 Dikp~Nill~~~~~~kl~Dfg~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~ 253 (372)
||||+||+++.++.+||+|||++..... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999875432 223456788999999998899999999999999999999 888876
Q ss_pred chhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 254 SHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.............. .....+..++.++.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 279 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 279 GMAHEEVIYYVRDG-----NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TSCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCChHHHHHHHhCC-----CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 54322221111111 111234556789999999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.35 Aligned_cols=251 Identities=16% Similarity=0.170 Sum_probs=209.0
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
...|.+++.||+|+||.||+|.. .+++.||+|.+.... .+...+.+|+++++.++||||+++++++...+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46799999999999999999994 568899999997543 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC--CCCceeeccCCcccCCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~-- 210 (372)
+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999999964 334699999999999999999999999 9999999999999986 7899999999998765543
Q ss_pred -cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...+|+.|+|||++.+..++.++||||||+++|+|++|..||................... ........+.++.+|+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--DEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CHHHHTTSCHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC--ChhhhccCCHHHHHHH
Confidence 3457899999999998889999999999999999999999986543322211111110000 0000123467899999
Q ss_pred HHHccCCCCCCCChHHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+||..||.+|||+.++++|-+
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHcCCChhHCcCHHHHhcChh
Confidence 9999999999999999999855
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=367.29 Aligned_cols=246 Identities=18% Similarity=0.245 Sum_probs=205.3
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
...+|++++.||+|+||.||+|+. .+++.||||++.... ....+.+.+|..+|..+ +||||+++++++...+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 467899999999999999999994 568999999997431 12345688999999988 7999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999974 35699999999999999999999999 999999999999999999999999999986432
Q ss_pred ---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............... ...++...+.++
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~ 251 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLHEDA 251 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHH
Confidence 23456899999999999888999999999999999999999998765433222111111 112345567889
Q ss_pred HHHHHHHccCCCCCCCCh------HHHHHH
Q 017395 286 VRLASRCLQYEPRERPNP------RSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~------~~il~~ 309 (372)
.+|+.+||+.||.+||++ .++++|
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 999999999999999998 888887
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=374.79 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=213.6
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..+|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++. ....++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45688889999999999999998888899999998654 45778999999999999999999999986 66799999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----C
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----~ 210 (372)
++|+|.++++......+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..... .
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 999999999754334689999999999999999999999 9999999999999999999999999999875432 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|+|||++.+..++.++|||||||++|||++ |+.||............ ........+..++.++.+|+
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~~~~~~~~l~~li 418 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-----ERGYRMPRPENCPEELYNIM 418 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-----HHTCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHHHHHH
Confidence 2345678999999998899999999999999999999 88887653322211111 11112223456678999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.+||+.||.+|||+.+|++.|+.+....
T Consensus 419 ~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 419 MRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999999999886543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=355.74 Aligned_cols=253 Identities=19% Similarity=0.218 Sum_probs=202.6
Q ss_pred cCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.-..+|++++.||+|+||+||+|...+++.||||++...... ..+.+.+|++++++++||||+++++++......++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345789999999999999999999888999999999754322 246789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|||+++ +|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EcCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 999985 78888864 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------c------------
Q 017395 210 --RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------T------------ 267 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------~------------ 267 (372)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............. .
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 23467899999999986 4589999999999999999999998864321111000000 0
Q ss_pred -----cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 -----LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..............++++.+|+.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000112345789999999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=365.23 Aligned_cols=249 Identities=16% Similarity=0.218 Sum_probs=207.1
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
++++|.+++.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++|+.++||||++++++|......|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56789999999999999999999 4568899999986432 2335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+.||+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999997 345699999999999999999999999 9999999999999999999999999999876443
Q ss_pred --CcccCCCCcCCcccccC---CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ...+.. ....++...+.+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~~~~--~~~~~p~~~s~~ 246 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI-VHTFET--TVVTYPSAWSQE 246 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH-HHHHHH--CCCCCCTTSCHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH-HHHHhh--cccCCCCcCCHH
Confidence 34678999999999974 4589999999999999999999999863211110000 000000 112345566789
Q ss_pred HHHHHHHHccCCCCCCCC-hHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPN-PRSLVTA 309 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps-~~~il~~ 309 (372)
+.+|+.+||+.||.+||+ +.++++|
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 999999999999999998 7888775
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=349.28 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=199.8
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc----cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
++.+|++.+.||+|+||.||+|... ++.||||++...... ..+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 5678999999999999999999974 788999999754332 24678999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---cccccccCcceeecC--------CCCceeec
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER---ALYHDLNAYRIVFDD--------DVNPRLSC 199 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~---iiH~Dikp~Nill~~--------~~~~kl~D 199 (372)
||||+++++|.+++. .+.+++..++.++.|++.||.|||++ | ++||||||+||+++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999984 45799999999999999999999998 8 899999999999985 77899999
Q ss_pred cCCcccCCCC--CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 200 FGLMKNSRDG--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 200 fg~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
||++...... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||............ .........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~ 235 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV----AMNKLALPI 235 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----HTSCCCCCC
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh----hcCCCCCCC
Confidence 9999765433 2356789999999999988999999999999999999999988654322211111 111112233
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+..++..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 455678999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=370.42 Aligned_cols=248 Identities=17% Similarity=0.174 Sum_probs=206.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+.|++++.||+|+||.||+|. ..+++.||+|++...... +.+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 368899999999999999998 467899999999765433 34568999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec---CCCCceeeccCCcccCCCC-
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~~~~~~- 209 (372)
|++||+|.+.+.. ...+++..+..++.||+.||.|||++ |++||||||+|||++ .++.+||+|||++......
T Consensus 91 ~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999999974 45699999999999999999999999 999999999999998 4678999999999876543
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.................. .........++++.
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--FPSPEWDTVTPEAK 245 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--CCTTTTTTSCHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCccccccCCHHHH
Confidence 2356899999999999989999999999999999999999998654332222111111110 01111234568899
Q ss_pred HHHHHHccCCCCCCCChHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+|+.+||+.||.+|||+.++++|
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=365.68 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=211.5
Q ss_pred CCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
...|.+++.||+|+||.||+|.+. +++.||||++..... ....++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357889999999999999999843 467899999975433 2345789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC---Cceeecc
Q 017395 129 LLVAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCF 200 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~---~~kl~Df 200 (372)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ |++||||||+|||++.++ .+||+||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 99999999999999997532 24589999999999999999999999 999999999999999554 5999999
Q ss_pred CCcccC------CCCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccc
Q 017395 201 GLMKNS------RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL 273 (372)
Q Consensus 201 g~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (372)
|+++.. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||............. ...
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-----~~~ 303 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-----SGG 303 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-----TTC
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCC
Confidence 998743 22334557889999999999999999999999999999998 888876543222221111 111
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
....+..++..+.+|+.+||+.||.+|||+.+|+++|+.+.....
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 122345566889999999999999999999999999999877643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=378.77 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=215.4
Q ss_pred CCccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
..+|.+.+.||+|+||.||+|.+. ++..||||.+.... ...+.|.+|+++|++++||||++++++|......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 456888999999999999999964 48899999998654 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+++|+|.++++......+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 9999999999875666799999999999999999999999 99999999999999999999999999998764322
Q ss_pred -cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
...++..|+|||++.+..++.++|||||||++|||++ |..||......... ...........+..++.++.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----ELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----HHHHTTCCCCCCTTCCHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHcCCCCCCCCCCCHHHHHH
Confidence 2234678999999998889999999999999999999 88777653222111 1111222233456677899999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
+.+||+.||.+|||+.+|++.|+.+...
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999987644
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=357.43 Aligned_cols=257 Identities=16% Similarity=0.135 Sum_probs=208.0
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
..|++++.||+|+||.||+|. ..+++.||||++..... .+.+.+|+++++++ +||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 468899999999999999999 46789999999975432 34588999999999 899999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC-----ceeeccCCcccCCCC
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-----PRLSCFGLMKNSRDG 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~-----~kl~Dfg~~~~~~~~ 209 (372)
+ +++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+|||++.++. +||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 9 99999999753 45799999999999999999999999 9999999999999998887 999999999864322
Q ss_pred -----------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh--ccccccccccccCC
Q 017395 210 -----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD--RNIQTLTDSCLEGQ 276 (372)
Q Consensus 210 -----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~ 276 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..+...........
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 24568999999999999999999999999999999999999986531110000 00000000000000
Q ss_pred CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
.....+ ++.+++.+||+.||.+||++.+|++.|+.+......
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 011234 899999999999999999999999999988765443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=357.17 Aligned_cols=248 Identities=17% Similarity=0.161 Sum_probs=206.1
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+++|++++||||+++++++......++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 588999999999999999995 56899999999754322 35779999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC----CceeeccCCcccC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg~~~~~ 206 (372)
||||+++++|.+++. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 92 ILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999996 345699999999999999999999999 999999999999999877 7999999999876
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||................ ...........+.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSA 246 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC--CCCCHHHHTTSCH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC--CCcCccccccCCH
Confidence 433 34568999999999998899999999999999999999999986543221111110000 0000001123457
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+.+|+.+||+.||.+|||+.++++|-
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 899999999999999999999999973
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=361.32 Aligned_cols=249 Identities=18% Similarity=0.205 Sum_probs=206.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|.+++.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 688999999999999999995 56899999999765432 346789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC---CCceeeccCCcccCCCCC-
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~~~~~~- 210 (372)
+++|+|.+++. ....+++..++.++.||+.||.|||++ |++||||||+|||++.+ +.+||+|||++.......
T Consensus 110 ~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 110 VTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred CCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999986 345699999999999999999999999 99999999999999865 459999999998765432
Q ss_pred --cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.................. ........++.++.+|
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTGGGGSCHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHHH
Confidence 356899999999999989999999999999999999999998654322221111111000 0001113456889999
Q ss_pred HHHHccCCCCCCCChHHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.+||+.||.+|||+.++++|-+
T Consensus 265 i~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSHH
T ss_pred HHHHcCCChhhCcCHHHHhcCcc
Confidence 99999999999999999998843
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=360.00 Aligned_cols=250 Identities=17% Similarity=0.137 Sum_probs=203.9
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+.+|++++.||+|+||+||+|.. .+++.||||++....... .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999995 478999999997543322 4568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++++|.+++. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999996 445699999999999999999999999 9999999999999999999999999999754321
Q ss_pred --CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... ................+..+.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH---HHHHTTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhcccccCCccccCCHHHH
Confidence 24568999999999987775 778999999999999999999986432110000 000000001111234568899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+|+.+||+.||.+|||+.+++++-+
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHccCChhhCcCHHHHhhChh
Confidence 9999999999999999999999854
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=363.88 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=213.8
Q ss_pred CCccccccccCCCCCCeEEEEEeC--------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 125 (372)
...|.+.+.||+|+||.||+|+.. .+..||||++...... ..+++.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457889999999999999999842 2357999999865433 346799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~ 191 (372)
+..++||||+++|+|.+++.... ...+++..++.|+.|++.||.|||++ |++||||||+|||++.
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcC
Confidence 99999999999999999997543 24599999999999999999999999 9999999999999999
Q ss_pred CCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 017395 192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~ 264 (372)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~ 306 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999865432 22345678999999999999999999999999999999 88887654332222111
Q ss_pred ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
........+..++.++.+|+.+||+.||++|||+.+++++|+.+.....
T Consensus 307 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 307 -----KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp -----HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111223345567899999999999999999999999999999876443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=353.74 Aligned_cols=258 Identities=13% Similarity=0.145 Sum_probs=209.2
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC--eeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~ 132 (372)
..|.+++.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 4689999999999999999995 4589999999975432 33567899999999999999999999998765 789999
Q ss_pred ecCCCCCHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee----cCCCCceeeccCCcccCC
Q 017395 133 EYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill----~~~~~~kl~Dfg~~~~~~ 207 (372)
||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||++ +.++.+||+|||+++...
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999999975332 3499999999999999999999999 99999999999999 777889999999998765
Q ss_pred CCC---cccCCCCcCCccccc--------CCCCCCCCceeehHHHHHHHHhCCCCCCchhh-----HHh---hhcccccc
Q 017395 208 DGR---SYSTNLAFTPPEYLR--------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----DLI---RDRNIQTL 268 (372)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~--------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-----~~~---~~~~~~~~ 268 (372)
... ...+|..|+|||++. +..++.++|||||||++|||++|+.||..... ... ........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 443 346789999999986 46789999999999999999999988752111 000 00000000
Q ss_pred c---------------cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 269 T---------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 269 ~---------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
. .......++...+..+.+++.+||+.||++|||+++++++......
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 0 0011123457788999999999999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=367.28 Aligned_cols=251 Identities=16% Similarity=0.219 Sum_probs=206.1
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCee
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 128 (372)
....+|++++.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|..+|.++ +||||+++++++...+..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3567899999999999999999994 56889999999754322 234578999999887 899999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||++||+|..++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999999974 35699999999999999999999999 999999999999999999999999999985322
Q ss_pred ----CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc-----cccccccccccCCCCh
Q 017395 209 ----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR-----NIQTLTDSCLEGQFSS 279 (372)
Q Consensus 209 ----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 279 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+.. ....+|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~ 283 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR 283 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCC
Confidence 2345789999999999999999999999999999999999999853211100000 0001111 1123456
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCh------HHHHHH
Q 017395 280 DEGTELVRLASRCLQYEPRERPNP------RSLVTA 309 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~------~~il~~ 309 (372)
..+.++.+||.+||+.||.+||++ .+|++|
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 677899999999999999999985 688877
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=360.84 Aligned_cols=247 Identities=17% Similarity=0.172 Sum_probs=210.9
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
...+|++++.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++|+.++||||+++++++.+....|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 457899999999999999999995 568999999986432 2235678999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999999974 34699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|+|||++.+..++.++|||||||++|||++|..||.............. . ...++...+.++.+|+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----G--KVRFPSHFSSDLKDLL 269 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----C--CCCCCTTCCHHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHH
Confidence 345789999999999999999999999999999999999999875432222111111 1 1124556678999999
Q ss_pred HHHccCCCCCCCC-----hHHHHHHH
Q 017395 290 SRCLQYEPRERPN-----PRSLVTAL 310 (372)
Q Consensus 290 ~~cl~~dp~~Rps-----~~~il~~l 310 (372)
.+||+.||.+||+ +.+|++|-
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCc
Confidence 9999999999998 99999883
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=364.92 Aligned_cols=259 Identities=14% Similarity=0.148 Sum_probs=206.4
Q ss_pred CCCccccccccCCC--CCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEK--APNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
+..+|++++.||+| +||.||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 44579999999999 9999999995 47999999999754322 2456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
+||||+++|+|.+++.......+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||.+.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999999865556799999999999999999999999 999999999999999999999999998754311
Q ss_pred ----------CCcccCCCCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccc----c--
Q 017395 209 ----------GRSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----D-- 270 (372)
Q Consensus 209 ----------~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----~-- 270 (372)
.....+|..|+|||++.+ ..++.++|||||||++|||++|+.||................. +
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 122367888999999987 5689999999999999999999999864321111100000000 0
Q ss_pred ----------------------------------ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH--HHhhh
Q 017395 271 ----------------------------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ 314 (372)
Q Consensus 271 ----------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--l~~~~ 314 (372)
......++...++++.+|+.+||+.||.+|||+.++++| ++.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000011234456789999999999999999999999998 44443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=361.49 Aligned_cols=254 Identities=17% Similarity=0.261 Sum_probs=206.2
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcE----EEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFR----IAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
-.+|++++.||+|+||+||+|.+ .+++. ||+|.+..... ...+.+.+|+.++++++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35789999999999999999994 44544 88888864432 22456789999999999999999999985 46789
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+.+|+|.+++... ...+++..++.|+.|++.||.|||++ |++||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 999999999999999743 35689999999999999999999999 9999999999999999999999999999875433
Q ss_pred ------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 ------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
....++..|+|||++.+..++.++||||||+++|+|++ |..||.......... ..........+..++
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-----LLEKGERLAQPQICT 243 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-----HHHTTCBCCCCTTBC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-----HHHcCCCCCCCCcCc
Confidence 22346778999999999999999999999999999999 998876532221111 111111122344456
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.++.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 78999999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=349.72 Aligned_cols=251 Identities=16% Similarity=0.221 Sum_probs=202.3
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.+|++++.||+|+||+||+|...+++.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999999878999999999754322 246789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
+++ +|.+++.. ..+.+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 976 89998864 335699999999999999999999999 9999999999999999999999999998765422 2
Q ss_pred cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-----------cc-----c----
Q 017395 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------TL-----T---- 269 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-----------~~-----~---- 269 (372)
...+|+.|+|||++.+. .++.++|||||||++|||++|+.||.............. .. .
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 34678999999999764 489999999999999999999998865321111100000 00 0
Q ss_pred ---cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 ---DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 ---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+.....+....+.++.+|+.+||+.||++|||+.++++|-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000112234568899999999999999999999999873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=361.81 Aligned_cols=249 Identities=18% Similarity=0.215 Sum_probs=208.3
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
..+..|.+++.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++||||+++++++......+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3457899999999999999999994 678999999986421 122457899999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+ +|+|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+|||+++++.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999999 6789998863 35699999999999999999999999 9999999999999999999999999999865543
Q ss_pred ---CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+.. .....+...++++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~--~~~~~p~~~s~~~ 235 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNS--CVYVMPDFLSPGA 235 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCS--SCCCCCTTSCHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHc--CCCCCcccCCHHH
Confidence 34568999999999998775 78999999999999999999988653221111 11111 0112455567899
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.+|+.+||+.||.+|||+.+++++-+-
T Consensus 236 ~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 236 QSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 999999999999999999999998553
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=346.11 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=206.7
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc-------HHHHHHHHHHHhcCCCcceeeEeeEEEeCC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-------ARQFLEEARAVGQLRNRRLANLLGCCCEGD 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 126 (372)
.-.+|++.+.||+|+||.||+|.. .+++.||||++....... .+.+.+|++++++++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346789999999999999999995 578999999997544322 167899999999999999999999986654
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeecCCCC-----ceeec
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVN-----PRLSC 199 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~~~~~-----~kl~D 199 (372)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ | ++||||||+||+++.++. +||+|
T Consensus 97 --~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred --eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999998865 345699999999999999999999999 8 999999999999987776 99999
Q ss_pred cCCcccCCCC-CcccCCCCcCCccccc--CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCC
Q 017395 200 FGLMKNSRDG-RSYSTNLAFTPPEYLR--TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (372)
Q Consensus 200 fg~~~~~~~~-~~~~~t~~y~aPE~~~--~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (372)
||+++..... ....+|+.|+|||++. ...++.++||||||+++|+|++|+.||.......... ............
T Consensus 173 fg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCCCC
T ss_pred CCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCCCC
Confidence 9999865443 3356899999999994 4457899999999999999999999886432111100 011111122234
Q ss_pred CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.+..+++++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 4566678999999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=350.61 Aligned_cols=249 Identities=17% Similarity=0.213 Sum_probs=198.8
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhc--CCCcceeeEeeEEEeC----CeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEG----DERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~----~~~~l 130 (372)
.+|.+++.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... ...++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4788999999999999999998 6889999999743 34566777777766 7999999999987543 45899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCcccccccCcceeecCCCCceeeccCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT--------SKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH--------~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
||||+++|+|.++++ ...+++..++.++.|++.||.||| +. +++||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999999999994 456999999999999999999999 88 999999999999999999999999999
Q ss_pred cccCCCC--------CcccCCCCcCCcccccCC------CCCCCCceeehHHHHHHHHhC----------CCCCCchhh-
Q 017395 203 MKNSRDG--------RSYSTNLAFTPPEYLRTG------RVTPESVMYSFGTLLLDLLSG----------KHIPPSHAL- 257 (372)
Q Consensus 203 ~~~~~~~--------~~~~~t~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg----------~~p~~~~~~- 257 (372)
++..... ....+|+.|+|||++.+. .++.++||||||+++|||++| +.||.....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 8754332 223689999999999876 345789999999999999999 766643211
Q ss_pred ----HHhhhccccc-cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 258 ----DLIRDRNIQT-LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 258 ----~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.......... ..........+...+.++.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111100000 0111111112345788999999999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=354.40 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=212.2
Q ss_pred CCccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
...|.+.+.||+|+||.||+|.. .++..||||++..... ...+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788999999999999999985 2357899999986443 2356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcc
Q 017395 129 LLVAEYMPNDTLAKHLFHWET----------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~N 186 (372)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dikp~N 180 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARN 180 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCcccccchhe
Confidence 999999999999999975432 3489999999999999999999999 99999999999
Q ss_pred eeecCCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHH
Q 017395 187 IVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDL 259 (372)
Q Consensus 187 ill~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~ 259 (372)
|+++.++.+||+|||++....... ...+++.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998654332 2345678999999998889999999999999999999 888876543222
Q ss_pred hhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
... ..........+..++.++.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 261 ~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 LFN-----LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHH-----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH-----HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 111 1111112234456678999999999999999999999999999987653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=356.03 Aligned_cols=245 Identities=17% Similarity=0.247 Sum_probs=198.3
Q ss_pred CccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC--------
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD-------- 126 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------- 126 (372)
.+|++++.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 47889999999999999999954 7899999999754433 3567999999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEecCCCCCHHhhhhcCCC-CCCCHHH
Q 017395 127 -------------------------------------------------ERLLVAEYMPNDTLAKHLFHWET-QPMKWAM 156 (372)
Q Consensus 127 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~ 156 (372)
..++||||+++++|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 37999999999999999975432 3356778
Q ss_pred HHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----------------CcccCCCCcCC
Q 017395 157 RLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----------------RSYSTNLAFTP 220 (372)
Q Consensus 157 ~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----------------~~~~~t~~y~a 220 (372)
++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++..... ....+|+.|+|
T Consensus 166 ~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 999999999999999999 9999999999999999999999999999875543 23458899999
Q ss_pred cccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCC
Q 017395 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300 (372)
Q Consensus 221 PE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 300 (372)
||++.+..++.++||||||+++|||++|..|+.... ....... ...........++++.+|+.+||+.||.+|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-RIITDVR------NLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-HHHHHHH------TTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-HHHHHhh------ccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 999999999999999999999999999986532211 1111000 000001123455788999999999999999
Q ss_pred CChHHHHHH
Q 017395 301 PNPRSLVTA 309 (372)
Q Consensus 301 ps~~~il~~ 309 (372)
||+.+++++
T Consensus 318 ps~~~~l~~ 326 (332)
T 3qd2_B 318 PEATDIIEN 326 (332)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhhc
Confidence 999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=364.17 Aligned_cols=252 Identities=19% Similarity=0.162 Sum_probs=209.8
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++.|++++.||+|+||.||+|.. .+++.||+|++......+...+.+|+++|++++||||+++++++......++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 35789999999999999999995 56899999999866544566799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec--CCCCceeeccCCcccCCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~--~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
+++|+|.+++.. ....+++..++.++.||+.||.|||++ |++||||||+|||++ .++.+||+|||++.......
T Consensus 130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999999964 334699999999999999999999999 999999999999997 45779999999998765442
Q ss_pred -cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...+|+.|+|||++.+..++.++|||||||++|||++|..||............... ............+.++.+|+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--DWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--CCCCCSSTTTTSCHHHHHHH
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccccccCCHHHHHHH
Confidence 346899999999999988999999999999999999999998654322111111000 00011122345678999999
Q ss_pred HHHccCCCCCCCChHHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+||+.||.+|||+.++++|-+
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTT
T ss_pred HHHcCCChhHCcCHHHHhhCcc
Confidence 9999999999999999999843
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=359.65 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=212.8
Q ss_pred CccccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEE--eCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC--EGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~ 129 (372)
..|++++.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999984 458899999998776555677999999999999999999999986 456789
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++++|.+++... ...+++..++.|+.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999999999999642 34599999999999999999999999 9999999999999999999999999999866433
Q ss_pred C-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc----------ccccccccc
Q 017395 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR----------NIQTLTDSC 272 (372)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~----------~~~~~~~~~ 272 (372)
. ...+|..|+|||++.+..++.++||||||+++|+|++|..||........... .........
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 2 23467779999999988899999999999999999999988765433222111 011111122
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
.....+..++.++.+|+.+||+.||.+|||+.+++++|+.+.....
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 2233456677899999999999999999999999999998876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=344.30 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=213.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+.++|++++.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 4568899999999999999999987888999999986543 457899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 9999999999753 35689999999999999999999999 9999999999999999999999999998865432
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||.............. ......+...+..+.++
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-----GFRLYKPRLASTHVYQI 237 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----TCCCCCCTTSCHHHHHH
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-----CCcCCCCccCcHHHHHH
Confidence 23445678999999998889999999999999999999 7877754332222111111 11112344456889999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.+||+.||.+|||+.+++++|+.+.+
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=361.41 Aligned_cols=246 Identities=17% Similarity=0.217 Sum_probs=207.6
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
...+|.+++.||+|+||.||+|+. .+++.||||+++... ....+.+.+|..++..+ +||||+++++++.+....|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 567899999999999999999995 568999999997532 22356688999999887 8999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
+||||++||+|.+++.. .+.+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999974 35699999999999999999999999 999999999999999999999999999986432
Q ss_pred ---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.............. . ...++...+.++
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~ 245 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----D--NPFYPRWLEKEA 245 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----C--CCCCCTTSCHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh----C--CCCCCcccCHHH
Confidence 2345789999999999999999999999999999999999999875433222111111 0 123445567899
Q ss_pred HHHHHHHccCCCCCCCChH-HHHHH
Q 017395 286 VRLASRCLQYEPRERPNPR-SLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~-~il~~ 309 (372)
.+|+.+||..||.+||++. +|++|
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcC
Confidence 9999999999999999998 78776
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=365.03 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=209.5
Q ss_pred cCCCccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 125 (372)
-..++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+.+|++++.++ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 3456788999999999999999973 23678999999865433 345799999999999 799999999999876
Q ss_pred C-eeEEEEecCCCCCHHhhhhcCCC-------------------------------------------------------
Q 017395 126 D-ERLLVAEYMPNDTLAKHLFHWET------------------------------------------------------- 149 (372)
Q Consensus 126 ~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 149 (372)
+ ..++||||+++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 48999999999999999975432
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC------cccC
Q 017395 150 ---------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYST 214 (372)
Q Consensus 150 ---------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~ 214 (372)
..+++..++.|+.|++.||.|||++ |++||||||+||+++.++.+||+|||++....... ...+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 1289999999999999999999999 99999999999999999999999999998653322 2345
Q ss_pred CCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHc
Q 017395 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (372)
Q Consensus 215 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 293 (372)
|+.|+|||++.+..++.++||||||+++|||++ |..||.......... ...........+...++++.+++.+||
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEGTRMRAPDYTTPEMYQTMLDCW 333 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH----HHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH----HHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 788999999999999999999999999999998 998876532111110 111111122334556688999999999
Q ss_pred cCCCCCCCChHHHHHHHHhhhc
Q 017395 294 QYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 294 ~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.||.+|||+.+++++|+.+.+
T Consensus 334 ~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 334 HGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=358.01 Aligned_cols=249 Identities=18% Similarity=0.177 Sum_probs=204.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCC-----CCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS-----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.|++++.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 689999999999999999994 56899999998632 122467799999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC---ceeeccCCcccC
Q 017395 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNS 206 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~~~~ 206 (372)
|||+++++|.+.+... ....+++..++.++.||+.||.|||++ |++||||||+|||++.++. +||+|||++...
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999999887542 234589999999999999999999999 9999999999999986654 999999999876
Q ss_pred CCC----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 207 RDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||................. . ........+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~-~--~~~~~~~~s 260 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK-M--NPRQWSHIS 260 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCC-C--CHHHHTTSC
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCC-C--CccccccCC
Confidence 543 234689999999999998999999999999999999999999876433222111000000 0 000012346
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.++.+|+.+||+.||.+|||+.++++|-
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 7899999999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=372.22 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=209.3
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
...|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.. ...++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35688889999999999999998887889999998654 345789999999999999999999999866 7789999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----C
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----~ 210 (372)
++|+|.+++.......+++..++.++.|++.||.|||++ |++||||||+|||+++++.+||+|||+++..... .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 999999999653345699999999999999999999999 9999999999999999999999999999865432 1
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|+|||++.++.++.++||||||+++|||++ |+.||............ ........+..++..+.+|+
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~~~~~~~~l~~li 414 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-----ERGYRMPCPPECPESLHDLM 414 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-----HTTCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHHHHHH
Confidence 2335678999999998999999999999999999999 88887653322111111 11112233556678999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.+||+.||++|||+.++++.|+.+....
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 9999999999999999999999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=349.26 Aligned_cols=255 Identities=18% Similarity=0.271 Sum_probs=202.7
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++.+|++.+.||+|+||.||+|... ++.||||.+... ...+.|.+|++++++++||||+++++++. +..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 5678999999999999999999984 678999999743 34567999999999999999999999886 457999999
Q ss_pred CCCCCHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhc---CCCcccccccCcceeecCCCC-ceeeccCCcccCCCC
Q 017395 135 MPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTS---KERALYHDLNAYRIVFDDDVN-PRLSCFGLMKNSRDG 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~~iiH~Dikp~Nill~~~~~-~kl~Dfg~~~~~~~~ 209 (372)
+++++|.+++..... ..+++..++.++.|++.||.|||+ + |++||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999975332 247899999999999999999999 7 9999999999999998887 799999998765432
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....+|..|+|||++.+..++.++||||||+++|||++|+.||.......... ............+..++..+.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHHHHTTCCCCCBTTCCHHHHHH
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHHHhcCCCCCcccccCHHHHHH
Confidence 34568999999999999899999999999999999999999886421111000 00000011112334556889999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
+.+||+.||.+|||+.++++.|+.+.+...
T Consensus 237 i~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999998876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=356.58 Aligned_cols=249 Identities=19% Similarity=0.229 Sum_probs=207.5
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|.+++.||+|+||+||+|. ..+++.||||++....... .+.+.+|+++|++++||||+++++++...+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 47888999999999999999 4679999999997554322 4568999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 213 (372)
|+. |+|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++..........
T Consensus 135 ~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 211 (348)
T 1u5q_A 135 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211 (348)
T ss_dssp CCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred cCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCccc
Confidence 997 578888753 345699999999999999999999999 99999999999999999999999999998877777788
Q ss_pred CCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 214 TNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 214 ~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
+|+.|+|||++. ++.++.++|||||||++|||++|+.||........... +.........+...+..+.+|+.
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCHHHHHHHH
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCCCCCCCCHHHHHHHH
Confidence 999999999985 46689999999999999999999998765322111110 11111111123345678999999
Q ss_pred HHccCCCCCCCChHHHHHHHHhh
Q 017395 291 RCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
+||+.||++|||+.+++++..-.
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHH
T ss_pred HHcccChhhCcCHHHHhhChhhh
Confidence 99999999999999999986643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=358.88 Aligned_cols=253 Identities=18% Similarity=0.272 Sum_probs=204.0
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCc----EEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+|++++.||+|+||+||+|.+ .+++ .||+|.+..... ...+.+.+|+.++++++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 4688999999999999999994 3444 368888864332 3467799999999999999999999999775 4789
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
|+||+.+|+|.+++... ...+++..++.|+.|++.||.|||++ |++||||||+|||++.++.+||+|||+++......
T Consensus 94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 99999999999999753 45699999999999999999999999 99999999999999999999999999987654322
Q ss_pred ------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
...+|..|+|||++.+..++.++|||||||++|||++ |+.||......... ...........+..++.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----SILEKGERLPQPPICTI 246 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHHTTCCCCCCTTBCH
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-----HHHHcCCCCCCCccCCH
Confidence 2345678999999999999999999999999999999 88887643222111 11111122233555678
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
++.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999999887653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=357.37 Aligned_cols=250 Identities=16% Similarity=0.224 Sum_probs=205.9
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
...+|++++.||+|+||.||+|+. .+++.||||++...... ..+.+.+|..++.++ +||||+++++++......|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 456799999999999999999995 56899999999754322 245688999999988 8999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999974 35699999999999999999999999 999999999999999999999999999985322
Q ss_pred ---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHh-----hhccccccccccccCCCChH
Q 017395 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI-----RDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 280 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+... ...++..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~ 241 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRS 241 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCCCTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCCCCC
Confidence 2345789999999999999999999999999999999999998853210000 00000011111 1234556
Q ss_pred HHHHHHHHHHHHccCCCCCCCCh------HHHHHH
Q 017395 281 EGTELVRLASRCLQYEPRERPNP------RSLVTA 309 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~------~~il~~ 309 (372)
.+.++.+|+.+||+.||.+||++ .++++|
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 77899999999999999999996 678777
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=359.52 Aligned_cols=246 Identities=19% Similarity=0.238 Sum_probs=207.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
...+|++++.||+|+||.||+|+.. +++.||||++.... ....+.+.+|..+|..+ +||||+++++++...+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4678999999999999999999954 58899999997532 23356788999999988 7999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999973 34699999999999999999999999 999999999999999999999999999986322
Q ss_pred ---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............. . ...++...+.++
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~ 248 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----H--NVAYPKSMSKEA 248 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----C--CCCCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh----C--CCCCCCCCCHHH
Confidence 2345789999999999999999999999999999999999999876433222211111 1 113455667899
Q ss_pred HHHHHHHccCCCCCCCC-----hHHHHHH
Q 017395 286 VRLASRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps-----~~~il~~ 309 (372)
.+|+.+||..||.+||+ +.+|++|
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999995 5888877
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=349.02 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=215.7
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
...+|.+.+.||+|+||.||+|.. .++..||||++.... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 345788999999999999999995 458899999997544 346789999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
|+++++|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 99999999999876667799999999999999999999999 99999999999999999999999999998765432
Q ss_pred --cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
...+++.|+|||++.+..++.++||||||+++|+|++ |..||.......... ..........+..++..+.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKDYRMERPEGCPEKVYE 243 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----HHHTTCCCCCCTTCCHHHHH
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHhccCCCCCCCCCCHHHHH
Confidence 2234678999999998999999999999999999999 887776433221111 11111222334556789999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 288 LASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
|+.+||+.||.+|||+.++++.|+.+...
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=355.33 Aligned_cols=259 Identities=19% Similarity=0.262 Sum_probs=197.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeCC-Cc---EEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLEN-QF---RIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
....|.+++.||+|+||.||+|.... +. .||||++.... ....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34578899999999999999999533 32 79999997653 33467799999999999999999999999876654
Q ss_pred ------EEEEecCCCCCHHhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceee
Q 017395 129 ------LLVAEYMPNDTLAKHLFHWE----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (372)
Q Consensus 129 ------~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~ 198 (372)
++||||+++|+|.+++.... ...+++..++.|+.|++.||.|||++ |++||||||+||++++++.+||+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEEC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCCCEEEe
Confidence 99999999999999986422 22589999999999999999999999 99999999999999999999999
Q ss_pred ccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccc
Q 017395 199 CFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 199 Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
|||+++...... ...+++.|+|||++.+..++.++||||||+++|||++ |..||..............
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~----- 254 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG----- 254 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc-----
Confidence 999997654322 2345678999999999999999999999999999999 8877754322211111111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
......+..++.++.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 111223455668999999999999999999999999999999877654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=354.34 Aligned_cols=247 Identities=17% Similarity=0.204 Sum_probs=200.3
Q ss_pred CCCccccccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCCC----ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQLRNRRLANLLGCCCEGD 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 126 (372)
...+|++++.||+|+||.||+|+. .+++.||||++..... .....+.+|+++|++++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 345799999999999999999996 4789999999986432 23456889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..|+||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999973 35689999999999999999999999 9999999999999999999999999998754
Q ss_pred CCC----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 207 RDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.............. . ...++...+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~ 245 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK----C--KLNLPPYLT 245 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----T--CCCCCTTSC
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----C--CCCCCCCCC
Confidence 322 345689999999999988899999999999999999999999875432222111111 1 112345567
Q ss_pred HHHHHHHHHHccCCCCCCC-----ChHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERP-----NPRSLVTAL 310 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rp-----s~~~il~~l 310 (372)
.++.+|+.+||+.||.+|| ++.++++|-
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 8999999999999999999 788998883
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=352.54 Aligned_cols=253 Identities=17% Similarity=0.238 Sum_probs=190.8
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
..+|++++.||+|+||.||+|. ..+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 3578899999999999999999 45689999999975433 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 134 YMPNDTLAKHLFHWE----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
|++ ++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 998 48999886421 24589999999999999999999999 9999999999999999999999999999865432
Q ss_pred ----CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------ccc--------
Q 017395 210 ----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TLT-------- 269 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------~~~-------- 269 (372)
....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.............. ...
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 335678999999999864 589999999999999999999998865432211100000 000
Q ss_pred -cc------------cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 -DS------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 -~~------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.. ......+...+.++.+|+.+||+.||++|||+.++++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 00 000011123467899999999999999999999999883
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=346.27 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=198.9
Q ss_pred CCccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
...|++.+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 3578899999999999999998532 457999998764433 355799999999999999999999998 4567899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++......
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999999999753 34699999999999999999999999 99999999999999999999999999998654432
Q ss_pred -----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
...+++.|+|||++.+..++.++||||||+++|||++ |..||........... .........+..++.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-----i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----IENGERLPMPPNCPPT 245 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTCCCCCCTTCCHH
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-----HHcCCCCCCCCCCCHH
Confidence 2345678999999998889999999999999999997 8877754322111110 0011112244566789
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=367.21 Aligned_cols=258 Identities=17% Similarity=0.141 Sum_probs=210.7
Q ss_pred HHHHHhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEE
Q 017395 48 TLRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCC 123 (372)
Q Consensus 48 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 123 (372)
.+........+|++++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3445556678899999999999999999995 568999999986421 112335789999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
+....|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999964 3599999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC-----CcccCCCCcCCcccccCCC----CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc
Q 017395 204 KNSRDG-----RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 204 ~~~~~~-----~~~~~t~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
+..... ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.................. ..
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~ 293 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--LT 293 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CC
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc--cc
Confidence 876543 2467899999999998755 789999999999999999999998765332221111111000 00
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCC--CCChHHHHHHHH
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRE--RPNPRSLVTALV 311 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~l~ 311 (372)
.......+.++.+||.+||..+|.+ ||++.+|++|-+
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 0111245689999999999999988 999999999943
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=360.60 Aligned_cols=248 Identities=19% Similarity=0.163 Sum_probs=200.2
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.+...+.||+|+||.||+|.. .+++.||||++........+.+.+|+++|++++||||+++++++...+..++||||++
T Consensus 90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 344456799999999999994 5689999999987665567789999999999999999999999999999999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee--cCCCCceeeccCCcccCCCC---Cc
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF--DDDVNPRLSCFGLMKNSRDG---RS 211 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill--~~~~~~kl~Dfg~~~~~~~~---~~ 211 (372)
+++|.+++.. ....+++..++.++.||+.||.|||++ |++||||||+|||+ +.++.+||+|||+++..... ..
T Consensus 170 ~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 170 GGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp TCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999998864 334699999999999999999999999 99999999999999 56788999999999876543 23
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..+|+.|+|||++.+..++.++|||||||++|||++|+.||.................. .........++++.+|+.+
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--LEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--SCSGGGTTSCHHHHHHHHT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CChhhhccCCHHHHHHHHH
Confidence 45899999999999888999999999999999999999998754322111111110000 0001113456889999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||+.||.+|||+.++++|
T Consensus 326 ~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HcCCChhhCCCHHHHhcC
Confidence 999999999999999997
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=356.70 Aligned_cols=246 Identities=20% Similarity=0.222 Sum_probs=190.7
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++|++++||||+++++++......++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 588899999999999999995 458899999997543 34568899999999999999999999999999999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---CCCceeeccCCcccCCCC---C
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG---R 210 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~~~~~~~~---~ 210 (372)
+++|.+++. ..+.+++..++.++.|++.||.|||++ |++||||||+||+++. ++.+||+|||+++..... .
T Consensus 132 ~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 132 GGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp SCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999996 345699999999999999999999999 9999999999999975 889999999998865443 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...+|+.|+|||++.+..++.++|||||||++|||++|..||............+.... ...........+.++.+|+.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-YYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC-CCCCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC-CccCCchhhhCCHHHHHHHH
Confidence 45679999999999998999999999999999999999999865432211100000000 00111223456688999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||+.||++|||+.++++|
T Consensus 288 ~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 288 KLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=371.00 Aligned_cols=246 Identities=20% Similarity=0.243 Sum_probs=201.0
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCC---CCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
...+|++++.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 44679999999999999999999 467899999999742 22334568899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+ + ||+||||||+|||++.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999999974 4569999999999999999999998 7 9999999999999999999999999999764322
Q ss_pred ----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............... ...++...++++
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~ 376 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLGPEA 376 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHH
Confidence 3456899999999999999999999999999999999999998765433222211111 112455567899
Q ss_pred HHHHHHHccCCCCCCC-----ChHHHHHH
Q 017395 286 VRLASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
.+||.+||+.||.+|| |+.++++|
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999999999999999 99999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=367.79 Aligned_cols=247 Identities=18% Similarity=0.252 Sum_probs=208.9
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
...|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45789999999999999999995 479999999996432 12346789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|||+++|+|.+++. ..+.+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999996 345699999999999999999999999 9999999999999999999999999999876543
Q ss_pred -CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||................ ...+...++++.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~ 245 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------FYTPQYLNPSVIS 245 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------CCCCTTCCHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------cCCCccCCHHHHH
Confidence 34568999999999998775 679999999999999999999987543322221111111 1224445688999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
|+.+||+.||.+|||+.++++|-+
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHHcCCCchhCcCHHHHHhCHH
Confidence 999999999999999999999843
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=352.92 Aligned_cols=253 Identities=17% Similarity=0.216 Sum_probs=199.4
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCe----e
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE----R 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 128 (372)
+.|++++.||+|+||.||+|. ..+++.||||++......+ ...+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 578999999999999999999 4678999999998654333 4568999999999999999999999876543 4
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|+||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999973 35699999999999999999999999 999999999999999999999999999976543
Q ss_pred C-------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 209 G-------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 209 ~-------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
. ....||+.|+|||++.+..++.++||||||+++|||++|+.||................... ........
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 246 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGL 246 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--HHHHSTTC
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--cccccCCC
Confidence 2 22457999999999999999999999999999999999999986543222211111110000 00012235
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHH-HHhhh
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTA-LVTLQ 314 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~-l~~~~ 314 (372)
+.++.+++.+||+.||.+||++.+++.+ +..+.
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 6789999999999999999977776665 44443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=345.77 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=197.3
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
-..|.+.+.||+|+||+||+|+..+ .||||++...... ..+.|.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3478899999999999999998644 5999999765432 356799999999999999999999965 5567899999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999999999964 345699999999999999999999999 9999999999999999999999999998754321
Q ss_pred --CcccCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhH-HhhhccccccccccccCCCChHHHH
Q 017395 210 --RSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....+|+.|+|||++. +..++.++||||||+++|+|++|+.||...... ............. ........++.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-DLSKVRSNCPK 256 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-CTTSSCTTSCH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-chhhccccCCH
Confidence 2345789999999997 566888999999999999999999988653211 1111111111111 11123345678
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
++.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus 257 ~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 257 RMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 99999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=351.73 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=211.8
Q ss_pred CCccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 127 (372)
..+|.+.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788999999999999999984 34689999999865432 356799999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWET----------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~ 191 (372)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH 180 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEET
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcC
Confidence 9999999999999999975432 2589999999999999999999999 9999999999999999
Q ss_pred CCCceeeccCCcccCCCCCc------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 017395 192 DVNPRLSCFGLMKNSRDGRS------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~ 264 (372)
++.+||+|||++........ ..+|+.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-- 258 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-- 258 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH--
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH--
Confidence 99999999999987654322 234678999999998899999999999999999999 888775432111111
Q ss_pred ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
...........+...+.++.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 259 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 259 --KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp --HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111112223445668999999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=357.73 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=208.1
Q ss_pred CCCccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 126 (372)
....|.+.+.||+|+||.||+|.. .++..||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 446788999999999999999995 2456899999975432 2356799999999999 8999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCc
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWET---------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~ 185 (372)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~ 201 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAAR 201 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChh
Confidence 99999999999999999975432 2489999999999999999999999 9999999999
Q ss_pred ceeecCCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhH
Q 017395 186 RIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALD 258 (372)
Q Consensus 186 Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~ 258 (372)
||+++.++.+||+|||++....... ...+|+.|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 9999999999999999997654322 2335678999999998899999999999999999998 88887543211
Q ss_pred HhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 259 LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
... ............+...+.++.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 282 ~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 282 ANF----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HHH----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHH----HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 111 1111111222334556789999999999999999999999999999886543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=352.69 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=211.1
Q ss_pred CCccccccccCCCCCCeEEEEEe--------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 125 (372)
..+|.+.+.||+|+||.||+|.. .++..||||++...... ..+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 35788999999999999999985 34678999999865432 356789999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~ 191 (372)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTE 192 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcC
Confidence 999999999999999999975431 2489999999999999999999999 9999999999999999
Q ss_pred CCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 017395 192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~ 264 (372)
++.+||+|||++...... ....+++.|+|||++.+..++.++||||||+++|||++ |..||............
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 272 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence 999999999999865543 22345678999999998889999999999999999999 88887654322221111
Q ss_pred ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
........+..++.++.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 273 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 273 -----KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp -----HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111112234556788999999999999999999999999999886543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=346.62 Aligned_cols=259 Identities=16% Similarity=0.186 Sum_probs=204.4
Q ss_pred hcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
...+..|++++.||+|+||.||+|.. .+++.||||++......+ .+.+.+|+.++++++||||+++++++...+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 34578899999999999999999995 468899999997543322 36789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 110 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999999974 35699999999999999999999999 999999999999999999999999999876543
Q ss_pred C-----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 209 G-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 209 ~-----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
. ....+++.|+|||++.+..++.++||||||+++|+|++|+.||.................. ....+..++.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 263 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPR---PSTVRPGIPV 263 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCC---GGGTSTTCCT
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCC---ccccCCCCCH
Confidence 2 2346789999999999888999999999999999999999998765433222111111111 1122345567
Q ss_pred HHHHHHHHHccCCCCCCC-ChHHHHHHHHhhhcCC
Q 017395 284 ELVRLASRCLQYEPRERP-NPRSLVTALVTLQKDT 317 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rp-s~~~il~~l~~~~~~~ 317 (372)
++.+++.+||+.||.+|| |++++++.|+......
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 899999999999999999 9999999998775543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=349.14 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=210.7
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEE--EEEEcCCCC-CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRI--AVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
++.+|++.+.||+|+||.||+|. ..++..+ |||.+.... ....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 45688999999999999999999 4556644 999987532 22355789999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCc
Q 017395 130 LVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~ 195 (372)
+||||+++++|.+++.... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCCCeE
Confidence 9999999999999997532 24699999999999999999999999 99999999999999999999
Q ss_pred eeeccCCcccCCC---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccc
Q 017395 196 RLSCFGLMKNSRD---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 196 kl~Dfg~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
||+|||+++.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..............
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~----- 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----- 256 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-----
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-----
Confidence 9999999875332 223445788999999998889999999999999999998 9988765432222211111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
......+..++.++.+|+.+||+.||.+|||+.+++++|+.+......
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 112233455678999999999999999999999999999998776543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=358.90 Aligned_cols=258 Identities=16% Similarity=0.173 Sum_probs=204.7
Q ss_pred CCccccccccCCCCCCeEEEEEeCC------CcEEEEEEcCCCCCcc-----------HHHHHHHHHHHhcCCCcceeeE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN------QFRIAVKRFNRSAWPD-----------ARQFLEEARAVGQLRNRRLANL 118 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l 118 (372)
-..|.+++.||+|+||.||+|.+.. ++.||||++....... ...+.+|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3479999999999999999998644 4789999987654211 1124456667788899999999
Q ss_pred eeEEEeC----CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec--CC
Q 017395 119 LGCCCEG----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DD 192 (372)
Q Consensus 119 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~--~~ 192 (372)
++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++ |++||||||+|||++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCT
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCC
Confidence 9998764 4589999999 9999999975 345699999999999999999999999 999999999999999 88
Q ss_pred CCceeeccCCcccCCCC-----------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh
Q 017395 193 VNPRLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR 261 (372)
Q Consensus 193 ~~~kl~Dfg~~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~ 261 (372)
+.+||+|||+++..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+...
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 99999999999764322 2234899999999999999999999999999999999999998643111100
Q ss_pred --------hccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 262 --------DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 262 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
......+.+.++. ...++.++.+++..||+.||.+||++.+|++.|+.+......
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0111222222211 123457899999999999999999999999999988765444
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=351.77 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=210.1
Q ss_pred cccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 130 (372)
|++++.||+|+||+||++.+ .+++.||||++...... ..+.+.+|+++|++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999998864 25889999999865432 356799999999999999999999999874 67899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999953 3499999999999999999999999 99999999999999999999999999998765432
Q ss_pred -------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh----------hccccccccccc
Q 017395 211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTDSCL 273 (372)
Q Consensus 211 -------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~----------~~~~~~~~~~~~ 273 (372)
...+|..|+|||++.+..++.++||||||+++|+|++|..||......... ............
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 234677899999999888999999999999999999999887543222111 011111222222
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
....+..++.++.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 33345667789999999999999999999999999999886543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=346.15 Aligned_cols=252 Identities=15% Similarity=0.160 Sum_probs=201.4
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-----ccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCC-
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLR---NRRLANLLGCCCEGD- 126 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~- 126 (372)
.+|++++.||+|+||+||+|+ ..+++.||||++..... .....+.+|++++++++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 478999999999999999999 46789999999864321 12346778888777764 999999999998765
Q ss_pred ----eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 127 ----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 127 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
..++||||+. ++|.+++.......+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 5899999997 5999999865556699999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccc-----------
Q 017395 203 MKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL----------- 268 (372)
Q Consensus 203 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~----------- 268 (372)
++..... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 9865543 23567999999999999999999999999999999999999886543221111100000
Q ss_pred ---ccccccC-------CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 269 ---TDSCLEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 269 ---~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
....... ......+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 0000000 01123567899999999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=362.69 Aligned_cols=252 Identities=15% Similarity=0.131 Sum_probs=196.4
Q ss_pred CCccccc-cccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhc-CCCcceeeEeeEEEe----CCee
Q 017395 56 FAMENIV-SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQ-LRNRRLANLLGCCCE----GDER 128 (372)
Q Consensus 56 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~----~~~~ 128 (372)
+.+|.++ +.||.|+||+||+|.. .+++.||||++.. ...+.+|++++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567777 5799999999999994 5689999999863 2467889998754 489999999999875 5678
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---CCCceeeccCCccc
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKN 205 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~~~~ 205 (372)
||||||++||+|.+++.......+++..++.|+.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++.
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999999999865556799999999999999999999999 9999999999999997 78899999999987
Q ss_pred CCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccc--ccCCCChH
Q 017395 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC--LEGQFSSD 280 (372)
Q Consensus 206 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 280 (372)
.... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...............+.... ........
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 5543 345679999999999999999999999999999999999999865321110000000000000 00111234
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
++.++.+||.+||+.||.+|||+.++++|-+-.
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 678899999999999999999999999996543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=350.67 Aligned_cols=241 Identities=19% Similarity=0.202 Sum_probs=196.5
Q ss_pred ccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP--DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|+++++||+|+||+||+|... +++.||||++...... ...++.+|+..+.++ +||||++++++|...+..++|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 6889999999999999999954 7999999998754332 233566666666665 89999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---C
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~ 210 (372)
|+ +++|.+++... +..+++..++.|+.|++.||.|||++ +++||||||+|||++.++.+||+|||++...... .
T Consensus 138 ~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 138 LC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp CC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred cc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 99 66899988653 45699999999999999999999999 9999999999999999999999999998766443 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh-hHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...||+.|+|||++.+ .++.++|||||||++|||++|..++.... ...+.... ....++...+.++.+|+
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY--------LPPEFTAGLSSELRSVL 285 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTC--------CCHHHHTTSCHHHHHHH
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccC--------CCcccccCCCHHHHHHH
Confidence 3457999999999885 78999999999999999999977665432 22111111 11112234468899999
Q ss_pred HHHccCCCCCCCChHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l 310 (372)
.+||+.||++|||+.+++++-
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHcCCChhhCcCHHHHHhCc
Confidence 999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=349.53 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=206.4
Q ss_pred CCCccccccccCCCCCCeEEEEEeCC-----CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
+...|.+.+.||+|+||.||+|.... +..||||++...... ....+.+|++++++++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 33567888999999999999998532 245999999865432 345689999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 122 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999975 345699999999999999999999999 999999999999999999999999999986543
Q ss_pred CC-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 209 GR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 209 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
.. ...+|..|+|||++.+..++.++||||||+++|||++ |+.||............. .......+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~ 274 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-----DGFRLPTPMD 274 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-----TTCCCCCCTT
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-----CCCcCCCccc
Confidence 21 1234678999999998899999999999999999999 988875432221111111 1111123445
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
++..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 67889999999999999999999999999998876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=345.60 Aligned_cols=247 Identities=19% Similarity=0.295 Sum_probs=206.6
Q ss_pred ccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe------------
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE------------ 124 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------------ 124 (372)
+|++++.||+|+||.||+|... +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 6888999999999999999964 78999999997543 357799999999999999999998854
Q ss_pred ----CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeecc
Q 017395 125 ----GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (372)
Q Consensus 125 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Df 200 (372)
....++||||+++++|.+++.......+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEECcc
Confidence 34589999999999999999765556799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 201 GLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 201 g~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
|++...... ....+++.|+|||++.+..++.++||||||+++|+|++|..|+.... .... .+. ....
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-~~~~-----~~~----~~~~ 236 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-KFFT-----DLR----DGII 236 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-HHHH-----HHH----TTCC
T ss_pred hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-HHHH-----Hhh----cccc
Confidence 998876543 33567899999999999889999999999999999999997754321 1111 111 1122
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
+...+..+.+++.+||+.||.+|||+.+++++|+.+.+....
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 344557899999999999999999999999999998776543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=354.74 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=202.4
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCC--cceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv 131 (372)
-..|++++.||+|+||.||+|...+++.||||++...... ..+.+.+|+.+|++++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4579999999999999999999888999999999754332 24678999999999986 9999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
||+ .+++|.+++.. ...+++..++.|+.|++.||.|||++ |++||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp ECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 995 57899999974 45699999999999999999999999 999999999999997 678999999999865433
Q ss_pred ----CcccCCCCcCCcccccC-----------CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc
Q 017395 210 ----RSYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~ 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---HHHHHhcCCcc
Confidence 23468999999999865 5688999999999999999999998864221111 11111222222
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
..++...+.++.+|+.+||+.||.+|||+.++++|.+-
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 33444556789999999999999999999999999653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=343.23 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=205.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCC---cEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee-EEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQ---FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDER-LLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~lv 131 (372)
.|++.+.||+|+||+||+|.. .++ ..||+|.+...... ..+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 344558899999999999984 333 37999999864432 356799999999999999999999999776654 999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999975 345689999999999999999999999 9999999999999999999999999999754322
Q ss_pred ------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 210 ------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....++..|+|||.+.+..++.++||||||+++|+|++|..|+........ .............+...+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----LTHFLAQGRRLPQPEYCPD 255 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----HHHHHHTTCCCCCCTTCCH
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----HHHHhhcCCCCCCCccchH
Confidence 234567889999999999999999999999999999997766543221111 1111111111223445668
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=343.50 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=211.0
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
...|++++.||+|+||.||+|...++..||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 35789999999999999999998888899999997654 34678999999999999999999999986 45689999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-----
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 210 (372)
++++|.+++.......+++..++.++.|++.||.|||++ |++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 999999999643333699999999999999999999999 99999999999999999999999999998764432
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|+|||++.+..++.++||||||+++|||++ |..||............. .......+..++.++.+++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-----RGYRMVRPDNCPEELYQLM 243 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----TTCCCCCCTTCCHHHHHHH
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-----cccCCCCcccccHHHHHHH
Confidence 2345678999999998889999999999999999999 887776533221111111 1111223455668999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.+||+.||.+|||+.++++.|+.+...
T Consensus 244 ~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999999988654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=344.68 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=206.7
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+.+|.+++.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 456899999999999999999984 5678999999864321 124568899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999974 35699999999999999999999999 9999999999999999999999999988654432
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....++..|+|||++.+..++.++||||||+++|+|++|..||.............. ....++...+..+.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDL 237 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCCCTTSCHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh------CCCCCCCcCCHHHHHH
Confidence 345678999999999998899999999999999999999999875433222111111 1112345566889999
Q ss_pred HHHHccCCCCCCCChHHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.+||+.||.+|||+.++++|-+
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHH
T ss_pred HHHHhccChhhCCCHHHHhhCcc
Confidence 99999999999999999999954
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=348.44 Aligned_cols=255 Identities=18% Similarity=0.301 Sum_probs=206.7
Q ss_pred ccccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC--CeeE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 129 (372)
.|++++.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 588999999999999999983 4588999999985432 3357799999999999999999999999876 6689
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 102 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999999999954 335699999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh----------hcccccccccc
Q 017395 210 R-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTDSC 272 (372)
Q Consensus 210 ~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~----------~~~~~~~~~~~ 272 (372)
. ...+|..|+|||++.+..++.++||||||+++|+|++|..|+......... ...........
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2 344677899999999888999999999999999999999765332111100 00011111111
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
.....+..++.++.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222345567789999999999999999999999999998874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=346.09 Aligned_cols=263 Identities=16% Similarity=0.199 Sum_probs=204.5
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
..+..|++++.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 3556899999999999999999994 67899999999754322 3557899999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+||||+++++|.+++... ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998642 345689999999999999999999999 99999999999999999999999999987654
Q ss_pred CC----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 208 DG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
.. ....++..|+|||++.+..++.++||||||+++|+|++|+.||........... ..+.............+.
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC--KKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH--HHHHTTCSCCCCTTTSCH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH--HHhhcccCCCCcccccCH
Confidence 33 234578999999999998899999999999999999999998865321111000 000000011111234568
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
++.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 899999999999999999999999999999876544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=345.43 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=211.1
Q ss_pred Ccccccc-ccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVS-EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
..|.+++ .||+|+||.||+|... ++..||||++..... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4677777 8999999999999853 578899999986543 2356799999999999999999999999 55679999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
|||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999964 345699999999999999999999999 99999999999999999999999999998664322
Q ss_pred ------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||........... .........+..++.
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----i~~~~~~~~~~~~~~ 240 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-----IEQGKRMECPPECPP 240 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-----HHTTCCCCCCTTCCH
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----HhcCCcCCCCCCcCH
Confidence 2335788999999998889999999999999999998 9988765332211111 111112234556678
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
++.+++.+||+.||.+|||+.+++++|+.+......
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 999999999999999999999999999998765443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=344.45 Aligned_cols=255 Identities=16% Similarity=0.148 Sum_probs=208.6
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.+|.+++.||+|+||.||+|. ..+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 468999999999999999999 4679999999986543 234578999999999 799999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC-----ceeeccCCcccCCCC
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-----PRLSCFGLMKNSRDG 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~-----~kl~Dfg~~~~~~~~ 209 (372)
+ +++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++. +||+|||++......
T Consensus 88 ~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 88 L-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred c-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9 99999999753 44699999999999999999999999 9999999999999987766 999999999865432
Q ss_pred -----------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh----hHHhhhcccccccccccc
Q 017395 210 -----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA----LDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 210 -----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~ 274 (372)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||.... ...... ..........
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 242 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--IGEKKQSTPL 242 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH--HHHHHHHSCH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH--HHhhccCccH
Confidence 23457899999999999899999999999999999999999986521 111100 0000000000
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
......++.++.+++.+||+.||.+|||+.+|++.|+.+.+...
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 01122446789999999999999999999999999999876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=344.82 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=204.2
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-CeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e 133 (372)
+..+|++++.||+|+||.||+|.. +++.||||++.... ..+.+.+|++++++++||||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 456899999999999999999987 47899999997543 457799999999999999999999997554 47899999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-Ccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 212 (372)
|+++++|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...... ...
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 99999999999753333489999999999999999999999 9999999999999999999999999998765443 234
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
.++..|+|||++.+..++.++||||||+++|+|++ |..||............ ........+..+++.+.+++.+
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-----TTTCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----hcCCCCCCcccCCHHHHHHHHH
Confidence 56789999999998889999999999999999998 88887643322111111 1111223455667899999999
Q ss_pred HccCCCCCCCChHHHHHHHHhhhcC
Q 017395 292 CLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
||+.||.+|||+.++++.|+.+...
T Consensus 250 ~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999988653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=367.09 Aligned_cols=256 Identities=16% Similarity=0.123 Sum_probs=207.6
Q ss_pred HhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 52 ATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 52 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
......+|++++.||+|+||+||+|+. .+++.||||++..... .....+.+|+.++..++||||++++++|.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 344557889999999999999999995 4588999999964211 112348899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.|+||||++||+|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 9999999999999999974 245699999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC-----cccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 208 DGR-----SYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 208 ~~~-----~~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
... ...||+.|+|||++. ...++.++|||||||++|||++|+.||................. ....+..
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~ 305 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RFQFPTQ 305 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-HCCCCSS
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-cccCCcc
Confidence 332 357899999999997 45689999999999999999999999876432222111111000 0001111
Q ss_pred ChHHHHHHHHHHHHHccCCCCC--CCChHHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRE--RPNPRSLVTAL 310 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~--Rps~~~il~~l 310 (372)
....++++.+||.+||..+|++ ||++.++++|-
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 2335789999999999888888 99999999983
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.18 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=212.6
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..+|++.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.. ...+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 35678889999999999999998888889999998654 345789999999999999999999999865 7789999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----C
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----~ 210 (372)
++|+|.++++......+++..++.|+.||+.||.|||++ +++||||||+|||+++++.+||+|||+++..... .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 999999999653345699999999999999999999999 9999999999999999999999999999876432 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...++..|+|||++.+..++.++|||||||++|||++ |+.||............ ........+..++.++.+||
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~~~~~~~~l~~li 497 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-----ERGYRMPCPPECPESLHDLM 497 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-----HTTCCCCCCTTCCHHHHHHH
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHHHHHH
Confidence 2345678999999998899999999999999999999 88887653222111111 11112233456678999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.+||+.||++|||+.+|++.|+.+....
T Consensus 498 ~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 498 CQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 9999999999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.51 Aligned_cols=250 Identities=20% Similarity=0.178 Sum_probs=202.7
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-----CcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----NRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~~~~l 130 (372)
..|.++++||+|+||+||+|.. .+++.||||++.... ...+.+.+|+++++.++ ||||+++++++...+..++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 4788999999999999999995 678999999997432 33456788999999996 9999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-------------------
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD------------------- 191 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~------------------- 191 (372)
||||+ +++|.+++.......+++..++.++.||+.||.|||++ |++||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 99999 88999999876656799999999999999999999999 9999999999999975
Q ss_pred ------CCCceeeccCCcccCCCC-CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc
Q 017395 192 ------DVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (372)
Q Consensus 192 ------~~~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~ 264 (372)
++.+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 271 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 788999999999865443 4567899999999999999999999999999999999999988643211110000
Q ss_pred ---c----------------cccc-cccccCCCC--------------------hHHHHHHHHHHHHHccCCCCCCCChH
Q 017395 265 ---I----------------QTLT-DSCLEGQFS--------------------SDEGTELVRLASRCLQYEPRERPNPR 304 (372)
Q Consensus 265 ---~----------------~~~~-~~~~~~~~~--------------------~~~~~~l~~li~~cl~~dp~~Rps~~ 304 (372)
. .... .......++ ...++.+.+|+.+||+.||.+|||+.
T Consensus 272 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~ 351 (360)
T 3llt_A 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPA 351 (360)
T ss_dssp HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHH
Confidence 0 0000 000000000 01126788999999999999999999
Q ss_pred HHHHH
Q 017395 305 SLVTA 309 (372)
Q Consensus 305 ~il~~ 309 (372)
++++|
T Consensus 352 elL~h 356 (360)
T 3llt_A 352 ELLKH 356 (360)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99876
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=349.03 Aligned_cols=247 Identities=18% Similarity=0.201 Sum_probs=205.9
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++......++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 688999999999999999995 56899999999754322 35679999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC----CceeeccCCcccC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg~~~~~ 206 (372)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999973 45699999999999999999999999 999999999999999887 7999999999876
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
... ....+|+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........+.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 247 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--FDEEFFSHTSE 247 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--cChhhhcccCH
Confidence 543 3346789999999999989999999999999999999999998654322211111100000 00001123457
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+.+|+.+||+.||.+|||+.++++|
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 89999999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=357.15 Aligned_cols=246 Identities=19% Similarity=0.206 Sum_probs=197.5
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHH-HhcCCCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARA-VGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
..++|++++.||+|+||.||+|+. .+++.||||++..... .....+.+|..+ ++.++||||+++++++...+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 446899999999999999999995 5688999999975432 223456777776 57789999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC--
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-- 207 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~-- 207 (372)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||+++...
T Consensus 116 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999974 35689999999999999999999999 99999999999999999999999999998532
Q ss_pred --CCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 208 --DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 208 --~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
......||+.|+|||++.+..++.++|||||||++|||++|..||.............. . ...++...+.++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~--~~~~~~~~~~~~ 266 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----K--PLQLKPNITNSA 266 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH----S--CCCCCSSSCHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----c--ccCCCCCCCHHH
Confidence 22346789999999999999999999999999999999999999875433222211111 1 112345567889
Q ss_pred HHHHHHHccCCCCCCCChH----HHHHH
Q 017395 286 VRLASRCLQYEPRERPNPR----SLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~----~il~~ 309 (372)
.+|+.+||+.||.+||++. ++++|
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 9999999999999999974 55555
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=341.95 Aligned_cols=251 Identities=18% Similarity=0.195 Sum_probs=208.0
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+.|++++.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999994 5689999999975432 23567889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC---ceeeccCCcccCCCC
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNSRDG 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~~~~~~~ 209 (372)
||+++++|.+.+.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999998864 35699999999999999999999999 9999999999999986655 999999999766544
Q ss_pred C---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 R---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ~---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
. ...+|+.|+|||++.+..++.++||||||+++|+|++|..||................... ........++++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY--PSPEWDTVTPEAK 239 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTTTTTSCHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC--CchhhcccCHHHH
Confidence 3 3567899999999999999999999999999999999999986543332222111111110 1111234568899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+|+.+||+.||.+|||+.+++++-+
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHcccChhhCCCHHHHhcCcc
Confidence 9999999999999999999999844
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=339.74 Aligned_cols=245 Identities=18% Similarity=0.208 Sum_probs=206.0
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|.+.+.||+|+||.||+|.. .++..||+|++........+.+.+|++++++++||||+++++++......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 3688999999999999999995 457899999998765566788999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee---cCCCCceeeccCCcccCCCC---
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||++ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 89 TGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99999999874 45699999999999999999999999 99999999999999 78899999999999765543
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh----HHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS----DEGTEL 285 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l 285 (372)
....+|+.|+|||++.+. ++.++||||||+++|+|++|+.||................ ...+. ..++.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT------FTFPEKDWLNVSPQA 238 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCHHHHTTSCHHH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------CCCCchhhhcCCHHH
Confidence 345688999999998754 8999999999999999999999886543222111111100 01121 346789
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+++.+||+.||.+|||+.++++|-.
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHH
Confidence 99999999999999999999998743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=363.66 Aligned_cols=250 Identities=15% Similarity=0.168 Sum_probs=185.6
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----Cee
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 128 (372)
.+|++++.||+|+||+||+|. ..+++.||||++..... ...+++.+|+++|+.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 579999999999999999999 45789999999975432 2356799999999999999999999998543 568
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|+||||+. ++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999984 68999997 445699999999999999999999999 999999999999999999999999999986532
Q ss_pred C-------------------------------CcccCCCCcCCccccc-CCCCCCCCceeehHHHHHHHHh---------
Q 017395 209 G-------------------------------RSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLS--------- 247 (372)
Q Consensus 209 ~-------------------------------~~~~~t~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~t--------- 247 (372)
. ....||+.|+|||++. +..++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 1 2345689999999864 5669999999999999999999
Q ss_pred --CCCCCCchhhH---------------------Hhh------hcc---------------cccccccccc---CCCChH
Q 017395 248 --GKHIPPSHALD---------------------LIR------DRN---------------IQTLTDSCLE---GQFSSD 280 (372)
Q Consensus 248 --g~~p~~~~~~~---------------------~~~------~~~---------------~~~~~~~~~~---~~~~~~ 280 (372)
|+++|++.... .+. ... .......... ....+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 55555432100 000 000 0000000000 001123
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+.++.+||.+||..||.+|||+.++++|-
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 468899999999999999999999999983
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=346.20 Aligned_cols=248 Identities=17% Similarity=0.172 Sum_probs=198.6
Q ss_pred ccccc-cccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIV-SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~-~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|.++ +.||+|+||.||+|. ..+++.||||++........+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 57776 568999999999999 567899999999876655677899999999985 799999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC---ceeeccCCcccCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~~~~~~~-- 209 (372)
+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++. +||+|||++......
T Consensus 93 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 93 MRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999974 35699999999999999999999999 9999999999999997766 999999998754321
Q ss_pred ---------CcccCCCCcCCcccccC-----CCCCCCCceeehHHHHHHHHhCCCCCCchhhHH-----------hhhcc
Q 017395 210 ---------RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----------IRDRN 264 (372)
Q Consensus 210 ---------~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~-----------~~~~~ 264 (372)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 12347899999999975 458899999999999999999999886431100 00000
Q ss_pred ccccccccccCCCC----hHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 265 IQTLTDSCLEGQFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 265 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
...+.... ..++ ...+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 250 ~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 250 FESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 00000000 0122 13467899999999999999999999999973
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=348.82 Aligned_cols=258 Identities=18% Similarity=0.200 Sum_probs=207.0
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe----CCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 129 (372)
+-..|++++.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 345799999999999999999995 6789999999976555556789999999999999999999999863 34789
Q ss_pred EEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+||||+++++|.+++... ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999998642 346699999999999999999999999 99999999999999999999999999987653
Q ss_pred CC-------------CcccCCCCcCCcccccCCC---CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccc
Q 017395 208 DG-------------RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 208 ~~-------------~~~~~t~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 271 (372)
.. ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ..........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~ 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALAVQN 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHHHHC
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHHhhc
Confidence 21 1234588999999998654 689999999999999999999887432110 0001111111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
......+...+.++.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 111122345568899999999999999999999999999987643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=343.28 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=204.9
Q ss_pred CCccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEE-eCCeeE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCC-EGDERL 129 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~ 129 (372)
...|++.+.||+|+||+||+|...+ ...||+|.+...... ..+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999998532 236899999864432 3567999999999999999999999864 456789
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++++|.+++.. ....+++..++.|+.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999964 345689999999999999999999999 9999999999999999999999999999765432
Q ss_pred --------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCch-hhHHhhhccccccccccccCCCChH
Q 017395 210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 210 --------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
....+|+.|+|||.+.+..++.++||||||+++|+|++|..|+... ........ .........+..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 256 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-----LLQGRRLLQPEY 256 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-----HHTTCCCCCCTT
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-----HhcCCCCCCCcc
Confidence 2234567899999999999999999999999999999966554322 11111100 001111122344
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 5678999999999999999999999999999987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=354.23 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=197.7
Q ss_pred CccccccccCCCCCCeEEEEEeC--C--CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEe-CCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE--N--QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~l 130 (372)
..|++.+.||+|+||+||+|... + +..||||.++.... ...++|.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35677889999999999999842 2 24689999975432 346679999999999999999999998754 457899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||+++++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999974 345689999999999999999999999 9999999999999999999999999999754322
Q ss_pred -------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhC-CCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 210 -------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
....+++.|+|||++.+..++.++||||||+++|||++| .+||.......... ..........+..+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-----~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----YLLQGRRLLQPEYC 321 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-----HHHTTCCCCCCTTC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-----HHHcCCCCCCCCCC
Confidence 123456789999999999999999999999999999995 44443321110000 00011111234456
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 6889999999999999999999999999999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=357.32 Aligned_cols=248 Identities=18% Similarity=0.232 Sum_probs=201.5
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCC--CcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~ 132 (372)
..|.+++.||+|+||.||+|...+++.||||++..... ...+.+.+|+++|++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999999977799999999975432 23567999999999996 599999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
| +.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 568899999974 34689999999999999999999999 999999999999996 589999999999865432
Q ss_pred ---CcccCCCCcCCcccccC-----------CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccC
Q 017395 210 ---RSYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (372)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....+.......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEI 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccC
Confidence 23568999999999875 358889999999999999999999886432110 0111122222222
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
.++...+.++.+|+.+||+.||.+|||+.+++++.+-
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 3344446789999999999999999999999998553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=373.35 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=211.2
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
....+|++++.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|+.++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3456788999999999999999995 579999999996432 223556889999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||++||+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999999765555699999999999999999999999 9999999999999999999999999999876543
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+...... ....++...+.++.
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-~i~~~i~~-~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-VPEEYSERFSPQAR 417 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-HHHHHHHH-CCCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-HHHHHhhc-ccccCCccCCHHHH
Confidence 23578999999999998889999999999999999999999986532100000 00000000 11234556678999
Q ss_pred HHHHHHccCCCCCCC-----ChHHHHHH
Q 017395 287 RLASRCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rp-----s~~~il~~ 309 (372)
+|+.+||+.||.+|| ++.++++|
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 999999999999999 78999988
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=349.29 Aligned_cols=254 Identities=18% Similarity=0.270 Sum_probs=204.1
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcE----EEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFR----IAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
-.+|++++.||+|+||.||+|.+ .+++. ||+|.+.... ....+.+.+|+.++++++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 45789999999999999999994 44543 5888876433 23467899999999999999999999999765 488
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+|+||+.+|+|.+++... ...+++..++.|+.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 999999999999999753 45699999999999999999999999 9999999999999999999999999999865432
Q ss_pred C------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 R------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 ~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
. ...+|+.|+|||++.+..++.++||||||+++|||++ |..||......... ...........+..++
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 245 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----SILEKGERLPQPPICT 245 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHHTTCCCCCCTTBC
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----HHHHcCCCCCCCccCC
Confidence 2 2335678999999999999999999999999999999 88887653322211 1111111223345567
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.++.+++.+||+.||.+|||+.++++.|..+....
T Consensus 246 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 88999999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=340.62 Aligned_cols=251 Identities=18% Similarity=0.242 Sum_probs=210.3
Q ss_pred HhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 52 ATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 52 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
..-...+|.+++.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 344567899999999999999999995 468899999986432 1234678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999999974 34699999999999999999999999 99999999999999999999999999987654
Q ss_pred CC--CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 208 DG--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 208 ~~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.. ....++..|+|||++.+..++.++||||||+++|+|++|..||.............. ....++...+.++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 239 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------VDLKFPPFLSDGS 239 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSCHHH
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc------cccCCCCcCCHHH
Confidence 32 345678999999999998999999999999999999999998865432221111111 0112345567889
Q ss_pred HHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+++.+||+.||.+|||+.++++|-.
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 99999999999999999999999844
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=343.71 Aligned_cols=244 Identities=17% Similarity=0.198 Sum_probs=204.9
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+|++++.||+|+||.||+|.. .+++.||||++..... ....++.+|+..+..+ +||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 3688999999999999999995 4789999999976432 3356789999999999 8999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC------------------
Q 017395 133 EYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD------------------ 192 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~------------------ 192 (372)
||+++++|.+++.... ...+++..++.++.|++.||.|||++ |++||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC--------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999997432 25699999999999999999999999 99999999999999844
Q ss_pred -CCceeeccCCcccCCCCCcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchh-hHHhhhccccccc
Q 017395 193 -VNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQTLT 269 (372)
Q Consensus 193 -~~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~-~~~~~~~~~~~~~ 269 (372)
..+||+|||++..........+|..|+|||++.+. .++.++||||||+++|+|++|.+++.... ...+....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----- 244 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR----- 244 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTC-----
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCC-----
Confidence 47999999999988777777899999999999876 46789999999999999999997654332 11111111
Q ss_pred cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
....+...+.++.+++.+||+.||.+|||+.++++|-
T Consensus 245 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 245 ----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp ----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred ----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 1223445668899999999999999999999999873
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=340.73 Aligned_cols=250 Identities=17% Similarity=0.204 Sum_probs=189.7
Q ss_pred hcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
...+.+|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 34567899999999999999999995 678999999996432 12246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999974 335699999999999999999999999 999999999999999999999999999886543
Q ss_pred C----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 209 G----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 209 ~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
. ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ..... ....+...+.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~--~~~~~~~~~~~ 238 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLA--DYEMPSFLSIE 238 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSS--CCCCCTTSCHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhc--ccCCccccCHH
Confidence 2 23467899999999998889999999999999999999999886432111111 11100 11234456789
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+.+++.+||+.||.+|||+.+++++-
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 99999999999999999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=343.33 Aligned_cols=250 Identities=15% Similarity=0.147 Sum_probs=205.8
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|.+++.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 3688999999999999999995 478999999998665445567899999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee---cCCCCceeeccCCcccCCCCC--
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
++++|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+||++ ++++.+||+|||++.......
T Consensus 89 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 89 SGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp CSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred CCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 99999999863 34699999999999999999999999 99999999999999 788999999999987654432
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...+|+.|+|||++.+..++.++||||||+++|+|++|..||................. ..........+.++.+++.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY--EFESPFWDDISESAKDFIC 243 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC--CCCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCccccccCCHHHHHHHH
Confidence 24578999999999998899999999999999999999998865432222111111100 0111223456689999999
Q ss_pred HHccCCCCCCCChHHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~ 311 (372)
+||+.||.+|||+.+++++-.
T Consensus 244 ~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 244 HLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHCSSTTTSCCHHHHHTSHH
T ss_pred HHcCCChhHCcCHHHHhcCcc
Confidence 999999999999999999744
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=361.51 Aligned_cols=257 Identities=18% Similarity=0.144 Sum_probs=207.2
Q ss_pred HHHHhcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEe
Q 017395 49 LRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCE 124 (372)
Q Consensus 49 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 124 (372)
+.......++|++++.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 334455667899999999999999999995 5799999999964221 123347899999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
.+..|+||||++||+|.+++.+. +..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999999999999999742 34699999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCC-----cccCCCCcCCccccc-------CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccc
Q 017395 205 NSRDGR-----SYSTNLAFTPPEYLR-------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 205 ~~~~~~-----~~~~t~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
...... ...||+.|+|||++. +..++.++|||||||++|||++|+.||............... ....
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~ 289 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY-KEHL 289 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH-HHHC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCc
Confidence 765432 357899999999997 356899999999999999999999998764322221111110 0000
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCC---CChHHHHHH
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRER---PNPRSLVTA 309 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~il~~ 309 (372)
..+..+...+.++.+||.+||. +|.+| |++.++++|
T Consensus 290 ~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 290 SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0111223456899999999999 99998 599999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=349.60 Aligned_cols=240 Identities=19% Similarity=0.181 Sum_probs=203.8
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
..|++++.||+|+||.||+|. ..+++.||||++...... ..+.+.+|+++|++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 478999999999999999999 567899999999765321 23357789999999999999999999999999
Q ss_pred eEEEEecCCCC-CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 128 RLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 128 ~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
.++||||+.+| +|.+++. ....+++..++.|+.|++.||.|||++ |++||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999776 9999997 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC---cccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 207 RDGR---SYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 207 ~~~~---~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
.... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ..... ...+...+
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~--~~~~~~~~ 248 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAA--IHPPYLVS 248 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTC--CCCSSCCC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhc--cCCCcccC
Confidence 5443 3468999999999998876 7899999999999999999998854211 00000 01233356
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.++.+|+.+||+.||.+|||+.+++++-+
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 78999999999999999999999999843
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=344.99 Aligned_cols=251 Identities=19% Similarity=0.222 Sum_probs=200.0
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+.+|++++.||+|+||+||+|.. .+++.||||++....... .+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 35789999999999999999995 458999999987654332 456889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
||+++++|.+++. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999999886 345699999999999999999999999 9999999999999999999999999999875532
Q ss_pred -CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc---c-----------------cc
Q 017395 210 -RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---I-----------------QT 267 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~---~-----------------~~ 267 (372)
....+|..|+|||++.+ ..++.++||||||+++|+|++|..||............ . ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 23467889999999986 56899999999999999999999988654221111000 0 00
Q ss_pred cccccccCC-----CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 LTDSCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 ~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...+..... .....+.++.+|+.+||+.||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 012456789999999999999999999999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=348.85 Aligned_cols=258 Identities=19% Similarity=0.291 Sum_probs=211.4
Q ss_pred CCccccccccCCCCCCeEEEEEe-----CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC--ee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~ 128 (372)
...|++++.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999983 358899999998776666778999999999999999999999986644 78
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 9999999999999999753 34699999999999999999999999 999999999999999999999999999987654
Q ss_pred CC-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh---c--------ccccccc
Q 017395 209 GR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD---R--------NIQTLTD 270 (372)
Q Consensus 209 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~---~--------~~~~~~~ 270 (372)
.. ...++..|+|||++.+..++.++||||||+++|||++|..|+.......... . .......
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 2345667999999998889999999999999999999998765332111110 0 0111111
Q ss_pred ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.......+..++.++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111223355667899999999999999999999999999998865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=348.54 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=208.4
Q ss_pred CccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
..|.+.+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 46889999999999999999853 3778999999855432 3456899999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 130 LVAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999986421 14579999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccccc
Q 017395 202 LMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLE 274 (372)
Q Consensus 202 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 274 (372)
++...... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||............... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~ 258 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-----GL 258 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-----CC
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC-----Cc
Confidence 98754332 12345778999999998899999999999999999999 77776543222221111111 11
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
...+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 12344566889999999999999999999999999988755
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.84 Aligned_cols=248 Identities=16% Similarity=0.198 Sum_probs=194.7
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------C
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 126 (372)
..+|++++.||+|+||+||+|. ..+++.||||++.... ....+++.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 3578999999999999999999 4568999999997542 22356789999999999999999999999654 3
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..|+||||++++ |.+.+. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 579999999774 777774 2399999999999999999999999 9999999999999999999999999999876
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-----------------
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------- 266 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~----------------- 266 (372)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+............
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 543 346789999999999999999999999999999999999999875421111000000
Q ss_pred ----------------ccccccccCC---CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 ----------------TLTDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ----------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.......... .....+.++.+|+.+||+.||.+|||+.|+++|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 011236789999999999999999999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=340.72 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=205.3
Q ss_pred CCCccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
...+|.+.+.||+|+||+||+|...+ +..||||.+..... ...+.+.+|+.++++++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34578899999999999999998532 34699999986533 235679999999999999999999999864 5679
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 89 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999965 334699999999999999999999999 9999999999999999999999999998865443
Q ss_pred -----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||........... .........+..+++
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-----LEKGDRLPKPDLCPP 241 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-----HHHTCCCCCCTTCCH
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-----HhcCCCCCCCCCCCH
Confidence 22345678999999998889999999999999999998 9988754321111110 111111123445568
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999988754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=356.98 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=190.9
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCC--eeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGD--ERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~~~l 130 (372)
.+|++++.||+|+||.||+|. ..+++.||||++.... ....+++.+|+.+|+.+. ||||+++++++...+ ..|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 578999999999999999999 4678999999996532 233567889999999997 999999999997554 6899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC--
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~-- 208 (372)
||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. |++||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999997 589999863 4699999999999999999999999 999999999999999999999999999976432
Q ss_pred -----------------------CCcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc
Q 017395 209 -----------------------GRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (372)
Q Consensus 209 -----------------------~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~ 264 (372)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 123468899999999987 56899999999999999999999998754321111100
Q ss_pred ccccc-----------------------------cccccC------------CCChHHHHHHHHHHHHHccCCCCCCCCh
Q 017395 265 IQTLT-----------------------------DSCLEG------------QFSSDEGTELVRLASRCLQYEPRERPNP 303 (372)
Q Consensus 265 ~~~~~-----------------------------~~~~~~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (372)
...+- ...... ..+..+++++.+|+.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 00000 000000 0011345789999999999999999999
Q ss_pred HHHHHH
Q 017395 304 RSLVTA 309 (372)
Q Consensus 304 ~~il~~ 309 (372)
.++++|
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=340.04 Aligned_cols=247 Identities=15% Similarity=0.186 Sum_probs=200.1
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|.+.+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 688999999999999999994 5688999999975432 34678999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee---cCCCCceeeccCCcccCCCC-
Q 017395 136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 136 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~~~~~- 209 (372)
++++|.+++... ....+++..++.++.|++.||.|||++ |++||||||+||++ +.++.+||+|||++......
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 999999988542 235699999999999999999999999 99999999999999 45678999999999765433
Q ss_pred --CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
....+|+.|+|||++. +.++.++||||||+++|+|++|+.||.................... ......++++.+
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 257 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA---VECRPLTPQAVD 257 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---C--CCCCHHHHH
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc---cccCcCCHHHHH
Confidence 3456789999999986 5688999999999999999999999876543322221111110000 011124578999
Q ss_pred HHHHHccCCCCCCCChHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (372)
|+.+||+.||.+|||+.+++++
T Consensus 258 li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=348.91 Aligned_cols=253 Identities=17% Similarity=0.258 Sum_probs=202.0
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.+..|++++.||+|+||.||+|.. .+++.||||++....... .+.+.+|++++++++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 456899999999999999999995 458999999986554332 44588999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|||+++++|.+++. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999988875 345699999999999999999999999 9999999999999999999999999999765432
Q ss_pred --CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc--------------------cc
Q 017395 210 --RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN--------------------IQ 266 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~--------------------~~ 266 (372)
....+|..|+|||++.+. .++.++||||||+++|+|++|+.||............ ..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 335678999999999875 6899999999999999999999988654211110000 00
Q ss_pred ccccccccCC-----CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 267 TLTDSCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 267 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
....+..... ..+..+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000000 1124568899999999999999999999999883
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=368.35 Aligned_cols=253 Identities=17% Similarity=0.216 Sum_probs=209.4
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
...+.|.+++.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++|++++||||+++++++......|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3557889999999999999999995 569999999996432 123567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 130 LVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+||||++||+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++...
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999987533 34699999999999999999999999 99999999999999999999999999998754
Q ss_pred CC----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 208 DG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 208 ~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+... ...++...+.
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCcccCH
Confidence 43 23478999999999999999999999999999999999999986532100000000111111 1234566778
Q ss_pred HHHHHHHHHccCCCCCCCCh-----HHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNP-----RSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~-----~~il~~ 309 (372)
++.+|+.+||+.||.+||++ .+|++|
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 99999999999999999964 778876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=342.47 Aligned_cols=253 Identities=21% Similarity=0.258 Sum_probs=207.1
Q ss_pred CCCcccccc-ccCCCCCCeEEEEEe---CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 55 GFAMENIVS-EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 55 ~~~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
+...|.+.+ .||+|+||.||+|.+ .+++.||||++...... ..+.+.+|++++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345788888 899999999999963 34688999999865332 256799999999999999999999999 66788
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999974 45699999999999999999999999 999999999999999999999999999987644
Q ss_pred CCc-------ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 209 GRS-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 209 ~~~-------~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
... ..++..|+|||++.+..++.++||||||+++|+|++ |+.||........... .........+..
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~ 244 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-----LEKGERMGCPAG 244 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTCCCCCCTT
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----HHcCCCCCCCCC
Confidence 321 234678999999998889999999999999999999 9988765432222111 111112234556
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
++.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 678999999999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=352.73 Aligned_cols=257 Identities=18% Similarity=0.278 Sum_probs=209.1
Q ss_pred cCCCccccccccCCCCCCeEEEEEeCC-C-----cEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKLEN-Q-----FRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 125 (372)
-....|.+.+.||+|+||.||+|.... + ..||+|.+...... ..+.+.+|+++++++ +||||+++++++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345688999999999999999999532 3 47999999865433 356799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWE------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~ 193 (372)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCC
Confidence 99999999999999999986421 34689999999999999999999999 999999999999999999
Q ss_pred CceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccc
Q 017395 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~ 266 (372)
.+||+|||++....... ...+|+.|+|||++.+..++.++||||||+++|||++ |..||......... .
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~----~ 277 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF----Y 277 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH----H
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH----H
Confidence 99999999997643322 2334678999999998899999999999999999999 88777543211110 1
Q ss_pred ccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
...........+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1111111122344456889999999999999999999999999987754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=354.02 Aligned_cols=255 Identities=17% Similarity=0.143 Sum_probs=197.9
Q ss_pred CccccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCCcc-----------HHHHHHHHHHHhcCCCcceeeEeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPD-----------ARQFLEEARAVGQLRNRRLANLLGC 121 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l~~~ 121 (372)
.+|.+++.||+|+||.||+|... ++..||||++....... ...+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999964 57889999997654321 2246788899999999999999999
Q ss_pred EEe----CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC--Cc
Q 017395 122 CCE----GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV--NP 195 (372)
Q Consensus 122 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~--~~ 195 (372)
+.. ....++||||+ +++|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcE
Confidence 988 67899999999 9999999974 33799999999999999999999999 999999999999999777 99
Q ss_pred eeeccCCcccCCCC-----------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh---
Q 017395 196 RLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR--- 261 (372)
Q Consensus 196 kl~Dfg~~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~--- 261 (372)
||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999765321 2346789999999999988999999999999999999999988542111110
Q ss_pred --hccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 262 --DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 262 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
......+.............+.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 000000000000000011455789999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=350.19 Aligned_cols=242 Identities=17% Similarity=0.208 Sum_probs=181.5
Q ss_pred cccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecCCCCCH
Q 017395 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL 140 (372)
+.||+|+||.||+|.. .+++.||||++... ....+.+|+.+++.++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 6789999999999995 56899999999643 3467889999999997 99999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC---CceeeccCCcccCCCC----Cccc
Q 017395 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNSRDG----RSYS 213 (372)
Q Consensus 141 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~---~~kl~Dfg~~~~~~~~----~~~~ 213 (372)
.+++.. .+.+++..++.|+.|++.||.|||++ |++||||||+||+++.++ .+||+|||+++..... ....
T Consensus 94 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 94 FERIKK--KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp HHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 999974 45699999999999999999999999 999999999999997665 7999999999865433 2345
Q ss_pred CCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCC--CC----hHHHHHHHH
Q 017395 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ--FS----SDEGTELVR 287 (372)
Q Consensus 214 ~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~l~~ 287 (372)
+|+.|+|||++.+..++.++||||||+++|+|++|..||......... .....+......+. ++ ...+.++.+
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCCCCcccccCCCHHHHH
Confidence 689999999999999999999999999999999999998653211000 00001111111111 11 235689999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
|+.+||+.||.+|||+.++++|-+
T Consensus 250 li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 250 LIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred HHHHHCCCChhHCCCHHHHhcChh
Confidence 999999999999999999988743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=353.10 Aligned_cols=256 Identities=15% Similarity=0.139 Sum_probs=205.8
Q ss_pred CccccccccCCCCCCeEEEEEeC---------CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceee----------
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE---------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLAN---------- 117 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------- 117 (372)
..|.+++.||+|+||.||+|... +++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57999999999999999999954 3789999999754 35889999999999999988
Q ss_pred -----EeeEEEe-CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC
Q 017395 118 -----LLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (372)
Q Consensus 118 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~ 191 (372)
+++++.. ....++||||+ +++|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEET
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcC
Confidence 6777766 67899999999 99999999865456799999999999999999999999 9999999999999999
Q ss_pred CC--CceeeccCCcccCCCC-----------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh--
Q 017395 192 DV--NPRLSCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-- 256 (372)
Q Consensus 192 ~~--~~kl~Dfg~~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~-- 256 (372)
++ .+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 88 8999999999764322 23467899999999999899999999999999999999999886532
Q ss_pred hHHhhhcc--cccccccccc-CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 257 LDLIRDRN--IQTLTDSCLE-GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 257 ~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
........ .......... .......+.++.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 11111100 0000000000 001123458899999999999999999999999999998776544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=351.30 Aligned_cols=250 Identities=19% Similarity=0.140 Sum_probs=199.1
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCC-----CCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRS-----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.|++++.||+|+||.||+|.. .++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 688999999999999999994 56889999998643 223456799999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 017395 132 AEYMPNDTLAKHLFHW--------------------------------------ETQPMKWAMRLRVALHIAEALEYCTS 173 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qi~~al~~lH~ 173 (372)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998521 01124677889999999999999999
Q ss_pred CCCcccccccCcceeecCCC--CceeeccCCcccCCC--------CCcccCCCCcCCcccccC--CCCCCCCceeehHHH
Q 017395 174 KERALYHDLNAYRIVFDDDV--NPRLSCFGLMKNSRD--------GRSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTL 241 (372)
Q Consensus 174 ~~~iiH~Dikp~Nill~~~~--~~kl~Dfg~~~~~~~--------~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvi 241 (372)
+ |++||||||+||+++.++ .+||+|||++..... .....+|+.|+|||++.+ ..++.++||||||++
T Consensus 187 ~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 187 Q-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp T-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred C-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 9 999999999999998766 899999999975422 134567899999999975 568999999999999
Q ss_pred HHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 242 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+|||++|+.||.................. .........++++.+|+.+||+.||.+|||+.+++++-
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC--TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccc--cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 99999999998654322211111111000 00011123568899999999999999999999999983
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=348.39 Aligned_cols=254 Identities=17% Similarity=0.239 Sum_probs=196.1
Q ss_pred hcCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeE
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 129 (372)
...+.+|++++.||+|+||+||+|. ..+++.||||++....... .+.+.+|++++++++||||+++++++......+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3456789999999999999999999 5578999999997554322 456789999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-----CCCCceeeccCCcc
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-----DDVNPRLSCFGLMK 204 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-----~~~~~kl~Dfg~~~ 204 (372)
+||||+++ +|.+++.. ...+++..++.|+.||+.||.|||++ |++||||||+|||++ .++.+||+|||++.
T Consensus 110 lv~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999975 99999974 34599999999999999999999999 999999999999994 44559999999987
Q ss_pred cCCCC----CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc--ccc-------
Q 017395 205 NSRDG----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT--LTD------- 270 (372)
Q Consensus 205 ~~~~~----~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~--~~~------- 270 (372)
..... ....+|..|+|||++.+.. ++.++|||||||++|||++|..||............... ...
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 65422 3345689999999998754 899999999999999999999988654221111100000 000
Q ss_pred ---------------ccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 271 ---------------SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 271 ---------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
..+....+...+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 0000001112467899999999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=343.01 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=200.0
Q ss_pred CCCccccccccCCCCCCeEEEEEeC----CCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC--
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD-- 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-- 126 (372)
+...|.+.+.||+|+||.||+|... ++..||||++...... ..+.+.+|+.++++++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4457889999999999999999843 3458999999765432 3467999999999999999999999997754
Q ss_pred ---eeEEEEecCCCCCHHhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeec
Q 017395 127 ---ERLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (372)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~D 199 (372)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECS
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEee
Confidence 359999999999999998432 345699999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccc
Q 017395 200 FGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 200 fg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
||++...... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.............. .
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~ 265 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-----G 265 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----T
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc-----C
Confidence 9998765432 22345678999999999899999999999999999999 7777654322211111111 1
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.....+..++.++.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11223455668899999999999999999999999999988653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=372.76 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=204.7
Q ss_pred cccc-ccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 60 NIVS-EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 60 ~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.+.+ +||+|+||.||+|.+. ++..||||+++.... ...+.|.+|+++|++++||||+++++++.. +..++||||
T Consensus 338 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~ 416 (613)
T 2ozo_A 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 416 (613)
T ss_dssp EEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred eEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEe
Confidence 3344 6899999999999853 466799999986533 346789999999999999999999999976 569999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 210 (372)
+++|+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++......
T Consensus 417 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 417 AGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp CTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred CCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999999999964 345699999999999999999999999 99999999999999999999999999998754322
Q ss_pred ---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||.......... .+........+..++.++.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-----~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-----HHHTTCCCCCCTTCCHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCcCCHHHH
Confidence 1234578999999999999999999999999999998 998886533221111 1111122234566778999
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=341.79 Aligned_cols=247 Identities=16% Similarity=0.246 Sum_probs=208.5
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|.+++.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 588899999999999999994 5689999999975543 34678999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
++++|.+++. ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++...... ..
T Consensus 103 ~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 103 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp TTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999999994 45699999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..++..|+|||++.+..++.++||||||+++|+|++|+.|+........... .........+...+..+.+|+.+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-----IPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCCSSCCHHHHHHHHH
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-----hhcCCCCCCccccCHHHHHHHHH
Confidence 5678899999999998999999999999999999999988764322111110 00111122344556789999999
Q ss_pred HccCCCCCCCChHHHHHHHHhh
Q 017395 292 CLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~ 313 (372)
||+.||.+|||+.+++++..-.
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHH
T ss_pred HcCCChhhCcCHHHHhhChhhh
Confidence 9999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=346.16 Aligned_cols=248 Identities=16% Similarity=0.149 Sum_probs=208.4
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
....|.+.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 345789999999999999999995 4588999999875422 235678999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999999864 35699999999999999999999999 9999999999999999999999999999865422
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....+|..|+|||++.+..++.++||||||+++|+|++|+.||.............. . ...++...+.++.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~ 269 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----N--EYSIPKHINPVAA 269 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----T--CCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc----C--CCCCCccCCHHHH
Confidence 235678999999999988899999999999999999999998865432211111000 0 1123445567899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+|+.+||+.||.+|||+.+++++-.
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHHHccCChhHCcCHHHHhcCcc
Confidence 9999999999999999999999844
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=350.60 Aligned_cols=247 Identities=17% Similarity=0.234 Sum_probs=196.4
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC------e
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~ 127 (372)
..|++++.||+|+||.||+|.. .+++.||||++...... ..+++.+|+++|+.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4689999999999999999995 57999999999654322 2457899999999999999999999997653 4
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 69999999 7899999964 4699999999999999999999999 99999999999999999999999999998765
Q ss_pred CC-CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc--------------------
Q 017395 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------------------- 265 (372)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~-------------------- 265 (372)
.. ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 43 34578999999999987 679999999999999999999999987542211100000
Q ss_pred ------cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 266 ------QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 266 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
....... ........++++.+|+.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 260 NYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCCCCCCC-HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000 011223456889999999999999999999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=342.64 Aligned_cols=251 Identities=17% Similarity=0.244 Sum_probs=201.0
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC--CCcceeeEeeEEEeC----CeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL--RNRRLANLLGCCCEG----DERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~----~~~~l 130 (372)
.+|++++.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++... ...++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 37889999999999999999984 789999998642 334566677776665 899999999999887 78999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CcccccccCcceeecCCCCceeeccCCc
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE-------RALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-------~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
||||+++|+|.++++. ..+++..++.++.|++.||.|||++. |++||||||+||+++.++.+||+|||++
T Consensus 113 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 9999999999999963 36999999999999999999999752 8999999999999999999999999999
Q ss_pred ccCCCCC--------cccCCCCcCCcccccCCCCCCC------CceeehHHHHHHHHhC----------CCCCCchh---
Q 017395 204 KNSRDGR--------SYSTNLAFTPPEYLRTGRVTPE------SVMYSFGTLLLDLLSG----------KHIPPSHA--- 256 (372)
Q Consensus 204 ~~~~~~~--------~~~~t~~y~aPE~~~~~~~~~~------~Dv~SlGvil~el~tg----------~~p~~~~~--- 256 (372)
....... ...||+.|+|||++.+...+.. +|||||||++|||++| ..|+....
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 7654322 3468899999999988776665 9999999999999999 54443211
Q ss_pred --hHHhhhccccccccccccCCCC-----hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 257 --LDLIRDRNIQTLTDSCLEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 257 --~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
........ ........++ ..++.++.+|+.+||+.||.+|||+.+++++|+.+.+...
T Consensus 270 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 270 PSYEDMREIV----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CchhhhHHHH----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 00011100 0111111222 3678899999999999999999999999999999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=338.18 Aligned_cols=248 Identities=16% Similarity=0.149 Sum_probs=208.4
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
....|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 345789999999999999999995 4588999999875432 235568999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999999863 35699999999999999999999999 9999999999999999999999999999865422
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....+|..|+|||++.+..++.++||||||+++|+|++|+.||.............. . ....+...+..+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~ 243 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----N--EYSIPKHINPVAA 243 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----T--CCCCCTTSCHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----c--cCCCccccCHHHH
Confidence 234678999999999988899999999999999999999998865432211111100 0 1123445568899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+++.+||+.||++|||+.+++++-.
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHHHcccChhhCcCHHHHhhChh
Confidence 9999999999999999999999854
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=342.27 Aligned_cols=254 Identities=17% Similarity=0.215 Sum_probs=207.4
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCE--GDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 129 (372)
...+|++++.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 456899999999999999999995 57899999999765432 35568999999999999999999998854 56899
Q ss_pred EEEecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccccccCcceeecCCCCceeeccCC
Q 017395 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER-----ALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~-----iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
+||||+++++|.+++... ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999642 234599999999999999999999998 8 99999999999999999999999999
Q ss_pred cccCCCCC----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 203 MKNSRDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 203 ~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
+....... ...++..|+|||++.+..++.++||||||+++|+|++|+.||.............. ......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~ 237 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-----GKFRRIP 237 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----TCCCCCC
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-----cccccCC
Confidence 88765433 24578999999999988899999999999999999999988865432221111111 1111334
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
...+.++.+++.+||+.||.+|||+.+++++++...
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 556789999999999999999999999999876433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=347.13 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=208.9
Q ss_pred cCCCccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 125 (372)
-...+|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3456889999999999999999983 34689999999865433 245789999999999 799999999998775
Q ss_pred C-eeEEEEecCCCCCHHhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec
Q 017395 126 D-ERLLVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (372)
Q Consensus 126 ~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~ 190 (372)
+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||+++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLS 182 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEC
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEEC
Confidence 4 58999999999999999975432 1288999999999999999999999 999999999999999
Q ss_pred CCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhc
Q 017395 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDR 263 (372)
Q Consensus 191 ~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~ 263 (372)
.++.+||+|||+++...... ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~- 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC- 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH-
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH-
Confidence 99999999999998654332 2345778999999999999999999999999999998 888875432111100
Q ss_pred cccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
...........+...++++.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 262 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 262 ---RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ---HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0001111122344456889999999999999999999999999998765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=345.66 Aligned_cols=257 Identities=20% Similarity=0.295 Sum_probs=207.7
Q ss_pred CCCccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
....|.+++.||+|+||.||+|.+ .+++.||||.+..... ....++.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 345789999999999999999983 3477899999975432 335579999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---CCCceeec
Q 017395 128 RLLVAEYMPNDTLAKHLFHWET-----QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSC 199 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~~~~kl~D 199 (372)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||+++. +..+||+|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999999976432 3589999999999999999999999 9999999999999984 44699999
Q ss_pred cCCcccCCC------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcccccccccc
Q 017395 200 FGLMKNSRD------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 200 fg~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
||++..... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.............. .
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-----~ 261 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----G 261 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----T
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc-----C
Confidence 999864322 223456789999999998899999999999999999998 8877765432222111111 1
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
.....+..++..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 112234456688999999999999999999999999999887654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=336.27 Aligned_cols=247 Identities=17% Similarity=0.130 Sum_probs=203.4
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.+|++++.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 4788999999999999999995 4689999999975432 3356789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC------
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------ 208 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 208 (372)
+++++|.+++. ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999996 345699999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
.....++..|+|||++.+..+ +.++||||||+++|+|++|+.||.......... ................+..+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH---HHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHhhhcccccCchhhcCHHHHH
Confidence 233567899999999987765 778999999999999999999886432110000 0000000001112345688999
Q ss_pred HHHHHccCCCCCCCChHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (372)
|+.+||+.||.+|||+.+++++
T Consensus 241 li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCCchhCCCHHHHhcC
Confidence 9999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=349.55 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=201.0
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+.|++++.||+|+||.||+|.. .+++.||||++..... ...+|++++.++ +||||+++++++.+....|+||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 4689999999999999999995 5689999999976543 235788888888 799999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-C---CceeeccCCcccCCCC-
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-V---NPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-~---~~kl~Dfg~~~~~~~~- 209 (372)
++||+|.+++. ..+.+++..+..++.||+.||.|||++ |++||||||+|||+.++ + .+||+|||+++.....
T Consensus 98 ~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 98 MKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999997 345699999999999999999999999 99999999999998533 3 4999999999865432
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh---hHHhhhccccccccccccCCCChHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....+|+.|+|||++.+..++.++|||||||++|||++|..||.... ...+....... ............+.
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--KFSLSGGYWNSVSD 252 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--CCCCCSTTTTTSCH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--CcccCccccccCCH
Confidence 23567899999999988788999999999999999999999886421 11111000000 00011122345678
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
++.+|+.+||..||.+|||+.++++|-+-
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 99999999999999999999999998553
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=349.02 Aligned_cols=253 Identities=17% Similarity=0.241 Sum_probs=197.5
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+..|.+++.||+|+||+||+|.. .+++.||||++....... ...+.+|+++|++++||||+++++++...+..++|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 35799999999999999999995 478999999997543222 1245689999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++ +|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLDK-DLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9975 89998875 345699999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------ccccccc--------
Q 017395 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TLTDSCL-------- 273 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~-------- 273 (372)
....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.............. .......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 23456899999999987 5589999999999999999999998875432211110000 0000000
Q ss_pred -----cC----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 274 -----EG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 274 -----~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.. ......+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 00 011234678999999999999999999999999843
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=362.29 Aligned_cols=248 Identities=19% Similarity=0.188 Sum_probs=204.5
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|++++.||+|+||+||+|.. .+++.||||++.... ......+.+|+++|++++||||+++++++......++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 799999999999999999995 578999999986421 23467799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec---CCCCceeeccCCcccCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~~~~~~-- 209 (372)
+.+++|.+.+.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++ .++.+||+|||++......
T Consensus 103 ~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 103 YTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 999999998864 35699999999999999999999999 999999999999995 4567999999999865543
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.................. .........+.++.+|
T Consensus 180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA--FDLPQWRTISDDAKDL 256 (486)
T ss_dssp --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SCSGGGGGSCHHHHHH
T ss_pred cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCcccCCCCHHHHHH
Confidence 34568999999999985 5899999999999999999999998754322221111110000 0001123456889999
Q ss_pred HHHHccCCCCCCCChHHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.+||+.||.+|||+.++++|-+
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHh
Confidence 99999999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=339.13 Aligned_cols=250 Identities=17% Similarity=0.231 Sum_probs=203.1
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+..+.....||+|+||.||+|. ..+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3444455578999999999999 466889999999876655567899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-CCCceeeccCCcccCCCC---
Q 017395 135 MPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~~~~~--- 209 (372)
+++++|.+++.... ...+++..++.++.|++.||.|||++ |++|+||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99999999997543 23567999999999999999999999 9999999999999987 899999999999865432
Q ss_pred -CcccCCCCcCCcccccCCC--CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....++..|+|||++.+.. ++.++||||||+++|+|++|+.||............ .........++...+.++.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHHHCCCCCCCTTSCHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hccccccccccccCCHHHH
Confidence 3456789999999997654 788999999999999999999887543211110000 0001112234556678999
Q ss_pred HHHHHHccCCCCCCCChHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+++.+||+.||++|||+.+++++
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=338.13 Aligned_cols=248 Identities=18% Similarity=0.224 Sum_probs=201.0
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe----CCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~ 127 (372)
+-..|.+.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 334578888999999999999994 5688999999875432 235678999999999999999999999875 356
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeec-CCCCceeeccCCcc
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMK 204 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~-~~~~~kl~Dfg~~~ 204 (372)
.++||||+++++|.+++.. ...+++..++.|+.|++.||.|||++ + ++||||||+||+++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 8999999999999999974 35699999999999999999999999 8 99999999999998 88999999999997
Q ss_pred cCCCCC--cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhH-HhhhccccccccccccCCCChHH
Q 017395 205 NSRDGR--SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 205 ~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
...... ...+|+.|+|||++. +.++.++||||||+++|+|++|+.||...... ............ ..++...
T Consensus 181 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~ 255 (290)
T 1t4h_A 181 LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----ASFDKVA 255 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----GGGGGCC
T ss_pred cccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----cccCCCC
Confidence 655432 356899999999887 45899999999999999999999988642211 111111111111 1122333
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
++++.+++.+||+.||.+|||+.++++|-
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 47899999999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.17 Aligned_cols=248 Identities=18% Similarity=0.219 Sum_probs=200.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|++++.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 4688999999999999999995 458999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC----CCCCc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGRS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~----~~~~~ 211 (372)
++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++... .....
T Consensus 99 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 99 PGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999998864 245699999999999999999999999 9999999999999999999999999986532 12234
Q ss_pred ccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 212 YSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 212 ~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
..+|..|+|||++. +..++.++||||||+++|+|++|..|+............... .......+..++.++.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---DPPTLLTPSKWSVEFR 253 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSSGGGSCHHHH
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---CCcccCCccccCHHHH
Confidence 56889999999984 567899999999999999999999887653221111110000 0001112345568899
Q ss_pred HHHHHHccCCCCCCCChHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+++.+||+.||.+|||+.++++|
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999886
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=350.14 Aligned_cols=254 Identities=17% Similarity=0.209 Sum_probs=205.8
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
..+|++++.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 35799999999999999999995 46899999999865333 25678999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC--CCCc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRS 211 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~--~~~~ 211 (372)
|+++++|.+++.. ...+++..+..++.|++.||.|||++.|++||||||+||+++.++.+||+|||++.... ....
T Consensus 112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence 9999999999974 34699999999999999999999984389999999999999999999999999986432 2234
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc--------------------------
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------------------------- 265 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~-------------------------- 265 (372)
..+|+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 578999999999999999999999999999999999999986532221110000
Q ss_pred ------------cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 266 ------------QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 266 ------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..+.............+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000000001112235678999999999999999999999999844
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=347.14 Aligned_cols=252 Identities=16% Similarity=0.169 Sum_probs=191.5
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEe--------CC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCE--------GD 126 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--------~~ 126 (372)
..|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 3789999999999999999994 578999999987655455677999999999996 9999999999843 34
Q ss_pred eeEEEEecCCCCCHHhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeecCCCCceeeccCCc
Q 017395 127 ERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
..++||||+. |+|.+++... ....+++..++.++.|++.||.|||++ | ++||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5899999996 6899988642 345699999999999999999999999 8 999999999999999999999999999
Q ss_pred ccCCCCC----------------cccCCCCcCCcccc---cCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc
Q 017395 204 KNSRDGR----------------SYSTNLAFTPPEYL---RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (372)
Q Consensus 204 ~~~~~~~----------------~~~~t~~y~aPE~~---~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~ 264 (372)
....... ...+|+.|+|||++ .+..++.++||||||+++|+|++|+.||...........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~- 264 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG- 264 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC-
Confidence 8654322 23478899999998 456688999999999999999999998864322211111
Q ss_pred ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
......+...+..+.+|+.+||+.||.+|||+.+++++|+.+.....
T Consensus 265 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 265 -------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 11111122334568999999999999999999999999998876443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=344.25 Aligned_cols=254 Identities=17% Similarity=0.209 Sum_probs=200.0
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEe-------
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCE------- 124 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 124 (372)
...+|++++.||+|+||.||+|.. .+++.||||++...... ....+.+|++++++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 456899999999999999999995 67899999999654332 24578899999999999999999999977
Q ss_pred -CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
.+..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999976 78777754 335699999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC--------CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-------ccc
Q 017395 204 KNSRDG--------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-------IQT 267 (372)
Q Consensus 204 ~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-------~~~ 267 (372)
+..... ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||............ ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 765421 234568899999999864 5899999999999999999999888654322111000 000
Q ss_pred ccccc-----------ccCC---CCh-----HHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 268 LTDSC-----------LEGQ---FSS-----DEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 268 ~~~~~-----------~~~~---~~~-----~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..... .... ... ..++++.+|+.+||+.||.+|||+.++++|-+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 00000 0000 000 11467999999999999999999999999843
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=375.05 Aligned_cols=246 Identities=19% Similarity=0.232 Sum_probs=209.1
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCC---CCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
...+|++++.||+|+||.||+|. ..+++.||||++... .....+.+.+|..+|..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 46789999999999999999999 456889999999742 122356788999999988 7999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC-
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~- 208 (372)
|||||++||+|.+++.. .+.+++..++.|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999974 35699999999999999999999999 999999999999999999999999999985322
Q ss_pred ---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 ---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............. . ...++...+.++
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~ 569 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----H--NVAYPKSMSKEA 569 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS----S--CCCCCTTSCHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh----C--CCCCCccCCHHH
Confidence 2346789999999999999999999999999999999999999876543322221111 1 123456677899
Q ss_pred HHHHHHHccCCCCCCCCh-----HHHHHH
Q 017395 286 VRLASRCLQYEPRERPNP-----RSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~-----~~il~~ 309 (372)
.+||.+||+.||.+||++ ++|++|
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 999999999999999997 888877
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=336.42 Aligned_cols=249 Identities=18% Similarity=0.168 Sum_probs=202.9
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC----CccHHHHHHHHHHHhcCCCcceeeEeeEEE--eCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCC--EGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~ 128 (372)
...|.+++.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46799999999999999999994 568899999997532 223567999999999999999999999984 45678
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||++++ |.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999886 88888765667799999999999999999999999 999999999999999999999999999986543
Q ss_pred C------CcccCCCCcCCcccccCCC--CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 209 G------RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 209 ~------~~~~~t~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
. ....+|..|+|||++.+.. ++.++||||||+++|+|++|+.||.............. . ...++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~----~--~~~~~~~ 235 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK----G--SYAIPGD 235 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----C--CCCCCSS
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc----C--CCCCCCc
Confidence 2 2345789999999998654 47799999999999999999998875432222111110 0 1123445
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHh
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~ 312 (372)
++..+.+++.+||+.||.+|||+.+++++-.-
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 66889999999999999999999999998543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=357.91 Aligned_cols=249 Identities=15% Similarity=0.174 Sum_probs=195.1
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----Cee
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 128 (372)
..|.+++.||+|+||.||+|. ..+++.||||++..... ...+++.+|+++|++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 478999999999999999999 45688999999975432 2356799999999999999999999999766 568
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|+||||+. ++|.+++. ....+++..++.++.||+.||.|||+. |++||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999996 59999997 345699999999999999999999999 999999999999999999999999999986543
Q ss_pred C--------------------------CcccCCCCcCCcccc-cCCCCCCCCceeehHHHHHHHHhCCCCCC--------
Q 017395 209 G--------------------------RSYSTNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLSGKHIPP-------- 253 (372)
Q Consensus 209 ~--------------------------~~~~~t~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~p~~-------- 253 (372)
. ....+|+.|+|||++ .+..++.++|||||||++|||++|..|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2 345679999999986 45569999999999999999998544332
Q ss_pred ---chhh------------------HHh---------------h---hccccccccccc-cCC-----CChHHHHHHHHH
Q 017395 254 ---SHAL------------------DLI---------------R---DRNIQTLTDSCL-EGQ-----FSSDEGTELVRL 288 (372)
Q Consensus 254 ---~~~~------------------~~~---------------~---~~~~~~~~~~~~-~~~-----~~~~~~~~l~~l 288 (372)
+... +.+ . ............ ... ..+..++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 1100 000 0 000000000000 000 012356889999
Q ss_pred HHHHccCCCCCCCChHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+||+.||.+|||+.++++|
T Consensus 342 l~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=362.29 Aligned_cols=248 Identities=18% Similarity=0.143 Sum_probs=206.5
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|++++.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 688999999999999999995 478999999996543 2346789999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee---cCCCCceeeccCCcccCCCCC
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
|+.+|+|.+++. ....+++..++.++.|++.||.|||++ |++||||||+|||+ +.++.+||+|||++.......
T Consensus 107 ~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 107 VYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp CCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred cCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999999997 345699999999999999999999999 99999999999999 567899999999998765443
Q ss_pred ---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||................... ........++++.+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF--ELPQWKKVSESAKD 260 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CSGGGGGSCHHHHH
T ss_pred ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CCcccccCCHHHHH
Confidence 3468999999999975 68999999999999999999999987543222211111100000 00112345789999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
|+.+||+.||.+|||+.++++|-+
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHHCCCChhHCcCHHHHhhChh
Confidence 999999999999999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=361.69 Aligned_cols=246 Identities=15% Similarity=0.179 Sum_probs=199.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|++++.||+|+||+||+|.. .++..||||++.... ......+.+|+.+|+.++||||+++++++......++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 689999999999999999995 568899999997543 22356789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC---CCceeeccCCcccCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~~~~~-- 209 (372)
+++|+|.+++.. ...+++..++.|+.||+.||.|||++ |++||||||+|||++.. +.+||+|||++......
T Consensus 118 ~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 118 YKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 999999998863 35699999999999999999999999 99999999999999754 45999999999875543
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....||+.|+|||++. +.++.++|||||||++|+|++|..||................... ........+.++.+|
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--DSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CSGGGTTSCHHHHHH
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CchhcccCCHHHHHH
Confidence 3456899999999987 569999999999999999999999987643322221111110000 000112456889999
Q ss_pred HHHHccCCCCCCCChHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~ 309 (372)
+.+||+.||.+|||+.++++|
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999999999999999988
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=355.08 Aligned_cols=259 Identities=13% Similarity=0.147 Sum_probs=209.6
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC--eeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~ 132 (372)
..|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 4789999999999999999995 4589999999975432 23567889999999999999999999998765 789999
Q ss_pred ecCCCCCHHhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee----cCCCCceeeccCCcccCC
Q 017395 133 EYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill----~~~~~~kl~Dfg~~~~~~ 207 (372)
||+++|+|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||++ +.++.+||+|||+++...
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999999975322 3399999999999999999999999 99999999999999 777789999999998765
Q ss_pred CCC---cccCCCCcCCcccccC--------CCCCCCCceeehHHHHHHHHhCCCCCCchh-----hHHh---hhcccccc
Q 017395 208 DGR---SYSTNLAFTPPEYLRT--------GRVTPESVMYSFGTLLLDLLSGKHIPPSHA-----LDLI---RDRNIQTL 268 (372)
Q Consensus 208 ~~~---~~~~t~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~-----~~~~---~~~~~~~~ 268 (372)
... ...+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... .+.+ ........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 432 3568999999999875 457889999999999999999998874311 1111 01110000
Q ss_pred c---------------cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 269 T---------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 269 ~---------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
. .......++...+..+.+++.+||+.||++|||+.++++.+..+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 00111234577889999999999999999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=338.14 Aligned_cols=250 Identities=16% Similarity=0.186 Sum_probs=202.5
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
....|.+++.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 345789999999999999999995 458999999997643 35679999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+++++|.+++.. ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 105 YCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp CCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 9999999999863 245699999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....++..|+|||++.+..++.++||||||+++|+|++|..||........... .... .......+...+..+.+|+
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-IPTN--PPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHS--CCCCCSSGGGSCHHHHHHH
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhcC--CCcccCCcccCCHHHHHHH
Confidence 234678899999999998999999999999999999999998864321111100 0000 0001112344568899999
Q ss_pred HHHccCCCCCCCChHHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.+||+.||.+|||+.+++++-.
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHH
T ss_pred HHHccCChhhCcCHHHHHhCHH
Confidence 9999999999999999998743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=337.11 Aligned_cols=253 Identities=17% Similarity=0.192 Sum_probs=205.5
Q ss_pred ccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.|++++.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 5889999999999999999954 6899999998754321 36779999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC----CceeeccCCcccC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg~~~~~ 206 (372)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999963 45699999999999999999999999 999999999999998777 7999999999876
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
... ....+++.|+|||++.+..++.++||||||+++|+|++|..||................. ..........+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 240 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY--DFDEEYFSNTSE 240 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--CCCHHHHTTCCH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc--CCcchhcccCCH
Confidence 443 234578999999999988999999999999999999999998865432211111000000 000001123457
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHH--HHhhhc
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~--l~~~~~ 315 (372)
.+.+++.+||+.||.+|||+.+++++ ++.+..
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 89999999999999999999999997 444443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=362.25 Aligned_cols=249 Identities=15% Similarity=0.143 Sum_probs=202.5
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-------------ccHHHHHHHHHHHhcCCCcceeeEeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-------------PDARQFLEEARAVGQLRNRRLANLLGCC 122 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~l~~~~ 122 (372)
..|.+++.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+.+|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4789999999999999999994 5688999999975432 2246789999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC---Cceeec
Q 017395 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSC 199 (372)
Q Consensus 123 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~---~~kl~D 199 (372)
......++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ |++||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999864 35699999999999999999999999 999999999999998765 699999
Q ss_pred cCCcccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCC
Q 017395 200 FGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (372)
Q Consensus 200 fg~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (372)
||++...... ....||+.|+|||++. +.++.++|||||||++|+|++|..||................... ...
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~ 269 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF--DFN 269 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--Ccc
Confidence 9999876543 3456899999999987 568999999999999999999999987643322221111110000 000
Q ss_pred CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 277 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.....+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 01234688999999999999999999999999854
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=341.12 Aligned_cols=255 Identities=18% Similarity=0.263 Sum_probs=188.3
Q ss_pred cCCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
-+...|++++.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 355689999999999999999999 45788999999975432 2356788999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 132 AEYMPNDTLAKHLFH------WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999999999999863 1245699999999999999999999999 999999999999999999999999999875
Q ss_pred CCCC---------CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh----ccccccccc
Q 017395 206 SRDG---------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD----RNIQTLTDS 271 (372)
Q Consensus 206 ~~~~---------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~----~~~~~~~~~ 271 (372)
.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 4322 23457899999999976 568999999999999999999999886532111110 111111111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..........+.++.+++.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11112233456789999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=343.60 Aligned_cols=251 Identities=16% Similarity=0.130 Sum_probs=204.7
Q ss_pred ccccc-cccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIV-SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 132 (372)
.|.++ +.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.+++ ||||+++++++......++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 46666 7799999999999994 4689999999975432 23667999999999995 699999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---CCCceeeccCCcccCCCC
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~~~~~~~~ 209 (372)
||+++|+|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++. ++.+||+|||++......
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999999999999765567799999999999999999999999 9999999999999987 789999999999876543
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....+|+.|+|||++.+..++.++||||||+++|+|++|+.||............... ...........++..+.
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQLAT 265 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHHHH
Confidence 2356899999999999999999999999999999999999998654322221111110 01111122345668899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+|+.+||+.||.+|||+.++++|-+
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred HHHHHHcCCChhhCcCHHHHhCCHh
Confidence 9999999999999999999998844
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.93 Aligned_cols=252 Identities=17% Similarity=0.193 Sum_probs=202.8
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC------CCcceeeEeeEEEeCCeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL------RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~~~ 129 (372)
.+|++++.||+|+||+||+|. ..+++.||||++.... ...+++.+|+++++.+ +|+||+++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 368999999999999999998 4568999999997532 2345678888888877 5779999999999999999
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC--ceeeccCCcccCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNSR 207 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~--~kl~Dfg~~~~~~ 207 (372)
+||||+. ++|.+++.......+++..++.|+.||+.||.|||++ ||+||||||+|||++.++. +||+|||++....
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 9999996 5899999876666799999999999999999999999 9999999999999998887 9999999997655
Q ss_pred CC-CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc-------cc----------cc
Q 017395 208 DG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QT----------LT 269 (372)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~-------~~----------~~ 269 (372)
.. ....+|+.|+|||++.+..++.++|||||||++|||++|..||............. .. ..
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~ 333 (429)
T 3kvw_A 254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333 (429)
T ss_dssp CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHB
T ss_pred CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhcc
Confidence 43 34578999999999999999999999999999999999998886542211100000 00 00
Q ss_pred c--------------------------------cc----ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 270 D--------------------------------SC----LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 270 ~--------------------------------~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
. .. +...++...++++.+||.+||+.||.+|||+.++++|-+
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw 411 (429)
T 3kvw_A 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411 (429)
T ss_dssp CTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred CCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence 0 00 000011123578999999999999999999999999843
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=357.33 Aligned_cols=244 Identities=15% Similarity=0.173 Sum_probs=191.7
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--------ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
+.|.+++.||+|+||+||+|. ..+++.||||++..... .....+.+|+++|++++||||+++++++. ...
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 468899999999999999999 45689999999864321 11224889999999999999999999975 566
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC---CCceeeccCCcc
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMK 204 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~ 204 (372)
.++||||+++|+|.+++. ..+.+++..++.++.|++.||.|||++ |++||||||+|||++.+ +.+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccce
Confidence 899999999999999986 445699999999999999999999999 99999999999999754 459999999998
Q ss_pred cCCCC---CcccCCCCcCCcccccC---CCCCCCCceeehHHHHHHHHhCCCCCCchhhH-----Hhhhccccccccccc
Q 017395 205 NSRDG---RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNIQTLTDSCL 273 (372)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 273 (372)
..... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .+...... ...
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~-~~~--- 366 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FIP--- 366 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC-CCH---
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC-CCc---
Confidence 76543 24568999999999864 56788999999999999999999988643211 11111000 000
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
......+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 367 --~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 367 --EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp --HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred --hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 00123467899999999999999999999999973
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=341.46 Aligned_cols=245 Identities=18% Similarity=0.203 Sum_probs=200.2
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEe--CCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCE--GDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv 131 (372)
..+|++++.||+|+||+||+|. ..+++.||||++... ..+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 3579999999999999999998 467899999999743 3567999999999997 9999999999987 5678999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcccCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~~- 209 (372)
|||+++++|.+++. .+++..++.++.|++.||.|||++ |++||||||+|||++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999984 389999999999999999999999 999999999999999766 8999999999865433
Q ss_pred --CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHH------------------hhhcc----
Q 017395 210 --RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL------------------IRDRN---- 264 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~------------------~~~~~---- 264 (372)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... +....
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 33567889999999987 568999999999999999999999884321100 00000
Q ss_pred ----------ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 265 ----------IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 265 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.............+...+.++.+|+.+||+.||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000111112223357899999999999999999999999997
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=342.79 Aligned_cols=249 Identities=16% Similarity=0.219 Sum_probs=203.6
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhc--CCCcceeeEeeEEEeCC----eeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEGD----ERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~----~~~lv 131 (372)
.|.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++.... ..++|
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 678889999999999999998 5889999999643 35678889999887 78999999999998776 78999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT--------SKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH--------~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
|||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +++||||||+||+++.++.+||+|||++
T Consensus 119 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp ECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999999964 45999999999999999999999 77 9999999999999999999999999998
Q ss_pred ccCCCC--------CcccCCCCcCCcccccCCC------CCCCCceeehHHHHHHHHhC----------CCCCCchh---
Q 017395 204 KNSRDG--------RSYSTNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSG----------KHIPPSHA--- 256 (372)
Q Consensus 204 ~~~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~Dv~SlGvil~el~tg----------~~p~~~~~--- 256 (372)
...... ....+|+.|+|||++.+.. ++.++||||||+++|||++| ..||....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 765432 2346789999999998753 33689999999999999999 55654321
Q ss_pred --hHHhhhccccccccccccCCC-----ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 257 --LDLIRDRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 257 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
...+... +........+ ...++..+.+|+.+||+.||.+|||+.+++++|+.+.+...
T Consensus 275 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 275 PSVEEMRKV----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CCHHHHHHH----HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred ccHHHHHHH----HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 1111111 1111111222 23667899999999999999999999999999999877643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=359.43 Aligned_cols=240 Identities=15% Similarity=0.107 Sum_probs=190.9
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCC---CCccHHHHHHHH---HHHhcCCCcceeeEe-------eEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEA---RAVGQLRNRRLANLL-------GCC 122 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~~ 122 (372)
..|.+.+.||+|+||+||+|+ ..+++.||||++... .....+.+.+|+ +.|++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 568889999999999999999 467999999999743 223457799999 555666899999998 666
Q ss_pred EeCC-----------------eeEEEEecCCCCCHHhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc
Q 017395 123 CEGD-----------------ERLLVAEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYH 180 (372)
Q Consensus 123 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~ 180 (372)
...+ ..|+||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||++ |++||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr 230 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT 230 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence 5543 289999999 679999997421 11234588899999999999999999 99999
Q ss_pred cccCcceeecCCCCceeeccCCcccCCCC-CcccCCCCcCCcccccCC-----------CCCCCCceeehHHHHHHHHhC
Q 017395 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTG-----------RVTPESVMYSFGTLLLDLLSG 248 (372)
Q Consensus 181 Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~SlGvil~el~tg 248 (372)
||||+|||++.++.+||+|||+++..... ....| +.|+|||++.+. .++.++|||||||++|||++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999865543 23456 899999999887 799999999999999999999
Q ss_pred CCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 249 KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 249 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.||....... ....+.. ....++.++.+|+.+||+.||.+|||+.+++++
T Consensus 310 ~~Pf~~~~~~~----~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 310 DLPITKDAALG----GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp SCCC------C----CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred CCCCccccccc----chhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99886432111 1111111 113445789999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=334.15 Aligned_cols=248 Identities=18% Similarity=0.240 Sum_probs=200.8
Q ss_pred CCCccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
....|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467899999999999999999954 78999999986432 2235678999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999974 34699999999999999999999999 9999999999999999999999999998876543
Q ss_pred --CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||............... ....+...+.++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~ 239 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------VFYIPEYLNRSVA 239 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------cccCchhcCHHHH
Confidence 23457889999999987765 68999999999999999999988654322221111100 0123444568899
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+++.+||+.||.+|||+.++++|-.
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHccCChhhCCCHHHHHhChh
Confidence 9999999999999999999999843
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=351.88 Aligned_cols=252 Identities=17% Similarity=0.213 Sum_probs=204.9
Q ss_pred CCCccccccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCCC----ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEG 125 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 125 (372)
....|++++.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+++|+.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 346899999999999999999996 3689999999975321 2245677899999999 699999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
...++||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999974 34699999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC-----CcccCCCCcCCcccccCC--CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 206 SRDG-----RSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 206 ~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
.... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...............+.. ....++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC
Confidence 5322 234689999999999864 3788999999999999999999988543211000000000100 112345
Q ss_pred hHHHHHHHHHHHHHccCCCCCCC-----ChHHHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERP-----NPRSLVTALV 311 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~il~~l~ 311 (372)
...+..+.+|+.+||+.||.+|| |+.+++++..
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 56678899999999999999999 9999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=344.15 Aligned_cols=254 Identities=19% Similarity=0.195 Sum_probs=197.5
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc-----HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
....|.+++.||+|+||.||+|.. .+++.||||++....... .+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 456789999999999999999994 568999999997543221 24688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
++||||+++ +|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999986 89988864 335689999999999999999999999 999999999999999999999999999986543
Q ss_pred C----CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc--------cc------
Q 017395 209 G----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT--------LT------ 269 (372)
Q Consensus 209 ~----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~------ 269 (372)
. ....+|+.|+|||++.+. .++.++|||||||++|||++|..||............... ..
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 235678999999999765 4889999999999999999999887654221111000000 00
Q ss_pred ccccc---CCC-----ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 270 DSCLE---GQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 270 ~~~~~---~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.... ... ....+.++.+|+.+||+.||.+|||+.++++|-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00000 000 1344688999999999999999999999999854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.63 Aligned_cols=253 Identities=15% Similarity=0.150 Sum_probs=205.1
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEE-EeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCC-CEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~ 134 (372)
..|++++.||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++|++++..+.++ ......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4788999999999999999994 6799999999875443 34688999999999988766655554 667788999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee---cCCCCceeeccCCcccCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
+ +++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||++ +.++.+||+|||++......
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9 8899999964 345699999999999999999999999 99999999999999 48889999999998865432
Q ss_pred ---------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-------HHhhhccccccccccc
Q 017395 210 ---------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNIQTLTDSCL 273 (372)
Q Consensus 210 ---------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 273 (372)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ........... ..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~-- 240 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IE-- 240 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HH--
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hH--
Confidence 334678999999999999999999999999999999999998864211 01111100000 00
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
..+..++.++.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 241 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 241 --VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp --HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred --HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 11233457899999999999999999999999999998766544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=349.97 Aligned_cols=249 Identities=18% Similarity=0.232 Sum_probs=184.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------Ce
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 127 (372)
..|++++.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 478999999999999999999 56789999999975432 2356788999999999999999999998654 56
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+ +++|.+++. .+.+++..++.++.||+.||.|||+. |++||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 679999885 35699999999999999999999999 99999999999999999999999999998754
Q ss_pred CC-CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 017395 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------- 266 (372)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~------------------- 266 (372)
.. ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+............
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 43 34578999999999987 5689999999999999999999999875432111000000
Q ss_pred ccccc---cccCC---CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 267 TLTDS---CLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 267 ~~~~~---~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
..... ..... .....++.+.+|+.+||+.||.+|||+.++++|-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 00000 00000 0123457899999999999999999999999983
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=339.79 Aligned_cols=250 Identities=14% Similarity=0.195 Sum_probs=200.5
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEe------CC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE------GD 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------~~ 126 (372)
....|++++.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 446788999999999999999995 578999999997544 3456789999999999 79999999999987 46
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++||||+++++|.+++.......+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++...
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 799999999999999999865556799999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC----CcccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 207 RDG----RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~----~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
... ....+|..|+|||++. +..++.++||||||+++|+|++|..||........... +.........
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~ 255 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLK 255 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCS
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCC
Confidence 432 3346789999999997 45689999999999999999999988854322111110 0011111112
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 334567899999999999999999999999973
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=338.75 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=199.1
Q ss_pred CCCccccccccCCCCCCeEEEEEeC--CCc--EEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE--NQF--RIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
+..+|++++.||+|+||+||+|.+. ++. .||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3457999999999999999999842 233 69999997543 233567999999999999999999999997654
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 89999999999999999742 34699999999999999999999999 99999999999999999999999999988764
Q ss_pred CCC-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCCh
Q 017395 208 DGR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (372)
Q Consensus 208 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (372)
... ...++..|+|||++.+..++.++||||||+++|+|++ |..||............ .........+.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~ 248 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----DKEGERLPRPE 248 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTSCCCCCCCT
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH----HccCCCCCCCc
Confidence 432 2345678999999998889999999999999999999 89887654322221111 11111112344
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
.++.++.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 5678999999999999999999999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=345.44 Aligned_cols=250 Identities=15% Similarity=0.177 Sum_probs=194.2
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC------
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ 126 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 126 (372)
...|.+++.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 35789999999999999999994 5688999999975432 23456889999999999999999999997654
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 78999999975 7888885 3489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccc---------------
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------------- 268 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~--------------- 268 (372)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 543 34567899999999999899999999999999999999999986542211110000000
Q ss_pred ------------------ccccccCC---CChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 269 ------------------TDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 269 ------------------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
......+. .+...+.++.+|+.+||+.||.+|||+.++++|-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00000000 01234788999999999999999999999999844
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=348.28 Aligned_cols=254 Identities=19% Similarity=0.203 Sum_probs=199.6
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC---------
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--------- 125 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------- 125 (372)
-..|.+++.||+|+||+||+|. ..+++.||||++..... ...+|+++|+.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 3578999999999999999999 46799999999865432 234799999999999999999998543
Q ss_pred -----------------------------CeeEEEEecCCCCCHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 017395 126 -----------------------------DERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSK 174 (372)
Q Consensus 126 -----------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~lH~~ 174 (372)
...++||||+++ +|.+.+.. .....+++..++.++.|++.||.|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 348899999985 78777653 2456799999999999999999999999
Q ss_pred CCcccccccCcceeec-CCCCceeeccCCcccCCCC---CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCC
Q 017395 175 ERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGK 249 (372)
Q Consensus 175 ~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~~---~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~ 249 (372)
|++||||||+||+++ .++.+||+|||+++..... ....+|..|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 999999999999998 6889999999999865433 3456789999999998754 899999999999999999999
Q ss_pred CCCCchhhHHhhhccc-----------------------cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHH
Q 017395 250 HIPPSHALDLIRDRNI-----------------------QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306 (372)
Q Consensus 250 ~p~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 306 (372)
.||............. .......+...++...+.++.+|+.+||+.||.+|||+.++
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9887542211110000 00001111112344567889999999999999999999999
Q ss_pred HHH--HHhhhc
Q 017395 307 VTA--LVTLQK 315 (372)
Q Consensus 307 l~~--l~~~~~ 315 (372)
++| ++.+..
T Consensus 320 l~hp~f~~~~~ 330 (383)
T 3eb0_A 320 MAHPFFDHLRN 330 (383)
T ss_dssp HTSGGGHHHHH
T ss_pred hcCHHHHHHHh
Confidence 988 444443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.73 Aligned_cols=248 Identities=12% Similarity=0.024 Sum_probs=184.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc---cHHHHHHHHH---HHhcCCCcceeeEe-------eEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEAR---AVGQLRNRRLANLL-------GCCC 123 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~hpniv~l~-------~~~~ 123 (372)
.|.+++.||+|+||+||+|.. .+++.||||++...... ..+.+.+|++ .|+. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 488999999999999999994 57899999999875532 2445778854 5555 799988755 4444
Q ss_pred eC-----------------CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCcccc
Q 017395 124 EG-----------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMR------LRVALHIAEALEYCTSKERALYH 180 (372)
Q Consensus 124 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qi~~al~~lH~~~~iiH~ 180 (372)
.. ...|+||||++ |+|.+++... +..+++..+ +.++.||+.||+|||++ |++||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCccC
Confidence 33 33799999998 7999999753 223455556 78889999999999999 99999
Q ss_pred cccCcceeecCCCCceeeccCCcccCCCCC-cccCCCCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCCCchhh
Q 017395 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL 257 (372)
Q Consensus 181 Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~ 257 (372)
||||+|||++.++.+||+|||+++...... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776554 5567799999999987 6699999999999999999999998865422
Q ss_pred HHhhhccc---cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 258 DLIRDRNI---QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 258 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
........ ...............++..+.+|+.+||+.||++|||+.++++|
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110000 00001111111123567899999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.52 Aligned_cols=257 Identities=14% Similarity=0.149 Sum_probs=201.9
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEE-EeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCC-CEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~ 134 (372)
+.|.+++.||+|+||.||+|.. .+++.||||++..... .+++.+|+++++.++|++++..++++ ......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4688999999999999999994 6789999998765432 23578999999999987766665554 667789999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee---cCCCCceeeccCCcccCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
+ +++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||++ +.++.+||+|||++......
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9 8999999964 245699999999999999999999999 99999999999999 78899999999999865432
Q ss_pred ---------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc---CCC
Q 017395 210 ---------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE---GQF 277 (372)
Q Consensus 210 ---------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 277 (372)
....+|+.|+|||++.+..++.++|||||||++|+|++|+.||......... .....+...... ...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHSCHHHH
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccccchhhhh
Confidence 2346789999999999999999999999999999999999998642110000 000000000000 001
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCCC
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEV 319 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 319 (372)
...++.++.+++.+||+.||++|||+.++++.|+.+......
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 123457899999999999999999999999999998765443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=371.04 Aligned_cols=244 Identities=20% Similarity=0.254 Sum_probs=201.4
Q ss_pred cccCCCCCCeEEEEEe---CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 63 SEHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
++||+|+||.||+|.+ .+++.||||+++.... ...+++.+|+++|++++||||+++++++. ....++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 3689999999999964 3467899999975432 23578999999999999999999999986 4568999999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-------
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------- 210 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~------- 210 (372)
|+|.+++.. ...+++..++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 999999973 45699999999999999999999999 99999999999999999999999999998654332
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...+|+.|+|||++.+..++.++|||||||++|||++ |+.||........... +........+..++.++.+||
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-----i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-----LEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTCCCCCCTTCCHHHHHHH
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHHHHH
Confidence 2234678999999999999999999999999999998 9988865433222111 111122234556778999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+||+.||++|||+.+|++.|+.+..
T Consensus 606 ~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999987754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=352.59 Aligned_cols=249 Identities=17% Similarity=0.190 Sum_probs=204.1
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC-cceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~ 134 (372)
..|++++.||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++| +++..+..++......+|||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4789999999999999999994 6789999999875443 2358899999999986 6677777777888899999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee---cCCCCceeeccCCcccCCCCC-
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF---DDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
+ +++|.+++.. ....+++..++.|+.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++......
T Consensus 85 ~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9 8899999974 245699999999999999999999999 99999999999999 588999999999998654322
Q ss_pred ----------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-------HHhhhccccccccccc
Q 017395 211 ----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNIQTLTDSCL 273 (372)
Q Consensus 211 ----------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 273 (372)
...||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-- 239 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA-- 239 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH--
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH--
Confidence 45689999999999999999999999999999999999999865211 11111111111111
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+...++.++.+|+..||+.||.+||++.+|++.|+.+..
T Consensus 240 ---l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 240 ---LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp ---HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 112335789999999999999999999999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=335.61 Aligned_cols=253 Identities=17% Similarity=0.182 Sum_probs=190.5
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc-H-HHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-A-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
..++|++++.||+|+||+||+|.. .+++.||||++....... . +.+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 346789999999999999999994 678999999997654322 2 2344555568888999999999999999999999
Q ss_pred EecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
|||+++ +|.+++... ....+++..++.|+.|++.||.|||++.|++||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 999975 888877531 34679999999999999999999998548999999999999999999999999998765443
Q ss_pred C---cccCCCCcCCcccc----cCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 210 R---SYSTNLAFTPPEYL----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 ~---~~~~t~~y~aPE~~----~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
. ...+|+.|+|||++ .+..++.++||||||+++|+|++|+.||.......... ............+...+
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCTTTSC
T ss_pred ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCcccccCC
Confidence 2 24688999999996 45568999999999999999999999886422111110 01111111111223456
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.++.+++.+||+.||.+|||+.++++|-.
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 88999999999999999999999999743
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=343.87 Aligned_cols=248 Identities=19% Similarity=0.202 Sum_probs=201.9
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc----c----HHHHHHHHHHHhcC-CCcceeeEeeEEEeCC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP----D----ARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 126 (372)
..|++.+.||.|+||.||+|.. .+|+.||||++...... + .+.+.+|+++++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4688889999999999999996 47999999998754321 1 34578999999999 7999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999973 35699999999999999999999999 9999999999999999999999999998866
Q ss_pred CCC---CcccCCCCcCCcccccC------CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCC
Q 017395 207 RDG---RSYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (372)
... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................... ..
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~ 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS--PE 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH--HH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--cc
Confidence 543 34568999999999864 35889999999999999999999988653221111110000000000 00
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
....+..+.+|+.+||+.||.+|||+.++++|
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01235789999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=343.97 Aligned_cols=247 Identities=12% Similarity=0.118 Sum_probs=203.1
Q ss_pred CCCccccccccCCCCCCeEEEEE------eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC---CcceeeEeeEEEeC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK------LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEG 125 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 125 (372)
+-..|.+.+.||+|+||+||+|. ..+++.||||++... ...++.+|++++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678899999999999999993 456889999999754 3457888888888887 99999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-----------
Q 017395 126 DERLLVAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----------- 191 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~----------- 191 (372)
+..++||||+++|+|.+++... ....+++..++.|+.||+.||+|||++ ||+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC------
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999642 345699999999999999999999999 9999999999999998
Q ss_pred CCCceeeccCCcccCC---C---CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc
Q 017395 192 DVNPRLSCFGLMKNSR---D---GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~---~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 265 (372)
++.+||+|||+++... . .....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ...
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~ 295 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---CKP 295 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---EEE
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---eee
Confidence 8999999999996532 1 134568999999999999999999999999999999999998875432110 001
Q ss_pred cccccccccCCCChHHHHHHHHHHHHHccCCCCCC-CChHHHHHHHHhhhc
Q 017395 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER-PNPRSLVTALVTLQK 315 (372)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~il~~l~~~~~ 315 (372)
. .... .. ..+..+.+++..||+.+|.+| |+++++.+.|+.+..
T Consensus 296 ~----~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 296 E----GLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp C----SCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred c----hhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 1 1111 11 235788999999999999999 578888888887654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=343.64 Aligned_cols=252 Identities=17% Similarity=0.170 Sum_probs=204.9
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc-----------------HHHHHHHHHHHhcCCCcceeeE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-----------------ARQFLEEARAVGQLRNRRLANL 118 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpniv~l 118 (372)
..+|.+++.||+|+||.||+|.. +++.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986432111 1789999999999999999999
Q ss_pred eeEEEeCCeeEEEEecCCCCCHHhh------hhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecC
Q 017395 119 LGCCCEGDERLLVAEYMPNDTLAKH------LFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDD 191 (372)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~ 191 (372)
++++...+..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ + |++||||||+||+++.
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcC
Confidence 9999999999999999999999999 654336779999999999999999999999 8 9999999999999999
Q ss_pred CCCceeeccCCcccCCCC--CcccCCCCcCCcccccCC-CCCC-CCceeehHHHHHHHHhCCCCCCchhh-HHhhhcccc
Q 017395 192 DVNPRLSCFGLMKNSRDG--RSYSTNLAFTPPEYLRTG-RVTP-ESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQ 266 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~-~~Dv~SlGvil~el~tg~~p~~~~~~-~~~~~~~~~ 266 (372)
++.+||+|||++...... ....++..|+|||++.+. .++. ++||||||+++|||++|..||..... .........
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 999999999999875433 345678999999999987 5666 99999999999999999998864322 111110000
Q ss_pred cccc-cc-----c-------cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 TLTD-SC-----L-------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 ~~~~-~~-----~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.... +. . ........+.++.+|+.+||+.||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00 0 000113456899999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=339.79 Aligned_cols=259 Identities=20% Similarity=0.244 Sum_probs=199.0
Q ss_pred hcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHH--HhcCCCcceeeEeeEEEe-----C
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARA--VGQLRNRRLANLLGCCCE-----G 125 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~-----~ 125 (372)
.-++.+|++++.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++++.. .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 34678999999999999999999987 6789999999743 23455555555 445899999999986543 2
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CcccccccCcceeecCCCCcee
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE--------RALYHDLNAYRIVFDDDVNPRL 197 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--------~iiH~Dikp~Nill~~~~~~kl 197 (372)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. |++||||||+|||++.++.+||
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred ceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 357899999999999999963 34689999999999999999999852 8999999999999999999999
Q ss_pred eccCCcccCCCC------------CcccCCCCcCCcccccC-------CCCCCCCceeehHHHHHHHHhCCCCCCchhhH
Q 017395 198 SCFGLMKNSRDG------------RSYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALD 258 (372)
Q Consensus 198 ~Dfg~~~~~~~~------------~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~ 258 (372)
+|||+++..... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 999999765422 13458899999999987 34667899999999999999997765432100
Q ss_pred H-h--------hhcc-----ccccccccccCCC------ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 259 L-I--------RDRN-----IQTLTDSCLEGQF------SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 259 ~-~--------~~~~-----~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
. . .... ............+ ...++.++.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 0 0 0000 0000001111111 23467899999999999999999999999999999876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=333.91 Aligned_cols=252 Identities=17% Similarity=0.150 Sum_probs=205.6
Q ss_pred hcCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---------ccHHHHHHHHHHHhcCC-CcceeeEeeE
Q 017395 53 TSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---------PDARQFLEEARAVGQLR-NRRLANLLGC 121 (372)
Q Consensus 53 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv~l~~~ 121 (372)
..-+..|++++.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 34567899999999999999999995 5689999999975431 11346889999999995 9999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
+......++||||+++++|.+++.. ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999999974 35699999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC---CcccCCCCcCCccccc------CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccc
Q 017395 202 LMKNSRDG---RSYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC 272 (372)
Q Consensus 202 ~~~~~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 272 (372)
++...... ....+++.|+|||++. ...++.++||||||+++|+|++|..||..................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 247 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-- 247 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc--
Confidence 99875543 2346789999999985 456889999999999999999999988654322211111110000
Q ss_pred ccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.........+..+.+++.+||+.||.+|||+.++++|
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0011123456889999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=338.43 Aligned_cols=255 Identities=19% Similarity=0.246 Sum_probs=201.7
Q ss_pred cCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
-.+..|++.+.||+|+||.||+|...+ .||+|++..... ...+.+.+|+.++++++||||+++++++......++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 356789999999999999999999754 499999975432 2245678999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC---
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--- 208 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 208 (372)
|||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred eecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999999964 334699999999999999999999999 999999999999998 67999999999765421
Q ss_pred ------CCcccCCCCcCCcccccC---------CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccc
Q 017395 209 ------GRSYSTNLAFTPPEYLRT---------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273 (372)
Q Consensus 209 ------~~~~~~t~~y~aPE~~~~---------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (372)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||...................
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 262 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN-- 262 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--
Confidence 122347889999999875 347889999999999999999999886543322221111111111
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
..+...+.++.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 263 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 263 --LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 112234567999999999999999999999999999887654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=337.12 Aligned_cols=250 Identities=17% Similarity=0.173 Sum_probs=204.8
Q ss_pred CccccccccCCCCCCeEEEEEe--CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc------eeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR------LANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~~ 128 (372)
.+|++++.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++.++|+| ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4799999999999999999985 368899999997532 33567889999999987665 99999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-----------------
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----------------- 191 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~----------------- 191 (372)
++||||+ +++|.+++......++++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999999 88999999866556799999999999999999999999 9999999999999987
Q ss_pred --CCCceeeccCCcccCCCC-CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc---c
Q 017395 192 --DVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---I 265 (372)
Q Consensus 192 --~~~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~---~ 265 (372)
++.+||+|||++...... ....+|+.|+|||++.+..++.++||||||+++|||++|..||............ .
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 250 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 678999999999875543 3457899999999999989999999999999999999999998654221110000 0
Q ss_pred ccc----------------------------------ccc-cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 266 QTL----------------------------------TDS-CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 266 ~~~----------------------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
... ... ......+...+.++.+|+.+||+.||.+|||+.++++|
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 000 000 00011234567899999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=346.28 Aligned_cols=250 Identities=18% Similarity=0.231 Sum_probs=199.9
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeC-----CeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 129 (372)
..|.+++.||+|+||.||+|.. .+++.||||++....... .+.+.+|+++|++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 3789999999999999999994 568899999997544332 46789999999999999999999998765 3689
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+.+ +|.+++.. +.+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 107 iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 107 IVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99999975 89999853 4599999999999999999999999 9999999999999999999999999999865432
Q ss_pred -------CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc--------------
Q 017395 210 -------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------------- 267 (372)
Q Consensus 210 -------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------------- 267 (372)
....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...............
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 234689999999987654 4899999999999999999999988654211111000000
Q ss_pred -----cccccc-cC-----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 268 -----LTDSCL-EG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 268 -----~~~~~~-~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...... .. ......+.++.+|+.+||+.||.+|||+.++++|-.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000000 00 011334678999999999999999999999999843
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.94 Aligned_cols=250 Identities=17% Similarity=0.219 Sum_probs=194.4
Q ss_pred CccccccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEE------------
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC------------ 123 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~------------ 123 (372)
.+|++++.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57899999999999999999954 58999999998665555678999999999999999999999873
Q ss_pred --eCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeecc
Q 017395 124 --EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCF 200 (372)
Q Consensus 124 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Df 200 (372)
.....++||||++ |+|.+++. .+.+++..++.++.|++.||+|||++ |++||||||+||+++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999997 59999994 45699999999999999999999999 999999999999997 6678999999
Q ss_pred CCcccCCCC-------CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccc----
Q 017395 201 GLMKNSRDG-------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL---- 268 (372)
Q Consensus 201 g~~~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~---- 268 (372)
|++...... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999865422 23446889999999876 668999999999999999999999886542211110000000
Q ss_pred --------------ccccc-cC-----CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 269 --------------TDSCL-EG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 269 --------------~~~~~-~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..... .. ......+.++.+|+.+||+.||.+|||+.++++|-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 00000 00 011235688999999999999999999999999843
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=337.97 Aligned_cols=251 Identities=18% Similarity=0.205 Sum_probs=201.0
Q ss_pred CccccccccCCCCCCeEEEEEe--CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcC---CCcceeeEeeEEE-----e
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQL---RNRRLANLLGCCC-----E 124 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-----~ 124 (372)
..|++++.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4689999999999999999996 4688999999864321 1223566788777766 8999999999987 4
Q ss_pred CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
....++||||+. |+|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 567899999997 5999999866566699999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc--------ccc----
Q 017395 205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------TLT---- 269 (372)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~--------~~~---- 269 (372)
..... ....+|..|+|||++.+..++.++||||||+++|+|++|+.||.............. ...
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 65432 235678999999999998999999999999999999999998865422111100000 000
Q ss_pred ---------cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 270 ---------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 270 ---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.......+....+..+.+|+.+||+.||.+|||+.++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000011234456889999999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=340.27 Aligned_cols=242 Identities=15% Similarity=0.170 Sum_probs=195.1
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--------ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
.|.+++.||+|+||.||+|.. .+++.||||++..... .....+.+|+++|++++||||+++++++... ..
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DY 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ce
Confidence 688999999999999999995 5688999999975432 1133588999999999999999999998665 48
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC---ceeeccCCccc
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKN 205 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~~~~ 205 (372)
++||||+++++|.+++. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++. +||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 99999999999999986 445799999999999999999999999 9999999999999986654 99999999987
Q ss_pred CCCCC---cccCCCCcCCccccc---CCCCCCCCceeehHHHHHHHHhCCCCCCchhhH-----Hhhhcccccccccccc
Q 017395 206 SRDGR---SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNIQTLTDSCLE 274 (372)
Q Consensus 206 ~~~~~---~~~~t~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~ 274 (372)
..... ...+|+.|+|||++. +..++.++||||||+++|+|++|..||...... .+...... ...
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~---- 241 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FIP---- 241 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC-CCH----
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc-cCc----
Confidence 65542 345789999999974 456899999999999999999999988643211 11111100 000
Q ss_pred CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 275 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
......+.++.+|+.+||+.||.+|||+.++++|
T Consensus 242 -~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 242 -EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0112346789999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=332.11 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=194.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe------------
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE------------ 124 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------------ 124 (372)
+|++++.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 688999999999999999995 578999999996432 335678999999999999999999998865
Q ss_pred -CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCc
Q 017395 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (372)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~ 203 (372)
....++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 3568999999999999999975 334588899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC------------------CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc
Q 017395 204 KNSRDG------------------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN 264 (372)
Q Consensus 204 ~~~~~~------------------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~ 264 (372)
...... ....+|..|+|||++.+. .++.++||||||+++|+|++ |+............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 765421 234578899999999865 68999999999999999998 34322111100000
Q ss_pred ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
... ........++...+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 241 LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 110 11112223455667889999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=349.45 Aligned_cols=251 Identities=14% Similarity=0.189 Sum_probs=201.5
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC--------CcceeeEeeEEE----
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--------NRRLANLLGCCC---- 123 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~---- 123 (372)
..|++++.||+|+||+||+|+ ..+++.||||++.... ...+.+.+|+++|+.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 579999999999999999998 4668999999997542 33567899999999995 788999999987
Q ss_pred eCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC----------
Q 017395 124 EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---------- 193 (372)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~---------- 193 (372)
.....++||||+ +++|.+.+.....+.+++..++.|+.||+.||.|||++.|++||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456799999999 556777776545567999999999999999999999854899999999999999775
Q ss_pred ---------------------------------------CceeeccCCcccCCCC-CcccCCCCcCCcccccCCCCCCCC
Q 017395 194 ---------------------------------------NPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPES 233 (372)
Q Consensus 194 ---------------------------------------~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~ 233 (372)
.+||+|||++...... ....+|..|+|||++.+..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 7999999999865443 345689999999999999999999
Q ss_pred ceeehHHHHHHHHhCCCCCCchhhH-------Hhh---h------------ccc-----------cccccc---------
Q 017395 234 VMYSFGTLLLDLLSGKHIPPSHALD-------LIR---D------------RNI-----------QTLTDS--------- 271 (372)
Q Consensus 234 Dv~SlGvil~el~tg~~p~~~~~~~-------~~~---~------------~~~-----------~~~~~~--------- 271 (372)
|||||||++|||++|+.||...... ... . ... ..+...
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 9999999999999999988532100 000 0 000 000000
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.....++...+..+.+|+.+||+.||.+|||+.++++|
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00112456778899999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=343.13 Aligned_cols=251 Identities=15% Similarity=0.181 Sum_probs=193.9
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc-----------HHHHHHHHHHHhcCCCcceeeEeeEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-----------ARQFLEEARAVGQLRNRRLANLLGCCCE 124 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l~~~~~~ 124 (372)
-..|.+++.||+|+||.||+|...+++.||||++....... .+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 45677888899999999999997789999999996432211 3679999999999999999999999854
Q ss_pred C-----CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeec
Q 017395 125 G-----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (372)
Q Consensus 125 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~D 199 (372)
. ...++||||+. |+|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCCCEEEEe
Confidence 3 36899999997 588888864 345699999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCCCC---CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc---------
Q 017395 200 FGLMKNSRDG---RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------- 266 (372)
Q Consensus 200 fg~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~--------- 266 (372)
||++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 9999754432 33567889999999987 6689999999999999999999999865421111110000
Q ss_pred --------------cccccccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 267 --------------TLTDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 267 --------------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
........ .......++.+.+|+.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000000 01123346789999999999999999999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=349.26 Aligned_cols=247 Identities=22% Similarity=0.225 Sum_probs=193.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------CeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~l 130 (372)
.|.+++.||+|+||.||+|+. .+++.||||++.... ..+.+|+++|++++||||++++++|... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 588999999999999999995 568999999986543 2234799999999999999999998542 23679
Q ss_pred EEecCCCCCHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-CCceeeccCCcccCC
Q 017395 131 VAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR 207 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-~~~kl~Dfg~~~~~~ 207 (372)
||||+++ +|.+.+.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++...
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 9999986 67666542 1346799999999999999999999999 99999999999999955 568999999998654
Q ss_pred CC---CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc------------------
Q 017395 208 DG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI------------------ 265 (372)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~------------------ 265 (372)
.. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 32 345689999999999765 68999999999999999999999987542111000000
Q ss_pred cccccc-----cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 266 QTLTDS-----CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 266 ~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.....+ .+...++...+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 000000 000012334568999999999999999999999999983
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=339.11 Aligned_cols=248 Identities=15% Similarity=0.146 Sum_probs=176.6
Q ss_pred ccccccc-cCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHH-HHHhcCCCcceeeEeeEEEe----CCeeEE
Q 017395 58 MENIVSE-HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEA-RAVGQLRNRRLANLLGCCCE----GDERLL 130 (372)
Q Consensus 58 ~~~~~~~-lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~----~~~~~l 130 (372)
+|.++++ ||+|+||.||+|.. .+++.||||++... ....+|+ ..++.++||||+++++++.. ....++
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 6788765 89999999999995 46899999999642 2223333 34566799999999999876 445899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---CCCceeeccCCcccCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSR 207 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~~~~~~ 207 (372)
||||+++|+|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++. ++.+||+|||++....
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99999999999999866556799999999999999999999999 9999999999999985 4559999999998655
Q ss_pred CC--CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccc--cccCCCChHHHH
Q 017395 208 DG--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS--CLEGQFSSDEGT 283 (372)
Q Consensus 208 ~~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 283 (372)
.. ....+|+.|+|||++.+..++.++||||||+++|+|++|..||...............+... .........++.
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 43 33567899999999988889999999999999999999999886543222211111111111 011111235678
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
++.+|+.+||+.||.+|||+.++++|-+
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 9999999999999999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=335.66 Aligned_cols=256 Identities=16% Similarity=0.174 Sum_probs=184.3
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHH-HHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
...+|++++.||+|+||.||+|.. .+++.||||++...... ...++.+|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 346889999999999999999995 57899999999765432 2345666666 77788999999999999999999999
Q ss_pred EecCCCCCHHhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 132 AEYMPNDTLAKHLFH---WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|||+++ +|.+++.. .....+++..+..++.|++.||.|||++.|++||||||+||+++.++.+||+|||++.....
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 999986 78877752 23567999999999999999999999854899999999999999999999999999976544
Q ss_pred CC---cccCCCCcCCcccc----cCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 209 GR---SYSTNLAFTPPEYL----RTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 209 ~~---~~~~t~~y~aPE~~----~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
.. ...+|..|+|||++ .+..++.++||||||+++|+|++|+.||....................+........
T Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3aln_A 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCC
T ss_pred ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccC
Confidence 32 23678999999999 455689999999999999999999998865321110000110000111111122345
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+.++.+|+.+||+.||.+|||+.+++++-.
T Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 689999999999999999999999999743
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=340.61 Aligned_cols=248 Identities=15% Similarity=0.205 Sum_probs=196.7
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCee-----
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDER----- 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~----- 128 (372)
..|.+++.||+|+||.||+|. ..+++.||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 478889999999999999999 4568999999997644322 46789999999999999999999999877654
Q ss_pred -EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 129 -LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 129 -~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
++||||+. ++|.+++. ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58888873 3499999999999999999999999 99999999999999999999999999998655
Q ss_pred CC-CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 017395 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------- 266 (372)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~------------------- 266 (372)
.. ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 43 34567999999999987 6789999999999999999999999865321111100000
Q ss_pred cc---ccccccC---CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 267 TL---TDSCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 267 ~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.. ....... ......++++.+|+.+||+.||.+|||+.++++|-
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00 0000000 01123468899999999999999999999999983
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=345.84 Aligned_cols=247 Identities=18% Similarity=0.200 Sum_probs=193.5
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCC------eeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------ERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~l 130 (372)
..|.+++.||+|+||+||+|+...+..||+|++..... ...+|+++|+.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 36899999999999999999976666799998864332 1237999999999999999999996543 3889
Q ss_pred EEecCCCCCHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeeccCCcccCC
Q 017395 131 VAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~ 207 (372)
||||++++ |...+.. .....+++..++.++.|++.||.|||++ |++||||||+|||++ .++.+||+|||+++...
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99999875 4443321 1345799999999999999999999999 999999999999999 79999999999998654
Q ss_pred CC---CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-------------------
Q 017395 208 DG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------- 264 (372)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------------------- 264 (372)
.. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+..........
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 32 345678999999999765 4899999999999999999999998754211110000
Q ss_pred ----ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 265 ----IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 265 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
........+...++...++++.+|+.+||+.||.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000111233456899999999999999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=338.72 Aligned_cols=250 Identities=15% Similarity=0.193 Sum_probs=199.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----CeeE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 129 (372)
++|.+++.||+|+||.||+|.. .+++.||||++...... ....+.+|++++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 4788999999999999999995 46899999999754432 245688999999999999999999988654 6789
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 209 (372)
+||||+. ++|.+++.. +.+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999997 589999863 4699999999999999999999999 9999999999999999999999999999865422
Q ss_pred --------------CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc---------
Q 017395 210 --------------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI--------- 265 (372)
Q Consensus 210 --------------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~--------- 265 (372)
....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 12357889999998865 668999999999999999999999886543211100000
Q ss_pred -----------cccccccc---c---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 266 -----------QTLTDSCL---E---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 266 -----------~~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
........ . .......+.++.+|+.+||+.||.+|||+.++++|-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00000000 0 0011345688999999999999999999999999743
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.68 Aligned_cols=252 Identities=20% Similarity=0.272 Sum_probs=206.2
Q ss_pred CCccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
..+|.+.+.||+|+||.||+|.+.. +..||||.+....... .+.+.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 3568889999999999999998532 4679999987644332 467999999999999999999999984 467899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++......
T Consensus 468 v~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 468 IMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999975 334699999999999999999999999 99999999999999999999999999998765432
Q ss_pred -----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
...+|+.|+|||++.+..++.++||||||+++|||++ |..||............ ........+..++..
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGERLPMPPNCPPT 620 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-----HHTCCCCCCTTCCHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----HcCCCCCCCccccHH
Confidence 2345678999999998899999999999999999997 88777643222111111 011112345566789
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=332.88 Aligned_cols=249 Identities=18% Similarity=0.222 Sum_probs=200.1
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCC--CcceeeEeeEEEeCCeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~l 130 (372)
.-..|++++.||+|+||.||+|...+++.||||++..... ...+.+.+|++++.+++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 3457899999999999999999987899999999975432 23567899999999997 5999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||| +.+++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||++++ +.+||+|||++......
T Consensus 106 v~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999 557899999974 35699999999999999999999999 9999999999999974 89999999999865432
Q ss_pred -----CcccCCCCcCCcccccC-----------CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccc
Q 017395 210 -----RSYSTNLAFTPPEYLRT-----------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL 273 (372)
Q Consensus 210 -----~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 273 (372)
....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ..........
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~ 257 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNH 257 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTS
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhccc
Confidence 23457899999999875 4678899999999999999999998864321111 0111112222
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
...++...+.++.+++.+||+.||.+|||+.+++++-.
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 22334444678999999999999999999999999855
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=338.16 Aligned_cols=253 Identities=17% Similarity=0.160 Sum_probs=200.9
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-Cc-----ceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NR-----RLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~~~~ 128 (372)
..+|++++.||+|+||+||+|.. .+++.||||++.... ....++.+|+.+++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 35789999999999999999994 568899999997432 23456788999888885 54 499999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeec--CCCCceeeccCCccc
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFD--DDVNPRLSCFGLMKN 205 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~--~~~~~kl~Dfg~~~~ 205 (372)
++||||+.+ +|.+++.......+++..+..++.|++.||.|||+ ..||+||||||+|||++ .++.+||+|||+++.
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999999965 99999987655679999999999999999999995 23999999999999995 578899999999987
Q ss_pred CCCC-CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc-------------------
Q 017395 206 SRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI------------------- 265 (372)
Q Consensus 206 ~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~------------------- 265 (372)
.... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHH
T ss_pred cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHH
Confidence 6543 44678999999999999999999999999999999999999987532111100000
Q ss_pred --cccccccc-------------------------------------cCCCChHHHHHHHHHHHHHccCCCCCCCChHHH
Q 017395 266 --QTLTDSCL-------------------------------------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306 (372)
Q Consensus 266 --~~~~~~~~-------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 306 (372)
..+.+..+ ..........++.+||.+||+.||++|||+.++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~ 370 (382)
T 2vx3_A 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYA 370 (382)
T ss_dssp HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHH
Confidence 00000000 000112344689999999999999999999999
Q ss_pred HHHH
Q 017395 307 VTAL 310 (372)
Q Consensus 307 l~~l 310 (372)
++|-
T Consensus 371 L~hp 374 (382)
T 2vx3_A 371 LQHS 374 (382)
T ss_dssp TTSG
T ss_pred hcCc
Confidence 9873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=337.16 Aligned_cols=253 Identities=17% Similarity=0.188 Sum_probs=188.1
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe------
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE------ 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 127 (372)
.++.|.+++.||+|+||.||+|+. .+++.||||++.... .....+.++++.+..++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 345788999999999999999995 568999999986543 223457788889999999999999999976433
Q ss_pred -eEEEEecCCCCCHHhhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCcccccccCcceeecC-CCCceeeccC
Q 017395 128 -RLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCT--SKERALYHDLNAYRIVFDD-DVNPRLSCFG 201 (372)
Q Consensus 128 -~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~lH--~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg 201 (372)
.++||||+++ +|...+.. .....+++..++.++.|++.||.||| ++ |++||||||+|||++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 8899999987 45544432 24556899999999999999999999 88 9999999999999996 8999999999
Q ss_pred CcccCCCC---CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc-------cc-
Q 017395 202 LMKNSRDG---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------LT- 269 (372)
Q Consensus 202 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~- 269 (372)
++...... ....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||............... ..
T Consensus 178 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 178 SAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp TCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 99876543 2456789999999997655 899999999999999999999988654221111100000 00
Q ss_pred ------------------cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 270 ------------------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 270 ------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
-.......+...+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 00001112233578999999999999999999999999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=326.67 Aligned_cols=248 Identities=18% Similarity=0.176 Sum_probs=202.0
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
..|++++.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 3789999999999999999995 478999999986432 2346789999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC---CCceeeccCCcccCCCCC
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~---~~~kl~Dfg~~~~~~~~~ 210 (372)
|+++++|.+++.. ...+++..++.++.|++.||.|||++ |++|+||||+||+++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999998863 34699999999999999999999999 99999999999999754 469999999988665432
Q ss_pred ---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
...++..|+|||++.+ .++.++||||||+++|+|++|..||................... ........+.++.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD 255 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CSGGGTTSCHHHHH
T ss_pred ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CchhhhhcCHHHHH
Confidence 2346788999999875 48999999999999999999999886543222211111100000 00001234678999
Q ss_pred HHHHHccCCCCCCCChHHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l 310 (372)
++.+||+.||.+|||+.+++++-
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSH
T ss_pred HHHHHcccChhhCcCHHHHhcCH
Confidence 99999999999999999999973
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=340.55 Aligned_cols=254 Identities=16% Similarity=0.200 Sum_probs=203.2
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-----------CcceeeEeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----------NRRLANLLGCCC 123 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~ 123 (372)
-..|.+++.||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999994 678999999997532 23466889999999886 899999999987
Q ss_pred eCC----eeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec------CCC
Q 017395 124 EGD----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD------DDV 193 (372)
Q Consensus 124 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~------~~~ 193 (372)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++.|++||||||+|||++ ..+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 789999999 889999998766677999999999999999999999954899999999999994 444
Q ss_pred CceeeccCCcccCCCC-CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh-------h---
Q 017395 194 NPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-------D--- 262 (372)
Q Consensus 194 ~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~-------~--- 262 (372)
.+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 176 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 7999999999866543 3457899999999999999999999999999999999999988643211000 0
Q ss_pred --ccc-----------------cccccc-------------cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 263 --RNI-----------------QTLTDS-------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 263 --~~~-----------------~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
+.. ...... .....++...+.++.+||.+||+.||.+|||+.++++|-
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 000 000000 001134567889999999999999999999999999984
Q ss_pred H
Q 017395 311 V 311 (372)
Q Consensus 311 ~ 311 (372)
.
T Consensus 336 ~ 336 (373)
T 1q8y_A 336 W 336 (373)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=343.07 Aligned_cols=251 Identities=14% Similarity=0.202 Sum_probs=183.7
Q ss_pred cccccc-ccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeEEE
Q 017395 58 MENIVS-EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLV 131 (372)
Q Consensus 58 ~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv 131 (372)
.|++.+ +||+|+||+||+|... +++.||||++..... ...+.+|+.+|++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 366655 6999999999999954 578999999975432 3568899999999999999999999965 6789999
Q ss_pred EecCCCCCHHhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee----cCCCCceeecc
Q 017395 132 AEYMPNDTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCF 200 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill----~~~~~~kl~Df 200 (372)
|||+.+ +|.+++... ....+++..++.|+.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 999975 788877521 123599999999999999999999999 99999999999999 67789999999
Q ss_pred CCcccCCCC-------CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc---------
Q 017395 201 GLMKNSRDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR--------- 263 (372)
Q Consensus 201 g~~~~~~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--------- 263 (372)
|+++..... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.....+.....
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 999865432 235679999999999875 489999999999999999999998854321100000
Q ss_pred -----------ccccc-------------ccccccC--------CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 264 -----------NIQTL-------------TDSCLEG--------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 264 -----------~~~~~-------------~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
....+ ....... ......+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00000 0000000 000111567899999999999999999999999855
Q ss_pred h
Q 017395 312 T 312 (372)
Q Consensus 312 ~ 312 (372)
-
T Consensus 337 f 337 (405)
T 3rgf_A 337 F 337 (405)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=333.96 Aligned_cols=248 Identities=15% Similarity=0.195 Sum_probs=197.1
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEeCCe------
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDE------ 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 127 (372)
..|.+.+.||+|+||.||+|.. .+++.||||++....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 4688889999999999999995 568999999997643322 4578999999999999999999999977654
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+. ++|.+++. ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 58888773 3499999999999999999999999 99999999999999999999999999998654
Q ss_pred CC-CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------------------
Q 017395 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------- 266 (372)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~------------------- 266 (372)
.. ....+|..|+|||++.+ ..++.++||||||+++|+|++|+.||..............
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 43 33567899999999987 5689999999999999999999998865321111000000
Q ss_pred ---cccccccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 267 ---TLTDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 267 ---~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
........ .......+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000000 112345678999999999999999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=332.62 Aligned_cols=250 Identities=15% Similarity=0.143 Sum_probs=201.5
Q ss_pred CccccccccCCCCCCeEEEEEe-CCC-cEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc------eeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR------LANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~~ 128 (372)
..|++++.||+|+||.||+|.. .++ +.||||++.... ...+.+.+|++++++++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 4789999999999999999995 344 789999997532 33567889999999998766 99999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee-------------------
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF------------------- 189 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill------------------- 189 (372)
++||||+ +++|.+++.......+++..++.++.||+.||.|||++ |++||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccc
Confidence 9999999 56787877665556799999999999999999999999 99999999999999
Q ss_pred cCCCCceeeccCCcccCCCC-CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc---cc
Q 017395 190 DDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR---NI 265 (372)
Q Consensus 190 ~~~~~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~---~~ 265 (372)
+.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|..||........... ..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 56789999999999865443 345789999999999999999999999999999999999999865322111000 00
Q ss_pred ccc----------------------------------ccc-cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 266 QTL----------------------------------TDS-CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 266 ~~~----------------------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
... ... ..........+.++.+|+.+||+.||.+|||+.++++|
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000 00001123456789999999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=332.03 Aligned_cols=241 Identities=20% Similarity=0.279 Sum_probs=195.8
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcC----CCcceeeEeeEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQL----RNRRLANLLGCCCE 124 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpniv~l~~~~~~ 124 (372)
..+|++.+.||+|+||.||+|. ..+++.||||++...... ....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 3468899999999999999998 467889999999765432 123466799999988 89999999999999
Q ss_pred CCeeEEEEec-CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeeccCC
Q 017395 125 GDERLLVAEY-MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGL 202 (372)
Q Consensus 125 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~ 202 (372)
.+..++|||| +.+++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++ .++.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 8999999999 789999999974 44699999999999999999999999 999999999999999 889999999999
Q ss_pred cccCCCC--CcccCCCCcCCcccccCCCCC-CCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCCh
Q 017395 203 MKNSRDG--RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (372)
Q Consensus 203 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (372)
+...... ....++..|+|||++.+..+. .++||||||+++|+|++|+.||..... .... ...++.
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~----------~~~~~~ 254 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--ILEA----------ELHFPA 254 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHT----------CCCCCT
T ss_pred hhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hhhh----------ccCCcc
Confidence 8876543 345678999999999877664 589999999999999999988865321 1110 112344
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
..+.++.+++.+||+.||++|||+.+++++-.
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 56688999999999999999999999999743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=333.83 Aligned_cols=241 Identities=18% Similarity=0.259 Sum_probs=202.1
Q ss_pred CCCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCC--CcceeeEeeEEEeC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLR--NRRLANLLGCCCEG 125 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~ 125 (372)
-...|.+++.||+|+||.||+|. ..+++.||||++...... ..+.+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 44679999999999999999999 467899999999754322 1245778999999996 59999999999999
Q ss_pred CeeEEEEecCCC-CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec-CCCCceeeccCCc
Q 017395 126 DERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLM 203 (372)
Q Consensus 126 ~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~-~~~~~kl~Dfg~~ 203 (372)
+..++||||+.+ ++|.+++.. ...+++..++.++.|++.||.|||++ |++||||||+||+++ +++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999976 899999974 45699999999999999999999999 999999999999999 7899999999999
Q ss_pred ccCCCC--CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 204 KNSRDG--RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 204 ~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
...... ....+|+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ..... ..++..
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~----------~~~~~~ 265 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRGQ----------VFFRQR 265 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHCC----------CCCSSC
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hhccc----------cccccc
Confidence 876543 33568899999999987765 6789999999999999999998865421 11110 012334
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
.+.++.+|+.+||+.||.+|||+.+++++-
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 557899999999999999999999999873
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=320.04 Aligned_cols=232 Identities=13% Similarity=0.106 Sum_probs=185.8
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
..|++++.||+|+||.||+|+. .+++.||||++......+ .+.+.+|+..+.+++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 4689999999999999999995 458999999998654332 367999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcc
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 212 (372)
||++|++|.++++. + .....+..|+.|++.||.|||++ |++||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999952 2 45667899999999999999999 99999999999999999999998543
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccc-ccCCCChHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-LEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 291 (372)
|++ .++.++|||||||++|||++|+.||.................... ........++.++.+++.+
T Consensus 175 -----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (286)
T 3uqc_A 175 -----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242 (286)
T ss_dssp -----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred -----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence 333 368899999999999999999998865321100000000000000 0001223456889999999
Q ss_pred HccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 292 CLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
||+.||.+| |+.++++.|+.+....
T Consensus 243 ~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 243 SVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999 9999999999887643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=338.35 Aligned_cols=243 Identities=18% Similarity=0.130 Sum_probs=186.5
Q ss_pred ccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++|+++ +||||+++++++......++||||+. |
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 344668999999998777668999999998643 245688999999986 89999999999999999999999996 5
Q ss_pred CHHhhhhcCCCCC-----CCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC-------------CCceeecc
Q 017395 139 TLAKHLFHWETQP-----MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-------------VNPRLSCF 200 (372)
Q Consensus 139 sL~~~l~~~~~~~-----l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~-------------~~~kl~Df 200 (372)
+|.+++....... .++..++.++.||+.||.|||++ |++||||||+|||++.+ +.+||+||
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999997532211 12334678999999999999999 99999999999999754 47999999
Q ss_pred CCcccCCCCC--------cccCCCCcCCcccccC-------CCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhcc
Q 017395 201 GLMKNSRDGR--------SYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 264 (372)
Q Consensus 201 g~~~~~~~~~--------~~~~t~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~ 264 (372)
|+++...... ...||+.|+|||++.+ ..++.++|||||||++|||++ |..||......... .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--i 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN--I 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH--H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH--H
Confidence 9998765432 2468999999999976 568999999999999999999 88777543211110 0
Q ss_pred ccccc-cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 265 IQTLT-DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 265 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..... ........+...+.++.+|+.+||+.||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 00000 0111112245678999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.03 Aligned_cols=249 Identities=17% Similarity=0.242 Sum_probs=182.8
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc-HHH-HHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD-ARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~-~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.+.+|++++.||+|+||.||+|.. .+++.||||++....... ..+ +.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 456889999999999999999995 478999999997654332 223 44455578888999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
|||+ ++.+..+... ....+++..++.++.|++.||.|||+ . |++||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC-CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 5556555532 34579999999999999999999998 5 8999999999999999999999999998765433
Q ss_pred --CcccCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH-hhhccccccccccccCCCChHH
Q 017395 210 --RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
....+|+.|+|||++. +..++.++||||||+++|+|++|+.||....... .......... ... ......
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~--~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PLL--PGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-CCC--CSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-CCC--CccCCC
Confidence 2346789999999995 4568899999999999999999998886421111 1000011000 000 011235
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+.++.+++.+||+.||.+|||+.+++++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 6789999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=335.47 Aligned_cols=244 Identities=14% Similarity=0.119 Sum_probs=188.4
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|.+.+.||+|+||+||.....+++.||||++...... .+.+|+++|+++ +||||+++++++......|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 357788889999999976555567889999999754432 356899999999 7999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-----CCCceeeccCCcccCCCC-
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----DVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-----~~~~kl~Dfg~~~~~~~~- 209 (372)
. |+|.+++.... ..+.+..++.++.||+.||.|||++ ||+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 6 59999997533 3455556789999999999999999 9999999999999953 235789999999865432
Q ss_pred ------CcccCCCCcCCcccccC---CCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCCh
Q 017395 210 ------RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (372)
....||+.|+|||++.+ ..++.++|||||||++|||++ |..||........... ....... ......
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~--~~~~~~ 254 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-LGACSLD--CLHPEK 254 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-TTCCCCT--TSCTTC
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-hccCCcc--ccCccc
Confidence 23568999999999984 557889999999999999999 7766643322111110 0000000 011234
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..+..+.+|+.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 567789999999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=351.31 Aligned_cols=253 Identities=18% Similarity=0.169 Sum_probs=198.5
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEe------CC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE------GD 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~ 126 (372)
.+..|++++.||.|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 456899999999999999999994 5689999999976432 235679999999999999999999998755 56
Q ss_pred eeEEEEecCCCCCHHhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC---ceeeccCC
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGL 202 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~---~kl~Dfg~ 202 (372)
..++||||+++|+|.+++.... ...+++..++.|+.|++.||.|||+. |++||||||+||+++.++. +||+|||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 7899999999999999997533 23689999999999999999999999 9999999999999997665 89999999
Q ss_pred cccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhh----------ccccccc
Q 017395 203 MKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD----------RNIQTLT 269 (372)
Q Consensus 203 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~----------~~~~~~~ 269 (372)
+...... ....+|..|+|||++.+..++.++||||||+++|+|++|..||.......... .......
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 9876543 33568899999999999999999999999999999999999886431111000 0000000
Q ss_pred --------cccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHH
Q 017395 270 --------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (372)
Q Consensus 270 --------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~ 308 (372)
........+...+..+.+++.+||..||.+|||+.++++
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 000112345568899999999999999999999988543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.47 Aligned_cols=229 Identities=16% Similarity=0.140 Sum_probs=184.4
Q ss_pred Cccccc-cccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHH-hcCCCcceeeEeeEEEe----CCeeE
Q 017395 57 AMENIV-SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAV-GQLRNRRLANLLGCCCE----GDERL 129 (372)
Q Consensus 57 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~~ 129 (372)
..|.++ +.||+|+||.||+|.. .+++.||||++.. ...+.+|++++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 467787 5699999999999994 6789999999863 35678899988 55689999999999877 66799
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---CCCceeeccCCcccC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNS 206 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~~~~~ 206 (372)
+||||+++++|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++. ++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 999999999999999876566799999999999999999999999 9999999999999997 788999999998643
Q ss_pred CCCCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC----hHHH
Q 017395 207 RDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS----SDEG 282 (372)
Q Consensus 207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 282 (372)
. +..++.++|||||||++|||++|+.||...............+.... ..++ ...+
T Consensus 171 ~------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 230 (299)
T 3m2w_A 171 T------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YEFPNPEWSEVS 230 (299)
T ss_dssp T------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC--CSSCHHHHTTSC
T ss_pred c------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc--ccCCchhcccCC
Confidence 2 24577899999999999999999998865432211111111111110 1112 2356
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.++.+|+.+||+.||.+|||+.++++|-.
T Consensus 231 ~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 89999999999999999999999999854
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=351.68 Aligned_cols=238 Identities=18% Similarity=0.220 Sum_probs=195.0
Q ss_pred CccccccccCCCCCCeEEEEEeC--CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe-----e
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLE--NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDE-----R 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-----~ 128 (372)
..|++++.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57999999999999999999964 5899999999754432 34568999999999999999999999987655 7
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
||||||++|++|.+++.. .+++..++.|+.||+.||.|||++ ||+||||||+|||++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999987742 699999999999999999999999 99999999999999975 899999999998877
Q ss_pred CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
.....||+.|+|||++.++. +.++|||||||++|+|++|..|+.... ...+. ........+..+.+|
T Consensus 234 ~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~--------~~~~~----~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 234 FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY--------VDGLP----EDDPVLKTYDSYGRL 300 (681)
T ss_dssp CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE--------CSSCC----TTCHHHHHCHHHHHH
T ss_pred CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc--------ccccc----ccccccccCHHHHHH
Confidence 77778999999999998654 889999999999999999987654321 00110 001112345789999
Q ss_pred HHHHccCCCCCCCC-hHHHHHHHHhh
Q 017395 289 ASRCLQYEPRERPN-PRSLVTALVTL 313 (372)
Q Consensus 289 i~~cl~~dp~~Rps-~~~il~~l~~~ 313 (372)
+.+||+.||.+||+ ++++...|..+
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHHH
Confidence 99999999999995 55555556554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=332.91 Aligned_cols=239 Identities=15% Similarity=0.111 Sum_probs=181.7
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc---cHHHHHHHHHHHhcCCC-cceee---------------
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRN-RRLAN--------------- 117 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-pniv~--------------- 117 (372)
.+.+.+.||+|+||+||+|. ..+++.||||++...... ..+.+.+|+.+++.++| +|...
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 46667789999999999999 567999999999844332 25679999999999987 22111
Q ss_pred ------EeeEEEe-----CCeeEEEEecCCCCCHHhhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccc
Q 017395 118 ------LLGCCCE-----GDERLLVAEYMPNDTLAKHLF-----HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181 (372)
Q Consensus 118 ------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~D 181 (372)
+..++.. ....+++|+++ +++|.+++. ......+++..++.++.|++.||+|||++ ||+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrD 236 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTY 236 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence 1111111 22467778776 679999884 22345688899999999999999999999 999999
Q ss_pred ccCcceeecCCCCceeeccCCcccCCCC-CcccCCCCcCCcccc----------cCCCCCCCCceeehHHHHHHHHhCCC
Q 017395 182 LNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYL----------RTGRVTPESVMYSFGTLLLDLLSGKH 250 (372)
Q Consensus 182 ikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~t~~y~aPE~~----------~~~~~~~~~Dv~SlGvil~el~tg~~ 250 (372)
|||+|||++.++.+||+|||+++..... ....| +.|+|||++ .+..++.++|||||||++|||++|+.
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999998765543 23456 899999999 55558889999999999999999999
Q ss_pred CCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 251 IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 251 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
||....... ....+... ....+.++.+|+.+||+.||.+|||+.+++++
T Consensus 316 Pf~~~~~~~----~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 316 PNTDDAALG----GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CCCTTGGGS----CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcchhh----hHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 886543211 11111111 11334789999999999999999998888765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=325.01 Aligned_cols=243 Identities=12% Similarity=0.059 Sum_probs=188.4
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC--------ccHHHHHHHHHHHhcCC---------Ccceee
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--------PDARQFLEEARAVGQLR---------NRRLAN 117 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------hpniv~ 117 (372)
...+|.+++.||+|+||+||+|+. +++.||||++..... ...+.+.+|+.+|+.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345789999999999999999998 679999999975432 22477899999998886 666666
Q ss_pred EeeEE-----------------Ee-------------CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHH
Q 017395 118 LLGCC-----------------CE-------------GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEA 167 (372)
Q Consensus 118 l~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~a 167 (372)
+.+++ .. ....||||||+++|++.+.+. ++.+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHH
Confidence 66553 32 678999999999998777773 3568999999999999999
Q ss_pred HHHhh-cCCCcccccccCcceeecCCC--------------------CceeeccCCcccCCCCCcccCCCCcCCcccccC
Q 017395 168 LEYCT-SKERALYHDLNAYRIVFDDDV--------------------NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT 226 (372)
Q Consensus 168 l~~lH-~~~~iiH~Dikp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~~ 226 (372)
|.||| ++ ||+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.+
T Consensus 174 L~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 174 LAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCC
T ss_pred HHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcC
Confidence 99999 88 999999999999999887 8999999999876543 4578999999999987
Q ss_pred CCCCCCCceeehHHH-HHHHHhCCCCCCchhhHH-hhhccccc-cccccccCCCChHHHHHHHHHHHHHccCCCCCCCCh
Q 017395 227 GRVTPESVMYSFGTL-LLDLLSGKHIPPSHALDL-IRDRNIQT-LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303 (372)
Q Consensus 227 ~~~~~~~Dv~SlGvi-l~el~tg~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 303 (372)
.. +.++||||+|++ .+++++|..||....+.. ........ ..........+...++++.+|+.+||+.| |+
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa 325 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA 325 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence 66 889999998777 777888988775422111 11111100 01111111123568899999999999977 99
Q ss_pred HHHH-HH
Q 017395 304 RSLV-TA 309 (372)
Q Consensus 304 ~~il-~~ 309 (372)
.+++ +|
T Consensus 326 ~e~l~~H 332 (336)
T 2vuw_A 326 TDLLCQH 332 (336)
T ss_dssp HHHHHHC
T ss_pred HHHHhcC
Confidence 9998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=290.54 Aligned_cols=179 Identities=12% Similarity=0.063 Sum_probs=129.2
Q ss_pred ccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC----------ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeEEE
Q 017395 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW----------PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 64 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 131 (372)
..+.|++|.+..+. .-.|+.+|||++..... ...++|.+|+++|+++ .|+||+++++++.+.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777777766 44688899999975432 1245699999999999 699999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 210 (372)
|||++|++|.++|. ..++++.. .|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||+++......
T Consensus 321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999997 45567764 4789999999999999 99999999999999999999999999998765432
Q ss_pred ---cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCC
Q 017395 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK 249 (372)
Q Consensus 211 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~ 249 (372)
...||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 3457899999999985 4677899999999988876654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=250.25 Aligned_cols=176 Identities=14% Similarity=0.134 Sum_probs=143.9
Q ss_pred cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCcc--------HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+.||+|+||.||+|.. .+..+++|......... .+++.+|+++|++++||||+++..++......||||||
T Consensus 342 ~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 342 HLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp ------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4679999999999965 56789999875433221 34589999999999999999666666677888999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
++|++|.+++.. +..|+.|++.||.|||++ ||+||||||+|||++. .+||+|||+++.....
T Consensus 421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999963 568999999999999999 9999999999999998 9999999999987653
Q ss_pred ------CcccCCCCcCCcccccC--CCCCCCCceeehHHHHHHHHhCCCCC
Q 017395 210 ------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIP 252 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~ 252 (372)
....||+.|+|||++.. ..|+..+|+||..+-.++.+.++.++
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 24567999999999987 55788899999999998888776543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-27 Score=212.05 Aligned_cols=158 Identities=16% Similarity=0.074 Sum_probs=125.7
Q ss_pred CHHHHHHHhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc------------------cHHHHHHHHHH
Q 017395 45 SIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP------------------DARQFLEEARA 106 (372)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~ 106 (372)
+...+....+.-..|.+.+.||+|+||.||+|...+++.||||+++..... ....+.+|+++
T Consensus 78 ~~~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~ 157 (282)
T 1zar_A 78 SLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157 (282)
T ss_dssp HHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence 344455555666667777999999999999999977999999999743211 24568999999
Q ss_pred HhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcc
Q 017395 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186 (372)
Q Consensus 107 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~N 186 (372)
|++++ | +++.+++.. +..++||||++|++|.+ +. . .....++.|++.||.|||+. |++||||||+|
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~N 223 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHR-GIVHGDLSQYN 223 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTS
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHH
Confidence 99999 4 666665543 56799999999999998 52 1 13457999999999999999 99999999999
Q ss_pred eeecCCCCceeeccCCcccCCCCCcccCCCCcCCcccccC
Q 017395 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT 226 (372)
Q Consensus 187 ill~~~~~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~~ 226 (372)
||++ ++.+||+|||+++.. ..++|||++..
T Consensus 224 ILl~-~~~vkl~DFG~a~~~---------~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV---------GEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET---------TSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC---------CCCCHHHHHHH
Confidence 9999 999999999998643 35788998763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.3e-23 Score=181.02 Aligned_cols=150 Identities=13% Similarity=0.068 Sum_probs=115.8
Q ss_pred CHHHHHHHhcCCCccccccccCCCCCCeEEEEEe-CCCcE--EEEEEcCCCCCcc------------------------H
Q 017395 45 SIETLRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFR--IAVKRFNRSAWPD------------------------A 97 (372)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~ 97 (372)
+...+....+.-..|.+.+.||+|+||.||+|.. .+|+. ||||+++...... .
T Consensus 35 ~~~~l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (258)
T 1zth_A 35 TLKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVF 114 (258)
T ss_dssp HHHHHHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHH
T ss_pred HHHHHHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHH
Confidence 3444555555666788899999999999999996 78888 9999976432110 1
Q ss_pred HHHHHHHHHHhcCCCcce--eeEeeEEEeCCeeEEEEecCCC-C----CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 017395 98 RQFLEEARAVGQLRNRRL--ANLLGCCCEGDERLLVAEYMPN-D----TLAKHLFHWETQPMKWAMRLRVALHIAEALEY 170 (372)
Q Consensus 98 ~~~~~E~~~l~~l~hpni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~ 170 (372)
..+.+|+.+|.+++|+++ +.++++ ...+|||||+.+ | +|.+.... .++..+..++.|++.||.|
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHH
Confidence 257899999999988754 444442 356899999942 3 67776532 2345678899999999999
Q ss_pred hh-cCCCcccccccCcceeecCCCCceeeccCCcccC
Q 017395 171 CT-SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (372)
Q Consensus 171 lH-~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~ 206 (372)
|| +. |++||||||+|||++. .++|+|||++...
T Consensus 186 lH~~~-givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 186 LYQEA-ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHTS-CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHC-CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99 88 9999999999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-20 Score=173.56 Aligned_cols=153 Identities=10% Similarity=0.037 Sum_probs=110.3
Q ss_pred cCHHHHHHHhcCCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCC--------------ccHHH--------HH
Q 017395 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW--------------PDARQ--------FL 101 (372)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~ 101 (372)
|++-.|.+..+.-.-|.+.++||.|+||.||+|...+|+.||||+++.... ..... ..
T Consensus 82 yD~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~ 161 (397)
T 4gyi_A 82 LDYLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAI 161 (397)
T ss_dssp HHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHH
Confidence 344456677777777999999999999999999988899999999763210 00111 23
Q ss_pred HHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccc
Q 017395 102 EEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHD 181 (372)
Q Consensus 102 ~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~D 181 (372)
+|...|.++.+.++....-+... ..+|||||++|++|..+.. . .....++.|++.+|.+||+. |+||||
T Consensus 162 kE~~nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~-gIVHrD 230 (397)
T 4gyi_A 162 KEFAFMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH-GLIHGD 230 (397)
T ss_dssp HHHHHHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred HHHHHHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC-CCcCCC
Confidence 46666666644433221111112 2379999999998876542 1 13456889999999999999 999999
Q ss_pred ccCcceeecCCCC----------ceeeccCCcccCC
Q 017395 182 LNAYRIVFDDDVN----------PRLSCFGLMKNSR 207 (372)
Q Consensus 182 ikp~Nill~~~~~----------~kl~Dfg~~~~~~ 207 (372)
|||.|||+++++. +.|+||+.+....
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999999987763 8899999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-14 Score=127.22 Aligned_cols=139 Identities=14% Similarity=-0.021 Sum_probs=110.0
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.|.+...+|.|+.+.||++... ++.+++|+...........+.+|+++++.+. +.+++++++++...+..|+||||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 5677777788888999999864 5789999987532122345889999999884 6788999999998889999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------ 174 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------------ 174 (372)
|.+|.+.+. +......++.+++.+|+.||+.
T Consensus 94 G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 94 GVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999987642 1122347788999999999981
Q ss_pred ----------------CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 175 ----------------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 175 ----------------~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 258999999999999876556799998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.7e-12 Score=114.58 Aligned_cols=134 Identities=13% Similarity=0.072 Sum_probs=99.4
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc--eeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~ 135 (372)
.+.+....+.|..+.||++...+|..++||+..... ...+.+|+.+++.+.+.+ +++++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 344433334566699999987777889999986542 245778999999885434 667888888777899999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE---------------------------------------- 175 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---------------------------------------- 175 (372)
+|.+|. .. . .+ ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 998884 21 1 22 2356778888888888741
Q ss_pred -----------------CcccccccCcceeecCCCCceeeccCCcc
Q 017395 176 -----------------RALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 176 -----------------~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
.++|+|++|.||++++++.+.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 28999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.1e-11 Score=114.94 Aligned_cols=146 Identities=14% Similarity=0.139 Sum_probs=109.7
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcC--CCCC-ccHHHHHHHHHHHhcCC--CcceeeEeeEEEeC---Ce
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFN--RSAW-PDARQFLEEARAVGQLR--NRRLANLLGCCCEG---DE 127 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~~ 127 (372)
+.....++.++.|.++.||+....+ ..+++|+.. .... .....+.+|+.+++.+. +..+++++.++.+. +.
T Consensus 37 ~~~~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 37 FAGPLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCCCCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CCCCceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 3444456788999999999998755 578889876 3221 12346788999999996 45688999988766 45
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--------------------------------- 174 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--------------------------------- 174 (372)
.|+||||++|..+.+.. -..++......++.+++..|+.||+.
T Consensus 116 ~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 89999999998875422 12478888899999999999999971
Q ss_pred ------------------------CCcccccccCcceeecCCCC--ceeeccCCcccC
Q 017395 175 ------------------------ERALYHDLNAYRIVFDDDVN--PRLSCFGLMKNS 206 (372)
Q Consensus 175 ------------------------~~iiH~Dikp~Nill~~~~~--~kl~Dfg~~~~~ 206 (372)
..++|+|+++.||+++.++. +.|+||+.+...
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999997653 689999987643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=9.6e-12 Score=112.59 Aligned_cols=182 Identities=13% Similarity=0.094 Sum_probs=122.5
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-Ccc--eeeEeeEEEeCC---eeEEEEecC
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRR--LANLLGCCCEGD---ERLLVAEYM 135 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~ 135 (372)
++.++.|..+.||+.. ..+++|+.... .....+.+|+++|+.+. +.. +++++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4557889999999863 45899986532 23467899999998883 332 455555543332 358999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK----------------------------------------- 174 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----------------------------------------- 174 (372)
+|.+|.+... ..++..+...++.+++..|+.||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875432 2367778888888888888888851
Q ss_pred ----------------CCcccccccCcceeecC--CCCceeeccCCcccCCCCCcccCCCCc---CCcccccC-----CC
Q 017395 175 ----------------ERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGRSYSTNLAF---TPPEYLRT-----GR 228 (372)
Q Consensus 175 ----------------~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~t~~y---~aPE~~~~-----~~ 228 (372)
..++|+|++|.||++++ ...+.|+||+.+..............+ ..|+.... +.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 24699999999999997 456789999988764432221111111 23332211 00
Q ss_pred ---------CCCCCceeehHHHHHHHHhCCCCCC
Q 017395 229 ---------VTPESVMYSFGTLLLDLLSGKHIPP 253 (372)
Q Consensus 229 ---------~~~~~Dv~SlGvil~el~tg~~p~~ 253 (372)
.....+.|++|.++|.+.+|..++.
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0112578999999999999986543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=6.1e-08 Score=87.52 Aligned_cols=134 Identities=13% Similarity=0.044 Sum_probs=93.8
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCc---ceeeEeeEEE-eCCeeEEEEecCCC
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCC-EGDERLLVAEYMPN 137 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~ 137 (372)
+..++.|....||+. +..++||+... ......+.+|+++|+.+.+. .+++.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 455688888899988 45688998532 12345789999999999642 3667777764 34567899999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------- 174 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------------- 174 (372)
.+|.+... ..++......++.+++..|+.||+.
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88876321 1245555555566666665555542
Q ss_pred ----------------CCcccccccCcceeecC---CCCc-eeeccCCccc
Q 017395 175 ----------------ERALYHDLNAYRIVFDD---DVNP-RLSCFGLMKN 205 (372)
Q Consensus 175 ----------------~~iiH~Dikp~Nill~~---~~~~-kl~Dfg~~~~ 205 (372)
..++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 14589999999999987 4554 7999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.4e-07 Score=83.46 Aligned_cols=125 Identities=15% Similarity=0.050 Sum_probs=90.8
Q ss_pred CeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCC
Q 017395 71 NVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE 148 (372)
Q Consensus 71 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 148 (372)
+.||+... .++..+.||+-.. .....+.+|+..|+.+. +--+.++++++...+..|+|||+++|.++.+....
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-- 113 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-- 113 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--
T ss_pred CeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC--
Confidence 36898874 4567899998653 23456888999998884 44478889999999999999999999888776532
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------------------
Q 017395 149 TQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------------------ 174 (372)
Q Consensus 149 ~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------------------------ 174 (372)
.......+..+++..|.-||+.
T Consensus 114 ----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 114 ----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp ----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred ----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 1122334555555566655531
Q ss_pred ---CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 175 ---ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 175 ---~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
..++|+|+.+.||++++++.+-|+||+.+.
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 026899999999999987767799998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=6.3e-08 Score=89.31 Aligned_cols=82 Identities=5% Similarity=-0.037 Sum_probs=56.9
Q ss_pred ccccc-CCCCCCeEEEEEeC-------CCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCC-C--cceeeEeeEEEeC-
Q 017395 61 IVSEH-GEKAPNVVYKGKLE-------NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-N--RRLANLLGCCCEG- 125 (372)
Q Consensus 61 ~~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~- 125 (372)
.++.| +.|..+.+|+.... ++..+++|+..... ......+.+|+.+++.+. + -.+++++.++...
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34566 77888999998754 25679999875432 111235678888888884 2 3577888877654
Q ss_pred --CeeEEEEecCCCCCHHh
Q 017395 126 --DERLLVAEYMPNDTLAK 142 (372)
Q Consensus 126 --~~~~lv~e~~~~gsL~~ 142 (372)
+..|+||||++|.++.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35789999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=9.8e-07 Score=82.58 Aligned_cols=76 Identities=13% Similarity=0.044 Sum_probs=51.1
Q ss_pred cccccCCCCCCeEEEEEeC-CCcEEEEEEcCCCCC-------ccHHHHHHHHHHHhcCCC--c-ceeeEeeEEEeCCeeE
Q 017395 61 IVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-------PDARQFLEEARAVGQLRN--R-RLANLLGCCCEGDERL 129 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-niv~l~~~~~~~~~~~ 129 (372)
.++.+|.|..+.||++... +++.++||....... ...+++..|+++|+.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3567899999999999743 567899998653211 123457789999887742 3 45566654 345578
Q ss_pred EEEecCCCC
Q 017395 130 LVAEYMPND 138 (372)
Q Consensus 130 lv~e~~~~g 138 (372)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=4.5e-06 Score=76.13 Aligned_cols=138 Identities=9% Similarity=0.095 Sum_probs=79.1
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC--CcceeeEee------EEEeCCeeEEEEe
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--NRRLANLLG------CCCEGDERLLVAE 133 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~------~~~~~~~~~lv~e 133 (372)
+..++.|..+.||+....++ .+++|+.... ..++..|+.++..+. .-.+++++. +....+..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677889999987555 5899998752 234445555555553 112334433 1234567899999
Q ss_pred cCCCCCHH--------------hhhhcC-C----C-------CCCCHHHH------------------------------
Q 017395 134 YMPNDTLA--------------KHLFHW-E----T-------QPMKWAMR------------------------------ 157 (372)
Q Consensus 134 ~~~~gsL~--------------~~l~~~-~----~-------~~l~~~~~------------------------------ 157 (372)
|++|.++. ..++.. . . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 111110 0 0 00122110
Q ss_pred -HHHHHHHHHHHHHhhc------------CCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 158 -LRVALHIAEALEYCTS------------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 158 -~~i~~qi~~al~~lH~------------~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
..+..++..++.+|+. ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223345556642 2489999999999999878899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.7e-05 Score=71.48 Aligned_cols=76 Identities=16% Similarity=0.059 Sum_probs=60.7
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC---CcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
-++.++.|..+.+|+... ++..++||+.... ....+.+|+..|+.+. ...+++++.++...+..++||||++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 345679999999999986 4567889987632 3566889999998884 36788999988877889999999998
Q ss_pred CCH
Q 017395 138 DTL 140 (372)
Q Consensus 138 gsL 140 (372)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.13 E-value=4.7e-06 Score=74.32 Aligned_cols=78 Identities=21% Similarity=0.215 Sum_probs=57.3
Q ss_pred cccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-C--cceeeEeeEEEeCCeeEEEEecC
Q 017395 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-N--RRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..-+..+|.|..+.||+.+..+|+.|.||+...........|.+|+..|+.+. . --+++++++. .-++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 34467789999999999999899999999976544333446889999998884 2 2355555542 248999999
Q ss_pred CCCCH
Q 017395 136 PNDTL 140 (372)
Q Consensus 136 ~~gsL 140 (372)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.00 E-value=4.3e-05 Score=71.94 Aligned_cols=74 Identities=16% Similarity=0.256 Sum_probs=46.3
Q ss_pred cccccCCCCCCeEEEEEeCCCcEEEEEEcCC------CCCc---cHHHHHHHHHHHh-cCCCcceeeEeeEEEeCCeeEE
Q 017395 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNR------SAWP---DARQFLEEARAVG-QLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------~~~~---~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~l 130 (372)
-++.+|.|..+.||++.. ++..++||.... .... ....+..|+..+. ......+++++.+. ....++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999975 456899994321 1101 2233444443322 12235677777765 567799
Q ss_pred EEecC-CC
Q 017395 131 VAEYM-PN 137 (372)
Q Consensus 131 v~e~~-~~ 137 (372)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.97 E-value=2e-05 Score=66.02 Aligned_cols=140 Identities=12% Similarity=0.010 Sum_probs=92.4
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCcccccccCcceeecCCCCceeeccCCcccCCCCCcccCCC
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT-SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNL 216 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~t~ 216 (372)
-||.++|.. .+.+++++++|.++.|.+.+|.-+- .+ .-..+=+.|..|++..+|++.+.+ +.+ .....
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s--------~~~~~ 101 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR-QPRHRVRSAAQIRVWRDGAVTLAP-AAD--------DAGEP 101 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cCCceecCCcceEEecCCceeccc-ccc--------ccccc
Confidence 479999875 5678999999999999999987762 22 112333457899999999888764 111 11223
Q ss_pred CcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHHHccC-
Q 017395 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY- 295 (372)
Q Consensus 217 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~- 295 (372)
.+.+||... ...+.+.=|||||+++|..+--..|.. -+...+++|.+||..|...
T Consensus 102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-----------------------eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-----------------------EERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-----------------------EEECCCHHHHHHHHHHTTCC
T ss_pred CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-----------------------cchhhCHHHHHHHHHHHhcc
Confidence 567888764 344667789999999999887554321 1223457788899888765
Q ss_pred ------------------------CCCCCCChHHHHHHHHh
Q 017395 296 ------------------------EPRERPNPRSLVTALVT 312 (372)
Q Consensus 296 ------------------------dp~~Rps~~~il~~l~~ 312 (372)
.+..|++.++|++.-..
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 24578899999887553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00015 Score=65.50 Aligned_cols=159 Identities=11% Similarity=0.122 Sum_probs=87.2
Q ss_pred ccCHHHHHHHhcCCCc--cccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc--eeeE
Q 017395 43 EYSIETLRTATSGFAM--ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANL 118 (372)
Q Consensus 43 ~~~~~~~~~~~~~~~~--~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l 118 (372)
.++.+++...-..|.. ..-++.++.|....+|+....++ .+++|+..... ..+.+..|+.++..+...+ ++++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3556666666655543 22345677788889999987666 68899987531 1234556777776663211 3333
Q ss_pred eeE------EEeCCeeEEEEecCCCCCHHh--------------hhhc----CCCC---CCC---HHHHHH---------
Q 017395 119 LGC------CCEGDERLLVAEYMPNDTLAK--------------HLFH----WETQ---PMK---WAMRLR--------- 159 (372)
Q Consensus 119 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~~~---~l~---~~~~~~--------- 159 (372)
+.. ....+..+++|+|++|..+.. .++. .... ... |...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 123456799999999865321 0111 0000 011 211100
Q ss_pred ---HHHHHHHHHHHhhc------CCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 160 ---VALHIAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 160 ---i~~qi~~al~~lH~------~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
+...+...+..+.. ..+++|+|+++.||++++++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113334444432 1378999999999999977556899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00013 Score=66.34 Aligned_cols=141 Identities=8% Similarity=-0.023 Sum_probs=72.8
Q ss_pred ccccCCCCCCe-EEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC--CcceeeEeeEEEeCCeeEEEEecCCCC
Q 017395 62 VSEHGEKAPNV-VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAEYMPND 138 (372)
Q Consensus 62 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g 138 (372)
+..++.|+... +|+....++..+++|....... ..+..|+.+++.+. .-.+++++.+.... .+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 34555554444 6677654466788887654321 22345666666553 23456677664333 37899999876
Q ss_pred CHHhhhhcC---------------------CC---CCCCHHHHH-------HHH-------------HHHHHHHHHhh--
Q 017395 139 TLAKHLFHW---------------------ET---QPMKWAMRL-------RVA-------------LHIAEALEYCT-- 172 (372)
Q Consensus 139 sL~~~l~~~---------------------~~---~~l~~~~~~-------~i~-------------~qi~~al~~lH-- 172 (372)
++.+.+... .. ..++..... .+. ..+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665433210 00 112221110 000 01111222221
Q ss_pred ---cCCCcccccccCcceeecCC----CCceeeccCCcccCC
Q 017395 173 ---SKERALYHDLNAYRIVFDDD----VNPRLSCFGLMKNSR 207 (372)
Q Consensus 173 ---~~~~iiH~Dikp~Nill~~~----~~~kl~Dfg~~~~~~ 207 (372)
....++|+|+.+.||+++.+ +.+.|+||+.+....
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 12378999999999999864 678999999876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00046 Score=62.33 Aligned_cols=161 Identities=19% Similarity=0.145 Sum_probs=90.0
Q ss_pred ccccCHHHHHHHhcCCCcc--ccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC--ccee
Q 017395 41 FCEYSIETLRTATSGFAME--NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN--RRLA 116 (372)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~--~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv 116 (372)
+..++.+.+...-..+... .-+..++ |....||+....+|+.+++|+...... ....+..|..++..+.. -.++
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeec
Confidence 3445555555444433221 1234456 778899998876777899999874322 34567778888777742 1244
Q ss_pred eEeeE-----EEeCCeeEEEEecCCCCCHH-----h------h---hhc----CC---CCCCCHHHH-------------
Q 017395 117 NLLGC-----CCEGDERLLVAEYMPNDTLA-----K------H---LFH----WE---TQPMKWAMR------------- 157 (372)
Q Consensus 117 ~l~~~-----~~~~~~~~lv~e~~~~gsL~-----~------~---l~~----~~---~~~l~~~~~------------- 157 (372)
+++.. ....+..+++|+|++|.++. . . ++. .. ....++...
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 44432 22345678999999885432 0 0 110 00 011222111
Q ss_pred ---------HHHHHHHHHHHHHhh---cCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 158 ---------LRVALHIAEALEYCT---SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 158 ---------~~i~~qi~~al~~lH---~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
...+..++..+.-+. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111122222222221 112689999999999999 4 899999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=8.6e-05 Score=66.47 Aligned_cols=71 Identities=14% Similarity=0.132 Sum_probs=44.4
Q ss_pred ccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcce-eeEeeEEEeCCeeEEEEecC-CCCC
Q 017395 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYM-PNDT 139 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~-~~gs 139 (372)
++.++.|..+.+|+. ..+++|+....... .-...+|+.+++.+...++ +++++++ ...-++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 566788888999998 45889988653211 1123467777777642222 5666543 33457899999 6654
Q ss_pred H
Q 017395 140 L 140 (372)
Q Consensus 140 L 140 (372)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00015 Score=67.10 Aligned_cols=138 Identities=14% Similarity=0.152 Sum_probs=84.0
Q ss_pred ccccCCCCCCeEEEEEeC--------CCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEE
Q 017395 62 VSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 132 (372)
++.+..|-...+|+.... ++..+++|+.... ........+|.++++.+. +.-.+++++++.. .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345666888899999864 2478999996432 223556779999998884 3334677776643 3999
Q ss_pred ecCCCCCHHhh-----------------hhcCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 017395 133 EYMPNDTLAKH-----------------LFHWE---TQPMK--WAMRLRVALHIAE-------------------ALEYC 171 (372)
Q Consensus 133 e~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~qi~~-------------------al~~l 171 (372)
||++|.+|..- ++... .+... +.++.++..++-. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 11111 11222 4566666655432 12222
Q ss_pred h----c---CCCcccccccCcceeecCC----CCceeeccCCcc
Q 017395 172 T----S---KERALYHDLNAYRIVFDDD----VNPRLSCFGLMK 204 (372)
Q Consensus 172 H----~---~~~iiH~Dikp~Nill~~~----~~~kl~Dfg~~~ 204 (372)
. . ...++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 1 1368999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00024 Score=67.00 Aligned_cols=73 Identities=16% Similarity=0.289 Sum_probs=50.6
Q ss_pred ccccCCCCCCeEEEEEeCC--------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEEE
Q 017395 62 VSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVA 132 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~ 132 (372)
+..++.|....+|+....+ +..+++|+..... ....+.+|+.+++.+...+ .+++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567778889999998653 4789999984321 1255678999988885333 3677776532 4899
Q ss_pred ecCCCCCH
Q 017395 133 EYMPNDTL 140 (372)
Q Consensus 133 e~~~~gsL 140 (372)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00042 Score=65.75 Aligned_cols=74 Identities=14% Similarity=0.086 Sum_probs=47.6
Q ss_pred ccccCCCCCCeEEEEEeCC-CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcce-eeEeeEEEeCCeeEEEEecCCCCC
Q 017395 62 VSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDT 139 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~gs 139 (372)
+..|+.|-...+|+....+ +..+++|+....... .-+-.+|+.++..+...++ +++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3467778889999998755 478899987543211 1112578888888864444 67777762 2 35999998854
Q ss_pred H
Q 017395 140 L 140 (372)
Q Consensus 140 L 140 (372)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00028 Score=65.02 Aligned_cols=74 Identities=14% Similarity=0.213 Sum_probs=45.0
Q ss_pred ccccCCCCCCeEEEEEeCC---------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEE
Q 017395 62 VSEHGEKAPNVVYKGKLEN---------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLV 131 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv 131 (372)
+..++.|....+|+....+ +..+++|+..... ....+...|.++++.+...+ ++++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888889999998644 2678899875432 11112357888887774323 45666554 2 3789
Q ss_pred EecCCCCCH
Q 017395 132 AEYMPNDTL 140 (372)
Q Consensus 132 ~e~~~~gsL 140 (372)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.004 Score=56.54 Aligned_cols=68 Identities=7% Similarity=-0.000 Sum_probs=43.6
Q ss_pred CCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC---CcceeeEeeE------EEeCCeeEEEEecCC
Q 017395 66 GEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGC------CCEGDERLLVAEYMP 136 (372)
Q Consensus 66 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~------~~~~~~~~lv~e~~~ 136 (372)
|.|....||+....++ .+++|+...... .+|+.++..|. -|++++.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4455689999997677 899998765432 24555555442 2224444432 233567899999999
Q ss_pred CCCH
Q 017395 137 NDTL 140 (372)
Q Consensus 137 ~gsL 140 (372)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0049 Score=57.73 Aligned_cols=138 Identities=12% Similarity=0.078 Sum_probs=83.7
Q ss_pred cccccCCCCCCeEEEEEeCC--------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEE
Q 017395 61 IVSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 131 (372)
-++.+..|-...+|+....+ +..+++|+...... ..-+-.+|..+++.+. +.-.+++++.+ . -++|
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 34567778889999998753 57899999754321 1112357888888774 33345666543 2 2889
Q ss_pred EecCCCCCHHh--------------hh---hc--C---------CCCCCCHHHHHHHHHHHHH-----------------
Q 017395 132 AEYMPNDTLAK--------------HL---FH--W---------ETQPMKWAMRLRVALHIAE----------------- 166 (372)
Q Consensus 132 ~e~~~~gsL~~--------------~l---~~--~---------~~~~l~~~~~~~i~~qi~~----------------- 166 (372)
|||++|.+|.. .+ +. . ...+.-+.++.+|..++-.
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999865421 00 00 0 1111224555555443322
Q ss_pred --HHHHhh--------------------c---CCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 167 --ALEYCT--------------------S---KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 167 --al~~lH--------------------~---~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
.+.+|. . ...++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 222221 1 125789999999999 778889999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.54 E-value=0.092 Score=48.68 Aligned_cols=28 Identities=14% Similarity=0.075 Sum_probs=23.7
Q ss_pred cccccccCcceee------cCCCCceeeccCCcc
Q 017395 177 ALYHDLNAYRIVF------DDDVNPRLSCFGLMK 204 (372)
Q Consensus 177 iiH~Dikp~Nill------~~~~~~kl~Dfg~~~ 204 (372)
++|+|+.+.|||+ +++..+.++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456679999998765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.03 E-value=0.65 Score=38.66 Aligned_cols=113 Identities=16% Similarity=0.140 Sum_probs=75.5
Q ss_pred CCcceeeEeeEEEeCCeeEEEEecCCC-CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceee
Q 017395 111 RNRRLANLLGCCCEGDERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (372)
Q Consensus 111 ~hpniv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill 189 (372)
.||+.+.. .+-...+.+.+.++.-+. -++.. + +.++....++++.+|+....+++.. +|--++|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~r---~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRTR---YTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGSS---EECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcCc---eEEEEecceEEE
Confidence 58888865 455566666666665432 23333 3 2378889999999999888666544 677899999999
Q ss_pred cCCCCceeeccCCcccCCCCCcccCCCCcCCcccccCCCCCCCCce-eehHHHHHHHHhCCCCC
Q 017395 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVM-YSFGTLLLDLLSGKHIP 252 (372)
Q Consensus 190 ~~~~~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv-~SlGvil~el~tg~~p~ 252 (372)
+.++.+++.-.|+... ++|.- .+ ..|. -.+=+++..+++++..|
T Consensus 113 ~~~~~p~i~~RGik~~-------------l~P~~-----~~-ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-------------VDPLP-----VS-EAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTT-------------BSCCC-----CC-HHHHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccC-------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999987765322 22211 11 1222 25678888999998654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.72 E-value=0.035 Score=52.56 Aligned_cols=62 Identities=5% Similarity=0.013 Sum_probs=19.3
Q ss_pred ccccccCCCCCCeEEEEEeCC-CcEEEE------EEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe
Q 017395 60 NIVSEHGEKAPNVVYKGKLEN-QFRIAV------KRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE 124 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 124 (372)
.+.+++| ||.||+|.+.. ...||| |....... .....|.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4556777 99999999643 467888 76654322 223468899999999999999999887643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.31 E-value=1.1 Score=37.37 Aligned_cols=113 Identities=14% Similarity=0.188 Sum_probs=74.5
Q ss_pred CCcceeeEeeEEEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCcccccccCcceee
Q 017395 111 RNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE-YCTSKERALYHDLNAYRIVF 189 (372)
Q Consensus 111 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~-~lH~~~~iiH~Dikp~Nill 189 (372)
.||++ -..+-.+.+.+.+.++.-+++.=...++ .++....++++.+|+.... +++.. +|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~r---~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSARR---LIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSSS---EECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhCc---eeEEEeCceEEE
Confidence 57887 3333456677777776653432223342 3788999999999988776 55543 677889999999
Q ss_pred cCCCCceeeccCCcccCCCCCcccCCCCcCCcccccCCCCCCCCcee-ehHHHHHHHHhCCCCC
Q 017395 190 DDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMY-SFGTLLLDLLSGKHIP 252 (372)
Q Consensus 190 ~~~~~~kl~Dfg~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~-SlGvil~el~tg~~p~ 252 (372)
+.++.+++.-.|+-.. ++|.-+. ..|.| ++=+++..++.++..|
T Consensus 118 ~~~~~p~i~hRGi~~~-------------lpP~e~~------ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 118 NRALEPFFLHVGVKES-------------LPPDEWD------DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CTTCCEEESCCEETTT-------------BSSCSCC------HHHHHHHHHHHHHHHTTCSSCH
T ss_pred eCCCcEEEEEcCCccc-------------CCCCCCC------HHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999987776322 2332211 12222 5667888888887543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 372 | ||||
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-25 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-15 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-06 |
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 4e-42
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 12/245 (4%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VV GK Q+ +A+K + + +F+EEA+ + L + +L L G C + ++
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM N L +L + L + + EA+EY SK + L+ DL A + +D
Sbjct: 78 TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVND 135
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++S FGL + D S+ + ++PPE L + + +S +++FG L+ ++
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
S +P + L ++ + C + ERP + L
Sbjct: 196 SLGKMPYER----FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
Query: 307 VTALV 311
++ ++
Sbjct: 252 LSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-41
Identities = 52/249 (20%), Positives = 105/249 (42%), Gaps = 12/249 (4%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
+V+ G N+ ++A+K A + F+EEA + +L + +L L G C E LV
Sbjct: 20 LVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
E+M + L+ + + L + L + E + Y ++ DL A + +
Sbjct: 79 FEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGE 136
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ ++S FG+ + D + S+ + + PE R + +S ++SFG L+ ++
Sbjct: 137 NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
S IP + + +I + T + ++ + C + P +RP L
Sbjct: 197 SEGKIPYENRSNSEVVEDIS----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252
Query: 307 VTALVTLQK 315
+ L + +
Sbjct: 253 LRQLAEIAE 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 7e-41
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 20/251 (7%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL-L 130
V G ++AVK A A+ FL EA + QLR+ L LLG E L +
Sbjct: 22 DVMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V EYM +L +L + L+ +L + EA+EY ++ DL A ++
Sbjct: 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVS 137
Query: 191 DDVNPRLSCFGLMKN-SRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK 249
+D ++S FGL K S + + +T PE LR + + +S ++SFG LL ++ S
Sbjct: 138 EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 250 HIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
+P + + D C + + C + RP+
Sbjct: 198 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFL 248
Query: 305 SLVTALVTLQK 315
L L ++
Sbjct: 249 QLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 3e-39
Identities = 55/258 (21%), Positives = 111/258 (43%), Gaps = 12/258 (4%)
Query: 72 VVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 32 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
+ E+M L +L Q + + L +A I+ A+EY K ++ DL A +
Sbjct: 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVG 149
Query: 191 DDVNPRLSCFGLMKNSRDGRSYST-----NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
++ +++ FGL + + + +T PE L + + +S +++FG LL ++
Sbjct: 150 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
+ P +DL + L + + ++ L C Q+ P +RP+
Sbjct: 210 ATYGM-SPYPGIDL---SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 265
Query: 306 LVTALVTLQKDTEVPSHV 323
+ A T+ +++ + V
Sbjct: 266 IHQAFETMFQESSISDEV 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-39
Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 22/249 (8%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G ++AVK + + FL EA + QL+++RL L + + ++
Sbjct: 28 EVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM N +L L + L +A IAE + + + ++ DL A I+ D
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-IHRDLRAANILVSD 144
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + + +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 247 SGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
+ IP + + D+C E EL +L C + P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255
Query: 302 NPRSLVTAL 310
L + L
Sbjct: 256 TFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (347), Expect = 1e-38
Identities = 57/293 (19%), Positives = 113/293 (38%), Gaps = 26/293 (8%)
Query: 44 YSIETLRTATSGFAMENIVSEH------GEKAPNVVYKGKL----ENQFRIAVKRFNRSA 93
++ E A FA E +S G V G L + + +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 94 WPDA-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPM 152
R FL EA +GQ + + +L G + +++ E+M N +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 153 KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212
+ + IA ++Y ++ DL A I+ + ++ ++S FGL + D S
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 213 STN---------LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR 263
T + +T PE ++ + T S ++S+G ++ +++S P + ++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----MTNQ 240
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
++ + D + L +L C Q + RP +V L + ++
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-38
Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 12/244 (4%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
V+ G R+A+K FL+EA+ + +LR+ +L L E + +V
Sbjct: 32 EVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
EYM +L L + ++ + +A IA + Y ++ DL A I+ +
Sbjct: 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGE 148
Query: 192 DVNPRLSCFGLMKNSRDGRSYSTN-----LAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
++ +++ FGL + D + + +T PE GR T +S ++SFG LL +L
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ +P + +R + + + L L +C + EP ERP L
Sbjct: 209 TKGRVPYPG----MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264
Query: 307 VTAL 310
L
Sbjct: 265 QAFL 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-37
Identities = 50/257 (19%), Positives = 105/257 (40%), Gaps = 20/257 (7%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131
VYKGK + + + F E + + R+ + +G + +V
Sbjct: 23 TVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIV 81
Query: 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191
++ +L HL ET + + +A A+ ++Y +K ++ DL + I +
Sbjct: 82 TQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHE 139
Query: 192 DVNPRLSCFGL--MKNSRDGRSYSTNLAFTP----PEYLRT---GRVTPESVMYSFGTLL 242
D+ ++ FGL +K+ G L+ + PE +R + +S +Y+FG +L
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 243 LDLLSGK----HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
+L++G+ +I + + R + S + + RL + CL+ +
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK----AMKRLMAECLKKKRD 255
Query: 299 ERPNPRSLVTALVTLQK 315
ERP ++ ++ L +
Sbjct: 256 ERPLFPQILASIELLAR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-36
Identities = 55/260 (21%), Positives = 100/260 (38%), Gaps = 17/260 (6%)
Query: 56 FAMEN--IVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQ 109
+A+E+ I G+ VY + +++F +A+K ++ A Q E
Sbjct: 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
LR+ + L G + L+ EY P T+ + L +A AL
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALS 120
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTG 227
YC SK R ++ D+ ++ +++ FG ++ R + L + PPE +
Sbjct: 121 YCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 228 RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287
+ ++S G L + L GK ++ R + +E F
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARD 233
Query: 288 LASRCLQYEPRERPNPRSLV 307
L SR L++ P +RP R ++
Sbjct: 234 LISRLLKHNPSQRPMLREVL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-36
Identities = 57/265 (21%), Positives = 110/265 (41%), Gaps = 36/265 (13%)
Query: 72 VVYKGKL------ENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
+VY+G E + R+A+K N +A R +FL EA + + + LLG +
Sbjct: 35 MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94
Query: 125 GDERLLVAEYMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKER 176
G L++ E M L +L P + +++A IA+ + Y + +
Sbjct: 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-K 153
Query: 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVT 230
++ DL A + +D ++ FG+ ++ + Y + + PE L+ G T
Sbjct: 154 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213
Query: 231 PESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285
S ++SFG +L ++ + P L + + + D+C + L
Sbjct: 214 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 264
Query: 286 VRLASRCLQYEPRERPNPRSLVTAL 310
L C QY P+ RP+ +++++
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 8e-36
Identities = 49/277 (17%), Positives = 98/277 (35%), Gaps = 44/277 (15%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
VV+K + +A K + P R Q + E + + + + + G E
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+ E+M +L + L + + + +V++ + + L Y K + ++ D+ I+
Sbjct: 81 ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS 247
+ +L FG+ D + S ++ PE L+ + +S ++S G L+++
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 248 GKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT----------------------- 283
G++ IPP A +L Q D+ G
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 284 --------------ELVRLASRCLQYEPRERPNPRSL 306
E ++CL P ER + + L
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-35
Identities = 55/271 (20%), Positives = 101/271 (37%), Gaps = 32/271 (11%)
Query: 72 VVYKGKL---ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V +G + Q +A+K + D + + EA+ + QL N + L+G C + +
Sbjct: 24 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 82
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
+LV E L K L + + + + ++ ++Y K ++ DL A +
Sbjct: 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNV 140
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFGT 240
+ + ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200
Query: 241 LLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295
+ + LS P + I C EL L S C Y
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWIY 251
Query: 296 EPRERPNPRSLVTAL----VTLQKDTEVPSH 322
+ +RP+ ++ + +L E H
Sbjct: 252 KWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-35
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 30/256 (11%)
Query: 72 VVYKGKLENQ---FRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGD 126
V KG + + +AVK A A + L EA + QL N + ++G C E +
Sbjct: 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 80
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
+LV E L K+L + + +K + + ++ ++Y ++ DL A
Sbjct: 81 SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARN 137
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYSFG 239
++ ++S FGL K R +Y + + PE + + + +S ++SFG
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197
Query: 240 TLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294
L+ + S P S ++ C E+ L + C
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCWT 248
Query: 295 YEPRERPNPRSLVTAL 310
Y+ RP ++ L
Sbjct: 249 YDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 7e-35
Identities = 46/243 (18%), Positives = 84/243 (34%), Gaps = 14/243 (5%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
VY + + N +A+K+ + S + ++E R + +LR+ GC
Sbjct: 30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
LV EY H +P++ V + L Y S ++ D+ A I
Sbjct: 90 AWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNI 146
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLD 244
+ + +L FG S+ + PE + G+ + ++S G ++
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
L K + Q + + G +S CLQ P++RP
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE----YFRNFVDSCLQKIPQDRPTSE 262
Query: 305 SLV 307
L+
Sbjct: 263 VLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 9e-35
Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 72 VVYKGKLEN----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD 126
VY G L + + AVK NR + QFL E + + + +LLG C +
Sbjct: 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101
Query: 127 ER-LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L+V YM + L ++ ET + L +A+ +++ SK + ++ DL A
Sbjct: 102 GSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAAR 159
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPPEYLRTGRVTPESVMYS 237
+ D+ +++ FGL ++ D S + + + E L+T + T +S ++S
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ---FSSDEGTELVRLASRCLQ 294
FG LL +L++ P D N +T L+G+ L + +C
Sbjct: 220 FGVLLWELMTRGAPPYP-------DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWH 272
Query: 295 YEPRERPNPRSLVTALVTLQKD 316
+ RP+ LV+ + +
Sbjct: 273 PKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-34
Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 50/279 (17%)
Query: 72 VVYKGKLENQFR------IAVKRFNRSAWPDAR-QFLEEARAVGQLRNRRLANLLGCCCE 124
V++ + +AVK A D + F EA + + N + LLG C
Sbjct: 28 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87
Query: 125 GDERLLVAEYMPNDTLAKHLFHW----------------------ETQPMKWAMRLRVAL 162
G L+ EYM L + L P+ A +L +A
Sbjct: 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 147
Query: 163 HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------L 216
+A + Y + + + ++ DL + +++ +++ FGL +N Y + +
Sbjct: 148 QVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206
Query: 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNIQTLTDS 271
+ PPE + R T ES ++++G +L ++ S P + +RD NI ++
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN 266
Query: 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
C EL L C P +RP+ S+ L
Sbjct: 267 CPL---------ELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-34
Identities = 46/255 (18%), Positives = 87/255 (34%), Gaps = 28/255 (10%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
K + + + K + + +A + + E + +L++ + +
Sbjct: 19 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 129 LL--VAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYH---- 180
L V EY LA + E Q + LRV + AL+ C + +
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMY 236
DL + D N +L FGL + S++ TP PE + +S ++
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 198
Query: 237 SFGTLLLDLLSGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292
S G LL +L + IR+ + + + EL + +R
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD---------ELNEIITRM 249
Query: 293 LQYEPRERPNPRSLV 307
L + RP+ ++
Sbjct: 250 LNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-33
Identities = 54/270 (20%), Positives = 104/270 (38%), Gaps = 33/270 (12%)
Query: 72 VVYKGKLEN---QFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRR-LANLLGCCCEGD 126
V K +++ + A+KR A D R F E + +L + + NLLG C
Sbjct: 25 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84
Query: 127 ERLLVAEYMPNDTLAKHL--------------FHWETQPMKWAMRLRVALHIAEALEYCT 172
L EY P+ L L + + L A +A ++Y +
Sbjct: 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144
Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRV 229
K + ++ DL A I+ ++ +++ FGL + + + + E L
Sbjct: 145 QK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203
Query: 230 TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFSSDEGTELV 286
T S ++S+G LL +++S P L + +G + + E+
Sbjct: 204 TTNSDVWSYGVLLWEIVSLGGTPY-------CGMTCAELYEKLPQGYRLEKPLNCDDEVY 256
Query: 287 RLASRCLQYEPRERPNPRSLVTALVTLQKD 316
L +C + +P ERP+ ++ +L + ++
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-33
Identities = 48/259 (18%), Positives = 101/259 (38%), Gaps = 19/259 (7%)
Query: 72 VVYKGKL-----ENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLLGCCCEG 125
VYKG + + +A+K + P A ++ L+EA + + N + LLG C
Sbjct: 24 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
+L+ + MP L + + L + IA+ + Y + R ++ DL A
Sbjct: 84 TVQLIT-QLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAAR 140
Query: 186 RIVFDDDVNPRLSCFGLMK--NSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFG 239
++ + +++ FGL K + + ++ E + T +S ++S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRE 299
+ +L++ P D I I ++ + ++ + +C +
Sbjct: 201 VTVWELMTFGSKPY----DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 300 RPNPRSLVTALVTLQKDTE 318
RP R L+ + +D +
Sbjct: 257 RPKFRELIIEFSKMARDPQ 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-33
Identities = 44/256 (17%), Positives = 90/256 (35%), Gaps = 15/256 (5%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
I+ E G+ A VYK + E A K + + + ++ E + + + LL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
+ ++ E+ + + E +P+ + V +AL Y + ++
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN-KIIH 133
Query: 180 HDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST----NLAFTPPEYLRT-----GRVT 230
DL A I+F D + +L+ FG+ + + PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 231 PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290
++ ++S G L+++ + PP H L+ +R + S +
Sbjct: 194 YKADVWSLGITLIEMAEIE--PPHHELNPMRVLL-KIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 291 RCLQYEPRERPNPRSL 306
+CL+ R L
Sbjct: 251 KCLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 3e-32
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 20/244 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VY + +A+++ N P + E + + +N + N L GDE +
Sbjct: 35 TVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
V EY+ +L + M V +ALE+ S + ++ D+ + I+
Sbjct: 95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG 150
Query: 191 DDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLLDLL 246
D + +L+ FG +S + + TP PE + P+ ++S G + ++++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 247 SGKH----IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
G+ P AL LI L Q +RCL + +R +
Sbjct: 211 EGEPPYLNENPLRALYLIATNGTPEL-------QNPEKLSAIFRDFLNRCLDMDVEKRGS 263
Query: 303 PRSL 306
+ L
Sbjct: 264 AKEL 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 4e-32
Identities = 54/274 (19%), Positives = 99/274 (36%), Gaps = 39/274 (14%)
Query: 72 VVYKG------KLENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCC 123
V K ++AVK A R+ + E + + QL + + NLLG C
Sbjct: 52 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111
Query: 124 EGDERLLVAEYMPNDTLAKHLF---------------------HWETQPMKWAMRLRVAL 162
L+ EY L +L + + + L A
Sbjct: 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 163 HIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------L 216
+A+ +E+ K ++ DL A ++ ++ FGL ++ +Y +
Sbjct: 172 QVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
Query: 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276
+ PE L G T +S ++S+G LL ++ S P + D N L + +
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP---GIPVDANFYKLIQNGFKMD 287
Query: 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310
E+ + C ++ R+RP+ +L + L
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-32
Identities = 53/278 (19%), Positives = 107/278 (38%), Gaps = 22/278 (7%)
Query: 54 SGFAMENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWPDAR-QFLEEARAV 107
S + ++ G VYKG L+ + +A+K R FL EA +
Sbjct: 7 SCVTRQKVI---GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 108 GQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEA 167
GQ + + L G + +++ EYM N + + + IA
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTP 220
++Y + ++ DL A I+ + ++ ++S FGL + D + + +T
Sbjct: 123 MKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 221 PEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280
PE + + T S ++SFG ++ ++++ P + + + + D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPTPMD 237
Query: 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318
+ + +L +C Q E RP +V+ L L + +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-32
Identities = 51/269 (18%), Positives = 94/269 (34%), Gaps = 34/269 (12%)
Query: 72 VVYKGKLENQFR------IAVKRFNRSAWPDARQ-FLEEARAVGQLRN-RRLANLLGCCC 123
V + + +AVK SA R+ + E + + L N + NLLG C
Sbjct: 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 124 EGDERLLVAEYMPNDTLAKHLFHW----------------ETQPMKWAMRLRVALHIAEA 167
G L++ EY L L + + L + +A+
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPP 221
+ + SK ++ DL A I+ ++ FGL ++ ++ +Y + + P
Sbjct: 158 MAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
E + T ES ++S+G L +L S P + D +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---MPVDSKFYKMIKEGFRMLSPEHA 273
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310
E+ + C +P +RP + +V +
Sbjct: 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (301), Expect = 1e-31
Identities = 45/241 (18%), Positives = 77/241 (31%), Gaps = 10/241 (4%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VV++ A K D +E + + LR+ L NL + +E ++
Sbjct: 41 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
+ E+M L + + E M + + + L + ++ DL I+F
Sbjct: 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFT 158
Query: 191 DDVNPR--LSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ L FGL + +S F PE V + M+S G L L
Sbjct: 159 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRS 305
LSG P + D ++ S + + L +P R
Sbjct: 219 LSGL--SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 306 L 306
Sbjct: 277 A 277
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-31
Identities = 42/288 (14%), Positives = 91/288 (31%), Gaps = 50/288 (17%)
Query: 72 VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEA--RAVGQLRNRRLANLLGCCCEGD--- 126
V++GK + +AVK F+ + R + EA LR+ + + + +
Sbjct: 18 EVWRGKWRGE-EVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73
Query: 127 -ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-------TSKERAL 178
+ LV++Y + +L +L + +++AL A L + K
Sbjct: 74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 179 YHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY----STNLAFTP----PEYLRT---- 226
+ DL + I+ + ++ GL + T PE L
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 227 --GRVTPESVMYSFGTLLLDLLSGKHIPPSH---------------ALDLIRDRNIQTLT 269
+ +Y+ G + ++ I H +++ +R +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 270 DSCLEGQFSSDEGT-ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
+ ++ S E + ++ C R + L L +
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-31
Identities = 40/240 (16%), Positives = 73/240 (30%), Gaps = 15/240 (6%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
V + +AVK + D + +E L + + G EG+ +
Sbjct: 20 EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
L EY L + M R + + Y + D+ ++
Sbjct: 80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLL 136
Query: 190 DDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPEYLRTGRVTPESV-MYSFGTLL 242
D+ N ++S FGL R L + PE L+ E V ++S G +L
Sbjct: 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+L+G+ + + + + L+ + L P R
Sbjct: 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARIT 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 8e-31
Identities = 51/263 (19%), Positives = 98/263 (37%), Gaps = 27/263 (10%)
Query: 72 VVYKGKL----ENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGD 126
V++G +A+K R+ FL+EA + Q + + L+G E +
Sbjct: 22 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 80
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
++ E L + + A + A ++ AL Y SK R ++ D+ A
Sbjct: 81 PVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARN 138
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEY-----LRTGRVTPESVMYSFGTL 241
++ + +L FGL + D Y + P ++ + R T S ++ FG
Sbjct: 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198
Query: 242 LLDLLSGKHIP-----PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 249
Query: 297 PRERPNPRSLVTALVTLQKDTEV 319
P RP L L T+ ++ +
Sbjct: 250 PSRRPRFTELKAQLSTILEEEKA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-30
Identities = 45/247 (18%), Positives = 90/247 (36%), Gaps = 17/247 (6%)
Query: 72 VVYKGKL-ENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLANLLGCCCEGDER 128
VYKG E +A + ++F EEA + L++ + +
Sbjct: 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 129 ----LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLN 183
+LV E M + TL +L + MK + I + L++ ++ + H DL
Sbjct: 84 KKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 141
Query: 184 AYRIVFDD-DVNPRLSCFGLMKNSRDGRSYST--NLAFTPPEYLRTGRVTPESVMYSFGT 240
I + ++ GL R + + F PE + +Y+FG
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGM 200
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300
+L++ + ++ P S + + + +T F E+ + C++ ER
Sbjct: 201 CMLEMATSEY-PYSECQN--AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
Query: 301 PNPRSLV 307
+ + L+
Sbjct: 258 YSIKDLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-30
Identities = 51/257 (19%), Positives = 91/257 (35%), Gaps = 20/257 (7%)
Query: 72 VVYKGKLE----NQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCE 124
VV +G+ + +AVK F+ E A+ L +R L L G
Sbjct: 23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
+ +V E P +L R A+ +AE + Y SK ++ DL A
Sbjct: 83 PPMK-MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-IHRDLAA 139
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN-------LAFTPPEYLRTGRVTPESVMYS 237
++ ++ FGLM+ + A+ PE L+T + S +
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199
Query: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297
FG L ++ + P L + + + D ++ + +C ++P
Sbjct: 200 FGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 256
Query: 298 RERPNPRSLVTALVTLQ 314
+RP +L L+ Q
Sbjct: 257 EDRPTFVALRDFLLEAQ 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 114 bits (287), Expect = 1e-29
Identities = 49/244 (20%), Positives = 83/244 (34%), Gaps = 16/244 (6%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
VV++ K N D E + QL + +L NL + E +L
Sbjct: 44 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103
Query: 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190
+ E++ L + E M A + E L++ ++ D+ I+ +
Sbjct: 104 ILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCE 161
Query: 191 DDVNPR--LSCFGLMKNSRDGRS---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDL 245
+ FGL + F PE + V + M++ G L L
Sbjct: 162 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 246 LSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFS--SDEGTELVRLASRCLQYEPRERPN 302
LSG L+ + +N++ E FS S E + ++ LQ EPR+R
Sbjct: 222 LSGLSPFAGEDDLETL--QNVKRCDWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLT 276
Query: 303 PRSL 306
Sbjct: 277 VHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 1e-28
Identities = 38/242 (15%), Positives = 73/242 (30%), Gaps = 11/242 (4%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ-FLEEARAVGQLRNRRLANLLGCCCEGDERL 129
V + Q +A+K + A E + ++++ + L G
Sbjct: 24 EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA--LYHDLNAYRI 187
L+ + + L + E R+ + +A++Y N
Sbjct: 84 LIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRVTPESVMYSFGTLLLD 244
D+D +S FGL K G ST + PE L + +S G +
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201
Query: 245 LLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304
LL G PP + + + + + + D ++ +P +R
Sbjct: 202 LLCGY--PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259
Query: 305 SL 306
Sbjct: 260 QA 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-28
Identities = 40/255 (15%), Positives = 80/255 (31%), Gaps = 23/255 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V + L A+K + E + +L + L + ++
Sbjct: 23 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
Y N L K++ I ALEY K ++ DL I
Sbjct: 83 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENI 139
Query: 188 VFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTL 241
+ ++D++ +++ FG K S+ + PE L S +++ G +
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 199
Query: 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELVRLASRCLQYEPRE 299
+ L++G PP R N + ++ ++ E + L + L + +
Sbjct: 200 IYQLVAGL--PP------FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 251
Query: 300 RPNPRSLVTALVTLQ 314
R +
Sbjct: 252 RLGCEEMEGYGPLKA 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-28
Identities = 40/258 (15%), Positives = 92/258 (35%), Gaps = 23/258 (8%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119
I + G +V++ ++ K D +E + R+R + +L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLH 67
Query: 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179
+E +++ E++ + + + + + + + EAL++ S +
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHNIG-H 125
Query: 180 HDLNAYRIVFDDDVNPR--LSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESV 234
D+ I++ + + FG + + G ++ + PE + V+ +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 235 MYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT------ELVRL 288
M+S GTL+ LLSG + Q + ++ + +++ DE E +
Sbjct: 186 MWSLGTLVYVLLSGIN--------PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 289 ASRCLQYEPRERPNPRSL 306
R L E + R
Sbjct: 238 VDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 108 bits (270), Expect = 7e-28
Identities = 45/245 (18%), Positives = 79/245 (32%), Gaps = 20/245 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCE--- 124
V+ + L +AVK D +F EA+ L + + +
Sbjct: 22 EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81
Query: 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
G +V EY+ TL + PM + V +AL + ++ D+
Sbjct: 82 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVK 138
Query: 184 AYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNL-------AFTPPEYLRTGRVTPESVMY 236
I+ ++ FG+ + D + T + PE R V S +Y
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198
Query: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296
S G +L ++L+G+ PP + D +L + + L
Sbjct: 199 SLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256
Query: 297 PRERP 301
P R
Sbjct: 257 PENRY 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 9e-27
Identities = 48/271 (17%), Positives = 91/271 (33%), Gaps = 33/271 (12%)
Query: 72 VVYKG------KLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCC- 123
V + K +AVK A + R + E + + + + L C
Sbjct: 28 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87
Query: 124 -EGDERLLVAEYMPNDTLAKHLFH--------------WETQPMKWAMRLRVALHIAEAL 168
G +++ E+ L+ +L + + + +A+ +
Sbjct: 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147
Query: 169 EYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPPE 222
E+ S+ + ++ DL A I+ + ++ FGL ++ Y L + PE
Sbjct: 148 EFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206
Query: 223 YLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282
+ T +S ++SFG LL ++ S P + D +
Sbjct: 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEFCRRLKEGTRMRAPDYTT 263
Query: 283 TELVRLASRCLQYEPRERPNPRSLVTALVTL 313
E+ + C EP +RP LV L L
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 52/269 (19%), Positives = 98/269 (36%), Gaps = 35/269 (13%)
Query: 72 VVYKGKL--------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGC 121
V + ++AVK A D + E + + +++ + NLLG
Sbjct: 28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87
Query: 122 CCEGDERLLVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEA 167
C + ++ EY L ++L + + + A +A
Sbjct: 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 147
Query: 168 LEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN------LAFTPP 221
+EY SK + ++ DL A ++ +D +++ FGL ++ Y + + P
Sbjct: 148 MEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206
Query: 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281
E L T +S ++SFG LL ++ + P + + + L S+
Sbjct: 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGG-SPYPGVPV---EELFKLLKEGHRMDKPSNC 262
Query: 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310
EL + C P +RP + LV L
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (261), Expect = 3e-26
Identities = 44/258 (17%), Positives = 94/258 (36%), Gaps = 20/258 (7%)
Query: 56 FAMEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQ 109
+++++ I+ G + V+ + N A+K + +Q +E +
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 110 LRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
+ + + + G + + ++ +Y+ L ++Q + A + ALE
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGR 228
Y SK +Y DL I+ D + + +++ FG K D + + PE + T
Sbjct: 119 YLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT--ELV 286
+SFG L+ ++L+G D N + L + ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPPFFNEDVK 229
Query: 287 RLASRCLQYEPRERPNPR 304
L SR + + +R
Sbjct: 230 DLLSRLITRDLSQRLGNL 247
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (260), Expect = 7e-26
Identities = 45/240 (18%), Positives = 78/240 (32%), Gaps = 16/240 (6%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPD------ARQFLEEARAVGQLRNRRLANLLGCCCE 124
VY + + A+K ++ A V + +
Sbjct: 19 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
D+ + + M L HL A A I LE+ ++ +Y DL
Sbjct: 79 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKP 135
Query: 185 YRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTGR-VTPESVMYSFGTL 241
I+ D+ + R+S GL + + +++ + PE L+ G + +S G +
Sbjct: 136 ANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 242 LLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301
L LL G H + + TLT + S E L+ LQ + R
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRL 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-25
Identities = 44/253 (17%), Positives = 82/253 (32%), Gaps = 27/253 (10%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ------FLEEARAVGQLRNRRLANLLGCCCE 124
VV K + + A K + +R+ E + ++++ + L
Sbjct: 25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84
Query: 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNA 184
+ +L+ E + L E + + I + Y S + A + DL
Sbjct: 85 KTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQIA-HFDLKP 141
Query: 185 YRIVFDDDVNPR----LSCFGLMKNSRDGRSYSTNL---AFTPPEYLRTGRVTPESVMYS 237
I+ D P+ + FGL G + F PE + + E+ M+S
Sbjct: 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201
Query: 238 FGTLLLDLLSGKHIPPSH----ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293
G + LLSG L + N + E ++ S+ R L
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAVNYE------FEDEYFSNTSALAKDFIRRLL 255
Query: 294 QYEPRERPNPRSL 306
+P++R +
Sbjct: 256 VKDPKKRMTIQDS 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-25
Identities = 45/242 (18%), Positives = 81/242 (33%), Gaps = 22/242 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVG-QLRNRRLANLLGCCCEGD 126
V+ + + A+K + D + E R + + L ++ +
Sbjct: 17 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76
Query: 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYR 186
V EY+ L H+ + A I L++ SK +Y DL
Sbjct: 77 NLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDN 133
Query: 187 IVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT----PPEYLRTGRVTPESVMYSFGTLL 242
I+ D D + +++ FG+ K + G + + T PE L + +SFG LL
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193
Query: 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG--TELVRLASRCLQYEPRER 300
++L G+ ++ + L S E L + EP +R
Sbjct: 194 YEMLIGQSPFH--------GQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245
Query: 301 PN 302
Sbjct: 246 LG 247
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 100 bits (250), Expect = 5e-25
Identities = 44/255 (17%), Positives = 79/255 (30%), Gaps = 25/255 (9%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA---------RQFLEEARAVGQLRN-RRLANLLG 120
VV + AVK + + L+E + ++ + L
Sbjct: 18 VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77
Query: 121 CCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180
LV + M L +L E + ++ + E + ++
Sbjct: 78 TYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKL-NIVHR 134
Query: 181 DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST---NLAFTPPEYLRTGRV------TP 231
DL I+ DDD+N +L+ FG G ++ PE +
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 232 ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291
E M+S G ++ LL+G PP + + + D + L SR
Sbjct: 195 EVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 292 CLQYEPRERPNPRSL 306
L +P++R
Sbjct: 253 FLVVQPQKRYTAEEA 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 1e-23
Identities = 48/248 (19%), Positives = 90/248 (36%), Gaps = 27/248 (10%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS------AWPDARQFLEEARAVGQLRN--RRLANLLGCC 122
VY G + + +A+K + P+ + E + ++ + + LL
Sbjct: 19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78
Query: 123 CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
D +L+ E E ++ + + EA+ +C + L+ D+
Sbjct: 79 ERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGV-LHRDI 136
Query: 183 NAYRIVFD-DDVNPRLSCFGLMKNSRDGRSYSTN--LAFTPPEYLRTGRVTPESV-MYSF 238
I+ D + +L FG +D + ++PPE++R R S ++S
Sbjct: 137 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196
Query: 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPR 298
G LL D++ G P H ++IR + F +E L CL P
Sbjct: 197 GILLYDMVCGDI-PFEHDEEIIRGQVF-----------FRQRVSSECQHLIRWCLALRPS 244
Query: 299 ERPNPRSL 306
+RP +
Sbjct: 245 DRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 1e-23
Identities = 38/257 (14%), Positives = 76/257 (29%), Gaps = 23/257 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERL 129
+Y G + +A+K Q E++ ++ + C EGD +
Sbjct: 22 DIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79
Query: 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189
+V E + LF++ ++ L +A + +EY SK ++ D+ +
Sbjct: 80 MVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLM 136
Query: 190 ---DDDVNPRLSCFGLMKNSRDGRSYSTN-----------LAFTPPEYLRTGRVTPESVM 235
+ FGL K RD R++ + + +
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196
Query: 236 YSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTD--SCLEGQFSSDEGTELVRLASRCL 293
S G +L+ G R + + S +E + C
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 256
Query: 294 QYEPRERPNPRSLVTAL 310
++P+ L
Sbjct: 257 SLRFDDKPDYSYLRQLF 273
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 3e-23
Identities = 47/268 (17%), Positives = 82/268 (30%), Gaps = 36/268 (13%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDA-----RQFLEEARAVGQLRNRRLANLLGCCCEG 125
VYK + +A+K+ +A R L E + + +L + + LL
Sbjct: 13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
LV ++M D + + + + L + LEY + DL
Sbjct: 73 SNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL-HRDLKPN 129
Query: 186 RIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTGRVTPESVMYSFGT 240
++ D++ +L+ FGL K+ T+ T P M++ G
Sbjct: 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE----------------------GQFS 278
+L +LL P + R +TL E
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 279 SDEGTELVRLASRCLQYEPRERPNPRSL 306
S G +L+ L + P R
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.0 bits (235), Expect = 6e-23
Identities = 42/281 (14%), Positives = 95/281 (33%), Gaps = 35/281 (12%)
Query: 58 MEN--IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNR 113
ME + + GE VVYK + A+K+ + + E + +L++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS 173
+ L +LV E++ D L ++ L + + YC
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 174 KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP-----PEYLRTGR 228
+ R L+ DL ++ + + +++ FGL + T+ T + + +
Sbjct: 119 R-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPS-----------------------HALDLIRDRNI 265
+ ++S G + ++++G + P + +L +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
T+ + F + L S+ L+ +P +R +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.9 bits (235), Expect = 7e-23
Identities = 42/284 (14%), Positives = 83/284 (29%), Gaps = 32/284 (11%)
Query: 60 NIVSEH-------GEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR 111
N+V H GE + V+++G L N ++A+K R + DA Q +E R L
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA 58
Query: 112 NRR-LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY 170
+ N+ EG +LV + + L + A + ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 171 CTSKERALYHDLNAYRIVFDDDVNPRLSC-----FGLMKNSRDGRSYSTN---------- 215
K +Y D+ + + + FG++K RD +
Sbjct: 117 IHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 216 -LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP--SHALDLIRDRNIQTLTDSC 272
+ + + + G + + L G A + + I S
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316
+ + E + P+ L + +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 1e-22
Identities = 50/271 (18%), Positives = 85/271 (31%), Gaps = 41/271 (15%)
Query: 72 VVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER-- 128
VVY+ KL ++ +A+K+ + D R E + + +L + + L E+
Sbjct: 35 VVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90
Query: 129 ----LLVAEYMPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLN 183
LV +Y+P + Q + + +L Y S + D+
Sbjct: 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIK 149
Query: 184 AYRIVFDDD-VNPRLSCFGLMKNSRDGRSYSTNLAFT----PPEYLRTGRVTPESVMYSF 238
++ D D +L FG K G + + P T ++S
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 209
Query: 239 GTLLLDLLSGKHI----PPSHALDLI-------------------RDRNIQTLTDSCLEG 275
G +L +LL G+ I L I + +
Sbjct: 210 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
F E + L SR L+Y P R P
Sbjct: 270 VFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 4e-22
Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 35/282 (12%)
Query: 58 MEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRN 112
MEN V + GE VVYK + +A+K+ + + E + +L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
+ LL ++ LV E++ D L K + + + + + L +C
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTG 227
S R L+ DL ++ + + +L+ FGL + T+ T P L
Sbjct: 120 SH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 228 RVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRD--RNIQTLTDSCLEGQFSSDE--- 281
+ ++S G + ++++ + + P +D + R + T + G S +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 282 -----------------GTELVRLASRCLQYEPRERPNPRSL 306
+ L S+ L Y+P +R + ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 6e-22
Identities = 38/271 (14%), Positives = 91/271 (33%), Gaps = 37/271 (13%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129
+V N+ R+A+K+ + ++ L E + + + R+ + +
Sbjct: 23 MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82
Query: 130 LVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIV 188
+ Y+ + L+ +TQ + I L+Y S L+ DL ++
Sbjct: 83 MKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLL 141
Query: 189 FDDDVNPRLSCFGLMKNSRDGRSYST-------NLAFTPPEYLRTGRVTPESV-MYSFGT 240
+ + ++ FGL + + ++ + PE + + +S+ ++S G
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201
Query: 241 LLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE-------------------------G 275
+L ++LS + I P + + L E
Sbjct: 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ + ++ + L + L + P +R
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 3e-21
Identities = 45/242 (18%), Positives = 82/242 (33%), Gaps = 17/242 (7%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127
V + A+K + A + + E+R + R+ L L D
Sbjct: 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
V EY L HL + A I ALEY S+ +Y D+ +
Sbjct: 80 LCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHSR-DVVYRDIKLENL 136
Query: 188 VFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTP----PEYLRTGRVTPESVMYSFGTLLL 243
+ D D + +++ FGL K + TP PE L + G ++
Sbjct: 137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 244 DLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303
+++ G+ + + + + + E +F E L + L+ +P++R
Sbjct: 197 EMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
Query: 304 RS 305
Sbjct: 251 GP 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 5e-21
Identities = 42/249 (16%), Positives = 77/249 (30%), Gaps = 20/249 (8%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCC----CEG 125
V + Q + A+K D + E + + + ++
Sbjct: 27 KVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81
Query: 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185
L+V E + L + Q + I EA++Y S + D+
Sbjct: 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPE 140
Query: 186 RIVFDDDVNP---RLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGRVTPESVMYSFG 239
+++ +L+ FG K + S +T + PE L + M+S G
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200
Query: 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDEGTELVRLASRCLQYEP 297
++ LL G S+ I + E S+ E+ L L+ EP
Sbjct: 201 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 260
Query: 298 RERPNPRSL 306
+R
Sbjct: 261 TQRMTITEF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 1e-20
Identities = 37/271 (13%), Positives = 88/271 (32%), Gaps = 41/271 (15%)
Query: 72 VVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-- 126
V ++A+K+ R + A++ E R + +R+ + LL +
Sbjct: 33 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 127 ----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182
+ LV +M D + + + + + + L Y + ++ DL
Sbjct: 93 DDFTDFYLVMPFMGTD----LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDL 147
Query: 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF--TPPEYLRTGRVTPESVMYSFGT 240
+ ++D ++ FGL + + + + P L R T ++S G
Sbjct: 148 KPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207
Query: 241 LLLDLLSGKHI-------------------PPSHALDLIRDRNIQTLTDSCLE------G 275
++ ++++GK + PP+ + ++ + E
Sbjct: 208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 267
Query: 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
++ V L + L + +R
Sbjct: 268 SILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 2e-19
Identities = 41/281 (14%), Positives = 85/281 (30%), Gaps = 36/281 (12%)
Query: 61 IVSEHGEKAPNVVYKGK--LENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNR 113
V+E GE A V+K + +A+KR + + + R + +
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 114 RLANLLGCCCEGDERLLVAEYMPNDTLA----KHLFHWETQPMKWAMRLRVALHIAEALE 169
+ L C + + + +L + + + L+
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRT 226
+ S R ++ DL I+ +L+ FGL + + ++ L + PE L
Sbjct: 131 FLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 227 GRVTPESVMYSFGTLLLDLLSGKHI---------------------PPSHALDLIRDRNI 265
++S G + ++ K + D+ R
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ +F +D L +CL + P +R + S
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 4e-19
Identities = 40/283 (14%), Positives = 80/283 (28%), Gaps = 37/283 (13%)
Query: 58 MEN--IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRN 112
M+ + + GE V+K K E +A+KR + L E + +L++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 113 RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172
+ + L + LV E+ D F + + + + L +C
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFT-----PPEYLRTG 227
S+ L+ DL ++ + + +L+ FGL + + T P
Sbjct: 119 SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 228 RVTPESVMYSFGTLLLDLLSGKHIP------------------------PSHALDLIRDR 263
+ M+S G + +L + L +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ L L+ P +R +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 83.3 bits (205), Expect = 2e-18
Identities = 45/236 (19%), Positives = 76/236 (32%), Gaps = 14/236 (5%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQLRNRRLANLLGCCCEGDE 127
V K E+ A+K ++ +Q L E R + + L L +
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
+V EY+ + HL A I EY S +Y DL +
Sbjct: 116 LYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENL 172
Query: 188 VFDDDVNPRLSCFGLMKNSRD-GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246
+ D +++ FG K + + PE + + ++ G L+ ++
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302
+G PP A I+ FSS +L L LQ + +R
Sbjct: 233 AGY--PPFFADQPIQIYEKIVSGKVRFPSHFSS----DLKDLLRNLLQVDLTKRFG 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 1e-17
Identities = 45/292 (15%), Positives = 95/292 (32%), Gaps = 49/292 (16%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA--RQFLEEARAVGQLRNRRLAN 117
+++ G+ V+K + + ++A+K+ + L E + + L++ + N
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 118 LLGCCCEGDER--------LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALE 169
L+ C LV ++ +D L + RV + L
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 170 YCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN--------LAFTPP 221
Y + L+ D+ A ++ D +L+ FGL + ++ N L + PP
Sbjct: 132 YIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 222 EYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPS----HALDLIRD-------------- 262
E L R P ++ G ++ ++ + I H L LI
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 263 --------RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
++ + + + L + L +P +R +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 4e-16
Identities = 46/262 (17%), Positives = 84/262 (32%), Gaps = 23/262 (8%)
Query: 58 MEN--IVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWPD----ARQFLEEARAV 107
+EN ++ G A V+ + + A+K ++ E + +
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 108 GQLRNRRLANLLGCCCEGDERLLVA-EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE 166
+R L + + +L + +Y+ L HL E I
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--YVGEIVL 140
Query: 167 ALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEY--- 223
ALE+ +Y D+ I+ D + + L+ FGL K + EY
Sbjct: 141 ALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 224 --LRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279
+R G +S G L+ +LL+G P + + E +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 280 DEGTELVRLASRCLQYEPRERP 301
+ L R L +P++R
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRL 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 6e-15
Identities = 42/278 (15%), Positives = 84/278 (30%), Gaps = 33/278 (11%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLAN 117
+S G A V + R+AVK+ +R + A++ E R + +++ +
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 118 LLGCCCEGDERLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKE 175
LL + L + + Q + + I L+Y S
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 176 RALYHDLNAYRIVFDDDVNPRLSCFGL--MKNSRDGRSYSTNLAFTPPEYLRTGRVTPES 233
++ DL + ++D ++ FGL + +T P L
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 234 VMYSFGTLLLDLLSGKH-------------------IPPSHALDLIRDRNIQTLTDSCLE 274
++S G ++ +LL+G+ P + L I + + S +
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 275 ------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
V L + L + +R
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 70.3 bits (171), Expect = 4e-14
Identities = 42/276 (15%), Positives = 87/276 (31%), Gaps = 50/276 (18%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERL 129
V++ + N ++ VK ++ E + + LR + L + R
Sbjct: 50 EVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106
Query: 130 --LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRI 187
LV E++ N + Q + I +AL+YC S ++ D+ + +
Sbjct: 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNV 160
Query: 188 VFD-DDVNPRLSCFGLMKNSRDGRSYS----TNLAFTPPEYLRTGRVTPESVMYSFGTLL 242
+ D + RL +GL + G+ Y+ + P + M+S G +L
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 243 LDLLSGKH--------------------------------IPPSHALDLIRDRNIQTLTD 270
++ K I + I R+ + +
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ + E + + L+Y+ + R R
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.7 bits (169), Expect = 8e-14
Identities = 42/299 (14%), Positives = 91/299 (30%), Gaps = 65/299 (21%)
Query: 72 VVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130
V+ K + N +A+K +E + + ++ + +LL
Sbjct: 28 TVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86
Query: 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKER 176
+ +E + + +++ + L+Y +
Sbjct: 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 146
Query: 177 ALYHDLNAYRIVFDDD------VNPRLSCFGLMKNSRDGRSYS-TNLAFTPPEYLRTGRV 229
++ D+ ++ + + +++ G + + S + PE L
Sbjct: 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPW 206
Query: 230 TPESVMYSFGTLLLDLLSGKHI-------------------------PPSHALDLIRD-- 262
+ ++S L+ +L++G + PS+ L +
Sbjct: 207 GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266
Query: 263 ---------RNIQTLTDSCLEG------QFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
RNI L LE +FS DE E+ S LQ +PR+R + L
Sbjct: 267 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.2 bits (168), Expect = 1e-13
Identities = 39/294 (13%), Positives = 90/294 (30%), Gaps = 54/294 (18%)
Query: 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLAN 117
+ G A +V +A+K+ +R A++ E + + ++ + +
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 118 LLGCCC------EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171
LL E + LV E M + + + + +++
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKHL 135
Query: 172 TSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN---LAFTPPEYLRTGR 228
S ++ DL IV D ++ FGL + + + + PE +
Sbjct: 136 HSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 229 VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE-------------- 274
++S G ++ +++ K + P ++ I+ L C E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 275 ----------------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSL 306
+ + + ++ L S+ L +P +R +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 20/147 (13%), Positives = 35/147 (23%), Gaps = 25/147 (17%)
Query: 72 VVYKGKLENQFRIAVKRFNRSA----------WPDARQFLEEARAVGQLRNRRLANLLGC 121
V+ E VK F A + R L L G
Sbjct: 15 AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74
Query: 122 CC----EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177
+ ++ E + E ++ V I E + +
Sbjct: 75 AVPKVYAWEGNAVLMELI---------DAKELYRVRVENPDEVLDMILEEVAKFYHR-GI 124
Query: 178 LYHDLNAYRIVFDDDVNPRLSCFGLMK 204
++ DL+ Y V + + F
Sbjct: 125 VHGDLSQY-NVLVSEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 372 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.04 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.67 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=417.17 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=206.8
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
+-++|+++++||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|+|...+..++||||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 346789999999999999999998888899999998654 3457899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
+++|+|.+++.. ....+++..++.|+.|++.||.|||++ +++||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 82 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred cCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999999864 345689999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCch-hhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....||+.|+|||++.+..++.++|||||||++|||+|++.|+... ....... ..........|..+++++.+|
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~-----~i~~~~~~~~p~~~~~~l~~l 234 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----DISTGFRLYKPRLASTHVYQI 234 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH-----HHHHTCCCCCCTTSCHHHHHH
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHhcCCCCCccccCHHHHHH
Confidence 2245788999999999999999999999999999999965555432 2111111 111112223455667899999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.+||+.||++|||+++|+++|+++.+
T Consensus 235 i~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-59 Score=421.82 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=218.6
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
+.++|++.++||+|+||+||+|.+ .+++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 345788899999999999999995 468899999997654 356789999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCc--
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-- 211 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 211 (372)
||++|+|.+++.......+++..+..|+.||+.||.|||++ ||+||||||+|||+++++.+||+|||+++.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99999999999876667899999999999999999999999 999999999999999999999999999987654322
Q ss_pred ---ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchh-hHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 212 ---~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
..+++.|+|||++.++.++.++|||||||++|||++|+.|+.... .... ............+..+++++.+
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~-----~~~i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----HHHHHTTCCCCCCTTCCHHHHH
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH-----HHHHhcCCCCCCCccchHHHHH
Confidence 236788999999999999999999999999999999877764322 1111 1112222233456667789999
Q ss_pred HHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 288 LASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
|+.+||+.||++|||+++|++.|+.+.++.
T Consensus 248 li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 999999999999999999999999886654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-59 Score=420.20 Aligned_cols=246 Identities=17% Similarity=0.247 Sum_probs=211.3
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
..|+++++||+|+||+||+|. ..+|+.||||++........+.+.+|+++|++++|||||++++++...+..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 369999999999999999999 5679999999998766566778999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----Cc
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~ 211 (372)
+||+|.+++.+ +.+++.+++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 99999998853 4699999999999999999999999 9999999999999999999999999999876432 34
Q ss_pred ccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 212 ~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ........+..++.++.+|+.+
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHHH
Confidence 5689999999999999999999999999999999999999865432111111111 1111123345677899999999
Q ss_pred HccCCCCCCCChHHHHHH
Q 017395 292 CLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~ 309 (372)
||+.||.+|||+.|+++|
T Consensus 253 ~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HTCSSTTTSCCHHHHTTC
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999887
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-59 Score=415.29 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=206.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCC--CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
+.++|.+.+.||+|+||+||+|++.+ .||||+++... ....+.|.+|+++|++++|||||++++++. .+..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 45678899999999999999998643 59999997543 234678999999999999999999999875 46789999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
|||++|+|.+++.. .+..+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 83 Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp ECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred ecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999964 345699999999999999999999999 9999999999999999999999999999765432
Q ss_pred ---CcccCCCCcCCcccccCC---CCCCCCceeehHHHHHHHHhCCCCCCchhhH-HhhhccccccccccccCCCChHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
....||+.|+|||++.+. .++.++|||||||++|||+||+.||...... ............+ .....+..++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~ 239 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP-DLSKVRSNCP 239 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-CGGGSCTTCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-cchhccccch
Confidence 235689999999999753 4789999999999999999999998653211 1111111111111 1112345567
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
+++.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 8999999999999999999999999999988764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-59 Score=414.54 Aligned_cols=246 Identities=21% Similarity=0.288 Sum_probs=211.1
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.++|++++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999995 568999999986422 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
||||++|+|.+++.. .+.+++..+..|+.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 mEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred EeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 999999999999973 45699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ....+|...++++.+|+
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDLI 235 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TCCCCCTTSCHHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCccCCHHHHHHH
Confidence 345689999999999999999999999999999999999999876433222211111 11234556778999999
Q ss_pred HHHccCCCCCCCChHHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l 310 (372)
.+||+.||++|||++|+++|-
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCH
T ss_pred HHHccCCHhHCcCHHHHHcCc
Confidence 999999999999999999873
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=416.63 Aligned_cols=247 Identities=17% Similarity=0.128 Sum_probs=203.8
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++|++++.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+++|++++||||+++++++.+.+..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4799999999999999999995 57899999999765432 245689999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC------
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------ 208 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 208 (372)
|++|+|.+++. ....+++..++.++.|++.||.|||++ ||+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999996 455799999999999999999999999 999999999999999999999999999986532
Q ss_pred CCcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 209 GRSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 209 ~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... ................++++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH---HHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCCCCccccCCHHHHH
Confidence 234568999999999988776 578999999999999999999885432111000 0001111111122455788999
Q ss_pred HHHHHccCCCCCCCChHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (372)
|+.+||+.||++|||++|+++|
T Consensus 239 li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-59 Score=420.09 Aligned_cols=255 Identities=20% Similarity=0.285 Sum_probs=204.0
Q ss_pred CCccccccccCCCCCCeEEEEEeC-CC---cEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.+.|++.+.||+|+||+||+|++. ++ ..||||.+...... ..++|.+|+++|++++|||||+++|++...+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356788889999999999999953 33 36899998765433 35679999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
|||||++|+|.+++.. ..+.+++.+++.|+.||+.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 105 v~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999998864 345699999999999999999999999 99999999999999999999999999998654321
Q ss_pred ---------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 211 ---------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 211 ---------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
...+|+.|+|||++.++.++.++|||||||++|||+| |+.||............ ........+..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~ 257 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-----EQDYRLPPPMD 257 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-----HTTCCCCCCTT
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCcc
Confidence 1345788999999999999999999999999999998 78777654322221111 11122234556
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
++.++.+|+.+||+.||.+|||+.+|++.|+.+.+++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 7789999999999999999999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-59 Score=415.86 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=212.0
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++++|+++++||+|+||+||+|.+++++.||||+++... ...+.|.+|+++|++++|||||++++++. .+..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 345788999999999999999998888899999997654 34678999999999999999999999875 4668999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 209 (372)
+++|+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 9999999988654445699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....+|+.|+|||++.++.++.++|||||||++|||+||+.|+......... ...+........+..+++++.+|+
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~----~~~i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----IQNLERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCCCCcccChHHHHHHH
Confidence 2345788999999999889999999999999999999977665432211110 011111122234556778999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+||+.||++|||+++|++.|+.+..
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-59 Score=416.90 Aligned_cols=247 Identities=16% Similarity=0.203 Sum_probs=208.8
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.|+++++||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 589999999999999999994 5789999999987766667789999999999999999999999999999999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC----CCcc
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSY 212 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~~~ 212 (372)
+|+|.+++.+ ..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 93 ~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 93 GGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp TEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 9999998764 245699999999999999999999999 999999999999999999999999999876432 2356
Q ss_pred cCCCCcCCccccc-----CCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 213 STNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 213 ~~t~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
.||+.|+|||++. +..|+.++|||||||++|||+||+.||............... .......+..+++++.+
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHHHH
Confidence 7899999999985 345889999999999999999999988653221111111110 01111234567789999
Q ss_pred HHHHHccCCCCCCCChHHHHHH
Q 017395 288 LASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~~il~~ 309 (372)
|+.+||+.||++|||+.|+++|
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-58 Score=412.73 Aligned_cols=247 Identities=17% Similarity=0.225 Sum_probs=199.2
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc--HHHHHHHHHHHhcCCCcceeeEeeEEEe--CCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv 131 (372)
++|++++.||+|+||+||+|+ ..+|+.||||++....... .+.+.+|+++|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 579999999999999999999 4678999999998654332 4568999999999999999999999864 4568999
Q ss_pred EecCCCCCHHhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----cccccccCcceeecCCCCceeeccCCcc
Q 017395 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER-----ALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~-----iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
||||++|+|.+++.+. .+..+++..++.++.|++.||.|||++ + ||||||||+|||++.++.+||+|||+++
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999998642 345799999999999999999999986 5 9999999999999999999999999998
Q ss_pred cCCCC----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChH
Q 017395 205 NSRDG----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (372)
Q Consensus 205 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (372)
..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.............. . .....+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~----~-~~~~~~~~ 237 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----G-KFRRIPYR 237 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----T-CCCCCCTT
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc----C-CCCCCCcc
Confidence 76543 345689999999999999999999999999999999999999876433322211111 1 11234556
Q ss_pred HHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 281 EGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 281 ~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+++++.+|+.+||+.||.+|||+.|+++|
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 67899999999999999999999999876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-58 Score=414.72 Aligned_cols=246 Identities=18% Similarity=0.220 Sum_probs=209.1
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
.|+++++||+|+||+||+|+ ..+++.||||++....... .+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 38899999999999999999 5678999999997654332 4568999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCCccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS 213 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 213 (372)
||.+|+|..++. .++++++..++.++.||+.||.|||++ |||||||||+|||++.++.+||+|||+++.........
T Consensus 96 ~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (309)
T d1u5ra_ 96 YCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172 (309)
T ss_dssp CCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred ecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCCCccc
Confidence 999999987765 345799999999999999999999999 99999999999999999999999999999888778889
Q ss_pred CCCCcCCcccccC---CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 214 TNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 214 ~t~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
||+.|+|||++.+ +.|+.++|||||||++|||++|..||........... +.........+..+++++.+|+.
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCTTSCHHHHHHHH
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCCCCCCCHHHHHHHH
Confidence 9999999999964 4589999999999999999999999865432211111 11111111123445689999999
Q ss_pred HHccCCCCCCCChHHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l 310 (372)
+||+.||.+|||++++++|-
T Consensus 249 ~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTCH
T ss_pred HHCcCChhHCcCHHHHHhCH
Confidence 99999999999999999873
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=402.97 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=213.2
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
-++|+++++||+|+||+||+|++++++.||||.++.... ..++|.+|++++++++||||++++|+|.+.+.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 457889999999999999999998888999999986553 4578999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----C
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----~ 210 (372)
++|+|.+++.. ....+++..+++|+.|++.||.|||++ ||+||||||+||++++++.+||+|||+++..... .
T Consensus 82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999999764 345689999999999999999999999 9999999999999999999999999999764432 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||............ ....+...|...++++.+|+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-----HTTCCCCCCTTCCHHHHHHH
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-----HhCCCCCCcccccHHHHHHH
Confidence 3457889999999999999999999999999999998 78777654332222111 11122334566678999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.+||+.||++|||+++|+++|..+
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHccCCHhHCcCHHHHHHHhhCC
Confidence 999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-57 Score=410.52 Aligned_cols=247 Identities=15% Similarity=0.173 Sum_probs=194.6
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|++++.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+++|++++||||+++++++.+.+..|||||||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 489999999999999999995 56899999999765433 2456889999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec---CCCCceeeccCCcccCCCC---
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~~~~~~--- 209 (372)
+||+|.+++. ..+.+++..+..++.||+.||.|||++ |++||||||+||++. +++.+||+|||+++.....
T Consensus 90 ~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 90 SGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999997 455799999999999999999999999 999999999999995 5789999999999876543
Q ss_pred CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+............... ......+...++++.+|+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--EFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC--CCCTTTTTTSCHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--CCCCccccCCCHHHHHHH
Confidence 345689999999999999999999999999999999999999876543322221111111 111123355678999999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+||+.||++|||+.|+++|
T Consensus 245 ~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHS
T ss_pred HHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=416.74 Aligned_cols=251 Identities=18% Similarity=0.240 Sum_probs=205.1
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++|+++++||+|+||+||+|+. .+++.||||+++..... ..+++.+|+.+|++++|||||+++++|.+.+..||||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4789999999999999999994 67899999999765333 356799999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC--CCcc
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--GRSY 212 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~ 212 (372)
++||+|.+++.+ .+.+++..+..++.|++.||.|||++.||+||||||+|||+++++.+||+|||+++.... ....
T Consensus 86 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 86 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred CCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence 999999999974 356999999999999999999999732899999999999999999999999999986432 3456
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccc-------------------------
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------------------- 267 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~------------------------- 267 (372)
.||+.|+|||++.+..|+.++||||+||++|||++|+.||...............
T Consensus 164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243 (322)
T ss_dssp CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence 8999999999999999999999999999999999999998653211110000000
Q ss_pred ---------ccc---ccccCCCC-hHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 ---------LTD---SCLEGQFS-SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 ---------~~~---~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
... .......+ ...+.++.+|+.+||+.||.+|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 00000111 1246789999999999999999999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=403.75 Aligned_cols=243 Identities=19% Similarity=0.245 Sum_probs=199.1
Q ss_pred cccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe----CCeeEEE
Q 017395 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLV 131 (372)
Q Consensus 59 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv 131 (372)
|++..+||+|+||+||+|.. .+++.||+|.+..... ...+.|.+|+++|++++|||||++++++.. ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 46667899999999999995 5688999999875432 235679999999999999999999999865 3468999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--cccccccCcceeec-CCCCceeeccCCcccCCC
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~--iiH~Dikp~Nill~-~~~~~kl~Dfg~~~~~~~ 208 (372)
|||+++|+|.+++.+ ...+++..+..|+.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999973 45699999999999999999999998 7 99999999999997 578999999999986554
Q ss_pred C--CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhh-HHhhhccccccccccccCCCChHHHHHH
Q 017395 209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
. ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ............ ...++...++++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEV 242 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC----CcccCccCCHHH
Confidence 3 34578999999999875 599999999999999999999999864321 111111111111 112233456789
Q ss_pred HHHHHHHccCCCCCCCChHHHHHH
Q 017395 286 VRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.+|+.+||+.||++|||+.|+++|
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCCHhHCcCHHHHhCC
Confidence 999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=408.98 Aligned_cols=246 Identities=17% Similarity=0.162 Sum_probs=209.0
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
++|++++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999995 578999999986432 233567999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC---
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 209 (372)
|||+||+|.+++. ..+.+++..++.++.|++.||.|||++ |||||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999987 345699999999999999999999999 9999999999999999999999999999876432
Q ss_pred ---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHH
Q 017395 210 ---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 286 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.............. . ...++...++++.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----L--EYDFPEKFFPKAR 238 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT----T--CCCCCTTCCHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc----C--CCCCCccCCHHHH
Confidence 235689999999999999999999999999999999999999876433222211111 1 1134556778999
Q ss_pred HHHHHHccCCCCCCCChHHHHHHHH
Q 017395 287 RLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
+||.+||+.||.+|||++|++++.+
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHH
Confidence 9999999999999999999876543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=402.16 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=205.7
Q ss_pred CccccccccCCCCCCeEEEEEeCC-C----cEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLEN-Q----FRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
+.|++.+.||+|+||+||+|.+.+ + ..||||+++...... ..+|.+|+++|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 457777888999999999998543 2 479999997654333 4579999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+.+++|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999999998865 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred ------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 210 ------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
....||+.|+|||++.++.++.++|||||||++|||++|+.|+....... .....+....+...+..++.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTTCCCCCCTTCBH
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH----HHHHHHhccCCCCCchhhHH
Confidence 12346889999999999999999999999999999999876665432111 11111122223345566778
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999999988764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-57 Score=403.23 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=209.1
Q ss_pred CCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
+++|++.+.||+|+||+||+|++.+++.||||+++... ...+.|.+|+.+|++++|||||++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 45799999999999999999998888889999997554 45678999999999999999999999985 46689999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-----C
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-----~ 210 (372)
++|+|..++.....+.+++.+++.++.||+.||+|||++ |++||||||+|||+++++++||+|||+++..... .
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 999999998754456799999999999999999999999 9999999999999999999999999999865432 2
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...+|+.|+|||++.++.++.++|||||||++|||++|+.|+......... ...+........+..+++++.+|+.
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~----~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----LDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCCCCCcccCHHHHHHHH
Confidence 245788999999999999999999999999999999987766543211100 0111111222345667789999999
Q ss_pred HHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 291 RCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
+||+.||++|||+++|++.|+.....
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 99999999999999999998876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-57 Score=403.54 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=205.6
Q ss_pred cccccc-ccCCCCCCeEEEEEeC---CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEE
Q 017395 58 MENIVS-EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 58 ~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 132 (372)
.+.+.. +||+|+||+||+|.+. ++..||||+++..... ..++|.+|+++|++++|||||+++|++.. +..||||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 344555 4899999999999753 3557999999765433 35679999999999999999999999864 5689999
Q ss_pred ecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC--
Q 017395 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
|||++|+|.+++.. .+..+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 88 E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 88 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp ECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999999999854 345699999999999999999999999 99999999999999999999999999998654332
Q ss_pred -----cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 211 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
...+|+.|+|||++.++.++.++|||||||++|||+| |+.||......... ..+....+...|..++++
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-----~~i~~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----AFIEQGKRMECPPECPPE 240 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-----HHHHTTCCCCCCTTCCHH
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-----HHHHcCCCCCCCCcCCHH
Confidence 3456889999999999999999999999999999998 88887643222111 111112223456677889
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-56 Score=414.15 Aligned_cols=250 Identities=19% Similarity=0.158 Sum_probs=212.3
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++.|++++.||+|+||+||+|.. .+|+.||||+++.....+.+.+.+|+++|++++|||||+++++|.+.+..||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999994 67999999999876555566789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec--CCCCceeeccCCcccCCCCC--
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGR-- 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~--~~~~~kl~Dfg~~~~~~~~~-- 210 (372)
|+||+|.+++.. ...++++..++.|+.||+.||.|||++ |||||||||+|||++ .++.+||+|||+++......
T Consensus 108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 999999998754 344699999999999999999999999 999999999999998 67899999999998876543
Q ss_pred -cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||.+.............. ...........++++.+||
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--WEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--CCCCSSTTTTSCHHHHHHH
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCcccccCCCHHHHHHH
Confidence 3568999999999999999999999999999999999999987643222211111100 1111223345678999999
Q ss_pred HHHccCCCCCCCChHHHHHH
Q 017395 290 SRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~ 309 (372)
.+||+.||.+|||+.|+++|
T Consensus 264 ~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999997
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-56 Score=412.47 Aligned_cols=249 Identities=19% Similarity=0.148 Sum_probs=210.9
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecC
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 135 (372)
++|++++.||+|+||+||+|+. .+|+.||||++......+.+.+.+|+++|++++|||||++++++.+.+..|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4789999999999999999994 679999999998766566778999999999999999999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec--CCCCceeeccCCcccCCCCC---
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~--~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
+||+|.+++.. ..+.+++..+..|+.||+.||.|||++ |+|||||||+|||++ .++.+||+|||+++......
T Consensus 106 ~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 106 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999854 345699999999999999999999999 999999999999996 46789999999998765543
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+............... .........+++++.+||.
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW--NMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CSCCGGGGGCCHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCCCHHHHHHHH
Confidence 35789999999999999999999999999999999999999875432222111110000 0111122456789999999
Q ss_pred HHccCCCCCCCChHHHHHH
Q 017395 291 RCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rps~~~il~~ 309 (372)
+||+.||++|||++|+++|
T Consensus 262 ~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-57 Score=411.67 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=206.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeC-CC-----cEEEEEEcCCCCC-ccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQ-----FRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGD 126 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 126 (372)
+.++|++.+.||+|+||+||+|++. .+ ..||||.+..... .....+.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3457889999999999999999853 22 3699999875432 3356799999999998 8999999999999999
Q ss_pred eeEEEEecCCCCCHHhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCc
Q 017395 127 ERLLVAEYMPNDTLAKHLFHWET---------------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (372)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~ 185 (372)
..++|||||++|+|.++++.... ..+++..++.|+.|++.||+|||++ +||||||||+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRDlKp~ 193 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAAR 193 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCchh
Confidence 99999999999999999975322 3589999999999999999999999 9999999999
Q ss_pred ceeecCCCCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhH
Q 017395 186 RIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALD 258 (372)
Q Consensus 186 Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~ 258 (372)
|||++.++.+||+|||+++...... ...+|+.|+|||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654332 2346889999999999999999999999999999998 78887643211
Q ss_pred HhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHH
Q 017395 259 LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (372)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~ 311 (372)
.. ...++....+...|..+++++.+||.+||+.||++|||+++|+++|.
T Consensus 274 ~~----~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN----FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 11122222233456667789999999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=401.17 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=198.9
Q ss_pred cccCCCCCCeEEEEEeCC---CcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEecCCC
Q 017395 63 SEHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 137 (372)
++||+|+||+||+|.+.+ ++.||||+++..... ..++|.+|+++|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 368999999999998532 568999999754322 25679999999999999999999999864 567899999999
Q ss_pred CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC-------
Q 017395 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------- 210 (372)
Q Consensus 138 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~------- 210 (372)
|+|.++++. ...+++..++.|+.||+.||.|||++ ++|||||||+|||++.++.+||+|||+++......
T Consensus 92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999973 45699999999999999999999999 99999999999999999999999999998654332
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (372)
...||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....... ..+....+...|..++.++.+|+
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-----~~i~~~~~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-----AMLEKGERMGCPAGCPREMYDLM 243 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-----HHHHcCCCCCCCcccCHHHHHHH
Confidence 2357889999999999999999999999999999998 78887653222111 11111222345566778999999
Q ss_pred HHHccCCCCCCCChHHHHHHHHhh
Q 017395 290 SRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 290 ~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.+||+.||.+|||+++|++.|+..
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCH
Confidence 999999999999999999887754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-56 Score=406.41 Aligned_cols=245 Identities=17% Similarity=0.226 Sum_probs=211.9
Q ss_pred CCccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.++|++++.||+|+||.||+|+ ..+++.||||++++.. ....+++.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 4689999999999999999999 4679999999997432 23467789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++ |||||||||+|||++.+|.+||+|||+++.....
T Consensus 84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999999973 45699999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
....||+.|+|||++.+..|+.++|||||||++|||++|+.||.......+....... ...+|...++++.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKS 234 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------CCCCCccCCHHHHH
Confidence 2456899999999999999999999999999999999999998765443322211111 12346667889999
Q ss_pred HHHHHccCCCCCCCC-----hHHHHHH
Q 017395 288 LASRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps-----~~~il~~ 309 (372)
||.+||+.||.+|++ +.++++|
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhccCCchhhcccccccHHHHHcC
Confidence 999999999999994 8899987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=395.87 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=203.8
Q ss_pred CCCccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEe-CCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e 133 (372)
+.++|++++.||+|+||.||+|.+ .|..||||+++.+. ..+.|.+|+++|++++||||++++|+|.+ .+.+++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 345788999999999999999998 46789999997543 45779999999999999999999999865 456899999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-Ccc
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 212 (372)
|+++|+|.+++.......+++..++.|+.||+.||.|||++ +++||||||+||+++.++.+||+|||+++..... ...
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 99999999999754444689999999999999999999999 9999999999999999999999999999875443 335
Q ss_pred cCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHHH
Q 017395 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (372)
Q Consensus 213 ~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (372)
.++..|+|||++.++.++.++|||||||++|||+| |+.|+.......+... +....+..++..+++++.+|+.+
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-----i~~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-----HTTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcCCCCCCCccCCHHHHHHHHH
Confidence 67889999999999999999999999999999998 5655543322211111 11223334566677899999999
Q ss_pred HccCCCCCCCChHHHHHHHHhhhc
Q 017395 292 CLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 292 cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
||+.||.+|||+.+|+++|+.++.
T Consensus 236 cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-55 Score=401.07 Aligned_cols=245 Identities=18% Similarity=0.213 Sum_probs=211.0
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
.++|++++.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 35799999999999999999995 669999999996422 23456799999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-C
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 210 (372)
||||+||+|..++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 83 mE~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 83 MDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp ECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred eeecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 99999999999987 445689999999999999999999999 9999999999999999999999999999876544 3
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.............. . ...++...++++.+++.
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----A--ELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----C--CCCCCTTSCHHHHHHHH
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHH
Confidence 56799999999999999999999999999999999999999876533222211111 1 11345566789999999
Q ss_pred HHccCCCCCCC-----ChHHHHHH
Q 017395 291 RCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rp-----s~~~il~~ 309 (372)
+||..||.+|+ |++++++|
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccchhhHHHHHcC
Confidence 99999999996 89999988
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=399.37 Aligned_cols=247 Identities=17% Similarity=0.159 Sum_probs=206.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC------ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.|++++.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..||
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 489999999999999999995 6799999999964322 235779999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC----CceeeccCCcccC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNS 206 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~----~~kl~Dfg~~~~~ 206 (372)
|||||++|+|.+++.. .+.+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++...
T Consensus 91 v~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999974 35699999999999999999999999 999999999999998776 4999999999876
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+............... ......+...+.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~ 245 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY--EFEDEYFSNTSA 245 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--CCCHHHHTTSCH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CCCchhcCCCCH
Confidence 543 345678999999999999999999999999999999999999875432222111111000 000011234567
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
++.+||.+||+.||.+|||++++++|
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=392.78 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=200.7
Q ss_pred CCccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
.++|++.+.||+|+||+||+|++.. +..||||.++...... .+.|.+|+++|++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4679999999999999999998532 3579999987554333 457999999999999999999999985 567899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+||++++++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998764 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred ----CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHHH
Q 017395 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (372)
Q Consensus 210 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (372)
....+|+.|+|||++.+..++.++|||||||++|||+| |.+|+........... .........+..++++
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-----i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----IENGERLPMPPNCPPT 237 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTCCCCCCTTCCHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHH
Confidence 23456889999999999999999999999999999998 6766654322211111 1111122346677889
Q ss_pred HHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 285 l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
+.+||.+||+.||++|||+.+|+++|+.+.+
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-55 Score=397.41 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=210.1
Q ss_pred CCCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCcc-HHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
..++|+++++||+|+||+||+|++. +++.||||+++.....+ .++|.+|+++|++++||||++++++|.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3457889999999999999999853 35789999998655443 5579999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCc
Q 017395 128 RLLVAEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~ 185 (372)
.++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||++ ++|||||||+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrDlKp~ 169 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATR 169 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeEEccc
Confidence 999999999999999996421 23489999999999999999999999 9999999999
Q ss_pred ceeecCCCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCC-CCchhhH
Q 017395 186 RIVFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALD 258 (372)
Q Consensus 186 Nill~~~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p-~~~~~~~ 258 (372)
|||++.++.+||+|||+++..... ....+++.|+|||.+.+..++.++|||||||++|||++|..| +......
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 999999999999999998754322 234567899999999999999999999999999999999754 4332222
Q ss_pred HhhhccccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhh
Q 017395 259 LIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (372)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~ 314 (372)
..... + ........+..+++++.+|+.+||+.||++||||.+|++.|+++.
T Consensus 250 e~~~~----v-~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 EVIYY----V-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHH----H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHH----H-HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111 1 111122345667789999999999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-55 Score=403.60 Aligned_cols=245 Identities=17% Similarity=0.175 Sum_probs=210.7
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEE
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 131 (372)
+++|++++.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999995 579999999986422 23356789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-C
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R 210 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 210 (372)
|||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+++..... .
T Consensus 120 ~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999999999973 35699999999999999999999999 9999999999999999999999999999876543 3
Q ss_pred cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHHHH
Q 017395 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (372)
...||+.|+|||++.+..++.++|||||||++|||+||+.||............... ...++..+++++.+|+.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTCCHHHHHHHH
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------CCCCCccCCHHHHHHHH
Confidence 467899999999999999999999999999999999999998764332222111111 11234566789999999
Q ss_pred HHccCCCCCCC-----ChHHHHHH
Q 017395 291 RCLQYEPRERP-----NPRSLVTA 309 (372)
Q Consensus 291 ~cl~~dp~~Rp-----s~~~il~~ 309 (372)
+||+.||.+|+ |++++++|
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccccccHHHHHcC
Confidence 99999999994 89999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.4e-55 Score=390.44 Aligned_cols=253 Identities=17% Similarity=0.205 Sum_probs=204.7
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc---HHHHHHHHHHHhcCCCcceeeEeeEEEeCC----ee
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGD----ER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 128 (372)
++|++++.||+|+||+||+|+ ..+++.||||+++.....+ .+.|.+|+++|++++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 469999999999999999999 4679999999998654333 456899999999999999999999987654 38
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
||||||++|++|.+++. ..+.+++.+++.|+.||+.||.|||++ |++||||||+|||++.++..+|+|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999999886 345699999999999999999999999 999999999999999999999999998875432
Q ss_pred C-------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHH
Q 017395 209 G-------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (372)
Q Consensus 209 ~-------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (372)
. ....||+.|+|||++.+..++.++|||||||++|||+||+.||................. .........+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--IPPSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--CCGGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC--CCCchhccCC
Confidence 2 235689999999999999999999999999999999999999875432222111111100 0111123445
Q ss_pred HHHHHHHHHHHccCCCCCCC-ChHHHHHHHHhhh
Q 017395 282 GTELVRLASRCLQYEPRERP-NPRSLVTALVTLQ 314 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rp-s~~~il~~l~~~~ 314 (372)
++++.+|+.+||+.||++|| |+++++..|.++.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 68999999999999999999 8999999988775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.6e-55 Score=388.77 Aligned_cols=249 Identities=18% Similarity=0.158 Sum_probs=208.7
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCcc---------HHHHHHHHHHHhcCC-CcceeeEeeEEEe
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---------ARQFLEEARAVGQLR-NRRLANLLGCCCE 124 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 124 (372)
+++|++++.||+|+||+||+|+. .+++.||||+++...... .+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 56899999999999999999994 679999999997654321 235889999999997 9999999999999
Q ss_pred CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
++..|||||||++|+|.++++. .+.+++.+++.++.||+.||+|||++ |++||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999974 45799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCC---CcccCCCCcCCcccccC------CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccC
Q 017395 205 NSRDG---RSYSTNLAFTPPEYLRT------GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (372)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 275 (372)
..... ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||................. ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~--~~~~ 236 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY--QFGS 236 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC--CCCC
Confidence 76543 34568999999999863 3478899999999999999999999876543322211111111 1111
Q ss_pred CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 276 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
......++++.+|+.+||+.||.+|||+.|+++|
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2234677899999999999999999999999887
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=395.14 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=210.7
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCc--EEEEEEcCCCC-CccHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCeeE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQF--RIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 129 (372)
+|++|++.+.||+|+||+||+|++ .++. .||||.+.... ....+.|.+|+++|+++ +|||||+++++|.+.+..+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 567888999999999999999995 4444 57888886433 23456799999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCc
Q 017395 130 LVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~ 195 (372)
+||||+++|+|.++++.. ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCCce
Confidence 999999999999999753 235699999999999999999999999 99999999999999999999
Q ss_pred eeeccCCcccCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCC-chhhHHhhhccccccccc
Q 017395 196 RLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPP-SHALDLIRDRNIQTLTDS 271 (372)
Q Consensus 196 kl~Dfg~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~-~~~~~~~~~~~~~~~~~~ 271 (372)
||+|||+++..... ....+|..|+|||.+.++.++.++|||||||++|||++|..||. ......+... +..
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-----i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-----LPQ 241 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----GGG
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-----HHh
Confidence 99999998765432 23457899999999999999999999999999999999876543 3222211111 111
Q ss_pred cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCCC
Q 017395 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (372)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 318 (372)
..+...+..+++++.+||.+||+.||++|||+.+|+++|+.+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 12334556678899999999999999999999999999999876543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-55 Score=397.65 Aligned_cols=252 Identities=18% Similarity=0.276 Sum_probs=205.2
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCc----EEEEEEcCCCCC-ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 130 (372)
++|++++.||+|+||+||+|.+ .+|+ .||+|.++.... ...++|.+|+++|++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 4799999999999999999985 3443 689999875432 346789999999999999999999999976 45778
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 210 (372)
++||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 8999999999998865 455799999999999999999999999 99999999999999999999999999998754322
Q ss_pred ------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCChHHHH
Q 017395 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (372)
Q Consensus 211 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (372)
...||+.|+|||++.++.++.++|||||||++|||+| |..||.......+ ...+....+...+..++.
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-----~~~i~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKGERLPQPPICTI 240 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-----HHHHHHTCCCCCCTTBCH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcCCCCCCCcccCH
Confidence 2347899999999999999999999999999999999 5666543322111 111112222344566778
Q ss_pred HHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 284 ELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 284 ~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
++.+|+.+||+.||.+|||+.+|+++|..+.++
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999988654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=397.36 Aligned_cols=251 Identities=16% Similarity=0.174 Sum_probs=209.0
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
-|++|.+++.||+|+||+||+|.. .+++.||||+++... .+...+.+|+++|++++||||+++++++.+.+.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 477899999999999999999994 578999999998654 334568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC--CCCceeeccCCcccCCCCC-
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD--DVNPRLSCFGLMKNSRDGR- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~--~~~~kl~Dfg~~~~~~~~~- 210 (372)
||+||+|.+++.. .+..+++.+++.|+.||+.||.|||++ ||+||||||+|||++. ...+||+|||+++......
T Consensus 82 ~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 9999999999964 234699999999999999999999999 9999999999999984 4579999999998765543
Q ss_pred --cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 211 --~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
...+|+.|+|||.+.+..++.++|||||||++|+|++|..||.................. .........++++.+|
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHHHTTSCHHHHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CChhhccCCCHHHHHH
Confidence 345789999999999999999999999999999999999998765432222111110000 0000112356789999
Q ss_pred HHHHccCCCCCCCChHHHHHHH
Q 017395 289 ASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l 310 (372)
+.+||..||.+|||+.|+++|-
T Consensus 238 i~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHccCChhHCcCHHHHhcCH
Confidence 9999999999999999999973
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=397.47 Aligned_cols=248 Identities=17% Similarity=0.145 Sum_probs=201.2
Q ss_pred Cccccccc-cCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcC-CCcceeeEeeEEEe----CCeeE
Q 017395 57 AMENIVSE-HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE----GDERL 129 (372)
Q Consensus 57 ~~~~~~~~-lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~~ 129 (372)
++|.++++ ||+|+||+||+|+ ..+++.||||+++. ...+.+|++++.++ +|||||+++++|.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 57889876 9999999999999 46789999999863 35678999987655 89999999999865 35689
Q ss_pred EEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC---CCCceeeccCCcccC
Q 017395 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNS 206 (372)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~---~~~~kl~Dfg~~~~~ 206 (372)
||||||+||+|.+++.......+++.+++.|+.||+.||+|||++ ||+||||||+|||+++ ++.+||+|||+++..
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeec
Confidence 999999999999999865556799999999999999999999999 9999999999999985 567999999999865
Q ss_pred CCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccccccccc--CCCChHH
Q 017395 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDE 281 (372)
Q Consensus 207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 281 (372)
... ....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.............+...... ......+
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 443 34578999999999999899999999999999999999999986543211111111111111110 0111356
Q ss_pred HHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 282 GTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 282 ~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
++++.+|+.+||+.||++|||+.++++|-
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 78999999999999999999999999983
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=390.26 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=199.6
Q ss_pred CCCccccccccCCCCCCeEEEEEeCC----CcEEEEEEcCCCCC---ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 127 (372)
+..+|+++++||+|+||+||+|++.. ...||||+++.... ...++|.+|+++|++++||||++++|+|.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 34679999999999999999998422 24789999975432 235679999999999999999999999965 56
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.++||||+++|+|.+++.. ..+.+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred hheeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 7899999999999998864 345699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhccccccccccccCCCCh
Q 017395 208 DGR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (372)
Q Consensus 208 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (372)
... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.......... .+.........+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~----~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----KIDKEGERLPRPE 238 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTSCCCCCCCT
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH----HHHhCCCCCCCcc
Confidence 432 2346778999999999999999999999999999998 788876543322211 1111222223455
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhh
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~ 313 (372)
.++.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 6678999999999999999999999999998865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=393.04 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=198.9
Q ss_pred CCCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeC-
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG- 125 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~- 125 (372)
+.++|+++++||+|+||.||+|.+. +++.||||+++..... ..+.+.+|...+.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 4468999999999999999999842 2468999999764433 355688898888887 689999999998665
Q ss_pred CeeEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~ 191 (372)
...++|||||++|+|.++++... ...+++.+++.++.||+.||.|||++ +||||||||+|||+++
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSE 169 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeECC
Confidence 46899999999999999996432 23589999999999999999999999 9999999999999999
Q ss_pred CCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCC-CCchhhHHhhhcc
Q 017395 192 DVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRN 264 (372)
Q Consensus 192 ~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p-~~~~~~~~~~~~~ 264 (372)
++.+||+|||+++..... ....||+.|+|||++.++.++.++|||||||++|||+||..| |........
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---- 245 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 999999999999764432 234678999999999999999999999999999999998654 433211110
Q ss_pred ccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 265 IQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.............+..+++++.+|+.+||+.||++|||+.+|+++|+.+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111112234455677899999999999999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-54 Score=400.35 Aligned_cols=248 Identities=17% Similarity=0.138 Sum_probs=202.9
Q ss_pred CCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC---ccHHHHH---HHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFL---EEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
.++|++++.||+|+||.||+|+. .+|+.||||++..... .....+. +|+++++.++|||||++++++...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999994 5799999999864221 1122344 447778888999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++ |+|||||||+|||++.+|.+||+|||+++....
T Consensus 83 ~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999974 45689999999999999999999999 999999999999999999999999999987654
Q ss_pred C--CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHH
Q 017395 209 G--RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (372)
Q Consensus 209 ~--~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (372)
. ....||+.|+|||++.. ..++.++|||||||++|||+||+.||........... ..... .....++..+++++
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~--~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTL--TMAVELPDSFSPEL 236 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSS--SCCCCCCSSSCHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcc--cCCCCCCCCCCHHH
Confidence 3 34578999999999975 4589999999999999999999999865321111000 00000 11123455677899
Q ss_pred HHHHHHHccCCCCCCCC-----hHHHHHH
Q 017395 286 VRLASRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 286 ~~li~~cl~~dp~~Rps-----~~~il~~ 309 (372)
.+||.+||+.||.+||| ++++++|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999 6999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=393.96 Aligned_cols=244 Identities=18% Similarity=0.232 Sum_probs=206.5
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCC---CccHHHHHHHHHHHh-cCCCcceeeEeeEEEeCCeeEEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVG-QLRNRRLANLLGCCCEGDERLLV 131 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lv 131 (372)
++|++++.||+|+||+||+|+. .+++.||||+++... ....+.+.+|..++. .++||||+++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999994 579999999996432 233556778887765 68999999999999999999999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC--
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 209 (372)
|||+++|+|.+++. ....+++.++..++.||+.||.|||++ |++||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999997 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHH
Q 017395 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (372)
Q Consensus 210 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (372)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+............. ...+|..+++++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d 232 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEAKD 232 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCccCCHHHHH
Confidence 3356899999999999999999999999999999999999998765433222111111 12345566789999
Q ss_pred HHHHHccCCCCCCCChH-HHHHH
Q 017395 288 LASRCLQYEPRERPNPR-SLVTA 309 (372)
Q Consensus 288 li~~cl~~dp~~Rps~~-~il~~ 309 (372)
|+.+||+.||.+|||+. ++++|
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHhcccCCCCCcCHHHHHHhC
Confidence 99999999999999995 78775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=384.23 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=203.6
Q ss_pred cccCCCCCCeEEEEEeCC----CcEEEEEEcCCCC-CccHHHHHHHHHHHhcCCCcceeeEeeEEEe-CCeeEEEEecCC
Q 017395 63 SEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEYMP 136 (372)
Q Consensus 63 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~ 136 (372)
+.||+|+||+||+|++.+ ...||||+++... ....++|.+|+++|++++||||++++|++.. .+..++|||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 468999999999999533 2368999997543 3345779999999999999999999999876 468999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-------
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------- 209 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~------- 209 (372)
+|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 113 ~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 113 HGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp TCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred cCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 9999999864 445688999999999999999999999 9999999999999999999999999999865432
Q ss_pred -CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHHHHHHHH
Q 017395 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (372)
Q Consensus 210 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (372)
....+|..|+|||.+.++.++.++||||||+++|||+||+.||....... .....+....+...|..++.++.+|
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HHHHHHHcCCCCCCcccCcHHHHHH
Confidence 12356889999999999999999999999999999999888876532111 1111111111223455667899999
Q ss_pred HHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 289 ASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 289 i~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
+.+||+.||++|||+.||+++|+.+....
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999997653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=386.76 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=207.4
Q ss_pred CCCccccccccCCCCCCeEEEEEeCC--------CcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEe
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCE 124 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 124 (372)
+.++|++.+.||+|+||.||+|+..+ +..||||+++..... ...++.+|+..+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34689999999999999999998422 347999999865543 356789999999988 79999999999999
Q ss_pred CCeeEEEEecCCCCCHHhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec
Q 017395 125 GDERLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (372)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~ 190 (372)
.+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||++ ++|||||||+|||++
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEC
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeecccceeec
Confidence 999999999999999999997542 24589999999999999999999999 999999999999999
Q ss_pred CCCCceeeccCCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHh-CCCCCCchhhHHhhhc
Q 017395 191 DDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDR 263 (372)
Q Consensus 191 ~~~~~kl~Dfg~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~ 263 (372)
.++.+||+|||+++..... ....+|+.|+|||.+.++.++.++|||||||++|||++ |..||.........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-- 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-- 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH--
Confidence 9999999999998865432 23457889999999999999999999999999999998 56665443322211
Q ss_pred cccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
..+........+..+++++.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 248 ---~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 ---KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1112223334556677899999999999999999999999999998864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=386.20 Aligned_cols=246 Identities=19% Similarity=0.205 Sum_probs=194.6
Q ss_pred cccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCcc-----HHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-----ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 61 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
.|+.||+|+||+||+|+ ..+|+.||||+++...... .+.+.+|+++|++++|||||++++++...+..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46778999999999999 4679999999997543322 24688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
+.++++..+.. ....+++..+..++.||+.||+|||++ |++||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99987776664 456699999999999999999999999 9999999999999999999999999999765443 2
Q ss_pred cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc--------cc---cc---ccccc-
Q 017395 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI--------QT---LT---DSCLE- 274 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~--------~~---~~---~~~~~- 274 (372)
...+|+.|+|||++.+. .++.++|||||||++|||++|..||............. .. .. .....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 35689999999998755 57999999999999999999998886532211110000 00 00 00000
Q ss_pred --CC-----CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 275 --GQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 275 --~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.. .....++++.+|+.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 012346789999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=380.46 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=200.6
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
++|+++++||+|+||+||+|+. .+++.||||+++..... ..+++.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999994 67999999999754322 35679999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 209 (372)
|+.++ +.+++.......+++..+..++.|++.||+|||++ |||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99764 55555544566799999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc------ccccc-ccc-----cccCC
Q 017395 210 RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR------NIQTL-TDS-----CLEGQ 276 (372)
Q Consensus 210 ~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~-~~~-----~~~~~ 276 (372)
....||+.|+|||++.... ++.++|||||||++|+|++|+.||........... ..... ... .....
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 2346899999999987766 57899999999999999999999865321111000 00000 000 00000
Q ss_pred -----------CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 277 -----------FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 277 -----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.....+.++.+|+.+||..||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 012346789999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=385.75 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=210.7
Q ss_pred CccccccccCCCCCCeEEEEEe------CCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcC-CCcceeeEeeEEEeCCee
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 128 (372)
++|++.+.||+|+||.||+|++ .+++.||||+++..... ....|.+|+.+++++ +|||||+++++|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788899999999999999984 34678999999865443 355699999999999 699999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWE----------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~ 192 (372)
++|||||++|+|.++++... ...+++..+..++.||+.||+|||++ ++|||||||+||+++.+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeeccccccccccccc
Confidence 99999999999999997532 23589999999999999999999999 99999999999999999
Q ss_pred CCceeeccCCcccCCCCC------cccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCch-hhHHhhhccc
Q 017395 193 VNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNI 265 (372)
Q Consensus 193 ~~~kl~Dfg~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~-~~~~~~~~~~ 265 (372)
+.+||+|||+++...... ...+|+.|+|||++.++.++.++|||||||++|||+|++.|+... ... ..+
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~----~~~ 257 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SKF 257 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----HHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence 999999999998765432 245688999999999999999999999999999999965554322 110 011
Q ss_pred cccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcC
Q 017395 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (372)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 316 (372)
..+.....+...+...+.++.+||.+||+.||.+|||+.+|++.|+++..+
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 112222233344556678999999999999999999999999999876544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=383.80 Aligned_cols=254 Identities=20% Similarity=0.310 Sum_probs=208.6
Q ss_pred CCccccccccCCCCCCeEEEEEeC------CCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCee
Q 017395 56 FAMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (372)
Q Consensus 56 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 128 (372)
.++|++.++||+|+||+||+|.+. +++.||||+++..... ....|.+|++++++++||||++++++|......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 457889999999999999999853 2578999999764433 245689999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeecc
Q 017395 129 LLVAEYMPNDTLAKHLFHW--------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Df 200 (372)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++++||+||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeec
Confidence 9999999999999988632 123578999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCC-CCchhhHHhhhccccccccccc
Q 017395 201 GLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQTLTDSCL 273 (372)
Q Consensus 201 g~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~ 273 (372)
|+++..... ....+|+.|+|||.+.++.++.++||||||+++|||+||..+ +.......... .+.+ ..
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~----~i~~-~~ 252 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----FVME-GG 252 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----HHHT-TC
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHh-CC
Confidence 999865432 223568999999999999999999999999999999999644 43322211111 1111 11
Q ss_pred cCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 274 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
....+..+++.+.+++.+||+.||++|||+.+|+++|+...+
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 223455667899999999999999999999999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-52 Score=377.51 Aligned_cols=250 Identities=16% Similarity=0.208 Sum_probs=202.3
Q ss_pred CccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEec
Q 017395 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 134 (372)
++|+++++||+|+||+||+|++.+++.||||+++..... ..+++.+|+.+|++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 579999999999999999999888999999999765322 256899999999999999999999999999999999999
Q ss_pred CCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC----C
Q 017395 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (372)
Q Consensus 135 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~----~ 210 (372)
+.++.+..+.. ..+.+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 98876666654 456799999999999999999999999 9999999999999999999999999998765432 3
Q ss_pred cccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcc-----------------cccc----
Q 017395 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------------IQTL---- 268 (372)
Q Consensus 211 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-----------------~~~~---- 268 (372)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.......... ....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 34578899999999765 4689999999999999999999998643211110000 0000
Q ss_pred --ccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 --TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 --~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.............++++.+|+.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000011233456899999999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=379.69 Aligned_cols=238 Identities=18% Similarity=0.268 Sum_probs=199.9
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc------cHHHHHHHHHHHhcCC--CcceeeEeeEEEeCCe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLR--NRRLANLLGCCCEGDE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 127 (372)
++|++.+.||+|+||+||+|+ ..+++.||||++...... ...++.+|+.+|++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 368999999999999999999 467999999998753221 1234678999999996 8999999999999999
Q ss_pred eEEEEecCCC-CCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-CCCceeeccCCccc
Q 017395 128 RLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (372)
Q Consensus 128 ~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-~~~~kl~Dfg~~~~ 205 (372)
.++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||++ |++||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 678888863 45699999999999999999999999 9999999999999984 57899999999986
Q ss_pred CCCC--CcccCCCCcCCcccccCCCC-CCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCChHHH
Q 017395 206 SRDG--RSYSTNLAFTPPEYLRTGRV-TPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (372)
Q Consensus 206 ~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (372)
.... ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..... ..++...+
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--i~~~~----------~~~~~~~s 228 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRGQ----------VFFRQRVS 228 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHCC----------CCCSSCCC
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--Hhhcc----------cCCCCCCC
Confidence 5543 34678999999999987775 5678999999999999999998865421 11111 12344556
Q ss_pred HHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 283 TELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 283 ~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
+++.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 899999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=377.73 Aligned_cols=253 Identities=15% Similarity=0.202 Sum_probs=195.4
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHH--HHHHhcCCCcceeeEeeEEEeCC----eeEEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEE--ARAVGQLRNRRLANLLGCCCEGD----ERLLV 131 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~hpniv~l~~~~~~~~----~~~lv 131 (372)
+|.+.++||+|+||+||+|++ +|+.||||+++... .+.+.+| +..+.+++||||+++++++...+ .+|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 456667899999999999997 67899999996432 3444444 44556789999999999997654 58999
Q ss_pred EecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-------~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
|||+++|+|.+++++ ..+++..++.++.|++.||.|||+. .|||||||||+|||++.++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999964 3599999999999999999999961 399999999999999999999999999988
Q ss_pred cCCCC--------CcccCCCCcCCcccccCCC------CCCCCceeehHHHHHHHHhCCCCCCchhhHHhh---------
Q 017395 205 NSRDG--------RSYSTNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR--------- 261 (372)
Q Consensus 205 ~~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~--------- 261 (372)
..... ....||+.|+|||++.+.. ++.++|||||||++|||+||..|+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 65332 2356899999999987643 577899999999999999998765321100000
Q ss_pred --hccccccccccccCCC-----ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 262 --DRNIQTLTDSCLEGQF-----SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 262 --~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
............++.+ +......+.+|+.+||+.||++|||+.||++.|+++..+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0000011111112222 2345677999999999999999999999999999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=376.05 Aligned_cols=251 Identities=18% Similarity=0.190 Sum_probs=197.7
Q ss_pred CccccccccCCCCCCeEEEEEe-CC-CcEEEEEEcCCCCC--ccHHHHHHHHHHHhcC---CCcceeeEeeEEEe-----
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-EN-QFRIAVKRFNRSAW--PDARQFLEEARAVGQL---RNRRLANLLGCCCE----- 124 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~----- 124 (372)
++|+++++||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5799999999999999999995 44 67899999864322 2233566788777665 79999999999853
Q ss_pred CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcc
Q 017395 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
....+++|||+.++.+..... .....+++..++.++.|++.||+|||++ +||||||||+|||+++++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 246899999998876654443 3556799999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc--------c------
Q 017395 205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------T------ 267 (372)
Q Consensus 205 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~--------~------ 267 (372)
..... ....||+.|+|||++.+..++.++||||+||++|||++|+.||.............. .
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 65433 346789999999999999999999999999999999999999865422111000000 0
Q ss_pred -------cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 -------LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 -------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.........+....++.+.+|+.+||+.||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000112234557889999999999999999999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=368.29 Aligned_cols=254 Identities=15% Similarity=0.168 Sum_probs=196.8
Q ss_pred cCCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEe------
Q 017395 54 SGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE------ 124 (372)
Q Consensus 54 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------ 124 (372)
+..++|+++++||+|+||+||+|+. .+|+.||||++..... ...+++.+|+++|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 3467899999999999999999995 6799999999865432 235678999999999999999999999855
Q ss_pred --CCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCC
Q 017395 125 --GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (372)
Q Consensus 125 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~ 202 (372)
.+..++||||+.++.+..... ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecce
Confidence 346899999998876655443 445699999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC--------CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccc-------
Q 017395 203 MKNSRDG--------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------- 266 (372)
Q Consensus 203 ~~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~------- 266 (372)
++..... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9754421 234689999999999865 589999999999999999999988864321111100000
Q ss_pred ccc------------cccccCCCC-------hHHHHHHHHHHHHHccCCCCCCCChHHHHHHH
Q 017395 267 TLT------------DSCLEGQFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (372)
Q Consensus 267 ~~~------------~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l 310 (372)
... ........+ ...++++.+||.+||+.||++|||++|+++|=
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 000 000000000 11246788999999999999999999999983
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=373.44 Aligned_cols=247 Identities=16% Similarity=0.238 Sum_probs=195.3
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC------e
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~ 127 (372)
..|+++++||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4789999999999999999994 56999999999864332 2557899999999999999999999997654 5
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
+|+||||+ +.+|..+++ ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccC
Confidence 79999999 667888774 34699999999999999999999999 99999999999999999999999999998766
Q ss_pred CC-CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc----------------------
Q 017395 208 DG-RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR---------------------- 263 (372)
Q Consensus 208 ~~-~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~---------------------- 263 (372)
.. ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...........
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 54 346789999999999864 478999999999999999999998865321110000
Q ss_pred ----cccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 264 ----NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 264 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.........+ .......++++.+||.+||..||.+|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 253 NYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 11223456889999999999999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=373.31 Aligned_cols=249 Identities=17% Similarity=0.222 Sum_probs=193.6
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc-cHHHHHHHHHHHhcCCCcceeeEeeEEEeCC----eeEE
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGD----ERLL 130 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~l 130 (372)
+.|+++++||+|+||+||+|+ ..+|+.||||++...... ..+++.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 359999999999999999998 467999999999765432 3567899999999999999999999986643 2345
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCC-
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 209 (372)
+++|+.+|+|.+++.. +.+++..+..++.|++.||+|||++ |||||||||+|||+++++.+||+|||+++.....
T Consensus 88 l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 5566679999999963 3699999999999999999999999 9999999999999999999999999998764332
Q ss_pred ------CcccCCCCcCCcccccC-CCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccc--------------
Q 017395 210 ------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------------- 268 (372)
Q Consensus 210 ------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------------- 268 (372)
....||+.|+|||++.. ..++.++||||+||++|||++|+.||................
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 33457899999999855 457889999999999999999999986432111100000000
Q ss_pred --------cccccc---CCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 --------TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 --------~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
...... .......+.++.+|+.+||+.||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00112345789999999999999999999999988
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=361.82 Aligned_cols=250 Identities=16% Similarity=0.178 Sum_probs=204.3
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCC--ccHHHHHHHHHHHhcCCCcceeeEeeEEEeCCeeEEEEe
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 133 (372)
++|+++++||+|+||+||+|+ ..+++.||||+++.... ...+++.+|+.+|+.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 479999999999999999999 46789999999965443 235689999999999999999999999999999999999
Q ss_pred cCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCCCC---
Q 017395 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (372)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 210 (372)
++.+++|..++. ..+.+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999999988876 456789999999999999999999999 99999999999999999999999999998765432
Q ss_pred -cccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhh-H-Hhhh------c----cc---cc------
Q 017395 211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-D-LIRD------R----NI---QT------ 267 (372)
Q Consensus 211 -~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~-~-~~~~------~----~~---~~------ 267 (372)
...++..|+|||++.+.. ++.++|||||||++|||++|+.||..... . .... . .. ..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 334678899999988765 68999999999999999999998753211 1 0000 0 00 00
Q ss_pred ---cccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 268 ---LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 268 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..............++.+.+|+.+||+.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001112234557889999999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=370.16 Aligned_cols=252 Identities=20% Similarity=0.211 Sum_probs=196.0
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcceeeEeeEEEeC------CeeEE
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLL 130 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~l 130 (372)
+|+.++.||+|+||+||+|+. .+++.||||++..... .+.+|+++|++++||||++++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 688889999999999999995 5799999999976442 234799999999999999999998643 35799
Q ss_pred EEecCCCCCHHhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcccCCC
Q 017395 131 VAEYMPNDTLAKHLFH-WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD 208 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~ 208 (372)
|||||+++.+..+... .....+++.+++.|+.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9999987643333221 2455799999999999999999999999 999999999999999765 899999999987644
Q ss_pred C---CcccCCCCcCCcccccCC-CCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc---------------------
Q 017395 209 G---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR--------------------- 263 (372)
Q Consensus 209 ~---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--------------------- 263 (372)
. ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||...........
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 3 345688999999988764 589999999999999999999998864321111000
Q ss_pred --cccccccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH--HHhhh
Q 017395 264 --NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ 314 (372)
Q Consensus 264 --~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~--l~~~~ 314 (372)
..................++++.+|+.+||..||++|||+.|+++| ++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000000001111233457889999999999999999999999998 55554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=365.49 Aligned_cols=246 Identities=18% Similarity=0.202 Sum_probs=198.5
Q ss_pred CCCccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeC--CeeEE
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEG--DERLL 130 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~l 130 (372)
+.++|+++++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|++++ ||||++++++|... ...++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 446899999999999999999994 67999999999753 3567899999999995 99999999999754 56899
Q ss_pred EEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCC-CceeeccCCcccCCCC
Q 017395 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG 209 (372)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~-~~kl~Dfg~~~~~~~~ 209 (372)
|||||.+++|..+. +.+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999997764 3599999999999999999999999 999999999999998655 5999999999876543
Q ss_pred ---CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHh------------------hhccc--
Q 017395 210 ---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLI------------------RDRNI-- 265 (372)
Q Consensus 210 ---~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~------------------~~~~~-- 265 (372)
....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||........ .....
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 3456789999999988754 79999999999999999999998854211100 00000
Q ss_pred ----ccc--------ccccccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 266 ----QTL--------TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 266 ----~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
... .............++++.+||.+||..||.+|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00011111223457889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=369.01 Aligned_cols=250 Identities=17% Similarity=0.212 Sum_probs=203.9
Q ss_pred CCCccccccccCCCCCCeEEEEEe----CCCcEEEEEEcCCCCC----ccHHHHHHHHHHHhcCCC-cceeeEeeEEEeC
Q 017395 55 GFAMENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQLRN-RRLANLLGCCCEG 125 (372)
Q Consensus 55 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~ 125 (372)
+.++|++++.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++| |||+++++++...
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 346799999999999999999984 2478999999975321 234568899999999976 8999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCccc
Q 017395 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
...++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999999973 45688999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC-----CcccCCCCcCCcccccCCC--CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccccccccccccCCCC
Q 017395 206 SRDG-----RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (372)
Q Consensus 206 ~~~~-----~~~~~t~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (372)
.... ....+++.|++||.+.+.. ++.++|||||||+||||++|+.||.................. ....++
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--~~~~~~ 256 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP 256 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--CCCCCc
Confidence 5432 2356789999999998654 688999999999999999999998654211111111111111 112345
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCC-----hHHHHHH
Q 017395 279 SDEGTELVRLASRCLQYEPRERPN-----PRSLVTA 309 (372)
Q Consensus 279 ~~~~~~l~~li~~cl~~dp~~Rps-----~~~il~~ 309 (372)
...++++.+|+.+||+.||.+||| ++|+++|
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 567899999999999999999994 7899886
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-49 Score=354.80 Aligned_cols=255 Identities=15% Similarity=0.130 Sum_probs=204.3
Q ss_pred ccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC-cceeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|++++.||+|+||+||+|+ ..+++.||||++..... ...+.+|++.++.++| +|++.+++++......++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 68899999999999999999 45789999999865432 3457789999999975 89999999999999999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecC-----CCCceeeccCCcccCCC--
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-----DVNPRLSCFGLMKNSRD-- 208 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~-----~~~~kl~Dfg~~~~~~~-- 208 (372)
+++|.+++.. ....+++.++..++.|++.||.|||++ |++||||||+|||++. ++.+||+|||+++....
T Consensus 84 -~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 -GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp -CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred -CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 6799998865 345699999999999999999999999 9999999999999974 57799999999986432
Q ss_pred ---------CCcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhh--hccccccccccccCCC
Q 017395 209 ---------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR--DRNIQTLTDSCLEGQF 277 (372)
Q Consensus 209 ---------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 277 (372)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...+............
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 12356899999999999999999999999999999999999998632111000 0000000000000111
Q ss_pred ChHHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhcCC
Q 017395 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (372)
Q Consensus 278 ~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 317 (372)
...+++++.+++..|++.+|++||+++.+.+.|+.+.+..
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 2334578999999999999999999999999988876544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=363.88 Aligned_cols=247 Identities=16% Similarity=0.186 Sum_probs=190.5
Q ss_pred CccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEe------CCe
Q 017395 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCE------GDE 127 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 127 (372)
.+|+++++||+|+||+||+|.. .+|+.||||++...... ..+++.+|+.+|++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 4799999999999999999995 56999999999755432 24568999999999999999999999964 367
Q ss_pred eEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCC
Q 017395 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (372)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~ 207 (372)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhccc
Confidence 89999999775 444442 3589999999999999999999999 99999999999999999999999999987655
Q ss_pred CC---CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhccc-------------------
Q 017395 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI------------------- 265 (372)
Q Consensus 208 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~------------------- 265 (372)
.. ....+|+.|+|||++.+..++.++||||+||+++||++|+.||.............
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 43 34567899999999999999999999999999999999999886432111110000
Q ss_pred --------------cccccccccC---CCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 266 --------------QTLTDSCLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 266 --------------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
.......... ......++++.+|+.+||..||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 0123457899999999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-49 Score=356.88 Aligned_cols=253 Identities=15% Similarity=0.142 Sum_probs=197.2
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcc-eeeEeeEEEeCCeeEEEEecC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYM 135 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~ 135 (372)
.|+++++||+|+||+||+|++ .+++.||||++..... .+++.+|++++++++|+| |+.+.+++...+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 589999999999999999994 6689999999876443 245789999999998766 555566667888999999999
Q ss_pred CCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeec---CCCCceeeccCCcccCCCC---
Q 017395 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG--- 209 (372)
Q Consensus 136 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~---~~~~~kl~Dfg~~~~~~~~--- 209 (372)
. ++|.+.+.. ..+.+++..+..++.|++.||+|||++ |||||||||+|||++ .+..+||+|||+++.....
T Consensus 86 ~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 G-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp C-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred C-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 4 567776654 445799999999999999999999999 999999999999875 4567999999999865432
Q ss_pred --------CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhc--cccccccccccCCCCh
Q 017395 210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDR--NIQTLTDSCLEGQFSS 279 (372)
Q Consensus 210 --------~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 279 (372)
....||+.|+|||++.+..++.++|||||||++|||+||+.||........... ................
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence 234689999999999999999999999999999999999999864321111000 0000000000011123
Q ss_pred HHHHHHHHHHHHHccCCCCCCCChHHHHHHHHhhhc
Q 017395 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (372)
Q Consensus 280 ~~~~~l~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 315 (372)
.+++++.+++.+||+.||.+||++.++.+.|+.+..
T Consensus 243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 456889999999999999999999999888877643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=365.44 Aligned_cols=249 Identities=16% Similarity=0.206 Sum_probs=195.0
Q ss_pred CccccccccCCCCCCeEEEEE-eCCCcEEEEEEcCCCCCc--cHHHHHHHHHHHhcCCCcceeeEeeEEEeC-----Cee
Q 017395 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG-----DER 128 (372)
Q Consensus 57 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 128 (372)
++|+++++||+|+||+||+|+ ..+|+.||||++...... ..+++.+|+++|++++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 369999999999999999999 467999999999865432 345789999999999999999999998643 234
Q ss_pred EEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccCCcccCCC
Q 017395 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (372)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~~~~~ 208 (372)
+++|+|+.+|+|.+++. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCc
Confidence 66677788999999994 35699999999999999999999999 999999999999999999999999999876543
Q ss_pred C-CcccCCCCcCCcccccCCC-CCCCCceeehHHHHHHHHhCCCCCCchhhHHhhhcccccc------------------
Q 017395 209 G-RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL------------------ 268 (372)
Q Consensus 209 ~-~~~~~t~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~------------------ 268 (372)
. ....||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+..............
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 3 3456788999999987654 6889999999999999999999986542111110000000
Q ss_pred ----ccccccCC---CChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 269 ----TDSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 269 ----~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
........ .....++++.+||.+||..||.+|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000 012346789999999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-43 Score=324.11 Aligned_cols=251 Identities=15% Similarity=0.180 Sum_probs=191.4
Q ss_pred ccccccccCCCCCCeEEEEEe-CCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-----------CcceeeEeeEEEeC
Q 017395 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----------NRRLANLLGCCCEG 125 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~~~ 125 (372)
+|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 599999999999999999994 679999999998543 23456788999988875 47899999987643
Q ss_pred --CeeEEEEecCCCC-CHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCC------ce
Q 017395 126 --DERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN------PR 196 (372)
Q Consensus 126 --~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~------~k 196 (372)
...+++|+++..+ .............+++..++.++.||+.||+|||+..||+||||||+|||++.++. ++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 4566666665443 33343444455678999999999999999999998339999999999999986553 89
Q ss_pred eeccCCcccCCCC-CcccCCCCcCCcccccCCCCCCCCceeehHHHHHHHHhCCCCCCchhhHH----------------
Q 017395 197 LSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---------------- 259 (372)
Q Consensus 197 l~Dfg~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~---------------- 259 (372)
++|||.+...... ....+|+.|+|||++.+..++.++||||+||++++|++|+.||.......
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 9999998765443 44568999999999999999999999999999999999999875321000
Q ss_pred ------hhhcc----------ccccccc----------cccCCCChHHHHHHHHHHHHHccCCCCCCCChHHHHHH
Q 017395 260 ------IRDRN----------IQTLTDS----------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (372)
Q Consensus 260 ------~~~~~----------~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~il~~ 309 (372)
..... ....... .....++...++++.+|+.+||..||.+|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0000000 00123456778999999999999999999999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2e-26 Score=193.32 Aligned_cols=163 Identities=15% Similarity=0.114 Sum_probs=120.6
Q ss_pred ccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCc-------------c-----HHHHHHHHHHHhcCCCcceeeEeeE
Q 017395 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-------------D-----ARQFLEEARAVGQLRNRRLANLLGC 121 (372)
Q Consensus 60 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~-----~~~~~~E~~~l~~l~hpniv~l~~~ 121 (372)
.+-++||+|+||+||+|+..+|+.||||+++..... . .....+|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 345678999999999999888999999987532110 0 1234578899999999999998876
Q ss_pred EEeCCeeEEEEecCCCCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccccCcceeecCCCCceeeccC
Q 017395 122 CCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFG 201 (372)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~iiH~Dikp~Nill~~~~~~kl~Dfg 201 (372)
. . .+++|||+++..+.+ ++...+..++.|++.||.|||++ |++||||||+|||++++ .++|+|||
T Consensus 83 ~--~--~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred c--C--CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-CEEEEECC
Confidence 3 2 389999998865543 33345678999999999999999 99999999999999965 48999999
Q ss_pred CcccCCCCCcccCCCCcCCc------ccccCCCCCCCCceeehHHHH
Q 017395 202 LMKNSRDGRSYSTNLAFTPP------EYLRTGRVTPESVMYSFGTLL 242 (372)
Q Consensus 202 ~~~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~Dv~SlGvil 242 (372)
++......... .|... +.+ ...|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR----EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 98766433221 11111 111 24578899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=1.1e-08 Score=87.91 Aligned_cols=139 Identities=13% Similarity=-0.026 Sum_probs=93.9
Q ss_pred ccccccccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEEecCC
Q 017395 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMP 136 (372)
Q Consensus 58 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 136 (372)
.|++++..+-++.+.||+... +++.+.||+...........+.+|...+..+. +--+.+++.++..++..++||++++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 445555544455578998875 45567888886544334445778888887774 4447788888888899999999999
Q ss_pred CCCHHhhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 017395 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------ 174 (372)
Q Consensus 137 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------------ 174 (372)
|.++.+..... .. ...++.+++..++.||+.
T Consensus 94 G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 94 GVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred ccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 98886654210 11 122334444444444421
Q ss_pred ----------------CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 175 ----------------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 175 ----------------~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
..++|+|+.|.||++++++..-|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999977666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=5.1e-06 Score=70.34 Aligned_cols=68 Identities=19% Similarity=0.187 Sum_probs=51.6
Q ss_pred CeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCC--CcceeeEeeEEEeCCeeEEEEecCCCCCHH
Q 017395 71 NVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (372)
Q Consensus 71 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 141 (372)
+.||+....++..+.+|........ .+.+|+..|+.+. .-.+++++.+..+++..++||++++|.++.
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 6799999878888999987654432 3567777777663 334677888888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.04 E-value=9.5e-06 Score=73.46 Aligned_cols=76 Identities=14% Similarity=0.144 Sum_probs=50.1
Q ss_pred ccccCCCCCCeEEEEEe-CCCcEEEEEEcCC------CCC-ccHHHHHHHHHHHhcCC-C--cceeeEeeEEEeCCeeEE
Q 017395 62 VSEHGEKAPNVVYKGKL-ENQFRIAVKRFNR------SAW-PDARQFLEEARAVGQLR-N--RRLANLLGCCCEGDERLL 130 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~------~~~-~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~~~~l 130 (372)
++++|.|....||+... .+++.|+||.-.. ..+ ....+...|++.|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999985 4477899996532 111 12345567888887663 3 356666655 4456689
Q ss_pred EEecCCCCC
Q 017395 131 VAEYMPNDT 139 (372)
Q Consensus 131 v~e~~~~gs 139 (372)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.61 E-value=8.1e-05 Score=65.31 Aligned_cols=133 Identities=21% Similarity=0.188 Sum_probs=78.0
Q ss_pred CCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCCcce--eeEe-----eEEEeCCeeEEEEecCCCCCHH-
Q 017395 70 PNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL--ANLL-----GCCCEGDERLLVAEYMPNDTLA- 141 (372)
Q Consensus 70 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~- 141 (372)
-..||+++..+|+.|++|+.+.... ..+++..|...+..|...++ +..+ ..+......+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 4689999988999999999875433 35668888888877742222 1111 1234556788999999764321
Q ss_pred ----hh---------hh----cC---CCCCCCH----------------------HHHHHHHHHHHHHHHHhh-c--CCC
Q 017395 142 ----KH---------LF----HW---ETQPMKW----------------------AMRLRVALHIAEALEYCT-S--KER 176 (372)
Q Consensus 142 ----~~---------l~----~~---~~~~l~~----------------------~~~~~i~~qi~~al~~lH-~--~~~ 176 (372)
.+ ++ .. ....++. ......+.++...+.-.- . ..+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 00 00 0011111 112223333333332221 1 137
Q ss_pred cccccccCcceeecCCCCceeeccCCccc
Q 017395 177 ALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (372)
Q Consensus 177 iiH~Dikp~Nill~~~~~~kl~Dfg~~~~ 205 (372)
+||+|+.+.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.00052 Score=61.65 Aligned_cols=73 Identities=15% Similarity=0.255 Sum_probs=50.8
Q ss_pred ccccCCCCCCeEEEEEeCC--------CcEEEEEEcCCCCCccHHHHHHHHHHHhcCC-CcceeeEeeEEEeCCeeEEEE
Q 017395 62 VSEHGEKAPNVVYKGKLEN--------QFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (372)
Q Consensus 62 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 132 (372)
+++|+-|--..+|+....+ ...|.+++..... ......+|..+++.+. +.-.+++++++.. ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4677888889999998643 3567777765322 2334568888888885 4435678887743 7899
Q ss_pred ecCCCCCH
Q 017395 133 EYMPNDTL 140 (372)
Q Consensus 133 e~~~~gsL 140 (372)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.67 E-value=0.0031 Score=54.32 Aligned_cols=158 Identities=10% Similarity=-0.006 Sum_probs=81.9
Q ss_pred cCHHHHHHHhcCCCccccc--cccCCCCCCeEEEEEeCCCcEEEEEEcCCCCCccHHHHHHHHHHHhcCCC-----ccee
Q 017395 44 YSIETLRTATSGFAMENIV--SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN-----RRLA 116 (372)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----pniv 116 (372)
++.+++...-.+|+--.+. +.|..|--.+.|+.+..+| .+++|+..... +.+++..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4567777777666432333 3456676788999987666 48999986532 22334456666666532 2222
Q ss_pred eEe---eEEEeCCeeEEEEecCCCCCHHh--------------hhhc---C-C---CCCCCH------------------
Q 017395 117 NLL---GCCCEGDERLLVAEYMPNDTLAK--------------HLFH---W-E---TQPMKW------------------ 154 (372)
Q Consensus 117 ~l~---~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~---~-~---~~~l~~------------------ 154 (372)
... .+.........++.++.+..... .++. . . ......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 211 01223455667777776532211 0000 0 0 000000
Q ss_pred HHHHHHHHHHHHHHHHhhcC---CCcccccccCcceeecCCCCceeeccCCcc
Q 017395 155 AMRLRVALHIAEALEYCTSK---ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (372)
Q Consensus 155 ~~~~~i~~qi~~al~~lH~~---~~iiH~Dikp~Nill~~~~~~kl~Dfg~~~ 204 (372)
......+......+.-.+.. .|+||+|+.++||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01112222222333332221 389999999999999988777899999864
|